CPR:2	Binding of  bbbbb1 CHEMICALIN eeeee1  to m- bbbbb2 GENEIN eeeee2  in LNCaP cells resulted in a concentration-dependent stimulation of GENEIN expression, suggesting that CHEMICALIN acted as an agonist of the m-GENEIN
CPR:2	Analogous to the antiandrogens,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, binding of CHEMICALIN metabolites to the  bbbbb2 GENEIN eeeee2  was observed
CPR:2	Analogous to the antiandrogens, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , binding of CHEMICALIN metabolites to the  bbbbb2 GENEIN eeeee2  was observed
CPR:2	Analogous to the antiandrogens, CHEMICALIN and CHEMICALIN, binding of  bbbbb1 CHEMICALIN eeeee1  metabolites to the  bbbbb2 GENEIN eeeee2  was observed
CPR:3	Binding of  bbbbb1 CHEMICALIN eeeee1  to m-GENEIN in LNCaP cells resulted in a concentration-dependent stimulation of  bbbbb2 GENEIN eeeee2  expression, suggesting that CHEMICALIN acted as an agonist of the m-GENEIN
CPR:4	Down-regulation of  bbbbb1 GENEIN eeeee1  (GENEIN) expression, an GENEIN-target gene, by  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN was accompanied by the blockade of the mutated GENEIN
CPR:4	Down-regulation of GENEIN ( bbbbb1 GENEIN eeeee1 ) expression, an GENEIN-target gene, by  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN was accompanied by the blockade of the mutated GENEIN
CPR:4	Down-regulation of GENEIN (GENEIN) expression, an  bbbbb1 GENEIN eeeee1 -target gene, by  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN was accompanied by the blockade of the mutated GENEIN
CPR:4	Down-regulation of  bbbbb1 GENEIN eeeee1  (GENEIN) expression, an GENEIN-target gene, by CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  was accompanied by the blockade of the mutated GENEIN
CPR:4	Down-regulation of GENEIN ( bbbbb1 GENEIN eeeee1 ) expression, an GENEIN-target gene, by CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  was accompanied by the blockade of the mutated GENEIN
CPR:4	Down-regulation of GENEIN (GENEIN) expression, an  bbbbb1 GENEIN eeeee1 -target gene, by CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  was accompanied by the blockade of the mutated GENEIN
CPR:4	The levels of  bbbbb1 GENEIN eeeee1  mRNA decreased 56 and 90% when LNCaP cells were treated with 5 and 10 microM of  bbbbb2 CHEMICALIN eeeee2 , respectively (IC50 = 10.97 +/- 1.68 microM)
CPR:4	Down-regulation of GENEIN (GENEIN) expression, an GENEIN-target gene, by  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN was accompanied by the blockade of the mutated  bbbbb2 GENEIN eeeee2 
CPR:4	Down-regulation of GENEIN (GENEIN) expression, an GENEIN-target gene, by CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  was accompanied by the blockade of the mutated  bbbbb2 GENEIN eeeee2 
CPR:4	Exposure of LNCaP cells to  bbbbb1 CHEMICALIN eeeee1  for 24 hr caused transcriptional inhibition of  bbbbb2 GENEIN eeeee2  in a concentration-dependent manner
CPR:5	Binding of CHEMICALIN to m-GENEIN in LNCaP cells resulted in a concentration-dependent stimulation of GENEIN expression, suggesting that  bbbbb1 CHEMICALIN eeeee1  acted as an agonist of the m- bbbbb2 GENEIN eeeee2 
CPR:6	Our data indicate that  bbbbb1 CHEMICALIN eeeee1  metabolites perform as CHEMICALIN antagonists of  bbbbb2 GENEIN eeeee2 , an additional mechanism involved in the therapeutic effect of CHEMICALNOTIN in patients with prostate cancer.
CPR:6	Our data indicate that CHEMICALIN metabolites perform as  bbbbb1 CHEMICALIN eeeee1  antagonists of  bbbbb2 GENEIN eeeee2 , an additional mechanism involved in the therapeutic effect of CHEMICALNOTIN in patients with prostate cancer.
CPR:6	 bbbbb1 CHEMICALIN eeeee1  antagonistic effect of CHEMICALIN (CHEMICALIN) metabolites on wild-type and mutated  bbbbb2 GENEIN eeeee2 
CPR:6	CHEMICALIN antagonistic effect of  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) metabolites on wild-type and mutated  bbbbb2 GENEIN eeeee2 
CPR:6	CHEMICALIN antagonistic effect of CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) metabolites on wild-type and mutated  bbbbb2 GENEIN eeeee2 
CPR:4	In order to address one aspect of the feasibility of performing time-resolved studies on GENENOTIN, a data set has been collected using the Laue technique on a trigonal crystal of  bbbbb1 GENEIN eeeee1  soaked with the reversible inhibitor  bbbbb2 CHEMICALIN eeeee2 , using a total X-ray exposure time of 24 ms
CPR:4	The current study evaluates the effects of a selective  bbbbb1 GENEIN eeeee1  inhibitor ( bbbbb2 CHEMICALIN eeeee2 ) on renal function in cirrhotic rats with ascites
CPR:4	RESULTS: Administration of CHEMICALNOTIN to cirrhotic animals did not produce significant renal effects, whereas administration of the nonselective  bbbbb1 GENEIN eeeee1 /GENEIN inhibitor,  bbbbb2 CHEMICALIN eeeee2 , resulted in a marked reduction in urine volume, urinary excretion of CHEMICALIN, and glomerular filtration rate and in a significant impairment in renal water metabolism
CPR:4	RESULTS: Administration of CHEMICALNOTIN to cirrhotic animals did not produce significant renal effects, whereas administration of the nonselective GENEIN/ bbbbb1 GENEIN eeeee1  inhibitor,  bbbbb2 CHEMICALIN eeeee2 , resulted in a marked reduction in urine volume, urinary excretion of CHEMICALIN, and glomerular filtration rate and in a significant impairment in renal water metabolism
CPR:9	Selective inhibition of  bbbbb1 GENEIN eeeee1  spares renal function and  bbbbb2 CHEMICALIN eeeee2  synthesis in cirrhotic rats with ascites
CPR:9	RESULTS: Administration of CHEMICALNOTIN to cirrhotic animals did not produce significant renal effects, whereas administration of the nonselective  bbbbb1 GENEIN eeeee1 /GENEIN inhibitor, CHEMICALIN, resulted in a marked reduction in urine volume, urinary excretion of  bbbbb2 CHEMICALIN eeeee2 , and glomerular filtration rate and in a significant impairment in renal water metabolism
CPR:9	RESULTS: Administration of CHEMICALNOTIN to cirrhotic animals did not produce significant renal effects, whereas administration of the nonselective GENEIN/ bbbbb1 GENEIN eeeee1  inhibitor, CHEMICALIN, resulted in a marked reduction in urine volume, urinary excretion of  bbbbb2 CHEMICALIN eeeee2 , and glomerular filtration rate and in a significant impairment in renal water metabolism
CPR:2	By contrast, membrane expression of  bbbbb1 GENEIN eeeee1 , which was not minimal at 30 min, was substantial at 48 h for eosinophils treated with > 10(-)10 M  bbbbb2 CHEMICALIN eeeee2 , and inhibition of CHEMICALNOTIN synthesis was reversed by exogenous CHEMICALNOTIN (CHEMICALNOTIN)
CPR:2	 bbbbb1 CHEMICALIN eeeee1 /CHEMICALIN-stimulated translocation of  bbbbb2 GENEIN eeeee2  to the nuclear envelope assessed by specific immunohistochemical staining also was blocked by CHEMICALIN
CPR:2	CHEMICALIN/ bbbbb1 CHEMICALIN eeeee1 -stimulated translocation of  bbbbb2 GENEIN eeeee2  to the nuclear envelope assessed by specific immunohistochemical staining also was blocked by CHEMICALIN
CPR:2	Eosinophils were isolated from peripheral blood, treated with either buffer or 10(-)10 M to 10(-)6 M  bbbbb1 CHEMICALIN eeeee1  in the presence of 10 pg/ml  bbbbb2 GENEIN eeeee2  (GENEIN) and activated with CHEMICALIN (CHEMICALIN) + CHEMICALIN (CHEMICALIN)
CPR:2	Eosinophils were isolated from peripheral blood, treated with either buffer or 10(-)10 M to 10(-)6 M  bbbbb1 CHEMICALIN eeeee1  in the presence of 10 pg/ml GENEIN ( bbbbb2 GENEIN eeeee2 ) and activated with CHEMICALIN (CHEMICALIN) + CHEMICALIN (CHEMICALIN)
CPR:2	Eosinophils were isolated from peripheral blood, treated with either buffer or 10(-)10 M to 10(-)6 M CHEMICALIN in the presence of 10 pg/ml  bbbbb1 GENEIN eeeee1  (GENEIN) and activated with  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) + CHEMICALIN (CHEMICALIN)
CPR:2	Eosinophils were isolated from peripheral blood, treated with either buffer or 10(-)10 M to 10(-)6 M CHEMICALIN in the presence of 10 pg/ml GENEIN ( bbbbb1 GENEIN eeeee1 ) and activated with  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) + CHEMICALIN (CHEMICALIN)
CPR:2	Eosinophils were isolated from peripheral blood, treated with either buffer or 10(-)10 M to 10(-)6 M CHEMICALIN in the presence of 10 pg/ml  bbbbb1 GENEIN eeeee1  (GENEIN) and activated with CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) + CHEMICALIN (CHEMICALIN)
CPR:2	Eosinophils were isolated from peripheral blood, treated with either buffer or 10(-)10 M to 10(-)6 M CHEMICALIN in the presence of 10 pg/ml GENEIN ( bbbbb1 GENEIN eeeee1 ) and activated with CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) + CHEMICALIN (CHEMICALIN)
CPR:2	Eosinophils were isolated from peripheral blood, treated with either buffer or 10(-)10 M to 10(-)6 M CHEMICALIN in the presence of 10 pg/ml  bbbbb1 GENEIN eeeee1  (GENEIN) and activated with CHEMICALIN (CHEMICALIN) +  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN)
CPR:2	Eosinophils were isolated from peripheral blood, treated with either buffer or 10(-)10 M to 10(-)6 M CHEMICALIN in the presence of 10 pg/ml GENEIN ( bbbbb1 GENEIN eeeee1 ) and activated with CHEMICALIN (CHEMICALIN) +  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN)
CPR:2	Eosinophils were isolated from peripheral blood, treated with either buffer or 10(-)10 M to 10(-)6 M CHEMICALIN in the presence of 10 pg/ml  bbbbb1 GENEIN eeeee1  (GENEIN) and activated with CHEMICALIN (CHEMICALIN) + CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 )
CPR:2	Eosinophils were isolated from peripheral blood, treated with either buffer or 10(-)10 M to 10(-)6 M CHEMICALIN in the presence of 10 pg/ml GENEIN ( bbbbb1 GENEIN eeeee1 ) and activated with CHEMICALIN (CHEMICALIN) + CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 )
CPR:3	Inhibition of CHEMICALNOTIN synthesis precedes the global cytotoxic effects of  bbbbb1 CHEMICALIN eeeee1  as indicated by the simultaneous upregulation of  bbbbb2 GENEIN eeeee2  expression
CPR:4	CHEMICALIN/CHEMICALIN-stimulated translocation of  bbbbb1 GENEIN eeeee1  to the nuclear envelope assessed by specific immunohistochemical staining also was blocked by  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Inhibition of  bbbbb1 GENEIN eeeee1  translocation and CHEMICALNOTIN secretion by  bbbbb2 CHEMICALIN eeeee2  in exogenously activated human eosinophils
CPR:4	We find that  bbbbb1 CHEMICALIN eeeee1  causes a decrease in stimulated eosinophil secretion of CHEMICALIN that is regulated by  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:9	We find that CHEMICALIN causes a decrease in stimulated eosinophil secretion of  bbbbb1 CHEMICALIN eeeee1  that is regulated by  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:9	We find that CHEMICALIN causes a decrease in stimulated eosinophil secretion of  bbbbb1 CHEMICALIN eeeee1  that is regulated by GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:2	CHEMICALIN treatment decreases  bbbbb1 CHEMICALIN eeeee1  binding and  bbbbb2 GENEIN eeeee2  mRNA in SK-N-SHSY5Y cells
CPR:4	We conclude that decreased GENENOTIN synthesis may contribute to the chronic, but not acute, effect of  bbbbb1 CHEMICALIN eeeee1  to downregulate the  bbbbb2 GENEIN eeeee2 .
CPR:4	The antidepressant  bbbbb1 CHEMICALIN eeeee1  has been shown to decrease synaptic membrane concentrations of the GENEIN ( bbbbb2 GENEIN eeeee2 ) in vivo and in vitro, on both an acute and a chronic basis
CPR:4	The antidepressant  bbbbb1 CHEMICALIN eeeee1  has been shown to decrease synaptic membrane concentrations of the  bbbbb2 GENEIN eeeee2  (GENEIN) in vivo and in vitro, on both an acute and a chronic basis
CPR:4	 bbbbb1 CHEMICALIN eeeee1  treatment decreases CHEMICALIN binding and  bbbbb2 GENEIN eeeee2  mRNA in SK-N-SHSY5Y cells
CPR:2	These findings suggested affinity for open and/or inactivated channel states. 4 Inactivation was significantly accelerated by CHEMICALNOTIN in a concentration-dependent manner and there was a small (-7 mV) shift in the voltage dependence of steady state inactivation. 5 Channel blockade by CHEMICALNOTIN was modulated by [CHEMICALNOTIN]o, with a 26% reduction in the potency of channel blockade when [CHEMICALNOTIN]o was increased from 1 to 10 mM. 6 In conclusion,  bbbbb1 GENEIN eeeee1  channel inhibition by CHEMICALIN exhibits features consistent with open and inactivated state binding and is sensitive to external  bbbbb2 CHEMICALIN eeeee2  concentration
CPR:4	nhibition of the  bbbbb1 GENEIN eeeee1  by  bbbbb2 CHEMICALIN eeeee2 : affinity for open and inactivated states. 1 CHEMICALNOTIN is a prokinetic agent which has been associated with QT prolongation, torsades de pointes and cardiac arrest
CPR:4	These findings suggested affinity for open and/or inactivated channel states. 4 Inactivation was significantly accelerated by CHEMICALNOTIN in a concentration-dependent manner and there was a small (-7 mV) shift in the voltage dependence of steady state inactivation. 5 Channel blockade by CHEMICALNOTIN was modulated by [CHEMICALNOTIN]o, with a 26% reduction in the potency of channel blockade when [CHEMICALNOTIN]o was increased from 1 to 10 mM. 6 In conclusion,  bbbbb1 GENEIN eeeee1  channel inhibition by  bbbbb2 CHEMICALIN eeeee2  exhibits features consistent with open and inactivated state binding and is sensitive to external CHEMICALIN concentration
CPR:4	The cellular mechanism for these observations is high affinity blockade of GENENOTIN (encoded by GENENOTIN). 2 In a chronic transfection model using CHO-K1 cells,  bbbbb1 CHEMICALIN eeeee1  inhibited  bbbbb2 GENEIN eeeee2  tail currents after a step to +25 mV with similar potency at room and physiological temperatures (IC50 16. 4 nM at 20-22 degrees C and 23.6 nM at 37 degrees C). 3 Channel inhibition exhibited time-, voltage- and frequency-dependence
CPR:2	 bbbbb1 CHEMICALIN eeeee1  is a novel antipsychotic agent which binds with high affinity to GENEIN (Ki = 3.4 nM), in addition to  bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN sites
CPR:2	 bbbbb1 CHEMICALIN eeeee1  is a novel antipsychotic agent which binds with high affinity to GENEIN (Ki = 3.4 nM), in addition to GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN sites
CPR:2	 bbbbb1 CHEMICALIN eeeee1  is a novel antipsychotic agent which binds with high affinity to GENEIN (Ki = 3.4 nM), in addition to GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2  sites
CPR:2	 bbbbb1 CHEMICALIN eeeee1  is a novel antipsychotic agent which binds with high affinity to  bbbbb2 GENEIN eeeee2  (Ki = 3.4 nM), in addition to GENEIN, GENEIN, and GENEIN sites
CPR:2	The goal of the present study was to examine the  bbbbb1 GENEIN eeeee1  properties of  bbbbb2 CHEMICALIN eeeee2  in vivo using as a marker of central GENENOTIN activity the inhibition of firing of CHEMICALNOTIN-containing neurons in the dorsal raphe nucleus
CPR:2	Pretreatment with the  bbbbb1 GENEIN eeeee1  antagonist CHEMICALIN (10 micrograms/kg i.v.) prevented the  bbbbb2 CHEMICALIN eeeee2 -induced inhibition; the same dose of CHEMICALIN had little effect on the inhibition produced by CHEMICALIN and CHEMICALIN
CPR:2	Pretreatment with the  bbbbb1 GENEIN eeeee1  antagonist CHEMICALIN (10 micrograms/kg i.v.) prevented the CHEMICALIN-induced inhibition; the same dose of CHEMICALIN had little effect on the inhibition produced by  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:2	Pretreatment with the  bbbbb1 GENEIN eeeee1  antagonist CHEMICALIN (10 micrograms/kg i.v.) prevented the CHEMICALIN-induced inhibition; the same dose of CHEMICALIN had little effect on the inhibition produced by CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:2	Comparison of the novel antipsychotic  bbbbb1 CHEMICALIN eeeee1  with CHEMICALIN and CHEMICALIN: inhibition of dorsal raphe cell firing and the role of  bbbbb2 GENEIN eeeee2  activation
CPR:2	Comparison of the novel antipsychotic CHEMICALIN with  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN: inhibition of dorsal raphe cell firing and the role of  bbbbb2 GENEIN eeeee2  activation
CPR:2	Comparison of the novel antipsychotic CHEMICALIN with CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 : inhibition of dorsal raphe cell firing and the role of  bbbbb2 GENEIN eeeee2  activation
CPR:5	These profiles suggest a mechanism of action for each agent,  bbbbb1 GENEIN eeeee1  agonism for  bbbbb2 CHEMICALIN eeeee2  and alpha 1 antagonism for CHEMICALNOTIN and CHEMICALNOTIN
CPR:5	The  bbbbb1 GENEIN eeeee1  agonist activity reported here clearly distinguishes  bbbbb2 CHEMICALIN eeeee2  from currently available antipsychotic agents and suggests that this property may play a significant role in its pharmacologic actions.
CPR:5	While it is an antagonist at these latter receptors,  bbbbb1 CHEMICALIN eeeee1  behaves as a  bbbbb2 GENEIN eeeee2  agonist in vitro in GENENOTIN measurements
CPR:6	Pretreatment with the  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2  (10 micrograms/kg i.v.) prevented the CHEMICALIN-induced inhibition; the same dose of CHEMICALIN had little effect on the inhibition produced by CHEMICALIN and CHEMICALIN
CPR:6	Pretreatment with the  bbbbb1 GENEIN eeeee1  antagonist CHEMICALIN (10 micrograms/kg i.v.) prevented the CHEMICALIN-induced inhibition; the same dose of  bbbbb2 CHEMICALIN eeeee2  had little effect on the inhibition produced by CHEMICALIN and CHEMICALIN
CPR:4	The nonselective and irreversible  bbbbb1 GENEIN eeeee1  inhibitors,  bbbbb2 CHEMICALIN eeeee2  (3-10 mg/kg), CHEMICALIN (1-3 mg/kg), and CHEMICALIN (30 mg/kg), decreased rates of responding maintained by CHEMICALNOTIN reinforcement
CPR:4	The nonselective and irreversible  bbbbb1 GENEIN eeeee1  inhibitors, CHEMICALIN (3-10 mg/kg),  bbbbb2 CHEMICALIN eeeee2  (1-3 mg/kg), and CHEMICALIN (30 mg/kg), decreased rates of responding maintained by CHEMICALNOTIN reinforcement
CPR:4	The nonselective and irreversible  bbbbb1 GENEIN eeeee1  inhibitors, CHEMICALIN (3-10 mg/kg), CHEMICALIN (1-3 mg/kg), and  bbbbb2 CHEMICALIN eeeee2  (30 mg/kg), decreased rates of responding maintained by CHEMICALNOTIN reinforcement
CPR:4	The irreversible  bbbbb1 GENEIN eeeee1  inhibitors,  bbbbb2 CHEMICALIN eeeee2  (30 mg/kg) and CHEMICALIN (3-10 mg/kg) also decreased responding maintained by CHEMICALNOTIN reinforcement; these results are consistent with previous findings that both drugs decreased CHEMICALNOTIN intake in mice
CPR:4	The reversible  bbbbb1 GENEIN eeeee1  inhibitor,  bbbbb2 CHEMICALIN eeeee2  (0.3-3 mg/kg), and the irreversible GENEIN inhibitor, CHEMICALIN (10-30 mg/kg), also reduced CHEMICALNOTIN self-administration
CPR:4	The reversible GENEIN inhibitor, CHEMICALIN (0.3-3 mg/kg), and the irreversible  bbbbb1 GENEIN eeeee1  inhibitor,  bbbbb2 CHEMICALIN eeeee2  (10-30 mg/kg), also reduced CHEMICALNOTIN self-administration
CPR:4	The irreversible  bbbbb1 GENEIN eeeee1  inhibitors, CHEMICALIN (30 mg/kg) and  bbbbb2 CHEMICALIN eeeee2  (3-10 mg/kg) also decreased responding maintained by CHEMICALNOTIN reinforcement; these results are consistent with previous findings that both drugs decreased CHEMICALNOTIN intake in mice
CPR:4	 bbbbb1 CHEMICALIN eeeee1 , a potent inhibitor of  bbbbb2 GENEIN eeeee2 , at high concentration (500 microm ) caused only a 72% decrease in the utilization of CHEMICALNOTIN
CPR:2	A novel missense mutation,  bbbbb1 GENEIN eeeee1 , in exon 5 of the GENEIN gene (GENEIN) was identified in a Japanese male with  bbbbb2 CHEMICALIN eeeee2 -responsive sideroblastic anemia
CPR:2	A novel missense mutation, GENEIN, in exon 5 of the  bbbbb1 GENEIN eeeee1  gene (GENEIN) was identified in a Japanese male with  bbbbb2 CHEMICALIN eeeee2 -responsive sideroblastic anemia
CPR:2	A novel missense mutation, GENEIN, in exon 5 of the GENEIN gene ( bbbbb1 GENEIN eeeee1 ) was identified in a Japanese male with  bbbbb2 CHEMICALIN eeeee2 -responsive sideroblastic anemia
CPR:2	Activity of the mutant  bbbbb1 GENEIN eeeee1  protein expressed in vitro was 15.1% compared with the normal control, but was increased up to 34.5% by the addition of CHEMICALIN, consistent with the clinical response of the patient to  bbbbb2 CHEMICALIN eeeee2  treatment
CPR:2	A novel mutation of the  bbbbb1 GENEIN eeeee1  gene in a patient with non-inherited  bbbbb2 CHEMICALIN eeeee2 -responsive sideroblastic anemia
CPR:3	Activity of the mutant  bbbbb1 GENEIN eeeee1  protein expressed in vitro was 15.1% compared with the normal control, but was increased up to 34.5% by the addition of  bbbbb2 CHEMICALIN eeeee2 , consistent with the clinical response of the patient to CHEMICALIN treatment
CPR:4	Preferential cerebrospinal fluid  bbbbb1 GENEIN eeeee1  inhibition by  bbbbb2 CHEMICALIN eeeee2  in humans
CPR:4	Inhibition of  bbbbb1 GENEIN eeeee1  in the CSF after  bbbbb2 CHEMICALIN eeeee2  administration was significantly greater than after placebo for up to 8.4 hours after the dose and was maximal (40%) at 2.4 hours
CPR:4	Plasma  bbbbb1 GENEIN eeeee1  activity was significantly lower after  bbbbb2 CHEMICALIN eeeee2  than after placebo, but this was not clinically relevant
CPR:4	 bbbbb1 GENEIN eeeee1  activity in CSF was significantly lower after  bbbbb2 CHEMICALIN eeeee2  than after placebo for up to 3.6 hours after dosing, but this difference was not sustained
CPR:4	This study confirms the feasibility of using continuous measurement of GENENOTIN activity in CSF over prolonged periods, that  bbbbb1 CHEMICALIN eeeee1  markedly inhibits CSF  bbbbb2 GENEIN eeeee2  after a single oral dose of 3 mg, and that the inhibition of central GENEIN is substantially greater than that of peripheral GENEIN or GENEIN.
CPR:4	This study confirms the feasibility of using continuous measurement of GENENOTIN activity in CSF over prolonged periods, that  bbbbb1 CHEMICALIN eeeee1  markedly inhibits CSF GENEIN after a single oral dose of 3 mg, and that the inhibition of central  bbbbb2 GENEIN eeeee2  is substantially greater than that of peripheral GENEIN or GENEIN.
CPR:4	This study confirms the feasibility of using continuous measurement of GENENOTIN activity in CSF over prolonged periods, that  bbbbb1 CHEMICALIN eeeee1  markedly inhibits CSF GENEIN after a single oral dose of 3 mg, and that the inhibition of central GENEIN is substantially greater than that of peripheral  bbbbb2 GENEIN eeeee2  or GENEIN.
CPR:4	This study confirms the feasibility of using continuous measurement of GENENOTIN activity in CSF over prolonged periods, that  bbbbb1 CHEMICALIN eeeee1  markedly inhibits CSF GENEIN after a single oral dose of 3 mg, and that the inhibition of central GENEIN is substantially greater than that of peripheral GENEIN or  bbbbb2 GENEIN eeeee2 .
CPR:1	 bbbbb1 CHEMICALIN eeeee1  between Ile(183) and Val(191) are necessary for proper  bbbbb2 GENEIN eeeee2  activation, but additional sequence between Ser(195) and Ile(197) or between Phe(260) and Ser(265) is required for complete restoration of activation.
CPR:1	To identify key  bbbbb1 CHEMICALIN eeeee1  involved in  bbbbb2 GENEIN eeeee2  activation, recombinant GENEIN proteins containing CHEMICALIN substitutions for wild-type sequence were expressed in 293 fibroblasts and tested in a plasma clotting assay
CPR:1	To identify key CHEMICALIN involved in GENEIN activation, recombinant  bbbbb1 GENEIN eeeee1  proteins containing  bbbbb2 CHEMICALIN eeeee2  substitutions for wild-type sequence were expressed in 293 fibroblasts and tested in a plasma clotting assay
CPR:1	Substitutions for Ile(183)-Val(191) and Ser(195)-Ile(197) at the  bbbbb1 CHEMICALIN eeeee1  terminus and for Ser(258)-Ser(264) at the CHEMICALIN terminus of the  bbbbb2 GENEIN eeeee2  markedly decreased GENENOTIN coagulant activity
CPR:1	Substitutions for Ile(183)-Val(191) and Ser(195)-Ile(197) at the CHEMICALIN terminus and for Ser(258)-Ser(264) at the  bbbbb1 CHEMICALIN eeeee1  terminus of the  bbbbb2 GENEIN eeeee2  markedly decreased GENENOTIN coagulant activity
CPR:1	Identification of  bbbbb1 CHEMICALIN eeeee1  in the  bbbbb2 GENEIN eeeee2  required for activation of GENEIN
CPR:1	Identification of  bbbbb1 CHEMICALIN eeeee1  in the GENEIN required for activation of  bbbbb2 GENEIN eeeee2 
CPR:2	 bbbbb1 CHEMICALIN eeeee1  displays marked affinity at GENENOTIN, significant affinity for  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN, and GENEIN and weak affinity for GENEIN
CPR:2	 bbbbb1 CHEMICALIN eeeee1  displays marked affinity at GENENOTIN, significant affinity for GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN and weak affinity for GENEIN
CPR:2	 bbbbb1 CHEMICALIN eeeee1  displays marked affinity at GENENOTIN, significant affinity for GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN and weak affinity for GENEIN
CPR:2	 bbbbb1 CHEMICALIN eeeee1  displays marked affinity at GENENOTIN, significant affinity for GENEIN, GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2  and weak affinity for GENEIN
CPR:2	 bbbbb1 CHEMICALIN eeeee1  displays marked affinity at GENENOTIN, significant affinity for GENEIN, GENEIN, GENEIN, and GENEIN and weak affinity for  bbbbb2 GENEIN eeeee2 
CPR:2	In [ bbbbb1 CHEMICALIN eeeee1 ]GTPgammaS binding protocols, CHEMICALIN exerts antagonist actions at  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN, and GENEIN sites, yet partial agonist actions at GENEIN sites
CPR:2	In [ bbbbb1 CHEMICALIN eeeee1 ]GTPgammaS binding protocols, CHEMICALIN exerts antagonist actions at GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN sites, yet partial agonist actions at GENEIN sites
CPR:2	In [ bbbbb1 CHEMICALIN eeeee1 ]GTPgammaS binding protocols, CHEMICALIN exerts antagonist actions at GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN sites, yet partial agonist actions at GENEIN sites
CPR:2	In [ bbbbb1 CHEMICALIN eeeee1 ]GTPgammaS binding protocols, CHEMICALIN exerts antagonist actions at GENEIN, GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2  sites, yet partial agonist actions at GENEIN sites
CPR:2	In [ bbbbb1 CHEMICALIN eeeee1 ]GTPgammaS binding protocols, CHEMICALIN exerts antagonist actions at GENEIN, GENEIN, GENEIN, and GENEIN sites, yet partial agonist actions at  bbbbb2 GENEIN eeeee2  sites
CPR:2	Herein, we evaluate the interaction of the GENEIN,  bbbbb1 CHEMICALIN eeeee1 , as compared to CHEMICALIN, at multiple  bbbbb2 GENEIN eeeee2  and examine their roles in the modulation of adrenergic, dopaminergic and serotonergic transmission in freely-moving rats
CPR:2	Herein, we evaluate the interaction of the GENEIN, CHEMICALIN, as compared to  bbbbb1 CHEMICALIN eeeee1 , at multiple  bbbbb2 GENEIN eeeee2  and examine their roles in the modulation of adrenergic, dopaminergic and serotonergic transmission in freely-moving rats
CPR:5	However, in contrast to the selective GENEIN antagonist, CHEMICALIN, the  bbbbb1 GENEIN eeeee1  agonist actions of  bbbbb2 CHEMICALIN eeeee2  suppress CHEMICALNOTIN levels alone and underlie its inability to augment the influence of CHEMICALNOTIN upon CHEMICALNOTIN levels.
CPR:5	In [CHEMICALIN]GTPgammaS binding protocols,  bbbbb1 CHEMICALIN eeeee1  exerts antagonist actions at GENEIN, GENEIN, GENEIN, and GENEIN sites, yet partial agonist actions at  bbbbb2 GENEIN eeeee2  sites
CPR:5	In vivo, agonist actions of  bbbbb1 CHEMICALIN eeeee1  at  bbbbb2 GENEIN eeeee2  sites are revealed by CHEMICALIN-reversible induction of hypothermia in the rat
CPR:5	In guinea pigs, antagonist actions of CHEMICALIN at GENEIN receptors are revealed by blockade of hypothermia evoked by the  bbbbb1 GENEIN eeeee1  agonist,  bbbbb2 CHEMICALIN eeeee2 
CPR:5	In distinction to  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN shows only modest partial agonist actions at  bbbbb2 GENEIN eeeee2  sites versus marked antagonist actions at GENEIN
CPR:5	In distinction to CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  shows only modest partial agonist actions at  bbbbb2 GENEIN eeeee2  sites versus marked antagonist actions at GENEIN
CPR:5	Agonist and antagonist actions of  bbbbb1 CHEMICALIN eeeee1  as compared to CHEMICALIN at GENEIN  bbbbb2 GENEIN eeeee2 , CHEMICALNOTIN GENEIN, GENEIN, GENEIN and GENENOTIN
CPR:5	Agonist and antagonist actions of  bbbbb1 CHEMICALIN eeeee1  as compared to CHEMICALIN at GENEIN GENEIN, CHEMICALNOTIN  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN and GENENOTIN
CPR:5	Agonist and antagonist actions of  bbbbb1 CHEMICALIN eeeee1  as compared to CHEMICALIN at GENEIN GENEIN, CHEMICALNOTIN GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN and GENENOTIN
CPR:5	Agonist and antagonist actions of  bbbbb1 CHEMICALIN eeeee1  as compared to CHEMICALIN at GENEIN GENEIN, CHEMICALNOTIN GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2  and GENENOTIN
CPR:5	Agonist and antagonist actions of  bbbbb1 CHEMICALIN eeeee1  as compared to CHEMICALIN at  bbbbb2 GENEIN eeeee2  GENEIN, CHEMICALNOTIN GENEIN, GENEIN, GENEIN and GENENOTIN
CPR:5	Agonist and antagonist actions of CHEMICALIN as compared to  bbbbb1 CHEMICALIN eeeee1  at GENEIN  bbbbb2 GENEIN eeeee2 , CHEMICALNOTIN GENEIN, GENEIN, GENEIN and GENENOTIN
CPR:5	Agonist and antagonist actions of CHEMICALIN as compared to  bbbbb1 CHEMICALIN eeeee1  at  bbbbb2 GENEIN eeeee2  GENEIN, CHEMICALNOTIN GENEIN, GENEIN, GENEIN and GENENOTIN
CPR:6	In conclusion, the  bbbbb1 GENEIN eeeee1  antagonist properties of  bbbbb2 CHEMICALIN eeeee2  increase CHEMICALNOTIN and CHEMICALNOTIN levels both alone and in association with fluoxetine
CPR:6	However, in contrast to the selective  bbbbb1 GENEIN eeeee1  antagonist,  bbbbb2 CHEMICALIN eeeee2 , the GENEIN agonist actions of CHEMICALIN suppress CHEMICALNOTIN levels alone and underlie its inability to augment the influence of CHEMICALNOTIN upon CHEMICALNOTIN levels.
CPR:6	In [CHEMICALIN]GTPgammaS binding protocols,  bbbbb1 CHEMICALIN eeeee1  exerts antagonist actions at  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN, and GENEIN sites, yet partial agonist actions at GENEIN sites
CPR:6	In [CHEMICALIN]GTPgammaS binding protocols,  bbbbb1 CHEMICALIN eeeee1  exerts antagonist actions at GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN sites, yet partial agonist actions at GENEIN sites
CPR:6	In [CHEMICALIN]GTPgammaS binding protocols,  bbbbb1 CHEMICALIN eeeee1  exerts antagonist actions at GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN sites, yet partial agonist actions at GENEIN sites
CPR:6	In [CHEMICALIN]GTPgammaS binding protocols,  bbbbb1 CHEMICALIN eeeee1  exerts antagonist actions at GENEIN, GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2  sites, yet partial agonist actions at GENEIN sites
CPR:6	Herein, we evaluate the interaction of the  bbbbb1 GENEIN eeeee1 ,  bbbbb2 CHEMICALIN eeeee2 , as compared to CHEMICALIN, at multiple GENEIN and examine their roles in the modulation of adrenergic, dopaminergic and serotonergic transmission in freely-moving rats
CPR:6	In vivo, agonist actions of CHEMICALIN at  bbbbb1 GENEIN eeeee1  sites are revealed by  bbbbb2 CHEMICALIN eeeee2 -reversible induction of hypothermia in the rat
CPR:6	In guinea pigs, antagonist actions of  bbbbb1 CHEMICALIN eeeee1  at  bbbbb2 GENEIN eeeee2  receptors are revealed by blockade of hypothermia evoked by the GENEIN agonist, CHEMICALIN
CPR:6	Herein, we evaluate the interaction of the  bbbbb1 GENEIN eeeee1 , CHEMICALIN, as compared to  bbbbb2 CHEMICALIN eeeee2 , at multiple GENEIN and examine their roles in the modulation of adrenergic, dopaminergic and serotonergic transmission in freely-moving rats
CPR:6	In distinction to  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN shows only modest partial agonist actions at GENEIN sites versus marked antagonist actions at  bbbbb2 GENEIN eeeee2 
CPR:6	In distinction to CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  shows only modest partial agonist actions at GENEIN sites versus marked antagonist actions at  bbbbb2 GENEIN eeeee2 
CPR:6	Agonist and antagonist actions of  bbbbb1 CHEMICALIN eeeee1  as compared to CHEMICALIN at GENEIN  bbbbb2 GENEIN eeeee2 , CHEMICALNOTIN GENEIN, GENEIN, GENEIN and GENENOTIN
CPR:6	Agonist and antagonist actions of  bbbbb1 CHEMICALIN eeeee1  as compared to CHEMICALIN at GENEIN GENEIN, CHEMICALNOTIN  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN and GENENOTIN
CPR:6	Agonist and antagonist actions of  bbbbb1 CHEMICALIN eeeee1  as compared to CHEMICALIN at GENEIN GENEIN, CHEMICALNOTIN GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN and GENENOTIN
CPR:6	Agonist and antagonist actions of  bbbbb1 CHEMICALIN eeeee1  as compared to CHEMICALIN at GENEIN GENEIN, CHEMICALNOTIN GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2  and GENENOTIN
CPR:6	Agonist and antagonist actions of  bbbbb1 CHEMICALIN eeeee1  as compared to CHEMICALIN at  bbbbb2 GENEIN eeeee2  GENEIN, CHEMICALNOTIN GENEIN, GENEIN, GENEIN and GENENOTIN
CPR:6	Agonist and antagonist actions of CHEMICALIN as compared to  bbbbb1 CHEMICALIN eeeee1  at GENEIN  bbbbb2 GENEIN eeeee2 , CHEMICALNOTIN GENEIN, GENEIN, GENEIN and GENENOTIN
CPR:6	Agonist and antagonist actions of CHEMICALIN as compared to  bbbbb1 CHEMICALIN eeeee1  at  bbbbb2 GENEIN eeeee2  GENEIN, CHEMICALNOTIN GENEIN, GENEIN, GENEIN and GENENOTIN
CPR:5	Parenteral administration of selective agonists of the GENEIN (CHEMICALIN), GENEIN (CHEMICALIN and CHEMICALIN), and  bbbbb1 GENEIN eeeee1  ( bbbbb2 CHEMICALIN eeeee2 ) produced dose-related inhibition of CHEMICALNOTIN-induced cough with ED(50) values of 7.3, 5.2, 5.1, and 5.3 mg/kg, respectively
CPR:5	The nonselective  bbbbb1 GENEIN eeeee1  antagonist, CHEMICALIN (3 mg/kg, i.m.), attenuated the antitussive effects of  bbbbb2 CHEMICALIN eeeee2  or CHEMICALIN, indicating that the antitussive activity of both compounds is GENEIN-mediated
CPR:5	The nonselective GENEIN antagonist, CHEMICALIN (3 mg/kg, i.m.), attenuated the antitussive effects of  bbbbb1 CHEMICALIN eeeee1  or CHEMICALIN, indicating that the antitussive activity of both compounds is  bbbbb2 GENEIN eeeee2 -mediated
CPR:5	The nonselective  bbbbb1 GENEIN eeeee1  antagonist, CHEMICALIN (3 mg/kg, i.m.), attenuated the antitussive effects of CHEMICALIN or  bbbbb2 CHEMICALIN eeeee2 , indicating that the antitussive activity of both compounds is GENEIN-mediated
CPR:5	The nonselective GENEIN antagonist, CHEMICALIN (3 mg/kg, i.m.), attenuated the antitussive effects of CHEMICALIN or  bbbbb1 CHEMICALIN eeeee1 , indicating that the antitussive activity of both compounds is  bbbbb2 GENEIN eeeee2 -mediated
CPR:5	The  bbbbb1 GENEIN eeeee1  antagonist, CHEMICALIN (10 mg/kg, i.p.), inhibited the antitussive effect of  bbbbb2 CHEMICALIN eeeee2  (20 mg/kg, i.p.)
CPR:5	In this study, the activity of the  bbbbb1 GENEIN eeeee1  subtype-selective agonist,  bbbbb2 CHEMICALIN eeeee2 , was investigated in a guinea pig model of CHEMICALNOTIN-induced cough
CPR:5	The  bbbbb1 GENEIN eeeee1  antagonist CHEMICALIN (3 mg/kg, i.p.) inhibited the antitussive effect of  bbbbb2 CHEMICALIN eeeee2  (30 mg/kg, i.p.), a sigma-receptor agonist, but not that of CHEMICALNOTIN
CPR:5	These studies provide compelling evidence that the antitussive effects of  bbbbb1 CHEMICALIN eeeee1  in this guinea pig cough model are mediated by agonist activity at the  bbbbb2 GENEIN eeeee2 .
CPR:5	Parenteral administration of selective agonists of the  bbbbb1 GENEIN eeeee1  ( bbbbb2 CHEMICALIN eeeee2 ), GENEIN (CHEMICALIN and CHEMICALIN), and GENEIN (CHEMICALIN) produced dose-related inhibition of CHEMICALNOTIN-induced cough with ED(50) values of 7.3, 5.2, 5.1, and 5.3 mg/kg, respectively
CPR:5	Parenteral administration of selective agonists of the GENEIN (CHEMICALIN),  bbbbb1 GENEIN eeeee1  ( bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN), and GENEIN (CHEMICALIN) produced dose-related inhibition of CHEMICALNOTIN-induced cough with ED(50) values of 7.3, 5.2, 5.1, and 5.3 mg/kg, respectively
CPR:5	Parenteral administration of selective agonists of the GENEIN (CHEMICALIN),  bbbbb1 GENEIN eeeee1  (CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 ), and GENEIN (CHEMICALIN) produced dose-related inhibition of CHEMICALNOTIN-induced cough with ED(50) values of 7.3, 5.2, 5.1, and 5.3 mg/kg, respectively
CPR:6	The nonselective  bbbbb1 GENEIN eeeee1  antagonist,  bbbbb2 CHEMICALIN eeeee2  (3 mg/kg, i.m.), attenuated the antitussive effects of CHEMICALIN or CHEMICALIN, indicating that the antitussive activity of both compounds is GENEIN-mediated
CPR:6	The  bbbbb1 GENEIN eeeee1  antagonist,  bbbbb2 CHEMICALIN eeeee2  (10 mg/kg, i.p.), inhibited the antitussive effect of CHEMICALIN (20 mg/kg, i.p.)
CPR:6	In contrast, combined pretreatment with  bbbbb1 CHEMICALIN eeeee1  ( bbbbb2 GENEIN eeeee2  antagonist; 20 mg/kg, s.c.) and CHEMICALIN (GENEIN antagonist; 20 mg/kg, s.c.), at doses that inhibited the antitussive activity of GENENOTIN agonists, respectively, was without effect on the antitussive response of CHEMICALNOTIN (20 mg/kg, i.p.)
CPR:6	In contrast, combined pretreatment with CHEMICALIN (GENEIN antagonist; 20 mg/kg, s.c.) and  bbbbb1 CHEMICALIN eeeee1  ( bbbbb2 GENEIN eeeee2  antagonist; 20 mg/kg, s.c.), at doses that inhibited the antitussive activity of GENENOTIN agonists, respectively, was without effect on the antitussive response of CHEMICALNOTIN (20 mg/kg, i.p.)
CPR:6	The  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2  (3 mg/kg, i.p.) inhibited the antitussive effect of CHEMICALIN (30 mg/kg, i.p.), a sigma-receptor agonist, but not that of CHEMICALNOTIN
CPR:4	New modes of therapy have recently been introduced, and data on the  bbbbb1 GENEIN eeeee1  (GENEIN)-specific inhibitors  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN suggest that these agents will meet the need for safe and effective therapeutic alternatives to conventional NSAIDs.
CPR:4	New modes of therapy have recently been introduced, and data on the GENEIN ( bbbbb1 GENEIN eeeee1 )-specific inhibitors  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN suggest that these agents will meet the need for safe and effective therapeutic alternatives to conventional NSAIDs.
CPR:4	New modes of therapy have recently been introduced, and data on the  bbbbb1 GENEIN eeeee1  (GENEIN)-specific inhibitors CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  suggest that these agents will meet the need for safe and effective therapeutic alternatives to conventional NSAIDs.
CPR:4	New modes of therapy have recently been introduced, and data on the GENEIN ( bbbbb1 GENEIN eeeee1 )-specific inhibitors CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  suggest that these agents will meet the need for safe and effective therapeutic alternatives to conventional NSAIDs.
CPR:4	 bbbbb1 CHEMICALIN eeeee1  was found to be a time-dependent inhibitor of the rat enzyme, with the lowest inhibition constant (Ki* = 0.77 nM) determined so far for  bbbbb2 GENEIN eeeee2 
CPR:4	Another inhibitor,  bbbbb1 CHEMICALIN eeeee1  was previously reported to be a slow-binding inhibitor of the  bbbbb2 GENEIN eeeee2  [W
CPR:4	Loffler, Species-related inhibition of  bbbbb1 GENEIN eeeee1  by immunosuppressive  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN derivatives, Biochem
CPR:4	Loffler, Species-related inhibition of  bbbbb1 GENEIN eeeee1  by immunosuppressive CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  derivatives, Biochem
CPR:4	With respect to the substrate  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN was an uncompetitive inhibitor of  bbbbb2 GENEIN eeeee2  (Kiu = 11.6 microM) and a non-competitive inhibitor of the rat enzyme (Kiu = 905/ Kic = 1,012 nM). 1.5 mM CHEMICALNOTIN, a natural CHEMICALNOTIN from fungi, influenced the activity of the human enzyme only slightly; the activity of the rat enzyme was decreased by 30%
CPR:4	With respect to the substrate CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  was an uncompetitive inhibitor of  bbbbb2 GENEIN eeeee2  (Kiu = 11.6 microM) and a non-competitive inhibitor of the rat enzyme (Kiu = 905/ Kic = 1,012 nM). 1.5 mM CHEMICALNOTIN, a natural CHEMICALNOTIN from fungi, influenced the activity of the human enzyme only slightly; the activity of the rat enzyme was decreased by 30%
CPR:4	Kinetics of inhibition of  bbbbb1 GENEIN eeeee1  by CHEMICALIN, CHEMICALIN derivatives,  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:4	Kinetics of inhibition of  bbbbb1 GENEIN eeeee1  by CHEMICALIN, CHEMICALIN derivatives, CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Kinetics of inhibition of  bbbbb1 GENEIN eeeee1  by  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN derivatives, CHEMICALIN and CHEMICALIN
CPR:4	Kinetics of inhibition of  bbbbb1 GENEIN eeeee1  by CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2  derivatives, CHEMICALIN and CHEMICALIN
CPR:4	With respect to the CHEMICALIN co-substrate of the GENEIN,  bbbbb1 CHEMICALIN eeeee1  (Kic = 2.7 microM) and CHEMICALIN (Kic = 9.8 nM) were shown to be competitive inhibitors of  bbbbb2 GENEIN eeeee2 
CPR:4	With respect to the CHEMICALIN co-substrate of the GENEIN, CHEMICALIN (Kic = 2.7 microM) and  bbbbb1 CHEMICALIN eeeee1  (Kic = 9.8 nM) were shown to be competitive inhibitors of  bbbbb2 GENEIN eeeee2 
CPR:9	Mitochondrially-bound  bbbbb1 GENEIN eeeee1  (GENEIN) catalyzes the fourth sequential step in the de novo synthesis of  bbbbb2 CHEMICALIN eeeee2 
CPR:9	Mitochondrially-bound GENEIN ( bbbbb1 GENEIN eeeee1 ) catalyzes the fourth sequential step in the de novo synthesis of  bbbbb2 CHEMICALIN eeeee2 
CPR:9	With respect to the  bbbbb1 CHEMICALIN eeeee1  co-substrate of the  bbbbb2 GENEIN eeeee2 , CHEMICALIN (Kic = 2.7 microM) and CHEMICALIN (Kic = 9.8 nM) were shown to be competitive inhibitors of GENEIN
CPR:2	METHODS AND RESULTS: The effect of intravenous  bbbbb1 CHEMICALIN eeeee1  (1 mg/kg), CHEMICALIN (10 mg/kg), or CHEMICALIN (2 mg/kg) on the ECG was studied in 34 patients with the syndrome and transient normalization of the ECG (group A), 11 members of 3 families in whom a  bbbbb2 GENEIN eeeee2  mutation was associated with the syndrome and 8 members in whom it was not (group B), and 53 control subjects (group C)
CPR:2	METHODS AND RESULTS: The effect of intravenous CHEMICALIN (1 mg/kg),  bbbbb1 CHEMICALIN eeeee1  (10 mg/kg), or CHEMICALIN (2 mg/kg) on the ECG was studied in 34 patients with the syndrome and transient normalization of the ECG (group A), 11 members of 3 families in whom a  bbbbb2 GENEIN eeeee2  mutation was associated with the syndrome and 8 members in whom it was not (group B), and 53 control subjects (group C)
CPR:2	METHODS AND RESULTS: The effect of intravenous CHEMICALIN (1 mg/kg), CHEMICALIN (10 mg/kg), or  bbbbb1 CHEMICALIN eeeee1  (2 mg/kg) on the ECG was studied in 34 patients with the syndrome and transient normalization of the ECG (group A), 11 members of 3 families in whom a  bbbbb2 GENEIN eeeee2  mutation was associated with the syndrome and 8 members in whom it was not (group B), and 53 control subjects (group C)
CPR:2	To further analyze the mechanism governing the  bbbbb1 GENEIN eeeee1 - bbbbb2 CHEMICALIN eeeee2  interaction, we examined the effect of CHEMICALNOTIN on various recombinant GENENOTIN expressed in mammalian cells from their cloned cDNAs, using CHEMICALNOTIN as the permeant ion at physiological concentration
CPR:2	Therefore, we conclude that the tissue and sub-cellular localization of  bbbbb1 GENEIN eeeee1  subunits as well as their specific associations are essential parameters to understand the in vivo effects of  bbbbb2 CHEMICALIN eeeee2 .
CPR:4	 bbbbb1 CHEMICALIN eeeee1  blocked alpha1A and alpha1E with a Kd comparable to that reported for  bbbbb2 GENEIN eeeee2 , but had a lower affinity (approximately 30-fold) for alpha1C
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) belongs to a new chemical class of these molecules which differs from other CHEMICALNOTIN antagonists by its ability to potently block  bbbbb2 GENEIN eeeee2 
CPR:4	Determinants of voltage-dependent inactivation affect  bbbbb1 CHEMICALIN eeeee1  block of  bbbbb2 GENEIN eeeee2 
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) belongs to a new chemical class of these molecules which differs from other CHEMICALNOTIN antagonists by its ability to potently block  bbbbb2 GENEIN eeeee2 
CPR:4	Postoperative concentrations of  bbbbb1 GENEIN eeeee1  were decreased significantly in the  bbbbb2 CHEMICALIN eeeee2  group (P < 0.001)
CPR:5	Iontophoresis of  bbbbb1 CHEMICALIN eeeee1 , whose serotonergic actions include antagonism and partial agonism at  bbbbb2 GENEIN eeeee2  receptors, also increased CHEMICALNOTIN and decreased firing (n=4)
CPR:6	 bbbbb1 CHEMICALIN eeeee1  (intravenous, 1 mg/kg), whose serotonergic actions include  bbbbb2 GENEIN eeeee2  and GENEIN antagonism, typically raised CHEMICALNOTIN levels (four of five cells) and always blocked inhibition by CHEMICALNOTIN (n = 3)
CPR:6	 bbbbb1 CHEMICALIN eeeee1  (intravenous, 1 mg/kg), whose serotonergic actions include GENEIN and  bbbbb2 GENEIN eeeee2  antagonism, typically raised CHEMICALNOTIN levels (four of five cells) and always blocked inhibition by CHEMICALNOTIN (n = 3)
CPR:6	Iontophoresis of  bbbbb1 CHEMICALIN eeeee1 , whose serotonergic actions include antagonism and partial agonism at  bbbbb2 GENEIN eeeee2  receptors, also increased CHEMICALNOTIN and decreased firing (n=4)
CPR:10	Treatment with  bbbbb1 CHEMICALIN eeeee1 , however, does not affect the activation of  bbbbb2 GENEIN eeeee2 , which is a plasma membrane enzyme coupled to the GENENOTIN after T-cell stimulation
CPR:4	In this study, we demonstrate that  bbbbb1 CHEMICALIN eeeee1  treatment blocks  bbbbb2 GENEIN eeeee2  secretion, GENEIN expression, and proliferation of stimulated T-lymphocytes
CPR:4	In this study, we demonstrate that  bbbbb1 CHEMICALIN eeeee1  treatment blocks GENEIN secretion,  bbbbb2 GENEIN eeeee2  expression, and proliferation of stimulated T-lymphocytes
CPR:4	Moreover,  bbbbb1 CHEMICALIN eeeee1  decreases the amount and phosphorylation of  bbbbb2 GENEIN eeeee2  and GENEIN GENEIN and prevents activation of the GENEIN GENEIN
CPR:4	Moreover,  bbbbb1 CHEMICALIN eeeee1  decreases the amount and phosphorylation of GENEIN and  bbbbb2 GENEIN eeeee2  GENEIN and prevents activation of the GENEIN GENEIN
CPR:4	Moreover,  bbbbb1 CHEMICALIN eeeee1  decreases the amount and phosphorylation of GENEIN and GENEIN  bbbbb2 GENEIN eeeee2  and prevents activation of the GENEIN GENEIN
CPR:4	Through demonstrating the selective inhibition of  bbbbb1 GENEIN eeeee1 -related T-lymphocyte responses by  bbbbb2 CHEMICALIN eeeee2 , our results emphasize the substantial role of GENENOTIN-GENENOTIN complexes in T-cell activation.
CPR:4	Improper function of these proteins can be induced by selective disruption of their complexes with  bbbbb1 GENEIN eeeee1  using the  bbbbb2 CHEMICALIN eeeee2  CHEMICALIN
CPR:4	Improper function of these proteins can be induced by selective disruption of their complexes with  bbbbb1 GENEIN eeeee1  using the CHEMICALIN  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Moreover,  bbbbb1 CHEMICALIN eeeee1  decreases the amount and phosphorylation of  bbbbb2 GENEIN eeeee2  and GENEIN GENEIN and prevents activation of the GENEIN GENEIN
CPR:4	Moreover,  bbbbb1 CHEMICALIN eeeee1  decreases the amount and phosphorylation of GENEIN and  bbbbb2 GENEIN eeeee2  GENEIN and prevents activation of the GENEIN GENEIN
CPR:4	Moreover,  bbbbb1 CHEMICALIN eeeee1  decreases the amount and phosphorylation of GENEIN and GENEIN  bbbbb2 GENEIN eeeee2  and prevents activation of the GENEIN GENEIN
CPR:4	Moreover,  bbbbb1 CHEMICALIN eeeee1  decreases the amount and phosphorylation of GENEIN and GENEIN GENEIN and prevents activation of the  bbbbb2 GENEIN eeeee2  GENEIN
CPR:4	Moreover,  bbbbb1 CHEMICALIN eeeee1  decreases the amount and phosphorylation of GENEIN and GENEIN GENEIN and prevents activation of the GENEIN  bbbbb2 GENEIN eeeee2 
CPR:4	 bbbbb1 CHEMICALIN eeeee1  also disrupts the  bbbbb2 GENEIN eeeee2 -mediated activation of GENEIN (GENEIN)
CPR:4	 bbbbb1 CHEMICALIN eeeee1  also disrupts the GENEIN-mediated activation of  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:4	 bbbbb1 CHEMICALIN eeeee1  also disrupts the GENEIN-mediated activation of GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:4	The  bbbbb1 GENEIN eeeee1 -specific inhibitor  bbbbb2 CHEMICALIN eeeee2  selectively disrupts GENEIN-mediated signaling events of T-lymphocyte activation
CPR:4	The GENEIN-specific inhibitor  bbbbb1 CHEMICALIN eeeee1  selectively disrupts  bbbbb2 GENEIN eeeee2 -mediated signaling events of T-lymphocyte activation
CPR:2	 bbbbb1 GENEIN eeeee1  catalyse the last step in CHEMICALIN biosynthesis, the formation of CHEMICALIN from CHEMICALIN, a reaction dependent on  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN and CHEMICALIN
CPR:2	 bbbbb1 GENEIN eeeee1  catalyse the last step in CHEMICALIN biosynthesis, the formation of CHEMICALIN from CHEMICALIN, a reaction dependent on CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN and CHEMICALIN
CPR:2	 bbbbb1 GENEIN eeeee1  catalyse the last step in CHEMICALIN biosynthesis, the formation of CHEMICALIN from CHEMICALIN, a reaction dependent on CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:2	 bbbbb1 GENEIN eeeee1  catalyse the last step in CHEMICALIN biosynthesis, the formation of CHEMICALIN from CHEMICALIN, a reaction dependent on CHEMICALIN, CHEMICALIN, CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:9	 bbbbb1 GENEIN eeeee1  catalyse the last step in  bbbbb2 CHEMICALIN eeeee2  biosynthesis, the formation of CHEMICALIN from CHEMICALIN, a reaction dependent on CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN
CPR:9	 bbbbb1 GENEIN eeeee1  catalyse the last step in CHEMICALIN biosynthesis, the formation of  bbbbb2 CHEMICALIN eeeee2  from CHEMICALIN, a reaction dependent on CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN
CPR:9	 bbbbb1 GENEIN eeeee1  catalyse the last step in CHEMICALIN biosynthesis, the formation of CHEMICALIN from  bbbbb2 CHEMICALIN eeeee2 , a reaction dependent on CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN
CPR:10	 bbbbb1 CHEMICALIN eeeee1  do not promote dissociation of CHEMICALIN- bbbbb2 GENEIN eeeee2  GENEIN complexes
CPR:10	 bbbbb1 CHEMICALIN eeeee1  do not promote dissociation of CHEMICALIN-GENEIN  bbbbb2 GENEIN eeeee2  complexes
CPR:2	 bbbbb1 CHEMICALIN eeeee1  promotes dissociation of CHEMICALIN- bbbbb2 GENEIN eeeee2  GENEIN complexes both in the absence and the presence of unlabeled GENEIN
CPR:2	 bbbbb1 CHEMICALIN eeeee1  promotes dissociation of CHEMICALIN-GENEIN  bbbbb2 GENEIN eeeee2  complexes both in the absence and the presence of unlabeled GENEIN
CPR:2	CHEMICALIN promotes dissociation of  bbbbb1 CHEMICALIN eeeee1 - bbbbb2 GENEIN eeeee2  GENEIN complexes both in the absence and the presence of unlabeled GENEIN
CPR:2	CHEMICALIN promotes dissociation of  bbbbb1 CHEMICALIN eeeee1 -GENEIN  bbbbb2 GENEIN eeeee2  complexes both in the absence and the presence of unlabeled GENEIN
CPR:2	It has no influence on the rate of association of  bbbbb1 CHEMICALIN eeeee1 - bbbbb2 GENEIN eeeee2  to GENEIN
CPR:2	It has no influence on the rate of association of  bbbbb1 CHEMICALIN eeeee1 -GENEIN to  bbbbb2 GENEIN eeeee2 
CPR:2	CHEMICALIN do not promote dissociation of  bbbbb1 CHEMICALIN eeeee1 - bbbbb2 GENEIN eeeee2  GENEIN complexes
CPR:2	CHEMICALIN do not promote dissociation of  bbbbb1 CHEMICALIN eeeee1 -GENEIN  bbbbb2 GENEIN eeeee2  complexes
CPR:2	 bbbbb1 CHEMICALIN eeeee1  inhibit CHEMICALIN- bbbbb2 GENEIN eeeee2  binding to recombinant GENEIN
CPR:2	 bbbbb1 CHEMICALIN eeeee1  inhibit CHEMICALIN-GENEIN binding to recombinant  bbbbb2 GENEIN eeeee2 
CPR:2	CHEMICALIN inhibit  bbbbb1 CHEMICALIN eeeee1 - bbbbb2 GENEIN eeeee2  binding to recombinant GENEIN
CPR:2	This study shows that  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, its major blood metabolite, reverse contractile actions of  bbbbb2 GENEIN eeeee2  (GENEIN) in isolated rat aorta and human mammary arteries
CPR:2	This study shows that  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, its major blood metabolite, reverse contractile actions of GENEIN ( bbbbb2 GENEIN eeeee2 ) in isolated rat aorta and human mammary arteries
CPR:2	This study shows that CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , its major blood metabolite, reverse contractile actions of  bbbbb2 GENEIN eeeee2  (GENEIN) in isolated rat aorta and human mammary arteries
CPR:2	This study shows that CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , its major blood metabolite, reverse contractile actions of GENEIN ( bbbbb2 GENEIN eeeee2 ) in isolated rat aorta and human mammary arteries
CPR:2	 bbbbb1 CHEMICALIN eeeee1  promotes dissociation of CHEMICALIN-GENEIN GENEIN complexes both in the absence and the presence of unlabeled  bbbbb2 GENEIN eeeee2 
CPR:2	CHEMICALIN promotes dissociation of  bbbbb1 CHEMICALIN eeeee1 -GENEIN GENEIN complexes both in the absence and the presence of unlabeled  bbbbb2 GENEIN eeeee2 
CPR:2	The results also suggest that: 1) irreversible GENENOTIN binding probably limits actions of receptor antagonists in vivo, and 2) an association of  bbbbb1 CHEMICALIN eeeee1  and GENENOTIN antagonists should be used to evaluate the physiopathological role of  bbbbb2 GENEIN eeeee2  and may be of therapeutic interest in the treatment of ischemic heart disease.
CPR:4	Inhibition of the actions of  bbbbb1 GENEIN eeeee1  by  bbbbb2 CHEMICALIN eeeee2  is apparently competitive
CPR:7	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN inhibit endothelin  bbbbb2 GENEIN eeeee2  by an allosteric type of mechanism
CPR:7	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  inhibit endothelin  bbbbb2 GENEIN eeeee2  by an allosteric type of mechanism
CPR:7	It is concluded that  bbbbb1 CHEMICALIN eeeee1  are allosteric inhibitors of  bbbbb2 GENEIN eeeee2 
CPR:2	The cytosolic fractions from liver and colon tissues of GENENOTIN-/- mice showed similar amounts of DNA cross-linking upon exposure to  bbbbb1 CHEMICALIN eeeee1 , as observed in  bbbbb2 GENEIN eeeee2 +/+ mice
CPR:4	Among the various enzymes,  bbbbb1 CHEMICALIN eeeee1  inhibitable cytosolic  bbbbb2 GENEIN eeeee2  (GENEIN) was shown to catalyse bioreductive activation of CHEMICALIN leading to cross-linking of the DNA and cytotoxicity
CPR:4	Among the various enzymes,  bbbbb1 CHEMICALIN eeeee1  inhibitable cytosolic GENEIN ( bbbbb2 GENEIN eeeee2 ) was shown to catalyse bioreductive activation of CHEMICALIN leading to cross-linking of the DNA and cytotoxicity
CPR:4	This activity, like  bbbbb1 GENEIN eeeee1 , was inhibited by  bbbbb2 CHEMICALIN eeeee2  and immunologically related to GENENOTIN.
CPR:9	Among the various enzymes, CHEMICALIN inhibitable cytosolic  bbbbb1 GENEIN eeeee1  (GENEIN) was shown to catalyse bioreductive activation of  bbbbb2 CHEMICALIN eeeee2  leading to cross-linking of the DNA and cytotoxicity
CPR:9	Among the various enzymes, CHEMICALIN inhibitable cytosolic GENEIN ( bbbbb1 GENEIN eeeee1 ) was shown to catalyse bioreductive activation of  bbbbb2 CHEMICALIN eeeee2  leading to cross-linking of the DNA and cytotoxicity
CPR:9	However, the role of  bbbbb1 GENEIN eeeee1  in metabolic activation of  bbbbb2 CHEMICALIN eeeee2  has been disputed
CPR:9	In this report, we present cellular and animal models to demonstrate that  bbbbb1 GENEIN eeeee1  may play only a minor role in metabolic activation of  bbbbb2 CHEMICALIN eeeee2 
CPR:9	A unique cytosolic activity related but distinct from  bbbbb1 GENEIN eeeee1  catalyses metabolic activation of  bbbbb2 CHEMICALIN eeeee2 
CPR:2	In this study, we investigated the effect of  bbbbb1 CHEMICALIN eeeee1 , a ligand of the  bbbbb2 GENEIN eeeee2  GENEIN, on GENENOTIN expression and secretion in human adipocytes
CPR:2	In this study, we investigated the effect of  bbbbb1 CHEMICALIN eeeee1 , a ligand of the GENEIN  bbbbb2 GENEIN eeeee2 , on GENENOTIN expression and secretion in human adipocytes
CPR:4	In cultures from severely obese subjects,  bbbbb1 CHEMICALIN eeeee1  induced a decrease of  bbbbb2 GENEIN eeeee2  antigen secretion from newly differentiated omental adipocytes by 49 +/- 8% (p < 0.01) and from subcutaneous adipocytes by 30 +/- 7% (p < 0.05)
CPR:4	Exposure of freshly isolated subcutaneous and omental adipocytes in suspension culture to  bbbbb1 CHEMICALIN eeeee1  induced a similar reduction of  bbbbb2 GENEIN eeeee2  concentration in the culture medium (by 35 +/- 11%, p < 0.05, and 33 +/- 8%, p < 0.05 compared with control, respectively)
CPR:4	CONCLUSION/INTERPRETATION: This study provides evidence that  bbbbb1 CHEMICALIN eeeee1  reduces  bbbbb2 GENEIN eeeee2  production in human adipocytes, probably at the transcriptional level
CPR:4	RESULTS: Exposure of in vitro differentiated subcutaneous adipocytes from young normal-weight females to 1 microgram/ml  bbbbb1 CHEMICALIN eeeee1  for 72 h caused a reduction of both  bbbbb2 GENEIN eeeee2  secretion (by 29 +/- 5%; p < 0.01) and GENEIN mRNA expression (by 26 +/- 3%; p < 0.05)
CPR:4	RESULTS: Exposure of in vitro differentiated subcutaneous adipocytes from young normal-weight females to 1 microgram/ml  bbbbb1 CHEMICALIN eeeee1  for 72 h caused a reduction of both GENEIN secretion (by 29 +/- 5%; p < 0.01) and  bbbbb2 GENEIN eeeee2  mRNA expression (by 26 +/- 3%; p < 0.05)
CPR:4	 bbbbb1 CHEMICALIN eeeee1  reduces  bbbbb2 GENEIN eeeee2  expression and secretion in cultured human adipocytes
CPR:6	In these tissues,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN (a non-selective  bbbbb2 GENEIN eeeee2  antagonist), and CHEMICALIN (an GENEIN antagonist) competitively antagonized contraction in a concentration-dependent manner
CPR:6	In these tissues, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  (a non-selective  bbbbb2 GENEIN eeeee2  antagonist), and CHEMICALIN (an GENEIN antagonist) competitively antagonized contraction in a concentration-dependent manner
CPR:6	In these tissues, CHEMICALIN, CHEMICALIN (a non-selective GENEIN antagonist), and  bbbbb1 CHEMICALIN eeeee1  (an  bbbbb2 GENEIN eeeee2  antagonist) competitively antagonized contraction in a concentration-dependent manner
CPR:6	We examined the effect of CHEMICALIN (3- inverted question mark bbbbb1 CHEMICALIN eeeee1  CHEMICALIN inverted question mark-CHEMICALIN), a new  bbbbb2 GENEIN eeeee2  antagonist, on prostatic function in isolated canine prostate and in anesthetized dogs
CPR:6	We examined the effect of CHEMICALIN (3- inverted question markCHEMICALIN  bbbbb1 CHEMICALIN eeeee1  inverted question mark-CHEMICALIN), a new  bbbbb2 GENEIN eeeee2  antagonist, on prostatic function in isolated canine prostate and in anesthetized dogs
CPR:6	 bbbbb1 CHEMICALIN eeeee1  is expected to be an effective  bbbbb2 GENEIN eeeee2  antagonist for the treatment of urinary outlet obstruction by benign prostatic hypertrophy with a minimum effect on the cardiovascular system.
CPR:6	We examined the effect of CHEMICALIN (3- inverted question markCHEMICALIN CHEMICALIN inverted question mark- bbbbb1 CHEMICALIN eeeee1 ), a new  bbbbb2 GENEIN eeeee2  antagonist, on prostatic function in isolated canine prostate and in anesthetized dogs
CPR:6	We examined the effect of  bbbbb1 CHEMICALIN eeeee1  (3- inverted question markCHEMICALIN CHEMICALIN inverted question mark-CHEMICALIN), a new  bbbbb2 GENEIN eeeee2  antagonist, on prostatic function in isolated canine prostate and in anesthetized dogs
CPR:9	These data directly demonstrate that  bbbbb1 GENEIN eeeee1  is the major  bbbbb2 CHEMICALIN eeeee2  uptake mechanism across the basolateral membrane of acinar cells and is critical for driving saliva secretion in vivo.
CPR:9	The salivary fluid secretory mechanism is thought to require  bbbbb1 GENEIN eeeee1 -mediated  bbbbb2 CHEMICALIN eeeee2  uptake
CPR:2	UNLABELLED: Apparent  bbbbb1 GENEIN eeeee1  occupancy in mouse cerebral cortex, hippocampus, and striatum by CHEMICALIN, an antagonist, and CHEMICALIN, a relatively selective GENEIN antagonist, was estimated with competitive binding studies using two different radioligands: CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) and CHEMICALIN (CHEMICALIN)
CPR:2	UNLABELLED: Apparent  bbbbb1 GENEIN eeeee1  occupancy in mouse cerebral cortex, hippocampus, and striatum by CHEMICALIN, an antagonist, and CHEMICALIN, a relatively selective GENEIN antagonist, was estimated with competitive binding studies using two different radioligands: CHEMICALIN (CHEMICALIN) and  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN)
CPR:2	UNLABELLED: Apparent  bbbbb1 GENEIN eeeee1  occupancy in mouse cerebral cortex, hippocampus, and striatum by CHEMICALIN, an antagonist, and CHEMICALIN, a relatively selective GENEIN antagonist, was estimated with competitive binding studies using two different radioligands: CHEMICALIN (CHEMICALIN) and CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 )
CPR:2	Both radioligands labeled  bbbbb1 GENEIN eeeee1  in these brain regions, and the relative regional distributions of the specific binding of  bbbbb2 CHEMICALIN eeeee2  in vivo paralleled the distribution of GENEIN
CPR:2	Both radioligands labeled GENEIN in these brain regions, and the relative regional distributions of the specific binding of  bbbbb1 CHEMICALIN eeeee1  in vivo paralleled the distribution of  bbbbb2 GENEIN eeeee2 
CPR:2	A similar discrepancy in sensitivity to competitors between  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN was also observed when CHEMICALIN was used as a competitor, indicating that binding to different subtypes of the  bbbbb2 GENEIN eeeee2  could not account for the observed differences in sensitivity to competition
CPR:2	A similar discrepancy in sensitivity to competitors between CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  was also observed when CHEMICALIN was used as a competitor, indicating that binding to different subtypes of the  bbbbb2 GENEIN eeeee2  could not account for the observed differences in sensitivity to competition
CPR:2	A similar discrepancy in sensitivity to competitors between CHEMICALIN and CHEMICALIN was also observed when  bbbbb1 CHEMICALIN eeeee1  was used as a competitor, indicating that binding to different subtypes of the  bbbbb2 GENEIN eeeee2  could not account for the observed differences in sensitivity to competition
CPR:2	This finding, together with the more favorable accumulation of CHEMICALNOTIN in cerebral cortex, hippocampus, and striatum, leads us to conclude that  bbbbb1 CHEMICALIN eeeee1 , or its positron emitting counterpart, should be the more favorable radiotracer for the estimation of  bbbbb2 GENEIN eeeee2  occupancy by cholinergic drugs in the brain
CPR:2	UNLABELLED: Apparent  bbbbb1 GENEIN eeeee1  occupancy in mouse cerebral cortex, hippocampus, and striatum by CHEMICALIN, an antagonist, and CHEMICALIN, a relatively selective GENEIN antagonist, was estimated with competitive binding studies using two different radioligands:  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) and CHEMICALIN (CHEMICALIN)
CPR:6	UNLABELLED: Apparent  bbbbb1 GENEIN eeeee1  occupancy in mouse cerebral cortex, hippocampus, and striatum by  bbbbb2 CHEMICALIN eeeee2 , an antagonist, and CHEMICALIN, a relatively selective GENEIN antagonist, was estimated with competitive binding studies using two different radioligands: CHEMICALIN (CHEMICALIN) and CHEMICALIN (CHEMICALIN)
CPR:6	UNLABELLED: Apparent GENEIN occupancy in mouse cerebral cortex, hippocampus, and striatum by CHEMICALIN, an antagonist, and  bbbbb1 CHEMICALIN eeeee1 , a relatively selective  bbbbb2 GENEIN eeeee2  antagonist, was estimated with competitive binding studies using two different radioligands: CHEMICALIN (CHEMICALIN) and CHEMICALIN (CHEMICALIN)
CPR:10	However, in virgin mice,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN do not significantly affect  bbbbb2 GENEIN eeeee2  mRNA expression, whereas CHEMICALIN is at least as effective as it is in lactating dams
CPR:10	However, in virgin mice, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  do not significantly affect  bbbbb2 GENEIN eeeee2  mRNA expression, whereas CHEMICALIN is at least as effective as it is in lactating dams
CPR:2	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a specific ligand of the  bbbbb2 GENEIN eeeee2  subtype, causes the most dramatic increase in GENEIN mRNA, whereas CHEMICALIN, a specific activator of GENEIN, also significantly increases GENEIN mRNA abundance in skeletal muscle of lactating mice
CPR:2	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a specific ligand of the  bbbbb2 GENEIN eeeee2  subtype, causes the most dramatic increase in GENEIN mRNA, whereas CHEMICALIN, a specific activator of GENEIN, also significantly increases GENEIN mRNA abundance in skeletal muscle of lactating mice
CPR:2	Changes in  bbbbb1 GENEIN eeeee1  mRNA occur in parallel with modifications in the levels of free  bbbbb2 CHEMICALIN eeeee2 , which are reduced in lactation and are upregulated due to weaning or fasting
CPR:2	Conversely, when mice are fed a high-fat diet after parturition, the downregulation of  bbbbb1 GENEIN eeeee1  mRNA and GENEIN protein levels due to lactation is partially reversed, as is the reduction in serum free  bbbbb2 CHEMICALIN eeeee2  levels
CPR:2	Conversely, when mice are fed a high-fat diet after parturition, the downregulation of GENEIN mRNA and  bbbbb1 GENEIN eeeee1  protein levels due to lactation is partially reversed, as is the reduction in serum free  bbbbb2 CHEMICALIN eeeee2  levels
CPR:2	However, in virgin mice, CHEMICALIN and CHEMICALIN do not significantly affect  bbbbb1 GENEIN eeeee1  mRNA expression, whereas  bbbbb2 CHEMICALIN eeeee2  is at least as effective as it is in lactating dams
CPR:2	It is proposed that the  bbbbb1 GENEIN eeeee1  gene is regulated in skeletal muscle during lactation in response to changes in circulating free  bbbbb2 CHEMICALIN eeeee2  by mechanisms involving activation of GENEIN
CPR:2	The impaired expression of the  bbbbb1 GENEIN eeeee1  gene is consistent with the involvement of GENEIN gene regulation in the reduction of the use of  bbbbb2 CHEMICALIN eeeee2  as fuel by the skeletal muscle and in impaired adaptative thermogenesis, both of which are major metabolic adaptations that occur during lactation.
CPR:2	The impaired expression of the GENEIN gene is consistent with the involvement of  bbbbb1 GENEIN eeeee1  gene regulation in the reduction of the use of  bbbbb2 CHEMICALIN eeeee2  as fuel by the skeletal muscle and in impaired adaptative thermogenesis, both of which are major metabolic adaptations that occur during lactation.
CPR:3	Treatment of lactating mice with a single injection of  bbbbb1 CHEMICALIN eeeee1 , an activator of the  bbbbb2 GENEIN eeeee2  (GENEIN), raises GENEIN mRNA in skeletal muscle to levels similar to those in virgin mice
CPR:3	Treatment of lactating mice with a single injection of  bbbbb1 CHEMICALIN eeeee1 , an activator of the GENEIN ( bbbbb2 GENEIN eeeee2 ), raises GENEIN mRNA in skeletal muscle to levels similar to those in virgin mice
CPR:3	CHEMICALIN (CHEMICALIN), a specific ligand of the GENEIN subtype, causes the most dramatic increase in GENEIN mRNA, whereas  bbbbb1 CHEMICALIN eeeee1 , a specific activator of  bbbbb2 GENEIN eeeee2 , also significantly increases GENEIN mRNA abundance in skeletal muscle of lactating mice
CPR:3	It is proposed that the GENEIN gene is regulated in skeletal muscle during lactation in response to changes in circulating free  bbbbb1 CHEMICALIN eeeee1  by mechanisms involving activation of  bbbbb2 GENEIN eeeee2 
CPR:3	Impaired expression of the GENENOTIN gene in skeletal muscle during lactation: fibrates and  bbbbb1 CHEMICALIN eeeee1  reverse lactation-induced downregulation of the  bbbbb2 GENEIN eeeee2  gene
CPR:3	Treatment of lactating mice with a single injection of  bbbbb1 CHEMICALIN eeeee1 , an activator of the GENEIN (GENEIN), raises  bbbbb2 GENEIN eeeee2  mRNA in skeletal muscle to levels similar to those in virgin mice
CPR:3	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a specific ligand of the GENEIN subtype, causes the most dramatic increase in  bbbbb2 GENEIN eeeee2  mRNA, whereas CHEMICALIN, a specific activator of GENEIN, also significantly increases GENEIN mRNA abundance in skeletal muscle of lactating mice
CPR:3	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a specific ligand of the GENEIN subtype, causes the most dramatic increase in  bbbbb2 GENEIN eeeee2  mRNA, whereas CHEMICALIN, a specific activator of GENEIN, also significantly increases GENEIN mRNA abundance in skeletal muscle of lactating mice
CPR:3	CHEMICALIN (CHEMICALIN), a specific ligand of the GENEIN subtype, causes the most dramatic increase in GENEIN mRNA, whereas  bbbbb1 CHEMICALIN eeeee1 , a specific activator of GENEIN, also significantly increases  bbbbb2 GENEIN eeeee2  mRNA abundance in skeletal muscle of lactating mice
CPR:3	 bbbbb1 CHEMICALIN eeeee1 , a novel anti-convulsant, enhances activation of GENENOTIN  bbbbb2 GENEIN eeeee2 
CPR:2	This was the first study to investigate platelet  bbbbb1 CHEMICALIN eeeee1  binding in CHEMICALNOTIN-dependent and age-matched control subjects in relation to the  bbbbb2 GENEIN eeeee2  genotype
CPR:2	These results do not support previous results of altered  bbbbb1 CHEMICALIN eeeee1  binding sites in alcohol-dependent subjects or  bbbbb2 GENEIN eeeee2  S-allele carriers
CPR:2	Blood samples were taken from both CHEMICALNOTIN-dependent and control subjects to determine  bbbbb1 GENEIN eeeee1  genotypes using PCR of lymphocyte DNA, and to perform platelet  bbbbb2 CHEMICALIN eeeee2  binding (binding capacity: B(max); and dissociation constant: K(D))
CPR:2	 bbbbb1 GENEIN eeeee1  gene regulatory region polymorphism (GENEIN),  bbbbb2 CHEMICALIN eeeee2  binding in healthy control subjects and alcohol-dependent patients and their relationships to impulsivity
CPR:2	GENEIN gene regulatory region polymorphism ( bbbbb1 GENEIN eeeee1 ),  bbbbb2 CHEMICALIN eeeee2  binding in healthy control subjects and alcohol-dependent patients and their relationships to impulsivity
CPR:2	By using the technique of site-directed spin labeling combined with EPR spectroscopy, we have observed that binding of  bbbbb1 CHEMICALIN eeeee1  and nonsteroidal anti-inflammatory drugs induces conformational changes in the  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:2	By using the technique of site-directed spin labeling combined with EPR spectroscopy, we have observed that binding of  bbbbb1 CHEMICALIN eeeee1  and nonsteroidal anti-inflammatory drugs induces conformational changes in the GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:2	Proteolysis protection assays had previously provided circumstantial evidence that binding of heme and non- bbbbb1 CHEMICALIN eeeee1  anti-inflammatory drugs alters the conformation of  bbbbb2 GENEIN eeeee2 , but the present experiments are the first to directly measure such changes
CPR:2	The finding that  bbbbb1 CHEMICALIN eeeee1  can also induce a conformational change in  bbbbb2 GENEIN eeeee2  was unexpected, and the magnitude of changes suggests this structural flexibility may be integral to the GENEIN catalytic mechanism.
CPR:2	The finding that  bbbbb1 CHEMICALIN eeeee1  can also induce a conformational change in GENEIN was unexpected, and the magnitude of changes suggests this structural flexibility may be integral to the  bbbbb2 GENEIN eeeee2  catalytic mechanism.
CPR:2	Line shape broadening resulting from spin-spin coupling of  bbbbb1 CHEMICALIN eeeee1  pairs introduced into the membrane-binding helices of  bbbbb2 GENEIN eeeee2  was used to calculate the inter-helical distances and changes in these distances that occur in response to binding various ligands
CPR:2	However, inter-helical distances calculated and determined by EPR for  bbbbb1 GENEIN eeeee1  complexed with  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, and CHEMICALIN were in close agreement with those obtained from the cognate crystal structures
CPR:2	However, inter-helical distances calculated and determined by EPR for  bbbbb1 GENEIN eeeee1  complexed with CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , and CHEMICALIN were in close agreement with those obtained from the cognate crystal structures
CPR:2	However, inter-helical distances calculated and determined by EPR for  bbbbb1 GENEIN eeeee1  complexed with CHEMICALIN, CHEMICALIN, and  bbbbb2 CHEMICALIN eeeee2  were in close agreement with those obtained from the cognate crystal structures
CPR:2	 bbbbb1 CHEMICALIN eeeee1  and nonsteroidal anti-inflammatory drugs induce conformational changes in the GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:2	 bbbbb1 CHEMICALIN eeeee1  and nonsteroidal anti-inflammatory drugs induce conformational changes in the  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:10	Activation of GENENOTIN,  bbbbb1 GENEIN eeeee1 , and GENEIN was unaffected by  bbbbb2 CHEMICALIN eeeee2 
CPR:10	Activation of GENENOTIN, GENEIN, and  bbbbb1 GENEIN eeeee1  was unaffected by  bbbbb2 CHEMICALIN eeeee2 
CPR:2	Various drugs used in the treatment of IBD, such as glucocorticoids,  bbbbb1 CHEMICALIN eeeee1 , and CHEMICALIN, interfere with  bbbbb2 GENEIN eeeee2 /GENEIN signaling
CPR:2	Various drugs used in the treatment of IBD, such as glucocorticoids,  bbbbb1 CHEMICALIN eeeee1 , and CHEMICALIN, interfere with GENEIN/ bbbbb2 GENEIN eeeee2  signaling
CPR:2	Various drugs used in the treatment of IBD, such as glucocorticoids, CHEMICALIN, and  bbbbb1 CHEMICALIN eeeee1 , interfere with  bbbbb2 GENEIN eeeee2 /GENEIN signaling
CPR:2	Various drugs used in the treatment of IBD, such as glucocorticoids, CHEMICALIN, and  bbbbb1 CHEMICALIN eeeee1 , interfere with GENEIN/ bbbbb2 GENEIN eeeee2  signaling
CPR:3	RESULTS:  bbbbb1 GENEIN eeeee1 /GENEIN activity induced by GENENOTIN,  bbbbb2 CHEMICALIN eeeee2 , or overexpression of GENEIN, GENEIN, GENEIN, or constitutively active GENEIN and GENEIN mutants was inhibited dose dependently by CHEMICALIN
CPR:3	RESULTS: GENEIN/ bbbbb1 GENEIN eeeee1  activity induced by GENENOTIN,  bbbbb2 CHEMICALIN eeeee2 , or overexpression of GENEIN, GENEIN, GENEIN, or constitutively active GENEIN and GENEIN mutants was inhibited dose dependently by CHEMICALIN
CPR:4	The suppression of  bbbbb1 GENEIN eeeee1  activation by inhibition of the GENEIN contributes to the well-known anti-inflammatory and immunosuppressive effects of  bbbbb2 CHEMICALIN eeeee2 .
CPR:4	The suppression of GENEIN activation by inhibition of the  bbbbb1 GENEIN eeeee1  contributes to the well-known anti-inflammatory and immunosuppressive effects of  bbbbb2 CHEMICALIN eeeee2 .
CPR:4	The aim of this study was to define the molecular mechanism by which  bbbbb1 CHEMICALIN eeeee1  inhibits  bbbbb2 GENEIN eeeee2  activation
CPR:4	RESULTS:  bbbbb1 GENEIN eeeee1 /GENEIN activity induced by GENENOTIN, CHEMICALIN, or overexpression of GENEIN, GENEIN, GENEIN, or constitutively active GENEIN and GENEIN mutants was inhibited dose dependently by  bbbbb2 CHEMICALIN eeeee2 
CPR:4	RESULTS: GENEIN/ bbbbb1 GENEIN eeeee1  activity induced by GENENOTIN, CHEMICALIN, or overexpression of GENEIN, GENEIN, GENEIN, or constitutively active GENEIN and GENEIN mutants was inhibited dose dependently by  bbbbb2 CHEMICALIN eeeee2 
CPR:4	RESULTS: GENEIN/GENEIN activity induced by GENENOTIN, CHEMICALIN, or overexpression of  bbbbb1 GENEIN eeeee1 , GENEIN, GENEIN, or constitutively active GENEIN and GENEIN mutants was inhibited dose dependently by  bbbbb2 CHEMICALIN eeeee2 
CPR:4	RESULTS: GENEIN/GENEIN activity induced by GENENOTIN, CHEMICALIN, or overexpression of GENEIN,  bbbbb1 GENEIN eeeee1 , GENEIN, or constitutively active GENEIN and GENEIN mutants was inhibited dose dependently by  bbbbb2 CHEMICALIN eeeee2 
CPR:4	RESULTS: GENEIN/GENEIN activity induced by GENENOTIN, CHEMICALIN, or overexpression of GENEIN, GENEIN,  bbbbb1 GENEIN eeeee1 , or constitutively active GENEIN and GENEIN mutants was inhibited dose dependently by  bbbbb2 CHEMICALIN eeeee2 
CPR:4	RESULTS: GENEIN/GENEIN activity induced by GENENOTIN, CHEMICALIN, or overexpression of GENEIN, GENEIN, GENEIN, or constitutively active  bbbbb1 GENEIN eeeee1  and GENEIN mutants was inhibited dose dependently by  bbbbb2 CHEMICALIN eeeee2 
CPR:4	RESULTS: GENEIN/GENEIN activity induced by GENENOTIN, CHEMICALIN, or overexpression of GENEIN, GENEIN, GENEIN, or constitutively active GENEIN and  bbbbb1 GENEIN eeeee1  mutants was inhibited dose dependently by  bbbbb2 CHEMICALIN eeeee2 
CPR:4	 bbbbb1 CHEMICALIN eeeee1  inhibited  bbbbb2 GENEIN eeeee2 -induced activation of endogenous GENEIN in Jurkat T cells and SW620 colon cells, as well as the catalytic activity of purified GENEIN and GENEIN in vitro
CPR:4	 bbbbb1 CHEMICALIN eeeee1  inhibited GENEIN-induced activation of endogenous  bbbbb2 GENEIN eeeee2  in Jurkat T cells and SW620 colon cells, as well as the catalytic activity of purified GENEIN and GENEIN in vitro
CPR:4	 bbbbb1 CHEMICALIN eeeee1  inhibited GENEIN-induced activation of endogenous GENEIN in Jurkat T cells and SW620 colon cells, as well as the catalytic activity of purified  bbbbb2 GENEIN eeeee2  and GENEIN in vitro
CPR:4	 bbbbb1 CHEMICALIN eeeee1  inhibited GENEIN-induced activation of endogenous GENEIN in Jurkat T cells and SW620 colon cells, as well as the catalytic activity of purified GENEIN and  bbbbb2 GENEIN eeeee2  in vitro
CPR:4	Suppression of  bbbbb1 GENEIN eeeee1  activity by  bbbbb2 CHEMICALIN eeeee2  is mediated by direct inhibition of GENENOTIN
CPR:4	The decrease in substrate phosphorylation by GENENOTIN is associated with a decrease in autophosphorylation of  bbbbb1 GENEIN eeeee1  and can be antagonized by excess  bbbbb2 CHEMICALIN eeeee2 
CPR:10	Selective GENEIN inhibitors, such as  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN (CHEMICALIN), and CHEMICALIN (CHEMICALIN), are NSAIDs that have been modified chemically to preferentially inhibit GENEIN but not  bbbbb2 GENEIN eeeee2 
CPR:10	Selective GENEIN inhibitors, such as CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), and CHEMICALIN (CHEMICALIN), are NSAIDs that have been modified chemically to preferentially inhibit GENEIN but not  bbbbb2 GENEIN eeeee2 
CPR:10	Selective GENEIN inhibitors, such as CHEMICALIN, CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), and CHEMICALIN (CHEMICALIN), are NSAIDs that have been modified chemically to preferentially inhibit GENEIN but not  bbbbb2 GENEIN eeeee2 
CPR:10	Selective GENEIN inhibitors, such as CHEMICALIN, CHEMICALIN (CHEMICALIN), and  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), are NSAIDs that have been modified chemically to preferentially inhibit GENEIN but not  bbbbb2 GENEIN eeeee2 
CPR:10	Selective GENEIN inhibitors, such as CHEMICALIN, CHEMICALIN (CHEMICALIN), and CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), are NSAIDs that have been modified chemically to preferentially inhibit GENEIN but not  bbbbb2 GENEIN eeeee2 
CPR:10	For instance,  bbbbb1 CHEMICALIN eeeee1  inhibits the growth of cultured colon cancer cells (HCA-7 and Moser-S) that express GENEIN but has no effect on HCT-116 tumor cells that do not express  bbbbb2 GENEIN eeeee2 
CPR:4	This effect may due to induction of apoptosis through uncoupling of oxidative phosphorylation and down-regulation of  bbbbb1 GENEIN eeeee1 , as has been demonstrated for some nonselective NSAIDs, for instance,  bbbbb2 CHEMICALIN eeeee2 
CPR:4	In contrast, CHEMICALIN-like nonselective NSAIDs such as CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  inhibit not only the enzymatic action of the highly inducible, proinflammatory  bbbbb2 GENEIN eeeee2  but the constitutively expressed, cytoprotective GENEIN as well
CPR:4	In contrast, CHEMICALIN-like nonselective NSAIDs such as CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  inhibit not only the enzymatic action of the highly inducible, proinflammatory GENEIN but the constitutively expressed, cytoprotective  bbbbb2 GENEIN eeeee2  as well
CPR:4	Selective GENEIN inhibitors, such as  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN (CHEMICALIN), and CHEMICALIN (CHEMICALIN), are NSAIDs that have been modified chemically to preferentially inhibit  bbbbb2 GENEIN eeeee2  but not GENEIN
CPR:4	Selective  bbbbb1 GENEIN eeeee1  inhibitors, such as  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN (CHEMICALIN), and CHEMICALIN (CHEMICALIN), are NSAIDs that have been modified chemically to preferentially inhibit GENEIN but not GENEIN
CPR:4	Selective GENEIN inhibitors, such as CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), and CHEMICALIN (CHEMICALIN), are NSAIDs that have been modified chemically to preferentially inhibit  bbbbb2 GENEIN eeeee2  but not GENEIN
CPR:4	Selective  bbbbb1 GENEIN eeeee1  inhibitors, such as CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), and CHEMICALIN (CHEMICALIN), are NSAIDs that have been modified chemically to preferentially inhibit GENEIN but not GENEIN
CPR:4	Selective GENEIN inhibitors, such as CHEMICALIN, CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), and CHEMICALIN (CHEMICALIN), are NSAIDs that have been modified chemically to preferentially inhibit  bbbbb2 GENEIN eeeee2  but not GENEIN
CPR:4	Selective  bbbbb1 GENEIN eeeee1  inhibitors, such as CHEMICALIN, CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), and CHEMICALIN (CHEMICALIN), are NSAIDs that have been modified chemically to preferentially inhibit GENEIN but not GENEIN
CPR:4	Selective GENEIN inhibitors, such as CHEMICALIN, CHEMICALIN (CHEMICALIN), and  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), are NSAIDs that have been modified chemically to preferentially inhibit  bbbbb2 GENEIN eeeee2  but not GENEIN
CPR:4	Selective  bbbbb1 GENEIN eeeee1  inhibitors, such as CHEMICALIN, CHEMICALIN (CHEMICALIN), and  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), are NSAIDs that have been modified chemically to preferentially inhibit GENEIN but not GENEIN
CPR:4	Selective GENEIN inhibitors, such as CHEMICALIN, CHEMICALIN (CHEMICALIN), and CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), are NSAIDs that have been modified chemically to preferentially inhibit  bbbbb2 GENEIN eeeee2  but not GENEIN
CPR:4	Selective  bbbbb1 GENEIN eeeee1  inhibitors, such as CHEMICALIN, CHEMICALIN (CHEMICALIN), and CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), are NSAIDs that have been modified chemically to preferentially inhibit GENEIN but not GENEIN
CPR:4	For instance,  bbbbb1 CHEMICALIN eeeee1  inhibits the growth of cultured colon cancer cells (HCA-7 and Moser-S) that express  bbbbb2 GENEIN eeeee2  but has no effect on HCT-116 tumor cells that do not express GENEIN
CPR:4	In contrast,  bbbbb1 CHEMICALIN eeeee1 -like nonselective NSAIDs such as CHEMICALIN and CHEMICALIN inhibit not only the enzymatic action of the highly inducible, proinflammatory  bbbbb2 GENEIN eeeee2  but the constitutively expressed, cytoprotective GENEIN as well
CPR:4	In contrast,  bbbbb1 CHEMICALIN eeeee1 -like nonselective NSAIDs such as CHEMICALIN and CHEMICALIN inhibit not only the enzymatic action of the highly inducible, proinflammatory GENEIN but the constitutively expressed, cytoprotective  bbbbb2 GENEIN eeeee2  as well
CPR:4	In contrast, CHEMICALIN-like nonselective NSAIDs such as  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN inhibit not only the enzymatic action of the highly inducible, proinflammatory  bbbbb2 GENEIN eeeee2  but the constitutively expressed, cytoprotective GENEIN as well
CPR:4	In contrast, CHEMICALIN-like nonselective NSAIDs such as  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN inhibit not only the enzymatic action of the highly inducible, proinflammatory GENEIN but the constitutively expressed, cytoprotective  bbbbb2 GENEIN eeeee2  as well
CPR:9	 bbbbb1 GENEIN eeeee1  produces  bbbbb2 CHEMICALIN eeeee2  that inhibit apoptosis and stimulate angiogenesis and invasiveness
CPR:2	For lung tumor lines (carcinoid, two SCLC, and one large cell lung carcinoma),  bbbbb1 GENEIN eeeee1  activity was correlated with the potency of  bbbbb2 CHEMICALIN eeeee2 -induced cytotoxicity
CPR:4	To assess the feasibility of targeting these high GENENOTIN levels for chemotherapy,  bbbbb1 GENEIN eeeee1  inhibitors  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), CHEMICALIN (CHEMICALIN), and CHEMICALIN (CHEMICALIN) were incubated (72 h) with NCI-H727 human lung carcinoid cells
CPR:4	To assess the feasibility of targeting these high GENENOTIN levels for chemotherapy,  bbbbb1 GENEIN eeeee1  inhibitors CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), CHEMICALIN (CHEMICALIN), and CHEMICALIN (CHEMICALIN) were incubated (72 h) with NCI-H727 human lung carcinoid cells
CPR:4	To assess the feasibility of targeting these high GENENOTIN levels for chemotherapy,  bbbbb1 GENEIN eeeee1  inhibitors CHEMICALIN (CHEMICALIN),  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), and CHEMICALIN (CHEMICALIN) were incubated (72 h) with NCI-H727 human lung carcinoid cells
CPR:4	To assess the feasibility of targeting these high GENENOTIN levels for chemotherapy,  bbbbb1 GENEIN eeeee1  inhibitors CHEMICALIN (CHEMICALIN), CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), and CHEMICALIN (CHEMICALIN) were incubated (72 h) with NCI-H727 human lung carcinoid cells
CPR:4	To assess the feasibility of targeting these high GENENOTIN levels for chemotherapy,  bbbbb1 GENEIN eeeee1  inhibitors CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), and  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) were incubated (72 h) with NCI-H727 human lung carcinoid cells
CPR:4	To assess the feasibility of targeting these high GENENOTIN levels for chemotherapy,  bbbbb1 GENEIN eeeee1  inhibitors CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), and CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) were incubated (72 h) with NCI-H727 human lung carcinoid cells
CPR:2	In a search for less flexible analogues of CHEMICALIN (1), a CHEMICALIN  bbbbb1 CHEMICALIN eeeee1  endowed with an interesting  bbbbb2 GENEIN eeeee2  affinity profile, we discovered compound 2, in which the terminal CHEMICALNOTIN groups of 1 have been incorporated into a CHEMICALNOTIN system
CPR:2	In a search for less flexible analogues of  bbbbb1 CHEMICALIN eeeee1  (1), a CHEMICALIN CHEMICALIN endowed with an interesting  bbbbb2 GENEIN eeeee2  affinity profile, we discovered compound 2, in which the terminal CHEMICALNOTIN groups of 1 have been incorporated into a CHEMICALNOTIN system
CPR:2	In a search for less flexible analogues of CHEMICALIN (1), a  bbbbb1 CHEMICALIN eeeee1  CHEMICALIN endowed with an interesting  bbbbb2 GENEIN eeeee2  affinity profile, we discovered compound 2, in which the terminal CHEMICALNOTIN groups of 1 have been incorporated into a CHEMICALNOTIN system
CPR:4	 bbbbb1 CHEMICALIN eeeee1  derivatives as  bbbbb2 GENEIN eeeee2  inhibitors
CPR:4	Since this compound retains good  bbbbb1 GENEIN eeeee1  inhibitory activity and its  bbbbb2 CHEMICALIN eeeee2  moiety is reminiscent of the CHEMICALIN (3), we have designed and synthesized CHEMICALNOTIN 4-6, and their biological evaluation has been assessed in vitro against GENENOTIN and GENENOTIN
CPR:4	Since this compound retains good  bbbbb1 GENEIN eeeee1  inhibitory activity and its CHEMICALIN moiety is reminiscent of the  bbbbb2 CHEMICALIN eeeee2  (3), we have designed and synthesized CHEMICALNOTIN 4-6, and their biological evaluation has been assessed in vitro against GENENOTIN and GENENOTIN
CPR:2	Moreover, it was suggested that promotion of  bbbbb1 GENEIN eeeee1  mRNA expression in Th2 cells was partially involved due to an increase in level of  bbbbb2 CHEMICALIN eeeee2  in splenic tissue and the breakdown of Th cell responses locally in the splenic tissue, which then affected the maintenance of Th2 cell functions in the microenvironment of tumor-bearing mice.
CPR:4	When the anti-corticosterone drug  bbbbb1 CHEMICALIN eeeee1  (GENEIN inhibitor) was administered to B16F10 mice, CHEMICALNOTIN levels in splenic tissue or serum and  bbbbb2 GENEIN eeeee2  mRNA expression were decreased at 14 days after tumor inoculation
CPR:4	When the anti-corticosterone drug  bbbbb1 CHEMICALIN eeeee1  ( bbbbb2 GENEIN eeeee2  inhibitor) was administered to B16F10 mice, CHEMICALNOTIN levels in splenic tissue or serum and GENEIN mRNA expression were decreased at 14 days after tumor inoculation
CPR:10	Fibroblast cultures from the patient exhibited severe reduction of the rotenone-sensitive  bbbbb1 GENEIN eeeee1  activity of GENEIN, which was insensitive to  bbbbb2 CHEMICALIN eeeee2  stimulation
CPR:10	Fibroblast cultures from the patient exhibited severe reduction of the rotenone-sensitive GENEIN activity of  bbbbb1 GENEIN eeeee1 , which was insensitive to  bbbbb2 CHEMICALIN eeeee2  stimulation
CPR:2	Furthermore, h[ bbbbb1 CHEMICALIN eeeee1 ]-GENENOTIN reduced chemotherapy-induced apoptosis, decreased activation of GENENOTIN, and inhibited GENEIN cleavage in heterologous cells transfected with the  bbbbb2 GENEIN eeeee2 
CPR:2	We report here that a human degradation-resistant  bbbbb1 GENEIN eeeee1  analogue, h[ bbbbb2 CHEMICALIN eeeee2 ]-GENENOTIN significantly improves survival, reduces bacteremia, attenuates epithelial injury, and inhibits crypt apoptosis in the murine gastrointestinal tract after administration of GENEIN inhibitor CHEMICALIN or the antimetabolite CHEMICALNOTIN. h[CHEMICALNOTIN]-GENENOTIN significantly improved survival and reduced weight loss but did not impair chemotherapy effectiveness in tumor-bearing mice treated with cyclical irinotecan
CPR:4	Furthermore, h[ bbbbb1 CHEMICALIN eeeee1 ]-GENENOTIN reduced chemotherapy-induced apoptosis, decreased activation of GENENOTIN, and inhibited  bbbbb2 GENEIN eeeee2  cleavage in heterologous cells transfected with the GENEIN
CPR:4	We report here that a human degradation-resistant GENEIN analogue, h[CHEMICALIN]-GENENOTIN significantly improves survival, reduces bacteremia, attenuates epithelial injury, and inhibits crypt apoptosis in the murine gastrointestinal tract after administration of  bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2  or the antimetabolite CHEMICALNOTIN. h[CHEMICALNOTIN]-GENENOTIN significantly improved survival and reduced weight loss but did not impair chemotherapy effectiveness in tumor-bearing mice treated with cyclical irinotecan
CPR:9	OBJECTIVES: The hypothesis of the present study was that differences among  bbbbb1 GENEIN eeeee1  (GENEIN) ligands in potency and effectiveness as a positive reinforcers were related to potency and effectiveness as  bbbbb2 CHEMICALIN eeeee2  uptake inhibitors
CPR:9	OBJECTIVES: The hypothesis of the present study was that differences among GENEIN ( bbbbb1 GENEIN eeeee1 ) ligands in potency and effectiveness as a positive reinforcers were related to potency and effectiveness as  bbbbb2 CHEMICALIN eeeee2  uptake inhibitors
CPR:9	Accordingly, self-administration of a group of local anesthetics that are  bbbbb1 GENEIN eeeee1  ligands was compared to their effects as  bbbbb2 CHEMICALIN eeeee2  uptake blockers in vitro in brain tissue
CPR:2	In conclusion, OMCD tubules from  bbbbb1 CHEMICALIN eeeee1 -treated rats secrete CHEMICALIN into the luminal fluid through  bbbbb2 GENEIN eeeee2 -mediated CHEMICALIN uptake across the basolateral membrane in series with CHEMICALIN efflux across the apical membrane
CPR:9	CHEMICALNOTIN-sensitive CHEMICALNOTIN secretion was dependent on extracellular CHEMICALNOTIN and either CHEMICALNOTIN or CHEMICALNOTIN, consistent with the ion dependency of  bbbbb1 GENEIN eeeee1 -mediated  bbbbb2 CHEMICALIN eeeee2  transport
CPR:9	Contribution of the  bbbbb1 GENEIN eeeee1  GENEIN to  bbbbb2 CHEMICALIN eeeee2  secretion in rat OMCD
CPR:9	Contribution of the GENEIN  bbbbb1 GENEIN eeeee1  to  bbbbb2 CHEMICALIN eeeee2  secretion in rat OMCD
CPR:9	In conclusion, OMCD tubules from CHEMICALIN-treated rats secrete  bbbbb1 CHEMICALIN eeeee1  into the luminal fluid through  bbbbb2 GENEIN eeeee2 -mediated CHEMICALIN uptake across the basolateral membrane in series with CHEMICALIN efflux across the apical membrane
CPR:9	In conclusion, OMCD tubules from CHEMICALIN-treated rats secrete CHEMICALIN into the luminal fluid through  bbbbb1 GENEIN eeeee1 -mediated  bbbbb2 CHEMICALIN eeeee2  uptake across the basolateral membrane in series with CHEMICALIN efflux across the apical membrane
CPR:9	In conclusion, OMCD tubules from CHEMICALIN-treated rats secrete CHEMICALIN into the luminal fluid through  bbbbb1 GENEIN eeeee1 -mediated CHEMICALIN uptake across the basolateral membrane in series with  bbbbb2 CHEMICALIN eeeee2  efflux across the apical membrane
CPR:9	The physiological role of  bbbbb1 GENEIN eeeee1 -mediated  bbbbb2 CHEMICALIN eeeee2  uptake remains to be determined
CPR:9	The purpose of this study was to determine whether rat outer medullary collecting duct (OMCD) secretes CHEMICALNOTIN and whether transepithelial CHEMICALNOTIN transport occurs, in part, through  bbbbb1 CHEMICALIN eeeee1  uptake across the basolateral membrane mediated by  bbbbb2 GENEIN eeeee2  in series with CHEMICALIN efflux across the apical membrane
CPR:9	The purpose of this study was to determine whether rat outer medullary collecting duct (OMCD) secretes CHEMICALNOTIN and whether transepithelial CHEMICALNOTIN transport occurs, in part, through CHEMICALIN uptake across the basolateral membrane mediated by  bbbbb1 GENEIN eeeee1  in series with  bbbbb2 CHEMICALIN eeeee2  efflux across the apical membrane
CPR:1	This mutation is the first described in exon 9 and impairs the last 27  bbbbb1 CHEMICALIN eeeee1  of the  bbbbb2 GENEIN eeeee2 
CPR:2	The anti-emetic and pharmacological profile of  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a novel and potent GENENOTIN and  bbbbb2 GENEIN eeeee2  ligand, was investigated in the present study
CPR:2	The anti-emetic and pharmacological profile of CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a novel and potent GENENOTIN and  bbbbb2 GENEIN eeeee2  ligand, was investigated in the present study
CPR:2	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, which have affinity for  bbbbb2 GENEIN eeeee2 , also inhibited CHEMICALIN-induced hypothermia
CPR:2	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , which have affinity for  bbbbb2 GENEIN eeeee2 , also inhibited CHEMICALIN-induced hypothermia
CPR:2	CHEMICALIN and CHEMICALIN, which have affinity for  bbbbb1 GENEIN eeeee1 , also inhibited  bbbbb2 CHEMICALIN eeeee2 -induced hypothermia
CPR:4	In mice,  bbbbb1 CHEMICALIN eeeee1  (1.0 - 3.0 mg kg(-1) s.c.) potently inhibited hypothermia induced by the  bbbbb2 GENEIN eeeee2  agonist; CHEMICALIN (CHEMICALIN) (0.3 mg kg(-1) s.c.)
CPR:5	In guinea-pig isolated colon, CHEMICALIN produced a rightward shift of the concentration-response curves of  bbbbb1 CHEMICALIN eeeee1 , a  bbbbb2 GENEIN eeeee2  agonist (pA2 value of 7.04)
CPR:5	In mice, CHEMICALIN (1.0 - 3.0 mg kg(-1) s.c.) potently inhibited hypothermia induced by the  bbbbb1 GENEIN eeeee1  agonist;  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) (0.3 mg kg(-1) s.c.)
CPR:5	In mice, CHEMICALIN (1.0 - 3.0 mg kg(-1) s.c.) potently inhibited hypothermia induced by the  bbbbb1 GENEIN eeeee1  agonist; CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) (0.3 mg kg(-1) s.c.)
CPR:6	In guinea-pig isolated colon,  bbbbb1 CHEMICALIN eeeee1  produced a rightward shift of the concentration-response curves of CHEMICALIN, a  bbbbb2 GENEIN eeeee2  agonist (pA2 value of 7.04)
CPR:6	Other  bbbbb1 GENEIN eeeee1  antagonists also produced such a shift in the following antagonistic-potency order:  bbbbb2 CHEMICALIN eeeee2 > CHEMICALIN=CHEMICALIN>>CHEMICALIN
CPR:6	Other  bbbbb1 GENEIN eeeee1  antagonists also produced such a shift in the following antagonistic-potency order: CHEMICALIN>  bbbbb2 CHEMICALIN eeeee2 =CHEMICALIN>>CHEMICALIN
CPR:6	Other  bbbbb1 GENEIN eeeee1  antagonists also produced such a shift in the following antagonistic-potency order: CHEMICALIN> CHEMICALIN= bbbbb2 CHEMICALIN eeeee2 >>CHEMICALIN
CPR:6	Other  bbbbb1 GENEIN eeeee1  antagonists also produced such a shift in the following antagonistic-potency order: CHEMICALIN> CHEMICALIN=CHEMICALIN>> bbbbb2 CHEMICALIN eeeee2 
CPR:6	The broad-spectrum anti-emetic activity of  bbbbb1 CHEMICALIN eeeee1 , a novel GENENOTIN and  bbbbb2 GENEIN eeeee2  antagonist
CPR:6	In conclusion,  bbbbb1 CHEMICALIN eeeee1  is a potent GENENOTIN and  bbbbb2 GENEIN eeeee2  antagonist, and a novel anti-emetic agent with a broad-spectrum of anti-emetic activity
CPR:1	Recent studies have indicated that the basic residues CHEMICALIN(93), CHEMICALIN(96),  bbbbb1 CHEMICALIN eeeee1 (125), CHEMICALIN(165), CHEMICALIN(169), CHEMICALIN(236), and CHEMICALIN(240) ( bbbbb2 GENEIN eeeee2  numbering) constitute an exosite in the catalytic domain of GENEIN that can effectively bind heparin only if the acidic GENENOTIN of the GENENOTIN was neutralized by physiological levels of CHEMICALNOTIN
CPR:1	Recent studies have indicated that the basic residues CHEMICALIN(93), CHEMICALIN(96),  bbbbb1 CHEMICALIN eeeee1 (125), CHEMICALIN(165), CHEMICALIN(169), CHEMICALIN(236), and CHEMICALIN(240) (GENEIN numbering) constitute an exosite in the catalytic domain of  bbbbb2 GENEIN eeeee2  that can effectively bind heparin only if the acidic GENENOTIN of the GENENOTIN was neutralized by physiological levels of CHEMICALNOTIN
CPR:1	Recent studies have indicated that the basic residues CHEMICALIN(93), CHEMICALIN(96), CHEMICALIN(125),  bbbbb1 CHEMICALIN eeeee1 (165), CHEMICALIN(169), CHEMICALIN(236), and CHEMICALIN(240) ( bbbbb2 GENEIN eeeee2  numbering) constitute an exosite in the catalytic domain of GENEIN that can effectively bind heparin only if the acidic GENENOTIN of the GENENOTIN was neutralized by physiological levels of CHEMICALNOTIN
CPR:1	Recent studies have indicated that the basic residues CHEMICALIN(93), CHEMICALIN(96), CHEMICALIN(125),  bbbbb1 CHEMICALIN eeeee1 (165), CHEMICALIN(169), CHEMICALIN(236), and CHEMICALIN(240) (GENEIN numbering) constitute an exosite in the catalytic domain of  bbbbb2 GENEIN eeeee2  that can effectively bind heparin only if the acidic GENENOTIN of the GENENOTIN was neutralized by physiological levels of CHEMICALNOTIN
CPR:1	Recent studies have indicated that the basic residues CHEMICALIN(93), CHEMICALIN(96), CHEMICALIN(125), CHEMICALIN(165),  bbbbb1 CHEMICALIN eeeee1 (169), CHEMICALIN(236), and CHEMICALIN(240) ( bbbbb2 GENEIN eeeee2  numbering) constitute an exosite in the catalytic domain of GENEIN that can effectively bind heparin only if the acidic GENENOTIN of the GENENOTIN was neutralized by physiological levels of CHEMICALNOTIN
CPR:1	Recent studies have indicated that the basic residues CHEMICALIN(93), CHEMICALIN(96), CHEMICALIN(125), CHEMICALIN(165),  bbbbb1 CHEMICALIN eeeee1 (169), CHEMICALIN(236), and CHEMICALIN(240) (GENEIN numbering) constitute an exosite in the catalytic domain of  bbbbb2 GENEIN eeeee2  that can effectively bind heparin only if the acidic GENENOTIN of the GENENOTIN was neutralized by physiological levels of CHEMICALNOTIN
CPR:1	Recent studies have indicated that the basic residues CHEMICALIN(93), CHEMICALIN(96), CHEMICALIN(125), CHEMICALIN(165), CHEMICALIN(169),  bbbbb1 CHEMICALIN eeeee1 (236), and CHEMICALIN(240) ( bbbbb2 GENEIN eeeee2  numbering) constitute an exosite in the catalytic domain of GENEIN that can effectively bind heparin only if the acidic GENENOTIN of the GENENOTIN was neutralized by physiological levels of CHEMICALNOTIN
CPR:1	Recent studies have indicated that the basic residues CHEMICALIN(93), CHEMICALIN(96), CHEMICALIN(125), CHEMICALIN(165), CHEMICALIN(169),  bbbbb1 CHEMICALIN eeeee1 (236), and CHEMICALIN(240) (GENEIN numbering) constitute an exosite in the catalytic domain of  bbbbb2 GENEIN eeeee2  that can effectively bind heparin only if the acidic GENENOTIN of the GENENOTIN was neutralized by physiological levels of CHEMICALNOTIN
CPR:1	Recent studies have indicated that the basic residues CHEMICALIN(93), CHEMICALIN(96), CHEMICALIN(125), CHEMICALIN(165), CHEMICALIN(169), CHEMICALIN(236), and  bbbbb1 CHEMICALIN eeeee1 (240) ( bbbbb2 GENEIN eeeee2  numbering) constitute an exosite in the catalytic domain of GENEIN that can effectively bind heparin only if the acidic GENENOTIN of the GENENOTIN was neutralized by physiological levels of CHEMICALNOTIN
CPR:1	Recent studies have indicated that the basic residues CHEMICALIN(93), CHEMICALIN(96), CHEMICALIN(125), CHEMICALIN(165), CHEMICALIN(169), CHEMICALIN(236), and  bbbbb1 CHEMICALIN eeeee1 (240) (GENEIN numbering) constitute an exosite in the catalytic domain of  bbbbb2 GENEIN eeeee2  that can effectively bind heparin only if the acidic GENENOTIN of the GENENOTIN was neutralized by physiological levels of CHEMICALNOTIN
CPR:1	Recent studies have indicated that the basic residues  bbbbb1 CHEMICALIN eeeee1 (93), CHEMICALIN(96), CHEMICALIN(125), CHEMICALIN(165), CHEMICALIN(169), CHEMICALIN(236), and CHEMICALIN(240) ( bbbbb2 GENEIN eeeee2  numbering) constitute an exosite in the catalytic domain of GENEIN that can effectively bind heparin only if the acidic GENENOTIN of the GENENOTIN was neutralized by physiological levels of CHEMICALNOTIN
CPR:1	Recent studies have indicated that the basic residues  bbbbb1 CHEMICALIN eeeee1 (93), CHEMICALIN(96), CHEMICALIN(125), CHEMICALIN(165), CHEMICALIN(169), CHEMICALIN(236), and CHEMICALIN(240) (GENEIN numbering) constitute an exosite in the catalytic domain of  bbbbb2 GENEIN eeeee2  that can effectively bind heparin only if the acidic GENENOTIN of the GENENOTIN was neutralized by physiological levels of CHEMICALNOTIN
CPR:1	Recent studies have indicated that the basic residues CHEMICALIN(93),  bbbbb1 CHEMICALIN eeeee1 (96), CHEMICALIN(125), CHEMICALIN(165), CHEMICALIN(169), CHEMICALIN(236), and CHEMICALIN(240) ( bbbbb2 GENEIN eeeee2  numbering) constitute an exosite in the catalytic domain of GENEIN that can effectively bind heparin only if the acidic GENENOTIN of the GENENOTIN was neutralized by physiological levels of CHEMICALNOTIN
CPR:1	Recent studies have indicated that the basic residues CHEMICALIN(93),  bbbbb1 CHEMICALIN eeeee1 (96), CHEMICALIN(125), CHEMICALIN(165), CHEMICALIN(169), CHEMICALIN(236), and CHEMICALIN(240) (GENEIN numbering) constitute an exosite in the catalytic domain of  bbbbb2 GENEIN eeeee2  that can effectively bind heparin only if the acidic GENENOTIN of the GENENOTIN was neutralized by physiological levels of CHEMICALNOTIN
CPR:1	Moreover, certain basic residues of this site, particularly  bbbbb1 CHEMICALIN eeeee1 (165) and CHEMICALIN(169), play a key role in GENENOTIN and/or GENENOTIN recognition by  bbbbb2 GENEIN eeeee2  in the prothrombinase complex
CPR:1	Moreover, certain basic residues of this site, particularly CHEMICALIN(165) and  bbbbb1 CHEMICALIN eeeee1 (169), play a key role in GENENOTIN and/or GENENOTIN recognition by  bbbbb2 GENEIN eeeee2  in the prothrombinase complex
CPR:10	 bbbbb1 CHEMICALIN eeeee1  is a selective GENEIN inhibitor which has little or no effect on the  bbbbb2 GENEIN eeeee2  isoenzyme at doses up to 1000 mg/day
CPR:2	CHEMICALIN has greater selectivity for  bbbbb1 GENEIN eeeee1  than  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN and CHEMICALIN
CPR:2	CHEMICALIN has greater selectivity for  bbbbb1 GENEIN eeeee1  than CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN and CHEMICALIN
CPR:2	CHEMICALIN has greater selectivity for  bbbbb1 GENEIN eeeee1  than CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:2	CHEMICALIN has greater selectivity for  bbbbb1 GENEIN eeeee1  than CHEMICALIN, CHEMICALIN, CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:4	 bbbbb1 CHEMICALIN eeeee1  is a selective  bbbbb2 GENEIN eeeee2  inhibitor which has little or no effect on the GENEIN isoenzyme at doses up to 1000 mg/day
CPR:4	 bbbbb1 CHEMICALIN eeeee1  has greater selectivity for  bbbbb2 GENEIN eeeee2  than CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN
CPR:2	Different forms of therapy,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN substitution, CHEMICALIN and CHEMICALIN failed to fully correct hypokalemia and hypomagnesemia, but markedly improved growth velocity and normalized  bbbbb2 GENEIN eeeee2  levels in the three patients with short stature
CPR:2	Different forms of therapy, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  substitution, CHEMICALIN and CHEMICALIN failed to fully correct hypokalemia and hypomagnesemia, but markedly improved growth velocity and normalized  bbbbb2 GENEIN eeeee2  levels in the three patients with short stature
CPR:2	Different forms of therapy, CHEMICALIN and CHEMICALIN substitution,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN failed to fully correct hypokalemia and hypomagnesemia, but markedly improved growth velocity and normalized  bbbbb2 GENEIN eeeee2  levels in the three patients with short stature
CPR:2	Different forms of therapy, CHEMICALIN and CHEMICALIN substitution, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  failed to fully correct hypokalemia and hypomagnesemia, but markedly improved growth velocity and normalized  bbbbb2 GENEIN eeeee2  levels in the three patients with short stature
CPR:2	To elucidate the target genes regulated by these compounds, we treated Zucker diabetic fatty rats (ZDF) for 15 days with a GENEIN-specific compound, CHEMICALIN, a  bbbbb1 GENEIN eeeee1 -specific ligand,  bbbbb2 CHEMICALIN eeeee2 , and a GENENOTIN coagonist, CHEMICALNOTIN, and measured the levels of several messenger RNAs (mRNAs) in liver by real-time polymerase chain reaction
CPR:2	 bbbbb1 CHEMICALIN eeeee1  bind to the  bbbbb2 GENEIN eeeee2 , and CHEMICALIN are ligands of GENEIN
CPR:2	CHEMICALIN bind to the GENEIN, and  bbbbb1 CHEMICALIN eeeee1  are ligands of  bbbbb2 GENEIN eeeee2 
CPR:2	To elucidate the target genes regulated by these compounds, we treated Zucker diabetic fatty rats (ZDF) for 15 days with a  bbbbb1 GENEIN eeeee1 -specific compound,  bbbbb2 CHEMICALIN eeeee2 , a GENEIN-specific ligand, CHEMICALIN, and a GENENOTIN coagonist, CHEMICALNOTIN, and measured the levels of several messenger RNAs (mRNAs) in liver by real-time polymerase chain reaction
CPR:3	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN induced expression of  bbbbb2 GENEIN eeeee2  and GENEIN and reduced GENEIN and GENEIN mRNAs
CPR:3	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN induced expression of GENEIN and  bbbbb2 GENEIN eeeee2  and reduced GENEIN and GENEIN mRNAs
CPR:3	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  induced expression of  bbbbb2 GENEIN eeeee2  and GENEIN and reduced GENEIN and GENEIN mRNAs
CPR:3	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  induced expression of GENEIN and  bbbbb2 GENEIN eeeee2  and reduced GENEIN and GENEIN mRNAs
CPR:3	 bbbbb1 CHEMICALIN eeeee1  modestly increased GENEIN mRNA and had no effect on expression of the other 2 genes in the liver but increased the expression of  bbbbb2 GENEIN eeeee2  and GENEIN in adipose tissue
CPR:3	 bbbbb1 CHEMICALIN eeeee1  modestly increased GENEIN mRNA and had no effect on expression of the other 2 genes in the liver but increased the expression of GENEIN and  bbbbb2 GENEIN eeeee2  in adipose tissue
CPR:3	 bbbbb1 CHEMICALIN eeeee1  modestly increased  bbbbb2 GENEIN eeeee2  mRNA and had no effect on expression of the other 2 genes in the liver but increased the expression of GENEIN and GENEIN in adipose tissue
CPR:4	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN induced expression of GENEIN and GENEIN and reduced  bbbbb2 GENEIN eeeee2  and GENEIN mRNAs
CPR:4	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN induced expression of GENEIN and GENEIN and reduced GENEIN and  bbbbb2 GENEIN eeeee2  mRNAs
CPR:4	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  induced expression of GENEIN and GENEIN and reduced  bbbbb2 GENEIN eeeee2  and GENEIN mRNAs
CPR:4	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  induced expression of GENEIN and GENEIN and reduced GENEIN and  bbbbb2 GENEIN eeeee2  mRNAs
CPR:1	We have previously isolated from human hemofiltrate an  bbbbb1 CHEMICALIN eeeee1 -terminally truncated form of the  bbbbb2 GENEIN eeeee2  (GENEIN), and characterized GENENOTIN as a strong agonist of GENENOTIN, GENENOTIN, and to a lower extent GENENOTIN
CPR:1	We have previously isolated from human hemofiltrate an  bbbbb1 CHEMICALIN eeeee1 -terminally truncated form of the GENEIN ( bbbbb2 GENEIN eeeee2 ), and characterized GENENOTIN as a strong agonist of GENENOTIN, GENENOTIN, and to a lower extent GENENOTIN
CPR:2	 bbbbb1 CHEMICALIN eeeee1  are general anesthetics which can also act as uncharged noncompetitive inhibitors of the peripheral GENEIN (GENENOTIN) by binding to one or more specific sites on the  bbbbb2 GENEIN eeeee2 
CPR:2	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN sites on the  bbbbb2 GENEIN eeeee2  and their allosteric interaction
CPR:2	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  sites on the  bbbbb2 GENEIN eeeee2  and their allosteric interaction
CPR:4	 bbbbb1 CHEMICALIN eeeee1  are general anesthetics which can also act as uncharged noncompetitive inhibitors of the peripheral  bbbbb2 GENEIN eeeee2  (GENENOTIN) by binding to one or more specific sites on the GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  are naturally occurring, uncharged noncompetitive inhibitors of peripheral and neuronal  bbbbb2 GENEIN eeeee2 , which have no demonstrable general anesthetic activity in vivo
CPR:2	The  bbbbb1 GENEIN eeeee1  represents a novel target for  bbbbb2 CHEMICALIN eeeee2 -like drugs with high potential for application in therapy of lymphoblastic and other malignancies dependent on extracellular CHEMICALIN.
CPR:4	 bbbbb1 CHEMICALIN eeeee1  was fortuitously found to be a novel, potent inhibitor of the  bbbbb2 GENEIN eeeee2 
CPR:4	It showed high rat lymphoma growth-inhibitory and lytic activity in vitro (IC50 = 0.16 mM), based specifically on inhibition of  bbbbb1 GENEIN eeeee1 --mediated CHEMICALIN uptake, in contrast to its colonic metabolites,  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:4	It showed high rat lymphoma growth-inhibitory and lytic activity in vitro (IC50 = 0.16 mM), based specifically on inhibition of  bbbbb1 GENEIN eeeee1 --mediated CHEMICALIN uptake, in contrast to its colonic metabolites, CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:4	 bbbbb1 CHEMICALIN eeeee1 , a potent suppressor of lymphoma growth by inhibition of the  bbbbb2 GENEIN eeeee2 : a new action for an old drug
CPR:9	It showed high rat lymphoma growth-inhibitory and lytic activity in vitro (IC50 = 0.16 mM), based specifically on inhibition of  bbbbb1 GENEIN eeeee1 --mediated  bbbbb2 CHEMICALIN eeeee2  uptake, in contrast to its colonic metabolites, CHEMICALIN and CHEMICALIN
CPR:9	The  bbbbb1 GENEIN eeeee1  represents a novel target for CHEMICALIN-like drugs with high potential for application in therapy of lymphoblastic and other malignancies dependent on extracellular  bbbbb2 CHEMICALIN eeeee2 .
CPR:3	Like conventional GENEIN inhibitors,  bbbbb1 CHEMICALIN eeeee1  causes extracellular volume reduction and vasodilatation; moreover, it increases levels of  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:3	Like conventional GENEIN inhibitors,  bbbbb1 CHEMICALIN eeeee1  causes extracellular volume reduction and vasodilatation; moreover, it increases levels of GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:4	Like conventional  bbbbb1 GENEIN eeeee1  inhibitors,  bbbbb2 CHEMICALIN eeeee2  causes extracellular volume reduction and vasodilatation; moreover, it increases levels of GENEIN and GENEIN
CPR:4	Advances in antihypertensive combination therapy: benefits of low-dose CHEMICALNOTIN diuretics in conjunction with  bbbbb1 CHEMICALIN eeeee1 , a  bbbbb2 GENEIN eeeee2  inhibitor
CPR:4	 bbbbb1 CHEMICALIN eeeee1 , the prototypical  bbbbb2 GENEIN eeeee2  inhibitor, inhibits not only GENEIN but also GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1 , the prototypical GENEIN inhibitor, inhibits not only  bbbbb2 GENEIN eeeee2  but also GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1 , the prototypical GENEIN inhibitor, inhibits not only GENEIN but also  bbbbb2 GENEIN eeeee2 
CPR:9	The transport CHEMICALNOTIN-sensitive mechanism, that decreased the acidic intracellular pH change occurring in this medium, would correspond to  bbbbb1 CHEMICALIN eeeee1 -CHEMICALIN exchange ( bbbbb2 GENEIN eeeee2  isoform)
CPR:9	The transport CHEMICALNOTIN-sensitive mechanism, that decreased the acidic intracellular pH change occurring in this medium, would correspond to CHEMICALIN- bbbbb1 CHEMICALIN eeeee1  exchange ( bbbbb2 GENEIN eeeee2  isoform)
CPR:10	 bbbbb1 CHEMICALIN eeeee1  inhibited GENEIN activity stimulated by this specific heptapeptide but did not block CHEMICALIN binding or induce  bbbbb2 GENEIN eeeee2  expression
CPR:2	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN bind to  bbbbb2 GENEIN eeeee2  (GENENOTIN) and inhibit its GENEIN activity in human fibroblasts
CPR:2	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  bind to  bbbbb2 GENEIN eeeee2  (GENENOTIN) and inhibit its GENEIN activity in human fibroblasts
CPR:2	CHEMICALIN inhibited  bbbbb1 GENEIN eeeee1  activity stimulated by this specific heptapeptide but did not block  bbbbb2 CHEMICALIN eeeee2  binding or induce GENEIN expression
CPR:2	These results indicate that  bbbbb1 CHEMICALIN eeeee1  bind specifically to the polypeptide binding site of  bbbbb2 GENEIN eeeee2  in human cells that may interfere with folding and transport of proteins important in inflammation.
CPR:2	The Kd values of  bbbbb1 CHEMICALIN eeeee1  binding to crude extract and to recombinant  bbbbb2 GENEIN eeeee2  were 45.2 and 54.6 microM, respectively
CPR:4	 bbbbb1 CHEMICALIN eeeee1  inhibited  bbbbb2 GENEIN eeeee2  activity stimulated by this specific heptapeptide but did not block CHEMICALIN binding or induce GENEIN expression
CPR:4	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN bind to GENEIN (GENENOTIN) and inhibit its  bbbbb2 GENEIN eeeee2  activity in human fibroblasts
CPR:4	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  bind to GENEIN (GENENOTIN) and inhibit its  bbbbb2 GENEIN eeeee2  activity in human fibroblasts
CPR:9	The specific activity of only  bbbbb1 GENEIN eeeee1  (GENEIN), the rate-limiting enzyme in the conversion of CHEMICALIN to  bbbbb2 CHEMICALIN eeeee2 , increased in 2 weeks of hypertrophy
CPR:9	The specific activity of only GENEIN ( bbbbb1 GENEIN eeeee1 ), the rate-limiting enzyme in the conversion of CHEMICALIN to  bbbbb2 CHEMICALIN eeeee2 , increased in 2 weeks of hypertrophy
CPR:9	The specific activity of only  bbbbb1 GENEIN eeeee1  (GENEIN), the rate-limiting enzyme in the conversion of  bbbbb2 CHEMICALIN eeeee2  to CHEMICALIN, increased in 2 weeks of hypertrophy
CPR:9	The specific activity of only GENEIN ( bbbbb1 GENEIN eeeee1 ), the rate-limiting enzyme in the conversion of  bbbbb2 CHEMICALIN eeeee2  to CHEMICALIN, increased in 2 weeks of hypertrophy
CPR:2	Three replicate studies in the oral surgery model of acute pain used submucosal microdialysis sample collection for the measurement of CHEMICALIN (CHEMICALIN; a product of both GENEIN and GENEIN) and  bbbbb1 CHEMICALIN eeeee1  (as a biomarker for  bbbbb2 GENEIN eeeee2  activity) with parallel assessments of pain
CPR:2	CHEMICALIN selectively suppressed CHEMICALIN but not  bbbbb1 CHEMICALIN eeeee1  at time points consistent with  bbbbb2 GENEIN eeeee2  activity, while producing analgesia
CPR:4	A series of studies is reviewed that assesses the relationship between GENENOTIN released at the site of tissue injury and NSAID analgesia, and the in vivo selectivity of a selective  bbbbb1 GENEIN eeeee1  inhibitor ( bbbbb2 CHEMICALIN eeeee2 ) in comparison to a dual GENEIN/GENEIN inhibitor (CHEMICALIN)
CPR:4	A series of studies is reviewed that assesses the relationship between GENENOTIN released at the site of tissue injury and NSAID analgesia, and the in vivo selectivity of a selective GENEIN inhibitor (CHEMICALIN) in comparison to a dual  bbbbb1 GENEIN eeeee1 /GENEIN inhibitor ( bbbbb2 CHEMICALIN eeeee2 )
CPR:4	A series of studies is reviewed that assesses the relationship between GENENOTIN released at the site of tissue injury and NSAID analgesia, and the in vivo selectivity of a selective GENEIN inhibitor (CHEMICALIN) in comparison to a dual GENEIN/ bbbbb1 GENEIN eeeee1  inhibitor ( bbbbb2 CHEMICALIN eeeee2 )
CPR:4	 bbbbb1 CHEMICALIN eeeee1  selectively suppressed CHEMICALIN but not CHEMICALIN at time points consistent with  bbbbb2 GENEIN eeeee2  activity, while producing analgesia
CPR:9	Three replicate studies in the oral surgery model of acute pain used submucosal microdialysis sample collection for the measurement of  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN; a product of both  bbbbb2 GENEIN eeeee2  and GENEIN) and CHEMICALIN (as a biomarker for GENEIN activity) with parallel assessments of pain
CPR:9	Three replicate studies in the oral surgery model of acute pain used submucosal microdialysis sample collection for the measurement of  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN; a product of both GENEIN and  bbbbb2 GENEIN eeeee2 ) and CHEMICALIN (as a biomarker for GENEIN activity) with parallel assessments of pain
CPR:9	Three replicate studies in the oral surgery model of acute pain used submucosal microdialysis sample collection for the measurement of CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ; a product of both  bbbbb2 GENEIN eeeee2  and GENEIN) and CHEMICALIN (as a biomarker for GENEIN activity) with parallel assessments of pain
CPR:9	Three replicate studies in the oral surgery model of acute pain used submucosal microdialysis sample collection for the measurement of CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ; a product of both GENEIN and  bbbbb2 GENEIN eeeee2 ) and CHEMICALIN (as a biomarker for GENEIN activity) with parallel assessments of pain
CPR:9	The time course of  bbbbb1 CHEMICALIN eeeee1  production was consistent with early release due to  bbbbb2 GENEIN eeeee2  activity followed by increased production 2-3 hours after surgery, consistent with GENEIN expression
CPR:9	The time course of  bbbbb1 CHEMICALIN eeeee1  production was consistent with early release due to GENEIN activity followed by increased production 2-3 hours after surgery, consistent with  bbbbb2 GENEIN eeeee2  expression
CPR:9	CHEMICALIN selectively suppressed  bbbbb1 CHEMICALIN eeeee1  but not CHEMICALIN at time points consistent with  bbbbb2 GENEIN eeeee2  activity, while producing analgesia
CPR:9	These studies demonstrate the ability to assess the time course and selective effects of GENENOTIN inhibitors in vivo and suggest that suppression of  bbbbb1 GENEIN eeeee1  mediated  bbbbb2 CHEMICALIN eeeee2  is temporally related to NSAID analgesia.
CPR:2	These data indicate that a  bbbbb1 CHEMICALIN eeeee1  binding assay using  bbbbb2 GENEIN eeeee2  membranes may help identify compounds that prolong the QT interval.
CPR:2	 bbbbb1 CHEMICALIN eeeee1  binding to  bbbbb2 GENEIN eeeee2  transfected membranes: a potential high throughput preclinical screen
CPR:4	Acute and chronic  bbbbb1 CHEMICALIN eeeee1  administration increase brain CHEMICALNOTIN levels, an effect due, at least in part, to an inhibition of the activity of the CHEMICALIN metabolizing enzyme,  bbbbb2 GENEIN eeeee2  (GENEIN). 2
CPR:4	Acute and chronic  bbbbb1 CHEMICALIN eeeee1  administration increase brain CHEMICALNOTIN levels, an effect due, at least in part, to an inhibition of the activity of the CHEMICALIN metabolizing enzyme, GENEIN ( bbbbb2 GENEIN eeeee2 ). 2
CPR:4	The elevation in brain CHEMICALIN levels could be explained, at least in part, by a time- and dose-dependent inhibitory effect of  bbbbb1 CHEMICALIN eeeee1  on  bbbbb2 GENEIN eeeee2  (GENEIN), although as with CHEMICALNOTIN the increases are higher than expected from the degree of enzyme inhibition produced
CPR:4	The elevation in brain CHEMICALIN levels could be explained, at least in part, by a time- and dose-dependent inhibitory effect of  bbbbb1 CHEMICALIN eeeee1  on GENEIN ( bbbbb2 GENEIN eeeee2 ), although as with CHEMICALNOTIN the increases are higher than expected from the degree of enzyme inhibition produced
CPR:4	In addition, we also showed that the elevation in CHEMICALIN levels and the inhibition of  bbbbb1 GENEIN eeeee1  in the brain are retained after 14 days of  bbbbb2 CHEMICALIN eeeee2  treatment, and that CHEMICALNOTIN produces a marked increase in extracellular levels of CHEMICALNOTIN. 5
CPR:9	As with CHEMICALNOTIN, the metabolism of  bbbbb1 CHEMICALIN eeeee1  involves a  bbbbb2 GENEIN eeeee2 . 3
CPR:9	In the study reported here, the effects of acute CHEMICALNOTIN treatment on the levels of various  bbbbb1 CHEMICALIN eeeee1 , some of which are also metabolized by  bbbbb2 GENEIN eeeee2  were compared in rat whole brain
CPR:9	In addition, we also showed that the elevation in  bbbbb1 CHEMICALIN eeeee1  levels and the inhibition of  bbbbb2 GENEIN eeeee2  in the brain are retained after 14 days of CHEMICALIN treatment, and that CHEMICALNOTIN produces a marked increase in extracellular levels of CHEMICALNOTIN. 5
CPR:9	The elevation in brain  bbbbb1 CHEMICALIN eeeee1  levels could be explained, at least in part, by a time- and dose-dependent inhibitory effect of CHEMICALIN on  bbbbb2 GENEIN eeeee2  (GENEIN), although as with CHEMICALNOTIN the increases are higher than expected from the degree of enzyme inhibition produced
CPR:9	The elevation in brain  bbbbb1 CHEMICALIN eeeee1  levels could be explained, at least in part, by a time- and dose-dependent inhibitory effect of CHEMICALIN on GENEIN ( bbbbb2 GENEIN eeeee2 ), although as with CHEMICALNOTIN the increases are higher than expected from the degree of enzyme inhibition produced
CPR:9	Acute and chronic CHEMICALIN administration increase brain CHEMICALNOTIN levels, an effect due, at least in part, to an inhibition of the activity of the  bbbbb1 CHEMICALIN eeeee1  metabolizing enzyme,  bbbbb2 GENEIN eeeee2  (GENEIN). 2
CPR:9	Acute and chronic CHEMICALIN administration increase brain CHEMICALNOTIN levels, an effect due, at least in part, to an inhibition of the activity of the  bbbbb1 CHEMICALIN eeeee1  metabolizing enzyme, GENEIN ( bbbbb2 GENEIN eeeee2 ). 2
CPR:4	 bbbbb1 GENEIN eeeee1  (GENEIN) inhibitors ( bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN and CHEMICALIN) attenuated the CHEMICALNOTIN-induced contraction in a concentration-dependent manner, and GENEIN (GENEIN) inhibitors at high concentrations (CHEMICALIN and CHEMICALIN) slightly attenuated the contraction
CPR:4	GENEIN ( bbbbb1 GENEIN eeeee1 ) inhibitors ( bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN and CHEMICALIN) attenuated the CHEMICALNOTIN-induced contraction in a concentration-dependent manner, and GENEIN (GENEIN) inhibitors at high concentrations (CHEMICALIN and CHEMICALIN) slightly attenuated the contraction
CPR:4	 bbbbb1 GENEIN eeeee1  (GENEIN) inhibitors (CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN) attenuated the CHEMICALNOTIN-induced contraction in a concentration-dependent manner, and GENEIN (GENEIN) inhibitors at high concentrations (CHEMICALIN and CHEMICALIN) slightly attenuated the contraction
CPR:4	GENEIN ( bbbbb1 GENEIN eeeee1 ) inhibitors (CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN) attenuated the CHEMICALNOTIN-induced contraction in a concentration-dependent manner, and GENEIN (GENEIN) inhibitors at high concentrations (CHEMICALIN and CHEMICALIN) slightly attenuated the contraction
CPR:4	 bbbbb1 GENEIN eeeee1  (GENEIN) inhibitors (CHEMICALIN, CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 ) attenuated the CHEMICALNOTIN-induced contraction in a concentration-dependent manner, and GENEIN (GENEIN) inhibitors at high concentrations (CHEMICALIN and CHEMICALIN) slightly attenuated the contraction
CPR:4	GENEIN ( bbbbb1 GENEIN eeeee1 ) inhibitors (CHEMICALIN, CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 ) attenuated the CHEMICALNOTIN-induced contraction in a concentration-dependent manner, and GENEIN (GENEIN) inhibitors at high concentrations (CHEMICALIN and CHEMICALIN) slightly attenuated the contraction
CPR:4	GENEIN (GENEIN) inhibitors (CHEMICALIN, CHEMICALIN and CHEMICALIN) attenuated the CHEMICALNOTIN-induced contraction in a concentration-dependent manner, and  bbbbb1 GENEIN eeeee1  (GENEIN) inhibitors at high concentrations ( bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN) slightly attenuated the contraction
CPR:4	GENEIN (GENEIN) inhibitors (CHEMICALIN, CHEMICALIN and CHEMICALIN) attenuated the CHEMICALNOTIN-induced contraction in a concentration-dependent manner, and GENEIN ( bbbbb1 GENEIN eeeee1 ) inhibitors at high concentrations ( bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN) slightly attenuated the contraction
CPR:4	GENEIN (GENEIN) inhibitors (CHEMICALIN, CHEMICALIN and CHEMICALIN) attenuated the CHEMICALNOTIN-induced contraction in a concentration-dependent manner, and  bbbbb1 GENEIN eeeee1  (GENEIN) inhibitors at high concentrations (CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 ) slightly attenuated the contraction
CPR:4	GENEIN (GENEIN) inhibitors (CHEMICALIN, CHEMICALIN and CHEMICALIN) attenuated the CHEMICALNOTIN-induced contraction in a concentration-dependent manner, and GENEIN ( bbbbb1 GENEIN eeeee1 ) inhibitors at high concentrations (CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 ) slightly attenuated the contraction
CPR:4	A  bbbbb1 GENEIN eeeee1  inhibitor ( bbbbb2 CHEMICALIN eeeee2 ) attenuated the contraction to a small extent only at high concentrations
CPR:6	A  bbbbb1 GENEIN eeeee1  antagonist ( bbbbb2 CHEMICALIN eeeee2 ) attenuated the contraction in a concentration-dependent manner
CPR:6	A  bbbbb1 GENEIN eeeee1  antagonist ( bbbbb2 CHEMICALIN eeeee2 ) attenuated the contraction in part and an GENEIN antagonist (CHEMICALIN) nearly abolished the contraction
CPR:6	A GENEIN antagonist (CHEMICALIN) attenuated the contraction in part and an  bbbbb1 GENEIN eeeee1  antagonist ( bbbbb2 CHEMICALIN eeeee2 ) nearly abolished the contraction
CPR:2	Accordingly, docking of different  bbbbb1 GENEIN eeeee1  inhibitors, including selective and non-selective ligands: CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN and CHEMICALIN were undertaken using the AMBER program
CPR:2	Accordingly, docking of different  bbbbb1 GENEIN eeeee1  inhibitors, including selective and non-selective ligands: CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN and CHEMICALIN were undertaken using the AMBER program
CPR:2	Accordingly, docking of different  bbbbb1 GENEIN eeeee1  inhibitors, including selective and non-selective ligands: CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN were undertaken using the AMBER program
CPR:2	Accordingly, docking of different  bbbbb1 GENEIN eeeee1  inhibitors, including selective and non-selective ligands: CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  were undertaken using the AMBER program
CPR:2	Accordingly, docking of different  bbbbb1 GENEIN eeeee1  inhibitors, including selective and non-selective ligands:  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN were undertaken using the AMBER program
CPR:2	Accordingly, docking of different  bbbbb1 GENEIN eeeee1  inhibitors, including selective and non-selective ligands: CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN were undertaken using the AMBER program
CPR:2	Accordingly, docking of different  bbbbb1 GENEIN eeeee1  inhibitors, including selective and non-selective ligands: CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN were undertaken using the AMBER program
CPR:2	Accordingly, docking of different  bbbbb1 GENEIN eeeee1  inhibitors, including selective and non-selective ligands: CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN were undertaken using the AMBER program
CPR:4	Accordingly, docking of different  bbbbb1 GENEIN eeeee1  inhibitors, including selective and non-selective ligands: CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN and CHEMICALIN were undertaken using the AMBER program
CPR:4	Accordingly, docking of different  bbbbb1 GENEIN eeeee1  inhibitors, including selective and non-selective ligands: CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN and CHEMICALIN were undertaken using the AMBER program
CPR:4	Accordingly, docking of different  bbbbb1 GENEIN eeeee1  inhibitors, including selective and non-selective ligands: CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN were undertaken using the AMBER program
CPR:4	Accordingly, docking of different  bbbbb1 GENEIN eeeee1  inhibitors, including selective and non-selective ligands: CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  were undertaken using the AMBER program
CPR:4	Non- bbbbb1 CHEMICALIN eeeee1  anti-inflammatory drugs (NSAIDs) are competitive inhibitors of  bbbbb2 GENEIN eeeee2  (GENEIN), the enzyme that mediates biosynthesis of CHEMICALIN and CHEMICALIN from CHEMICALIN
CPR:4	Non- bbbbb1 CHEMICALIN eeeee1  anti-inflammatory drugs (NSAIDs) are competitive inhibitors of GENEIN ( bbbbb2 GENEIN eeeee2 ), the enzyme that mediates biosynthesis of CHEMICALIN and CHEMICALIN from CHEMICALIN
CPR:4	Accordingly, docking of different  bbbbb1 GENEIN eeeee1  inhibitors, including selective and non-selective ligands:  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN were undertaken using the AMBER program
CPR:4	Accordingly, docking of different  bbbbb1 GENEIN eeeee1  inhibitors, including selective and non-selective ligands: CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN were undertaken using the AMBER program
CPR:4	Accordingly, docking of different  bbbbb1 GENEIN eeeee1  inhibitors, including selective and non-selective ligands: CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN were undertaken using the AMBER program
CPR:4	Accordingly, docking of different  bbbbb1 GENEIN eeeee1  inhibitors, including selective and non-selective ligands: CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN were undertaken using the AMBER program
CPR:9	Non-CHEMICALIN anti-inflammatory drugs (NSAIDs) are competitive inhibitors of  bbbbb1 GENEIN eeeee1  (GENEIN), the enzyme that mediates biosynthesis of  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN from CHEMICALIN
CPR:9	Non-CHEMICALIN anti-inflammatory drugs (NSAIDs) are competitive inhibitors of GENEIN ( bbbbb1 GENEIN eeeee1 ), the enzyme that mediates biosynthesis of  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN from CHEMICALIN
CPR:9	Non-CHEMICALIN anti-inflammatory drugs (NSAIDs) are competitive inhibitors of  bbbbb1 GENEIN eeeee1  (GENEIN), the enzyme that mediates biosynthesis of CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  from CHEMICALIN
CPR:9	Non-CHEMICALIN anti-inflammatory drugs (NSAIDs) are competitive inhibitors of GENEIN ( bbbbb1 GENEIN eeeee1 ), the enzyme that mediates biosynthesis of CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  from CHEMICALIN
CPR:9	Non-CHEMICALIN anti-inflammatory drugs (NSAIDs) are competitive inhibitors of  bbbbb1 GENEIN eeeee1  (GENEIN), the enzyme that mediates biosynthesis of CHEMICALIN and CHEMICALIN from  bbbbb2 CHEMICALIN eeeee2 
CPR:9	Non-CHEMICALIN anti-inflammatory drugs (NSAIDs) are competitive inhibitors of GENEIN ( bbbbb1 GENEIN eeeee1 ), the enzyme that mediates biosynthesis of CHEMICALIN and CHEMICALIN from  bbbbb2 CHEMICALIN eeeee2 
CPR:2	CHEMICALIN (CHEMICALIN) (CHEMICALIN) and  bbbbb1 CHEMICALIN eeeee1  are competitive inhibitors of CHEMICALIN by binding to the  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:2	CHEMICALIN (CHEMICALIN) (CHEMICALIN) and  bbbbb1 CHEMICALIN eeeee1  are competitive inhibitors of CHEMICALIN by binding to the GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:2	CHEMICALIN (CHEMICALIN) (CHEMICALIN) and CHEMICALIN are competitive inhibitors of  bbbbb1 CHEMICALIN eeeee1  by binding to the  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:2	CHEMICALIN (CHEMICALIN) (CHEMICALIN) and CHEMICALIN are competitive inhibitors of  bbbbb1 CHEMICALIN eeeee1  by binding to the GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:2	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN are the most potent pure antiestrogens and CHEMICALIN has the highest affinity of all antiestrogens to  bbbbb2 GENEIN eeeee2 
CPR:2	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  are the most potent pure antiestrogens and CHEMICALIN has the highest affinity of all antiestrogens to  bbbbb2 GENEIN eeeee2 
CPR:2	CHEMICALIN and CHEMICALIN are the most potent pure antiestrogens and  bbbbb1 CHEMICALIN eeeee1  has the highest affinity of all antiestrogens to  bbbbb2 GENEIN eeeee2 
CPR:2	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) (CHEMICALIN) and CHEMICALIN are competitive inhibitors of CHEMICALIN by binding to the  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:2	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) (CHEMICALIN) and CHEMICALIN are competitive inhibitors of CHEMICALIN by binding to the GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:2	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) (CHEMICALIN) and CHEMICALIN are competitive inhibitors of CHEMICALIN by binding to the  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:2	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) (CHEMICALIN) and CHEMICALIN are competitive inhibitors of CHEMICALIN by binding to the GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:2	CHEMICALIN (CHEMICALIN) ( bbbbb1 CHEMICALIN eeeee1 ) and CHEMICALIN are competitive inhibitors of CHEMICALIN by binding to the  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:2	CHEMICALIN (CHEMICALIN) ( bbbbb1 CHEMICALIN eeeee1 ) and CHEMICALIN are competitive inhibitors of CHEMICALIN by binding to the GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:10	 bbbbb1 CHEMICALIN eeeee1  exerted no significant effects on action potential duration in isolated guinea pig ventricular myocytes, myocardium and  bbbbb2 GENEIN eeeee2 
CPR:6	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN) is a novel antiallergic/ bbbbb2 GENEIN eeeee2  antagonistic drug that was synthesized and evaluated in our laboratories
CPR:6	CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ) is a novel antiallergic/ bbbbb2 GENEIN eeeee2  antagonistic drug that was synthesized and evaluated in our laboratories
CPR:6	 bbbbb1 CHEMICALIN eeeee1  is a selective  bbbbb2 GENEIN eeeee2  antagonist possessing inhibitory effects on the release of inflammatory lipid mediators such as CHEMICALNOTIN and CHEMICALNOTIN from human polymorphonuclear leukocytes and eosinophils
CPR:6	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN) is a novel antiallergic/ bbbbb2 GENEIN eeeee2  antagonistic drug that was synthesized and evaluated in our laboratories
CPR:2	Considerable evidence indicates that serotonergic mechanisms, particularly the GENEIN ( bbbbb1 GENEIN eeeee1 ), may mediate central effects of  bbbbb2 CHEMICALIN eeeee2  and may also be involved in impulsive and aggressive behavior
CPR:2	Considerable evidence indicates that serotonergic mechanisms, particularly the  bbbbb1 GENEIN eeeee1  (GENEIN), may mediate central effects of  bbbbb2 CHEMICALIN eeeee2  and may also be involved in impulsive and aggressive behavior
CPR:2	Thus we have shown that low-dose CHEMICALIN exerts an anti-asthma effect through increasing activation of  bbbbb1 GENEIN eeeee1  which is subsequently recruited by  bbbbb2 CHEMICALIN eeeee2  to suppress inflammatory genes.
CPR:2	 bbbbb1 CHEMICALIN eeeee1  act, at least in part, by recruitment of  bbbbb2 GENEIN eeeee2  (GENEIN) to the site of active inflammatory gene transcription
CPR:2	 bbbbb1 CHEMICALIN eeeee1  act, at least in part, by recruitment of GENEIN ( bbbbb2 GENEIN eeeee2 ) to the site of active inflammatory gene transcription
CPR:2	This increased  bbbbb1 GENEIN eeeee1  activity is then available for  bbbbb2 CHEMICALIN eeeee2  recruitment and predicts a cooperative interaction between CHEMICALNOTIN and CHEMICALNOTIN
CPR:3	A molecular mechanism of action of  bbbbb1 CHEMICALIN eeeee1 : Induction of  bbbbb2 GENEIN eeeee2  activity to decrease inflammatory gene expression
CPR:3	Thus we have shown that low-dose  bbbbb1 CHEMICALIN eeeee1  exerts an anti-asthma effect through increasing activation of  bbbbb2 GENEIN eeeee2  which is subsequently recruited by CHEMICALIN to suppress inflammatory genes.
CPR:3	We show both in vitro and in vivo that low-dose  bbbbb1 CHEMICALIN eeeee1  enhances  bbbbb2 GENEIN eeeee2  activity in epithelial cells and macrophages
CPR:2	In conclusion, these results show that  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN interact with  bbbbb2 GENEIN eeeee2 -mediated substrate transport to different extents
CPR:2	In conclusion, these results show that CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  interact with  bbbbb2 GENEIN eeeee2 -mediated substrate transport to different extents
CPR:4	Inhibition of  bbbbb1 GENEIN eeeee1  can explain the previously observed effects of  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN on hepatic organic anion elimination.
CPR:4	Inhibition of  bbbbb1 GENEIN eeeee1  can explain the previously observed effects of CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  on hepatic organic anion elimination.
CPR:4	In complementary RNA (cRNA)-injected Xenopus laevis oocytes,  bbbbb1 CHEMICALIN eeeee1  (10 micromol/L) cis-inhibited  bbbbb2 GENEIN eeeee2  (GENEIN) (GENEIN), GENEIN (GENEIN) (GENEIN), GENEIN (GENEIN) (GENEIN), and GENEIN (GENEIN) (GENEIN) mediated BSP uptake by 69%, 79%, 89%, and 57%, respectively, as compared with uptake into control oocytes
CPR:4	In complementary RNA (cRNA)-injected Xenopus laevis oocytes,  bbbbb1 CHEMICALIN eeeee1  (10 micromol/L) cis-inhibited GENEIN ( bbbbb2 GENEIN eeeee2 ) (GENEIN), GENEIN (GENEIN) (GENEIN), GENEIN (GENEIN) (GENEIN), and GENEIN (GENEIN) (GENEIN) mediated BSP uptake by 69%, 79%, 89%, and 57%, respectively, as compared with uptake into control oocytes
CPR:4	In complementary RNA (cRNA)-injected Xenopus laevis oocytes,  bbbbb1 CHEMICALIN eeeee1  (10 micromol/L) cis-inhibited GENEIN (GENEIN) ( bbbbb2 GENEIN eeeee2 ), GENEIN (GENEIN) (GENEIN), GENEIN (GENEIN) (GENEIN), and GENEIN (GENEIN) (GENEIN) mediated BSP uptake by 69%, 79%, 89%, and 57%, respectively, as compared with uptake into control oocytes
CPR:4	In complementary RNA (cRNA)-injected Xenopus laevis oocytes,  bbbbb1 CHEMICALIN eeeee1  (10 micromol/L) cis-inhibited GENEIN (GENEIN) (GENEIN),  bbbbb2 GENEIN eeeee2  (GENEIN) (GENEIN), GENEIN (GENEIN) (GENEIN), and GENEIN (GENEIN) (GENEIN) mediated BSP uptake by 69%, 79%, 89%, and 57%, respectively, as compared with uptake into control oocytes
CPR:4	In complementary RNA (cRNA)-injected Xenopus laevis oocytes,  bbbbb1 CHEMICALIN eeeee1  (10 micromol/L) cis-inhibited GENEIN (GENEIN) (GENEIN), GENEIN ( bbbbb2 GENEIN eeeee2 ) (GENEIN), GENEIN (GENEIN) (GENEIN), and GENEIN (GENEIN) (GENEIN) mediated BSP uptake by 69%, 79%, 89%, and 57%, respectively, as compared with uptake into control oocytes
CPR:4	In complementary RNA (cRNA)-injected Xenopus laevis oocytes,  bbbbb1 CHEMICALIN eeeee1  (10 micromol/L) cis-inhibited GENEIN (GENEIN) (GENEIN), GENEIN (GENEIN) ( bbbbb2 GENEIN eeeee2 ), GENEIN (GENEIN) (GENEIN), and GENEIN (GENEIN) (GENEIN) mediated BSP uptake by 69%, 79%, 89%, and 57%, respectively, as compared with uptake into control oocytes
CPR:4	In complementary RNA (cRNA)-injected Xenopus laevis oocytes,  bbbbb1 CHEMICALIN eeeee1  (10 micromol/L) cis-inhibited GENEIN (GENEIN) (GENEIN), GENEIN (GENEIN) (GENEIN),  bbbbb2 GENEIN eeeee2  (GENEIN) (GENEIN), and GENEIN (GENEIN) (GENEIN) mediated BSP uptake by 69%, 79%, 89%, and 57%, respectively, as compared with uptake into control oocytes
CPR:4	In complementary RNA (cRNA)-injected Xenopus laevis oocytes,  bbbbb1 CHEMICALIN eeeee1  (10 micromol/L) cis-inhibited GENEIN (GENEIN) (GENEIN), GENEIN (GENEIN) (GENEIN), GENEIN ( bbbbb2 GENEIN eeeee2 ) (GENEIN), and GENEIN (GENEIN) (GENEIN) mediated BSP uptake by 69%, 79%, 89%, and 57%, respectively, as compared with uptake into control oocytes
CPR:4	In complementary RNA (cRNA)-injected Xenopus laevis oocytes,  bbbbb1 CHEMICALIN eeeee1  (10 micromol/L) cis-inhibited GENEIN (GENEIN) (GENEIN), GENEIN (GENEIN) (GENEIN), GENEIN (GENEIN) ( bbbbb2 GENEIN eeeee2 ), and GENEIN (GENEIN) (GENEIN) mediated BSP uptake by 69%, 79%, 89%, and 57%, respectively, as compared with uptake into control oocytes
CPR:4	In complementary RNA (cRNA)-injected Xenopus laevis oocytes,  bbbbb1 CHEMICALIN eeeee1  (10 micromol/L) cis-inhibited GENEIN (GENEIN) (GENEIN), GENEIN (GENEIN) (GENEIN), GENEIN (GENEIN) (GENEIN), and  bbbbb2 GENEIN eeeee2  (GENEIN) (GENEIN) mediated BSP uptake by 69%, 79%, 89%, and 57%, respectively, as compared with uptake into control oocytes
CPR:4	In complementary RNA (cRNA)-injected Xenopus laevis oocytes,  bbbbb1 CHEMICALIN eeeee1  (10 micromol/L) cis-inhibited GENEIN (GENEIN) (GENEIN), GENEIN (GENEIN) (GENEIN), GENEIN (GENEIN) (GENEIN), and GENEIN ( bbbbb2 GENEIN eeeee2 ) (GENEIN) mediated BSP uptake by 69%, 79%, 89%, and 57%, respectively, as compared with uptake into control oocytes
CPR:4	In complementary RNA (cRNA)-injected Xenopus laevis oocytes,  bbbbb1 CHEMICALIN eeeee1  (10 micromol/L) cis-inhibited GENEIN (GENEIN) (GENEIN), GENEIN (GENEIN) (GENEIN), GENEIN (GENEIN) (GENEIN), and GENEIN (GENEIN) ( bbbbb2 GENEIN eeeee2 ) mediated BSP uptake by 69%, 79%, 89%, and 57%, respectively, as compared with uptake into control oocytes
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (10 micromol/L) inhibited  bbbbb2 GENEIN eeeee2 -mediated CHEMICALIN uptake by 50%, whereas inhibition of GENEIN-, GENEIN-, and GENEIN-mediated CHEMICALIN transport was below 15%. 100 micromol/L CHEMICALIN inhibited GENEIN- and GENEIN-, GENEIN- and GENEIN-mediated CHEMICALIN uptake by 66%, 96%, 25%, and 49%, respectively
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (10 micromol/L) inhibited GENEIN-mediated CHEMICALIN uptake by 50%, whereas inhibition of  bbbbb2 GENEIN eeeee2 -, GENEIN-, and GENEIN-mediated CHEMICALIN transport was below 15%. 100 micromol/L CHEMICALIN inhibited GENEIN- and GENEIN-, GENEIN- and GENEIN-mediated CHEMICALIN uptake by 66%, 96%, 25%, and 49%, respectively
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (10 micromol/L) inhibited GENEIN-mediated CHEMICALIN uptake by 50%, whereas inhibition of GENEIN-,  bbbbb2 GENEIN eeeee2 -, and GENEIN-mediated CHEMICALIN transport was below 15%. 100 micromol/L CHEMICALIN inhibited GENEIN- and GENEIN-, GENEIN- and GENEIN-mediated CHEMICALIN uptake by 66%, 96%, 25%, and 49%, respectively
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (10 micromol/L) inhibited GENEIN-mediated CHEMICALIN uptake by 50%, whereas inhibition of GENEIN-, GENEIN-, and  bbbbb2 GENEIN eeeee2 -mediated CHEMICALIN transport was below 15%. 100 micromol/L CHEMICALIN inhibited GENEIN- and GENEIN-, GENEIN- and GENEIN-mediated CHEMICALIN uptake by 66%, 96%, 25%, and 49%, respectively
CPR:4	In rats,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN were shown to interfere with hepatic organic anion uptake by inhibition of the  bbbbb2 GENEIN eeeee2  GENEIN and GENEIN
CPR:4	In rats,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN were shown to interfere with hepatic organic anion uptake by inhibition of the GENEIN  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:4	In rats,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN were shown to interfere with hepatic organic anion uptake by inhibition of the GENEIN GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:4	CHEMICALIN (10 micromol/L) inhibited GENEIN-mediated CHEMICALIN uptake by 50%, whereas inhibition of GENEIN-, GENEIN-, and GENEIN-mediated CHEMICALIN transport was below 15%. 100 micromol/L  bbbbb1 CHEMICALIN eeeee1  inhibited  bbbbb2 GENEIN eeeee2 - and GENEIN-, GENEIN- and GENEIN-mediated CHEMICALIN uptake by 66%, 96%, 25%, and 49%, respectively
CPR:4	CHEMICALIN (10 micromol/L) inhibited GENEIN-mediated CHEMICALIN uptake by 50%, whereas inhibition of GENEIN-, GENEIN-, and GENEIN-mediated CHEMICALIN transport was below 15%. 100 micromol/L  bbbbb1 CHEMICALIN eeeee1  inhibited GENEIN- and  bbbbb2 GENEIN eeeee2 -, GENEIN- and GENEIN-mediated CHEMICALIN uptake by 66%, 96%, 25%, and 49%, respectively
CPR:4	CHEMICALIN (10 micromol/L) inhibited GENEIN-mediated CHEMICALIN uptake by 50%, whereas inhibition of GENEIN-, GENEIN-, and GENEIN-mediated CHEMICALIN transport was below 15%. 100 micromol/L  bbbbb1 CHEMICALIN eeeee1  inhibited GENEIN- and GENEIN-,  bbbbb2 GENEIN eeeee2 - and GENEIN-mediated CHEMICALIN uptake by 66%, 96%, 25%, and 49%, respectively
CPR:4	CHEMICALIN (10 micromol/L) inhibited GENEIN-mediated CHEMICALIN uptake by 50%, whereas inhibition of GENEIN-, GENEIN-, and GENEIN-mediated CHEMICALIN transport was below 15%. 100 micromol/L  bbbbb1 CHEMICALIN eeeee1  inhibited GENEIN- and GENEIN-, GENEIN- and  bbbbb2 GENEIN eeeee2 -mediated CHEMICALIN uptake by 66%, 96%, 25%, and 49%, respectively
CPR:4	In rats, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  were shown to interfere with hepatic organic anion uptake by inhibition of the  bbbbb2 GENEIN eeeee2  GENEIN and GENEIN
CPR:4	In rats, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  were shown to interfere with hepatic organic anion uptake by inhibition of the GENEIN  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:4	In rats, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  were shown to interfere with hepatic organic anion uptake by inhibition of the GENEIN GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:9	CHEMICALIN (10 micromol/L) inhibited  bbbbb1 GENEIN eeeee1 -mediated  bbbbb2 CHEMICALIN eeeee2  uptake by 50%, whereas inhibition of GENEIN-, GENEIN-, and GENEIN-mediated CHEMICALIN transport was below 15%. 100 micromol/L CHEMICALIN inhibited GENEIN- and GENEIN-, GENEIN- and GENEIN-mediated CHEMICALIN uptake by 66%, 96%, 25%, and 49%, respectively
CPR:9	CHEMICALIN (10 micromol/L) inhibited GENEIN-mediated CHEMICALIN uptake by 50%, whereas inhibition of  bbbbb1 GENEIN eeeee1 -, GENEIN-, and GENEIN-mediated  bbbbb2 CHEMICALIN eeeee2  transport was below 15%. 100 micromol/L CHEMICALIN inhibited GENEIN- and GENEIN-, GENEIN- and GENEIN-mediated CHEMICALIN uptake by 66%, 96%, 25%, and 49%, respectively
CPR:9	CHEMICALIN (10 micromol/L) inhibited GENEIN-mediated CHEMICALIN uptake by 50%, whereas inhibition of GENEIN-,  bbbbb1 GENEIN eeeee1 -, and GENEIN-mediated  bbbbb2 CHEMICALIN eeeee2  transport was below 15%. 100 micromol/L CHEMICALIN inhibited GENEIN- and GENEIN-, GENEIN- and GENEIN-mediated CHEMICALIN uptake by 66%, 96%, 25%, and 49%, respectively
CPR:9	CHEMICALIN (10 micromol/L) inhibited GENEIN-mediated CHEMICALIN uptake by 50%, whereas inhibition of GENEIN-, GENEIN-, and  bbbbb1 GENEIN eeeee1 -mediated  bbbbb2 CHEMICALIN eeeee2  transport was below 15%. 100 micromol/L CHEMICALIN inhibited GENEIN- and GENEIN-, GENEIN- and GENEIN-mediated CHEMICALIN uptake by 66%, 96%, 25%, and 49%, respectively
CPR:9	CHEMICALIN (10 micromol/L) inhibited GENEIN-mediated CHEMICALIN uptake by 50%, whereas inhibition of GENEIN-, GENEIN-, and GENEIN-mediated CHEMICALIN transport was below 15%. 100 micromol/L CHEMICALIN inhibited  bbbbb1 GENEIN eeeee1 - and GENEIN-, GENEIN- and GENEIN-mediated  bbbbb2 CHEMICALIN eeeee2  uptake by 66%, 96%, 25%, and 49%, respectively
CPR:9	CHEMICALIN (10 micromol/L) inhibited GENEIN-mediated CHEMICALIN uptake by 50%, whereas inhibition of GENEIN-, GENEIN-, and GENEIN-mediated CHEMICALIN transport was below 15%. 100 micromol/L CHEMICALIN inhibited GENEIN- and  bbbbb1 GENEIN eeeee1 -, GENEIN- and GENEIN-mediated  bbbbb2 CHEMICALIN eeeee2  uptake by 66%, 96%, 25%, and 49%, respectively
CPR:9	CHEMICALIN (10 micromol/L) inhibited GENEIN-mediated CHEMICALIN uptake by 50%, whereas inhibition of GENEIN-, GENEIN-, and GENEIN-mediated CHEMICALIN transport was below 15%. 100 micromol/L CHEMICALIN inhibited GENEIN- and GENEIN-,  bbbbb1 GENEIN eeeee1 - and GENEIN-mediated  bbbbb2 CHEMICALIN eeeee2  uptake by 66%, 96%, 25%, and 49%, respectively
CPR:9	CHEMICALIN (10 micromol/L) inhibited GENEIN-mediated CHEMICALIN uptake by 50%, whereas inhibition of GENEIN-, GENEIN-, and GENEIN-mediated CHEMICALIN transport was below 15%. 100 micromol/L CHEMICALIN inhibited GENEIN- and GENEIN-, GENEIN- and  bbbbb1 GENEIN eeeee1 -mediated  bbbbb2 CHEMICALIN eeeee2  uptake by 66%, 96%, 25%, and 49%, respectively
CPR:9	Direct transport of  bbbbb1 CHEMICALIN eeeee1  could be shown for  bbbbb2 GENEIN eeeee2  (apparent K(m) value 13 micromol/L) and GENEIN (2.3 micromol/L)
CPR:9	Direct transport of  bbbbb1 CHEMICALIN eeeee1  could be shown for GENEIN (apparent K(m) value 13 micromol/L) and  bbbbb2 GENEIN eeeee2  (2.3 micromol/L)
CPR:2	The increase in  bbbbb1 GENEIN eeeee1  activity was likely due to a change in muscle energy status because  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN concentrations were lower after CHEMICALIN treatment
CPR:2	The increase in  bbbbb1 GENEIN eeeee1  activity was likely due to a change in muscle energy status because CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  concentrations were lower after CHEMICALIN treatment
CPR:3	We recently reported that  bbbbb1 GENEIN eeeee1  is activated by  bbbbb2 CHEMICALIN eeeee2  in cultured rat hepatocytes, mediating the inhibitory effects of the drug on hepatic CHEMICALNOTIN production
CPR:3	In the present study, we evaluated whether therapeutic doses of  bbbbb1 CHEMICALIN eeeee1  increase  bbbbb2 GENEIN eeeee2  activity in vivo in subjects with type 2 diabetes
CPR:3	 bbbbb1 CHEMICALIN eeeee1  treatment for 10 weeks significantly increased  bbbbb2 GENEIN eeeee2  activity in the skeletal muscle, and this was associated with increased phosphorylation of GENEIN on Thr172 and decreased GENEIN activity
CPR:3	 bbbbb1 CHEMICALIN eeeee1  treatment for 10 weeks significantly increased GENEIN activity in the skeletal muscle, and this was associated with increased phosphorylation of  bbbbb2 GENEIN eeeee2  on Thr172 and decreased GENEIN activity
CPR:3	 bbbbb1 CHEMICALIN eeeee1  increases  bbbbb2 GENEIN eeeee2  activity in skeletal muscle of subjects with type 2 diabetes
CPR:3	The increase in  bbbbb1 GENEIN eeeee1  activity was likely due to a change in muscle energy status because CHEMICALIN and CHEMICALIN concentrations were lower after  bbbbb2 CHEMICALIN eeeee2  treatment
CPR:3	 bbbbb1 CHEMICALIN eeeee1 -induced increases in  bbbbb2 GENEIN eeeee2  activity were associated with higher rates of CHEMICALNOTIN disposal and muscle glycogen concentrations
CPR:4	 bbbbb1 CHEMICALIN eeeee1  treatment for 10 weeks significantly increased GENEIN activity in the skeletal muscle, and this was associated with increased phosphorylation of GENEIN on Thr172 and decreased  bbbbb2 GENEIN eeeee2  activity
CPR:9	 bbbbb1 GENEIN eeeee1  (GENEIN) activity increases in response to depletion of cellular energy stores, and this enzyme has been implicated in the stimulation of  bbbbb2 CHEMICALIN eeeee2  uptake into skeletal muscle and the inhibition of liver gluconeogenesis
CPR:9	GENEIN ( bbbbb1 GENEIN eeeee1 ) activity increases in response to depletion of cellular energy stores, and this enzyme has been implicated in the stimulation of  bbbbb2 CHEMICALIN eeeee2  uptake into skeletal muscle and the inhibition of liver gluconeogenesis
CPR:2	BACKGROUND & AIMS: Sensitization of Kupffer cells (KCs) to lipopolysaccharide (LPS) and overproduction of  bbbbb1 GENEIN eeeee1  are critical for progression of  bbbbb2 CHEMICALIN eeeee2  liver injury
CPR:4	CONCLUSIONS: These results collectively indicate that  bbbbb1 CHEMICALIN eeeee1  prevents alcoholic liver injury through suppression of  bbbbb2 GENEIN eeeee2  production and abolishment of KC sensitization.
CPR:4	 bbbbb1 CHEMICALIN eeeee1  has been shown to suppress  bbbbb2 GENEIN eeeee2  production from macrophages
CPR:4	 bbbbb1 CHEMICALIN eeeee1  prevents CHEMICALNOTIN liver injury in rats through suppression of Kupffer cell sensitization and  bbbbb2 GENEIN eeeee2  production
CPR:4	Furthermore,  bbbbb1 CHEMICALIN eeeee1  abolished the LPS-induced increase in  bbbbb2 GENEIN eeeee2  expression and [CHEMICALNOTIN]i elevation in KCs
CPR:4	Moreover,  bbbbb1 CHEMICALIN eeeee1  reduced the LPS-induced  bbbbb2 GENEIN eeeee2  production by KCs by decreasing GENEIN messenger RNA
CPR:4	Moreover,  bbbbb1 CHEMICALIN eeeee1  reduced the LPS-induced GENEIN production by KCs by decreasing  bbbbb2 GENEIN eeeee2  messenger RNA
CPR:10	Substrate specificity using lysates of GENENOTIN-transfected HEK-293 cells revealed that the newly identified  bbbbb1 GENEIN eeeee1  strongly favoured CHEMICALIN over CHEMICALIN and that it failed to act on  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN or the preferred GENEIN substrate, CHEMICALIN
CPR:10	Substrate specificity using lysates of GENENOTIN-transfected HEK-293 cells revealed that the newly identified  bbbbb1 GENEIN eeeee1  strongly favoured CHEMICALIN over CHEMICALIN and that it failed to act on CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2  or the preferred GENEIN substrate, CHEMICALIN
CPR:1	A BLAST search using  bbbbb1 GENEIN eeeee1  sequences identified homologous mammalian cDNAs derived from human hepatoma and mouse mammary carcinoma: the encoded proteins differed by 20  bbbbb2 CHEMICALIN eeeee2 
CPR:1	Identification and characterization of a novel  bbbbb1 CHEMICALIN eeeee1 -containing  bbbbb2 GENEIN eeeee2  of mammalian cell origin
CPR:4	The  bbbbb1 GENEIN eeeee1  inhibitor,  bbbbb2 CHEMICALIN eeeee2 , only partially blocked oxidation of CHEMICALNOTIN while a previously reported GENEIN substrate, CHEMICALIN, potently inhibited the reaction
CPR:9	During CHEMICALIN catabolism, CHEMICALIN and CHEMICALIN are first acetylated by GENEIN (GENEIN) and subsequently oxidized by  bbbbb1 GENEIN eeeee1  (GENEIN) to produce  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN, respectively
CPR:9	During CHEMICALIN catabolism, CHEMICALIN and CHEMICALIN are first acetylated by GENEIN (GENEIN) and subsequently oxidized by GENEIN ( bbbbb1 GENEIN eeeee1 ) to produce  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN, respectively
CPR:9	During CHEMICALIN catabolism, CHEMICALIN and CHEMICALIN are first acetylated by GENEIN (GENEIN) and subsequently oxidized by  bbbbb1 GENEIN eeeee1  (GENEIN) to produce CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 , respectively
CPR:9	During CHEMICALIN catabolism, CHEMICALIN and CHEMICALIN are first acetylated by GENEIN (GENEIN) and subsequently oxidized by GENEIN ( bbbbb1 GENEIN eeeee1 ) to produce CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 , respectively
CPR:9	During CHEMICALIN catabolism,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN are first acetylated by GENEIN ( bbbbb2 GENEIN eeeee2 ) and subsequently oxidized by GENEIN (GENEIN) to produce CHEMICALIN and CHEMICALIN, respectively
CPR:9	During CHEMICALIN catabolism,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN are first acetylated by  bbbbb2 GENEIN eeeee2  (GENEIN) and subsequently oxidized by GENEIN (GENEIN) to produce CHEMICALIN and CHEMICALIN, respectively
CPR:9	In attempting to clone the GENENOTIN involved in this back-conversion pathway, we encountered an GENENOTIN that preferentially cleaves  bbbbb1 CHEMICALIN eeeee1  in the absence of prior acetylation by  bbbbb2 GENEIN eeeee2 
CPR:9	During CHEMICALIN catabolism, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  are first acetylated by GENEIN ( bbbbb2 GENEIN eeeee2 ) and subsequently oxidized by GENEIN (GENEIN) to produce CHEMICALIN and CHEMICALIN, respectively
CPR:9	During CHEMICALIN catabolism, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  are first acetylated by  bbbbb2 GENEIN eeeee2  (GENEIN) and subsequently oxidized by GENEIN (GENEIN) to produce CHEMICALIN and CHEMICALIN, respectively
CPR:9	During  bbbbb1 CHEMICALIN eeeee1  catabolism, CHEMICALIN and CHEMICALIN are first acetylated by GENEIN ( bbbbb2 GENEIN eeeee2 ) and subsequently oxidized by GENEIN (GENEIN) to produce CHEMICALIN and CHEMICALIN, respectively
CPR:9	During  bbbbb1 CHEMICALIN eeeee1  catabolism, CHEMICALIN and CHEMICALIN are first acetylated by  bbbbb2 GENEIN eeeee2  (GENEIN) and subsequently oxidized by GENEIN (GENEIN) to produce CHEMICALIN and CHEMICALIN, respectively
CPR:9	Substrate specificity using lysates of GENENOTIN-transfected HEK-293 cells revealed that the newly identified  bbbbb1 GENEIN eeeee1  strongly favoured  bbbbb2 CHEMICALIN eeeee2  over CHEMICALIN and that it failed to act on CHEMICALIN, CHEMICALIN or the preferred GENEIN substrate, CHEMICALIN
CPR:9	Substrate specificity using lysates of GENENOTIN-transfected HEK-293 cells revealed that the newly identified  bbbbb1 GENEIN eeeee1  strongly favoured CHEMICALIN over  bbbbb2 CHEMICALIN eeeee2  and that it failed to act on CHEMICALIN, CHEMICALIN or the preferred GENEIN substrate, CHEMICALIN
CPR:9	Substrate specificity using lysates of GENENOTIN-transfected HEK-293 cells revealed that the newly identified GENEIN strongly favoured CHEMICALIN over CHEMICALIN and that it failed to act on CHEMICALIN, CHEMICALIN or the preferred  bbbbb1 GENEIN eeeee1  substrate,  bbbbb2 CHEMICALIN eeeee2 
CPR:9	The GENEIN inhibitor, CHEMICALIN, only partially blocked oxidation of CHEMICALNOTIN while a previously reported  bbbbb1 GENEIN eeeee1  substrate,  bbbbb2 CHEMICALIN eeeee2 , potently inhibited the reaction
CPR:10	A moderate (twofold) stimulation of  bbbbb1 GENEIN eeeee1  expression by abciximab but not by  bbbbb2 CHEMICALIN eeeee2  or CHEMICALIN was observed in one patient
CPR:10	A moderate (twofold) stimulation of  bbbbb1 GENEIN eeeee1  expression by abciximab but not by CHEMICALIN or  bbbbb2 CHEMICALIN eeeee2  was observed in one patient
CPR:3	In no other subject any activation of platelets by GENENOTIN inhibitors was observed and there were no statistically significant differences between GENENOTIN genotypes with respect to the effects of GENENOTIN inhibitors on basal or  bbbbb1 CHEMICALIN eeeee1 -stimulated  bbbbb2 GENEIN eeeee2  expression
CPR:3	Although a significant platelet hyperreactivity was observed in the patients, the GENENOTIN genotype did not influence basal or  bbbbb1 CHEMICALIN eeeee1 -induced  bbbbb2 GENEIN eeeee2  expression
CPR:1	Most halogenated CHEMICALIN are metabolized by CHEMICALNOTIN  bbbbb1 GENEIN eeeee1  to CHEMICALIN, CHEMICALIN, and an CHEMICALIN (with CHEMICALIN) or an CHEMICALIN (with CHEMICALIN) that may eliminate CHEMICALNOTIN to give a CHEMICALNOTIN, which reacts with  bbbbb2 CHEMICALIN eeeee2  groups of CHEMICALIN residues in proteins
CPR:1	Most halogenated CHEMICALIN are metabolized by CHEMICALNOTIN  bbbbb1 GENEIN eeeee1  to CHEMICALIN, CHEMICALIN, and an CHEMICALIN (with CHEMICALIN) or an CHEMICALIN (with CHEMICALIN) that may eliminate CHEMICALNOTIN to give a CHEMICALNOTIN, which reacts with CHEMICALIN groups of  bbbbb2 CHEMICALIN eeeee2  residues in proteins
CPR:9	Most halogenated CHEMICALIN are metabolized by CHEMICALNOTIN  bbbbb1 GENEIN eeeee1  to  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, and an CHEMICALIN (with CHEMICALIN) or an CHEMICALIN (with CHEMICALIN) that may eliminate CHEMICALNOTIN to give a CHEMICALNOTIN, which reacts with CHEMICALIN groups of CHEMICALIN residues in proteins
CPR:9	Most halogenated CHEMICALIN are metabolized by CHEMICALNOTIN  bbbbb1 GENEIN eeeee1  to CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , and an CHEMICALIN (with CHEMICALIN) or an CHEMICALIN (with CHEMICALIN) that may eliminate CHEMICALNOTIN to give a CHEMICALNOTIN, which reacts with CHEMICALIN groups of CHEMICALIN residues in proteins
CPR:9	Most halogenated CHEMICALIN are metabolized by CHEMICALNOTIN  bbbbb1 GENEIN eeeee1  to CHEMICALIN, CHEMICALIN, and an  bbbbb2 CHEMICALIN eeeee2  (with CHEMICALIN) or an CHEMICALIN (with CHEMICALIN) that may eliminate CHEMICALNOTIN to give a CHEMICALNOTIN, which reacts with CHEMICALIN groups of CHEMICALIN residues in proteins
CPR:9	Most halogenated CHEMICALIN are metabolized by CHEMICALNOTIN  bbbbb1 GENEIN eeeee1  to CHEMICALIN, CHEMICALIN, and an CHEMICALIN (with  bbbbb2 CHEMICALIN eeeee2 ) or an CHEMICALIN (with CHEMICALIN) that may eliminate CHEMICALNOTIN to give a CHEMICALNOTIN, which reacts with CHEMICALIN groups of CHEMICALIN residues in proteins
CPR:9	Most halogenated CHEMICALIN are metabolized by CHEMICALNOTIN  bbbbb1 GENEIN eeeee1  to CHEMICALIN, CHEMICALIN, and an CHEMICALIN (with CHEMICALIN) or an  bbbbb2 CHEMICALIN eeeee2  (with CHEMICALIN) that may eliminate CHEMICALNOTIN to give a CHEMICALNOTIN, which reacts with CHEMICALIN groups of CHEMICALIN residues in proteins
CPR:9	Most halogenated CHEMICALIN are metabolized by CHEMICALNOTIN  bbbbb1 GENEIN eeeee1  to CHEMICALIN, CHEMICALIN, and an CHEMICALIN (with CHEMICALIN) or an CHEMICALIN (with  bbbbb2 CHEMICALIN eeeee2 ) that may eliminate CHEMICALNOTIN to give a CHEMICALNOTIN, which reacts with CHEMICALIN groups of CHEMICALIN residues in proteins
CPR:9	Most halogenated  bbbbb1 CHEMICALIN eeeee1  are metabolized by CHEMICALNOTIN  bbbbb2 GENEIN eeeee2  to CHEMICALIN, CHEMICALIN, and an CHEMICALIN (with CHEMICALIN) or an CHEMICALIN (with CHEMICALIN) that may eliminate CHEMICALNOTIN to give a CHEMICALNOTIN, which reacts with CHEMICALIN groups of CHEMICALIN residues in proteins
CPR:9	The juvenile visceral steatosis (jvs) mouse, having a mutation in the  bbbbb1 CHEMICALIN eeeee1  transporter gene  bbbbb2 GENEIN eeeee2 , is a model of primary systemic CHEMICALNOTIN deficiency in humans (SCD, OMIM 212140)
CPR:10	However, CHEMICALNOTIN at a low concentration essentially blocked the radioactive outflow induced by all of these substances with the exception of  bbbbb1 CHEMICALIN eeeee1 , indicating the GENEIN and not an  bbbbb2 GENEIN eeeee2  as their primary site of action
CPR:10	No trans-stimulation of  bbbbb1 CHEMICALIN eeeee1  outflow was observed by the  bbbbb2 GENEIN eeeee2  and GENEIN substrate carnitine at 100 microM
CPR:10	No trans-stimulation of  bbbbb1 CHEMICALIN eeeee1  outflow was observed by the GENEIN and  bbbbb2 GENEIN eeeee2  substrate carnitine at 100 microM
CPR:4	The ensuing radioactive outflow from these cultures was enhanced by CHEMICALNOTIN and CHEMICALNOTIN, but reduced (in the presence of CHEMICALNOTIN) by the  bbbbb1 GENEIN eeeee1  inhibitors cyanine 863,  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:4	The ensuing radioactive outflow from these cultures was enhanced by CHEMICALNOTIN and CHEMICALNOTIN, but reduced (in the presence of CHEMICALNOTIN) by the  bbbbb1 GENEIN eeeee1  inhibitors cyanine 863, CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:9	However, CHEMICALNOTIN at a low concentration essentially blocked the radioactive outflow induced by all of these substances with the exception of  bbbbb1 CHEMICALIN eeeee1 , indicating the  bbbbb2 GENEIN eeeee2  and not an GENEIN as their primary site of action
CPR:9	Our observations indicate an  bbbbb1 GENEIN eeeee1 -mediated transmembrane transport of  bbbbb2 CHEMICALIN eeeee2 
CPR:9	Amongst the three  bbbbb1 GENEIN eeeee1  expressed in the SCG, GENEIN best fits the profile of substrates and antagonists that cause trans-stimulation and trans-inhibition, respectively, of  bbbbb2 CHEMICALIN eeeee2  release.
CPR:9	Amongst the three GENEIN expressed in the SCG,  bbbbb1 GENEIN eeeee1  best fits the profile of substrates and antagonists that cause trans-stimulation and trans-inhibition, respectively, of  bbbbb2 CHEMICALIN eeeee2  release.
CPR:9	Reuptake of extracellular  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) into superior cervical ganglion (SCG) neurones is mediated by means of the  bbbbb2 GENEIN eeeee2  (GENEIN, uptake 1)
CPR:9	Reuptake of extracellular  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) into superior cervical ganglion (SCG) neurones is mediated by means of the GENEIN ( bbbbb2 GENEIN eeeee2 , uptake 1)
CPR:9	Reuptake of extracellular CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) into superior cervical ganglion (SCG) neurones is mediated by means of the  bbbbb2 GENEIN eeeee2  (GENEIN, uptake 1)
CPR:9	Reuptake of extracellular CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) into superior cervical ganglion (SCG) neurones is mediated by means of the GENEIN ( bbbbb2 GENEIN eeeee2 , uptake 1)
CPR:9	The outflow of  bbbbb1 CHEMICALIN eeeee1  was significantly enhanced by CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN as potential substrates for  bbbbb2 GENEIN eeeee2 -related GENEIN
CPR:9	The outflow of  bbbbb1 CHEMICALIN eeeee1  was significantly enhanced by CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN as potential substrates for GENEIN-related  bbbbb2 GENEIN eeeee2 
CPR:9	The outflow of CHEMICALIN was significantly enhanced by  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN and CHEMICALIN as potential substrates for  bbbbb2 GENEIN eeeee2 -related GENEIN
CPR:9	The outflow of CHEMICALIN was significantly enhanced by  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN and CHEMICALIN as potential substrates for GENEIN-related  bbbbb2 GENEIN eeeee2 
CPR:9	The outflow of CHEMICALIN was significantly enhanced by CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and CHEMICALIN as potential substrates for  bbbbb2 GENEIN eeeee2 -related GENEIN
CPR:9	The outflow of CHEMICALIN was significantly enhanced by CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and CHEMICALIN as potential substrates for GENEIN-related  bbbbb2 GENEIN eeeee2 
CPR:9	The outflow of CHEMICALIN was significantly enhanced by CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN as potential substrates for  bbbbb2 GENEIN eeeee2 -related GENEIN
CPR:9	The outflow of CHEMICALIN was significantly enhanced by CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN as potential substrates for GENEIN-related  bbbbb2 GENEIN eeeee2 
CPR:9	The outflow of CHEMICALIN was significantly enhanced by CHEMICALIN, CHEMICALIN, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  as potential substrates for  bbbbb2 GENEIN eeeee2 -related GENEIN
CPR:9	The outflow of CHEMICALIN was significantly enhanced by CHEMICALIN, CHEMICALIN, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  as potential substrates for GENEIN-related  bbbbb2 GENEIN eeeee2 
CPR:3	Long-term administration of  bbbbb1 CHEMICALIN eeeee1  to rats increased the activities of antioxidative enzymes  bbbbb2 GENEIN eeeee2  (GENEIN) and GENEIN in the brain regions containing CHEMICALNOTIN neurons
CPR:3	Long-term administration of  bbbbb1 CHEMICALIN eeeee1  to rats increased the activities of antioxidative enzymes GENEIN ( bbbbb2 GENEIN eeeee2 ) and GENEIN in the brain regions containing CHEMICALNOTIN neurons
CPR:3	Long-term administration of  bbbbb1 CHEMICALIN eeeee1  to rats increased the activities of antioxidative enzymes GENEIN (GENEIN) and  bbbbb2 GENEIN eeeee2  in the brain regions containing CHEMICALNOTIN neurons
CPR:3	 bbbbb1 CHEMICALIN eeeee1  prevented the PT in mitochondria directly and also indirectly through induction of antiapoptotic  bbbbb2 GENEIN eeeee2  and a GENEIN, GENEIN (GENEIN)
CPR:3	 bbbbb1 CHEMICALIN eeeee1  prevented the PT in mitochondria directly and also indirectly through induction of antiapoptotic GENEIN and a  bbbbb2 GENEIN eeeee2 , GENEIN (GENEIN)
CPR:3	 bbbbb1 CHEMICALIN eeeee1  prevented the PT in mitochondria directly and also indirectly through induction of antiapoptotic GENEIN and a GENEIN,  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:3	 bbbbb1 CHEMICALIN eeeee1  prevented the PT in mitochondria directly and also indirectly through induction of antiapoptotic GENEIN and a GENEIN, GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:4	An inhibitor of  bbbbb1 GENEIN eeeee1  (GENEIN),  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), was reported to have neuroprotective activity, but clinical trials failed to confirm it
CPR:4	An inhibitor of GENEIN ( bbbbb1 GENEIN eeeee1 ),  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), was reported to have neuroprotective activity, but clinical trials failed to confirm it
CPR:4	An inhibitor of  bbbbb1 GENEIN eeeee1  (GENEIN), CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), was reported to have neuroprotective activity, but clinical trials failed to confirm it
CPR:4	An inhibitor of GENEIN ( bbbbb1 GENEIN eeeee1 ), CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), was reported to have neuroprotective activity, but clinical trials failed to confirm it
CPR:2	These differences from the horse might be the result of: (a) the presence in equine biological fluids of higher concentrations than in calves of the active CHEMICALNOTIN metabolite, CHEMICALNOTIN; (b) a greater degree of binding of CHEMICALNOTIN to plasma protein in calves; (c) species differences in the sensitivity to  bbbbb1 CHEMICALIN eeeee1  of the  bbbbb2 GENEIN eeeee2  (GENEIN) isoenzymes, GENEIN and GENEIN or; (d) a combination of these factors
CPR:2	These differences from the horse might be the result of: (a) the presence in equine biological fluids of higher concentrations than in calves of the active CHEMICALNOTIN metabolite, CHEMICALNOTIN; (b) a greater degree of binding of CHEMICALNOTIN to plasma protein in calves; (c) species differences in the sensitivity to  bbbbb1 CHEMICALIN eeeee1  of the GENEIN ( bbbbb2 GENEIN eeeee2 ) isoenzymes, GENEIN and GENEIN or; (d) a combination of these factors
CPR:2	These differences from the horse might be the result of: (a) the presence in equine biological fluids of higher concentrations than in calves of the active CHEMICALNOTIN metabolite, CHEMICALNOTIN; (b) a greater degree of binding of CHEMICALNOTIN to plasma protein in calves; (c) species differences in the sensitivity to  bbbbb1 CHEMICALIN eeeee1  of the GENEIN (GENEIN) isoenzymes,  bbbbb2 GENEIN eeeee2  and GENEIN or; (d) a combination of these factors
CPR:2	These differences from the horse might be the result of: (a) the presence in equine biological fluids of higher concentrations than in calves of the active CHEMICALNOTIN metabolite, CHEMICALNOTIN; (b) a greater degree of binding of CHEMICALNOTIN to plasma protein in calves; (c) species differences in the sensitivity to  bbbbb1 CHEMICALIN eeeee1  of the GENEIN (GENEIN) isoenzymes, GENEIN and  bbbbb2 GENEIN eeeee2  or; (d) a combination of these factors
CPR:6	A streamlined and high-yielding synthesis of  bbbbb1 CHEMICALIN eeeee1  (1), a potent  bbbbb2 GENEIN eeeee2  antagonist, is described
CPR:6	Practical asymmetric synthesis of  bbbbb1 CHEMICALIN eeeee1 , a potent human  bbbbb2 GENEIN eeeee2  antagonist, via a stereoselective Lewis acid-catalyzed trans acetalization reaction
CPR:2	Pentosan polysulfate  bbbbb1 CHEMICALIN eeeee1  (PPS) has been shown to exert antitumor activity by antagonizing the binding of  bbbbb2 GENEIN eeeee2  to cell surface receptors
CPR:6	Pentosan polysulfate  bbbbb1 CHEMICALIN eeeee1  (PPS) has been shown to exert antitumor activity by antagonizing the binding of  bbbbb2 GENEIN eeeee2  to cell surface receptors
CPR:2	Colocalization of  bbbbb1 GENEIN eeeee1  with GENENOTIN, the  bbbbb2 CHEMICALIN eeeee2 -sensitive transporter, and the GENENOTIN GENENOTIN and GENENOTIN demonstrated GENENOTIN immunoreactivity in all CNT cells and all CCD and ICT principal cells
CPR:9	These findings suggest that  bbbbb1 GENEIN eeeee1  and GENEIN may play important and cell-specific roles in  bbbbb2 CHEMICALIN eeeee2  transport and signaling in these regions of the kidney.
CPR:9	These findings suggest that GENEIN and  bbbbb1 GENEIN eeeee1  may play important and cell-specific roles in  bbbbb2 CHEMICALIN eeeee2  transport and signaling in these regions of the kidney.
CPR:4	This approach is validated by the clinical efficacy and safety of  bbbbb1 CHEMICALIN eeeee1 , the pioneering drug for selective  bbbbb2 GENEIN eeeee2  inhibitor therapy for ED
CPR:4	 bbbbb1 CHEMICALIN eeeee1  exhibits inhibitory potency against GENEIN and a 10-fold lower dose-related inhibitory potency against rod outer segment GENEIN, the predominant  bbbbb2 GENEIN eeeee2  in the phototransduction cascade in rods
CPR:4	 bbbbb1 CHEMICALIN eeeee1  exhibits inhibitory potency against  bbbbb2 GENEIN eeeee2  and a 10-fold lower dose-related inhibitory potency against rod outer segment GENEIN, the predominant GENEIN in the phototransduction cascade in rods
CPR:4	 bbbbb1 CHEMICALIN eeeee1  exhibits inhibitory potency against GENEIN and a 10-fold lower dose-related inhibitory potency against rod outer segment  bbbbb2 GENEIN eeeee2 , the predominant GENEIN in the phototransduction cascade in rods
CPR:4	As free  bbbbb1 CHEMICALIN eeeee1  plasma concentrations approach concentrations sufficient to inhibit retinal  bbbbb2 GENEIN eeeee2 , usually at higher therapeutic doses, transient, reversible visual adverse events can occur, albeit infrequently
CPR:4	Selective inhibition of  bbbbb1 GENEIN eeeee1  is a rational therapeutic approach in ED, as proved by the clinical success of  bbbbb2 CHEMICALIN eeeee2 .
CPR:4	Therefore, in men with ED, elevation of CHEMICALNOTIN in corpus cavernosal tissue via selective inhibition of  bbbbb1 CHEMICALIN eeeee1 -specific  bbbbb2 GENEIN eeeee2  is a means of improving erectile function at minimal risk of adverse events
CPR:9	 bbbbb1 GENEIN eeeee1  is the predominant GENEIN in the corpus cavernosum, and  bbbbb2 CHEMICALIN eeeee2  is its primary substrate
CPR:9	GENEIN is the predominant  bbbbb1 GENEIN eeeee1  in the corpus cavernosum, and  bbbbb2 CHEMICALIN eeeee2  is its primary substrate
CPR:10	These two alleles were shown previously to be associated with  bbbbb1 CHEMICALIN eeeee1  susceptibility (GENEIN) and resistance ( bbbbb2 GENEIN eeeee2 ), respectively
CPR:2	These two alleles were shown previously to be associated with  bbbbb1 CHEMICALIN eeeee1  susceptibility ( bbbbb2 GENEIN eeeee2 ) and resistance (GENEIN), respectively
CPR:2	Study of the nematode putative  bbbbb1 GENEIN eeeee1  subunits: evidence for modulation by  bbbbb2 CHEMICALIN eeeee2 
CPR:2	However, when coapplied with 10 micro m CHEMICALNOTIN, CHEMICALIN potentiated the  bbbbb1 CHEMICALIN eeeee1 -evoked current of the  bbbbb2 GENEIN eeeee2 /GENEIN receptor, but attenuated the CHEMICALIN response of the GENEIN/GENEIN receptor
CPR:2	However, when coapplied with 10 micro m CHEMICALNOTIN, CHEMICALIN potentiated the  bbbbb1 CHEMICALIN eeeee1 -evoked current of the GENEIN/ bbbbb2 GENEIN eeeee2  receptor, but attenuated the CHEMICALIN response of the GENEIN/GENEIN receptor
CPR:2	However, when coapplied with 10 micro m CHEMICALNOTIN, CHEMICALIN potentiated the CHEMICALIN-evoked current of the GENEIN/GENEIN receptor, but attenuated the  bbbbb1 CHEMICALIN eeeee1  response of the  bbbbb2 GENEIN eeeee2 /GENEIN receptor
CPR:2	However, when coapplied with 10 micro m CHEMICALNOTIN, CHEMICALIN potentiated the CHEMICALIN-evoked current of the GENEIN/GENEIN receptor, but attenuated the  bbbbb1 CHEMICALIN eeeee1  response of the GENEIN/ bbbbb2 GENEIN eeeee2  receptor
CPR:2	We demonstrated that the coexpressed  bbbbb1 GENEIN eeeee1  and GENEIN receptors are  bbbbb2 CHEMICALIN eeeee2 -responsive, and provide evidence for the possible involvement of GENEIN in the mechanism of CHEMICALIN resistance.
CPR:2	We demonstrated that the coexpressed GENEIN and  bbbbb1 GENEIN eeeee1  receptors are  bbbbb2 CHEMICALIN eeeee2 -responsive, and provide evidence for the possible involvement of GENEIN in the mechanism of CHEMICALIN resistance.
CPR:2	We demonstrated that the coexpressed GENEIN and GENEIN receptors are CHEMICALIN-responsive, and provide evidence for the possible involvement of  bbbbb1 GENEIN eeeee1  in the mechanism of  bbbbb2 CHEMICALIN eeeee2  resistance.
CPR:3	However, when coapplied with 10 micro m CHEMICALNOTIN,  bbbbb1 CHEMICALIN eeeee1  potentiated the CHEMICALIN-evoked current of the  bbbbb2 GENEIN eeeee2 /GENEIN receptor, but attenuated the CHEMICALIN response of the GENEIN/GENEIN receptor
CPR:3	However, when coapplied with 10 micro m CHEMICALNOTIN,  bbbbb1 CHEMICALIN eeeee1  potentiated the CHEMICALIN-evoked current of the GENEIN/ bbbbb2 GENEIN eeeee2  receptor, but attenuated the CHEMICALIN response of the GENEIN/GENEIN receptor
CPR:4	However, when coapplied with 10 micro m CHEMICALNOTIN,  bbbbb1 CHEMICALIN eeeee1  potentiated the CHEMICALIN-evoked current of the GENEIN/GENEIN receptor, but attenuated the CHEMICALIN response of the  bbbbb2 GENEIN eeeee2 /GENEIN receptor
CPR:4	However, when coapplied with 10 micro m CHEMICALNOTIN,  bbbbb1 CHEMICALIN eeeee1  potentiated the CHEMICALIN-evoked current of the GENEIN/GENEIN receptor, but attenuated the CHEMICALIN response of the GENEIN/ bbbbb2 GENEIN eeeee2  receptor
CPR:2	Each dimeric analog showed higher affinities for GENENOTIN versus the GENENOTIN; and  bbbbb1 CHEMICALIN eeeee1  dimers with spacers of n = 2, 3, 4, 18, and 24 exhibited selectivity for the  bbbbb2 GENEIN eeeee2 
CPR:2	The  bbbbb1 CHEMICALIN eeeee1  dimers n = 3 and n = 24 showed the highest potency and selectivity (32- and 82-fold. respectively) for the  bbbbb2 GENEIN eeeee2  in receptor binding and in functional studies (42- and 29-fold, respectively) measuring CHEMICALNOTIN changes using a cell-based luciferase reporter gene assay
CPR:2	These findings demonstrate that the addition of spacer linkages to bivalent  bbbbb1 CHEMICALIN eeeee1  molecules provides a successful approach to the development of ligands that are potent and highly selective for the  bbbbb2 GENEIN eeeee2 .
CPR:2	Initial studies showed that  bbbbb1 CHEMICALIN eeeee1  was about 4- and 15-fold more selective for the  bbbbb2 GENEIN eeeee2  in comparison with the GENENOTIN, respectively
CPR:2	 bbbbb1 CHEMICALIN eeeee1  dimers exhibiting selectivity for the  bbbbb2 GENEIN eeeee2  subtype
CPR:6	 bbbbb1 CHEMICALIN eeeee1  is a potent and selective  bbbbb2 GENEIN eeeee2  antagonist
CPR:2	These results demonstrate that  bbbbb1 CHEMICALIN eeeee1  molecules directly induce pDC maturation as determined by GENEIN induction,  bbbbb2 GENEIN eeeee2  and co-stimulatory marker expression and prolonging viability.
CPR:2	Plasmacytoid dendritic cells produce  bbbbb1 GENEIN eeeee1  and mature in response to the GENEIN agonists, CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:2	Plasmacytoid dendritic cells produce  bbbbb1 GENEIN eeeee1  and mature in response to the GENEIN agonists,  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:2	Results indicate that  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN induce GENEIN and GENEIN from purified pDC, and pDC are the principle  bbbbb2 GENEIN eeeee2 -producing cells in the blood
CPR:2	Results indicate that CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  induce  bbbbb2 GENEIN eeeee2  and GENEIN from purified pDC, and pDC are the principle GENEIN-producing cells in the blood
CPR:2	Results indicate that CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  induce GENEIN and GENEIN from purified pDC, and pDC are the principle  bbbbb2 GENEIN eeeee2 -producing cells in the blood
CPR:3	These results demonstrate that  bbbbb1 CHEMICALIN eeeee1  molecules directly induce pDC maturation as determined by  bbbbb2 GENEIN eeeee2  induction, GENEIN and co-stimulatory marker expression and prolonging viability.
CPR:3	The immune response modifiers,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, are GENEIN agonists that induce  bbbbb2 GENEIN eeeee2  in numerous species, including humans
CPR:3	Results indicate that  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN induce  bbbbb2 GENEIN eeeee2  and GENEIN from purified pDC, and pDC are the principle GENEIN-producing cells in the blood
CPR:3	Results indicate that  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN induce GENEIN and  bbbbb2 GENEIN eeeee2  from purified pDC, and pDC are the principle GENEIN-producing cells in the blood
CPR:3	The immune response modifiers, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , are GENEIN agonists that induce  bbbbb2 GENEIN eeeee2  in numerous species, including humans
CPR:3	 bbbbb1 CHEMICALIN eeeee1 -stimulated pDC also produce a number of other  bbbbb2 GENEIN eeeee2  including GENEIN and GENEIN
CPR:3	 bbbbb1 CHEMICALIN eeeee1 -stimulated pDC also produce a number of other GENEIN including  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:3	 bbbbb1 CHEMICALIN eeeee1 -stimulated pDC also produce a number of other GENEIN including GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:3	 bbbbb1 CHEMICALIN eeeee1  enhances co-stimulatory marker expression,  bbbbb2 GENEIN eeeee2  expression, and pDC viability
CPR:5	Plasmacytoid dendritic cells produce GENEIN and mature in response to the  bbbbb1 GENEIN eeeee1  agonists, CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:5	Plasmacytoid dendritic cells produce GENEIN and mature in response to the  bbbbb1 GENEIN eeeee1  agonists,  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:5	The immune response modifiers,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, are  bbbbb2 GENEIN eeeee2  agonists that induce GENEIN in numerous species, including humans
CPR:5	Here, we characterize the activation of human pDC with the  bbbbb1 GENEIN eeeee1  agonists  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:5	Here, we characterize the activation of human pDC with the  bbbbb1 GENEIN eeeee1  agonists CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:5	The immune response modifiers, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , are  bbbbb2 GENEIN eeeee2  agonists that induce GENEIN in numerous species, including humans
CPR:2	It is suggested that GENENOTIN expression at the time of  bbbbb1 CHEMICALIN eeeee1  exposure protects astrocytes from oxidative injury and apoptotic cell death by means of pro-survival  bbbbb2 GENEIN eeeee2 .
CPR:3	 bbbbb1 CHEMICALIN eeeee1  caused cell loss and increased cell death with features of apoptosis, i.e. TdT-mediated dUTP nick-end labelling (TUNEL) reaction and  bbbbb2 GENEIN eeeee2  activation
CPR:3	Pre-treatment with arsenite increased  bbbbb1 GENEIN eeeee1  (GENEIN) and GENENOTIN (GENENOTIN) phosphorylation after  bbbbb2 CHEMICALIN eeeee2 
CPR:3	Pre-treatment with arsenite increased GENEIN ( bbbbb1 GENEIN eeeee1 ) and GENENOTIN (GENENOTIN) phosphorylation after  bbbbb2 CHEMICALIN eeeee2 
CPR:3	The results show that transient  bbbbb1 CHEMICALIN eeeee1  pre-treatment induces GENEIN, GENEIN and, to a lesser extent, GENEIN; it reduces CHEMICALNOTIN-induced astrocyte death; and it causes selective activation of  bbbbb2 GENEIN eeeee2  following CHEMICALIN
CPR:3	The results show that transient CHEMICALIN pre-treatment induces GENEIN, GENEIN and, to a lesser extent, GENEIN; it reduces CHEMICALNOTIN-induced astrocyte death; and it causes selective activation of  bbbbb1 GENEIN eeeee1  following  bbbbb2 CHEMICALIN eeeee2 
CPR:3	Induction of  bbbbb1 GENEIN eeeee1  (GENEIN) by  bbbbb2 CHEMICALIN eeeee2  in cultured astrocytes and reduction of CHEMICALNOTIN-induced cell death
CPR:3	Induction of GENEIN ( bbbbb1 GENEIN eeeee1 ) by  bbbbb2 CHEMICALIN eeeee2  in cultured astrocytes and reduction of CHEMICALNOTIN-induced cell death
CPR:3	The results show that transient  bbbbb1 CHEMICALIN eeeee1  pre-treatment induces  bbbbb2 GENEIN eeeee2 , GENEIN and, to a lesser extent, GENEIN; it reduces CHEMICALNOTIN-induced astrocyte death; and it causes selective activation of GENEIN following CHEMICALIN
CPR:3	The results show that transient  bbbbb1 CHEMICALIN eeeee1  pre-treatment induces GENEIN,  bbbbb2 GENEIN eeeee2  and, to a lesser extent, GENEIN; it reduces CHEMICALNOTIN-induced astrocyte death; and it causes selective activation of GENEIN following CHEMICALIN
CPR:3	The results show that transient  bbbbb1 CHEMICALIN eeeee1  pre-treatment induces GENEIN, GENEIN and, to a lesser extent,  bbbbb2 GENEIN eeeee2 ; it reduces CHEMICALNOTIN-induced astrocyte death; and it causes selective activation of GENEIN following CHEMICALIN
CPR:3	 bbbbb1 CHEMICALIN eeeee1  triggered strong induction of  bbbbb2 GENEIN eeeee2 , which was prevented by 1 micro g/mL CHEMICALIN (CHEMICALIN)
CPR:4	CHEMICALIN triggered strong induction of  bbbbb1 GENEIN eeeee1 , which was prevented by 1 micro g/mL  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN)
CPR:4	CHEMICALIN triggered strong induction of  bbbbb1 GENEIN eeeee1 , which was prevented by 1 micro g/mL CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 )
CPR:4	However, while  bbbbb1 GENEIN eeeee1  phosphorylation was prevented by CHX, GENENOTIN phosphorylation was further enhanced by  bbbbb2 CHEMICALIN eeeee2 
CPR:10	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN increased the production of both GENEIN and GENEIN but not that of  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:10	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN increased the production of both GENEIN and GENEIN but not that of GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:10	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  increased the production of both GENEIN and GENEIN but not that of  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:10	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  increased the production of both GENEIN and GENEIN but not that of GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:10	Unlike  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN abolished the production of  bbbbb2 GENEIN eeeee2  and GENEIN, suggesting a better GENEIN inhibition effect over CHEMICALIN as no GENEIN activity was found
CPR:10	Unlike  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN abolished the production of GENEIN and  bbbbb2 GENEIN eeeee2 , suggesting a better GENEIN inhibition effect over CHEMICALIN as no GENEIN activity was found
CPR:10	Unlike CHEMICALIN, CHEMICALIN abolished the production of GENEIN and GENEIN, suggesting a better GENEIN inhibition effect over  bbbbb1 CHEMICALIN eeeee1  as no  bbbbb2 GENEIN eeeee2  activity was found
CPR:10	The production of  bbbbb1 GENEIN eeeee1  was reduced with CHEMICALIN while no significant change was observed with  bbbbb2 CHEMICALIN eeeee2  after 4 h of incubation
CPR:2	In human plasma the  bbbbb1 GENEIN eeeee1  half-life values in the absence or in the presence of  bbbbb2 CHEMICALIN eeeee2  (3.8 microM) or CHEMICALIN (32 nM) were 38.7 +/- 2.4, 51.2 +/- 4.7 and 114.7 +/- 9.3 min, respectively and CHEMICALNOTIN was degraded into CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN and CHEMICALNOTIN
CPR:2	In human plasma the  bbbbb1 GENEIN eeeee1  half-life values in the absence or in the presence of CHEMICALIN (3.8 microM) or  bbbbb2 CHEMICALIN eeeee2  (32 nM) were 38.7 +/- 2.4, 51.2 +/- 4.7 and 114.7 +/- 9.3 min, respectively and CHEMICALNOTIN was degraded into CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN and CHEMICALNOTIN
CPR:2	Investigation of  bbbbb1 GENEIN eeeee1  metabolism in human and rat plasma in the presence of the dual GENEIN/GENEIN inhibitors  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:2	Investigation of  bbbbb1 GENEIN eeeee1  metabolism in human and rat plasma in the presence of the dual GENEIN/GENEIN inhibitors CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:2	In rat plasma the  bbbbb1 GENEIN eeeee1  half-life values in the absence or in the presence of  bbbbb2 CHEMICALIN eeeee2  (530 nM) or CHEMICALIN (50 nM) were 9.31 +/- 1.7, 22.06 +/- 3.1 and 25.3 +/- 1.7 min, respectively and GENENOTIN was degraded into CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN and CHEMICALNOTIN plus CHEMICALNOTIN, CHEMICALNOTIN and CHEMICALNOTIN metabolites not found in human plasma
CPR:2	In rat plasma the  bbbbb1 GENEIN eeeee1  half-life values in the absence or in the presence of CHEMICALIN (530 nM) or  bbbbb2 CHEMICALIN eeeee2  (50 nM) were 9.31 +/- 1.7, 22.06 +/- 3.1 and 25.3 +/- 1.7 min, respectively and GENENOTIN was degraded into CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN and CHEMICALNOTIN plus CHEMICALNOTIN, CHEMICALNOTIN and CHEMICALNOTIN metabolites not found in human plasma
CPR:3	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN increased the production of both  bbbbb2 GENEIN eeeee2  and GENEIN but not that of GENEIN and GENEIN
CPR:3	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN increased the production of both GENEIN and  bbbbb2 GENEIN eeeee2  but not that of GENEIN and GENEIN
CPR:3	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  increased the production of both  bbbbb2 GENEIN eeeee2  and GENEIN but not that of GENEIN and GENEIN
CPR:3	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  increased the production of both GENEIN and  bbbbb2 GENEIN eeeee2  but not that of GENEIN and GENEIN
CPR:3	In addition the production of  bbbbb1 GENEIN eeeee1  was enhanced in the presence of these inhibitors with a greater accumulation being observed with  bbbbb2 CHEMICALIN eeeee2 
CPR:4	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN reduced the production of  bbbbb2 GENEIN eeeee2  and GENEIN with more effect being observed with CHEMICALIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN reduced the production of GENEIN and  bbbbb2 GENEIN eeeee2  with more effect being observed with CHEMICALIN
CPR:4	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  reduced the production of  bbbbb2 GENEIN eeeee2  and GENEIN with more effect being observed with CHEMICALIN
CPR:4	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  reduced the production of GENEIN and  bbbbb2 GENEIN eeeee2  with more effect being observed with CHEMICALIN
CPR:4	CHEMICALIN and CHEMICALIN reduced the production of  bbbbb1 GENEIN eeeee1  and GENEIN with more effect being observed with  bbbbb2 CHEMICALIN eeeee2 
CPR:4	CHEMICALIN and CHEMICALIN reduced the production of GENEIN and  bbbbb1 GENEIN eeeee1  with more effect being observed with  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Unlike CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  abolished the production of  bbbbb2 GENEIN eeeee2  and GENEIN, suggesting a better GENEIN inhibition effect over CHEMICALIN as no GENEIN activity was found
CPR:4	Unlike CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  abolished the production of GENEIN and  bbbbb2 GENEIN eeeee2 , suggesting a better GENEIN inhibition effect over CHEMICALIN as no GENEIN activity was found
CPR:4	The production of  bbbbb1 GENEIN eeeee1  was reduced with  bbbbb2 CHEMICALIN eeeee2  while no significant change was observed with CHEMICALIN after 4 h of incubation
CPR:4	This study shows that the potency of  bbbbb1 CHEMICALIN eeeee1  in comparison with CHEMICALIN is more than 100-fold lower in human, but less than 10-fold lower in rat plasma, suggesting that rat may not be a suitable in vivo model for the evaluation of  bbbbb2 GENEIN eeeee2 /GENEIN inhibition in relation to effects in humans.
CPR:4	This study shows that the potency of  bbbbb1 CHEMICALIN eeeee1  in comparison with CHEMICALIN is more than 100-fold lower in human, but less than 10-fold lower in rat plasma, suggesting that rat may not be a suitable in vivo model for the evaluation of GENEIN/ bbbbb2 GENEIN eeeee2  inhibition in relation to effects in humans.
CPR:4	This study shows that the potency of CHEMICALIN in comparison with  bbbbb1 CHEMICALIN eeeee1  is more than 100-fold lower in human, but less than 10-fold lower in rat plasma, suggesting that rat may not be a suitable in vivo model for the evaluation of GENEIN/ bbbbb2 GENEIN eeeee2  inhibition in relation to effects in humans.
CPR:4	In this work a novel approach combining HPLC-UV on-line with oaTOF-MS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled CHEMICALNOTIN (GENENOTIN) CHEMICALNOTIN in the presence of two new dual  bbbbb1 GENEIN eeeee1 /GENEIN inhibitors ( bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN) currently under clinical trial
CPR:4	In this work a novel approach combining HPLC-UV on-line with oaTOF-MS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled CHEMICALNOTIN (GENENOTIN) CHEMICALNOTIN in the presence of two new dual GENEIN/ bbbbb1 GENEIN eeeee1  inhibitors ( bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN) currently under clinical trial
CPR:4	In this work a novel approach combining HPLC-UV on-line with oaTOF-MS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled CHEMICALNOTIN (GENENOTIN) CHEMICALNOTIN in the presence of two new dual  bbbbb1 GENEIN eeeee1 /GENEIN inhibitors (CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 ) currently under clinical trial
CPR:4	In this work a novel approach combining HPLC-UV on-line with oaTOF-MS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled CHEMICALNOTIN (GENENOTIN) CHEMICALNOTIN in the presence of two new dual GENEIN/ bbbbb1 GENEIN eeeee1  inhibitors (CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 ) currently under clinical trial
CPR:4	Unlike CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  abolished the production of GENEIN and GENEIN, suggesting a better  bbbbb2 GENEIN eeeee2  inhibition effect over CHEMICALIN as no GENEIN activity was found
CPR:4	Unlike CHEMICALIN, CHEMICALIN abolished the production of GENEIN and GENEIN, suggesting a better  bbbbb1 GENEIN eeeee1  inhibition effect over  bbbbb2 CHEMICALIN eeeee2  as no GENEIN activity was found
CPR:4	Investigation of GENEIN metabolism in human and rat plasma in the presence of the dual  bbbbb1 GENEIN eeeee1 /GENEIN inhibitors  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:4	Investigation of GENEIN metabolism in human and rat plasma in the presence of the dual GENEIN/ bbbbb1 GENEIN eeeee1  inhibitors  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:4	Investigation of GENEIN metabolism in human and rat plasma in the presence of the dual  bbbbb1 GENEIN eeeee1 /GENEIN inhibitors CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Investigation of GENEIN metabolism in human and rat plasma in the presence of the dual GENEIN/ bbbbb1 GENEIN eeeee1  inhibitors CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:2	Experimental evidence from the use of agents with enhanced selectivity for  bbbbb1 GENEIN eeeee1  ( bbbbb2 CHEMICALIN eeeee2  analogues, CHEMICALIN) and the dual inhibitor of both GENEIN and GENEIN, CHEMICALIN, indicates potential therapeutic benefits of inhibiting both GENEIN and GENEIN in AD and related dementias
CPR:2	Experimental evidence from the use of agents with enhanced selectivity for  bbbbb1 GENEIN eeeee1  (CHEMICALIN analogues,  bbbbb2 CHEMICALIN eeeee2 ) and the dual inhibitor of both GENEIN and GENEIN, CHEMICALIN, indicates potential therapeutic benefits of inhibiting both GENEIN and GENEIN in AD and related dementias
CPR:4	The development of specific  bbbbb1 GENEIN eeeee1  inhibitors and further experience with the dual enzyme inhibitor  bbbbb2 CHEMICALIN eeeee2  will improve understanding of the aetiology of AD and should lead to a wider variety of potent treatment options.
CPR:4	Experimental evidence from the use of agents with enhanced selectivity for GENEIN (CHEMICALIN analogues, CHEMICALIN) and the dual inhibitor of both  bbbbb1 GENEIN eeeee1  and GENEIN,  bbbbb2 CHEMICALIN eeeee2 , indicates potential therapeutic benefits of inhibiting both GENEIN and GENEIN in AD and related dementias
CPR:4	Experimental evidence from the use of agents with enhanced selectivity for GENEIN (CHEMICALIN analogues, CHEMICALIN) and the dual inhibitor of both GENEIN and  bbbbb1 GENEIN eeeee1 ,  bbbbb2 CHEMICALIN eeeee2 , indicates potential therapeutic benefits of inhibiting both GENEIN and GENEIN in AD and related dementias
CPR:4	Experimental evidence from the use of agents with enhanced selectivity for GENEIN (CHEMICALIN analogues, CHEMICALIN) and the dual inhibitor of both GENEIN and GENEIN,  bbbbb1 CHEMICALIN eeeee1 , indicates potential therapeutic benefits of inhibiting both  bbbbb2 GENEIN eeeee2  and GENEIN in AD and related dementias
CPR:4	Experimental evidence from the use of agents with enhanced selectivity for GENEIN (CHEMICALIN analogues, CHEMICALIN) and the dual inhibitor of both GENEIN and GENEIN,  bbbbb1 CHEMICALIN eeeee1 , indicates potential therapeutic benefits of inhibiting both GENEIN and  bbbbb2 GENEIN eeeee2  in AD and related dementias
CPR:9	GENEIN ( bbbbb1 GENEIN eeeee1 ) predominates in the healthy brain, with GENEIN (GENEIN) considered to play a minor role in regulating brain  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) levels
CPR:9	GENEIN (GENEIN) predominates in the healthy brain, with  bbbbb1 GENEIN eeeee1  (GENEIN) considered to play a minor role in regulating brain  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) levels
CPR:9	GENEIN (GENEIN) predominates in the healthy brain, with GENEIN ( bbbbb1 GENEIN eeeee1 ) considered to play a minor role in regulating brain  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) levels
CPR:9	 bbbbb1 GENEIN eeeee1  (GENEIN) predominates in the healthy brain, with GENEIN (GENEIN) considered to play a minor role in regulating brain  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) levels
CPR:9	GENEIN ( bbbbb1 GENEIN eeeee1 ) predominates in the healthy brain, with GENEIN (GENEIN) considered to play a minor role in regulating brain CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) levels
CPR:9	GENEIN (GENEIN) predominates in the healthy brain, with  bbbbb1 GENEIN eeeee1  (GENEIN) considered to play a minor role in regulating brain CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) levels
CPR:9	GENEIN (GENEIN) predominates in the healthy brain, with GENEIN ( bbbbb1 GENEIN eeeee1 ) considered to play a minor role in regulating brain CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) levels
CPR:9	 bbbbb1 GENEIN eeeee1  (GENEIN) predominates in the healthy brain, with GENEIN (GENEIN) considered to play a minor role in regulating brain CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) levels
CPR:2	A low toxicity maintenance regime, using  bbbbb1 CHEMICALIN eeeee1  and readily available drugs, for mantle cell lymphoma and other malignancies with excess  bbbbb2 GENEIN eeeee2  levels
CPR:4	Agents which have recently been shown to block  bbbbb1 GENEIN eeeee1  translation by regulating calcium levels are the  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN (CHEMICALIN), the antidiabetic CHEMICALIN, and the antifungal agent, CHEMICALIN
CPR:4	Agents which have recently been shown to block  bbbbb1 GENEIN eeeee1  translation by regulating calcium levels are the CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), the antidiabetic CHEMICALIN, and the antifungal agent, CHEMICALIN
CPR:4	Agents which have recently been shown to block  bbbbb1 GENEIN eeeee1  translation by regulating calcium levels are the CHEMICALIN, CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), the antidiabetic CHEMICALIN, and the antifungal agent, CHEMICALIN
CPR:4	Agents which have recently been shown to block  bbbbb1 GENEIN eeeee1  translation by regulating calcium levels are the CHEMICALIN, CHEMICALIN (CHEMICALIN), the antidiabetic  bbbbb2 CHEMICALIN eeeee2 , and the antifungal agent, CHEMICALIN
CPR:4	Agents which have recently been shown to block  bbbbb1 GENEIN eeeee1  translation by regulating calcium levels are the CHEMICALIN, CHEMICALIN (CHEMICALIN), the antidiabetic CHEMICALIN, and the antifungal agent,  bbbbb2 CHEMICALIN eeeee2 
CPR:2	 bbbbb1 CHEMICALIN eeeee1  acting on  bbbbb2 GENEIN eeeee2  at the central nervous system appears to have an important role in these modulatory processes
CPR:4	We investigated the effect of  bbbbb1 GENEIN eeeee1  blockade in the NTS on the response to stimulation of HDA in anaesthetised rats treated with the neuromuscular blocking agent  bbbbb2 CHEMICALIN eeeee2 
CPR:6	 bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2  and the defence reaction in the anaesthetised rat
CPR:2	Defective processing of the  bbbbb1 GENEIN eeeee1  in  bbbbb2 CHEMICALIN eeeee2 -induced mouse colon tumors
CPR:10	Taken together, these findings support the view that (1) GENEIN is the only GENEIN peptide that binds to and activates the GENEIN receptor and (2)  bbbbb1 GENEIN eeeee1  does not bind or stimulate  bbbbb2 CHEMICALIN eeeee2  binding in cells expressing the GENEIN.
CPR:10	Taken together, these findings support the view that (1) GENEIN is the only GENEIN peptide that binds to and activates the GENEIN receptor and (2) GENEIN does not bind or stimulate  bbbbb1 CHEMICALIN eeeee1  binding in cells expressing the  bbbbb2 GENEIN eeeee2 .
CPR:1	Unlike GENEIN, high concentrations of its  bbbbb1 CHEMICALIN eeeee1 -terminal extension,  bbbbb2 GENEIN eeeee2 , stimulated CHEMICALIN binding in a GENEIN-like distribution and the effect was blocked by CHEMICALIN
CPR:2	Taken together, these findings support the view that (1)  bbbbb1 GENEIN eeeee1  is the only GENEIN peptide that binds to and activates the GENEIN receptor and (2) GENEIN does not bind or stimulate  bbbbb2 CHEMICALIN eeeee2  binding in cells expressing the GENEIN.
CPR:2	Taken together, these findings support the view that (1) GENEIN is the only  bbbbb1 GENEIN eeeee1  peptide that binds to and activates the GENEIN receptor and (2) GENEIN does not bind or stimulate  bbbbb2 CHEMICALIN eeeee2  binding in cells expressing the GENEIN.
CPR:2	Taken together, these findings support the view that (1) GENEIN is the only GENEIN peptide that binds to and activates the  bbbbb1 GENEIN eeeee1  receptor and (2) GENEIN does not bind or stimulate  bbbbb2 CHEMICALIN eeeee2  binding in cells expressing the GENEIN.
CPR:2	 bbbbb1 GENEIN eeeee1  (GENEIN) stimulated  bbbbb2 CHEMICALIN eeeee2  binding in a pattern similar to that described for [CHEMICALIN]-GENEIN at the endogenous GENENOTIN
CPR:2	GENEIN ( bbbbb1 GENEIN eeeee1 ) stimulated  bbbbb2 CHEMICALIN eeeee2  binding in a pattern similar to that described for [CHEMICALIN]-GENEIN at the endogenous GENENOTIN
CPR:2	GENEIN (GENEIN) stimulated CHEMICALIN binding in a pattern similar to that described for [ bbbbb1 CHEMICALIN eeeee1 ]- bbbbb2 GENEIN eeeee2  at the endogenous GENENOTIN
CPR:2	Unlike  bbbbb1 GENEIN eeeee1 , high concentrations of its CHEMICALIN-terminal extension, GENEIN, stimulated  bbbbb2 CHEMICALIN eeeee2  binding in a GENEIN-like distribution and the effect was blocked by CHEMICALIN
CPR:2	Unlike GENEIN, high concentrations of its CHEMICALIN-terminal extension, GENEIN, stimulated  bbbbb1 CHEMICALIN eeeee1  binding in a  bbbbb2 GENEIN eeeee2 -like distribution and the effect was blocked by CHEMICALIN
CPR:2	Unlike GENEIN, high concentrations of its CHEMICALIN-terminal extension, GENEIN, stimulated CHEMICALIN binding in a  bbbbb1 GENEIN eeeee1 -like distribution and the effect was blocked by  bbbbb2 CHEMICALIN eeeee2 
CPR:2	Binding and  bbbbb1 CHEMICALIN eeeee1  autoradiographic analysis of GENEIN products at the  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:2	Binding and  bbbbb1 CHEMICALIN eeeee1  autoradiographic analysis of GENEIN products at the GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:2	Binding and  bbbbb1 CHEMICALIN eeeee1  autoradiographic analysis of  bbbbb2 GENEIN eeeee2  products at the GENEIN and GENEIN
CPR:2	Unlike GENEIN, high concentrations of its CHEMICALIN-terminal extension,  bbbbb1 GENEIN eeeee1 , stimulated  bbbbb2 CHEMICALIN eeeee2  binding in a GENEIN-like distribution and the effect was blocked by CHEMICALIN
CPR:2	RESULTS:  bbbbb1 CHEMICALIN eeeee1  unmasked the inhibitory effect of  bbbbb2 GENEIN eeeee2  stimulation with CHEMICALIN and significantly attenuated the stimulated release of CHEMICALNOTIN and subsequent CHEMICALNOTIN
CPR:2	CONCLUSIONS: Inhibition of GENEIN by  bbbbb1 CHEMICALIN eeeee1  unmasks  bbbbb2 GENEIN eeeee2  blockade of CHEMICALNOTIN synthesis caused by FMLP/B.
CPR:3	RESULTS: CHEMICALIN unmasked the inhibitory effect of  bbbbb1 GENEIN eeeee1  stimulation with  bbbbb2 CHEMICALIN eeeee2  and significantly attenuated the stimulated release of CHEMICALNOTIN and subsequent CHEMICALNOTIN
CPR:4	Inhibition corresponded to increased CHEMICALNOTIN production caused by CHEMICALNOTIN alone or  bbbbb1 CHEMICALIN eeeee1  plus CHEMICALIN and blocked proportionately the phosphorylation and activation of  bbbbb2 GENEIN eeeee2  in FMLP/B-activated eosinophils
CPR:4	Inhibition corresponded to increased CHEMICALNOTIN production caused by CHEMICALNOTIN alone or CHEMICALIN plus  bbbbb1 CHEMICALIN eeeee1  and blocked proportionately the phosphorylation and activation of  bbbbb2 GENEIN eeeee2  in FMLP/B-activated eosinophils
CPR:4	CONCLUSIONS: Inhibition of  bbbbb1 GENEIN eeeee1  by  bbbbb2 CHEMICALIN eeeee2  unmasks GENEIN blockade of CHEMICALNOTIN synthesis caused by FMLP/B.
CPR:4	OBJECTIVE: To determine (a) whether  bbbbb1 GENEIN eeeee1  inhibition alone with  bbbbb2 CHEMICALIN eeeee2  blocked secretions of CHEMICALNOTIN (CHEMICALNOTIN) and CHEMICALNOTIN (CHEMICALNOTIN) caused by activation of eosinophils with CHEMICALNOTIN plus CHEMICALNOTIN (FMLP/B), (b) to determine if CHEMICALNOTIN inhibition plus GENENOTIN agonist act additively to augment endogenous CHEMICALNOTIN concentration, and (c) to determine the mechanism by which additive inhibition of CHEMICALNOTIN and CHEMICALNOTIN synthesis is regulated by CHEMICALNOTIN
CPR:9	Blockade of  bbbbb1 CHEMICALIN eeeee1  synthesis caused by additive inhibition of  bbbbb2 GENEIN eeeee2  phosphorylation: Effect of CHEMICALNOTIN and CHEMICALNOTIN inhibition in human eosinophils
CPR:2	CHEMICALIN is an CHEMICALIN which is metabolised to  bbbbb1 CHEMICALIN eeeee1  and which binds selectively to the  bbbbb2 GENEIN eeeee2  GENEIN and GENEIN
CPR:2	CHEMICALIN is an CHEMICALIN which is metabolised to  bbbbb1 CHEMICALIN eeeee1  and which binds selectively to the GENEIN  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:2	CHEMICALIN is an CHEMICALIN which is metabolised to  bbbbb1 CHEMICALIN eeeee1  and which binds selectively to the GENEIN GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:2	 bbbbb1 CHEMICALIN eeeee1  is an CHEMICALIN which is metabolised to CHEMICALIN and which binds selectively to the  bbbbb2 GENEIN eeeee2  GENEIN and GENEIN
CPR:2	 bbbbb1 CHEMICALIN eeeee1  is an CHEMICALIN which is metabolised to CHEMICALIN and which binds selectively to the GENEIN  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:2	 bbbbb1 CHEMICALIN eeeee1  is an CHEMICALIN which is metabolised to CHEMICALIN and which binds selectively to the GENEIN GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:2	CHEMICALIN is an  bbbbb1 CHEMICALIN eeeee1  which is metabolised to CHEMICALIN and which binds selectively to the  bbbbb2 GENEIN eeeee2  GENEIN and GENEIN
CPR:2	CHEMICALIN is an  bbbbb1 CHEMICALIN eeeee1  which is metabolised to CHEMICALIN and which binds selectively to the GENEIN  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:2	CHEMICALIN is an  bbbbb1 CHEMICALIN eeeee1  which is metabolised to CHEMICALIN and which binds selectively to the GENEIN GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:10	These effects were not mimicked by oral administration of the  bbbbb1 GENEIN eeeee1  agonist CHEMICALIN even at high dose (52 mg/kg diet), and the effects of CHEMICALIN were not inhibited by addition of  bbbbb2 CHEMICALIN eeeee2  (200 mg/kg diet)
CPR:10	The potent anabolic effects of the GENEIN agonist  bbbbb1 CHEMICALIN eeeee1  on skeletal muscle have been reported to be independent of actions on  bbbbb2 GENEIN eeeee2 
CPR:2	These results indicate that the anabolic effects of  bbbbb1 CHEMICALIN eeeee1  are dependent on interaction with the  bbbbb2 GENEIN eeeee2 
CPR:3	Anabolic effects of  bbbbb1 CHEMICALIN eeeee1  on skeletal muscle are mediated by  bbbbb2 GENEIN eeeee2  activation
CPR:5	These effects were not mimicked by oral administration of the  bbbbb1 GENEIN eeeee1  agonist  bbbbb2 CHEMICALIN eeeee2  even at high dose (52 mg/kg diet), and the effects of CHEMICALIN were not inhibited by addition of CHEMICALIN (200 mg/kg diet)
CPR:5	These effects were not mimicked by oral administration of the  bbbbb1 GENEIN eeeee1  agonist CHEMICALIN even at high dose (52 mg/kg diet), and the effects of  bbbbb2 CHEMICALIN eeeee2  were not inhibited by addition of CHEMICALIN (200 mg/kg diet)
CPR:5	The potent anabolic effects of the  bbbbb1 GENEIN eeeee1  agonist  bbbbb2 CHEMICALIN eeeee2  on skeletal muscle have been reported to be independent of actions on GENEIN
CPR:5	In the hot-plate test in mice, the antinociceptive action of the  bbbbb1 GENEIN eeeee1  agonist,  bbbbb2 CHEMICALIN eeeee2 , was abolished by the GENEIN antagonist, CHEMICALIN, the potent GENEIN antagonist, CHEMICALIN and the preferential GENEIN antagonist, CHEMICALIN
CPR:5	The preferential  bbbbb1 GENEIN eeeee1  partial agonist,  bbbbb2 CHEMICALIN eeeee2 , partially inhibited CHEMICALIN-induced antinociception
CPR:5	The preferential  bbbbb1 GENEIN eeeee1  partial agonist, CHEMICALIN, partially inhibited  bbbbb2 CHEMICALIN eeeee2 -induced antinociception
CPR:6	In the hot-plate test in mice, the antinociceptive action of the GENEIN agonist, CHEMICALIN, was abolished by the  bbbbb1 GENEIN eeeee1  antagonist,  bbbbb2 CHEMICALIN eeeee2 , the potent GENEIN antagonist, CHEMICALIN and the preferential GENEIN antagonist, CHEMICALIN
CPR:6	In the hot-plate test in mice, the antinociceptive action of the GENEIN agonist, CHEMICALIN, was abolished by the GENEIN antagonist, CHEMICALIN, the potent  bbbbb1 GENEIN eeeee1  antagonist,  bbbbb2 CHEMICALIN eeeee2  and the preferential GENEIN antagonist, CHEMICALIN
CPR:6	In the hot-plate test in mice, the antinociceptive action of the GENEIN agonist, CHEMICALIN, was abolished by the GENEIN antagonist, CHEMICALIN, the potent GENEIN antagonist, CHEMICALIN and the preferential  bbbbb1 GENEIN eeeee1  antagonist,  bbbbb2 CHEMICALIN eeeee2 
CPR:10	These characteristics of the bound CHEMICALIN suggest that  bbbbb1 GENEIN eeeee1  catalysis is not facilitated by forming the resonance-stabilized structure of the  bbbbb2 CHEMICALIN eeeee2  as seen in GENEIN
CPR:1	Formation of CHEMICALIN by  bbbbb1 GENEIN eeeee1  is a two-step reaction in which the  bbbbb2 CHEMICALIN eeeee2  group of CHEMICALIN is cleaved to produce CHEMICALIN, and then the CHEMICALNOTIN is deaminated by nonenzymatic hydrolysis to produce CHEMICALIN
CPR:1	Formation of CHEMICALIN by  bbbbb1 GENEIN eeeee1  is a two-step reaction in which the CHEMICALIN group of  bbbbb2 CHEMICALIN eeeee2  is cleaved to produce CHEMICALIN, and then the CHEMICALNOTIN is deaminated by nonenzymatic hydrolysis to produce CHEMICALIN
CPR:1	The phosphate group of  bbbbb1 CHEMICALIN eeeee1  is surrounded by a characteristic  bbbbb2 GENEIN eeeee2  ((168)CHEMICALIN(172)) and forms CHEMICALNOTIN bonds with the CHEMICALNOTIN groups of those CHEMICALNOTIN residues, suggesting that the CHEMICALNOTIN group can be protonated
CPR:1	The phosphate group of CHEMICALIN is surrounded by a characteristic  bbbbb1 GENEIN eeeee1  ((168) bbbbb2 CHEMICALIN eeeee2 (172)) and forms CHEMICALNOTIN bonds with the CHEMICALNOTIN groups of those CHEMICALNOTIN residues, suggesting that the CHEMICALNOTIN group can be protonated
CPR:2	These characteristics of the bound  bbbbb1 CHEMICALIN eeeee1  suggest that  bbbbb2 GENEIN eeeee2  catalysis is not facilitated by forming the resonance-stabilized structure of the CHEMICALIN as seen in GENEIN
CPR:2	The  bbbbb1 GENEIN eeeee1  crystallized with  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) was also determined at 2.6 A resolution by molecular replacement
CPR:2	The  bbbbb1 GENEIN eeeee1  crystallized with CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) was also determined at 2.6 A resolution by molecular replacement
CPR:2	The  bbbbb1 GENEIN eeeee1  contained PLP-OMS  bbbbb2 CHEMICALIN eeeee2  in the active site, indicating that CHEMICALIN can form the CHEMICALNOTIN linkage with CHEMICALIN, but the subsequent dehydration did not occur
CPR:2	The  bbbbb1 GENEIN eeeee1  contained PLP-OMS CHEMICALIN in the active site, indicating that  bbbbb2 CHEMICALIN eeeee2  can form the CHEMICALNOTIN linkage with CHEMICALIN, but the subsequent dehydration did not occur
CPR:2	These characteristics of the bound CHEMICALIN suggest that GENEIN catalysis is not facilitated by forming the resonance-stabilized structure of the  bbbbb1 CHEMICALIN eeeee1  as seen in  bbbbb2 GENEIN eeeee2 
CPR:8	 bbbbb1 GENEIN eeeee1  GENEIN, GENEIN) catalyzes the  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN)-dependent dehydration of CHEMICALIN to yield CHEMICALIN and CHEMICALIN
CPR:8	GENEIN GENEIN,  bbbbb1 GENEIN eeeee1 ) catalyzes the  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN)-dependent dehydration of CHEMICALIN to yield CHEMICALIN and CHEMICALIN
CPR:8	GENEIN  bbbbb1 GENEIN eeeee1 , GENEIN) catalyzes the  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN)-dependent dehydration of CHEMICALIN to yield CHEMICALIN and CHEMICALIN
CPR:8	 bbbbb1 GENEIN eeeee1  GENEIN, GENEIN) catalyzes the CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 )-dependent dehydration of CHEMICALIN to yield CHEMICALIN and CHEMICALIN
CPR:8	GENEIN GENEIN,  bbbbb1 GENEIN eeeee1 ) catalyzes the CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 )-dependent dehydration of CHEMICALIN to yield CHEMICALIN and CHEMICALIN
CPR:8	GENEIN  bbbbb1 GENEIN eeeee1 , GENEIN) catalyzes the CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 )-dependent dehydration of CHEMICALIN to yield CHEMICALIN and CHEMICALIN
CPR:8	The  bbbbb1 GENEIN eeeee1  contained PLP-OMS CHEMICALIN in the active site, indicating that CHEMICALIN can form the CHEMICALNOTIN linkage with  bbbbb2 CHEMICALIN eeeee2 , but the subsequent dehydration did not occur
CPR:9	Formation of  bbbbb1 CHEMICALIN eeeee1  by  bbbbb2 GENEIN eeeee2  is a two-step reaction in which the CHEMICALIN group of CHEMICALIN is cleaved to produce CHEMICALIN, and then the CHEMICALNOTIN is deaminated by nonenzymatic hydrolysis to produce CHEMICALIN
CPR:9	Formation of CHEMICALIN by  bbbbb1 GENEIN eeeee1  is a two-step reaction in which the CHEMICALIN group of CHEMICALIN is cleaved to produce CHEMICALIN, and then the CHEMICALNOTIN is deaminated by nonenzymatic hydrolysis to produce  bbbbb2 CHEMICALIN eeeee2 
CPR:9	 bbbbb1 GENEIN eeeee1  GENEIN, GENEIN) catalyzes the CHEMICALIN (CHEMICALIN)-dependent dehydration of CHEMICALIN to yield  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:9	GENEIN GENEIN,  bbbbb1 GENEIN eeeee1 ) catalyzes the CHEMICALIN (CHEMICALIN)-dependent dehydration of CHEMICALIN to yield  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:9	GENEIN  bbbbb1 GENEIN eeeee1 , GENEIN) catalyzes the CHEMICALIN (CHEMICALIN)-dependent dehydration of CHEMICALIN to yield  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:9	 bbbbb1 GENEIN eeeee1  GENEIN, GENEIN) catalyzes the CHEMICALIN (CHEMICALIN)-dependent dehydration of CHEMICALIN to yield CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:9	GENEIN GENEIN,  bbbbb1 GENEIN eeeee1 ) catalyzes the CHEMICALIN (CHEMICALIN)-dependent dehydration of CHEMICALIN to yield CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:9	GENEIN  bbbbb1 GENEIN eeeee1 , GENEIN) catalyzes the CHEMICALIN (CHEMICALIN)-dependent dehydration of CHEMICALIN to yield CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:9	 bbbbb1 GENEIN eeeee1  GENEIN, GENEIN) catalyzes the CHEMICALIN (CHEMICALIN)-dependent dehydration of  bbbbb2 CHEMICALIN eeeee2  to yield CHEMICALIN and CHEMICALIN
CPR:9	GENEIN GENEIN,  bbbbb1 GENEIN eeeee1 ) catalyzes the CHEMICALIN (CHEMICALIN)-dependent dehydration of  bbbbb2 CHEMICALIN eeeee2  to yield CHEMICALIN and CHEMICALIN
CPR:9	GENEIN  bbbbb1 GENEIN eeeee1 , GENEIN) catalyzes the CHEMICALIN (CHEMICALIN)-dependent dehydration of  bbbbb2 CHEMICALIN eeeee2  to yield CHEMICALIN and CHEMICALIN
CPR:9	Formation of CHEMICALIN by  bbbbb1 GENEIN eeeee1  is a two-step reaction in which the CHEMICALIN group of CHEMICALIN is cleaved to produce  bbbbb2 CHEMICALIN eeeee2 , and then the CHEMICALNOTIN is deaminated by nonenzymatic hydrolysis to produce CHEMICALIN
CPR:4	Blocking GENEIN signaling with the GENEIN/GENEIN kinase inhibitor (KI)  bbbbb1 CHEMICALIN eeeee1  decreased the postradiation survival of irradiated  bbbbb2 GENEIN eeeee2 -transformed cells and normal cells but had no effect on the survival of unirradiated cells
CPR:4	Blocking  bbbbb1 GENEIN eeeee1  signaling with the GENEIN/GENEIN kinase inhibitor (KI)  bbbbb2 CHEMICALIN eeeee2  decreased the postradiation survival of irradiated GENEIN-transformed cells and normal cells but had no effect on the survival of unirradiated cells
CPR:4	Thus,  bbbbb1 GENEIN eeeee1  utilizes autocrine signaling through GENENOTIN to increase radioresistance, and the GENEIN KI  bbbbb2 CHEMICALIN eeeee2  acts as a radiosensitizer
CPR:4	The observation that  bbbbb1 GENEIN eeeee1 -transformed cells can be sensitized to killing by ionizing radiation with  bbbbb2 CHEMICALIN eeeee2  demonstrates that GENEIN KIs could potentially be used to radiosensitize tumors in which radioresistance is dependent on GENENOTIN-driven autocrine signaling through GENENOTIN.
CPR:4	Blocking GENEIN signaling with the  bbbbb1 GENEIN eeeee1 /GENEIN kinase inhibitor (KI)  bbbbb2 CHEMICALIN eeeee2  decreased the postradiation survival of irradiated GENEIN-transformed cells and normal cells but had no effect on the survival of unirradiated cells
CPR:4	Blocking GENEIN signaling with the GENEIN/ bbbbb1 GENEIN eeeee1  kinase inhibitor (KI)  bbbbb2 CHEMICALIN eeeee2  decreased the postradiation survival of irradiated GENEIN-transformed cells and normal cells but had no effect on the survival of unirradiated cells
CPR:4	GENENOTIN-CM and GENENOTIN also increase  bbbbb1 GENEIN eeeee1  activity downstream of the GENEIN and increase postradiation survival, both of which are abrogated by  bbbbb2 CHEMICALIN eeeee2 
CPR:4	GENENOTIN-CM and GENENOTIN also increase GENEIN activity downstream of the  bbbbb1 GENEIN eeeee1  and increase postradiation survival, both of which are abrogated by  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Thus, GENEIN utilizes autocrine signaling through GENENOTIN to increase radioresistance, and the  bbbbb1 GENEIN eeeee1  KI  bbbbb2 CHEMICALIN eeeee2  acts as a radiosensitizer
CPR:4	The observation that GENEIN-transformed cells can be sensitized to killing by ionizing radiation with  bbbbb1 CHEMICALIN eeeee1  demonstrates that  bbbbb2 GENEIN eeeee2  KIs could potentially be used to radiosensitize tumors in which radioresistance is dependent on GENENOTIN-driven autocrine signaling through GENENOTIN.
CPR:5	CHEMICALNOTIN and a nonconventional  bbbbb1 GENEIN eeeee1  agonist,  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), induced concentration-dependent relaxation of CHEMICALNOTIN (0.3 microM) preconstricted spiral preparations
CPR:5	CHEMICALNOTIN and a nonconventional  bbbbb1 GENEIN eeeee1  agonist, CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), induced concentration-dependent relaxation of CHEMICALNOTIN (0.3 microM) preconstricted spiral preparations
CPR:6	Pretreatment with a combination of  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, a selective  bbbbb2 GENEIN eeeee2  antagonist) and CHEMICALIN (CHEMICALIN, a selective GENEIN antagonist) (0.1 microM for each) produced a 14-fold rightward shift of the concentration-response curve for CHEMICALNOTIN; however, the relaxation in response to CHEMICALNOTIN was unaffected by the blockade of GENENOTIN
CPR:6	Pretreatment with a combination of CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , a selective  bbbbb2 GENEIN eeeee2  antagonist) and CHEMICALIN (CHEMICALIN, a selective GENEIN antagonist) (0.1 microM for each) produced a 14-fold rightward shift of the concentration-response curve for CHEMICALNOTIN; however, the relaxation in response to CHEMICALNOTIN was unaffected by the blockade of GENENOTIN
CPR:6	Pretreatment with a combination of CHEMICALIN (CHEMICALIN, a selective GENEIN antagonist) and  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, a selective  bbbbb2 GENEIN eeeee2  antagonist) (0.1 microM for each) produced a 14-fold rightward shift of the concentration-response curve for CHEMICALNOTIN; however, the relaxation in response to CHEMICALNOTIN was unaffected by the blockade of GENENOTIN
CPR:6	Pretreatment with a combination of CHEMICALIN (CHEMICALIN, a selective GENEIN antagonist) and CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , a selective  bbbbb2 GENEIN eeeee2  antagonist) (0.1 microM for each) produced a 14-fold rightward shift of the concentration-response curve for CHEMICALNOTIN; however, the relaxation in response to CHEMICALNOTIN was unaffected by the blockade of GENENOTIN
CPR:2	BACKGROUND: The  bbbbb1 GENEIN eeeee1  (GENEIN) is a high-affinity transporter for  bbbbb2 CHEMICALIN eeeee2 
CPR:2	BACKGROUND: The GENEIN ( bbbbb1 GENEIN eeeee1 ) is a high-affinity transporter for  bbbbb2 CHEMICALIN eeeee2 
CPR:4	The specificity of tracer uptake was determined by adding the  bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2 
CPR:9	 bbbbb1 CHEMICALIN eeeee1  uptake in PC12 cells, which express the  bbbbb2 GENEIN eeeee2  endogenously, was 20- to 28-fold lower than in transduced cells
CPR:9	In vivo, A431 bbbbb1 GENEIN eeeee1  tumors demonstrated a 33-fold higher  bbbbb2 CHEMICALIN eeeee2  uptake than parental tumors
CPR:5	The aim of this study was, therefore, to provide comparative binding characteristics of agonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN) and antagonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) at all three subtypes of  bbbbb2 GENEIN eeeee2  in an identical cellular background
CPR:5	The aim of this study was, therefore, to provide comparative binding characteristics of agonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ) and antagonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) at all three subtypes of  bbbbb2 GENEIN eeeee2  in an identical cellular background
CPR:5	The aim of this study was, therefore, to provide comparative binding characteristics of agonists ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) and antagonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) at all three subtypes of  bbbbb2 GENEIN eeeee2  in an identical cellular background
CPR:5	The aim of this study was, therefore, to provide comparative binding characteristics of agonists (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) and antagonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) at all three subtypes of  bbbbb2 GENEIN eeeee2  in an identical cellular background
CPR:5	The aim of this study was, therefore, to provide comparative binding characteristics of agonists (CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) and antagonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) at all three subtypes of  bbbbb2 GENEIN eeeee2  in an identical cellular background
CPR:5	The aim of this study was, therefore, to provide comparative binding characteristics of agonists (CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) and antagonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) at all three subtypes of  bbbbb2 GENEIN eeeee2  in an identical cellular background
CPR:5	The aim of this study was, therefore, to provide comparative binding characteristics of agonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) and antagonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) at all three subtypes of  bbbbb2 GENEIN eeeee2  in an identical cellular background
CPR:5	The aim of this study was, therefore, to provide comparative binding characteristics of agonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN) and antagonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) at all three subtypes of  bbbbb2 GENEIN eeeee2  in an identical cellular background
CPR:5	The aim of this study was, therefore, to provide comparative binding characteristics of agonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN) and antagonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) at all three subtypes of  bbbbb2 GENEIN eeeee2  in an identical cellular background
CPR:6	The aim of this study was, therefore, to provide comparative binding characteristics of agonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) and antagonists ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) at all three subtypes of  bbbbb2 GENEIN eeeee2  in an identical cellular background
CPR:6	The aim of this study was, therefore, to provide comparative binding characteristics of agonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) and antagonists (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) at all three subtypes of  bbbbb2 GENEIN eeeee2  in an identical cellular background
CPR:6	The aim of this study was, therefore, to provide comparative binding characteristics of agonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) and antagonists (CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) at all three subtypes of  bbbbb2 GENEIN eeeee2  in an identical cellular background
CPR:6	The aim of this study was, therefore, to provide comparative binding characteristics of agonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) and antagonists (CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) at all three subtypes of  bbbbb2 GENEIN eeeee2  in an identical cellular background
CPR:6	The aim of this study was, therefore, to provide comparative binding characteristics of agonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) and antagonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) at all three subtypes of  bbbbb2 GENEIN eeeee2  in an identical cellular background
CPR:6	The aim of this study was, therefore, to provide comparative binding characteristics of agonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) and antagonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) at all three subtypes of  bbbbb2 GENEIN eeeee2  in an identical cellular background
CPR:6	The aim of this study was, therefore, to provide comparative binding characteristics of agonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) and antagonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) at all three subtypes of  bbbbb2 GENEIN eeeee2  in an identical cellular background
CPR:6	The aim of this study was, therefore, to provide comparative binding characteristics of agonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) and antagonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) at all three subtypes of  bbbbb2 GENEIN eeeee2  in an identical cellular background
CPR:6	The aim of this study was, therefore, to provide comparative binding characteristics of agonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) and antagonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN) at all three subtypes of  bbbbb2 GENEIN eeeee2  in an identical cellular background
CPR:6	The aim of this study was, therefore, to provide comparative binding characteristics of agonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) and antagonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN) at all three subtypes of  bbbbb2 GENEIN eeeee2  in an identical cellular background
CPR:6	The aim of this study was, therefore, to provide comparative binding characteristics of agonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) and antagonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN) at all three subtypes of  bbbbb2 GENEIN eeeee2  in an identical cellular background
CPR:6	The aim of this study was, therefore, to provide comparative binding characteristics of agonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN) and antagonists (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ) at all three subtypes of  bbbbb2 GENEIN eeeee2  in an identical cellular background
CPR:2	Responses to  bbbbb1 CHEMICALIN eeeee1  could be restored to normal by GENEIN blockade, suggesting a GENEIN-mediated inhibition of  bbbbb2 GENEIN eeeee2  signalling
CPR:2	Responses to  bbbbb1 CHEMICALIN eeeee1  were largely mediated through the  bbbbb2 GENEIN eeeee2  in control myocytes
CPR:2	Adenovirally-mediated overexpression of  bbbbb1 GENEIN eeeee1 , at levels, which did not alter basal contraction of myocytes, markedly depressed the  bbbbb2 CHEMICALIN eeeee2  concentration-response curve
CPR:2	Responses to  bbbbb1 CHEMICALIN eeeee1  could be restored to normal by  bbbbb2 GENEIN eeeee2  blockade, suggesting a GENEIN-mediated inhibition of GENEIN signalling
CPR:2	Responses to  bbbbb1 CHEMICALIN eeeee1  could be restored to normal by GENEIN blockade, suggesting a  bbbbb2 GENEIN eeeee2 -mediated inhibition of GENEIN signalling
CPR:2	GENENOTIN normalised  bbbbb1 CHEMICALIN eeeee1  responses in GENENOTIN cells, indicating that  bbbbb2 GENEIN eeeee2  effects were mediated by GENENOTIN
CPR:2	The nonsteroidal anti-inflammatory drugs  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN were modified in an attempt to alter the kinetics of inhibitor binding by  bbbbb2 GENEIN eeeee2 
CPR:2	The nonsteroidal anti-inflammatory drugs CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  were modified in an attempt to alter the kinetics of inhibitor binding by  bbbbb2 GENEIN eeeee2 
CPR:4	Manipulation of kinetic profiles in  bbbbb1 CHEMICALIN eeeee1   bbbbb2 GENEIN eeeee2  inhibitors
CPR:10	Exploration of potential mechanisms of resistance in SUM185 cells revealed failure of  bbbbb1 CHEMICALIN eeeee1  to inhibit downstream  bbbbb2 GENEIN eeeee2  and GENEIN activation, despite inhibition of GENEIN phosphorylation
CPR:10	Exploration of potential mechanisms of resistance in SUM185 cells revealed failure of  bbbbb1 CHEMICALIN eeeee1  to inhibit downstream GENEIN and  bbbbb2 GENEIN eeeee2  activation, despite inhibition of GENEIN phosphorylation
CPR:10	Resistance to  bbbbb1 CHEMICALIN eeeee1  was not due to a lack of receptor inhibition, but rather with a lack of inhibition of  bbbbb2 GENEIN eeeee2  and GENEIN, suggesting that measurement of inhibition of crucial signaling pathways may better predict response than inhibition of receptor phosphorylation
CPR:10	Resistance to  bbbbb1 CHEMICALIN eeeee1  was not due to a lack of receptor inhibition, but rather with a lack of inhibition of GENEIN and  bbbbb2 GENEIN eeeee2 , suggesting that measurement of inhibition of crucial signaling pathways may better predict response than inhibition of receptor phosphorylation
CPR:1	RESULTS: CHEMICALIN inhibited constitutive and/or ligand-induced  bbbbb1 GENEIN eeeee1  or GENEIN  bbbbb2 CHEMICALIN eeeee2  phosphorylation of all five cell lines, which correlated with the antiproliferative response in all but one cell line
CPR:1	RESULTS: CHEMICALIN inhibited constitutive and/or ligand-induced GENEIN or  bbbbb1 GENEIN eeeee1   bbbbb2 CHEMICALIN eeeee2  phosphorylation of all five cell lines, which correlated with the antiproliferative response in all but one cell line
CPR:2	 bbbbb1 CHEMICALIN eeeee1  radiosensitized  bbbbb2 GENEIN eeeee2 -overexpressing cell lines, but GENEIN-overexpressing cells were unable to form colonies after brief exposure to CHEMICALIN even in the absence of radiation, and thus could not be evaluated for radiosensitization
CPR:2	CHEMICALIN radiosensitized GENEIN-overexpressing cell lines, but  bbbbb1 GENEIN eeeee1 -overexpressing cells were unable to form colonies after brief exposure to  bbbbb2 CHEMICALIN eeeee2  even in the absence of radiation, and thus could not be evaluated for radiosensitization
CPR:4	Effects of the  bbbbb1 GENEIN eeeee1 /GENEIN GENEIN inhibitor  bbbbb2 CHEMICALIN eeeee2  on GENENOTIN- and GENENOTIN-overexpressing breast cancer cell line proliferation, radiosensitization, and resistance
CPR:4	Effects of the GENEIN/ bbbbb1 GENEIN eeeee1  GENEIN inhibitor  bbbbb2 CHEMICALIN eeeee2  on GENENOTIN- and GENENOTIN-overexpressing breast cancer cell line proliferation, radiosensitization, and resistance
CPR:4	Effects of the GENEIN/GENEIN  bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2  on GENENOTIN- and GENENOTIN-overexpressing breast cancer cell line proliferation, radiosensitization, and resistance
CPR:4	Exploration of potential mechanisms of resistance in SUM185 cells revealed failure of  bbbbb1 CHEMICALIN eeeee1  to inhibit downstream GENEIN and GENEIN activation, despite inhibition of  bbbbb2 GENEIN eeeee2  phosphorylation
CPR:4	CONCLUSION:  bbbbb1 CHEMICALIN eeeee1  potently inhibits receptor phosphorylation in either  bbbbb2 GENEIN eeeee2 - or GENEIN-overexpressing cell lines and has both antiproliferative and radiosensitizing effects
CPR:4	CONCLUSION:  bbbbb1 CHEMICALIN eeeee1  potently inhibits receptor phosphorylation in either GENEIN- or  bbbbb2 GENEIN eeeee2 -overexpressing cell lines and has both antiproliferative and radiosensitizing effects
CPR:4	To gauge the potential clinical utility of targeting both GENENOTIN and GENENOTIN to control growth and radiosensitize human breast cancers, we examined the effect of a dual  bbbbb1 GENEIN eeeee1 /GENEIN inhibitor,  bbbbb2 CHEMICALIN eeeee2 , on the proliferation and radiation response of either GENENOTIN- or GENENOTIN-overexpressing human breast cancer cell lines
CPR:4	To gauge the potential clinical utility of targeting both GENENOTIN and GENENOTIN to control growth and radiosensitize human breast cancers, we examined the effect of a dual GENEIN/ bbbbb1 GENEIN eeeee1  inhibitor,  bbbbb2 CHEMICALIN eeeee2 , on the proliferation and radiation response of either GENENOTIN- or GENENOTIN-overexpressing human breast cancer cell lines
CPR:4	RESULTS:  bbbbb1 CHEMICALIN eeeee1  inhibited constitutive and/or ligand-induced  bbbbb2 GENEIN eeeee2  or GENEIN CHEMICALIN phosphorylation of all five cell lines, which correlated with the antiproliferative response in all but one cell line
CPR:4	RESULTS:  bbbbb1 CHEMICALIN eeeee1  inhibited constitutive and/or ligand-induced GENEIN or  bbbbb2 GENEIN eeeee2  CHEMICALIN phosphorylation of all five cell lines, which correlated with the antiproliferative response in all but one cell line
CPR:2	 bbbbb1 CHEMICALIN eeeee1 , but not leptin, regulates  bbbbb2 GENEIN eeeee2  in pancreatic islets: impact on CHEMICALIN-stimulated GENEIN secretion
CPR:2	These studies demonstrate that  bbbbb1 GENEIN eeeee1  activity is subject to regulation by both  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN in pancreatic islets and clonal beta-cells
CPR:2	These studies demonstrate that  bbbbb1 GENEIN eeeee1  activity is subject to regulation by both CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  in pancreatic islets and clonal beta-cells
CPR:3	Incubation with  bbbbb1 CHEMICALIN eeeee1  (0.2-1 mM) activated  bbbbb2 GENEIN eeeee2  in both human islets and MIN6 beta-cells in parallel with an inhibition of GENEIN secretion, whereas leptin (10-100 nM) was without effect in MIN6 cells
CPR:3	 bbbbb1 CHEMICALIN eeeee1 , a drug widely used in the treatment of type 2 diabetes, has recently been shown to act on skeletal muscle and liver in part through the activation of  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:3	 bbbbb1 CHEMICALIN eeeee1 , a drug widely used in the treatment of type 2 diabetes, has recently been shown to act on skeletal muscle and liver in part through the activation of GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:3	Whether  bbbbb1 CHEMICALIN eeeee1  or the satiety factor leptin, which also stimulates  bbbbb2 GENEIN eeeee2  in muscle, regulates this enzyme in pancreatic islets is unknown
CPR:3	CHEMICALIN, but not leptin, regulates GENEIN in pancreatic islets: impact on  bbbbb1 CHEMICALIN eeeee1 -stimulated  bbbbb2 GENEIN eeeee2  secretion
CPR:4	Incubation with  bbbbb1 CHEMICALIN eeeee1  (0.2-1 mM) activated GENEIN in both human islets and MIN6 beta-cells in parallel with an inhibition of  bbbbb2 GENEIN eeeee2  secretion, whereas leptin (10-100 nM) was without effect in MIN6 cells
CPR:4	The inhibitory effects of  bbbbb1 CHEMICALIN eeeee1  on  bbbbb2 GENEIN eeeee2  secretion may therefore need to be considered with respect to the use of this drug for the treatment of type 2 diabetes.
CPR:4	Increases in  bbbbb1 CHEMICALIN eeeee1  concentration from 0 to 3 and from 3 to 17 mM inhibited  bbbbb2 GENEIN eeeee2  activity in primary islets from mouse, rat, and human, confirming previous findings in insulinoma cells
CPR:2	The ability of this cis-acting  bbbbb1 GENEIN eeeee1  to activate transcription in response to  bbbbb2 CHEMICALIN eeeee2  also depended on downstream sequences where an GENEIN (GENENOTIN) site and a GENEIN (GENEIN) site between this element and the transcriptional start, as well as a GENEIN (GENEIN) site between the transcriptional start and first exon of the GENEIN gene, were necessary
CPR:2	The ability of this cis-acting GENEIN to activate transcription in response to  bbbbb1 CHEMICALIN eeeee1  also depended on downstream sequences where an  bbbbb2 GENEIN eeeee2  (GENENOTIN) site and a GENEIN (GENEIN) site between this element and the transcriptional start, as well as a GENEIN (GENEIN) site between the transcriptional start and first exon of the GENEIN gene, were necessary
CPR:2	The ability of this cis-acting GENEIN to activate transcription in response to  bbbbb1 CHEMICALIN eeeee1  also depended on downstream sequences where an GENEIN (GENENOTIN) site and a  bbbbb2 GENEIN eeeee2  (GENEIN) site between this element and the transcriptional start, as well as a GENEIN (GENEIN) site between the transcriptional start and first exon of the GENEIN gene, were necessary
CPR:2	The ability of this cis-acting GENEIN to activate transcription in response to  bbbbb1 CHEMICALIN eeeee1  also depended on downstream sequences where an GENEIN (GENENOTIN) site and a GENEIN ( bbbbb2 GENEIN eeeee2 ) site between this element and the transcriptional start, as well as a GENEIN (GENEIN) site between the transcriptional start and first exon of the GENEIN gene, were necessary
CPR:2	The ability of this cis-acting GENEIN to activate transcription in response to  bbbbb1 CHEMICALIN eeeee1  also depended on downstream sequences where an GENEIN (GENENOTIN) site and a GENEIN (GENEIN) site between this element and the transcriptional start, as well as a  bbbbb2 GENEIN eeeee2  (GENEIN) site between the transcriptional start and first exon of the GENEIN gene, were necessary
CPR:2	The ability of this cis-acting GENEIN to activate transcription in response to  bbbbb1 CHEMICALIN eeeee1  also depended on downstream sequences where an GENEIN (GENENOTIN) site and a GENEIN (GENEIN) site between this element and the transcriptional start, as well as a GENEIN ( bbbbb2 GENEIN eeeee2 ) site between the transcriptional start and first exon of the GENEIN gene, were necessary
CPR:2	The ability of this cis-acting GENEIN to activate transcription in response to  bbbbb1 CHEMICALIN eeeee1  also depended on downstream sequences where an GENEIN (GENENOTIN) site and a GENEIN (GENEIN) site between this element and the transcriptional start, as well as a GENEIN (GENEIN) site between the transcriptional start and first exon of the  bbbbb2 GENEIN eeeee2  gene, were necessary
CPR:2	A transcription factor-transcription factor binding array analysis of nuclear lysate from  bbbbb1 CHEMICALIN eeeee1 -treated cells indicated several prominent GENEIN binding partners; among these,  bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN were identified by competition EMSA and supershift and chromatin immunoprecipitation assays as components of the complex
CPR:2	A transcription factor-transcription factor binding array analysis of nuclear lysate from  bbbbb1 CHEMICALIN eeeee1 -treated cells indicated several prominent GENEIN binding partners; among these, GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN were identified by competition EMSA and supershift and chromatin immunoprecipitation assays as components of the complex
CPR:2	A transcription factor-transcription factor binding array analysis of nuclear lysate from  bbbbb1 CHEMICALIN eeeee1 -treated cells indicated several prominent GENEIN binding partners; among these, GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2  were identified by competition EMSA and supershift and chromatin immunoprecipitation assays as components of the complex
CPR:2	In sum the results of the present study indicate that  bbbbb1 CHEMICALIN eeeee1 -induced expression of GENEIN expression depends on a novel  bbbbb2 GENEIN eeeee2 
CPR:2	Within this sequence GENENOTIN footprinting revealed that  bbbbb1 CHEMICALIN eeeee1  induced binding of a GENEIN to an element containing two  bbbbb2 GENEIN eeeee2 
CPR:2	Within this sequence GENENOTIN footprinting revealed that  bbbbb1 CHEMICALIN eeeee1  induced binding of a  bbbbb2 GENEIN eeeee2  to an element containing two GENEIN
CPR:2	Both  bbbbb1 GENEIN eeeee1  were needed for binding the complex, and mutation of either GENENOTIN caused the loss of transcriptional activation by  bbbbb2 CHEMICALIN eeeee2 
CPR:2	A transcription factor-transcription factor binding array analysis of nuclear lysate from  bbbbb1 CHEMICALIN eeeee1 -treated cells indicated several prominent  bbbbb2 GENEIN eeeee2  binding partners; among these, GENEIN, GENEIN, and GENEIN were identified by competition EMSA and supershift and chromatin immunoprecipitation assays as components of the complex
CPR:3	A 5'-flanking region capable of supporting  bbbbb1 CHEMICALIN eeeee1 -induced  bbbbb2 GENEIN eeeee2  activation in HL-60 cells was found to contain a 205-bp sequence in the distal portion that was necessary for transcriptional activation by CHEMICALNOTIN
CPR:3	CHEMICALIN is known to induce expression of the GENEIN (GENEIN) gene which propels CHEMICALNOTIN-induced cell cycle arrest and differentiation of HL-60 human myeloblastic leukemia cells, motivating the present analysis of transcriptional regulation of  bbbbb1 GENEIN eeeee1  expression by  bbbbb2 CHEMICALIN eeeee2 
CPR:3	A novel GENENOTIN regulates  bbbbb1 CHEMICALIN eeeee1 -induced  bbbbb2 GENEIN eeeee2  expression
CPR:3	 bbbbb1 CHEMICALIN eeeee1  is known to induce expression of the  bbbbb2 GENEIN eeeee2  (GENEIN) gene which propels CHEMICALNOTIN-induced cell cycle arrest and differentiation of HL-60 human myeloblastic leukemia cells, motivating the present analysis of transcriptional regulation of GENEIN expression by CHEMICALIN
CPR:3	 bbbbb1 CHEMICALIN eeeee1  is known to induce expression of the GENEIN ( bbbbb2 GENEIN eeeee2 ) gene which propels CHEMICALNOTIN-induced cell cycle arrest and differentiation of HL-60 human myeloblastic leukemia cells, motivating the present analysis of transcriptional regulation of GENEIN expression by CHEMICALIN
CPR:3	In sum the results of the present study indicate that  bbbbb1 CHEMICALIN eeeee1 -induced expression of  bbbbb2 GENEIN eeeee2  expression depends on a novel GENEIN
CPR:4	The ability of this cis-acting GENEIN to activate transcription in response to  bbbbb1 CHEMICALIN eeeee1  also depended on downstream sequences where an GENEIN (GENENOTIN) site and a  bbbbb2 GENEIN eeeee2  (GENEIN) site between this element and the transcriptional start, as well as a GENEIN (GENEIN) site between the transcriptional start and first exon of the GENEIN gene, were necessary
CPR:2	CHEMICALIN trapped in membranes was displaceable by the structurally unrelated GENEIN inhibitor, CHEMICALIN, in a concentration-dependent manner, implying interaction of retained  bbbbb1 CHEMICALIN eeeee1  with the  bbbbb2 GENEIN eeeee2 
CPR:2	The results demonstrate that  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN are persistently retained in cell membranes, at least partly in association with the  bbbbb2 GENEIN eeeee2 
CPR:2	The results demonstrate that CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  are persistently retained in cell membranes, at least partly in association with the  bbbbb2 GENEIN eeeee2 
CPR:2	The retention and slow diffusion of  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN from membranes may contribute to their pharmacological and modulatory action on  bbbbb2 GENEIN eeeee2 .
CPR:2	The retention and slow diffusion of CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  from membranes may contribute to their pharmacological and modulatory action on  bbbbb2 GENEIN eeeee2 .
CPR:2	 bbbbb1 CHEMICALIN eeeee1  trapped in membranes was displaceable by the structurally unrelated  bbbbb2 GENEIN eeeee2  inhibitor, CHEMICALIN, in a concentration-dependent manner, implying interaction of retained CHEMICALIN with the GENEIN
CPR:4	The persistent membrane retention of  bbbbb1 CHEMICALIN eeeee1  causes lasting inhibition of  bbbbb2 GENEIN eeeee2  function
CPR:4	CHEMICALIN trapped in membranes was displaceable by the structurally unrelated  bbbbb1 GENEIN eeeee1  inhibitor,  bbbbb2 CHEMICALIN eeeee2 , in a concentration-dependent manner, implying interaction of retained CHEMICALIN with the GENEIN
CPR:2	GENENOTIN-receptor antagonism in hypertension: what has been learned with CHEMICALNOTIN?  bbbbb1 CHEMICALIN eeeee1  is a long-acting GENEIN antagonist acting specifically at the level of the Type 1-receptor subtype ( bbbbb2 GENEIN eeeee2 -receptor)
CPR:4	 bbbbb1 CHEMICALIN eeeee1  may have antiatherosclerotic properties beyond those expected from blood pressure lowering per se: this GENEIN-blocker decreases the vascular oxidative stress and prevents the procoagulant as well as the pro-inflammatory effects of  bbbbb2 GENEIN eeeee2 
CPR:4	 bbbbb1 CHEMICALIN eeeee1  may have antiatherosclerotic properties beyond those expected from blood pressure lowering per se: this  bbbbb2 GENEIN eeeee2 -blocker decreases the vascular oxidative stress and prevents the procoagulant as well as the pro-inflammatory effects of GENEIN
CPR:6	GENENOTIN-receptor antagonism in hypertension: what has been learned with CHEMICALNOTIN?  bbbbb1 CHEMICALIN eeeee1  is a long-acting  bbbbb2 GENEIN eeeee2  antagonist acting specifically at the level of the Type 1-receptor subtype (GENEIN-receptor)
CPR:10	 bbbbb1 CHEMICALIN eeeee1  dissociated from the  bbbbb2 GENEIN eeeee2  with a fast component (k(off)=0.45 min(-1)), consistent with the L-site, and a slow component (k(off)=0.017-0.033 min(-1)), consistent with the H-site
CPR:2	We conclude that  bbbbb1 CHEMICALIN eeeee1  binds at two sites in the recombinant  bbbbb2 GENEIN eeeee2 
CPR:2	To verify the hypothesis that the non-conventional partial agonist CHEMICALIN binds at two GENEIN sites,  bbbbb1 GENEIN eeeee1 , expressed in CHO cells, were labelled with  bbbbb2 CHEMICALIN eeeee2 
CPR:2	To verify the hypothesis that the non-conventional partial agonist CHEMICALIN binds at two  bbbbb1 GENEIN eeeee1  sites, GENEIN, expressed in CHO cells, were labelled with  bbbbb2 CHEMICALIN eeeee2 
CPR:2	To verify the hypothesis that the non-conventional partial agonist  bbbbb1 CHEMICALIN eeeee1  binds at two GENEIN sites,  bbbbb2 GENEIN eeeee2 , expressed in CHO cells, were labelled with CHEMICALIN
CPR:2	To verify the hypothesis that the non-conventional partial agonist  bbbbb1 CHEMICALIN eeeee1  binds at two  bbbbb2 GENEIN eeeee2  sites, GENEIN, expressed in CHO cells, were labelled with CHEMICALIN
CPR:2	Binding of  bbbbb1 CHEMICALIN eeeee1  at two sites in recombinant  bbbbb2 GENEIN eeeee2  and interaction with beta-blockers
CPR:5	To verify the hypothesis that the non-conventional partial agonist  bbbbb1 CHEMICALIN eeeee1  binds at two GENEIN sites,  bbbbb2 GENEIN eeeee2 , expressed in CHO cells, were labelled with CHEMICALIN
CPR:5	To verify the hypothesis that the non-conventional partial agonist  bbbbb1 CHEMICALIN eeeee1  binds at two  bbbbb2 GENEIN eeeee2  sites, GENEIN, expressed in CHO cells, were labelled with CHEMICALIN
CPR:10	 bbbbb1 GENEIN eeeee1  release from peripheral blood CTLs after PMA/ionomycin-stimulation was not influenced significantly by  bbbbb2 CHEMICALIN eeeee2 
CPR:3	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), an activator of  bbbbb2 GENEIN eeeee2  (GENEIN), induces by several routes a profound anti-viral and anti-tumor effect in vivo
CPR:3	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), an activator of GENEIN ( bbbbb2 GENEIN eeeee2 ), induces by several routes a profound anti-viral and anti-tumor effect in vivo
CPR:3	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), an activator of  bbbbb2 GENEIN eeeee2  (GENEIN), induces by several routes a profound anti-viral and anti-tumor effect in vivo
CPR:3	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), an activator of GENEIN ( bbbbb2 GENEIN eeeee2 ), induces by several routes a profound anti-viral and anti-tumor effect in vivo
CPR:3	Thus, the biological activity of  bbbbb1 CHEMICALIN eeeee1  appears to exceed its previously known functions, inasmuch as it boosts up significantly the  bbbbb2 GENEIN eeeee2 -granule system.
CPR:3	In peripheral lymphocytes of healthy and diseased subjects,  bbbbb1 CHEMICALIN eeeee1  induced a significant increase of  bbbbb2 GENEIN eeeee2 (+) CTLs within 12h in all experiments performed
CPR:3	This effect was most pronounced in CTLs of patients suffering from atopic dermatitis, a model disorder for subnormal GENENOTIN expression: as compared to GENENOTIN(+) CTLs detected at time point zero (100%), up to 270% of  bbbbb1 GENEIN eeeee1 (+) CTLs were induced by 2.5 microg/ml [corrected]  bbbbb2 CHEMICALIN eeeee2 
CPR:3	 bbbbb1 CHEMICALIN eeeee1 , a GENEIN agonist, induces  bbbbb2 GENEIN eeeee2  in cytotoxic T lymphocytes in vitro
CPR:5	 bbbbb1 CHEMICALIN eeeee1 , a  bbbbb2 GENEIN eeeee2  agonist, induces GENEIN in cytotoxic T lymphocytes in vitro
CPR:3	 bbbbb1 GENEIN eeeee1  level in plasma and mesenteric arteries in CHEMICALIN group was significantly lower than that in  bbbbb2 CHEMICALIN eeeee2  group (P<0.05)
CPR:3	The  bbbbb1 GENEIN eeeee1  absorbed light value/GENEIN absorbed light value of mesenteric arteries in the SHR group was 0.850+/-0.015, which was significantly higher than that in the WKY,  bbbbb2 CHEMICALIN eeeee2 , and CHEMICALIN groups (0.582+/-0.013, 0.743+/-0.012, and 0.789+/-0.013, respectively, P<0.01), and was significantly lower in CHEMICALNOTIN group than in CHEMICALNOTIN group (P<0.05)
CPR:3	The GENEIN absorbed light value/ bbbbb1 GENEIN eeeee1  absorbed light value of mesenteric arteries in the SHR group was 0.850+/-0.015, which was significantly higher than that in the WKY,  bbbbb2 CHEMICALIN eeeee2 , and CHEMICALIN groups (0.582+/-0.013, 0.743+/-0.012, and 0.789+/-0.013, respectively, P<0.01), and was significantly lower in CHEMICALNOTIN group than in CHEMICALNOTIN group (P<0.05)
CPR:3	The  bbbbb1 GENEIN eeeee1  absorbed light value/GENEIN absorbed light value of mesenteric arteries in the SHR group was 0.850+/-0.015, which was significantly higher than that in the WKY, CHEMICALIN, and  bbbbb2 CHEMICALIN eeeee2  groups (0.582+/-0.013, 0.743+/-0.012, and 0.789+/-0.013, respectively, P<0.01), and was significantly lower in CHEMICALNOTIN group than in CHEMICALNOTIN group (P<0.05)
CPR:3	The GENEIN absorbed light value/ bbbbb1 GENEIN eeeee1  absorbed light value of mesenteric arteries in the SHR group was 0.850+/-0.015, which was significantly higher than that in the WKY, CHEMICALIN, and  bbbbb2 CHEMICALIN eeeee2  groups (0.582+/-0.013, 0.743+/-0.012, and 0.789+/-0.013, respectively, P<0.01), and was significantly lower in CHEMICALNOTIN group than in CHEMICALNOTIN group (P<0.05)
CPR:3	 bbbbb1 GENEIN eeeee1  level in plasma and mesenteric arteries in SHR group was the same or lower than that in WKY group, and was higher in  bbbbb2 CHEMICALIN eeeee2  group and lower in CHEMICALIN group
CPR:3	The ratio of  bbbbb1 GENEIN eeeee1  absorbed light value to GENEIN absorbed light value in the SHR group was 0.887+/-0.019, which was significantly higher than that in WKY group,  bbbbb2 CHEMICALIN eeeee2  group, and CHEMICALIN group with the ratios of 0.780+/-0.018, 0.803+/-0.005, and 0.847+/-0.017, respectively (P<0.01)
CPR:3	The ratio of GENEIN absorbed light value to  bbbbb1 GENEIN eeeee1  absorbed light value in the SHR group was 0.887+/-0.019, which was significantly higher than that in WKY group,  bbbbb2 CHEMICALIN eeeee2  group, and CHEMICALIN group with the ratios of 0.780+/-0.018, 0.803+/-0.005, and 0.847+/-0.017, respectively (P<0.01)
CPR:3	The ratio of  bbbbb1 GENEIN eeeee1  absorbed light value to GENEIN absorbed light value in the SHR group was 0.887+/-0.019, which was significantly higher than that in WKY group, CHEMICALIN group, and  bbbbb2 CHEMICALIN eeeee2  group with the ratios of 0.780+/-0.018, 0.803+/-0.005, and 0.847+/-0.017, respectively (P<0.01)
CPR:3	The ratio of GENEIN absorbed light value to  bbbbb1 GENEIN eeeee1  absorbed light value in the SHR group was 0.887+/-0.019, which was significantly higher than that in WKY group, CHEMICALIN group, and  bbbbb2 CHEMICALIN eeeee2  group with the ratios of 0.780+/-0.018, 0.803+/-0.005, and 0.847+/-0.017, respectively (P<0.01)
CPR:4	 bbbbb1 GENEIN eeeee1  level in plasma and mesenteric arteries in  bbbbb2 CHEMICALIN eeeee2  group was significantly lower than that in CHEMICALIN group (P<0.05)
CPR:4	CONCLUSION:  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN can not only control blood pressure but also inhibit mesenteric arteries remodeling and mRNA expression of  bbbbb2 GENEIN eeeee2 , GENEIN in SHR
CPR:4	CONCLUSION:  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN can not only control blood pressure but also inhibit mesenteric arteries remodeling and mRNA expression of GENEIN,  bbbbb2 GENEIN eeeee2  in SHR
CPR:4	CONCLUSION: CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  can not only control blood pressure but also inhibit mesenteric arteries remodeling and mRNA expression of  bbbbb2 GENEIN eeeee2 , GENEIN in SHR
CPR:4	CONCLUSION: CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  can not only control blood pressure but also inhibit mesenteric arteries remodeling and mRNA expression of GENEIN,  bbbbb2 GENEIN eeeee2  in SHR
CPR:4	 bbbbb1 GENEIN eeeee1  level in plasma and mesenteric arteries in SHR group was the same or lower than that in WKY group, and was higher in CHEMICALIN group and lower in  bbbbb2 CHEMICALIN eeeee2  group
CPR:2	Plasma from  bbbbb1 CHEMICALIN eeeee1 -treated subjects (ex vivo effect) dose-dependently decreased radioligand binding to  bbbbb2 GENEIN eeeee2  (maximum inhibition was 60%) (P=0.02)
CPR:6	BACKGROUND: To assess the sensitivity of biochemical, physiological, and pharmacological markers of peripheral GENENOTIN (GENENOTIN) function, we chronically antagonized  bbbbb1 GENEIN eeeee1  by a range of doses of  bbbbb2 CHEMICALIN eeeee2  [CHEMICALIN], which blocks the CHEMICALIN reuptake process
CPR:6	BACKGROUND: To assess the sensitivity of biochemical, physiological, and pharmacological markers of peripheral GENENOTIN (GENENOTIN) function, we chronically antagonized  bbbbb1 GENEIN eeeee1  by a range of doses of CHEMICALIN [ bbbbb2 CHEMICALIN eeeee2 ], which blocks the CHEMICALIN reuptake process
CPR:9	BACKGROUND: To assess the sensitivity of biochemical, physiological, and pharmacological markers of peripheral GENENOTIN (GENENOTIN) function, we chronically antagonized  bbbbb1 GENEIN eeeee1  by a range of doses of CHEMICALIN [CHEMICALIN], which blocks the  bbbbb2 CHEMICALIN eeeee2  reuptake process
CPR:4	 bbbbb1 CHEMICALIN eeeee1 , an antirheumatic gold compound, is an inhibitor of GENEIN, such as GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:4	 bbbbb1 CHEMICALIN eeeee1 , an antirheumatic gold compound, is an inhibitor of  bbbbb2 GENEIN eeeee2 , such as GENEIN and GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1 , an antirheumatic gold compound, is an inhibitor of GENEIN, such as  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:4	There was significantly less  bbbbb1 GENEIN eeeee1  activity in rat liver extracts, whereas the level of CHEMICALNOTIN activity remained unchanged, demonstrating that the dose of  bbbbb2 CHEMICALIN eeeee2  used was able to selectively inhibit one of these enzyme systems
CPR:2	Even though its inability to shift between the trivalent and a divalent oxidation state precludes that  bbbbb1 CHEMICALIN eeeee1  behaves as an CHEMICALIN analogue in every respect, it strongly interferes with cellular acquisition of iron from blood by competitive interaction with  bbbbb2 GENEIN eeeee2  and GENEIN-mediated endocytosis
CPR:2	Even though its inability to shift between the trivalent and a divalent oxidation state precludes that  bbbbb1 CHEMICALIN eeeee1  behaves as an CHEMICALIN analogue in every respect, it strongly interferes with cellular acquisition of iron from blood by competitive interaction with GENEIN and  bbbbb2 GENEIN eeeee2 -mediated endocytosis
CPR:2	Even though its inability to shift between the trivalent and a divalent oxidation state precludes that CHEMICALIN behaves as an  bbbbb1 CHEMICALIN eeeee1  analogue in every respect, it strongly interferes with cellular acquisition of iron from blood by competitive interaction with  bbbbb2 GENEIN eeeee2  and GENEIN-mediated endocytosis
CPR:2	Even though its inability to shift between the trivalent and a divalent oxidation state precludes that CHEMICALIN behaves as an  bbbbb1 CHEMICALIN eeeee1  analogue in every respect, it strongly interferes with cellular acquisition of iron from blood by competitive interaction with GENEIN and  bbbbb2 GENEIN eeeee2 -mediated endocytosis
CPR:2	Apart from the consequences of CHEMICALNOTIN deprivation,  bbbbb1 CHEMICALIN eeeee1  exerts cytotoxic effects by direct interaction with the CHEMICALIN-dependent enzyme  bbbbb2 GENEIN eeeee2 , resulting in reduced dNTP pools and inhibition of DNA synthesis
CPR:2	Apart from the consequences of CHEMICALNOTIN deprivation, CHEMICALIN exerts cytotoxic effects by direct interaction with the  bbbbb1 CHEMICALIN eeeee1 -dependent enzyme  bbbbb2 GENEIN eeeee2 , resulting in reduced dNTP pools and inhibition of DNA synthesis
CPR:2	Both the abundance of  bbbbb1 GENEIN eeeee1  and upregulation of GENEIN render tumors susceptible to  bbbbb2 CHEMICALIN eeeee2 -induced cytotoxicity
CPR:2	Both the abundance of GENEIN and upregulation of  bbbbb1 GENEIN eeeee1  render tumors susceptible to  bbbbb2 CHEMICALIN eeeee2 -induced cytotoxicity
CPR:4	Furthermore,  bbbbb1 CHEMICALIN eeeee1  also seems to affect intracellular availability of CHEMICALNOTIN already taken up via this pathway, probably due to its inhibitory activity on  bbbbb2 GENEIN eeeee2 
CPR:4	However, some experimental findings raise the question whether these effects resulting from the  bbbbb1 CHEMICALIN eeeee1 -mimicking properties of CHEMICALIN are solely responsible for its antineoplastic activity or whether additional mechanisms are involved, such as antimitotic effects which result from its capability of inhibiting  bbbbb2 GENEIN eeeee2  polymerization
CPR:4	However, some experimental findings raise the question whether these effects resulting from the CHEMICALIN-mimicking properties of  bbbbb1 CHEMICALIN eeeee1  are solely responsible for its antineoplastic activity or whether additional mechanisms are involved, such as antimitotic effects which result from its capability of inhibiting  bbbbb2 GENEIN eeeee2  polymerization
CPR:2	Here, we show that the  bbbbb1 GENEIN eeeee1  is the brain binding site of  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), a new antiepileptic drug with a unique activity profile in animal models of seizure and epilepsy
CPR:2	Here, we show that the  bbbbb1 GENEIN eeeee1  is the brain binding site of CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), a new antiepileptic drug with a unique activity profile in animal models of seizure and epilepsy
CPR:2	The  bbbbb1 GENEIN eeeee1  is the binding site for the antiepileptic drug  bbbbb2 CHEMICALIN eeeee2 
CPR:2	These experimental results suggest that  bbbbb1 GENEIN eeeee1  is the binding site of  bbbbb2 CHEMICALIN eeeee2  in the brain and that CHEMICALIN acts by modulating the function of GENEIN, supporting previous indications that CHEMICALNOTIN possesses a mechanism of action distinct from that of other antiepileptic drugs
CPR:2	These experimental results suggest that GENEIN is the binding site of CHEMICALIN in the brain and that  bbbbb1 CHEMICALIN eeeee1  acts by modulating the function of  bbbbb2 GENEIN eeeee2 , supporting previous indications that CHEMICALNOTIN possesses a mechanism of action distinct from that of other antiepileptic drugs
CPR:2	Brain membranes and purified synaptic vesicles from mice lacking GENENOTIN do not bind a tritiated CHEMICALNOTIN derivative, indicating that  bbbbb1 GENEIN eeeee1  is necessary for  bbbbb2 CHEMICALIN eeeee2  binding
CPR:2	 bbbbb1 CHEMICALIN eeeee1  and related compounds bind to  bbbbb2 GENEIN eeeee2  expressed in fibroblasts, indicating that GENEIN is sufficient for CHEMICALIN binding
CPR:2	CHEMICALIN and related compounds bind to GENEIN expressed in fibroblasts, indicating that  bbbbb1 GENEIN eeeee1  is sufficient for  bbbbb2 CHEMICALIN eeeee2  binding
CPR:2	Furthermore, there is a high degree of correlation between binding affinities of a series of  bbbbb1 CHEMICALIN eeeee1  derivatives to  bbbbb2 GENEIN eeeee2  in fibroblasts and to the CHEMICALNOTIN-binding site in brain
CPR:2	Their affinity for  bbbbb1 CHEMICALIN eeeee1  was moderate (EC50 = 30 microM), and the Hill coefficient was 1.3, corresponding to two  bbbbb2 GENEIN eeeee2 
CPR:2	 bbbbb1 CHEMICALIN eeeee1 -evoked currents were completely and reversibly blocked by the competitive  bbbbb2 GENEIN eeeee2  antagonist CHEMICALIN (IC50 = 1.7 microM), indicating expression of GENENOTIN but not GENENOTIN
CPR:2	Furthermore,  bbbbb1 GENEIN eeeee1  of horizontal cells were modulated by extracellular application of  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN, thus showing typical pharmacological properties of CNS GENENOTIN
CPR:2	Furthermore,  bbbbb1 GENEIN eeeee1  of horizontal cells were modulated by extracellular application of CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, and CHEMICALIN, thus showing typical pharmacological properties of CNS GENENOTIN
CPR:2	Furthermore,  bbbbb1 GENEIN eeeee1  of horizontal cells were modulated by extracellular application of CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, and CHEMICALIN, thus showing typical pharmacological properties of CNS GENENOTIN
CPR:2	Furthermore,  bbbbb1 GENEIN eeeee1  of horizontal cells were modulated by extracellular application of CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , and CHEMICALIN, thus showing typical pharmacological properties of CNS GENENOTIN
CPR:2	Furthermore,  bbbbb1 GENEIN eeeee1  of horizontal cells were modulated by extracellular application of CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and  bbbbb2 CHEMICALIN eeeee2 , thus showing typical pharmacological properties of CNS GENENOTIN
CPR:6	CHEMICALIN-evoked currents were completely and reversibly blocked by the competitive  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2  (IC50 = 1.7 microM), indicating expression of GENENOTIN but not GENENOTIN
CPR:2	Cerebral  bbbbb1 GENEIN eeeee1  (GENEIN) binding was measured in 10 patients with major depression and in 10 normal age-matched subjects using PET and  bbbbb2 CHEMICALIN eeeee2 
CPR:2	Cerebral GENEIN ( bbbbb1 GENEIN eeeee1 ) binding was measured in 10 patients with major depression and in 10 normal age-matched subjects using PET and  bbbbb2 CHEMICALIN eeeee2 
CPR:2	Central effects of CHEMICALIN and CHEMICALIN: measurement of psychomotor performance, subjective sleepiness, and brain  bbbbb1 GENEIN eeeee1  occupancy using  bbbbb2 CHEMICALIN eeeee2  positron emission tomography
CPR:2	This study compared the sedative profiles of the second-generation  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and CHEMICALIN, using 3 different criteria: subjective sleepiness evaluated by the Stanford Sleepiness Scale, objective psychomotor tests (simple and choice reaction time tests and visual discrimination tests at 4 different exposure durations), and measurement of  bbbbb2 GENEIN eeeee2  occupancy (H1RO) in the brain
CPR:2	This study compared the sedative profiles of the second-generation CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, using 3 different criteria: subjective sleepiness evaluated by the Stanford Sleepiness Scale, objective psychomotor tests (simple and choice reaction time tests and visual discrimination tests at 4 different exposure durations), and measurement of  bbbbb2 GENEIN eeeee2  occupancy (H1RO) in the brain
CPR:2	This study compared the sedative profiles of the second-generation CHEMICALIN, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , using 3 different criteria: subjective sleepiness evaluated by the Stanford Sleepiness Scale, objective psychomotor tests (simple and choice reaction time tests and visual discrimination tests at 4 different exposure durations), and measurement of  bbbbb2 GENEIN eeeee2  occupancy (H1RO) in the brain
CPR:2	Central effects of  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN: measurement of psychomotor performance, subjective sleepiness, and brain  bbbbb2 GENEIN eeeee2  occupancy using CHEMICALIN positron emission tomography
CPR:2	Central effects of CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 : measurement of psychomotor performance, subjective sleepiness, and brain  bbbbb2 GENEIN eeeee2  occupancy using CHEMICALIN positron emission tomography
CPR:6	 bbbbb1 GENEIN eeeee1  (GENEIN) antagonists, or  bbbbb2 CHEMICALIN eeeee2 , often induce sedative side effects when used for the treatment of allergic disorders
CPR:6	GENEIN ( bbbbb1 GENEIN eeeee1 ) antagonists, or  bbbbb2 CHEMICALIN eeeee2 , often induce sedative side effects when used for the treatment of allergic disorders
CPR:6	A novel membrane sensor for  bbbbb1 GENEIN eeeee1  antagonist " bbbbb2 CHEMICALIN eeeee2 "
CPR:2	 bbbbb1 GENEIN eeeee1  (GENEIN) continues to be a critical target for  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) and its prodrugs, CHEMICALIN/CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), and CHEMICALIN, primarily because this enzyme is essential for the synthesis of CHEMICALIN, a precursor for DNA synthesis
CPR:2	GENEIN ( bbbbb1 GENEIN eeeee1 ) continues to be a critical target for  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) and its prodrugs, CHEMICALIN/CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), and CHEMICALIN, primarily because this enzyme is essential for the synthesis of CHEMICALIN, a precursor for DNA synthesis
CPR:2	 bbbbb1 GENEIN eeeee1  (GENEIN) continues to be a critical target for CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) and its prodrugs, CHEMICALIN/CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), and CHEMICALIN, primarily because this enzyme is essential for the synthesis of CHEMICALIN, a precursor for DNA synthesis
CPR:2	GENEIN ( bbbbb1 GENEIN eeeee1 ) continues to be a critical target for CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) and its prodrugs, CHEMICALIN/CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), and CHEMICALIN, primarily because this enzyme is essential for the synthesis of CHEMICALIN, a precursor for DNA synthesis
CPR:2	 bbbbb1 GENEIN eeeee1  (GENEIN) continues to be a critical target for CHEMICALIN (CHEMICALIN) and its prodrugs,  bbbbb2 CHEMICALIN eeeee2 /CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), and CHEMICALIN, primarily because this enzyme is essential for the synthesis of CHEMICALIN, a precursor for DNA synthesis
CPR:2	GENEIN ( bbbbb1 GENEIN eeeee1 ) continues to be a critical target for CHEMICALIN (CHEMICALIN) and its prodrugs,  bbbbb2 CHEMICALIN eeeee2 /CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), and CHEMICALIN, primarily because this enzyme is essential for the synthesis of CHEMICALIN, a precursor for DNA synthesis
CPR:2	 bbbbb1 GENEIN eeeee1  (GENEIN) continues to be a critical target for CHEMICALIN (CHEMICALIN) and its prodrugs, CHEMICALIN/ bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), CHEMICALIN (CHEMICALIN), and CHEMICALIN, primarily because this enzyme is essential for the synthesis of CHEMICALIN, a precursor for DNA synthesis
CPR:2	GENEIN ( bbbbb1 GENEIN eeeee1 ) continues to be a critical target for CHEMICALIN (CHEMICALIN) and its prodrugs, CHEMICALIN/ bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), CHEMICALIN (CHEMICALIN), and CHEMICALIN, primarily because this enzyme is essential for the synthesis of CHEMICALIN, a precursor for DNA synthesis
CPR:2	 bbbbb1 GENEIN eeeee1  (GENEIN) continues to be a critical target for CHEMICALIN (CHEMICALIN) and its prodrugs, CHEMICALIN/CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), CHEMICALIN (CHEMICALIN), and CHEMICALIN, primarily because this enzyme is essential for the synthesis of CHEMICALIN, a precursor for DNA synthesis
CPR:2	GENEIN ( bbbbb1 GENEIN eeeee1 ) continues to be a critical target for CHEMICALIN (CHEMICALIN) and its prodrugs, CHEMICALIN/CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), CHEMICALIN (CHEMICALIN), and CHEMICALIN, primarily because this enzyme is essential for the synthesis of CHEMICALIN, a precursor for DNA synthesis
CPR:2	 bbbbb1 GENEIN eeeee1  (GENEIN) continues to be a critical target for CHEMICALIN (CHEMICALIN) and its prodrugs, CHEMICALIN/CHEMICALIN (CHEMICALIN),  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), and CHEMICALIN, primarily because this enzyme is essential for the synthesis of CHEMICALIN, a precursor for DNA synthesis
CPR:2	GENEIN ( bbbbb1 GENEIN eeeee1 ) continues to be a critical target for CHEMICALIN (CHEMICALIN) and its prodrugs, CHEMICALIN/CHEMICALIN (CHEMICALIN),  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), and CHEMICALIN, primarily because this enzyme is essential for the synthesis of CHEMICALIN, a precursor for DNA synthesis
CPR:2	 bbbbb1 GENEIN eeeee1  (GENEIN) continues to be a critical target for CHEMICALIN (CHEMICALIN) and its prodrugs, CHEMICALIN/CHEMICALIN (CHEMICALIN), CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), and CHEMICALIN, primarily because this enzyme is essential for the synthesis of CHEMICALIN, a precursor for DNA synthesis
CPR:2	GENEIN ( bbbbb1 GENEIN eeeee1 ) continues to be a critical target for CHEMICALIN (CHEMICALIN) and its prodrugs, CHEMICALIN/CHEMICALIN (CHEMICALIN), CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), and CHEMICALIN, primarily because this enzyme is essential for the synthesis of CHEMICALIN, a precursor for DNA synthesis
CPR:2	 bbbbb1 GENEIN eeeee1  (GENEIN) continues to be a critical target for CHEMICALIN (CHEMICALIN) and its prodrugs, CHEMICALIN/CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), and  bbbbb2 CHEMICALIN eeeee2 , primarily because this enzyme is essential for the synthesis of CHEMICALIN, a precursor for DNA synthesis
CPR:2	GENEIN ( bbbbb1 GENEIN eeeee1 ) continues to be a critical target for CHEMICALIN (CHEMICALIN) and its prodrugs, CHEMICALIN/CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), and  bbbbb2 CHEMICALIN eeeee2 , primarily because this enzyme is essential for the synthesis of CHEMICALIN, a precursor for DNA synthesis
CPR:4	While CHEMICALNOTIN antimetabolites have other sites of action, antifolates  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN) and CHEMICALIN (CHEMICALIN) are more specific and potent  bbbbb2 GENEIN eeeee2  inhibitors
CPR:4	While CHEMICALNOTIN antimetabolites have other sites of action, antifolates CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN) and CHEMICALIN (CHEMICALIN) are more specific and potent  bbbbb2 GENEIN eeeee2  inhibitors
CPR:4	While CHEMICALNOTIN antimetabolites have other sites of action, antifolates CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ) and CHEMICALIN (CHEMICALIN) are more specific and potent  bbbbb2 GENEIN eeeee2  inhibitors
CPR:4	While CHEMICALNOTIN antimetabolites have other sites of action, antifolates CHEMICALIN (CHEMICALIN, CHEMICALIN) and  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) are more specific and potent  bbbbb2 GENEIN eeeee2  inhibitors
CPR:4	While CHEMICALNOTIN antimetabolites have other sites of action, antifolates CHEMICALIN (CHEMICALIN, CHEMICALIN) and CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) are more specific and potent  bbbbb2 GENEIN eeeee2  inhibitors
CPR:9	 bbbbb1 GENEIN eeeee1  (GENEIN) continues to be a critical target for CHEMICALIN (CHEMICALIN) and its prodrugs, CHEMICALIN/CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), and CHEMICALIN, primarily because this enzyme is essential for the synthesis of  bbbbb2 CHEMICALIN eeeee2 , a precursor for DNA synthesis
CPR:9	GENEIN ( bbbbb1 GENEIN eeeee1 ) continues to be a critical target for CHEMICALIN (CHEMICALIN) and its prodrugs, CHEMICALIN/CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), and CHEMICALIN, primarily because this enzyme is essential for the synthesis of  bbbbb2 CHEMICALIN eeeee2 , a precursor for DNA synthesis
CPR:9	The availability of the CHEMICALNOTIN prodrugs offers the possibility of greater therapeutic selectivity based on the demonstration that  bbbbb1 GENEIN eeeee1 , the activating enzyme for  bbbbb2 CHEMICALIN eeeee2 , is expressed at a higher level in tumor tissue compared with normal tissue counterparts
CPR:4	 bbbbb1 CHEMICALIN eeeee1  is an inhibitor of  bbbbb2 GENEIN eeeee2  which is able to block the absorption of 30% of ingested fat
CPR:2	 bbbbb1 CHEMICALIN eeeee1  also decreased viability as measured by the  bbbbb2 GENEIN eeeee2 , CHEMICALNOTIN and CHEMICALNOTIN assays, with a LOAEL approximately 200 microM; however, a significant decrease in viability was not observed with the CHEMICALNOTIN assay
CPR:4	 bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and CHEMICALIN inhibit the  bbbbb2 GENEIN eeeee2  (GENEIN) which transports CHEMICALIN into bile
CPR:4	 bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and CHEMICALIN inhibit the GENEIN ( bbbbb2 GENEIN eeeee2 ) which transports CHEMICALIN into bile
CPR:4	CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN inhibit the  bbbbb2 GENEIN eeeee2  (GENEIN) which transports CHEMICALIN into bile
CPR:4	CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN inhibit the GENEIN ( bbbbb2 GENEIN eeeee2 ) which transports CHEMICALIN into bile
CPR:4	CHEMICALIN, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  inhibit the  bbbbb2 GENEIN eeeee2  (GENEIN) which transports CHEMICALIN into bile
CPR:4	CHEMICALIN, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  inhibit the GENEIN ( bbbbb2 GENEIN eeeee2 ) which transports CHEMICALIN into bile
CPR:9	CHEMICALIN, CHEMICALIN and CHEMICALIN inhibit the  bbbbb1 GENEIN eeeee1  (GENEIN) which transports  bbbbb2 CHEMICALIN eeeee2  into bile
CPR:9	CHEMICALIN, CHEMICALIN and CHEMICALIN inhibit the GENEIN ( bbbbb1 GENEIN eeeee1 ) which transports  bbbbb2 CHEMICALIN eeeee2  into bile
CPR:2	Unique binding interactions of  bbbbb1 CHEMICALIN eeeee1  with  bbbbb2 GENEIN eeeee2  translate into a fast rate of inactivation of GENEIN (110,000 M/s compared with 7000 M/s for CHEMICALIN and 80 M/s for CHEMICALIN)
CPR:2	The overall saturation binding affinity for  bbbbb1 GENEIN eeeee1  of  bbbbb2 CHEMICALIN eeeee2  is 2.6 nM (compared with 1.6 nM for CHEMICALIN, 51 nM for CHEMICALIN, and 260 nM for CHEMICALIN), with a slow off-rate (t(1/2) approximately 98 min)
CPR:2	The overall saturation binding affinity for  bbbbb1 GENEIN eeeee1  of CHEMICALIN is 2.6 nM (compared with 1.6 nM for  bbbbb2 CHEMICALIN eeeee2 , 51 nM for CHEMICALIN, and 260 nM for CHEMICALIN), with a slow off-rate (t(1/2) approximately 98 min)
CPR:2	The overall saturation binding affinity for  bbbbb1 GENEIN eeeee1  of CHEMICALIN is 2.6 nM (compared with 1.6 nM for CHEMICALIN, 51 nM for  bbbbb2 CHEMICALIN eeeee2 , and 260 nM for CHEMICALIN), with a slow off-rate (t(1/2) approximately 98 min)
CPR:2	The overall saturation binding affinity for  bbbbb1 GENEIN eeeee1  of CHEMICALIN is 2.6 nM (compared with 1.6 nM for CHEMICALIN, 51 nM for CHEMICALIN, and 260 nM for  bbbbb2 CHEMICALIN eeeee2 ), with a slow off-rate (t(1/2) approximately 98 min)
CPR:2	Unique binding interactions of CHEMICALIN with GENEIN translate into a fast rate of inactivation of  bbbbb1 GENEIN eeeee1  (110,000 M/s compared with 7000 M/s for  bbbbb2 CHEMICALIN eeeee2  and 80 M/s for CHEMICALIN)
CPR:2	 bbbbb1 CHEMICALIN eeeee1 : assessment of  bbbbb2 GENEIN eeeee2  potency and selectivity
CPR:2	Unique binding interactions of CHEMICALIN with GENEIN translate into a fast rate of inactivation of  bbbbb1 GENEIN eeeee1  (110,000 M/s compared with 7000 M/s for CHEMICALIN and 80 M/s for  bbbbb2 CHEMICALIN eeeee2 )
CPR:2	Collectively, these data provide a mechanistic basis for the potency and in vitro selectivity of  bbbbb1 CHEMICALIN eeeee1  for  bbbbb2 GENEIN eeeee2 
CPR:4	Unique binding interactions of  bbbbb1 CHEMICALIN eeeee1  with GENEIN translate into a fast rate of inactivation of  bbbbb2 GENEIN eeeee2  (110,000 M/s compared with 7000 M/s for CHEMICALIN and 80 M/s for CHEMICALIN)
CPR:4	We report here the pharmacological properties of a third selective  bbbbb1 GENEIN eeeee1  inhibitor,  bbbbb2 CHEMICALIN eeeee2 , which is the most potent and in vitro selective of the marketed GENEIN inhibitors that we have studied
CPR:4	We report here the pharmacological properties of a third selective GENEIN inhibitor,  bbbbb1 CHEMICALIN eeeee1 , which is the most potent and in vitro selective of the marketed  bbbbb2 GENEIN eeeee2  inhibitors that we have studied
CPR:4	 bbbbb1 CHEMICALIN eeeee1  potently inhibits recombinant  bbbbb2 GENEIN eeeee2 , with an IC(50) of 0.005 microM; this compares with IC values of 0.05 microM for CHEMICALIN, 0.5 microM for CHEMICALIN, and 5 microM for CHEMICALIN
CPR:4	CHEMICALIN potently inhibits recombinant  bbbbb1 GENEIN eeeee1 , with an IC(50) of 0.005 microM; this compares with IC values of 0.05 microM for  bbbbb2 CHEMICALIN eeeee2 , 0.5 microM for CHEMICALIN, and 5 microM for CHEMICALIN
CPR:4	CHEMICALIN potently inhibits recombinant  bbbbb1 GENEIN eeeee1 , with an IC(50) of 0.005 microM; this compares with IC values of 0.05 microM for CHEMICALIN, 0.5 microM for  bbbbb2 CHEMICALIN eeeee2 , and 5 microM for CHEMICALIN
CPR:4	CHEMICALIN potently inhibits recombinant  bbbbb1 GENEIN eeeee1 , with an IC(50) of 0.005 microM; this compares with IC values of 0.05 microM for CHEMICALIN, 0.5 microM for CHEMICALIN, and 5 microM for  bbbbb2 CHEMICALIN eeeee2 
CPR:4	 bbbbb1 CHEMICALIN eeeee1  inhibits  bbbbb2 GENEIN eeeee2  in a competitive fashion only at very high concentrations (IC(50) = 150 microM)
CPR:4	 bbbbb1 CHEMICALIN eeeee1  showed similar activity in the  bbbbb2 GENEIN eeeee2  assay (GENEIN IC(50) = 0.24 microM; GENEIN IC(50) = 21.9 microM)
CPR:4	 bbbbb1 CHEMICALIN eeeee1  showed similar activity in the GENEIN assay ( bbbbb2 GENEIN eeeee2  IC(50) = 0.24 microM; GENEIN IC(50) = 21.9 microM)
CPR:4	 bbbbb1 CHEMICALIN eeeee1  showed similar activity in the GENEIN assay (GENEIN IC(50) = 0.24 microM;  bbbbb2 GENEIN eeeee2  IC(50) = 21.9 microM)
CPR:9	The discovery of a GENENOTIN (GENENOTIN) led to the search for compounds that could selectively inhibit GENENOTIN in humans while sparing  bbbbb1 CHEMICALIN eeeee1  formation from  bbbbb2 GENEIN eeeee2 
CPR:3	An GENEIN antagonist,  bbbbb1 CHEMICALIN eeeee1  augments CHEMICALIN uptake and  bbbbb2 GENEIN eeeee2  protein expression in 3T3-L1 adipocytes
CPR:3	Treatment of both differentiating adipocytes and fully differentiated adipocytes with  bbbbb1 CHEMICALIN eeeee1  caused a dose-dependent increase in mRNA levels for  bbbbb2 GENEIN eeeee2  target genes such as GENEIN and GENEIN
CPR:3	Treatment of both differentiating adipocytes and fully differentiated adipocytes with  bbbbb1 CHEMICALIN eeeee1  caused a dose-dependent increase in mRNA levels for GENEIN target genes such as  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:3	Treatment of both differentiating adipocytes and fully differentiated adipocytes with  bbbbb1 CHEMICALIN eeeee1  caused a dose-dependent increase in mRNA levels for GENEIN target genes such as GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:3	By contrast,  bbbbb1 CHEMICALIN eeeee1  attenuated  bbbbb2 GENEIN eeeee2  mRNA level in differentiated adipocytes
CPR:3	Of note, we demonstrated for the first time that  bbbbb1 CHEMICALIN eeeee1  augmented  bbbbb2 GENEIN eeeee2  protein expression and CHEMICALIN uptake both in basal and GENENOTIN-stimulated state of adipocytes, which may contribute, at least partly, to its GENENOTIN-sensitizing ability.
CPR:6	An  bbbbb1 GENEIN eeeee1  antagonist,  bbbbb2 CHEMICALIN eeeee2  augments CHEMICALIN uptake and GENEIN protein expression in 3T3-L1 adipocytes
CPR:9	An GENEIN antagonist, CHEMICALIN augments  bbbbb1 CHEMICALIN eeeee1  uptake and  bbbbb2 GENEIN eeeee2  protein expression in 3T3-L1 adipocytes
CPR:9	Of note, we demonstrated for the first time that CHEMICALIN augmented  bbbbb1 GENEIN eeeee1  protein expression and  bbbbb2 CHEMICALIN eeeee2  uptake both in basal and GENENOTIN-stimulated state of adipocytes, which may contribute, at least partly, to its GENENOTIN-sensitizing ability.
CPR:1	We found a strong interaction of baseline FEV(1) with the  bbbbb1 GENEIN eeeee1  ( bbbbb2 CHEMICALIN eeeee2 ) polymorphism in predicting bronchodilator response
CPR:2	Genetic variants at the  bbbbb1 GENEIN eeeee1  (GENEIN) may modify asthma severity and  bbbbb2 CHEMICALIN eeeee2  responsiveness
CPR:2	Genetic variants at the GENEIN ( bbbbb1 GENEIN eeeee1 ) may modify asthma severity and  bbbbb2 CHEMICALIN eeeee2  responsiveness
CPR:2	We tested the association of  bbbbb1 GENEIN eeeee1  genotypes with asthma severity and bronchodilator response to  bbbbb2 CHEMICALIN eeeee2  in Puerto Ricans and Mexicans with asthma
CPR:4	Especially, the compound 1 showed strong inhibition (IC50=1.33 microM) against the enzyme  bbbbb1 GENEIN eeeee1 , as compared to the standard tyrosinase inhibitors  bbbbb2 CHEMICALIN eeeee2  (IC50=16.67 microM) and CHEMICALIN (IC50=3.68 microM), indicating its potential used for the treatment of hyperpigmentation associated with the high production of melanocytes.
CPR:4	Especially, the compound 1 showed strong inhibition (IC50=1.33 microM) against the enzyme  bbbbb1 GENEIN eeeee1 , as compared to the standard tyrosinase inhibitors CHEMICALIN (IC50=16.67 microM) and  bbbbb2 CHEMICALIN eeeee2  (IC50=3.68 microM), indicating its potential used for the treatment of hyperpigmentation associated with the high production of melanocytes.
CPR:10	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN did not alter  bbbbb2 GENEIN eeeee2  number or binding affinity significantly at each time point studied compared with controls
CPR:10	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  did not alter  bbbbb2 GENEIN eeeee2  number or binding affinity significantly at each time point studied compared with controls
CPR:2	In Experiment 2,  bbbbb1 CHEMICALIN eeeee1  induced a significant decrease (p<0.05) in  bbbbb2 GENEIN eeeee2  number and binding affinity at both 0.5 and 4 hours compared with controls
CPR:2	In conclusion,  bbbbb1 CHEMICALIN eeeee1  may inhibit the uterine response to GENEIN by decreasing GENEIN numbers and  bbbbb2 GENEIN eeeee2  binding affinity, which might explain the prolonged GENEIN antagonist activity of CHEMICALIN.
CPR:4	In Experiment 2,  bbbbb1 CHEMICALIN eeeee1  induced a significant decrease (p<0.05) in  bbbbb2 GENEIN eeeee2  number and binding affinity at both 0.5 and 4 hours compared with controls
CPR:4	In conclusion,  bbbbb1 CHEMICALIN eeeee1  may inhibit the uterine response to GENEIN by decreasing  bbbbb2 GENEIN eeeee2  numbers and GENEIN binding affinity, which might explain the prolonged GENEIN antagonist activity of CHEMICALIN.
CPR:4	In conclusion,  bbbbb1 CHEMICALIN eeeee1  may inhibit the uterine response to  bbbbb2 GENEIN eeeee2  by decreasing GENEIN numbers and GENEIN binding affinity, which might explain the prolonged GENEIN antagonist activity of CHEMICALIN.
CPR:4	The purpose of the present study was to confirm the duration of  bbbbb1 CHEMICALIN eeeee1  to block  bbbbb2 GENEIN eeeee2 -induced uterine contractions in estrous rats
CPR:4	GENEIN antagonist (OTA),  bbbbb1 CHEMICALIN eeeee1 , was developed by our group and shown to inhibit either spontaneous or  bbbbb2 GENEIN eeeee2 -induced uterine contractions in primates
CPR:4	In Experiment 1,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and CHEMICALIN inhibited the integrated uterine response to  bbbbb2 GENEIN eeeee2  at 5 minutes by 76%, 77% and 80%, respectively, compared to controls (p<0.05)
CPR:4	In Experiment 1, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN inhibited the integrated uterine response to  bbbbb2 GENEIN eeeee2  at 5 minutes by 76%, 77% and 80%, respectively, compared to controls (p<0.05)
CPR:4	In Experiment 1, CHEMICALIN, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  inhibited the integrated uterine response to  bbbbb2 GENEIN eeeee2  at 5 minutes by 76%, 77% and 80%, respectively, compared to controls (p<0.05)
CPR:6	In conclusion, CHEMICALIN may inhibit the uterine response to GENEIN by decreasing GENEIN numbers and GENEIN binding affinity, which might explain the prolonged  bbbbb1 GENEIN eeeee1  antagonist activity of  bbbbb2 CHEMICALIN eeeee2 .
CPR:6	 bbbbb1 GENEIN eeeee1  antagonist (OTA),  bbbbb2 CHEMICALIN eeeee2 , was developed by our group and shown to inhibit either spontaneous or GENEIN-induced uterine contractions in primates
CPR:10	In cellular assays,  bbbbb1 CHEMICALIN eeeee1  had an IC(50) of 0.14 microM in GENEIN-expressing dermal fibroblasts, but caused no inhibition of  bbbbb2 GENEIN eeeee2  at concentrations up to 30 microM (HEK 293 cells transfected with GENENOTIN). 3
CPR:4	This manuscript presents the preclinical profile of  bbbbb1 CHEMICALIN eeeee1 , a novel  bbbbb2 GENEIN eeeee2  (GENEIN) selective inhibitor. 2
CPR:4	This manuscript presents the preclinical profile of  bbbbb1 CHEMICALIN eeeee1 , a novel GENEIN ( bbbbb2 GENEIN eeeee2 ) selective inhibitor. 2
CPR:4	Ex vivo,  bbbbb1 CHEMICALIN eeeee1  inhibited  bbbbb2 GENEIN eeeee2 -derived CHEMICALIN (CHEMICALIN) generation with an ID(50) of 33 mg kg(-1), whereas GENEIN-derived production of CHEMICALIN (CHEMICALIN) in the lipopolysaccharide-stimulated rat air pouch was inhibited with an ID(50) value of 0.24 mg kg(-1). 6
CPR:4	reclinical pharmacology of  bbbbb1 CHEMICALIN eeeee1 : a novel selective inhibitor of  bbbbb2 GENEIN eeeee2 . 1
CPR:4	However, consistent with its low  bbbbb1 GENEIN eeeee1  inhibitory activity,  bbbbb2 CHEMICALIN eeeee2  at a dose of 100 mg kg(-1) orally caused no ulcers and was significantly less ulcerogenic than CHEMICALIN (P<0.05). 7
CPR:4	 bbbbb1 CHEMICALIN eeeee1  inhibited purified  bbbbb2 GENEIN eeeee2  and GENEIN with K(i) values of 3 and 0.06 microM, respectively
CPR:4	 bbbbb1 CHEMICALIN eeeee1  inhibited purified GENEIN and  bbbbb2 GENEIN eeeee2  with K(i) values of 3 and 0.06 microM, respectively
CPR:4	However, consistent with its low  bbbbb1 GENEIN eeeee1  inhibitory activity, CHEMICALIN at a dose of 100 mg kg(-1) orally caused no ulcers and was significantly less ulcerogenic than  bbbbb2 CHEMICALIN eeeee2  (P<0.05). 7
CPR:4	 bbbbb1 CHEMICALIN eeeee1  is a highly selective  bbbbb2 GENEIN eeeee2  inhibitor with anti-inflammatory, analgesic and antipyretic activities comparable with CHEMICALIN, the reference NSAID, but with much improved gastrointestinal safety.
CPR:4	CHEMICALIN is a highly selective  bbbbb1 GENEIN eeeee1  inhibitor with anti-inflammatory, analgesic and antipyretic activities comparable with  bbbbb2 CHEMICALIN eeeee2 , the reference NSAID, but with much improved gastrointestinal safety.
CPR:4	In cellular assays,  bbbbb1 CHEMICALIN eeeee1  had an IC(50) of 0.14 microM in  bbbbb2 GENEIN eeeee2 -expressing dermal fibroblasts, but caused no inhibition of GENEIN at concentrations up to 30 microM (HEK 293 cells transfected with GENENOTIN). 3
CPR:4	In a human whole blood assay, IC(50) values for  bbbbb1 CHEMICALIN eeeee1  were 0.13 microM for  bbbbb2 GENEIN eeeee2  and 67 microM for GENEIN (GENEIN/GENEIN selectivity ratio 515). 4
CPR:4	In a human whole blood assay, IC(50) values for  bbbbb1 CHEMICALIN eeeee1  were 0.13 microM for GENEIN and 67 microM for  bbbbb2 GENEIN eeeee2  (GENEIN/GENEIN selectivity ratio 515). 4
CPR:4	In a human whole blood assay, IC(50) values for  bbbbb1 CHEMICALIN eeeee1  were 0.13 microM for GENEIN and 67 microM for GENEIN ( bbbbb2 GENEIN eeeee2 /GENEIN selectivity ratio 515). 4
CPR:4	In a human whole blood assay, IC(50) values for  bbbbb1 CHEMICALIN eeeee1  were 0.13 microM for GENEIN and 67 microM for GENEIN (GENEIN/ bbbbb2 GENEIN eeeee2  selectivity ratio 515). 4
CPR:9	Ex vivo, CHEMICALIN inhibited  bbbbb1 GENEIN eeeee1 -derived  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) generation with an ID(50) of 33 mg kg(-1), whereas GENEIN-derived production of CHEMICALIN (CHEMICALIN) in the lipopolysaccharide-stimulated rat air pouch was inhibited with an ID(50) value of 0.24 mg kg(-1). 6
CPR:9	Ex vivo, CHEMICALIN inhibited  bbbbb1 GENEIN eeeee1 -derived CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) generation with an ID(50) of 33 mg kg(-1), whereas GENEIN-derived production of CHEMICALIN (CHEMICALIN) in the lipopolysaccharide-stimulated rat air pouch was inhibited with an ID(50) value of 0.24 mg kg(-1). 6
CPR:9	Ex vivo, CHEMICALIN inhibited GENEIN-derived CHEMICALIN (CHEMICALIN) generation with an ID(50) of 33 mg kg(-1), whereas  bbbbb1 GENEIN eeeee1 -derived production of  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) in the lipopolysaccharide-stimulated rat air pouch was inhibited with an ID(50) value of 0.24 mg kg(-1). 6
CPR:9	Ex vivo, CHEMICALIN inhibited GENEIN-derived CHEMICALIN (CHEMICALIN) generation with an ID(50) of 33 mg kg(-1), whereas  bbbbb1 GENEIN eeeee1 -derived production of CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) in the lipopolysaccharide-stimulated rat air pouch was inhibited with an ID(50) value of 0.24 mg kg(-1). 6
CPR:9	As  bbbbb1 CHEMICALIN eeeee1  metabolism deficiencies have been seen in placental infarcts previously, these indicate that  bbbbb2 GENEIN eeeee2 /GENEIN may have a role in placental diseases
CPR:9	As  bbbbb1 CHEMICALIN eeeee1  metabolism deficiencies have been seen in placental infarcts previously, these indicate that GENEIN/ bbbbb2 GENEIN eeeee2  may have a role in placental diseases
CPR:5	 bbbbb1 CHEMICALIN eeeee1  is metabolically more stable and better tolerated, and may enhance mucociliary clearance for a longer period of time than previously investigated  bbbbb2 GENEIN eeeee2  agonists
CPR:5	Safety and tolerability of  bbbbb1 CHEMICALIN eeeee1  inhalation solution, a novel  bbbbb2 GENEIN eeeee2  agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis
CPR:5	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) is a selective  bbbbb2 GENEIN eeeee2  agonist that stimulates ciliary beat frequency and CHEMICALNOTIN secretion in normal and cystic fibrosis (CF) airway epithelia, and is being investigated as an inhaled treatment for CF
CPR:5	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) is a selective  bbbbb2 GENEIN eeeee2  agonist that stimulates ciliary beat frequency and CHEMICALNOTIN secretion in normal and cystic fibrosis (CF) airway epithelia, and is being investigated as an inhaled treatment for CF
CPR:9	The  bbbbb1 CHEMICALIN eeeee1  secretory response is mediated via a non- bbbbb2 GENEIN eeeee2  pathway, and the driving force for CHEMICALNOTIN secretion is enhanced by the effect of GENENOTIN activation to also inhibit epithelial CHEMICALNOTIN transport
CPR:2	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN are high-affinity ligands at  bbbbb2 GENEIN eeeee2 
CPR:2	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  are high-affinity ligands at  bbbbb2 GENEIN eeeee2 
CPR:2	The anticonvulsant action of CHEMICALNOTIN or CHEMICALNOTIN was significantly counteracted by a selective GENEIN antagonist CHEMICALIN, suggesting that the anticonvulsant action of  bbbbb1 CHEMICALIN eeeee1  or CHEMICALIN is, at least in part, related to  bbbbb2 GENEIN eeeee2 -activated modulation of GENEIN transcription factors
CPR:2	The anticonvulsant action of CHEMICALNOTIN or CHEMICALNOTIN was significantly counteracted by a selective GENEIN antagonist CHEMICALIN, suggesting that the anticonvulsant action of  bbbbb1 CHEMICALIN eeeee1  or CHEMICALIN is, at least in part, related to GENEIN-activated modulation of  bbbbb2 GENEIN eeeee2  transcription factors
CPR:2	The CHEMICALIN analog CHEMICALIN attenuates kainate-induced seizures via  bbbbb1 GENEIN eeeee1  activation: comparison with the effects of  bbbbb2 CHEMICALIN eeeee2 
CPR:2	The anticonvulsant action of CHEMICALNOTIN or CHEMICALNOTIN was significantly counteracted by a selective GENEIN antagonist CHEMICALIN, suggesting that the anticonvulsant action of CHEMICALIN or  bbbbb1 CHEMICALIN eeeee1  is, at least in part, related to  bbbbb2 GENEIN eeeee2 -activated modulation of GENEIN transcription factors
CPR:2	The anticonvulsant action of CHEMICALNOTIN or CHEMICALNOTIN was significantly counteracted by a selective GENEIN antagonist CHEMICALIN, suggesting that the anticonvulsant action of CHEMICALIN or  bbbbb1 CHEMICALIN eeeee1  is, at least in part, related to GENEIN-activated modulation of  bbbbb2 GENEIN eeeee2  transcription factors
CPR:3	CHEMICALIN pre-treatment also attenuated the  bbbbb1 CHEMICALIN eeeee1 -induced increases in GENEIN/GENEIN expression,  bbbbb2 GENEIN eeeee2  DNA-binding activity, and loss of cells in the CA1 and CA3 fields of the hippocampus
CPR:3	The CHEMICALIN analog  bbbbb1 CHEMICALIN eeeee1  attenuates kainate-induced seizures via  bbbbb2 GENEIN eeeee2  activation: comparison with the effects of CHEMICALIN
CPR:3	The  bbbbb1 CHEMICALIN eeeee1  analog CHEMICALIN attenuates kainate-induced seizures via  bbbbb2 GENEIN eeeee2  activation: comparison with the effects of CHEMICALIN
CPR:3	CHEMICALIN pre-treatment also attenuated the  bbbbb1 CHEMICALIN eeeee1 -induced increases in  bbbbb2 GENEIN eeeee2 /GENEIN expression, GENEIN DNA-binding activity, and loss of cells in the CA1 and CA3 fields of the hippocampus
CPR:3	CHEMICALIN pre-treatment also attenuated the  bbbbb1 CHEMICALIN eeeee1 -induced increases in GENEIN/ bbbbb2 GENEIN eeeee2  expression, GENEIN DNA-binding activity, and loss of cells in the CA1 and CA3 fields of the hippocampus
CPR:4	 bbbbb1 CHEMICALIN eeeee1  pre-treatment also attenuated the CHEMICALIN-induced increases in  bbbbb2 GENEIN eeeee2 /GENEIN expression, GENEIN DNA-binding activity, and loss of cells in the CA1 and CA3 fields of the hippocampus
CPR:4	 bbbbb1 CHEMICALIN eeeee1  pre-treatment also attenuated the CHEMICALIN-induced increases in GENEIN/ bbbbb2 GENEIN eeeee2  expression, GENEIN DNA-binding activity, and loss of cells in the CA1 and CA3 fields of the hippocampus
CPR:4	 bbbbb1 CHEMICALIN eeeee1  pre-treatment also attenuated the CHEMICALIN-induced increases in GENEIN/GENEIN expression,  bbbbb2 GENEIN eeeee2  DNA-binding activity, and loss of cells in the CA1 and CA3 fields of the hippocampus
CPR:6	The anticonvulsant action of CHEMICALNOTIN or CHEMICALNOTIN was significantly counteracted by a selective  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2 , suggesting that the anticonvulsant action of CHEMICALIN or CHEMICALIN is, at least in part, related to GENEIN-activated modulation of GENEIN transcription factors
CPR:1	For both agonists, important binding domains were the extracellular  bbbbb1 CHEMICALIN eeeee1 -terminus (=E1) and the extracellular loops E2 and E3 from the  bbbbb2 GENEIN eeeee2 
CPR:2	In contrast, the binding of  bbbbb1 CHEMICALIN eeeee1  was significantly improved when the transmembrane domains 1 and 2 were transferred from the CHEMICALNOTIN receptor to the  bbbbb2 GENEIN eeeee2 
CPR:2	The binding domain of  bbbbb1 CHEMICALIN eeeee1  differs from the binding domain of the agonists and the nonselective  bbbbb2 GENEIN eeeee2  antagonist CHEMICALIN that has been used in previous studies
CPR:2	We have analyzed binding domains of the  bbbbb1 GENEIN eeeee1  for  bbbbb2 CHEMICALIN eeeee2 , a highly selective GENEIN antagonist, in comparison to the combined GENEIN antagonist CHEMICALIN and the agonists CHEMICALIN and CHEMICALIN
CPR:2	Binding domains of the  bbbbb1 GENEIN eeeee1  for the selective GENEIN antagonist  bbbbb2 CHEMICALIN eeeee2  in comparison to the agonists CHEMICALIN and CHEMICALIN
CPR:2	For the GENEIN antagonist  bbbbb1 CHEMICALIN eeeee1 , none of the receptor constructs were able to provide a binding with higher affinity than the starting  bbbbb2 GENEIN eeeee2 
CPR:5	We have analyzed binding domains of the GENEIN for CHEMICALIN, a highly selective GENEIN antagonist, in comparison to the combined  bbbbb1 GENEIN eeeee1  antagonist CHEMICALIN and the agonists  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:5	We have analyzed binding domains of the GENEIN for CHEMICALIN, a highly selective GENEIN antagonist, in comparison to the combined  bbbbb1 GENEIN eeeee1  antagonist CHEMICALIN and the agonists CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:5	Binding domains of the GENEIN for the selective  bbbbb1 GENEIN eeeee1  antagonist CHEMICALIN in comparison to the agonists  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:5	Binding domains of the GENEIN for the selective  bbbbb1 GENEIN eeeee1  antagonist CHEMICALIN in comparison to the agonists CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:6	The binding domain of CHEMICALIN differs from the binding domain of the agonists and the nonselective  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2  that has been used in previous studies
CPR:6	We have analyzed binding domains of the GENEIN for CHEMICALIN, a highly selective GENEIN antagonist, in comparison to the combined  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2  and the agonists CHEMICALIN and CHEMICALIN
CPR:6	We have analyzed binding domains of the GENEIN for  bbbbb1 CHEMICALIN eeeee1 , a highly selective  bbbbb2 GENEIN eeeee2  antagonist, in comparison to the combined GENEIN antagonist CHEMICALIN and the agonists CHEMICALIN and CHEMICALIN
CPR:6	Binding domains of the GENEIN for the selective  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2  in comparison to the agonists CHEMICALIN and CHEMICALIN
CPR:6	For the  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2 , none of the receptor constructs were able to provide a binding with higher affinity than the starting GENEIN
CPR:10	Using the reverse-transcription and real-time quantitative PCR (RQ-PCR) analysis, we indicated that  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN did not profoundly affect on  bbbbb2 GENEIN eeeee2  transcription in Jurkat T leukemia cells clone E6-1
CPR:10	Using the reverse-transcription and real-time quantitative PCR (RQ-PCR) analysis, we indicated that CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  did not profoundly affect on  bbbbb2 GENEIN eeeee2  transcription in Jurkat T leukemia cells clone E6-1
CPR:4	However, the flowcytometric analysis revealed that  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN decreased intracellular contents of  bbbbb2 GENEIN eeeee2  in these cells in dose dependent manner
CPR:4	However, the flowcytometric analysis revealed that CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  decreased intracellular contents of  bbbbb2 GENEIN eeeee2  in these cells in dose dependent manner
CPR:4	The compounds  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) and CHEMICALIN (CHEMICALIN) belong to inhibitors of  bbbbb2 GENEIN eeeee2 , whose low activity correlates with increase in transcription of various genes
CPR:4	The compounds CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) and CHEMICALIN (CHEMICALIN) belong to inhibitors of  bbbbb2 GENEIN eeeee2 , whose low activity correlates with increase in transcription of various genes
CPR:4	The compounds CHEMICALIN (CHEMICALIN) and  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) belong to inhibitors of  bbbbb2 GENEIN eeeee2 , whose low activity correlates with increase in transcription of various genes
CPR:4	The compounds CHEMICALIN (CHEMICALIN) and CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) belong to inhibitors of  bbbbb2 GENEIN eeeee2 , whose low activity correlates with increase in transcription of various genes
CPR:4	These findings suggest that the mechanism of antiproliferative toxicity of CHEMICALIN is at least partly due to  bbbbb1 GENEIN eeeee1  inhibitory activity of its active metabolite CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 )
CPR:4	Clinical studies in cancer patients treated with the new  bbbbb1 CHEMICALIN eeeee1  analogue CHEMICALIN (CHEMICALIN) have shown that plasma CHEMICALIN was significantly elevated after 1 week of treatment, consistent with inhibition of  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:4	Clinical studies in cancer patients treated with the new  bbbbb1 CHEMICALIN eeeee1  analogue CHEMICALIN (CHEMICALIN) have shown that plasma CHEMICALIN was significantly elevated after 1 week of treatment, consistent with inhibition of GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:4	Clinical studies in cancer patients treated with the new CHEMICALIN analogue  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) have shown that plasma CHEMICALIN was significantly elevated after 1 week of treatment, consistent with inhibition of  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:4	Clinical studies in cancer patients treated with the new CHEMICALIN analogue  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) have shown that plasma CHEMICALIN was significantly elevated after 1 week of treatment, consistent with inhibition of GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:4	Clinical studies in cancer patients treated with the new CHEMICALIN analogue CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) have shown that plasma CHEMICALIN was significantly elevated after 1 week of treatment, consistent with inhibition of  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:4	Clinical studies in cancer patients treated with the new CHEMICALIN analogue CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) have shown that plasma CHEMICALIN was significantly elevated after 1 week of treatment, consistent with inhibition of GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:4	Clinical studies in cancer patients treated with the new CHEMICALIN analogue CHEMICALIN (CHEMICALIN) have shown that plasma  bbbbb1 CHEMICALIN eeeee1  was significantly elevated after 1 week of treatment, consistent with inhibition of  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:4	Clinical studies in cancer patients treated with the new CHEMICALIN analogue CHEMICALIN (CHEMICALIN) have shown that plasma  bbbbb1 CHEMICALIN eeeee1  was significantly elevated after 1 week of treatment, consistent with inhibition of GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:4	These findings suggest that the mechanism of antiproliferative toxicity of  bbbbb1 CHEMICALIN eeeee1  is at least partly due to  bbbbb2 GENEIN eeeee2  inhibitory activity of its active metabolite CHEMICALIN (CHEMICALIN)
CPR:4	These findings suggest that the mechanism of antiproliferative toxicity of CHEMICALIN is at least partly due to  bbbbb1 GENEIN eeeee1  inhibitory activity of its active metabolite  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN)
CPR:2	An in vitro GENENOTIN assay showed that  bbbbb1 CHEMICALIN eeeee1  did not directly affect GENEIN  bbbbb2 GENEIN eeeee2  activity, suggesting involvement of GENEIN-activating molecules
CPR:2	An in vitro GENENOTIN assay showed that  bbbbb1 CHEMICALIN eeeee1  did not directly affect GENEIN GENEIN activity, suggesting involvement of  bbbbb2 GENEIN eeeee2 -activating molecules
CPR:2	An in vitro GENENOTIN assay showed that  bbbbb1 CHEMICALIN eeeee1  did not directly affect  bbbbb2 GENEIN eeeee2  GENEIN activity, suggesting involvement of GENEIN-activating molecules
CPR:2	Together, these results suggested that  bbbbb1 CHEMICALIN eeeee1  affects  bbbbb2 GENEIN eeeee2  activation and signaling pathways through rapid release and increased expression of endogenous GENEIN-activating ligands
CPR:2	Induction of  bbbbb1 GENEIN eeeee1  and activation of GENEIN in  bbbbb2 CHEMICALIN eeeee2 -treated squamous carcinoma cells
CPR:2	Together, these results suggested that  bbbbb1 CHEMICALIN eeeee1  affects  bbbbb2 GENEIN eeeee2  activation and signaling pathways through rapid release and increased expression of endogenous GENEIN-activating ligands
CPR:3	 bbbbb1 CHEMICALIN eeeee1 -induced changes were blocked with the GENENOTIN antagonist cetuximab, which suggested direct involvement of  bbbbb2 GENEIN eeeee2  in this process
CPR:3	Western blot analysis of cells incubated with  bbbbb1 CHEMICALIN eeeee1  demonstrated activation of  bbbbb2 GENEIN eeeee2  and downstream signaling that was reduced by inhibition of GENENOTIN (GENENOTIN) and GENENOTIN, but not GENENOTIN/GENENOTIN
CPR:3	Induction of GENEIN and activation of  bbbbb1 GENEIN eeeee1  in  bbbbb2 CHEMICALIN eeeee2 -treated squamous carcinoma cells
CPR:3	Inhibitors and neutralizing antibodies against GENENOTIN (GENENOTIN), and to a lesser extent GENENOTIN, reduced  bbbbb1 CHEMICALIN eeeee1 -mediated  bbbbb2 GENEIN eeeee2  (GENEIN) activation
CPR:3	Inhibitors and neutralizing antibodies against GENENOTIN (GENENOTIN), and to a lesser extent GENENOTIN, reduced  bbbbb1 CHEMICALIN eeeee1 -mediated GENEIN ( bbbbb2 GENEIN eeeee2 ) activation
CPR:3	 bbbbb1 CHEMICALIN eeeee1  stimulated the rapid release of soluble GENEIN and the subsequent induction of membrane-bound GENEIN, which correlated with biphasic  bbbbb2 GENEIN eeeee2  activation
CPR:3	Although,  bbbbb1 CHEMICALIN eeeee1  primarily inhibits GENEIN, it also stimulates the activity of  bbbbb2 GENEIN eeeee2  GENEIN in head and neck squamous tumors
CPR:3	Although,  bbbbb1 CHEMICALIN eeeee1  primarily inhibits GENEIN, it also stimulates the activity of GENEIN  bbbbb2 GENEIN eeeee2  in head and neck squamous tumors
CPR:3	Treatment of head and neck squamous carcinoma cells with clinically relevant concentrations of  bbbbb1 CHEMICALIN eeeee1 -induced changes in cell morphology and growth similar to changes associated with  bbbbb2 GENEIN eeeee2  (GENEIN) activation
CPR:3	Treatment of head and neck squamous carcinoma cells with clinically relevant concentrations of  bbbbb1 CHEMICALIN eeeee1 -induced changes in cell morphology and growth similar to changes associated with GENEIN ( bbbbb2 GENEIN eeeee2 ) activation
CPR:3	Western blot analysis of cells incubated with  bbbbb1 CHEMICALIN eeeee1  demonstrated activation of  bbbbb2 GENEIN eeeee2  and downstream signaling that was reduced by inhibition of GENENOTIN (GENENOTIN) and GENENOTIN, but not GENENOTIN/GENENOTIN
CPR:3	 bbbbb1 CHEMICALIN eeeee1  stimulated the rapid release of soluble  bbbbb2 GENEIN eeeee2  and the subsequent induction of membrane-bound GENEIN, which correlated with biphasic GENEIN activation
CPR:3	 bbbbb1 CHEMICALIN eeeee1  stimulated the rapid release of soluble GENEIN and the subsequent induction of membrane-bound  bbbbb2 GENEIN eeeee2 , which correlated with biphasic GENEIN activation
CPR:3	Together, these results suggested that  bbbbb1 CHEMICALIN eeeee1  affects GENEIN activation and signaling pathways through rapid release and increased expression of endogenous  bbbbb2 GENEIN eeeee2 -activating ligands
CPR:4	 bbbbb1 CHEMICALIN eeeee1  is a GENEIN inhibitor of the GENEIN, GENEIN ( bbbbb2 GENEIN eeeee2 ), and GENEIN GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  is a GENEIN inhibitor of the GENEIN, GENEIN (GENEIN), and  bbbbb2 GENEIN eeeee2  GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  is a GENEIN inhibitor of the GENEIN, GENEIN (GENEIN), and GENEIN  bbbbb2 GENEIN eeeee2 
CPR:4	 bbbbb1 CHEMICALIN eeeee1  is a  bbbbb2 GENEIN eeeee2  inhibitor of the GENEIN, GENEIN (GENEIN), and GENEIN GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  is a GENEIN inhibitor of the  bbbbb2 GENEIN eeeee2 , GENEIN (GENEIN), and GENEIN GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  is a GENEIN inhibitor of the GENEIN,  bbbbb2 GENEIN eeeee2  (GENEIN), and GENEIN GENEIN
CPR:4	Although,  bbbbb1 CHEMICALIN eeeee1  primarily inhibits  bbbbb2 GENEIN eeeee2 , it also stimulates the activity of GENEIN GENEIN in head and neck squamous tumors
CPR:2	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN [CHEMICALIN]) might be an effective therapy in this case, since CHEMICALIN targets both  bbbbb2 GENEIN eeeee2  and GENEIN oncoproteins.
CPR:2	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN [CHEMICALIN]) might be an effective therapy in this case, since CHEMICALIN targets both GENEIN and  bbbbb2 GENEIN eeeee2  oncoproteins.
CPR:2	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1  [CHEMICALIN]) might be an effective therapy in this case, since CHEMICALIN targets both  bbbbb2 GENEIN eeeee2  and GENEIN oncoproteins.
CPR:2	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1  [CHEMICALIN]) might be an effective therapy in this case, since CHEMICALIN targets both GENEIN and  bbbbb2 GENEIN eeeee2  oncoproteins.
CPR:2	CHEMICALIN (CHEMICALIN [ bbbbb1 CHEMICALIN eeeee1 ]) might be an effective therapy in this case, since CHEMICALIN targets both  bbbbb2 GENEIN eeeee2  and GENEIN oncoproteins.
CPR:2	CHEMICALIN (CHEMICALIN [ bbbbb1 CHEMICALIN eeeee1 ]) might be an effective therapy in this case, since CHEMICALIN targets both GENEIN and  bbbbb2 GENEIN eeeee2  oncoproteins.
CPR:2	CHEMICALIN (CHEMICALIN [CHEMICALIN]) might be an effective therapy in this case, since  bbbbb1 CHEMICALIN eeeee1  targets both  bbbbb2 GENEIN eeeee2  and GENEIN oncoproteins.
CPR:2	CHEMICALIN (CHEMICALIN [CHEMICALIN]) might be an effective therapy in this case, since  bbbbb1 CHEMICALIN eeeee1  targets both GENEIN and  bbbbb2 GENEIN eeeee2  oncoproteins.
CPR:4	The identity of the lung  bbbbb1 GENEIN eeeee1  was further demonstrated by their characteristic pH-activity profiles for CHEMICALIN oxidation, Km values for NAD and CHEMICALIN, and inhibition by  bbbbb2 CHEMICALIN eeeee2  or CHEMICALIN
CPR:4	The identity of the lung  bbbbb1 GENEIN eeeee1  was further demonstrated by their characteristic pH-activity profiles for CHEMICALIN oxidation, Km values for NAD and CHEMICALIN, and inhibition by CHEMICALIN or  bbbbb2 CHEMICALIN eeeee2 
CPR:9	The results suggest that individuals with high Vmax  bbbbb1 GENEIN eeeee1  and deficient in low-Km mitochondrial GENEIN, accounting for approximately 45% of the Chinese population, may end up with  bbbbb2 CHEMICALIN eeeee2  accumulation during CHEMICALIN consumption, rendering them vulnerable to tissue injury caused by this highly reactive and toxic metabolite.
CPR:9	The results suggest that individuals with high Vmax GENEIN and deficient in low-Km mitochondrial  bbbbb1 GENEIN eeeee1 , accounting for approximately 45% of the Chinese population, may end up with  bbbbb2 CHEMICALIN eeeee2  accumulation during CHEMICALIN consumption, rendering them vulnerable to tissue injury caused by this highly reactive and toxic metabolite.
CPR:9	These findings indicate that human pulmonary  bbbbb1 CHEMICALIN eeeee1 -metabolizing activities differ significantly with respect to genetic polymorphism at both the  bbbbb2 GENEIN eeeee2  and the GENEIN loci
CPR:9	These findings indicate that human pulmonary  bbbbb1 CHEMICALIN eeeee1 -metabolizing activities differ significantly with respect to genetic polymorphism at both the GENEIN and the  bbbbb2 GENEIN eeeee2  loci
CPR:9	The results suggest that individuals with high Vmax  bbbbb1 GENEIN eeeee1  and deficient in low-Km mitochondrial GENEIN, accounting for approximately 45% of the Chinese population, may end up with CHEMICALIN accumulation during  bbbbb2 CHEMICALIN eeeee2  consumption, rendering them vulnerable to tissue injury caused by this highly reactive and toxic metabolite.
CPR:9	The results suggest that individuals with high Vmax GENEIN and deficient in low-Km mitochondrial  bbbbb1 GENEIN eeeee1 , accounting for approximately 45% of the Chinese population, may end up with CHEMICALIN accumulation during  bbbbb2 CHEMICALIN eeeee2  consumption, rendering them vulnerable to tissue injury caused by this highly reactive and toxic metabolite.
CPR:9	The identity of the lung  bbbbb1 GENEIN eeeee1  was further demonstrated by their characteristic pH-activity profiles for  bbbbb2 CHEMICALIN eeeee2  oxidation, Km values for NAD and CHEMICALIN, and inhibition by CHEMICALIN or CHEMICALIN
CPR:9	The identity of the lung  bbbbb1 GENEIN eeeee1  was further demonstrated by their characteristic pH-activity profiles for CHEMICALIN oxidation, Km values for NAD and  bbbbb2 CHEMICALIN eeeee2 , and inhibition by CHEMICALIN or CHEMICALIN
CPR:2	In the presence of  bbbbb1 GENEIN eeeee1 ,  bbbbb2 CHEMICALIN eeeee2  suppressed the expression of GENEIN and GENEIN as well as the production of GENEIN, GENEIN and GENEIN in PBMC, contributing to the anti-inflammatory effect of CHEMICALNOTIN
CPR:2	The effects of CHEMICALNOTIN were abolished by the addition of the product of the GENEIN, CHEMICALIN, indicating the involvement of  bbbbb1 GENEIN eeeee1  in the action of  bbbbb2 CHEMICALIN eeeee2 .
CPR:3	The GENEIN production is located upstream of the  bbbbb1 GENEIN eeeee1  cascade activated by  bbbbb2 CHEMICALIN eeeee2 
CPR:3	In the presence of GENEIN,  bbbbb1 CHEMICALIN eeeee1  suppressed the expression of GENEIN and GENEIN as well as the production of  bbbbb2 GENEIN eeeee2 , GENEIN and GENEIN in PBMC, contributing to the anti-inflammatory effect of CHEMICALNOTIN
CPR:3	In the presence of GENEIN,  bbbbb1 CHEMICALIN eeeee1  suppressed the expression of GENEIN and GENEIN as well as the production of GENEIN,  bbbbb2 GENEIN eeeee2  and GENEIN in PBMC, contributing to the anti-inflammatory effect of CHEMICALNOTIN
CPR:3	In the presence of GENEIN,  bbbbb1 CHEMICALIN eeeee1  suppressed the expression of GENEIN and GENEIN as well as the production of GENEIN, GENEIN and  bbbbb2 GENEIN eeeee2  in PBMC, contributing to the anti-inflammatory effect of CHEMICALNOTIN
CPR:3	 bbbbb1 CHEMICALIN eeeee1  induces  bbbbb2 GENEIN eeeee2  production in human peripheral blood mononuclear cells
CPR:3	 bbbbb1 CHEMICALIN eeeee1 , an GENEIN inhibitor with mild inhibition of GENEIN, induced the production of  bbbbb2 GENEIN eeeee2 , GENEIN and GENEIN in human peripheral blood mononuclear cells (PBMC)
CPR:3	 bbbbb1 CHEMICALIN eeeee1 , an GENEIN inhibitor with mild inhibition of GENEIN, induced the production of GENEIN,  bbbbb2 GENEIN eeeee2  and GENEIN in human peripheral blood mononuclear cells (PBMC)
CPR:3	 bbbbb1 CHEMICALIN eeeee1 , an GENEIN inhibitor with mild inhibition of GENEIN, induced the production of GENEIN, GENEIN and  bbbbb2 GENEIN eeeee2  in human peripheral blood mononuclear cells (PBMC)
CPR:3	The  bbbbb1 GENEIN eeeee1  production is located upstream of the GENEIN cascade activated by  bbbbb2 CHEMICALIN eeeee2 
CPR:3	Moreover,  bbbbb1 CHEMICALIN eeeee1  concentration-dependently inhibited the expression of GENEIN and induced the expression of  bbbbb2 GENEIN eeeee2  on monocytes
CPR:4	In the presence of GENEIN,  bbbbb1 CHEMICALIN eeeee1  suppressed the expression of  bbbbb2 GENEIN eeeee2  and GENEIN as well as the production of GENEIN, GENEIN and GENEIN in PBMC, contributing to the anti-inflammatory effect of CHEMICALNOTIN
CPR:4	In the presence of GENEIN,  bbbbb1 CHEMICALIN eeeee1  suppressed the expression of GENEIN and  bbbbb2 GENEIN eeeee2  as well as the production of GENEIN, GENEIN and GENEIN in PBMC, contributing to the anti-inflammatory effect of CHEMICALNOTIN
CPR:4	Moreover,  bbbbb1 CHEMICALIN eeeee1  concentration-dependently inhibited the expression of  bbbbb2 GENEIN eeeee2  and induced the expression of GENEIN on monocytes
CPR:4	 bbbbb1 CHEMICALIN eeeee1 , an  bbbbb2 GENEIN eeeee2  inhibitor with mild inhibition of GENEIN, induced the production of GENEIN, GENEIN and GENEIN in human peripheral blood mononuclear cells (PBMC)
CPR:4	 bbbbb1 CHEMICALIN eeeee1 , an GENEIN inhibitor with mild inhibition of  bbbbb2 GENEIN eeeee2 , induced the production of GENEIN, GENEIN and GENEIN in human peripheral blood mononuclear cells (PBMC)
CPR:9	The effects of CHEMICALNOTIN were abolished by the addition of the product of the  bbbbb1 GENEIN eeeee1 ,  bbbbb2 CHEMICALIN eeeee2 , indicating the involvement of GENEIN in the action of CHEMICALIN.
CPR:4	However at IC80, CHEMICALIN (+134.4%) and CHEMICALIN (+29.7%) had greater GENEIN selectivity than at IC50, and CHEMICALIN (-41.2%) and  bbbbb1 CHEMICALIN eeeee1  (-12.9%) had lower  bbbbb2 GENEIN eeeee2  selectivity than at IC50
CPR:4	We report on the inhibitory activity of the NSAIDs CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and CHEMICALIN, on blood  bbbbb2 GENEIN eeeee2  in the horse using in vitro enzyme-linked assays
CPR:4	We report on the inhibitory activity of the NSAIDs CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, on blood  bbbbb2 GENEIN eeeee2  in the horse using in vitro enzyme-linked assays
CPR:4	We report on the inhibitory activity of the NSAIDs CHEMICALIN, CHEMICALIN, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , on blood  bbbbb2 GENEIN eeeee2  in the horse using in vitro enzyme-linked assays
CPR:4	 bbbbb1 GENEIN eeeee1  and GENEIN inhibition in horse blood by  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN and CHEMICALIN: an in vitro analysis
CPR:4	GENEIN and  bbbbb1 GENEIN eeeee1  inhibition in horse blood by  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN and CHEMICALIN: an in vitro analysis
CPR:4	 bbbbb1 GENEIN eeeee1  and GENEIN inhibition in horse blood by CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN and CHEMICALIN: an in vitro analysis
CPR:4	GENEIN and  bbbbb1 GENEIN eeeee1  inhibition in horse blood by CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN and CHEMICALIN: an in vitro analysis
CPR:4	 bbbbb1 GENEIN eeeee1  and GENEIN inhibition in horse blood by CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN: an in vitro analysis
CPR:4	GENEIN and  bbbbb1 GENEIN eeeee1  inhibition in horse blood by CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN: an in vitro analysis
CPR:4	 bbbbb1 GENEIN eeeee1  and GENEIN inhibition in horse blood by CHEMICALIN, CHEMICALIN, CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 : an in vitro analysis
CPR:4	GENEIN and  bbbbb1 GENEIN eeeee1  inhibition in horse blood by CHEMICALIN, CHEMICALIN, CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 : an in vitro analysis
CPR:4	As expected, comparison of IC50 indicated that  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN are more selective inhibitors of  bbbbb2 GENEIN eeeee2  than CHEMICALIN and CHEMICALIN; CHEMICALNOTIN was the most advantageous for horses of four NSAIDs examined
CPR:4	As expected, comparison of IC50 indicated that CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  are more selective inhibitors of  bbbbb2 GENEIN eeeee2  than CHEMICALIN and CHEMICALIN; CHEMICALNOTIN was the most advantageous for horses of four NSAIDs examined
CPR:4	As expected, comparison of IC50 indicated that CHEMICALIN and CHEMICALIN are more selective inhibitors of  bbbbb1 GENEIN eeeee1  than  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN; CHEMICALNOTIN was the most advantageous for horses of four NSAIDs examined
CPR:4	As expected, comparison of IC50 indicated that CHEMICALIN and CHEMICALIN are more selective inhibitors of  bbbbb1 GENEIN eeeee1  than CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 ; CHEMICALNOTIN was the most advantageous for horses of four NSAIDs examined
CPR:4	However at IC80,  bbbbb1 CHEMICALIN eeeee1  (+134.4%) and CHEMICALIN (+29.7%) had greater  bbbbb2 GENEIN eeeee2  selectivity than at IC50, and CHEMICALIN (-41.2%) and CHEMICALIN (-12.9%) had lower GENEIN selectivity than at IC50
CPR:4	However at IC80, CHEMICALIN (+134.4%) and  bbbbb1 CHEMICALIN eeeee1  (+29.7%) had greater  bbbbb2 GENEIN eeeee2  selectivity than at IC50, and CHEMICALIN (-41.2%) and CHEMICALIN (-12.9%) had lower GENEIN selectivity than at IC50
CPR:4	However at IC80, CHEMICALIN (+134.4%) and CHEMICALIN (+29.7%) had greater GENEIN selectivity than at IC50, and  bbbbb1 CHEMICALIN eeeee1  (-41.2%) and CHEMICALIN (-12.9%) had lower  bbbbb2 GENEIN eeeee2  selectivity than at IC50
CPR:4	We report on the inhibitory activity of the NSAIDs  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN and CHEMICALIN, on blood  bbbbb2 GENEIN eeeee2  in the horse using in vitro enzyme-linked assays
CPR:10	Treatment with  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, or CHEMICALIN did not significantly affect  bbbbb2 GENEIN eeeee2  and GENEIN proteins expression in the banding groups
CPR:10	Treatment with  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, or CHEMICALIN did not significantly affect GENEIN and  bbbbb2 GENEIN eeeee2  proteins expression in the banding groups
CPR:10	Treatment with CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , or CHEMICALIN did not significantly affect  bbbbb2 GENEIN eeeee2  and GENEIN proteins expression in the banding groups
CPR:10	Treatment with CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , or CHEMICALIN did not significantly affect GENEIN and  bbbbb2 GENEIN eeeee2  proteins expression in the banding groups
CPR:10	Treatment with CHEMICALIN, CHEMICALIN, or  bbbbb1 CHEMICALIN eeeee1  did not significantly affect  bbbbb2 GENEIN eeeee2  and GENEIN proteins expression in the banding groups
CPR:10	Treatment with CHEMICALIN, CHEMICALIN, or  bbbbb1 CHEMICALIN eeeee1  did not significantly affect GENEIN and  bbbbb2 GENEIN eeeee2  proteins expression in the banding groups
CPR:2	Treatment with  bbbbb1 CHEMICALIN eeeee1  is associated with a reversal of abnormal regulation of GENEIN, GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2  in the hypertrophic myocardium.
CPR:3	Treatment with  bbbbb1 CHEMICALIN eeeee1  reversed both protein and mRNA of GENEIN, GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2  to the baseline values
CPR:4	 bbbbb1 CHEMICALIN eeeee1  prevents cardiac hypertrophy and overexpression of  bbbbb2 GENEIN eeeee2  and GENEIN in pressure-overloaded rat heart
CPR:4	 bbbbb1 CHEMICALIN eeeee1  prevents cardiac hypertrophy and overexpression of GENEIN and  bbbbb2 GENEIN eeeee2  in pressure-overloaded rat heart
CPR:4	Treatment with  bbbbb1 CHEMICALIN eeeee1  reversed both protein and mRNA of  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN, and GENEIN to the baseline values
CPR:4	Treatment with  bbbbb1 CHEMICALIN eeeee1  reversed both protein and mRNA of GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN to the baseline values
CPR:4	Treatment with  bbbbb1 CHEMICALIN eeeee1  reversed both protein and mRNA of GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN to the baseline values
CPR:4	Increased immunohistochemical labeling of  bbbbb1 GENEIN eeeee1 , GENEIN, and GENEIN in the ventricular myocardium was observed in the banding group and  bbbbb2 CHEMICALIN eeeee2  again normalized the labeling
CPR:4	Increased immunohistochemical labeling of GENEIN,  bbbbb1 GENEIN eeeee1 , and GENEIN in the ventricular myocardium was observed in the banding group and  bbbbb2 CHEMICALIN eeeee2  again normalized the labeling
CPR:4	Increased immunohistochemical labeling of GENEIN, GENEIN, and  bbbbb1 GENEIN eeeee1  in the ventricular myocardium was observed in the banding group and  bbbbb2 CHEMICALIN eeeee2  again normalized the labeling
CPR:4	Treatment with  bbbbb1 CHEMICALIN eeeee1  is associated with a reversal of abnormal regulation of  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN, and GENEIN in the hypertrophic myocardium.
CPR:4	Treatment with  bbbbb1 CHEMICALIN eeeee1  is associated with a reversal of abnormal regulation of GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN in the hypertrophic myocardium.
CPR:4	Treatment with  bbbbb1 CHEMICALIN eeeee1  is associated with a reversal of abnormal regulation of GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN in the hypertrophic myocardium.
CPR:10	The reported mechanism of  bbbbb1 CHEMICALIN eeeee1  resistance in GISTs involves missense mutation in the  bbbbb2 GENEIN eeeee2  of GENEIN including GENEIN, GENEIN, and GENEIN
CPR:10	The reported mechanism of  bbbbb1 CHEMICALIN eeeee1  resistance in GISTs involves missense mutation in the GENEIN of  bbbbb2 GENEIN eeeee2  including GENEIN, GENEIN, and GENEIN
CPR:10	The reported mechanism of  bbbbb1 CHEMICALIN eeeee1  resistance in GISTs involves missense mutation in the GENEIN of GENEIN including  bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN
CPR:10	The reported mechanism of  bbbbb1 CHEMICALIN eeeee1  resistance in GISTs involves missense mutation in the GENEIN of GENEIN including GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN
CPR:10	The reported mechanism of  bbbbb1 CHEMICALIN eeeee1  resistance in GISTs involves missense mutation in the GENEIN of GENEIN including GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2 
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN, CHEMICALIN; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN-GENEIN, GENEIN, and GENEIN represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN, CHEMICALIN; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN-GENEIN, GENEIN, and GENEIN represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN, CHEMICALIN; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 -GENEIN, GENEIN, and GENEIN represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN, CHEMICALIN; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of GENEIN, GENEIN, GENEIN- bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN, CHEMICALIN; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of GENEIN, GENEIN, GENEIN-GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN, CHEMICALIN; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of GENEIN, GENEIN, GENEIN-GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2  represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN-GENEIN, GENEIN, and GENEIN represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN-GENEIN, GENEIN, and GENEIN represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 -GENEIN, GENEIN, and GENEIN represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of GENEIN, GENEIN, GENEIN- bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of GENEIN, GENEIN, GENEIN-GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of GENEIN, GENEIN, GENEIN-GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2  represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs
CPR:4	CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN-GENEIN, GENEIN, and GENEIN represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs
CPR:4	CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN-GENEIN, GENEIN, and GENEIN represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs
CPR:4	CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 -GENEIN, GENEIN, and GENEIN represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs
CPR:4	CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of GENEIN, GENEIN, GENEIN- bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs
CPR:4	CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of GENEIN, GENEIN, GENEIN-GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs
CPR:4	CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of GENEIN, GENEIN, GENEIN-GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2  represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs
CPR:4	CHEMICALIN (CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN-GENEIN, GENEIN, and GENEIN represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs
CPR:4	CHEMICALIN (CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN-GENEIN, GENEIN, and GENEIN represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs
CPR:4	CHEMICALIN (CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 -GENEIN, GENEIN, and GENEIN represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs
CPR:4	CHEMICALIN (CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of GENEIN, GENEIN, GENEIN- bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs
CPR:4	CHEMICALIN (CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of GENEIN, GENEIN, GENEIN-GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs
CPR:4	CHEMICALIN (CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ; Novartis Pharmaceuticals, East Hanover, NJ), a selective inhibitor of GENEIN, GENEIN, GENEIN-GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2  represents a new paradigm of targeted cancer therapy and has revolutionized the treatment of patients with chronic myelogenous leukemia and GISTs
CPR:2	Almost all of the tested GENENOTIN and GENENOTIN antagonists, including several important therapeutics, displaced less than 30% of specific  bbbbb1 CHEMICALIN eeeee1  binding to the  bbbbb2 GENEIN eeeee2  at concentrations up to 10 microM
CPR:2	Most of the tested GENENOTIN agonists and  bbbbb1 CHEMICALIN eeeee1 -based  bbbbb2 GENEIN eeeee2  ligands show micromolar-to-nanomolar range GENEIN affinity, and these ligands exert different intrinsic GENEIN activities, ranging from full agonists to inverse agonists
CPR:2	Most of the tested GENENOTIN agonists and  bbbbb1 CHEMICALIN eeeee1 -based GENEIN ligands show micromolar-to-nanomolar range  bbbbb2 GENEIN eeeee2  affinity, and these ligands exert different intrinsic GENEIN activities, ranging from full agonists to inverse agonists
CPR:2	Interestingly, we identified  bbbbb1 CHEMICALIN eeeee1  as a high-affinity  bbbbb2 GENEIN eeeee2  ligand (K(i) = 50 nM) that has a >100-fold selectivity for the GENEIN over the other GENEIN subtypes
CPR:2	Interestingly, we identified  bbbbb1 CHEMICALIN eeeee1  as a high-affinity GENEIN ligand (K(i) = 50 nM) that has a >100-fold selectivity for the  bbbbb2 GENEIN eeeee2  over the other GENEIN subtypes
CPR:2	Interestingly, we identified  bbbbb1 CHEMICALIN eeeee1  as a high-affinity GENEIN ligand (K(i) = 50 nM) that has a >100-fold selectivity for the GENEIN over the other  bbbbb2 GENEIN eeeee2  subtypes
CPR:2	The identification of  bbbbb1 CHEMICALIN eeeee1  as a potent GENEIN agonist is of major importance for future studies to unravel the physiological roles of the  bbbbb2 GENEIN eeeee2 .
CPR:3	Moreover,  bbbbb1 CHEMICALIN eeeee1  potently activated the  bbbbb2 GENEIN eeeee2  (pEC(50) = 7.4 +/- 0.1; alpha = 1), and this response was competitively antagonized by the selective GENEIN antagonist CHEMICALIN [CHEMICALIN] (pA(2) = 7.8)
CPR:5	Most of the tested GENENOTIN agonists and  bbbbb1 CHEMICALIN eeeee1 -based GENEIN ligands show micromolar-to-nanomolar range GENEIN affinity, and these ligands exert different intrinsic  bbbbb2 GENEIN eeeee2  activities, ranging from full agonists to inverse agonists
CPR:5	Evaluation of GENENOTIN ligands at the GENENOTIN: identification of  bbbbb1 CHEMICALIN eeeee1  as the first potent and selective  bbbbb2 GENEIN eeeee2  agonist
CPR:5	The identification of  bbbbb1 CHEMICALIN eeeee1  as a potent  bbbbb2 GENEIN eeeee2  agonist is of major importance for future studies to unravel the physiological roles of the GENEIN.
CPR:5	Most of the tested GENENOTIN agonists and  bbbbb1 CHEMICALIN eeeee1 -based GENEIN ligands show micromolar-to-nanomolar range GENEIN affinity, and these ligands exert different intrinsic  bbbbb2 GENEIN eeeee2  activities, ranging from full agonists to inverse agonists
CPR:6	Moreover, CHEMICALIN potently activated the GENEIN (pEC(50) = 7.4 +/- 0.1; alpha = 1), and this response was competitively antagonized by the selective  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2  [CHEMICALIN] (pA(2) = 7.8)
CPR:6	Moreover, CHEMICALIN potently activated the GENEIN (pEC(50) = 7.4 +/- 0.1; alpha = 1), and this response was competitively antagonized by the selective  bbbbb1 GENEIN eeeee1  antagonist CHEMICALIN [ bbbbb2 CHEMICALIN eeeee2 ] (pA(2) = 7.8)
CPR:2	Late-onset diarrhea appears to be associated with intestinal exposure to  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), the major active metabolite of CHEMICALIN, which may bind to  bbbbb2 GENEIN eeeee2  and induce apoptosis of intestinal epithelia, leading to the disturbance in the absorptive and secretory functions of mucosa
CPR:2	Late-onset diarrhea appears to be associated with intestinal exposure to CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), the major active metabolite of CHEMICALIN, which may bind to  bbbbb2 GENEIN eeeee2  and induce apoptosis of intestinal epithelia, leading to the disturbance in the absorptive and secretory functions of mucosa
CPR:2	Late-onset diarrhea appears to be associated with intestinal exposure to CHEMICALIN (CHEMICALIN), the major active metabolite of  bbbbb1 CHEMICALIN eeeee1 , which may bind to  bbbbb2 GENEIN eeeee2  and induce apoptosis of intestinal epithelia, leading to the disturbance in the absorptive and secretory functions of mucosa
CPR:3	Early-onset diarrhea is observed immediately after CHEMICALIN infusion and probably due to the inhibition of  bbbbb1 GENEIN eeeee1  activity, which can be eliminated by administration of  bbbbb2 CHEMICALIN eeeee2 
CPR:3	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN may also stimulate the production of pro-inflammatory  bbbbb2 GENEIN eeeee2  and CHEMICALNOTIN (CHEMICALNOTIN), thus inducing the secretion of CHEMICALNOTIN and CHEMICALNOTIN
CPR:3	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  may also stimulate the production of pro-inflammatory  bbbbb2 GENEIN eeeee2  and CHEMICALNOTIN (CHEMICALNOTIN), thus inducing the secretion of CHEMICALNOTIN and CHEMICALNOTIN
CPR:4	CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ) has exhibited clinical activities against a broad spectrum of carcinomas by inhibiting  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:4	CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ) has exhibited clinical activities against a broad spectrum of carcinomas by inhibiting GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:4	Early-onset diarrhea is observed immediately after  bbbbb1 CHEMICALIN eeeee1  infusion and probably due to the inhibition of  bbbbb2 GENEIN eeeee2  activity, which can be eliminated by administration of CHEMICALIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN) has exhibited clinical activities against a broad spectrum of carcinomas by inhibiting  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN) has exhibited clinical activities against a broad spectrum of carcinomas by inhibiting GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN) has exhibited clinical activities against a broad spectrum of carcinomas by inhibiting  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN) has exhibited clinical activities against a broad spectrum of carcinomas by inhibiting GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:10	To understand this interaction, we determined the crystal structure of GENEIN in complex with CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , and CHEMICALIN, the two latter derivatives being designed to bind to GENEIN but not to  bbbbb2 GENEIN eeeee2 
CPR:10	To understand this interaction, we determined the crystal structure of GENEIN in complex with CHEMICALIN, CHEMICALIN, and  bbbbb1 CHEMICALIN eeeee1 , the two latter derivatives being designed to bind to GENEIN but not to  bbbbb2 GENEIN eeeee2 
CPR:2	Affinity chromatography investigations have shown that  bbbbb1 CHEMICALIN eeeee1  also interacts with  bbbbb2 GENEIN eeeee2 
CPR:2	To understand this interaction, we determined the crystal structure of  bbbbb1 GENEIN eeeee1  in complex with  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, and CHEMICALIN, the two latter derivatives being designed to bind to GENEIN but not to GENEIN
CPR:2	To understand this interaction, we determined the crystal structure of  bbbbb1 GENEIN eeeee1  in complex with CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , and CHEMICALIN, the two latter derivatives being designed to bind to GENEIN but not to GENEIN
CPR:2	To understand this interaction, we determined the crystal structure of GENEIN in complex with CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , and CHEMICALIN, the two latter derivatives being designed to bind to  bbbbb2 GENEIN eeeee2  but not to GENEIN
CPR:2	To understand this interaction, we determined the crystal structure of  bbbbb1 GENEIN eeeee1  in complex with CHEMICALIN, CHEMICALIN, and  bbbbb2 CHEMICALIN eeeee2 , the two latter derivatives being designed to bind to GENEIN but not to GENEIN
CPR:2	To understand this interaction, we determined the crystal structure of GENEIN in complex with CHEMICALIN, CHEMICALIN, and  bbbbb1 CHEMICALIN eeeee1 , the two latter derivatives being designed to bind to  bbbbb2 GENEIN eeeee2  but not to GENEIN
CPR:2	Structural analysis revealed that these three  bbbbb1 CHEMICALIN eeeee1  bind similarly in the CHEMICALIN-binding site of  bbbbb2 GENEIN eeeee2  rather than in the anticipated CHEMICALIN-binding site
CPR:2	Structural analysis revealed that these three CHEMICALIN bind similarly in the  bbbbb1 CHEMICALIN eeeee1 -binding site of  bbbbb2 GENEIN eeeee2  rather than in the anticipated CHEMICALIN-binding site
CPR:2	Structural analysis revealed that these three CHEMICALIN bind similarly in the CHEMICALIN-binding site of  bbbbb1 GENEIN eeeee1  rather than in the anticipated  bbbbb2 CHEMICALIN eeeee2 -binding site
CPR:2	Crystal structure of  bbbbb1 GENEIN eeeee1  in complex with  bbbbb2 CHEMICALIN eeeee2  and derivatives
CPR:2	This work provides detailed structural information on the interactions between  bbbbb1 GENEIN eeeee1  and  bbbbb2 CHEMICALIN eeeee2  and analogs
CPR:2	 bbbbb1 GENEIN eeeee1  (GENEIN) catalyzes the phosphorylation of CHEMICALIN, CHEMICALIN, and CHEMICALIN in the presence of  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:2	GENEIN ( bbbbb1 GENEIN eeeee1 ) catalyzes the phosphorylation of CHEMICALIN, CHEMICALIN, and CHEMICALIN in the presence of  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:2	 bbbbb1 GENEIN eeeee1  (GENEIN) catalyzes the phosphorylation of CHEMICALIN, CHEMICALIN, and CHEMICALIN in the presence of CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:2	GENEIN ( bbbbb1 GENEIN eeeee1 ) catalyzes the phosphorylation of CHEMICALIN, CHEMICALIN, and CHEMICALIN in the presence of CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:2	It could also aid in the design of  bbbbb1 CHEMICALIN eeeee1  derivatives displaying strict selectivity for either  bbbbb2 GENEIN eeeee2  or GENEIN.
CPR:2	It could also aid in the design of  bbbbb1 CHEMICALIN eeeee1  derivatives displaying strict selectivity for either GENEIN or  bbbbb2 GENEIN eeeee2 .
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN) is a relatively selective inhibitor of  bbbbb2 GENEIN eeeee2  (GENEIN), currently evaluated for the treatment of cancers, neurodegenerative disorders, renal diseases, and several viral infections
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN) is a relatively selective inhibitor of GENEIN ( bbbbb2 GENEIN eeeee2 ), currently evaluated for the treatment of cancers, neurodegenerative disorders, renal diseases, and several viral infections
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN) is a relatively selective inhibitor of  bbbbb2 GENEIN eeeee2  (GENEIN), currently evaluated for the treatment of cancers, neurodegenerative disorders, renal diseases, and several viral infections
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN) is a relatively selective inhibitor of GENEIN ( bbbbb2 GENEIN eeeee2 ), currently evaluated for the treatment of cancers, neurodegenerative disorders, renal diseases, and several viral infections
CPR:4	CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ) is a relatively selective inhibitor of  bbbbb2 GENEIN eeeee2  (GENEIN), currently evaluated for the treatment of cancers, neurodegenerative disorders, renal diseases, and several viral infections
CPR:4	CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ) is a relatively selective inhibitor of GENEIN ( bbbbb2 GENEIN eeeee2 ), currently evaluated for the treatment of cancers, neurodegenerative disorders, renal diseases, and several viral infections
CPR:9	 bbbbb1 GENEIN eeeee1  (GENEIN) catalyzes the phosphorylation of  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, and CHEMICALIN in the presence of CHEMICALIN and CHEMICALIN
CPR:9	GENEIN ( bbbbb1 GENEIN eeeee1 ) catalyzes the phosphorylation of  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, and CHEMICALIN in the presence of CHEMICALIN and CHEMICALIN
CPR:9	 bbbbb1 GENEIN eeeee1  (GENEIN) catalyzes the phosphorylation of CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , and CHEMICALIN in the presence of CHEMICALIN and CHEMICALIN
CPR:9	GENEIN ( bbbbb1 GENEIN eeeee1 ) catalyzes the phosphorylation of CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , and CHEMICALIN in the presence of CHEMICALIN and CHEMICALIN
CPR:9	 bbbbb1 GENEIN eeeee1  (GENEIN) catalyzes the phosphorylation of CHEMICALIN, CHEMICALIN, and  bbbbb2 CHEMICALIN eeeee2  in the presence of CHEMICALIN and CHEMICALIN
CPR:9	GENEIN ( bbbbb1 GENEIN eeeee1 ) catalyzes the phosphorylation of CHEMICALIN, CHEMICALIN, and  bbbbb2 CHEMICALIN eeeee2  in the presence of CHEMICALIN and CHEMICALIN
CPR:10	The  bbbbb1 GENEIN eeeee1  secretory responses to CHEMICALIN, furthermore, were inhibited by CHEMICALIN, a selective inhibitor of GENEIN GENEIN responsible for ligand-independent GENEIN autophosphorylation, but not by GENEIN inhibitor,  bbbbb2 CHEMICALIN eeeee2 
CPR:10	The inhibition of GENEIN, moreover, did not cause attenuation in  bbbbb1 GENEIN eeeee1  secretion in response to  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:10	The inhibition of GENEIN, moreover, did not cause attenuation in  bbbbb1 GENEIN eeeee1  secretion in response to CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:2	The  bbbbb1 GENEIN eeeee1  secretory responses to  bbbbb2 CHEMICALIN eeeee2 , furthermore, were inhibited by CHEMICALIN, a selective inhibitor of GENEIN GENEIN responsible for ligand-independent GENEIN autophosphorylation, but not by GENEIN inhibitor, CHEMICALIN
CPR:3	Both inhibitors, moreover, blunted the GENEIN secretory responses to beta-adrenergic agonist-generated second messenger, CHEMICALIN as well as  bbbbb1 GENEIN eeeee1  activator,  bbbbb2 CHEMICALIN eeeee2 
CPR:3	The GENEIN secretory responses to CHEMICALIN, furthermore, were inhibited by  bbbbb1 CHEMICALIN eeeee1 , a selective inhibitor of GENEIN GENEIN responsible for ligand-independent  bbbbb2 GENEIN eeeee2  autophosphorylation, but not by GENEIN inhibitor, CHEMICALIN
CPR:4	Both inhibitors, moreover, blunted the  bbbbb1 GENEIN eeeee1  secretory responses to beta-adrenergic agonist-generated second messenger, CHEMICALIN as well as GENEIN activator,  bbbbb2 CHEMICALIN eeeee2 
CPR:4	The  bbbbb1 GENEIN eeeee1  secretory responses to CHEMICALIN, furthermore, were inhibited by  bbbbb2 CHEMICALIN eeeee2 , a selective inhibitor of GENEIN GENEIN responsible for ligand-independent GENEIN autophosphorylation, but not by GENEIN inhibitor, CHEMICALIN
CPR:4	Using CHEMICALNOTIN-labeled gastric mucosal cells, we show that stimulatory effect of beta-adrenergic agonist, isoproterenol, on  bbbbb1 GENEIN eeeee1  secretion was inhibited by GENEIN GENEIN inhibitor,  bbbbb2 CHEMICALIN eeeee2 , as well as CHEMICALIN, a specific inhibitor of GENEIN
CPR:4	Using CHEMICALNOTIN-labeled gastric mucosal cells, we show that stimulatory effect of beta-adrenergic agonist, isoproterenol, on  bbbbb1 GENEIN eeeee1  secretion was inhibited by GENEIN GENEIN inhibitor, CHEMICALIN, as well as  bbbbb2 CHEMICALIN eeeee2 , a specific inhibitor of GENEIN
CPR:4	The GENEIN secretory responses to CHEMICALIN, furthermore, were inhibited by  bbbbb1 CHEMICALIN eeeee1 , a selective inhibitor of  bbbbb2 GENEIN eeeee2  GENEIN responsible for ligand-independent GENEIN autophosphorylation, but not by GENEIN inhibitor, CHEMICALIN
CPR:4	The GENEIN secretory responses to CHEMICALIN, furthermore, were inhibited by  bbbbb1 CHEMICALIN eeeee1 , a selective inhibitor of GENEIN  bbbbb2 GENEIN eeeee2  responsible for ligand-independent GENEIN autophosphorylation, but not by GENEIN inhibitor, CHEMICALIN
CPR:4	The GENEIN secretory responses to CHEMICALIN, furthermore, were inhibited by CHEMICALIN, a selective inhibitor of GENEIN GENEIN responsible for ligand-independent GENEIN autophosphorylation, but not by  bbbbb1 GENEIN eeeee1  inhibitor,  bbbbb2 CHEMICALIN eeeee2 
CPR:4	The inhibition of  bbbbb1 GENEIN eeeee1 , moreover, did not cause attenuation in GENEIN secretion in response to  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:4	The inhibition of  bbbbb1 GENEIN eeeee1 , moreover, did not cause attenuation in GENEIN secretion in response to CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Using CHEMICALNOTIN-labeled gastric mucosal cells, we show that stimulatory effect of beta-adrenergic agonist, isoproterenol, on GENEIN secretion was inhibited by  bbbbb1 GENEIN eeeee1  GENEIN inhibitor,  bbbbb2 CHEMICALIN eeeee2 , as well as CHEMICALIN, a specific inhibitor of GENEIN
CPR:4	Using CHEMICALNOTIN-labeled gastric mucosal cells, we show that stimulatory effect of beta-adrenergic agonist, isoproterenol, on GENEIN secretion was inhibited by GENEIN  bbbbb1 GENEIN eeeee1  inhibitor,  bbbbb2 CHEMICALIN eeeee2 , as well as CHEMICALIN, a specific inhibitor of GENEIN
CPR:4	Using CHEMICALNOTIN-labeled gastric mucosal cells, we show that stimulatory effect of beta-adrenergic agonist, isoproterenol, on GENEIN secretion was inhibited by GENEIN GENEIN inhibitor, CHEMICALIN, as well as  bbbbb1 CHEMICALIN eeeee1 , a specific inhibitor of  bbbbb2 GENEIN eeeee2 
CPR:9	Both inhibitors, moreover, blunted the GENEIN secretory responses to beta-adrenergic agonist-generated second messenger,  bbbbb1 CHEMICALIN eeeee1  as well as  bbbbb2 GENEIN eeeee2  activator, CHEMICALIN
CPR:2	 bbbbb1 CHEMICALIN eeeee1  (parent compound), has moderate affinity for the  bbbbb2 GENEIN eeeee2  (competitive inhibition)
CPR:2	 bbbbb1 CHEMICALIN eeeee1  is well-absorbed orally as an active drug and is rapidly converted via oxidation in the human liver to a more potent metabolite (designated E3174) with an affinity 20- to 30-times greater for the  bbbbb2 GENEIN eeeee2  (non-competitive inhibition)
CPR:4	 bbbbb1 CHEMICALIN eeeee1  is well-absorbed orally as an active drug and is rapidly converted via oxidation in the human liver to a more potent metabolite (designated E3174) with an affinity 20- to 30-times greater for the  bbbbb2 GENEIN eeeee2  (non-competitive inhibition)
CPR:4	Clinical experience in heart failure is growing, and recent data suggest an improved survival with  bbbbb1 CHEMICALIN eeeee1  versus CHEMICALIN, a drug from the  bbbbb2 GENEIN eeeee2  inhibitor class with proven benefit in this population
CPR:4	Clinical experience in heart failure is growing, and recent data suggest an improved survival with CHEMICALIN versus  bbbbb1 CHEMICALIN eeeee1 , a drug from the  bbbbb2 GENEIN eeeee2  inhibitor class with proven benefit in this population
CPR:4	The current comprehensive CHEMICALNOTIN clinical end-point programme (4 large scale morbidity/mortality trials) should provide evidence regarding the efficacy of direct blockade of the  bbbbb1 GENEIN eeeee1  with  bbbbb2 CHEMICALIN eeeee2  compared to standard therapy: 1) The CHEMICALNOTIN Heart Failure Survival Study - ELITE II, 2) The CHEMICALNOTIN Post-Myocardial Infarction Survival Study - OPTIMAAL, 3) The CHEMICALNOTIN Hypertension Survival Study - LIFE and 4) The CHEMICALNOTIN Renal Protection Study - RENAAL.
CPR:6	 bbbbb1 CHEMICALIN eeeee1 : a selective  bbbbb2 GENEIN eeeee2  antagonist for the treatment of heart failure
CPR:6	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) is the prototype of a new class of potent and selective  bbbbb2 GENEIN eeeee2  antagonists with the largest published preclinical and clinical data base
CPR:6	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) is the prototype of a new class of potent and selective  bbbbb2 GENEIN eeeee2  antagonists with the largest published preclinical and clinical data base
CPR:3	Abrupt removal of  bbbbb1 CHEMICALIN eeeee1  or CHEMICALIN from the culture medium prior to LPS stimulation, however, caused significantly augmented  bbbbb2 GENEIN eeeee2  production
CPR:3	Abrupt removal of CHEMICALIN or  bbbbb1 CHEMICALIN eeeee1  from the culture medium prior to LPS stimulation, however, caused significantly augmented  bbbbb2 GENEIN eeeee2  production
CPR:4	We now demonstrate that  bbbbb1 CHEMICALIN eeeee1 , a noncatechol inotrope, strongly inhibits lipopolysaccharide (LPS)-induced  bbbbb2 GENEIN eeeee2  production at concentrations readily achieved in vivo
CPR:4	Combined application of  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN caused additive inhibition of  bbbbb2 GENEIN eeeee2  biosynthesis in vitro
CPR:4	Combined application of CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  caused additive inhibition of  bbbbb2 GENEIN eeeee2  biosynthesis in vitro
CPR:4	Therefore, decreases of  bbbbb1 GENEIN eeeee1  and GENEIN in the hippocampal CA1 region of aged brains may be involved in aging processes related with  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) function.
CPR:4	Therefore, decreases of GENEIN and  bbbbb1 GENEIN eeeee1  in the hippocampal CA1 region of aged brains may be involved in aging processes related with  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) function.
CPR:4	Therefore, decreases of  bbbbb1 GENEIN eeeee1  and GENEIN in the hippocampal CA1 region of aged brains may be involved in aging processes related with CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) function.
CPR:4	Therefore, decreases of GENEIN and  bbbbb1 GENEIN eeeee1  in the hippocampal CA1 region of aged brains may be involved in aging processes related with CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) function.
CPR:9	In the present study, age-related changes of  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) synthesizing enzymes, GENEIN ( bbbbb2 GENEIN eeeee2 ) and GENEIN (GENEIN), their protein contents and activities were examined in the gerbil hippocampus proper
CPR:9	In the present study, age-related changes of  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) synthesizing enzymes, GENEIN (GENEIN) and  bbbbb2 GENEIN eeeee2  (GENEIN), their protein contents and activities were examined in the gerbil hippocampus proper
CPR:9	In the present study, age-related changes of  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) synthesizing enzymes, GENEIN (GENEIN) and GENEIN ( bbbbb2 GENEIN eeeee2 ), their protein contents and activities were examined in the gerbil hippocampus proper
CPR:9	In the present study, age-related changes of  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) synthesizing enzymes,  bbbbb2 GENEIN eeeee2  (GENEIN) and GENEIN (GENEIN), their protein contents and activities were examined in the gerbil hippocampus proper
CPR:9	In the present study, age-related changes of CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) synthesizing enzymes, GENEIN ( bbbbb2 GENEIN eeeee2 ) and GENEIN (GENEIN), their protein contents and activities were examined in the gerbil hippocampus proper
CPR:9	In the present study, age-related changes of CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) synthesizing enzymes, GENEIN (GENEIN) and  bbbbb2 GENEIN eeeee2  (GENEIN), their protein contents and activities were examined in the gerbil hippocampus proper
CPR:9	In the present study, age-related changes of CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) synthesizing enzymes, GENEIN (GENEIN) and GENEIN ( bbbbb2 GENEIN eeeee2 ), their protein contents and activities were examined in the gerbil hippocampus proper
CPR:9	In the present study, age-related changes of CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) synthesizing enzymes,  bbbbb2 GENEIN eeeee2  (GENEIN) and GENEIN (GENEIN), their protein contents and activities were examined in the gerbil hippocampus proper
CPR:2	This process was reduced by a protonophore, CHEMICALNOTIN, and a typical GENEIN (GENEIN) inhibitor, CHEMICALIN, suggesting that CHEMICALIN uptake by rat astrocytes is mediated by  bbbbb1 CHEMICALIN eeeee1 -coupled  bbbbb2 GENEIN eeeee2 
CPR:2	These results provide biochemical evidence of a  bbbbb1 CHEMICALIN eeeee1 -coupled and saturable transport system, presumed to be a  bbbbb2 GENEIN eeeee2  GENEIN or other unknown GENEIN, for CHEMICALIN in rat cerebrocortical astrocytes.
CPR:2	These results provide biochemical evidence of a  bbbbb1 CHEMICALIN eeeee1 -coupled and saturable transport system, presumed to be a GENEIN  bbbbb2 GENEIN eeeee2  or other unknown GENEIN, for CHEMICALIN in rat cerebrocortical astrocytes.
CPR:4	This process was reduced by a protonophore, CHEMICALNOTIN, and a typical  bbbbb1 GENEIN eeeee1  (GENEIN) inhibitor,  bbbbb2 CHEMICALIN eeeee2 , suggesting that CHEMICALIN uptake by rat astrocytes is mediated by CHEMICALIN-coupled GENEIN
CPR:4	This process was reduced by a protonophore, CHEMICALNOTIN, and a typical GENEIN ( bbbbb1 GENEIN eeeee1 ) inhibitor,  bbbbb2 CHEMICALIN eeeee2 , suggesting that CHEMICALIN uptake by rat astrocytes is mediated by CHEMICALIN-coupled GENEIN
CPR:9	This process was reduced by a protonophore, CHEMICALNOTIN, and a typical GENEIN (GENEIN) inhibitor, CHEMICALIN, suggesting that  bbbbb1 CHEMICALIN eeeee1  uptake by rat astrocytes is mediated by CHEMICALIN-coupled  bbbbb2 GENEIN eeeee2 
CPR:9	Because CHEMICALNOTIN reduced to 67% of the CHEMICALNOTIN uptake even at 10mM, it is unlikely that  bbbbb1 CHEMICALIN eeeee1  uptake in rat astrocytes is mediated by  bbbbb2 GENEIN eeeee2  and/or GENEIN
CPR:9	Because CHEMICALNOTIN reduced to 67% of the CHEMICALNOTIN uptake even at 10mM, it is unlikely that  bbbbb1 CHEMICALIN eeeee1  uptake in rat astrocytes is mediated by GENEIN and/or  bbbbb2 GENEIN eeeee2 
CPR:9	These results provide biochemical evidence of a CHEMICALIN-coupled and saturable transport system, presumed to be a  bbbbb1 GENEIN eeeee1  GENEIN or other unknown GENEIN, for  bbbbb2 CHEMICALIN eeeee2  in rat cerebrocortical astrocytes.
CPR:9	These results provide biochemical evidence of a CHEMICALIN-coupled and saturable transport system, presumed to be a GENEIN  bbbbb1 GENEIN eeeee1  or other unknown GENEIN, for  bbbbb2 CHEMICALIN eeeee2  in rat cerebrocortical astrocytes.
CPR:9	These results provide biochemical evidence of a CHEMICALIN-coupled and saturable transport system, presumed to be a GENEIN GENEIN or other unknown  bbbbb1 GENEIN eeeee1 , for  bbbbb2 CHEMICALIN eeeee2  in rat cerebrocortical astrocytes.
CPR:2	The marked antihypertensive efficacy of  bbbbb1 CHEMICALIN eeeee1  may result from a unique pharmacological interaction of the drug with the  bbbbb2 GENEIN eeeee2  receptor, resulting in a potent, long-lasting, dose-dependent blockade of GENEIN
CPR:2	The  bbbbb1 GENEIN eeeee1 -mediated effects of  bbbbb2 CHEMICALIN eeeee2  play a key role in the pathophysiology of hypertension
CPR:4	A review of the structural and functional features of  bbbbb1 CHEMICALIN eeeee1 , an  bbbbb2 GENEIN eeeee2  blocker
CPR:4	The marked antihypertensive efficacy of  bbbbb1 CHEMICALIN eeeee1  may result from a unique pharmacological interaction of the drug with the GENEIN receptor, resulting in a potent, long-lasting, dose-dependent blockade of  bbbbb2 GENEIN eeeee2 
CPR:4	We examined the effects of the high dose of GENENOTIN (GENENOTIN), which is capable of increasing peripheral neutrophils, and a specific  bbbbb1 GENEIN eeeee1  inhibitor ( bbbbb2 CHEMICALIN eeeee2 ) on acid lung injury in rats
CPR:4	Effects of  bbbbb1 GENEIN eeeee1  (GENEIN) and GENEIN inhibitor ( bbbbb2 CHEMICALIN eeeee2 ) on acid-induced lung injury in rats
CPR:4	Effects of GENEIN ( bbbbb1 GENEIN eeeee1 ) and GENEIN inhibitor ( bbbbb2 CHEMICALIN eeeee2 ) on acid-induced lung injury in rats
CPR:4	Effects of GENEIN (GENEIN) and  bbbbb1 GENEIN eeeee1  inhibitor ( bbbbb2 CHEMICALIN eeeee2 ) on acid-induced lung injury in rats
CPR:4	 bbbbb1 CHEMICALIN eeeee1 , an CHEMICALIN that reversibly inhibits  bbbbb2 GENEIN eeeee2  and reduces intracellular substrate burden, is an oral treatment for patients with type 1 GD that was recently approved in the United States for symptomatic patients with mild to moderate clinical manifestations for whom ERT is not an option
CPR:4	CHEMICALIN, an  bbbbb1 CHEMICALIN eeeee1  that reversibly inhibits  bbbbb2 GENEIN eeeee2  and reduces intracellular substrate burden, is an oral treatment for patients with type 1 GD that was recently approved in the United States for symptomatic patients with mild to moderate clinical manifestations for whom ERT is not an option
CPR:10	GENEIN potentiator drugs, huprine X and  bbbbb1 CHEMICALIN eeeee1 , increase CHEMICALNOTIN release by blocking GENEIN activity but not acting on  bbbbb2 GENEIN eeeee2 
CPR:2	 bbbbb1 GENEIN eeeee1  potentiator drugs, huprine X and  bbbbb2 CHEMICALIN eeeee2 , increase CHEMICALNOTIN release by blocking GENEIN activity but not acting on GENEIN
CPR:4	This effect was reverted in the presence of  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN; 0.1 microM), which blocks the pre-synaptic  bbbbb2 GENEIN eeeee2 
CPR:4	This effect was reverted in the presence of CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ; 0.1 microM), which blocks the pre-synaptic  bbbbb2 GENEIN eeeee2 
CPR:4	GENEIN potentiator drugs, huprine X and  bbbbb1 CHEMICALIN eeeee1 , increase CHEMICALNOTIN release by blocking  bbbbb2 GENEIN eeeee2  activity but not acting on GENEIN
CPR:4	To test the role of  bbbbb1 GENEIN eeeee1  in the drugs' effects on CHEMICALNOTIN release,  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) 100 microM was used to block such receptors
CPR:4	To test the role of  bbbbb1 GENEIN eeeee1  in the drugs' effects on CHEMICALNOTIN release, CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) 100 microM was used to block such receptors
CPR:6	After that, a wide range of concentrations of drugs, concomitantly with CHEMICALNOTIN (0.1 microM), was studied in the presence of  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN; 0.01 microM), a  bbbbb2 GENEIN eeeee2  antagonist
CPR:6	After that, a wide range of concentrations of drugs, concomitantly with CHEMICALNOTIN (0.1 microM), was studied in the presence of CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ; 0.01 microM), a  bbbbb2 GENEIN eeeee2  antagonist
CPR:2	Markers of activation in freshly isolated HSC were decreased by either CHEMICALNOTIN or CHEMICALNOTIN without increases in HSC CHEMICALNOTIN concentration. mRNA levels for  bbbbb1 GENEIN eeeee1 , GENEIN and GENEIN, the GENEIN for  bbbbb2 CHEMICALIN eeeee2 , decreased during activation of freshly isolated HSC even with CHEMICALIN supplementation
CPR:2	Markers of activation in freshly isolated HSC were decreased by either CHEMICALNOTIN or CHEMICALNOTIN without increases in HSC CHEMICALNOTIN concentration. mRNA levels for GENEIN,  bbbbb1 GENEIN eeeee1  and GENEIN, the GENEIN for  bbbbb2 CHEMICALIN eeeee2 , decreased during activation of freshly isolated HSC even with CHEMICALIN supplementation
CPR:2	Markers of activation in freshly isolated HSC were decreased by either CHEMICALNOTIN or CHEMICALNOTIN without increases in HSC CHEMICALNOTIN concentration. mRNA levels for GENEIN, GENEIN and  bbbbb1 GENEIN eeeee1 , the GENEIN for  bbbbb2 CHEMICALIN eeeee2 , decreased during activation of freshly isolated HSC even with CHEMICALIN supplementation
CPR:2	Markers of activation in freshly isolated HSC were decreased by either CHEMICALNOTIN or CHEMICALNOTIN without increases in HSC CHEMICALNOTIN concentration. mRNA levels for GENEIN, GENEIN and GENEIN, the  bbbbb1 GENEIN eeeee1  for  bbbbb2 CHEMICALIN eeeee2 , decreased during activation of freshly isolated HSC even with CHEMICALIN supplementation
CPR:4	Markers of activation in freshly isolated HSC were decreased by either CHEMICALNOTIN or CHEMICALNOTIN without increases in HSC CHEMICALNOTIN concentration. mRNA levels for  bbbbb1 GENEIN eeeee1 , GENEIN and GENEIN, the GENEIN for CHEMICALIN, decreased during activation of freshly isolated HSC even with  bbbbb2 CHEMICALIN eeeee2  supplementation
CPR:4	Markers of activation in freshly isolated HSC were decreased by either CHEMICALNOTIN or CHEMICALNOTIN without increases in HSC CHEMICALNOTIN concentration. mRNA levels for GENEIN,  bbbbb1 GENEIN eeeee1  and GENEIN, the GENEIN for CHEMICALIN, decreased during activation of freshly isolated HSC even with  bbbbb2 CHEMICALIN eeeee2  supplementation
CPR:4	Markers of activation in freshly isolated HSC were decreased by either CHEMICALNOTIN or CHEMICALNOTIN without increases in HSC CHEMICALNOTIN concentration. mRNA levels for GENEIN, GENEIN and  bbbbb1 GENEIN eeeee1 , the GENEIN for CHEMICALIN, decreased during activation of freshly isolated HSC even with  bbbbb2 CHEMICALIN eeeee2  supplementation
CPR:4	Markers of activation in freshly isolated HSC were decreased by either CHEMICALNOTIN or CHEMICALNOTIN without increases in HSC CHEMICALNOTIN concentration. mRNA levels for GENEIN, GENEIN and GENEIN, the  bbbbb1 GENEIN eeeee1  for CHEMICALIN, decreased during activation of freshly isolated HSC even with  bbbbb2 CHEMICALIN eeeee2  supplementation
CPR:2	Preincubation (30 min) of bovine tracheal smooth muscle with various concentrations (0.1, 1 and 10 microM) of CHEMICALIN decreased CHEMICALIN-induced maximal relaxation (E(max)) of  bbbbb1 CHEMICALIN eeeee1 -contracted preparations in a concentration dependent fashion, indicating desensitization of the  bbbbb2 GENEIN eeeee2 
CPR:3	Preincubation with 1 microM of the  bbbbb1 GENEIN eeeee1  (GENEIN) activator CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) caused a small but significant decrease in CHEMICALIN-induced E(max), indicating activated GENEIN-mediated heterologous GENEIN desensitization
CPR:3	Preincubation with 1 microM of the GENEIN ( bbbbb1 GENEIN eeeee1 ) activator CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) caused a small but significant decrease in CHEMICALIN-induced E(max), indicating activated GENEIN-mediated heterologous GENEIN desensitization
CPR:3	Preincubation with 1 microM of the GENEIN (GENEIN) activator CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) caused a small but significant decrease in CHEMICALIN-induced E(max), indicating activated  bbbbb2 GENEIN eeeee2 -mediated heterologous GENEIN desensitization
CPR:3	Preincubation with 1 microM of the  bbbbb1 GENEIN eeeee1  (GENEIN) activator  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) caused a small but significant decrease in CHEMICALIN-induced E(max), indicating activated GENEIN-mediated heterologous GENEIN desensitization
CPR:3	Preincubation with 1 microM of the GENEIN ( bbbbb1 GENEIN eeeee1 ) activator  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) caused a small but significant decrease in CHEMICALIN-induced E(max), indicating activated GENEIN-mediated heterologous GENEIN desensitization
CPR:3	Preincubation with 1 microM of the GENEIN (GENEIN) activator  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) caused a small but significant decrease in CHEMICALIN-induced E(max), indicating activated  bbbbb2 GENEIN eeeee2 -mediated heterologous GENEIN desensitization
CPR:4	Preincubation with 1 microM of the GENEIN (GENEIN) activator CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) caused a small but significant decrease in CHEMICALIN-induced E(max), indicating activated GENEIN-mediated heterologous  bbbbb2 GENEIN eeeee2  desensitization
CPR:4	Preincubation (30 min) of bovine tracheal smooth muscle with various concentrations (0.1, 1 and 10 microM) of  bbbbb1 CHEMICALIN eeeee1  decreased CHEMICALIN-induced maximal relaxation (E(max)) of CHEMICALIN-contracted preparations in a concentration dependent fashion, indicating desensitization of the  bbbbb2 GENEIN eeeee2 
CPR:4	Preincubation with 1 microM of the GENEIN (GENEIN) activator  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) caused a small but significant decrease in CHEMICALIN-induced E(max), indicating activated GENEIN-mediated heterologous  bbbbb2 GENEIN eeeee2  desensitization
CPR:4	Moreover, the specific  bbbbb1 GENEIN eeeee1 -inhibitor  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) markedly increased the potency and E(max) of CHEMICALNOTIN for all conditions used, including control conditions, and the synergistic effects of CHEMICALNOTIN and CHEMICALNOTIN were completely prevented
CPR:4	Moreover, the specific  bbbbb1 GENEIN eeeee1 -inhibitor CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) markedly increased the potency and E(max) of CHEMICALNOTIN for all conditions used, including control conditions, and the synergistic effects of CHEMICALNOTIN and CHEMICALNOTIN were completely prevented
CPR:5	Preincubation with 1 microM of the GENEIN (GENEIN) activator CHEMICALIN (CHEMICALIN) caused a small but significant decrease in  bbbbb1 CHEMICALIN eeeee1 -induced E(max), indicating activated GENEIN-mediated heterologous  bbbbb2 GENEIN eeeee2  desensitization
CPR:5	Preincubation (30 min) of bovine tracheal smooth muscle with various concentrations (0.1, 1 and 10 microM) of CHEMICALIN decreased  bbbbb1 CHEMICALIN eeeee1 -induced maximal relaxation (E(max)) of CHEMICALIN-contracted preparations in a concentration dependent fashion, indicating desensitization of the  bbbbb2 GENEIN eeeee2 
CPR:4	GENEIN inhibitors are  bbbbb1 CHEMICALIN eeeee1 -derived, low molecular weight synthetic molecules that can block the intracellular GENEIN of several receptors, including GENEIN, GENEIN, and GENEIN, and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of  bbbbb2 GENEIN eeeee2  signaling
CPR:4	 bbbbb1 GENEIN eeeee1  inhibitors are  bbbbb2 CHEMICALIN eeeee2 -derived, low molecular weight synthetic molecules that can block the intracellular GENEIN of several receptors, including GENEIN, GENEIN, and GENEIN, and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of GENEIN signaling
CPR:4	GENEIN inhibitors are  bbbbb1 CHEMICALIN eeeee1 -derived, low molecular weight synthetic molecules that can block the intracellular  bbbbb2 GENEIN eeeee2  of several receptors, including GENEIN, GENEIN, and GENEIN, and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of GENEIN signaling
CPR:4	GENEIN inhibitors are  bbbbb1 CHEMICALIN eeeee1 -derived, low molecular weight synthetic molecules that can block the intracellular GENEIN of several receptors, including  bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN, and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of GENEIN signaling
CPR:4	GENEIN inhibitors are  bbbbb1 CHEMICALIN eeeee1 -derived, low molecular weight synthetic molecules that can block the intracellular GENEIN of several receptors, including GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN, and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of GENEIN signaling
CPR:4	GENEIN inhibitors are  bbbbb1 CHEMICALIN eeeee1 -derived, low molecular weight synthetic molecules that can block the intracellular GENEIN of several receptors, including GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2 , and thereby inhibit ligand-induced receptor phosphorylation and abrogate the biologic effect of GENEIN signaling
CPR:10	When expressed heterologously in a mammalian cell line,  bbbbb1 GENEIN eeeee1  mediates pH-dependent,  bbbbb2 CHEMICALIN eeeee2 -independent uptake of CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN
CPR:1	The GENENOTIN cDNA was isolated (2296bp including both 5' and 3' untranslated regions and GENENOTIN and the GENENOTIN codes for a protein of 475  bbbbb1 CHEMICALIN eeeee1  (92% identity to  bbbbb2 GENEIN eeeee2 )
CPR:9	When expressed heterologously in a mammalian cell line,  bbbbb1 GENEIN eeeee1  mediates pH-dependent, CHEMICALIN-independent uptake of  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN and CHEMICALIN
CPR:9	When expressed heterologously in a mammalian cell line,  bbbbb1 GENEIN eeeee1  mediates pH-dependent, CHEMICALIN-independent uptake of CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN and CHEMICALIN
CPR:9	When expressed heterologously in a mammalian cell line,  bbbbb1 GENEIN eeeee1  mediates pH-dependent, CHEMICALIN-independent uptake of CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:9	When expressed heterologously in a mammalian cell line,  bbbbb1 GENEIN eeeee1  mediates pH-dependent, CHEMICALIN-independent uptake of CHEMICALIN, CHEMICALIN, CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:9	In the presence of CHEMICALNOTIN and under conditions in which  bbbbb1 GENEIN eeeee1  transport function was suppressed, a second  bbbbb2 CHEMICALIN eeeee2  uptake system was detected that exhibited functional characteristics similar to those of the GENENOTIN
CPR:9	The functional characteristics of GENENOTIN in either mammalian cells or renal BBMV suggest that  bbbbb1 GENEIN eeeee1  is the low-affinity transporter of  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN and CHEMICALIN believed to be defective in patients with iminoglycinuria.
CPR:9	The functional characteristics of GENENOTIN in either mammalian cells or renal BBMV suggest that  bbbbb1 GENEIN eeeee1  is the low-affinity transporter of CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN believed to be defective in patients with iminoglycinuria.
CPR:9	The functional characteristics of GENENOTIN in either mammalian cells or renal BBMV suggest that  bbbbb1 GENEIN eeeee1  is the low-affinity transporter of CHEMICALIN, CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  believed to be defective in patients with iminoglycinuria.
CPR:2	Interestingly, exposure to a lower concentration (1 microM) of the antidepressants tended to increase T-cell-derived  bbbbb1 GENEIN eeeee1  production, with significant effects elicited by the CHEMICALNOTIN reuptake inhibitors  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:2	Interestingly, exposure to a lower concentration (1 microM) of the antidepressants tended to increase T-cell-derived  bbbbb1 GENEIN eeeee1  production, with significant effects elicited by the CHEMICALNOTIN reuptake inhibitors CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:2	In this study, antidepressants with selectivity for the  bbbbb1 GENEIN eeeee1  ( bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN), or the GENEIN (CHEMICALIN and CHEMICALIN) were examined in terms of their ability to promote an anti-inflammatory GENENOTIN phenotype in human blood
CPR:2	In this study, antidepressants with selectivity for the  bbbbb1 GENEIN eeeee1  (CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 ), or the GENEIN (CHEMICALIN and CHEMICALIN) were examined in terms of their ability to promote an anti-inflammatory GENENOTIN phenotype in human blood
CPR:2	In this study, antidepressants with selectivity for the GENEIN (CHEMICALIN and CHEMICALIN), or the  bbbbb1 GENEIN eeeee1  ( bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN) were examined in terms of their ability to promote an anti-inflammatory GENENOTIN phenotype in human blood
CPR:2	In this study, antidepressants with selectivity for the GENEIN (CHEMICALIN and CHEMICALIN), or the  bbbbb1 GENEIN eeeee1  (CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 ) were examined in terms of their ability to promote an anti-inflammatory GENENOTIN phenotype in human blood
CPR:4	The fact that  bbbbb1 CHEMICALIN eeeee1  also suppressed  bbbbb2 GENEIN eeeee2  production and T-cell proliferation indicates that these immunomodulatory actions of antidepressants are most likely unrelated to inhibition of CHEMICALNOTIN reuptake
CPR:1	 bbbbb1 GENEIN eeeee1  is a 167  bbbbb2 CHEMICALIN eeeee2  protein encoded by the obesity gene that is synthesized in adipose tissue and interacts with receptors in the hypothalamus linked to the regulation of appetite and metabolism
CPR:2	This increase may suggest that both  bbbbb1 GENEIN eeeee1  and  bbbbb2 CHEMICALIN eeeee2  may affect appetite via similar receptors and that CHEMICALNOTIN does not impair leptin activity through these receptors
CPR:2	 bbbbb1 CHEMICALIN eeeee1  is a CHEMICALIN CHEMICALIN that increases appetite through its antiserotonergic effect on  bbbbb2 GENEIN eeeee2  receptors in the brain
CPR:2	CHEMICALIN is a  bbbbb1 CHEMICALIN eeeee1  CHEMICALIN that increases appetite through its antiserotonergic effect on  bbbbb2 GENEIN eeeee2  receptors in the brain
CPR:2	CHEMICALIN is a CHEMICALIN  bbbbb1 CHEMICALIN eeeee1  that increases appetite through its antiserotonergic effect on  bbbbb2 GENEIN eeeee2  receptors in the brain
CPR:3	The mean body weight at baseline (52.59 kg) did not differ significantly from that at 1 week after treatment (52.84 kg; P > .05), but the mean  bbbbb1 GENEIN eeeee1  level after 1 week of treatment with  bbbbb2 CHEMICALIN eeeee2  (3.14 ng/mL) was 14.2% higher than that at baseline (2.75 ng/mL; P < .05)
CPR:10	We compared the effects of CHEMICALIN (an GENEIN inhibitor with -CHEMICALIN group), CHEMICALIN (an GENEIN-inhibitor without -CHEMICALNOTIN group),  bbbbb1 CHEMICALIN eeeee1  (only -CHEMICALNOTIN group not  bbbbb2 GENEIN eeeee2  inhibitor) on endothelial dysfunction injured by CHEMICALNOTIN-induced hyperhomocysteinemia (HHcy) in rats
CPR:10	It was found that a single intragastric gavage by  bbbbb1 CHEMICALIN eeeee1  resulted in inhibition of endothelium-dependent relaxation, markedly increased the serum level of CHEMICALNOTIN and decreased the activity of GENEIN and GENEIN, similarly decreased the level of CHEMICALNOTIN in the serum; but had no effects on endothelium-independent relaxation and  bbbbb2 GENEIN eeeee2  activity compared with the control group
CPR:2	However, there were some significant differences among  bbbbb1 CHEMICALIN eeeee1  (30 mg/kg or 45 mg/kg), CHEMICALIN (20 mg/kg), and CHEMICALIN particular in the activity of  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:2	However, there were some significant differences among  bbbbb1 CHEMICALIN eeeee1  (30 mg/kg or 45 mg/kg), CHEMICALIN (20 mg/kg), and CHEMICALIN particular in the activity of GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:2	However, there were some significant differences among CHEMICALIN (30 mg/kg or 45 mg/kg),  bbbbb1 CHEMICALIN eeeee1  (20 mg/kg), and CHEMICALIN particular in the activity of  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:2	However, there were some significant differences among CHEMICALIN (30 mg/kg or 45 mg/kg),  bbbbb1 CHEMICALIN eeeee1  (20 mg/kg), and CHEMICALIN particular in the activity of GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:2	However, there were some significant differences among CHEMICALIN (30 mg/kg or 45 mg/kg), CHEMICALIN (20 mg/kg), and  bbbbb1 CHEMICALIN eeeee1  particular in the activity of  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:2	However, there were some significant differences among CHEMICALIN (30 mg/kg or 45 mg/kg), CHEMICALIN (20 mg/kg), and  bbbbb1 CHEMICALIN eeeee1  particular in the activity of GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:3	Given the treatment with three doses of  bbbbb1 CHEMICALIN eeeee1  (15 approximately 45 mg/kg) markedly attenuated inhibition of vasodilator responses to CHEMICALNOTIN, and eliminated the increased level of CHEMICALNOTIN, the decreased level of CHEMICALNOTIN, activity of  bbbbb2 GENEIN eeeee2  and GENEIN in serum by single intragastric gavaged CHEMICALNOTIN
CPR:3	Given the treatment with three doses of  bbbbb1 CHEMICALIN eeeee1  (15 approximately 45 mg/kg) markedly attenuated inhibition of vasodilator responses to CHEMICALNOTIN, and eliminated the increased level of CHEMICALNOTIN, the decreased level of CHEMICALNOTIN, activity of GENEIN and  bbbbb2 GENEIN eeeee2  in serum by single intragastric gavaged CHEMICALNOTIN
CPR:3	These results suggested that CHEMICALNOTIN can protect the vascular endothelium against the damages induced by CHEMICALIN in rats, and the beneficial effects of  bbbbb1 CHEMICALIN eeeee1  may be related to attenuating the decrease in  bbbbb2 GENEIN eeeee2  activity and CHEMICALNOTIN levels
CPR:4	These results suggested that CHEMICALNOTIN can protect the vascular endothelium against the damages induced by  bbbbb1 CHEMICALIN eeeee1  in rats, and the beneficial effects of CHEMICALIN may be related to attenuating the decrease in  bbbbb2 GENEIN eeeee2  activity and CHEMICALNOTIN levels
CPR:4	We compared the effects of  bbbbb1 CHEMICALIN eeeee1  (an  bbbbb2 GENEIN eeeee2  inhibitor with -CHEMICALIN group), CHEMICALIN (an GENEIN-inhibitor without -CHEMICALNOTIN group), CHEMICALIN (only -CHEMICALNOTIN group not GENEIN inhibitor) on endothelial dysfunction injured by CHEMICALNOTIN-induced hyperhomocysteinemia (HHcy) in rats
CPR:4	We compared the effects of CHEMICALIN (an  bbbbb1 GENEIN eeeee1  inhibitor with - bbbbb2 CHEMICALIN eeeee2  group), CHEMICALIN (an GENEIN-inhibitor without -CHEMICALNOTIN group), CHEMICALIN (only -CHEMICALNOTIN group not GENEIN inhibitor) on endothelial dysfunction injured by CHEMICALNOTIN-induced hyperhomocysteinemia (HHcy) in rats
CPR:4	We compared the effects of CHEMICALIN (an GENEIN inhibitor with -CHEMICALIN group),  bbbbb1 CHEMICALIN eeeee1  (an  bbbbb2 GENEIN eeeee2 -inhibitor without -CHEMICALNOTIN group), CHEMICALIN (only -CHEMICALNOTIN group not GENEIN inhibitor) on endothelial dysfunction injured by CHEMICALNOTIN-induced hyperhomocysteinemia (HHcy) in rats
CPR:4	Comparison of  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN to study the role of the CHEMICALIN-group in improvement of endothelial dysfunction with  bbbbb2 GENEIN eeeee2  inhibitors in high dieted CHEMICALNOTIN mice
CPR:4	Comparison of CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  to study the role of the CHEMICALIN-group in improvement of endothelial dysfunction with  bbbbb2 GENEIN eeeee2  inhibitors in high dieted CHEMICALNOTIN mice
CPR:4	Comparison of CHEMICALIN and CHEMICALIN to study the role of the  bbbbb1 CHEMICALIN eeeee1 -group in improvement of endothelial dysfunction with  bbbbb2 GENEIN eeeee2  inhibitors in high dieted CHEMICALNOTIN mice
CPR:4	It was found that a single intragastric gavage by  bbbbb1 CHEMICALIN eeeee1  resulted in inhibition of endothelium-dependent relaxation, markedly increased the serum level of CHEMICALNOTIN and decreased the activity of  bbbbb2 GENEIN eeeee2  and GENEIN, similarly decreased the level of CHEMICALNOTIN in the serum; but had no effects on endothelium-independent relaxation and GENEIN activity compared with the control group
CPR:4	It was found that a single intragastric gavage by  bbbbb1 CHEMICALIN eeeee1  resulted in inhibition of endothelium-dependent relaxation, markedly increased the serum level of CHEMICALNOTIN and decreased the activity of GENEIN and  bbbbb2 GENEIN eeeee2 , similarly decreased the level of CHEMICALNOTIN in the serum; but had no effects on endothelium-independent relaxation and GENEIN activity compared with the control group
CPR:3	In addition,  bbbbb1 CHEMICALIN eeeee1  demonstrated significant activity against several GENEIN involved in neovascularization and tumor progression, including GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN GENEIN, and GENEIN
CPR:3	In addition,  bbbbb1 CHEMICALIN eeeee1  demonstrated significant activity against several GENEIN involved in neovascularization and tumor progression, including GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2  GENEIN, and GENEIN
CPR:3	In addition,  bbbbb1 CHEMICALIN eeeee1  demonstrated significant activity against several GENEIN involved in neovascularization and tumor progression, including GENEIN, GENEIN, GENEIN  bbbbb2 GENEIN eeeee2 , and GENEIN
CPR:3	In addition,  bbbbb1 CHEMICALIN eeeee1  demonstrated significant activity against several GENEIN involved in neovascularization and tumor progression, including GENEIN, GENEIN, GENEIN GENEIN, and  bbbbb2 GENEIN eeeee2 
CPR:3	In addition,  bbbbb1 CHEMICALIN eeeee1  demonstrated significant activity against several  bbbbb2 GENEIN eeeee2  involved in neovascularization and tumor progression, including GENEIN, GENEIN, GENEIN GENEIN, and GENEIN
CPR:3	In addition,  bbbbb1 CHEMICALIN eeeee1  demonstrated significant activity against several GENEIN involved in neovascularization and tumor progression, including  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN GENEIN, and GENEIN
CPR:4	Further characterization showed that  bbbbb1 CHEMICALIN eeeee1  suppresses both wild-type and  bbbbb2 GENEIN eeeee2  mutant GENEIN activity in vitro
CPR:4	Further characterization showed that  bbbbb1 CHEMICALIN eeeee1  suppresses both wild-type and GENEIN mutant  bbbbb2 GENEIN eeeee2  activity in vitro
CPR:4	 bbbbb1 CHEMICALIN eeeee1 , which belongs chemically to a class that can be described as CHEMICALIN, was selected for further pharmacologic characterization based on potent inhibition of  bbbbb2 GENEIN eeeee2  and its favorable GENEIN selectivity profile
CPR:4	 bbbbb1 CHEMICALIN eeeee1 , which belongs chemically to a class that can be described as CHEMICALIN, was selected for further pharmacologic characterization based on potent inhibition of GENEIN and its favorable  bbbbb2 GENEIN eeeee2  selectivity profile
CPR:4	CHEMICALIN, which belongs chemically to a class that can be described as  bbbbb1 CHEMICALIN eeeee1 , was selected for further pharmacologic characterization based on potent inhibition of  bbbbb2 GENEIN eeeee2  and its favorable GENEIN selectivity profile
CPR:4	CHEMICALIN, which belongs chemically to a class that can be described as  bbbbb1 CHEMICALIN eeeee1 , was selected for further pharmacologic characterization based on potent inhibition of GENEIN and its favorable  bbbbb2 GENEIN eeeee2  selectivity profile
CPR:2	In vivo angiogenesis assay utilising gelfoam sponges,  bbbbb1 CHEMICALIN eeeee1  reduced angiogenesis in sponges containing  bbbbb2 GENEIN eeeee2 , GENEIN and basic GENEIN to various extent
CPR:2	In vivo angiogenesis assay utilising gelfoam sponges,  bbbbb1 CHEMICALIN eeeee1  reduced angiogenesis in sponges containing GENEIN,  bbbbb2 GENEIN eeeee2  and basic GENEIN to various extent
CPR:2	In vivo angiogenesis assay utilising gelfoam sponges,  bbbbb1 CHEMICALIN eeeee1  reduced angiogenesis in sponges containing GENEIN, GENEIN and basic  bbbbb2 GENEIN eeeee2  to various extent
CPR:3	The ability of  bbbbb1 CHEMICALIN eeeee1  to inhibit angiogenesis and metastasis was dependent on activation of its heterodimerisation partner  bbbbb2 GENEIN eeeee2 
CPR:3	Analysis of tumour-conditioned medium indicated that  bbbbb1 CHEMICALIN eeeee1  decreased the secretion of angiogenic factors and GENEIN and increased the tissue inhibitor of  bbbbb2 GENEIN eeeee2 
CPR:4	Analysis of tumour-conditioned medium indicated that  bbbbb1 CHEMICALIN eeeee1  decreased the secretion of angiogenic factors and  bbbbb2 GENEIN eeeee2  and increased the tissue inhibitor of GENEIN
CPR:5	A selective  bbbbb1 GENEIN eeeee1  agonist  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN, CHEMICALIN) inhibits angiogenesis and metastasis in solid tumours
CPR:5	A selective  bbbbb1 GENEIN eeeee1  agonist CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN) inhibits angiogenesis and metastasis in solid tumours
CPR:5	A selective  bbbbb1 GENEIN eeeee1  agonist CHEMICALIN (CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 ) inhibits angiogenesis and metastasis in solid tumours
CPR:5	The present study determined the influence of a  bbbbb1 GENEIN eeeee1  agonist  bbbbb2 CHEMICALIN eeeee2  on angiogenesis and metastasis in solid tumours
CPR:2	The dysmenorrhea pain evoked by  bbbbb1 CHEMICALIN eeeee1  correlated poorly with area under the curve, which may suggest that the effect is mediated by more than one  bbbbb2 GENEIN eeeee2 
CPR:4	In subjects with dysmenorrhea the increase in pain following the administration of  bbbbb1 GENEIN eeeee1  was significantly lower during  bbbbb2 CHEMICALIN eeeee2  than during placebo infusion
CPR:4	CONCLUSIONS:  bbbbb1 CHEMICALIN eeeee1  reduces  bbbbb2 GENEIN eeeee2 -induced intrauterine pressure in both healthy volunteers and dysmenorrheics, and reported pain in subjects with dysmenorrhea
CPR:2	GENENOTIN expression in resectable and unresectable pancreatic cancer: role as predictive or prognostic marker? BACKGROUND AND AIMS:  bbbbb1 GENEIN eeeee1  (GENEIN) is an important enzyme for DNA synthesis and the target for  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN)
CPR:2	GENENOTIN expression in resectable and unresectable pancreatic cancer: role as predictive or prognostic marker? BACKGROUND AND AIMS: GENEIN ( bbbbb1 GENEIN eeeee1 ) is an important enzyme for DNA synthesis and the target for  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN)
CPR:2	GENENOTIN expression in resectable and unresectable pancreatic cancer: role as predictive or prognostic marker? BACKGROUND AND AIMS:  bbbbb1 GENEIN eeeee1  (GENEIN) is an important enzyme for DNA synthesis and the target for CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 )
CPR:2	GENENOTIN expression in resectable and unresectable pancreatic cancer: role as predictive or prognostic marker? BACKGROUND AND AIMS: GENEIN ( bbbbb1 GENEIN eeeee1 ) is an important enzyme for DNA synthesis and the target for CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 )
CPR:1	Removal of Pro128 from the hepatic  bbbbb1 GENEIN eeeee1  consisting of 328 residues, which is missing in the corresponding position of the isoform consisting of 329 residues, significantly changed the Michaelis constants and Kd value for CHEMICALIN, whereas addition of a  bbbbb2 CHEMICALIN eeeee2  residue to the isoform was without effect
CPR:8	Removal of Pro128 from the hepatic  bbbbb1 GENEIN eeeee1  consisting of 328 residues, which is missing in the corresponding position of the isoform consisting of 329 residues, significantly changed the Michaelis constants and Kd value for  bbbbb2 CHEMICALIN eeeee2 , whereas addition of a CHEMICALIN residue to the isoform was without effect
CPR:4	Novel highly affine GENENOTIN ligands with additional inhibitory effects on the main CHEMICALIN metabolizing enzyme in the brain, GENEIN, chemically show structural elements of the  bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2 
CPR:9	Some of the new compounds proved in a slightly modified colorimetric Ellmann's assay to be potent inhibitors of  bbbbb1 GENEIN eeeee1  and of GENEIN which is another catalytic enzyme hydrolysing  bbbbb2 CHEMICALIN eeeee2 
CPR:9	Some of the new compounds proved in a slightly modified colorimetric Ellmann's assay to be potent inhibitors of GENEIN and of  bbbbb1 GENEIN eeeee1  which is another catalytic enzyme hydrolysing  bbbbb2 CHEMICALIN eeeee2 
CPR:9	Novel highly affine GENENOTIN ligands with additional inhibitory effects on the main  bbbbb1 CHEMICALIN eeeee1  metabolizing enzyme in the brain,  bbbbb2 GENEIN eeeee2 , chemically show structural elements of the GENEIN inhibitor CHEMICALIN
CPR:4	For some, pharmacologic inhibitors are available, including  bbbbb1 CHEMICALIN eeeee1  for  bbbbb2 GENEIN eeeee2 , GENENOTIN inhibitors for GENENOTIN, CHEMICALIN for GENEIN/GENEIN, CHEMICALIN analogues for GENEIN, and agents that inhibit either GENENOTIN or its receptors
CPR:4	For some, pharmacologic inhibitors are available, including CHEMICALIN for GENEIN, GENENOTIN inhibitors for GENENOTIN,  bbbbb1 CHEMICALIN eeeee1  for  bbbbb2 GENEIN eeeee2 /GENEIN, CHEMICALIN analogues for GENEIN, and agents that inhibit either GENENOTIN or its receptors
CPR:4	For some, pharmacologic inhibitors are available, including CHEMICALIN for GENEIN, GENENOTIN inhibitors for GENENOTIN,  bbbbb1 CHEMICALIN eeeee1  for GENEIN/ bbbbb2 GENEIN eeeee2 , CHEMICALIN analogues for GENEIN, and agents that inhibit either GENENOTIN or its receptors
CPR:4	For some, pharmacologic inhibitors are available, including CHEMICALIN for GENEIN, GENENOTIN inhibitors for GENENOTIN, CHEMICALIN for GENEIN/GENEIN,  bbbbb1 CHEMICALIN eeeee1  analogues for  bbbbb2 GENEIN eeeee2 , and agents that inhibit either GENENOTIN or its receptors
CPR:10	Similar to the  bbbbb1 GENEIN eeeee1 , GENEIN is activated only by the naturally occurring CHEMICALIN isomer of PS and not the  bbbbb2 CHEMICALIN eeeee2  stereoisomer
CPR:10	Similar to the GENEIN,  bbbbb1 GENEIN eeeee1  is activated only by the naturally occurring CHEMICALIN isomer of PS and not the  bbbbb2 CHEMICALIN eeeee2  stereoisomer
CPR:10	Activation of GENEIN is also reduced by these modifications;  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, and CHEMICALIN, which are not transported by the plasma membrane flippase, do not activate  bbbbb2 GENEIN eeeee2 
CPR:10	Activation of GENEIN is also reduced by these modifications; CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, and CHEMICALIN, which are not transported by the plasma membrane flippase, do not activate  bbbbb2 GENEIN eeeee2 
CPR:10	Activation of GENEIN is also reduced by these modifications; CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , and CHEMICALIN, which are not transported by the plasma membrane flippase, do not activate  bbbbb2 GENEIN eeeee2 
CPR:10	Activation of GENEIN is also reduced by these modifications; CHEMICALIN, CHEMICALIN, CHEMICALIN, and  bbbbb1 CHEMICALIN eeeee1 , which are not transported by the plasma membrane flippase, do not activate  bbbbb2 GENEIN eeeee2 
CPR:10	The purified  bbbbb1 GENEIN eeeee1  is inactive in detergent micelles or in micelles containing  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, or CHEMICALIN, is minimally activated by CHEMICALIN or CHEMICALIN (CHEMICALIN), and is maximally activated by CHEMICALIN
CPR:10	However,  bbbbb1 CHEMICALIN eeeee1 , which is transported by the plasma membrane GENEIN at a rate equivalent to CHEMICALNOTIN, is incapable of activating  bbbbb2 GENEIN eeeee2  activity
CPR:10	The purified  bbbbb1 GENEIN eeeee1  is inactive in detergent micelles or in micelles containing CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , or CHEMICALIN, is minimally activated by CHEMICALIN or CHEMICALIN (CHEMICALIN), and is maximally activated by CHEMICALIN
CPR:10	The purified  bbbbb1 GENEIN eeeee1  is inactive in detergent micelles or in micelles containing CHEMICALIN, CHEMICALIN, or  bbbbb2 CHEMICALIN eeeee2 , is minimally activated by CHEMICALIN or CHEMICALIN (CHEMICALIN), and is maximally activated by CHEMICALIN
CPR:2	This aminophospholipid " bbbbb1 GENEIN eeeee1 " selectively transports CHEMICALIN to the cytosolic leaflet of the bilayer and is sensitive to  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, and modification by CHEMICALIN reagents
CPR:2	This aminophospholipid " bbbbb1 GENEIN eeeee1 " selectively transports CHEMICALIN to the cytosolic leaflet of the bilayer and is sensitive to CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , and modification by CHEMICALIN reagents
CPR:2	This aminophospholipid " bbbbb1 GENEIN eeeee1 " selectively transports CHEMICALIN to the cytosolic leaflet of the bilayer and is sensitive to CHEMICALIN, CHEMICALIN, and modification by  bbbbb2 CHEMICALIN eeeee2  reagents
CPR:3	Similar to the  bbbbb1 GENEIN eeeee1 , GENEIN is activated only by the naturally occurring  bbbbb2 CHEMICALIN eeeee2  isomer of PS and not the CHEMICALIN stereoisomer
CPR:3	Similar to the GENEIN,  bbbbb1 GENEIN eeeee1  is activated only by the naturally occurring  bbbbb2 CHEMICALIN eeeee2  isomer of PS and not the CHEMICALIN stereoisomer
CPR:3	Weakly translocated lipids ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, and CHEMICALIN) are also weak  bbbbb2 GENEIN eeeee2  activators
CPR:3	Weakly translocated lipids (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , and CHEMICALIN) are also weak  bbbbb2 GENEIN eeeee2  activators
CPR:3	Weakly translocated lipids (CHEMICALIN, CHEMICALIN, and  bbbbb1 CHEMICALIN eeeee1 ) are also weak  bbbbb2 GENEIN eeeee2  activators
CPR:3	These results indicate that the  bbbbb1 GENEIN eeeee1  activity of the secretory granule GENEIN is activated by phospholipids binding to a specific site whose properties ( bbbbb2 CHEMICALIN eeeee2  selectivity, dependence upon CHEMICALNOTIN but not CHEMICALNOTIN, stereochemistry, and vanadate sensitivity) are similar to, but distinct from, the properties of the substrate binding site of the plasma membrane GENENOTIN.
CPR:3	These results indicate that the GENEIN activity of the secretory granule  bbbbb1 GENEIN eeeee1  is activated by phospholipids binding to a specific site whose properties ( bbbbb2 CHEMICALIN eeeee2  selectivity, dependence upon CHEMICALNOTIN but not CHEMICALNOTIN, stereochemistry, and vanadate sensitivity) are similar to, but distinct from, the properties of the substrate binding site of the plasma membrane GENENOTIN.
CPR:3	The purified  bbbbb1 GENEIN eeeee1  is inactive in detergent micelles or in micelles containing CHEMICALIN, CHEMICALIN, or CHEMICALIN, is minimally activated by  bbbbb2 CHEMICALIN eeeee2  or CHEMICALIN (CHEMICALIN), and is maximally activated by CHEMICALIN
CPR:3	The purified  bbbbb1 GENEIN eeeee1  is inactive in detergent micelles or in micelles containing CHEMICALIN, CHEMICALIN, or CHEMICALIN, is minimally activated by CHEMICALIN or  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), and is maximally activated by CHEMICALIN
CPR:3	The purified  bbbbb1 GENEIN eeeee1  is inactive in detergent micelles or in micelles containing CHEMICALIN, CHEMICALIN, or CHEMICALIN, is minimally activated by CHEMICALIN or CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), and is maximally activated by CHEMICALIN
CPR:3	The purified  bbbbb1 GENEIN eeeee1  is inactive in detergent micelles or in micelles containing CHEMICALIN, CHEMICALIN, or CHEMICALIN, is minimally activated by CHEMICALIN or CHEMICALIN (CHEMICALIN), and is maximally activated by  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Activation of  bbbbb1 GENEIN eeeee1  is also reduced by these modifications;  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, and CHEMICALIN, which are not transported by the plasma membrane flippase, do not activate GENEIN
CPR:4	Activation of  bbbbb1 GENEIN eeeee1  is also reduced by these modifications; CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, and CHEMICALIN, which are not transported by the plasma membrane flippase, do not activate GENEIN
CPR:4	Activation of  bbbbb1 GENEIN eeeee1  is also reduced by these modifications; CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , and CHEMICALIN, which are not transported by the plasma membrane flippase, do not activate GENEIN
CPR:4	Activation of  bbbbb1 GENEIN eeeee1  is also reduced by these modifications; CHEMICALIN, CHEMICALIN, CHEMICALIN, and  bbbbb2 CHEMICALIN eeeee2 , which are not transported by the plasma membrane flippase, do not activate GENEIN
CPR:9	However,  bbbbb1 CHEMICALIN eeeee1 , which is transported by the plasma membrane  bbbbb2 GENEIN eeeee2  at a rate equivalent to CHEMICALNOTIN, is incapable of activating GENEIN activity
CPR:9	This aminophospholipid " bbbbb1 GENEIN eeeee1 " selectively transports  bbbbb2 CHEMICALIN eeeee2  to the cytosolic leaflet of the bilayer and is sensitive to CHEMICALIN, CHEMICALIN, and modification by CHEMICALIN reagents
CPR:2	This fundamental significance of  bbbbb1 GENEIN eeeee1 -related excitotoxicity is discussed in the context of the developing clinical success of  bbbbb2 CHEMICALIN eeeee2 , but moreover set into relation to various proteomic and genetic markers of said diseases
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) is a small-molecule inhibitor that has been shown to target members of multiple classes of  bbbbb2 GENEIN eeeee2  that are known to be involved in tumor cell proliferation and tumor angiogenesis
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) is a small-molecule inhibitor that has been shown to target members of multiple classes of  bbbbb2 GENEIN eeeee2  that are known to be involved in tumor cell proliferation and tumor angiogenesis
CPR:2	Here, we show that at noncytotoxic concentrations,  bbbbb1 CHEMICALIN eeeee1  was able to inhibit CHEMICALIN production and GENEIN (GENEIN) expression via  bbbbb2 GENEIN eeeee2  (GENEIN) expression in RAW264.7 macrophages stimulated with lipopolysaccharide (LPS)
CPR:2	Here, we show that at noncytotoxic concentrations,  bbbbb1 CHEMICALIN eeeee1  was able to inhibit CHEMICALIN production and GENEIN (GENEIN) expression via GENEIN ( bbbbb2 GENEIN eeeee2 ) expression in RAW264.7 macrophages stimulated with lipopolysaccharide (LPS)
CPR:2	 bbbbb1 CHEMICALIN eeeee1  inhibits CHEMICALNOTIN production and GENEIN via  bbbbb2 GENEIN eeeee2  expression in RAW264.7 macrophages stimulated with lipopolysaccharide
CPR:2	Interestingly, the inhibitory effect of  bbbbb1 CHEMICALIN eeeee1  on GENEIN activation was reversed by the transient transfection with GENENOTIN siRNA, but was mimicked by either  bbbbb2 GENEIN eeeee2  gene transfection or treatment with CHEMICALIN (CHEMICALIN), an end product of GENEIN
CPR:2	Collectively, our results suggest that  bbbbb1 CHEMICALIN eeeee1  can inhibit CHEMICALNOTIN production and GENEIN activation in LPS-stimulated macrophages through a mechanism that involves the action of  bbbbb2 GENEIN eeeee2 /CHEMICALIN.
CPR:3	Both  bbbbb1 CHEMICALIN eeeee1  solution prepared by bubbling pure CHEMICALNOTIN gas and CHEMICALNOTIN, a CHEMICALNOTIN donor, dose dependently induced GENEIN expression through the activation of the  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:3	Both  bbbbb1 CHEMICALIN eeeee1  solution prepared by bubbling pure CHEMICALNOTIN gas and CHEMICALNOTIN, a CHEMICALNOTIN donor, dose dependently induced GENEIN expression through the activation of the GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:3	Both  bbbbb1 CHEMICALIN eeeee1  solution prepared by bubbling pure CHEMICALNOTIN gas and CHEMICALNOTIN, a CHEMICALNOTIN donor, dose dependently induced  bbbbb2 GENEIN eeeee2  expression through the activation of the GENEIN (GENEIN)
CPR:4	 bbbbb1 CHEMICALIN eeeee1  treatment also inhibited LPS-induced CHEMICALIN production and  bbbbb2 GENEIN eeeee2  expression via its inactivation of GENEIN
CPR:4	Here, we show that at noncytotoxic concentrations,  bbbbb1 CHEMICALIN eeeee1  was able to inhibit CHEMICALIN production and  bbbbb2 GENEIN eeeee2  (GENEIN) expression via GENEIN (GENEIN) expression in RAW264.7 macrophages stimulated with lipopolysaccharide (LPS)
CPR:4	Here, we show that at noncytotoxic concentrations,  bbbbb1 CHEMICALIN eeeee1  was able to inhibit CHEMICALIN production and GENEIN ( bbbbb2 GENEIN eeeee2 ) expression via GENEIN (GENEIN) expression in RAW264.7 macrophages stimulated with lipopolysaccharide (LPS)
CPR:4	Pretreatment with  bbbbb1 CHEMICALIN eeeee1  or CHEMICALIN significantly inhibited LPS-induced  bbbbb2 GENEIN eeeee2  expression and CHEMICALIN production
CPR:4	Pretreatment with CHEMICALIN or  bbbbb1 CHEMICALIN eeeee1  significantly inhibited LPS-induced  bbbbb2 GENEIN eeeee2  expression and CHEMICALIN production
CPR:4	While either blockage of GENENOTIN activity by the GENENOTIN inhibitor, tin protoporphyrin IX, or down-regulation of GENENOTIN expression by GENENOTIN small interfering RNA (siRNA) reversed the inhibitory effects of  bbbbb1 CHEMICALIN eeeee1  on  bbbbb2 GENEIN eeeee2  expression and CHEMICALIN production, GENENOTIN overexpression produced the same inhibitory effects of CHEMICALNOTIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  treatment also inhibited LPS-induced CHEMICALIN production and GENEIN expression via its inactivation of  bbbbb2 GENEIN eeeee2 
CPR:4	Collectively, our results suggest that  bbbbb1 CHEMICALIN eeeee1  can inhibit CHEMICALNOTIN production and  bbbbb2 GENEIN eeeee2  activation in LPS-stimulated macrophages through a mechanism that involves the action of GENEIN/CHEMICALIN.
CPR:4	Moreover, CHEMICALNOTIN production in LPS-stimulated macrophages that are expressing GENEIN mRNA was significantly reduced by the addition of CHEMICALIN, a substrate for CHEMICALNOTIN, but enhanced by the selective  bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2  but not by the GENEIN inhibitor CHEMICALIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  inhibits CHEMICALNOTIN production and  bbbbb2 GENEIN eeeee2  via GENEIN expression in RAW264.7 macrophages stimulated with lipopolysaccharide
CPR:4	Moreover, CHEMICALNOTIN production in LPS-stimulated macrophages that are expressing GENEIN mRNA was significantly reduced by the addition of CHEMICALIN, a substrate for CHEMICALNOTIN, but enhanced by the selective GENEIN inhibitor CHEMICALIN but not by the  bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2 
CPR:4	In addition, LPS-induced nuclear factor  bbbbb1 GENEIN eeeee1  activation was diminished in RAW264.7 macrophages preincubated with  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Interestingly, the inhibitory effect of  bbbbb1 CHEMICALIN eeeee1  on  bbbbb2 GENEIN eeeee2  activation was reversed by the transient transfection with GENENOTIN siRNA, but was mimicked by either GENEIN gene transfection or treatment with CHEMICALIN (CHEMICALIN), an end product of GENEIN
CPR:9	Interestingly, the inhibitory effect of CHEMICALIN on GENEIN activation was reversed by the transient transfection with GENENOTIN siRNA, but was mimicked by either GENEIN gene transfection or treatment with  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), an end product of  bbbbb2 GENEIN eeeee2 
CPR:9	Interestingly, the inhibitory effect of CHEMICALIN on GENEIN activation was reversed by the transient transfection with GENENOTIN siRNA, but was mimicked by either GENEIN gene transfection or treatment with CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), an end product of  bbbbb2 GENEIN eeeee2 
CPR:9	CHEMICALIN treatment also inhibited LPS-induced  bbbbb1 CHEMICALIN eeeee1  production and  bbbbb2 GENEIN eeeee2  expression via its inactivation of GENEIN
CPR:9	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a regulatory gaseous molecule that is endogenously synthesized by GENEIN ( bbbbb2 GENEIN eeeee2 ) and/or GENEIN (GENEIN) from CHEMICALIN (CHEMICALIN) metabolism, is a putative vasodilator, and its role in CHEMICALNOTIN (CHEMICALNOTIN) production is unexplored
CPR:9	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a regulatory gaseous molecule that is endogenously synthesized by GENEIN (GENEIN) and/or  bbbbb2 GENEIN eeeee2  (GENEIN) from CHEMICALIN (CHEMICALIN) metabolism, is a putative vasodilator, and its role in CHEMICALNOTIN (CHEMICALNOTIN) production is unexplored
CPR:9	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a regulatory gaseous molecule that is endogenously synthesized by GENEIN (GENEIN) and/or GENEIN ( bbbbb2 GENEIN eeeee2 ) from CHEMICALIN (CHEMICALIN) metabolism, is a putative vasodilator, and its role in CHEMICALNOTIN (CHEMICALNOTIN) production is unexplored
CPR:9	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a regulatory gaseous molecule that is endogenously synthesized by  bbbbb2 GENEIN eeeee2  (GENEIN) and/or GENEIN (GENEIN) from CHEMICALIN (CHEMICALIN) metabolism, is a putative vasodilator, and its role in CHEMICALNOTIN (CHEMICALNOTIN) production is unexplored
CPR:9	Collectively, our results suggest that CHEMICALIN can inhibit CHEMICALNOTIN production and GENEIN activation in LPS-stimulated macrophages through a mechanism that involves the action of  bbbbb1 GENEIN eeeee1 / bbbbb2 CHEMICALIN eeeee2 .
CPR:9	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a regulatory gaseous molecule that is endogenously synthesized by GENEIN ( bbbbb2 GENEIN eeeee2 ) and/or GENEIN (GENEIN) from CHEMICALIN (CHEMICALIN) metabolism, is a putative vasodilator, and its role in CHEMICALNOTIN (CHEMICALNOTIN) production is unexplored
CPR:9	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a regulatory gaseous molecule that is endogenously synthesized by GENEIN (GENEIN) and/or  bbbbb2 GENEIN eeeee2  (GENEIN) from CHEMICALIN (CHEMICALIN) metabolism, is a putative vasodilator, and its role in CHEMICALNOTIN (CHEMICALNOTIN) production is unexplored
CPR:9	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a regulatory gaseous molecule that is endogenously synthesized by GENEIN (GENEIN) and/or GENEIN ( bbbbb2 GENEIN eeeee2 ) from CHEMICALIN (CHEMICALIN) metabolism, is a putative vasodilator, and its role in CHEMICALNOTIN (CHEMICALNOTIN) production is unexplored
CPR:9	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a regulatory gaseous molecule that is endogenously synthesized by  bbbbb2 GENEIN eeeee2  (GENEIN) and/or GENEIN (GENEIN) from CHEMICALIN (CHEMICALIN) metabolism, is a putative vasodilator, and its role in CHEMICALNOTIN (CHEMICALNOTIN) production is unexplored
CPR:9	Here, we show that at noncytotoxic concentrations, CHEMICALIN was able to inhibit  bbbbb1 CHEMICALIN eeeee1  production and  bbbbb2 GENEIN eeeee2  (GENEIN) expression via GENEIN (GENEIN) expression in RAW264.7 macrophages stimulated with lipopolysaccharide (LPS)
CPR:9	Here, we show that at noncytotoxic concentrations, CHEMICALIN was able to inhibit  bbbbb1 CHEMICALIN eeeee1  production and GENEIN ( bbbbb2 GENEIN eeeee2 ) expression via GENEIN (GENEIN) expression in RAW264.7 macrophages stimulated with lipopolysaccharide (LPS)
CPR:9	Pretreatment with CHEMICALIN or CHEMICALIN significantly inhibited LPS-induced  bbbbb1 GENEIN eeeee1  expression and  bbbbb2 CHEMICALIN eeeee2  production
CPR:9	While either blockage of GENENOTIN activity by the GENENOTIN inhibitor, tin protoporphyrin IX, or down-regulation of GENENOTIN expression by GENENOTIN small interfering RNA (siRNA) reversed the inhibitory effects of CHEMICALIN on  bbbbb1 GENEIN eeeee1  expression and  bbbbb2 CHEMICALIN eeeee2  production, GENENOTIN overexpression produced the same inhibitory effects of CHEMICALNOTIN
CPR:9	CHEMICALIN (CHEMICALIN), a regulatory gaseous molecule that is endogenously synthesized by GENEIN ( bbbbb1 GENEIN eeeee1 ) and/or GENEIN (GENEIN) from  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) metabolism, is a putative vasodilator, and its role in CHEMICALNOTIN (CHEMICALNOTIN) production is unexplored
CPR:9	CHEMICALIN (CHEMICALIN), a regulatory gaseous molecule that is endogenously synthesized by GENEIN (GENEIN) and/or  bbbbb1 GENEIN eeeee1  (GENEIN) from  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) metabolism, is a putative vasodilator, and its role in CHEMICALNOTIN (CHEMICALNOTIN) production is unexplored
CPR:9	CHEMICALIN (CHEMICALIN), a regulatory gaseous molecule that is endogenously synthesized by GENEIN (GENEIN) and/or GENEIN ( bbbbb1 GENEIN eeeee1 ) from  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) metabolism, is a putative vasodilator, and its role in CHEMICALNOTIN (CHEMICALNOTIN) production is unexplored
CPR:9	CHEMICALIN (CHEMICALIN), a regulatory gaseous molecule that is endogenously synthesized by  bbbbb1 GENEIN eeeee1  (GENEIN) and/or GENEIN (GENEIN) from  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) metabolism, is a putative vasodilator, and its role in CHEMICALNOTIN (CHEMICALNOTIN) production is unexplored
CPR:9	CHEMICALIN (CHEMICALIN), a regulatory gaseous molecule that is endogenously synthesized by GENEIN ( bbbbb1 GENEIN eeeee1 ) and/or GENEIN (GENEIN) from CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) metabolism, is a putative vasodilator, and its role in CHEMICALNOTIN (CHEMICALNOTIN) production is unexplored
CPR:9	CHEMICALIN (CHEMICALIN), a regulatory gaseous molecule that is endogenously synthesized by GENEIN (GENEIN) and/or  bbbbb1 GENEIN eeeee1  (GENEIN) from CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) metabolism, is a putative vasodilator, and its role in CHEMICALNOTIN (CHEMICALNOTIN) production is unexplored
CPR:9	CHEMICALIN (CHEMICALIN), a regulatory gaseous molecule that is endogenously synthesized by GENEIN (GENEIN) and/or GENEIN ( bbbbb1 GENEIN eeeee1 ) from CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) metabolism, is a putative vasodilator, and its role in CHEMICALNOTIN (CHEMICALNOTIN) production is unexplored
CPR:9	CHEMICALIN (CHEMICALIN), a regulatory gaseous molecule that is endogenously synthesized by  bbbbb1 GENEIN eeeee1  (GENEIN) and/or GENEIN (GENEIN) from CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) metabolism, is a putative vasodilator, and its role in CHEMICALNOTIN (CHEMICALNOTIN) production is unexplored
CPR:9	Moreover, CHEMICALNOTIN production in LPS-stimulated macrophages that are expressing  bbbbb1 GENEIN eeeee1  mRNA was significantly reduced by the addition of  bbbbb2 CHEMICALIN eeeee2 , a substrate for CHEMICALNOTIN, but enhanced by the selective GENEIN inhibitor CHEMICALIN but not by the GENEIN inhibitor CHEMICALIN
CPR:4	However, in vitro experiments simulating a uremic milieu revealed a marked concentration-dependent inhibition of  bbbbb1 GENEIN eeeee1  activity by  bbbbb2 CHEMICALIN eeeee2  in the tissue lysates
CPR:4	CONCLUSIONS: Although CRF does not change the abundance or intrinsic properties of  bbbbb1 GENEIN eeeee1 , the inherent rise in  bbbbb2 CHEMICALIN eeeee2  concentration inhibits its enzymatic activity
CPR:9	CHEMICALIN is converted to  bbbbb1 CHEMICALIN eeeee1  by  bbbbb2 GENEIN eeeee2  in the liver and GENEIN in the kidney
CPR:9	CHEMICALIN is converted to  bbbbb1 CHEMICALIN eeeee1  by GENEIN in the liver and  bbbbb2 GENEIN eeeee2  in the kidney
CPR:9	Sources of  bbbbb1 CHEMICALIN eeeee1  include dietary proteins and endogenous synthesis by  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:9	Sources of  bbbbb1 CHEMICALIN eeeee1  include dietary proteins and endogenous synthesis by GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:9	 bbbbb1 CHEMICALIN eeeee1  is converted to CHEMICALIN by  bbbbb2 GENEIN eeeee2  in the liver and GENEIN in the kidney
CPR:9	 bbbbb1 CHEMICALIN eeeee1  is converted to CHEMICALIN by GENEIN in the liver and  bbbbb2 GENEIN eeeee2  in the kidney
CPR:9	We hypothesized that preservation of plasma  bbbbb1 CHEMICALIN eeeee1  in CRF may be, partly, due to downregulation/inhibition of  bbbbb2 GENEIN eeeee2 
CPR:6	However, several promising nonpeptide,  bbbbb1 GENEIN eeeee1  antagonists have been described; these agents are  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), and CHEMICALIN
CPR:6	However, several promising nonpeptide,  bbbbb1 GENEIN eeeee1  antagonists have been described; these agents are CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), and CHEMICALIN
CPR:6	However, several promising nonpeptide,  bbbbb1 GENEIN eeeee1  antagonists have been described; these agents are CHEMICALIN (CHEMICALIN),  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), CHEMICALIN (CHEMICALIN), and CHEMICALIN
CPR:6	However, several promising nonpeptide,  bbbbb1 GENEIN eeeee1  antagonists have been described; these agents are CHEMICALIN (CHEMICALIN), CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), CHEMICALIN (CHEMICALIN), and CHEMICALIN
CPR:6	However, several promising nonpeptide,  bbbbb1 GENEIN eeeee1  antagonists have been described; these agents are CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN),  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), and CHEMICALIN
CPR:6	However, several promising nonpeptide,  bbbbb1 GENEIN eeeee1  antagonists have been described; these agents are CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), and CHEMICALIN
CPR:6	However, several promising nonpeptide,  bbbbb1 GENEIN eeeee1  antagonists have been described; these agents are CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), and  bbbbb2 CHEMICALIN eeeee2 
CPR:6	edation and  bbbbb1 GENEIN eeeee1  antagonism: studies in man with the enantiomers of CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 . 1
CPR:6	edation and  bbbbb1 GENEIN eeeee1  antagonism: studies in man with the enantiomers of  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN. 1
CPR:4	BG also showed a protective effect in the presence of a  bbbbb1 GENEIN eeeee1  inhibitor ( bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN), demonstrating that BG does not act through an anti-mutagenic mechanism of action involving GENENOTIN.
CPR:4	BG also showed a protective effect in the presence of a  bbbbb1 GENEIN eeeee1  inhibitor (CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 ), demonstrating that BG does not act through an anti-mutagenic mechanism of action involving GENENOTIN.
CPR:1	METHODS: We identified seven SNP(single  bbbbb1 CHEMICALIN eeeee1  polymorphism) (-141Cins>del, TaqIB, TaqID,  bbbbb2 GENEIN eeeee2 , rs6275, rs6277 and TaqIA) in the GENEIN gene in 146 schizophrenic inpatients (59 with EPS and 87 without EPS according to the Simpson-Angus Scale) treated with CHEMICALNOTIN after 8 weeks
CPR:1	METHODS: We identified seven SNP(single  bbbbb1 CHEMICALIN eeeee1  polymorphism) (-141Cins>del, TaqIB, TaqID, GENEIN, rs6275, rs6277 and TaqIA) in the  bbbbb2 GENEIN eeeee2  gene in 146 schizophrenic inpatients (59 with EPS and 87 without EPS according to the Simpson-Angus Scale) treated with CHEMICALNOTIN after 8 weeks
CPR:2	CONCLUSION: Our results did not lend strong support to the view that the genetic variation of the  bbbbb1 GENEIN eeeee1  gene plays a major role in the individually variable adverse effect induced by  bbbbb2 CHEMICALIN eeeee2 , at least in Chinese patients with schizophrenia
CPR:10	CHEMICALNOTIN-chelating reagents such as  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN prevented the cleavage of  bbbbb2 GENEIN eeeee2 
CPR:10	CHEMICALNOTIN-chelating reagents such as CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  prevented the cleavage of  bbbbb2 GENEIN eeeee2 
CPR:1	Previously, we reported that GENENOTIN (GENENOTIN) could be cleaved in vitro to release a stable truncated form which lacks CHEMICALNOTIN 1-69 from the  bbbbb1 CHEMICALIN eeeee1 -terminus,  bbbbb2 GENEIN eeeee2 
CPR:2	Agents that specifically target  bbbbb1 GENEIN eeeee1 , such as  bbbbb2 CHEMICALIN eeeee2 , as well as new molecules that function both upstream and downstream of GENENOTIN, are being actively investigated.
CPR:4	Our purpose was to test the impact of single and/or combined treatment with the  bbbbb1 GENEIN eeeee1 -receptor blocker  bbbbb2 CHEMICALIN eeeee2  and the GENEIN inhibitor CHEMICALIN on infarct size and neuroscore in transient cerebral ischemia in rats
CPR:4	Reduction of cerebral infarct size by the GENEIN-receptor blocker CHEMICALIN, the  bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2  and their combination
CPR:4	Reduction of cerebral infarct size by the  bbbbb1 GENEIN eeeee1 -receptor blocker  bbbbb2 CHEMICALIN eeeee2 , the GENEIN inhibitor CHEMICALIN and their combination
CPR:4	Our purpose was to test the impact of single and/or combined treatment with the GENEIN-receptor blocker CHEMICALIN and the  bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2  on infarct size and neuroscore in transient cerebral ischemia in rats
CPR:1	The phosphorylation by GENENOTIN resulted in activation of GENENOTIN because a  bbbbb1 GENEIN eeeee1  mutant in which CHEMICALIN-776 and CHEMICALIN-779 were substituted with  bbbbb2 CHEMICALIN eeeee2  to mimic phosphorylation exhibited significantly higher activity compared with wild type GENENOTIN and an unphosphorylatable GENENOTIN mutant
CPR:1	Mass spectrometric analysis and mutation studies revealed that  bbbbb1 GENEIN eeeee1   bbbbb2 CHEMICALIN eeeee2 -776 and CHEMICALIN-779 in the AD of GENEIN
CPR:1	Mass spectrometric analysis and mutation studies revealed that GENEIN CHEMICALIN-776 and  bbbbb1 CHEMICALIN eeeee1 -779 in the AD of  bbbbb2 GENEIN eeeee2 
CPR:1	The phosphorylation by GENENOTIN resulted in activation of GENENOTIN because a  bbbbb1 GENEIN eeeee1  mutant in which  bbbbb2 CHEMICALIN eeeee2 -776 and CHEMICALIN-779 were substituted with CHEMICALIN to mimic phosphorylation exhibited significantly higher activity compared with wild type GENENOTIN and an unphosphorylatable GENENOTIN mutant
CPR:1	The phosphorylation by GENENOTIN resulted in activation of GENENOTIN because a  bbbbb1 GENEIN eeeee1  mutant in which CHEMICALIN-776 and  bbbbb2 CHEMICALIN eeeee2 -779 were substituted with CHEMICALIN to mimic phosphorylation exhibited significantly higher activity compared with wild type GENENOTIN and an unphosphorylatable GENENOTIN mutant
CPR:2	 bbbbb1 GENEIN eeeee1  directly associated with GENEIN through its accessory domain (AD), depending on  bbbbb2 CHEMICALIN eeeee2  as well as CHEMICALIN/CHEMICALIN in vitro
CPR:2	GENEIN directly associated with  bbbbb1 GENEIN eeeee1  through its accessory domain (AD), depending on  bbbbb2 CHEMICALIN eeeee2  as well as CHEMICALIN/CHEMICALIN in vitro
CPR:2	 bbbbb1 GENEIN eeeee1  directly associated with GENEIN through its accessory domain (AD), depending on CHEMICALIN as well as  bbbbb2 CHEMICALIN eeeee2 /CHEMICALIN in vitro
CPR:2	GENEIN directly associated with  bbbbb1 GENEIN eeeee1  through its accessory domain (AD), depending on CHEMICALIN as well as  bbbbb2 CHEMICALIN eeeee2 /CHEMICALIN in vitro
CPR:2	 bbbbb1 GENEIN eeeee1  directly associated with GENEIN through its accessory domain (AD), depending on CHEMICALIN as well as CHEMICALIN/ bbbbb2 CHEMICALIN eeeee2  in vitro
CPR:2	GENEIN directly associated with  bbbbb1 GENEIN eeeee1  through its accessory domain (AD), depending on CHEMICALIN as well as CHEMICALIN/ bbbbb2 CHEMICALIN eeeee2  in vitro
CPR:7	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) acts as an allosteric activator of  bbbbb2 GENEIN eeeee2  (GENEIN) and is converted to CHEMICALIN by GENEIN (GENEIN)
CPR:7	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) acts as an allosteric activator of GENEIN ( bbbbb2 GENEIN eeeee2 ) and is converted to CHEMICALIN by GENEIN (GENEIN)
CPR:7	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) acts as an allosteric activator of  bbbbb2 GENEIN eeeee2  (GENEIN) and is converted to CHEMICALIN by GENEIN (GENEIN)
CPR:7	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) acts as an allosteric activator of GENEIN ( bbbbb2 GENEIN eeeee2 ) and is converted to CHEMICALIN by GENEIN (GENEIN)
CPR:9	CHEMICALIN (CHEMICALIN) acts as an allosteric activator of GENEIN (GENEIN) and is converted to  bbbbb1 CHEMICALIN eeeee1  by  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:9	CHEMICALIN (CHEMICALIN) acts as an allosteric activator of GENEIN (GENEIN) and is converted to  bbbbb1 CHEMICALIN eeeee1  by GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:9	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) acts as an allosteric activator of GENEIN (GENEIN) and is converted to CHEMICALIN by  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:9	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) acts as an allosteric activator of GENEIN (GENEIN) and is converted to CHEMICALIN by GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:9	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) acts as an allosteric activator of GENEIN (GENEIN) and is converted to CHEMICALIN by  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:9	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) acts as an allosteric activator of GENEIN (GENEIN) and is converted to CHEMICALIN by GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:2	Among all the CHEMICALIN tested, the combination of a methyl group and a negatively charged  bbbbb1 CHEMICALIN eeeee1  attached to the CHEMICALIN atom, CHEMICALIN- bbbbb2 GENEIN eeeee2 , conferred the greatest protection to the active site of aged or nonaged CHEMICALIN conjugates of GENEIN.
CPR:2	Among all the CHEMICALIN tested, the combination of a methyl group and a negatively charged CHEMICALIN attached to the  bbbbb1 CHEMICALIN eeeee1  atom, CHEMICALIN- bbbbb2 GENEIN eeeee2 , conferred the greatest protection to the active site of aged or nonaged CHEMICALIN conjugates of GENEIN.
CPR:2	Among all the CHEMICALIN tested, the combination of a methyl group and a negatively charged CHEMICALIN attached to the CHEMICALIN atom,  bbbbb1 CHEMICALIN eeeee1 - bbbbb2 GENEIN eeeee2 , conferred the greatest protection to the active site of aged or nonaged CHEMICALIN conjugates of GENEIN.
CPR:2	Among all the CHEMICALIN tested, the combination of a methyl group and a negatively charged CHEMICALIN attached to the CHEMICALIN atom, CHEMICALIN-GENEIN, conferred the greatest protection to the active site of aged or nonaged  bbbbb1 CHEMICALIN eeeee1  conjugates of  bbbbb2 GENEIN eeeee2 .
CPR:2	Among all the  bbbbb1 CHEMICALIN eeeee1  tested, the combination of a methyl group and a negatively charged CHEMICALIN attached to the CHEMICALIN atom, CHEMICALIN- bbbbb2 GENEIN eeeee2 , conferred the greatest protection to the active site of aged or nonaged CHEMICALIN conjugates of GENEIN.
CPR:4	Monoclonal antibody 25B1 appears to be directed against a conformational epitope located in close proximity to the catalytic center of the enzyme and was found to be most suitable for studying the stabilization of the active site of  bbbbb1 GENEIN eeeee1  against denaturation by heat or  bbbbb2 CHEMICALIN eeeee2  following phosphorylation by organophosphorus GENENOTIN compounds
CPR:4	Monoclonal antibody 25B1 generated against  bbbbb1 CHEMICALIN eeeee1  inhibited fetal  bbbbb2 GENEIN eeeee2  has been extensively characterized with respect to its GENENOTIN properties
CPR:2	The effect of  bbbbb1 CHEMICALIN eeeee1  level on this end-point was modulated by the  bbbbb2 GENEIN eeeee2  genotype (P for interaction = 0.02), with TT cells grown at low CHEMICALNOTIN concentration apparently resistant to the induction of radiation-induced bridges
CPR:2	The  bbbbb1 GENEIN eeeee1  polymorphism of the GENEIN (GENEIN) gene is associated with a reduction of catalytic activity and is suggested to modify cancer risk differently depending on  bbbbb2 CHEMICALIN eeeee2  status
CPR:2	The GENEIN polymorphism of the  bbbbb1 GENEIN eeeee1  (GENEIN) gene is associated with a reduction of catalytic activity and is suggested to modify cancer risk differently depending on  bbbbb2 CHEMICALIN eeeee2  status
CPR:2	The GENEIN polymorphism of the GENEIN ( bbbbb1 GENEIN eeeee1 ) gene is associated with a reduction of catalytic activity and is suggested to modify cancer risk differently depending on  bbbbb2 CHEMICALIN eeeee2  status
CPR:2	The main molecular target of  bbbbb1 CHEMICALIN eeeee1  antifungals is the  bbbbb2 GENEIN eeeee2  protein GENEIN/GENEIN
CPR:2	The main molecular target of  bbbbb1 CHEMICALIN eeeee1  antifungals is the GENEIN protein  bbbbb2 GENEIN eeeee2 /GENEIN
CPR:2	The main molecular target of  bbbbb1 CHEMICALIN eeeee1  antifungals is the GENEIN protein GENEIN/ bbbbb2 GENEIN eeeee2 
CPR:2	The  bbbbb1 CHEMICALIN eeeee1 , of which CHEMICALIN is the sole representative in human therapy, affect two targets in the ergosterol pathway:  bbbbb2 GENEIN eeeee2  (GENEIN) and GENEIN (GENEIN)
CPR:2	The  bbbbb1 CHEMICALIN eeeee1 , of which CHEMICALIN is the sole representative in human therapy, affect two targets in the ergosterol pathway: GENEIN ( bbbbb2 GENEIN eeeee2 ) and GENEIN (GENEIN)
CPR:2	The  bbbbb1 CHEMICALIN eeeee1 , of which CHEMICALIN is the sole representative in human therapy, affect two targets in the ergosterol pathway: GENEIN (GENEIN) and  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:2	The  bbbbb1 CHEMICALIN eeeee1 , of which CHEMICALIN is the sole representative in human therapy, affect two targets in the ergosterol pathway: GENEIN (GENEIN) and GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:2	The CHEMICALIN, of which  bbbbb1 CHEMICALIN eeeee1  is the sole representative in human therapy, affect two targets in the ergosterol pathway:  bbbbb2 GENEIN eeeee2  (GENEIN) and GENEIN (GENEIN)
CPR:2	The CHEMICALIN, of which  bbbbb1 CHEMICALIN eeeee1  is the sole representative in human therapy, affect two targets in the ergosterol pathway: GENEIN ( bbbbb2 GENEIN eeeee2 ) and GENEIN (GENEIN)
CPR:2	The CHEMICALIN, of which  bbbbb1 CHEMICALIN eeeee1  is the sole representative in human therapy, affect two targets in the ergosterol pathway: GENEIN (GENEIN) and  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:2	The CHEMICALIN, of which  bbbbb1 CHEMICALIN eeeee1  is the sole representative in human therapy, affect two targets in the ergosterol pathway: GENEIN (GENEIN) and GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:4	The  bbbbb1 CHEMICALIN eeeee1  group are protein synthesis inhibitors that work by blocking the function of  bbbbb2 GENEIN eeeee2 
CPR:2	The short lifetime of  bbbbb1 CHEMICALIN eeeee1  makes this detection very challenging in measuring  bbbbb2 GENEIN eeeee2  responses
CPR:2	We show here that  bbbbb1 CHEMICALIN eeeee1  can be used as a surrogate of CHEMICALIN to monitor  bbbbb2 GENEIN eeeee2  activation
CPR:2	We show here that CHEMICALIN can be used as a surrogate of  bbbbb1 CHEMICALIN eeeee1  to monitor  bbbbb2 GENEIN eeeee2  activation
CPR:2	 bbbbb1 CHEMICALIN eeeee1  as a surrogate of CHEMICALIN to monitor  bbbbb2 GENEIN eeeee2  activation
CPR:2	CHEMICALIN as a surrogate of  bbbbb1 CHEMICALIN eeeee1  to monitor  bbbbb2 GENEIN eeeee2  activation
CPR:2	 bbbbb1 GENEIN eeeee1  (GENEIN)-coupled GENEIN (GENEIN) activities traditionally are assessed by measuring CHEMICALIN triggered by  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), a GENEIN hydrolysis product, or by measuring the production of CHEMICALIN using cumbersome radioactive assays
CPR:2	GENEIN ( bbbbb1 GENEIN eeeee1 )-coupled GENEIN (GENEIN) activities traditionally are assessed by measuring CHEMICALIN triggered by  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), a GENEIN hydrolysis product, or by measuring the production of CHEMICALIN using cumbersome radioactive assays
CPR:2	GENEIN (GENEIN)-coupled  bbbbb1 GENEIN eeeee1  (GENEIN) activities traditionally are assessed by measuring CHEMICALIN triggered by  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), a GENEIN hydrolysis product, or by measuring the production of CHEMICALIN using cumbersome radioactive assays
CPR:2	GENEIN (GENEIN)-coupled GENEIN ( bbbbb1 GENEIN eeeee1 ) activities traditionally are assessed by measuring CHEMICALIN triggered by  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), a GENEIN hydrolysis product, or by measuring the production of CHEMICALIN using cumbersome radioactive assays
CPR:3	It has been known for decades that  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) leads to CHEMICALIN accumulation on  bbbbb2 GENEIN eeeee2  activation by inhibiting GENEIN, the final enzyme of the CHEMICALIN metabolic cascade
CPR:3	It has been known for decades that CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) leads to CHEMICALIN accumulation on  bbbbb2 GENEIN eeeee2  activation by inhibiting GENEIN, the final enzyme of the CHEMICALIN metabolic cascade
CPR:4	It has been known for decades that  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) leads to CHEMICALIN accumulation on GENEIN activation by inhibiting  bbbbb2 GENEIN eeeee2 , the final enzyme of the CHEMICALIN metabolic cascade
CPR:4	It has been known for decades that CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) leads to CHEMICALIN accumulation on GENEIN activation by inhibiting  bbbbb2 GENEIN eeeee2 , the final enzyme of the CHEMICALIN metabolic cascade
CPR:8	It has the advantage over the traditional  bbbbb1 CHEMICALIN eeeee1  assay of allowing the measurement of inverse agonist activity as well as the analysis of  bbbbb2 GENEIN eeeee2  activity in any nontransfected primary cultures
CPR:8	 bbbbb1 GENEIN eeeee1  (GENEIN)-coupled GENEIN (GENEIN) activities traditionally are assessed by measuring  bbbbb2 CHEMICALIN eeeee2  triggered by CHEMICALIN (CHEMICALIN), a GENEIN hydrolysis product, or by measuring the production of CHEMICALIN using cumbersome radioactive assays
CPR:8	GENEIN ( bbbbb1 GENEIN eeeee1 )-coupled GENEIN (GENEIN) activities traditionally are assessed by measuring  bbbbb2 CHEMICALIN eeeee2  triggered by CHEMICALIN (CHEMICALIN), a GENEIN hydrolysis product, or by measuring the production of CHEMICALIN using cumbersome radioactive assays
CPR:9	GENEIN (GENEIN)-coupled GENEIN (GENEIN) activities traditionally are assessed by measuring CHEMICALIN triggered by  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a  bbbbb2 GENEIN eeeee2  hydrolysis product, or by measuring the production of CHEMICALIN using cumbersome radioactive assays
CPR:9	GENEIN (GENEIN)-coupled GENEIN (GENEIN) activities traditionally are assessed by measuring CHEMICALIN triggered by CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a  bbbbb2 GENEIN eeeee2  hydrolysis product, or by measuring the production of CHEMICALIN using cumbersome radioactive assays
CPR:9	GENEIN (GENEIN)-coupled GENEIN (GENEIN) activities traditionally are assessed by measuring CHEMICALIN triggered by CHEMICALIN (CHEMICALIN), a  bbbbb1 GENEIN eeeee1  hydrolysis product, or by measuring the production of  bbbbb2 CHEMICALIN eeeee2  using cumbersome radioactive assays
CPR:9	It has been known for decades that CHEMICALIN (CHEMICALIN) leads to  bbbbb1 CHEMICALIN eeeee1  accumulation on GENEIN activation by inhibiting  bbbbb2 GENEIN eeeee2 , the final enzyme of the CHEMICALIN metabolic cascade
CPR:9	It has been known for decades that CHEMICALIN (CHEMICALIN) leads to CHEMICALIN accumulation on GENEIN activation by inhibiting  bbbbb1 GENEIN eeeee1 , the final enzyme of the  bbbbb2 CHEMICALIN eeeee2  metabolic cascade
CPR:9	Once formed, the molecule can be converted to  bbbbb1 CHEMICALIN eeeee1  by  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:9	Once formed, the molecule can be converted to  bbbbb1 CHEMICALIN eeeee1  by GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:2	GENEIN activates  bbbbb1 CHEMICALIN eeeee1  to CHEMICALIN to facilitate  bbbbb2 GENEIN eeeee2  (GENEIN)-mediated action
CPR:2	GENEIN activates  bbbbb1 CHEMICALIN eeeee1  to CHEMICALIN to facilitate GENEIN ( bbbbb2 GENEIN eeeee2 )-mediated action
CPR:2	GENEIN activates CHEMICALIN to  bbbbb1 CHEMICALIN eeeee1  to facilitate  bbbbb2 GENEIN eeeee2  (GENEIN)-mediated action
CPR:2	GENEIN activates CHEMICALIN to  bbbbb1 CHEMICALIN eeeee1  to facilitate GENEIN ( bbbbb2 GENEIN eeeee2 )-mediated action
CPR:2	By contrast,  bbbbb1 GENEIN eeeee1  plays a pivotal role in  bbbbb2 CHEMICALIN eeeee2  target tissues where it catalyses the opposite reaction (i.e. inactivation of CHEMICALIN to CHEMICALIN) to prevent activation of the GENEIN (GENEIN) by CHEMICALIN
CPR:3	By contrast, GENEIN plays a pivotal role in CHEMICALIN target tissues where it catalyses the opposite reaction (i.e. inactivation of CHEMICALIN to CHEMICALIN) to prevent activation of the  bbbbb1 GENEIN eeeee1  (GENEIN) by  bbbbb2 CHEMICALIN eeeee2 
CPR:3	By contrast, GENEIN plays a pivotal role in CHEMICALIN target tissues where it catalyses the opposite reaction (i.e. inactivation of CHEMICALIN to CHEMICALIN) to prevent activation of the GENEIN ( bbbbb1 GENEIN eeeee1 ) by  bbbbb2 CHEMICALIN eeeee2 
CPR:3	Mutations in the GENENOTIN gene cause a rare form of inherited hypertension, the syndrome of apparent mineralocorticoid excess (AME), in which  bbbbb1 CHEMICALIN eeeee1  activates the  bbbbb2 GENEIN eeeee2  resulting in severe hypertension and hypokalemia
CPR:4	Ingestion of competitive inhibitors of  bbbbb1 GENEIN eeeee1  such as liquorice and  bbbbb2 CHEMICALIN eeeee2  result in a similar but milder clinical phenotype
CPR:9	 bbbbb1 GENEIN eeeee1  activates CHEMICALIN to  bbbbb2 CHEMICALIN eeeee2  to facilitate GENEIN (GENEIN)-mediated action
CPR:9	By contrast,  bbbbb1 GENEIN eeeee1  plays a pivotal role in CHEMICALIN target tissues where it catalyses the opposite reaction (i.e. inactivation of CHEMICALIN to  bbbbb2 CHEMICALIN eeeee2 ) to prevent activation of the GENEIN (GENEIN) by CHEMICALIN
CPR:9	 bbbbb1 GENEIN eeeee1  activates  bbbbb2 CHEMICALIN eeeee2  to CHEMICALIN to facilitate GENEIN (GENEIN)-mediated action
CPR:9	By contrast,  bbbbb1 GENEIN eeeee1  plays a pivotal role in CHEMICALIN target tissues where it catalyses the opposite reaction (i.e. inactivation of  bbbbb2 CHEMICALIN eeeee2  to CHEMICALIN) to prevent activation of the GENEIN (GENEIN) by CHEMICALIN
CPR:3	 bbbbb1 CHEMICALIN eeeee1  regulates gene expression via the activation of the  bbbbb2 GENEIN eeeee2  in human DCs, and GENEIN acutely regulates GENEIN expression
CPR:3	 bbbbb1 CHEMICALIN eeeee1  regulates gene expression via the activation of the GENEIN in human DCs, and  bbbbb2 GENEIN eeeee2  acutely regulates GENEIN expression
CPR:3	 bbbbb1 CHEMICALIN eeeee1  regulates gene expression via the activation of the GENEIN in human DCs, and GENEIN acutely regulates  bbbbb2 GENEIN eeeee2  expression
CPR:3	The  bbbbb1 CHEMICALIN eeeee1 -induced elevated expression of  bbbbb2 GENEIN eeeee2  is coupled to enhanced iNKT cell activation
CPR:3	Furthermore, in vivo relevant lipids such as oxidized low-density lipoprotein can also elicit  bbbbb1 CHEMICALIN eeeee1  signaling leading to  bbbbb2 GENEIN eeeee2  up-regulation
CPR:9	Here we demonstrate that GENENOTIN, turns on  bbbbb1 CHEMICALIN eeeee1  synthesis by inducing the expression of CHEMICALIN and CHEMICALIN metabolizing enzymes such as  bbbbb2 GENEIN eeeee2  and GENEIN (GENEIN)
CPR:9	Here we demonstrate that GENENOTIN, turns on  bbbbb1 CHEMICALIN eeeee1  synthesis by inducing the expression of CHEMICALIN and CHEMICALIN metabolizing enzymes such as GENEIN and  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:9	Here we demonstrate that GENENOTIN, turns on  bbbbb1 CHEMICALIN eeeee1  synthesis by inducing the expression of CHEMICALIN and CHEMICALIN metabolizing enzymes such as GENEIN and GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:9	Here we demonstrate that GENENOTIN, turns on CHEMICALIN synthesis by inducing the expression of  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN metabolizing enzymes such as  bbbbb2 GENEIN eeeee2  and GENEIN (GENEIN)
CPR:9	Here we demonstrate that GENENOTIN, turns on CHEMICALIN synthesis by inducing the expression of  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN metabolizing enzymes such as GENEIN and  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:9	Here we demonstrate that GENENOTIN, turns on CHEMICALIN synthesis by inducing the expression of  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN metabolizing enzymes such as GENEIN and GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:9	Here we demonstrate that GENENOTIN, turns on CHEMICALIN synthesis by inducing the expression of CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  metabolizing enzymes such as  bbbbb2 GENEIN eeeee2  and GENEIN (GENEIN)
CPR:9	Here we demonstrate that GENENOTIN, turns on CHEMICALIN synthesis by inducing the expression of CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  metabolizing enzymes such as GENEIN and  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:9	Here we demonstrate that GENENOTIN, turns on CHEMICALIN synthesis by inducing the expression of CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  metabolizing enzymes such as GENEIN and GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:5	CONTEXT:  bbbbb1 CHEMICALIN eeeee1  is a novel  bbbbb2 GENEIN eeeee2  and GENEIN selective agonist recently approved for insomnia treatment
CPR:5	CONTEXT:  bbbbb1 CHEMICALIN eeeee1  is a novel GENEIN and  bbbbb2 GENEIN eeeee2  selective agonist recently approved for insomnia treatment
CPR:4	Late INa induced by the  bbbbb1 GENEIN eeeee1  long QT mutant GENEIN was reduced by  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:4	Late INa induced by the GENEIN long QT mutant  bbbbb1 GENEIN eeeee1  was reduced by  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:4	Late INa induced by the  bbbbb1 GENEIN eeeee1  long QT mutant GENEIN was reduced by CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Late INa induced by the GENEIN long QT mutant  bbbbb1 GENEIN eeeee1  was reduced by CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Enhancement of radiosensitivity by  bbbbb1 GENEIN eeeee1  inhibitor,  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN, in human lung adenocarcinoma A549 cells and kinetics of apoptosis and necrosis induction
CPR:4	Enhancement of radiosensitivity by  bbbbb1 GENEIN eeeee1  inhibitor, CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 , in human lung adenocarcinoma A549 cells and kinetics of apoptosis and necrosis induction
CPR:4	Similar to  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, CHEMICALIN and CHEMICALIN (CHEMICALIN) are  bbbbb2 GENEIN eeeee2  inhibitors
CPR:4	Similar to CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and CHEMICALIN (CHEMICALIN) are  bbbbb2 GENEIN eeeee2  inhibitors
CPR:4	Similar to CHEMICALIN and CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN (CHEMICALIN) are  bbbbb2 GENEIN eeeee2  inhibitors
CPR:4	Similar to CHEMICALIN and CHEMICALIN, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) are  bbbbb2 GENEIN eeeee2  inhibitors
CPR:4	Similar to CHEMICALIN and CHEMICALIN, CHEMICALIN and CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) are  bbbbb2 GENEIN eeeee2  inhibitors
CPR:10	Accumulated evidence in humans and animals shows that both  bbbbb1 CHEMICALIN eeeee1  and H. pylori upregulate the expression of GENEIN both at mRNA and protein levels at the ulcer margin, but failed to influence significantly that of  bbbbb2 GENEIN eeeee2 
CPR:3	It was, therefore, proposed that H. pylori may in fact, antagonize,  bbbbb1 CHEMICALIN eeeee1 -induced delay of ulcer healing due to suppression of acid secretion by the enhancement in CHEMICALIN possibly derived from  bbbbb2 GENEIN eeeee2  expression and activity and to the overexpression of growth factors such as GENEIN and GENEIN
CPR:3	Accumulated evidence in humans and animals shows that both  bbbbb1 CHEMICALIN eeeee1  and H. pylori upregulate the expression of  bbbbb2 GENEIN eeeee2  both at mRNA and protein levels at the ulcer margin, but failed to influence significantly that of GENEIN
CPR:3	It was, therefore, proposed that H. pylori may in fact, antagonize,  bbbbb1 CHEMICALIN eeeee1 -induced delay of ulcer healing due to suppression of acid secretion by the enhancement in CHEMICALIN possibly derived from GENEIN expression and activity and to the overexpression of growth factors such as  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:3	It was, therefore, proposed that H. pylori may in fact, antagonize,  bbbbb1 CHEMICALIN eeeee1 -induced delay of ulcer healing due to suppression of acid secretion by the enhancement in CHEMICALIN possibly derived from GENEIN expression and activity and to the overexpression of growth factors such as GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:3	It was, therefore, proposed that H. pylori may in fact, antagonize,  bbbbb1 CHEMICALIN eeeee1 -induced delay of ulcer healing due to suppression of acid secretion by the enhancement in CHEMICALIN possibly derived from  bbbbb2 GENEIN eeeee2  expression and activity and to the overexpression of growth factors such as GENEIN and GENEIN
CPR:9	It was, therefore, proposed that H. pylori may in fact, antagonize, CHEMICALIN-induced delay of ulcer healing due to suppression of acid secretion by the enhancement in  bbbbb1 CHEMICALIN eeeee1  possibly derived from  bbbbb2 GENEIN eeeee2  expression and activity and to the overexpression of growth factors such as GENEIN and GENEIN
CPR:2	Based on selective nucleoside protection,  bbbbb1 GENEIN eeeee1  was found to be the primary  bbbbb2 CHEMICALIN eeeee2  target in both cell lines with GENEIN inhibition requiring 20- to 30-fold higher CHEMICALIN concentrations
CPR:2	These data indicate that suppression of constitutive GENENOTIN has no effect on  bbbbb1 CHEMICALIN eeeee1  activity when the primary target is  bbbbb2 GENEIN eeeee2 
CPR:2	There is a modest salutary effect when the  bbbbb1 CHEMICALIN eeeee1  target is  bbbbb2 GENEIN eeeee2  alone.
CPR:4	Based on selective nucleoside protection, GENEIN was found to be the primary CHEMICALIN target in both cell lines with  bbbbb1 GENEIN eeeee1  inhibition requiring 20- to 30-fold higher  bbbbb2 CHEMICALIN eeeee2  concentrations
CPR:9	 bbbbb1 GENEIN eeeee1  (GENEIN) salvages CHEMICALNOTIN by releasing  bbbbb2 CHEMICALIN eeeee2  from CHEMICALIN and is often deleted in mesothelioma
CPR:9	GENEIN ( bbbbb1 GENEIN eeeee1 ) salvages CHEMICALNOTIN by releasing  bbbbb2 CHEMICALIN eeeee2  from CHEMICALIN and is often deleted in mesothelioma
CPR:9	 bbbbb1 GENEIN eeeee1  (GENEIN) salvages CHEMICALNOTIN by releasing CHEMICALIN from  bbbbb2 CHEMICALIN eeeee2  and is often deleted in mesothelioma
CPR:9	GENEIN ( bbbbb1 GENEIN eeeee1 ) salvages CHEMICALNOTIN by releasing CHEMICALIN from  bbbbb2 CHEMICALIN eeeee2  and is often deleted in mesothelioma
CPR:2	Our work shows that  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN additionally bind to  bbbbb2 GENEIN eeeee2  and exhibit GENEIN agonistic activity
CPR:2	Our work shows that CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  additionally bind to  bbbbb2 GENEIN eeeee2  and exhibit GENEIN agonistic activity
CPR:2	This dual mode of action of  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN may open new perspectives for the molecular pharmacology of antidiabetic drugs, because it provides evidence that drugs can be designed that target both the  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:2	This dual mode of action of  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN may open new perspectives for the molecular pharmacology of antidiabetic drugs, because it provides evidence that drugs can be designed that target both the GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:2	This dual mode of action of CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  may open new perspectives for the molecular pharmacology of antidiabetic drugs, because it provides evidence that drugs can be designed that target both the  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:2	This dual mode of action of CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  may open new perspectives for the molecular pharmacology of antidiabetic drugs, because it provides evidence that drugs can be designed that target both the GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:2	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN exhibit  bbbbb2 GENEIN eeeee2  activity: a combined virtual screening and biological assay approach
CPR:2	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  exhibit  bbbbb2 GENEIN eeeee2  activity: a combined virtual screening and biological assay approach
CPR:2	Most drugs currently employed in the treatment of type 2 diabetes either target the  bbbbb1 GENEIN eeeee1  stimulating GENEIN release ( bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN), or target the GENEIN (GENEIN) improving GENENOTIN resistance (CHEMICALIN)
CPR:2	Most drugs currently employed in the treatment of type 2 diabetes either target the  bbbbb1 GENEIN eeeee1  stimulating GENEIN release (CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 ), or target the GENEIN (GENEIN) improving GENENOTIN resistance (CHEMICALIN)
CPR:2	Most drugs currently employed in the treatment of type 2 diabetes either target the GENEIN stimulating GENEIN release (CHEMICALIN, CHEMICALIN), or target the  bbbbb1 GENEIN eeeee1  (GENEIN) improving GENENOTIN resistance ( bbbbb2 CHEMICALIN eeeee2 )
CPR:2	Most drugs currently employed in the treatment of type 2 diabetes either target the GENEIN stimulating GENEIN release (CHEMICALIN, CHEMICALIN), or target the GENEIN ( bbbbb1 GENEIN eeeee1 ) improving GENENOTIN resistance ( bbbbb2 CHEMICALIN eeeee2 )
CPR:3	The most active of these compounds,  bbbbb1 CHEMICALIN eeeee1 , is shown to be as potent as CHEMICALIN at inducing  bbbbb2 GENEIN eeeee2  target gene expression
CPR:3	The most active of these compounds, CHEMICALIN, is shown to be as potent as  bbbbb1 CHEMICALIN eeeee1  at inducing  bbbbb2 GENEIN eeeee2  target gene expression
CPR:3	Most drugs currently employed in the treatment of type 2 diabetes either target the GENEIN stimulating  bbbbb1 GENEIN eeeee1  release ( bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN), or target the GENEIN (GENEIN) improving GENENOTIN resistance (CHEMICALIN)
CPR:3	Most drugs currently employed in the treatment of type 2 diabetes either target the GENEIN stimulating  bbbbb1 GENEIN eeeee1  release (CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 ), or target the GENEIN (GENEIN) improving GENENOTIN resistance (CHEMICALIN)
CPR:5	Among the measured compounds,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN (two CHEMICALIN), as well as CHEMICALIN (a CHEMICALIN), exhibit  bbbbb2 GENEIN eeeee2  agonistic activity at concentrations comparable with those reached under pharmacological treatment
CPR:5	Among the measured compounds, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  (two CHEMICALIN), as well as CHEMICALIN (a CHEMICALIN), exhibit  bbbbb2 GENEIN eeeee2  agonistic activity at concentrations comparable with those reached under pharmacological treatment
CPR:5	Among the measured compounds, CHEMICALIN and CHEMICALIN (two  bbbbb1 CHEMICALIN eeeee1 ), as well as CHEMICALIN (a CHEMICALIN), exhibit  bbbbb2 GENEIN eeeee2  agonistic activity at concentrations comparable with those reached under pharmacological treatment
CPR:5	Among the measured compounds, CHEMICALIN and CHEMICALIN (two CHEMICALIN), as well as  bbbbb1 CHEMICALIN eeeee1  (a CHEMICALIN), exhibit  bbbbb2 GENEIN eeeee2  agonistic activity at concentrations comparable with those reached under pharmacological treatment
CPR:5	Among the measured compounds, CHEMICALIN and CHEMICALIN (two CHEMICALIN), as well as CHEMICALIN (a  bbbbb1 CHEMICALIN eeeee1 ), exhibit  bbbbb2 GENEIN eeeee2  agonistic activity at concentrations comparable with those reached under pharmacological treatment
CPR:5	 bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, and other CHEMICALIN may be promising leads in the development of new  bbbbb2 GENEIN eeeee2  agonists
CPR:5	CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , and other CHEMICALIN may be promising leads in the development of new  bbbbb2 GENEIN eeeee2  agonists
CPR:5	CHEMICALIN, CHEMICALIN, and other  bbbbb1 CHEMICALIN eeeee1  may be promising leads in the development of new  bbbbb2 GENEIN eeeee2  agonists
CPR:5	Our work shows that  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN additionally bind to GENEIN and exhibit  bbbbb2 GENEIN eeeee2  agonistic activity
CPR:5	Our work shows that CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  additionally bind to GENEIN and exhibit  bbbbb2 GENEIN eeeee2  agonistic activity
CPR:2	There is a growing appreciation that the  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN)- bbbbb2 GENEIN eeeee2  (GENEIN) signaling pathway is organized to form transduction units that function to deliver specific messages
CPR:2	There is a growing appreciation that the  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN)-GENEIN ( bbbbb2 GENEIN eeeee2 ) signaling pathway is organized to form transduction units that function to deliver specific messages
CPR:2	There is a growing appreciation that the CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 )- bbbbb2 GENEIN eeeee2  (GENEIN) signaling pathway is organized to form transduction units that function to deliver specific messages
CPR:2	There is a growing appreciation that the CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 )-GENEIN ( bbbbb2 GENEIN eeeee2 ) signaling pathway is organized to form transduction units that function to deliver specific messages
CPR:3	Such organization results in the local activation of  bbbbb1 GENEIN eeeee1  subsets through the generation of confined intracellular gradients of  bbbbb2 CHEMICALIN eeeee2 , but the mechanisms responsible for limiting the diffusion of CHEMICALNOTIN largely remain to be clarified
CPR:9	By using pharmacological and genetic manipulation of GENENOTIN (GENENOTIN), we demonstrate that compartmentalized  bbbbb1 GENEIN eeeee1  and GENEIN are responsible for selectively modulating the concentration of  bbbbb2 CHEMICALIN eeeee2  in individual subcellular compartments
CPR:9	By using pharmacological and genetic manipulation of GENENOTIN (GENENOTIN), we demonstrate that compartmentalized GENEIN and  bbbbb1 GENEIN eeeee1  are responsible for selectively modulating the concentration of  bbbbb2 CHEMICALIN eeeee2  in individual subcellular compartments
CPR:9	We propose a model whereby compartmentalized  bbbbb1 GENEIN eeeee1 , rather than representing an enzymatic barrier to CHEMICALNOTIN diffusion, act as a sink to drain the second messenger from discrete locations, resulting in multiple and simultaneous domains with different  bbbbb2 CHEMICALIN eeeee2  concentrations irrespective of their distance from the site of CHEMICALIN synthesis.
CPR:9	We propose a model whereby compartmentalized  bbbbb1 GENEIN eeeee1 , rather than representing an enzymatic barrier to CHEMICALNOTIN diffusion, act as a sink to drain the second messenger from discrete locations, resulting in multiple and simultaneous domains with different CHEMICALIN concentrations irrespective of their distance from the site of  bbbbb2 CHEMICALIN eeeee2  synthesis.
CPR:10	We failed to observe any significant activation of  bbbbb1 GENEIN eeeee1  following exposure to the anti-metabolite  bbbbb2 CHEMICALIN eeeee2 , the alkylating drug CHEMICALIN, or the microtubule interfering-agents CHEMICALIN and CHEMICALIN
CPR:10	We failed to observe any significant activation of  bbbbb1 GENEIN eeeee1  following exposure to the anti-metabolite CHEMICALIN, the alkylating drug  bbbbb2 CHEMICALIN eeeee2 , or the microtubule interfering-agents CHEMICALIN and CHEMICALIN
CPR:10	We failed to observe any significant activation of  bbbbb1 GENEIN eeeee1  following exposure to the anti-metabolite CHEMICALIN, the alkylating drug CHEMICALIN, or the microtubule interfering-agents  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:10	We failed to observe any significant activation of  bbbbb1 GENEIN eeeee1  following exposure to the anti-metabolite CHEMICALIN, the alkylating drug CHEMICALIN, or the microtubule interfering-agents CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:3	SK-Br3 cells cultured in the presence of GENEIN (GENEIN) inhibitors  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN (CHEMICALIN) demonstrated a 2- to 3-fold increase in  bbbbb2 GENEIN eeeee2  activity when compared with control cells growing in drug-free culture conditions
CPR:3	SK-Br3 cells cultured in the presence of GENEIN (GENEIN) inhibitors CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) demonstrated a 2- to 3-fold increase in  bbbbb2 GENEIN eeeee2  activity when compared with control cells growing in drug-free culture conditions
CPR:3	SK-Br3 cells cultured in the presence of GENEIN (GENEIN) inhibitors CHEMICALIN and CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) demonstrated a 2- to 3-fold increase in  bbbbb2 GENEIN eeeee2  activity when compared with control cells growing in drug-free culture conditions
CPR:4	SK-Br3 cells cultured in the presence of  bbbbb1 GENEIN eeeee1  (GENEIN) inhibitors  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN (CHEMICALIN) demonstrated a 2- to 3-fold increase in GENEIN activity when compared with control cells growing in drug-free culture conditions
CPR:4	SK-Br3 cells cultured in the presence of GENEIN ( bbbbb1 GENEIN eeeee1 ) inhibitors  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN (CHEMICALIN) demonstrated a 2- to 3-fold increase in GENEIN activity when compared with control cells growing in drug-free culture conditions
CPR:4	SK-Br3 cells cultured in the presence of  bbbbb1 GENEIN eeeee1  (GENEIN) inhibitors CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) demonstrated a 2- to 3-fold increase in GENEIN activity when compared with control cells growing in drug-free culture conditions
CPR:4	SK-Br3 cells cultured in the presence of GENEIN ( bbbbb1 GENEIN eeeee1 ) inhibitors CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) demonstrated a 2- to 3-fold increase in GENEIN activity when compared with control cells growing in drug-free culture conditions
CPR:4	SK-Br3 cells cultured in the presence of  bbbbb1 GENEIN eeeee1  (GENEIN) inhibitors CHEMICALIN and CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) demonstrated a 2- to 3-fold increase in GENEIN activity when compared with control cells growing in drug-free culture conditions
CPR:4	SK-Br3 cells cultured in the presence of GENEIN ( bbbbb1 GENEIN eeeee1 ) inhibitors CHEMICALIN and CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) demonstrated a 2- to 3-fold increase in GENEIN activity when compared with control cells growing in drug-free culture conditions
CPR:2	 bbbbb1 CHEMICALIN eeeee1  alters expression of endometrial  bbbbb2 GENEIN eeeee2  and their cofactors in new users of CHEMICALNOTIN
CPR:3	RESULT(S): The expression of endometrial  bbbbb1 GENEIN eeeee1 , GENEIN, GENEIN, and GENEIN was increased significantly after 1 week of  bbbbb2 CHEMICALIN eeeee2 , but the increase was no longer seen after 10 weeks
CPR:3	RESULT(S): The expression of endometrial GENEIN,  bbbbb1 GENEIN eeeee1 , GENEIN, and GENEIN was increased significantly after 1 week of  bbbbb2 CHEMICALIN eeeee2 , but the increase was no longer seen after 10 weeks
CPR:3	RESULT(S): The expression of endometrial GENEIN, GENEIN,  bbbbb1 GENEIN eeeee1 , and GENEIN was increased significantly after 1 week of  bbbbb2 CHEMICALIN eeeee2 , but the increase was no longer seen after 10 weeks
CPR:3	RESULT(S): The expression of endometrial GENEIN, GENEIN, GENEIN, and  bbbbb1 GENEIN eeeee1  was increased significantly after 1 week of  bbbbb2 CHEMICALIN eeeee2 , but the increase was no longer seen after 10 weeks
CPR:3	CONCLUSION(S): Short-term exposure of  bbbbb1 CHEMICALIN eeeee1  in new starters of DMPA increases the expression of endometrial  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN, and GENEIN and promotes cell proliferation
CPR:3	CONCLUSION(S): Short-term exposure of  bbbbb1 CHEMICALIN eeeee1  in new starters of DMPA increases the expression of endometrial GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN and promotes cell proliferation
CPR:3	CONCLUSION(S): Short-term exposure of  bbbbb1 CHEMICALIN eeeee1  in new starters of DMPA increases the expression of endometrial GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN and promotes cell proliferation
CPR:3	CONCLUSION(S): Short-term exposure of  bbbbb1 CHEMICALIN eeeee1  in new starters of DMPA increases the expression of endometrial GENEIN, GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2  and promotes cell proliferation
CPR:3	The cytosolic fraction obtained from pancreatic islets obtained from  bbbbb1 CHEMICALIN eeeee1 -treated rats had an increased  bbbbb2 GENEIN eeeee2  level compared to the levels obtained from the pancreatic islets of control rats
CPR:3	In the present study,  bbbbb1 CHEMICALIN eeeee1 -stimulated  bbbbb2 GENEIN eeeee2  secretion was significantly increased in CHEMICALIN-treated rats compared to controls
CPR:3	In the present study, CHEMICALIN-stimulated  bbbbb1 GENEIN eeeee1  secretion was significantly increased in  bbbbb2 CHEMICALIN eeeee2 -treated rats compared to controls
CPR:3	Levels of mRNA encoding  bbbbb1 GENEIN eeeee1 , GENEIN, and GENENOTIN were increased in the pancreatic islets of  bbbbb2 CHEMICALIN eeeee2 -treated rats
CPR:3	Levels of mRNA encoding GENEIN,  bbbbb1 GENEIN eeeee1 , and GENENOTIN were increased in the pancreatic islets of  bbbbb2 CHEMICALIN eeeee2 -treated rats
CPR:3	When the  bbbbb1 GENEIN eeeee1  in GENEIN mRNA was incubated with the islet cytosolic fraction, the RNA-protein complex level was increased in the cytosolic fraction obtained from  bbbbb2 CHEMICALIN eeeee2 -treated rats compared to the level in control rats
CPR:3	When the GENEIN in  bbbbb1 GENEIN eeeee1  mRNA was incubated with the islet cytosolic fraction, the RNA-protein complex level was increased in the cytosolic fraction obtained from  bbbbb2 CHEMICALIN eeeee2 -treated rats compared to the level in control rats
CPR:2	The changes in  bbbbb1 GENEIN eeeee1  expression 24 h after  bbbbb2 CHEMICALIN eeeee2  injection and the effects of a GENEIN antagonist, CHEMICALIN (0.01 and 0.1 mg/kg), an GENEIN antagonist, CHEMICALIN (30 mg/kg), and an antioxidant, CHEMICALNOTIN (9 mg/kg) were observed
CPR:2	 bbbbb1 GENEIN eeeee1  is involved in  bbbbb2 CHEMICALIN eeeee2 -mediated neuronal injury in mice
CPR:3	RESULTS: In the  bbbbb1 CHEMICALIN eeeee1 -injured brain, the  bbbbb2 GENEIN eeeee2  mRNA, and protein expression were upregulated, and the receptor was mainly localized in the neurons and not in the astrocytes
CPR:3	CONCLUSION:  bbbbb1 GENEIN eeeee1  expression in neurons is upregulated after  bbbbb2 CHEMICALIN eeeee2  injection, and CHEMICALNOTIN-induced responses are inhibited by GENENOTIN antagonists, indicating that the increased GENEIN is involved in CHEMICALIN excitotoxicity.
CPR:3	CONCLUSION: GENEIN expression in neurons is upregulated after CHEMICALIN injection, and CHEMICALNOTIN-induced responses are inhibited by GENENOTIN antagonists, indicating that the increased  bbbbb1 GENEIN eeeee1  is involved in  bbbbb2 CHEMICALIN eeeee2  excitotoxicity.
CPR:4	CHEMICALNOTIN, CHEMICALNOTIN and CHEMICALNOTIN decreased CHEMICALNOTIN-induced injury;  bbbbb1 CHEMICALIN eeeee1  (0.1 mg/kg) and CHEMICALIN inhibited the upregulated expression of the  bbbbb2 GENEIN eeeee2 
CPR:4	CHEMICALNOTIN, CHEMICALNOTIN and CHEMICALNOTIN decreased CHEMICALNOTIN-induced injury; CHEMICALIN (0.1 mg/kg) and  bbbbb1 CHEMICALIN eeeee1  inhibited the upregulated expression of the  bbbbb2 GENEIN eeeee2 
CPR:6	The changes in GENEIN expression 24 h after CHEMICALIN injection and the effects of a  bbbbb1 GENEIN eeeee1  antagonist,  bbbbb2 CHEMICALIN eeeee2  (0.01 and 0.1 mg/kg), an GENEIN antagonist, CHEMICALIN (30 mg/kg), and an antioxidant, CHEMICALNOTIN (9 mg/kg) were observed
CPR:6	The changes in GENEIN expression 24 h after CHEMICALIN injection and the effects of a GENEIN antagonist, CHEMICALIN (0.01 and 0.1 mg/kg), an  bbbbb1 GENEIN eeeee1  antagonist,  bbbbb2 CHEMICALIN eeeee2  (30 mg/kg), and an antioxidant, CHEMICALNOTIN (9 mg/kg) were observed
CPR:1	We have previously demonstrated that phosphorylation of  bbbbb1 GENEIN eeeee1  (GENEIN) at 194  bbbbb2 CHEMICALIN eeeee2  through GENEIN (GENEIN) activation sensitizes breast cancer cells to chemotherapy through accelerating cell cycle arrest at G2/M, and that GENEIN phosphorylation downstream of GENEIN/GENEIN plays an important role in cell growth suppression by CHEMICALIN
CPR:1	We have previously demonstrated that phosphorylation of GENEIN ( bbbbb1 GENEIN eeeee1 ) at 194  bbbbb2 CHEMICALIN eeeee2  through GENEIN (GENEIN) activation sensitizes breast cancer cells to chemotherapy through accelerating cell cycle arrest at G2/M, and that GENEIN phosphorylation downstream of GENEIN/GENEIN plays an important role in cell growth suppression by CHEMICALIN
CPR:2	We have previously demonstrated that phosphorylation of GENEIN (GENEIN) at 194 CHEMICALIN through GENEIN (GENEIN) activation sensitizes breast cancer cells to chemotherapy through accelerating cell cycle arrest at G2/M, and that  bbbbb1 GENEIN eeeee1  phosphorylation downstream of GENEIN/GENEIN plays an important role in cell growth suppression by  bbbbb2 CHEMICALIN eeeee2 
CPR:3	We have previously demonstrated that phosphorylation of  bbbbb1 GENEIN eeeee1  (GENEIN) at 194 CHEMICALIN through GENEIN (GENEIN) activation sensitizes breast cancer cells to chemotherapy through accelerating cell cycle arrest at G2/M, and that GENEIN phosphorylation downstream of GENEIN/GENEIN plays an important role in cell growth suppression by  bbbbb2 CHEMICALIN eeeee2 
CPR:3	We have previously demonstrated that phosphorylation of GENEIN ( bbbbb1 GENEIN eeeee1 ) at 194 CHEMICALIN through GENEIN (GENEIN) activation sensitizes breast cancer cells to chemotherapy through accelerating cell cycle arrest at G2/M, and that GENEIN phosphorylation downstream of GENEIN/GENEIN plays an important role in cell growth suppression by  bbbbb2 CHEMICALIN eeeee2 
CPR:3	We have previously demonstrated that phosphorylation of GENEIN (GENEIN) at 194 CHEMICALIN through  bbbbb1 GENEIN eeeee1  (GENEIN) activation sensitizes breast cancer cells to chemotherapy through accelerating cell cycle arrest at G2/M, and that GENEIN phosphorylation downstream of GENEIN/GENEIN plays an important role in cell growth suppression by  bbbbb2 CHEMICALIN eeeee2 
CPR:3	We have previously demonstrated that phosphorylation of GENEIN (GENEIN) at 194 CHEMICALIN through GENEIN ( bbbbb1 GENEIN eeeee1 ) activation sensitizes breast cancer cells to chemotherapy through accelerating cell cycle arrest at G2/M, and that GENEIN phosphorylation downstream of GENEIN/GENEIN plays an important role in cell growth suppression by  bbbbb2 CHEMICALIN eeeee2 
CPR:3	We have previously demonstrated that phosphorylation of GENEIN (GENEIN) at 194 CHEMICALIN through GENEIN (GENEIN) activation sensitizes breast cancer cells to chemotherapy through accelerating cell cycle arrest at G2/M, and that GENEIN phosphorylation downstream of  bbbbb1 GENEIN eeeee1 /GENEIN plays an important role in cell growth suppression by  bbbbb2 CHEMICALIN eeeee2 
CPR:3	We have previously demonstrated that phosphorylation of GENEIN (GENEIN) at 194 CHEMICALIN through GENEIN (GENEIN) activation sensitizes breast cancer cells to chemotherapy through accelerating cell cycle arrest at G2/M, and that GENEIN phosphorylation downstream of GENEIN/ bbbbb1 GENEIN eeeee1  plays an important role in cell growth suppression by  bbbbb2 CHEMICALIN eeeee2 
CPR:10	 bbbbb1 CHEMICALIN eeeee1  produced significant inhibition of the GENEIN mediated pressor response to CHEMICALIN in the pithed rat, but had no effect on the  bbbbb2 GENEIN eeeee2  mediated pressor response to CHEMICALIN, suggesting that CHEMICALIN is also an GENEIN antagonist at antihypertensive doses
CPR:10	 bbbbb1 CHEMICALIN eeeee1  had no effect on the pressor response elicited by  bbbbb2 GENEIN eeeee2 , indicating a lack of nonspecific vasodilator activity
CPR:2	This same dose of CHEMICALIN also inhibited, but to a lesser degree, the  bbbbb1 GENEIN eeeee1  mediated vasodepressor response to  bbbbb2 CHEMICALIN eeeee2  in pithed rats whose blood pressure was elevated by a constant intravenous infusion of GENENOTIN
CPR:2	CHEMICALIN produced significant inhibition of the  bbbbb1 GENEIN eeeee1  mediated pressor response to  bbbbb2 CHEMICALIN eeeee2  in the pithed rat, but had no effect on the GENEIN mediated pressor response to CHEMICALIN, suggesting that CHEMICALIN is also an GENEIN antagonist at antihypertensive doses
CPR:2	CHEMICALIN produced significant inhibition of the GENEIN mediated pressor response to CHEMICALIN in the pithed rat, but had no effect on the  bbbbb1 GENEIN eeeee1  mediated pressor response to  bbbbb2 CHEMICALIN eeeee2 , suggesting that CHEMICALIN is also an GENEIN antagonist at antihypertensive doses
CPR:3	CHEMICALIN (0.3 mg/kg, iv) produced a significant inhibition of the  bbbbb1 GENEIN eeeee1  mediated positive chronotropic response to  bbbbb2 CHEMICALIN eeeee2 
CPR:3	The vasopressor response to the  bbbbb1 GENEIN eeeee1  activator,  bbbbb2 CHEMICALIN eeeee2 , which is mediated through the opening of GENEIN and the subsequent translocation of extracellular CHEMICALIN, was significantly inhibited by CHEMICALIN (1 mg/kg, iv), suggesting that CHEMICALIN is also a GENEIN antagonist, consistent with our previous in vitro studies
CPR:3	The vasopressor response to the GENEIN activator,  bbbbb1 CHEMICALIN eeeee1 , which is mediated through the opening of  bbbbb2 GENEIN eeeee2  and the subsequent translocation of extracellular CHEMICALIN, was significantly inhibited by CHEMICALIN (1 mg/kg, iv), suggesting that CHEMICALIN is also a GENEIN antagonist, consistent with our previous in vitro studies
CPR:4	The vasopressor response to the GENEIN activator, CHEMICALIN, which is mediated through the opening of  bbbbb1 GENEIN eeeee1  and the subsequent translocation of extracellular CHEMICALIN, was significantly inhibited by  bbbbb2 CHEMICALIN eeeee2  (1 mg/kg, iv), suggesting that CHEMICALIN is also a GENEIN antagonist, consistent with our previous in vitro studies
CPR:4	Thus,  bbbbb1 CHEMICALIN eeeee1  blocks both GENENOTIN at antihypertensive doses, with modest selectivity being observed for the  bbbbb2 GENEIN eeeee2  subtype
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (0.3 mg/kg, iv) produced a significant inhibition of the  bbbbb2 GENEIN eeeee2  mediated positive chronotropic response to CHEMICALIN
CPR:4	This same dose of  bbbbb1 CHEMICALIN eeeee1  also inhibited, but to a lesser degree, the  bbbbb2 GENEIN eeeee2  mediated vasodepressor response to CHEMICALIN in pithed rats whose blood pressure was elevated by a constant intravenous infusion of GENENOTIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  produced significant inhibition of the  bbbbb2 GENEIN eeeee2  mediated pressor response to CHEMICALIN in the pithed rat, but had no effect on the GENEIN mediated pressor response to CHEMICALIN, suggesting that CHEMICALIN is also an GENEIN antagonist at antihypertensive doses
CPR:6	The vasopressor response to the GENEIN activator, CHEMICALIN, which is mediated through the opening of GENEIN and the subsequent translocation of extracellular CHEMICALIN, was significantly inhibited by CHEMICALIN (1 mg/kg, iv), suggesting that  bbbbb1 CHEMICALIN eeeee1  is also a  bbbbb2 GENEIN eeeee2  antagonist, consistent with our previous in vitro studies
CPR:6	In anesthetized spontaneously hypertensive rats, the antihypertensive activity of CHEMICALNOTIN was nearly abolished by combined pretreatment of the rats with high doses of the  bbbbb1 GENEIN eeeee1  antagonist,  bbbbb2 CHEMICALIN eeeee2  (1 mg/kg, iv), and the nonselective GENEIN antagonist, CHEMICALIN (3 mg/kg, iv), suggesting that the majority of the antihypertensive response produced by CHEMICALNOTIN may be accounted for by blockade of GENENOTIN
CPR:6	In anesthetized spontaneously hypertensive rats, the antihypertensive activity of CHEMICALNOTIN was nearly abolished by combined pretreatment of the rats with high doses of the GENEIN antagonist, CHEMICALIN (1 mg/kg, iv), and the nonselective  bbbbb1 GENEIN eeeee1  antagonist,  bbbbb2 CHEMICALIN eeeee2  (3 mg/kg, iv), suggesting that the majority of the antihypertensive response produced by CHEMICALNOTIN may be accounted for by blockade of GENENOTIN
CPR:6	We therefore conclude that  bbbbb1 CHEMICALIN eeeee1 , at antihypertensive doses, is an antagonist of GENENOTIN, and also of  bbbbb2 GENEIN eeeee2  in vascular smooth muscle.(ABSTRACT TRUNCATED AT 400 WORDS)
CPR:6	The mechanism(s) responsible for arterial vasodilation observed following acute administration of  bbbbb1 CHEMICALIN eeeee1 , a novel vasodilator/ bbbbb2 GENEIN eeeee2  antagonist, has been investigated in rats
CPR:6	CHEMICALIN produced significant inhibition of the GENEIN mediated pressor response to CHEMICALIN in the pithed rat, but had no effect on the GENEIN mediated pressor response to CHEMICALIN, suggesting that  bbbbb1 CHEMICALIN eeeee1  is also an  bbbbb2 GENEIN eeeee2  antagonist at antihypertensive doses
CPR:9	The vasopressor response to the GENEIN activator, CHEMICALIN, which is mediated through the opening of  bbbbb1 GENEIN eeeee1  and the subsequent translocation of extracellular  bbbbb2 CHEMICALIN eeeee2 , was significantly inhibited by CHEMICALIN (1 mg/kg, iv), suggesting that CHEMICALIN is also a GENEIN antagonist, consistent with our previous in vitro studies
CPR:2	 bbbbb1 GENEIN eeeee1  antagonism with CHEMICALIN reduced responses to  bbbbb2 CHEMICALIN eeeee2  in controls but not during inflammation
CPR:6	 bbbbb1 GENEIN eeeee1  antagonism with  bbbbb2 CHEMICALIN eeeee2  reduced responses to CHEMICALIN in controls but not during inflammation
CPR:10	CHEMICALNOTIN induction of cell cycle progression was also abrogated in cells expressing GENENOTIN, and no effect of  bbbbb1 CHEMICALIN eeeee1  on  bbbbb2 GENEIN eeeee2  expression and cell cycle was observed in the presence of GENEIN
CPR:10	 bbbbb1 CHEMICALIN eeeee1  activation of GENEIN/GENEIN occurred outside the nucleus with the GENEIN that was distributed between the cytoplasm and nucleus, but not with  bbbbb2 GENEIN eeeee2  that was predominantly nuclear
CPR:2	 bbbbb1 CHEMICALIN eeeee1  induction of the  bbbbb2 GENEIN eeeee2  gene, which lacks a GENENOTIN, was dependent on GENEIN activation of the GENEIN/GENEIN pathway, whereas induction of the GENEIN (GENEIN) gene that contains a functional GENENOTIN was unaffected by mutations that interfere with GENENOTIN activation of GENENOTIN
CPR:2	 bbbbb1 CHEMICALIN eeeee1  induction of the GENEIN gene, which lacks a GENENOTIN, was dependent on GENEIN activation of the GENEIN/GENEIN pathway, whereas induction of the  bbbbb2 GENEIN eeeee2  (GENEIN) gene that contains a functional GENENOTIN was unaffected by mutations that interfere with GENENOTIN activation of GENENOTIN
CPR:2	 bbbbb1 CHEMICALIN eeeee1  induction of the GENEIN gene, which lacks a GENENOTIN, was dependent on GENEIN activation of the GENEIN/GENEIN pathway, whereas induction of the GENEIN ( bbbbb2 GENEIN eeeee2 ) gene that contains a functional GENENOTIN was unaffected by mutations that interfere with GENENOTIN activation of GENENOTIN
CPR:2	The role of extranuclear signaling actions of  bbbbb1 GENEIN eeeee1  in mediating  bbbbb2 CHEMICALIN eeeee2  regulation of gene expression and the cell cycle
CPR:2	CHEMICALNOTIN induction of cell cycle progression was also abrogated in cells expressing GENENOTIN, and no effect of  bbbbb1 CHEMICALIN eeeee1  on GENEIN expression and cell cycle was observed in the presence of  bbbbb2 GENEIN eeeee2 
CPR:2	 bbbbb1 CHEMICALIN eeeee1  activation of GENEIN/GENEIN occurred outside the nucleus with the  bbbbb2 GENEIN eeeee2  that was distributed between the cytoplasm and nucleus, but not with GENEIN that was predominantly nuclear
CPR:3	These results highlight the importance of  bbbbb1 GENEIN eeeee1  activation of the GENEIN/GENEIN signaling pathway for  bbbbb2 CHEMICALIN eeeee2 -induced transcription of select target genes and cell cycle progression.
CPR:3	These results highlight the importance of GENEIN activation of the  bbbbb1 GENEIN eeeee1 /GENEIN signaling pathway for  bbbbb2 CHEMICALIN eeeee2 -induced transcription of select target genes and cell cycle progression.
CPR:3	These results highlight the importance of GENEIN activation of the GENEIN/ bbbbb1 GENEIN eeeee1  signaling pathway for  bbbbb2 CHEMICALIN eeeee2 -induced transcription of select target genes and cell cycle progression.
CPR:3	 bbbbb1 CHEMICALIN eeeee1  activation of  bbbbb2 GENEIN eeeee2 /GENEIN occurred outside the nucleus with the GENEIN that was distributed between the cytoplasm and nucleus, but not with GENEIN that was predominantly nuclear
CPR:3	 bbbbb1 CHEMICALIN eeeee1  activation of GENEIN/ bbbbb2 GENEIN eeeee2  occurred outside the nucleus with the GENEIN that was distributed between the cytoplasm and nucleus, but not with GENEIN that was predominantly nuclear
CPR:3	 bbbbb1 CHEMICALIN eeeee1  induction of the GENEIN gene, which lacks a GENENOTIN, was dependent on  bbbbb2 GENEIN eeeee2  activation of the GENEIN/GENEIN pathway, whereas induction of the GENEIN (GENEIN) gene that contains a functional GENENOTIN was unaffected by mutations that interfere with GENENOTIN activation of GENENOTIN
CPR:3	 bbbbb1 CHEMICALIN eeeee1  induction of the GENEIN gene, which lacks a GENENOTIN, was dependent on GENEIN activation of the  bbbbb2 GENEIN eeeee2 /GENEIN pathway, whereas induction of the GENEIN (GENEIN) gene that contains a functional GENENOTIN was unaffected by mutations that interfere with GENENOTIN activation of GENENOTIN
CPR:3	 bbbbb1 CHEMICALIN eeeee1  induction of the GENEIN gene, which lacks a GENENOTIN, was dependent on GENEIN activation of the GENEIN/ bbbbb2 GENEIN eeeee2  pathway, whereas induction of the GENEIN (GENEIN) gene that contains a functional GENENOTIN was unaffected by mutations that interfere with GENENOTIN activation of GENENOTIN
CPR:6	Relative to WT, electrophysiological recordings from ADNFLE mouse layer II/III cortical pyramidal cells reveal a >20-fold increase in CHEMICALNOTIN-evoked inhibitory postsynaptic currents with no effect on excitatory postsynaptic currents. i.p. injection of a subthreshold dose of  bbbbb1 CHEMICALIN eeeee1 , a use-dependent  bbbbb2 GENEIN eeeee2  antagonist, reduces cortical electroencephalogram delta power and transiently inhibits spontaneous seizure activity in ADNFLE mutant mice
CPR:2	CHEMICALIN (CHEMICALIN, 1) and  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, 2) were synthesized and evaluated for binding to the GENENOTIN ( bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN, respectively) using transfected cells
CPR:2	CHEMICALIN (CHEMICALIN, 1) and  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, 2) were synthesized and evaluated for binding to the GENENOTIN (GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN, respectively) using transfected cells
CPR:2	CHEMICALIN (CHEMICALIN, 1) and  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, 2) were synthesized and evaluated for binding to the GENENOTIN (GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2 , respectively) using transfected cells
CPR:2	Chase studies with  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN demonstrated that this uptake is the result of preferential binding to the  bbbbb2 GENEIN eeeee2 .
CPR:2	Chase studies with CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  demonstrated that this uptake is the result of preferential binding to the  bbbbb2 GENEIN eeeee2 .
CPR:2	Synthesis, radiosynthesis, and biological evaluation of  bbbbb1 CHEMICALIN eeeee1 : candidate radioligands for in vivo imaging of the  bbbbb2 GENEIN eeeee2  with positron emission tomography
CPR:2	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, 1) and CHEMICALIN (CHEMICALIN, 2) were synthesized and evaluated for binding to the GENENOTIN ( bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN, respectively) using transfected cells
CPR:2	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, 1) and CHEMICALIN (CHEMICALIN, 2) were synthesized and evaluated for binding to the GENENOTIN (GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN, respectively) using transfected cells
CPR:2	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, 1) and CHEMICALIN (CHEMICALIN, 2) were synthesized and evaluated for binding to the GENENOTIN (GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2 , respectively) using transfected cells
CPR:2	CHEMICALIN (CHEMICALIN, 1) and CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , 2) were synthesized and evaluated for binding to the GENENOTIN ( bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN, respectively) using transfected cells
CPR:2	CHEMICALIN (CHEMICALIN, 1) and CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , 2) were synthesized and evaluated for binding to the GENENOTIN (GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN, respectively) using transfected cells
CPR:2	CHEMICALIN (CHEMICALIN, 1) and CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , 2) were synthesized and evaluated for binding to the GENENOTIN (GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2 , respectively) using transfected cells
CPR:2	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , 1) and CHEMICALIN (CHEMICALIN, 2) were synthesized and evaluated for binding to the GENENOTIN ( bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN, respectively) using transfected cells
CPR:2	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , 1) and CHEMICALIN (CHEMICALIN, 2) were synthesized and evaluated for binding to the GENENOTIN (GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN, respectively) using transfected cells
CPR:2	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , 1) and CHEMICALIN (CHEMICALIN, 2) were synthesized and evaluated for binding to the GENENOTIN (GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2 , respectively) using transfected cells
CPR:9	MicroPET imaging in nonhuman primates with [ bbbbb1 CHEMICALIN eeeee1 ]1 and [CHEMICALIN]2 demonstrated that both tracers behave similarly in vivo with high uptake being observed in the  bbbbb2 GENEIN eeeee2 -rich brain regions and peak uptake being achieved in about 55 min postinjection
CPR:9	MicroPET imaging in nonhuman primates with [CHEMICALIN]1 and [ bbbbb1 CHEMICALIN eeeee1 ]2 demonstrated that both tracers behave similarly in vivo with high uptake being observed in the  bbbbb2 GENEIN eeeee2 -rich brain regions and peak uptake being achieved in about 55 min postinjection
CPR:6	This trial investigated the possibility of pharmacokinetic interactions between the  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2  and the CHEMICALNOTIN diuretic CHEMICALNOTIN in healthy subjects
CPR:2	In vivo, cromolyn inhibited tumor growth in mice bearing tumor with endogenous  bbbbb1 GENEIN eeeee1  (BxPC-3: control, mean = 1.6 x 10(9) photons/s, versus cromolyn, mean = 4.4 x 10(8) photons/s, difference = 1.2 x 10(9) photons/s; 95% CI = 6.2 x 10(8) to 1.6 x 10(9) photons/s; P<.001, n = 5; MPanc-96: control, mean = 1.1 x 10(10) photons/s, versus cromolyn, mean = 4.8 x 10(9) photons/s, difference = 6.2 x 10(9) photons/s; 95% CI = 1.9 x 10(9) to 1.0 x 10(10) photons/s; P = .009, n = 5) and increased the effectiveness of  bbbbb2 CHEMICALIN eeeee2  (BxPC-3: CHEMICALIN, mean = 9.2 x 10(8) photons/s, versus combination, mean = 1.8 x 10(8) photons/s, difference = 7.4 x 10(8) photons/s; 95% CI = 4.5 x 10(8) to 1.0 x 10(9) photons/s; P<.001; MPanc-96: CHEMICALNOTIN, mean = 4.1 x 10(9) photons/s, versus combination, mean = 2.0 x 10(9) photons/s, difference = 2.1 x 10(9) photons/s; 95% CI = 4.4 x 10(8) to 3.8 x 10(9) photons/s; P<.001)
CPR:2	In vivo, cromolyn inhibited tumor growth in mice bearing tumor with endogenous  bbbbb1 GENEIN eeeee1  (BxPC-3: control, mean = 1.6 x 10(9) photons/s, versus cromolyn, mean = 4.4 x 10(8) photons/s, difference = 1.2 x 10(9) photons/s; 95% CI = 6.2 x 10(8) to 1.6 x 10(9) photons/s; P<.001, n = 5; MPanc-96: control, mean = 1.1 x 10(10) photons/s, versus cromolyn, mean = 4.8 x 10(9) photons/s, difference = 6.2 x 10(9) photons/s; 95% CI = 1.9 x 10(9) to 1.0 x 10(10) photons/s; P = .009, n = 5) and increased the effectiveness of CHEMICALIN (BxPC-3:  bbbbb2 CHEMICALIN eeeee2 , mean = 9.2 x 10(8) photons/s, versus combination, mean = 1.8 x 10(8) photons/s, difference = 7.4 x 10(8) photons/s; 95% CI = 4.5 x 10(8) to 1.0 x 10(9) photons/s; P<.001; MPanc-96: CHEMICALNOTIN, mean = 4.1 x 10(9) photons/s, versus combination, mean = 2.0 x 10(9) photons/s, difference = 2.1 x 10(9) photons/s; 95% CI = 4.4 x 10(8) to 3.8 x 10(9) photons/s; P<.001)
CPR:2	CONCLUSION: Cromolyn binds  bbbbb1 GENEIN eeeee1 , prevents activation of RAGE, inhibits tumor growth, and increases the effectiveness of  bbbbb2 CHEMICALIN eeeee2  in experimental models.
CPR:10	In addition, we found that GENEIN could synthesize  bbbbb1 CHEMICALIN eeeee1  in vitro but  bbbbb2 GENEIN eeeee2  could not
CPR:8	Herein, comparative genomics and experimental analyses revealed that the  bbbbb1 GENEIN eeeee1  (GENEIN) is the previously identified  bbbbb2 CHEMICALIN eeeee2 -containing protein known as the GENEIN
CPR:8	Herein, comparative genomics and experimental analyses revealed that the GENEIN ( bbbbb1 GENEIN eeeee1 ) is the previously identified  bbbbb2 CHEMICALIN eeeee2 -containing protein known as the GENEIN
CPR:8	Herein, comparative genomics and experimental analyses revealed that the GENEIN (GENEIN) is the previously identified  bbbbb1 CHEMICALIN eeeee1 -containing protein known as the  bbbbb2 GENEIN eeeee2 
CPR:9	 bbbbb1 GENEIN eeeee1  required CHEMICALIN and CHEMICALIN-tRNA([Ser]Sec) as substrates to generate  bbbbb2 CHEMICALIN eeeee2 -tRNA([Ser]Sec)
CPR:9	In addition, we found that  bbbbb1 GENEIN eeeee1  could synthesize  bbbbb2 CHEMICALIN eeeee2  in vitro but GENEIN could not
CPR:9	 bbbbb1 GENEIN eeeee1  required CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 -tRNA([Ser]Sec) as substrates to generate CHEMICALIN-tRNA([Ser]Sec)
CPR:9	 bbbbb1 GENEIN eeeee1  required  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN-tRNA([Ser]Sec) as substrates to generate CHEMICALIN-tRNA([Ser]Sec)
CPR:10	 bbbbb1 CHEMICALIN eeeee1  (30 mg/kg) or CHEMICALIN treatment (30 mg/kg) did not reduce the levels of  bbbbb2 GENEIN eeeee2  or GENEIN immunostaining
CPR:10	 bbbbb1 CHEMICALIN eeeee1  (30 mg/kg) or CHEMICALIN treatment (30 mg/kg) did not reduce the levels of GENEIN or  bbbbb2 GENEIN eeeee2  immunostaining
CPR:10	CHEMICALIN (30 mg/kg) or  bbbbb1 CHEMICALIN eeeee1  treatment (30 mg/kg) did not reduce the levels of  bbbbb2 GENEIN eeeee2  or GENEIN immunostaining
CPR:10	CHEMICALIN (30 mg/kg) or  bbbbb1 CHEMICALIN eeeee1  treatment (30 mg/kg) did not reduce the levels of GENEIN or  bbbbb2 GENEIN eeeee2  immunostaining
CPR:10	 bbbbb1 CHEMICALIN eeeee1  (30 mg/kg) also significantly decreased the protein levels of GENEIN but not  bbbbb2 GENEIN eeeee2  or GENEIN in the cortex ipsilateral to the middle cerebral artery occlusion
CPR:10	 bbbbb1 CHEMICALIN eeeee1  (30 mg/kg) also significantly decreased the protein levels of GENEIN but not GENEIN or  bbbbb2 GENEIN eeeee2  in the cortex ipsilateral to the middle cerebral artery occlusion
CPR:2	 bbbbb1 CHEMICALIN eeeee1 , a selective  bbbbb2 GENEIN eeeee2 , and its active metabolite CHEMICALIN may inhibit apoptosis and inflammation after cerebral ischemia
CPR:2	CHEMICALIN, a selective  bbbbb1 GENEIN eeeee1 , and its active metabolite  bbbbb2 CHEMICALIN eeeee2  may inhibit apoptosis and inflammation after cerebral ischemia
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (30 mg/kg) also significantly decreased the protein levels of  bbbbb2 GENEIN eeeee2  but not GENEIN or GENEIN in the cortex ipsilateral to the middle cerebral artery occlusion
CPR:10	The  bbbbb1 GENEIN eeeee1  reduction was inhibited by CHEMICALIN, an GENEIN antagonist, but not by  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), an GENEIN antagonist
CPR:10	The  bbbbb1 GENEIN eeeee1  reduction was inhibited by CHEMICALIN, an GENEIN antagonist, but not by CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), an GENEIN antagonist
CPR:10	CHEMICALIN and CHEMICALIN (CHEMICALIN), two CHEMICALNOTIN chelators, but not  bbbbb1 CHEMICALIN eeeee1 , an GENEIN blocker, prevented  bbbbb2 GENEIN eeeee2  degradation
CPR:10	Here we report that  bbbbb1 CHEMICALIN eeeee1  stimulation caused a rapid reduction in protein levels of GENEIN, but not that of CHEMICALNOTIN receptor  bbbbb2 GENEIN eeeee2 , GENEIN and GENEIN (GENEIN) in rat primary cortical neuron cultures
CPR:10	Here we report that  bbbbb1 CHEMICALIN eeeee1  stimulation caused a rapid reduction in protein levels of GENEIN, but not that of CHEMICALNOTIN receptor GENEIN,  bbbbb2 GENEIN eeeee2  and GENEIN (GENEIN) in rat primary cortical neuron cultures
CPR:10	Here we report that  bbbbb1 CHEMICALIN eeeee1  stimulation caused a rapid reduction in protein levels of GENEIN, but not that of CHEMICALNOTIN receptor GENEIN, GENEIN and  bbbbb2 GENEIN eeeee2  (GENEIN) in rat primary cortical neuron cultures
CPR:10	Here we report that  bbbbb1 CHEMICALIN eeeee1  stimulation caused a rapid reduction in protein levels of GENEIN, but not that of CHEMICALNOTIN receptor GENEIN, GENEIN and GENEIN ( bbbbb2 GENEIN eeeee2 ) in rat primary cortical neuron cultures
CPR:2	Our results suggest that  bbbbb1 CHEMICALIN eeeee1  induces GENEIN degradation by GENEIN through an GENEIN-CHEMICALNOTIN pathway and that GENEIN degradation may play an important role in regulating  bbbbb2 GENEIN eeeee2  surface expression.
CPR:2	Furthermore,  bbbbb1 CHEMICALIN eeeee1  prevented CHEMICALIN-stimulated reduction in surface amount of  bbbbb2 GENEIN eeeee2 , and knockdown of GENENOTIN by RNAi against GENENOTIN reduced surface GENENOTIN in neurons
CPR:2	 bbbbb1 CHEMICALIN eeeee1  stimulates GENEIN degradation by GENEIN-GENEIN system to regulate surface expression of  bbbbb2 GENEIN eeeee2 
CPR:2	Down-regulation of  bbbbb1 GENEIN eeeee1  by CHEMICALIN was blocked by CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), a GENEIN inhibitor and by expression of GENENOTIN-GENENOTIN, a dominant negative form of GENENOTIN
CPR:2	Our results suggest that  bbbbb1 CHEMICALIN eeeee1  induces GENEIN degradation by  bbbbb2 GENEIN eeeee2  through an GENEIN-CHEMICALNOTIN pathway and that GENEIN degradation may play an important role in regulating GENEIN surface expression.
CPR:2	Our results suggest that  bbbbb1 CHEMICALIN eeeee1  induces GENEIN degradation by GENEIN through an  bbbbb2 GENEIN eeeee2 -CHEMICALNOTIN pathway and that GENEIN degradation may play an important role in regulating GENEIN surface expression.
CPR:2	 bbbbb1 CHEMICALIN eeeee1  stimulates GENEIN degradation by  bbbbb2 GENEIN eeeee2 -GENEIN system to regulate surface expression of GENEIN
CPR:2	 bbbbb1 CHEMICALIN eeeee1  stimulates GENEIN degradation by GENEIN- bbbbb2 GENEIN eeeee2  system to regulate surface expression of GENEIN
CPR:2	Down-regulation of  bbbbb1 GENEIN eeeee1  by CHEMICALIN was blocked by  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), a GENEIN inhibitor and by expression of GENENOTIN-GENENOTIN, a dominant negative form of GENENOTIN
CPR:3	The  bbbbb1 GENEIN eeeee1  reduction was inhibited by  bbbbb2 CHEMICALIN eeeee2 , an GENEIN antagonist, but not by CHEMICALIN (CHEMICALIN), an GENEIN antagonist
CPR:3	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN (CHEMICALIN), two CHEMICALNOTIN chelators, but not CHEMICALIN, an GENEIN blocker, prevented  bbbbb2 GENEIN eeeee2  degradation
CPR:3	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), two CHEMICALNOTIN chelators, but not CHEMICALIN, an GENEIN blocker, prevented  bbbbb2 GENEIN eeeee2  degradation
CPR:3	CHEMICALIN and CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), two CHEMICALNOTIN chelators, but not CHEMICALIN, an GENEIN blocker, prevented  bbbbb2 GENEIN eeeee2  degradation
CPR:4	Our results suggest that  bbbbb1 CHEMICALIN eeeee1  induces  bbbbb2 GENEIN eeeee2  degradation by GENEIN through an GENEIN-CHEMICALNOTIN pathway and that GENEIN degradation may play an important role in regulating GENEIN surface expression.
CPR:4	Our results suggest that  bbbbb1 CHEMICALIN eeeee1  induces GENEIN degradation by GENEIN through an GENEIN-CHEMICALNOTIN pathway and that  bbbbb2 GENEIN eeeee2  degradation may play an important role in regulating GENEIN surface expression.
CPR:4	 bbbbb1 CHEMICALIN eeeee1  stimulates  bbbbb2 GENEIN eeeee2  degradation by GENEIN-GENEIN system to regulate surface expression of GENEIN
CPR:4	Down-regulation of  bbbbb1 GENEIN eeeee1  by  bbbbb2 CHEMICALIN eeeee2  was blocked by CHEMICALIN (CHEMICALIN), a GENEIN inhibitor and by expression of GENENOTIN-GENENOTIN, a dominant negative form of GENENOTIN
CPR:4	Furthermore, CHEMICALIN prevented  bbbbb1 CHEMICALIN eeeee1 -stimulated reduction in surface amount of  bbbbb2 GENEIN eeeee2 , and knockdown of GENENOTIN by RNAi against GENENOTIN reduced surface GENENOTIN in neurons
CPR:4	Here we report that  bbbbb1 CHEMICALIN eeeee1  stimulation caused a rapid reduction in protein levels of  bbbbb2 GENEIN eeeee2 , but not that of CHEMICALNOTIN receptor GENEIN, GENEIN and GENEIN (GENEIN) in rat primary cortical neuron cultures
CPR:4	Down-regulation of GENEIN by CHEMICALIN was blocked by CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a  bbbbb2 GENEIN eeeee2  inhibitor and by expression of GENENOTIN-GENENOTIN, a dominant negative form of GENENOTIN
CPR:4	CHEMICALIN and CHEMICALIN (CHEMICALIN), two CHEMICALNOTIN chelators, but not  bbbbb1 CHEMICALIN eeeee1 , an  bbbbb2 GENEIN eeeee2  blocker, prevented GENEIN degradation
CPR:4	Down-regulation of GENEIN by CHEMICALIN was blocked by  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a  bbbbb2 GENEIN eeeee2  inhibitor and by expression of GENENOTIN-GENENOTIN, a dominant negative form of GENENOTIN
CPR:6	The GENEIN reduction was inhibited by  bbbbb1 CHEMICALIN eeeee1 , an  bbbbb2 GENEIN eeeee2  antagonist, but not by CHEMICALIN (CHEMICALIN), an GENEIN antagonist
CPR:6	The GENEIN reduction was inhibited by CHEMICALIN, an GENEIN antagonist, but not by  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), an  bbbbb2 GENEIN eeeee2  antagonist
CPR:6	The GENEIN reduction was inhibited by CHEMICALIN, an GENEIN antagonist, but not by CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), an  bbbbb2 GENEIN eeeee2  antagonist
CPR:2	GENENOTIN, lipopolysaccharides and other inflammatory mediators such as  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN are related to the secretion and production of  bbbbb2 GENEIN eeeee2 
CPR:2	GENENOTIN, lipopolysaccharides and other inflammatory mediators such as CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  are related to the secretion and production of  bbbbb2 GENEIN eeeee2 
CPR:2	However, the relationship of  bbbbb1 CHEMICALIN eeeee1  with  bbbbb2 GENEIN eeeee2  genes expression is not clear
CPR:3	RESULTS:  bbbbb1 CHEMICALIN eeeee1  upregulated  bbbbb2 GENEIN eeeee2  gene expression and GENEIN secretion in a dose dependent pattern
CPR:3	RESULTS:  bbbbb1 CHEMICALIN eeeee1  upregulated GENEIN gene expression and  bbbbb2 GENEIN eeeee2  secretion in a dose dependent pattern
CPR:3	The inhibitory effect of the GENENOTIN antagonist on  bbbbb1 CHEMICALIN eeeee1 -induced GENEIN gene expression and  bbbbb2 GENEIN eeeee2  secretion in human airway epithelial cells
CPR:3	The inhibitory effect of the GENENOTIN antagonist on  bbbbb1 CHEMICALIN eeeee1 -induced  bbbbb2 GENEIN eeeee2  gene expression and GENEIN secretion in human airway epithelial cells
CPR:3	CHEMICALIN (CHEMICALIN, 100 microM) downregulated the  bbbbb1 CHEMICALIN eeeee1 -induced  bbbbb2 GENEIN eeeee2  gene expression and GENEIN secretion
CPR:3	CHEMICALIN (CHEMICALIN, 100 microM) downregulated the  bbbbb1 CHEMICALIN eeeee1 -induced GENEIN gene expression and  bbbbb2 GENEIN eeeee2  secretion
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, 100 microM) downregulated the CHEMICALIN-induced  bbbbb2 GENEIN eeeee2  gene expression and GENEIN secretion
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, 100 microM) downregulated the CHEMICALIN-induced GENEIN gene expression and  bbbbb2 GENEIN eeeee2  secretion
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , 100 microM) downregulated the CHEMICALIN-induced  bbbbb2 GENEIN eeeee2  gene expression and GENEIN secretion
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , 100 microM) downregulated the CHEMICALIN-induced GENEIN gene expression and  bbbbb2 GENEIN eeeee2  secretion
CPR:6	METHODS: The effect of CHEMICALNOTIN and the  bbbbb1 GENEIN eeeee1  antagonist,  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) on the regulation of GENENOTIN gene expression and GENENOTIN secretion were observed in human airway NCI-H292 epithelial cells
CPR:6	METHODS: The effect of CHEMICALNOTIN and the  bbbbb1 GENEIN eeeee1  antagonist, CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) on the regulation of GENENOTIN gene expression and GENENOTIN secretion were observed in human airway NCI-H292 epithelial cells
CPR:10	CONCLUSION: In postmenopausal women, isolated  bbbbb1 CHEMICALIN eeeee1  treatment does not affect  bbbbb2 GENEIN eeeee2 -dependent CHEMICALIN efflux potential from macrophages but increases circulating GENEIN level, which could provide beneficial vascular effects.
CPR:10	Thus,  bbbbb1 CHEMICALIN eeeee1  supplementation did not affect  bbbbb2 GENEIN eeeee2 -dependent CHEMICALIN efflux to serum
CPR:2	We studied in a clinical trial whether isolated  bbbbb1 CHEMICALIN eeeee1  treatment in postmenopausal women could affect reverse CHEMICALNOTIN transport as evaluated by  bbbbb2 GENEIN eeeee2 - (GENEIN), dependent CHEMICALIN efflux from macrophages
CPR:2	We studied in a clinical trial whether isolated  bbbbb1 CHEMICALIN eeeee1  treatment in postmenopausal women could affect reverse CHEMICALNOTIN transport as evaluated by GENEIN- ( bbbbb2 GENEIN eeeee2 ), dependent CHEMICALIN efflux from macrophages
CPR:3	CONCLUSION: In postmenopausal women, isolated  bbbbb1 CHEMICALIN eeeee1  treatment does not affect GENEIN-dependent CHEMICALIN efflux potential from macrophages but increases circulating  bbbbb2 GENEIN eeeee2  level, which could provide beneficial vascular effects.
CPR:3	However, as a novel finding,  bbbbb1 CHEMICALIN eeeee1  treatment increased a subclass of  bbbbb2 GENEIN eeeee2 , the GENEIN levels by 18% without affecting any other serum lipid concentrations
CPR:3	However, as a novel finding,  bbbbb1 CHEMICALIN eeeee1  treatment increased a subclass of GENEIN, the  bbbbb2 GENEIN eeeee2  levels by 18% without affecting any other serum lipid concentrations
CPR:9	CONCLUSION: In postmenopausal women, isolated CHEMICALIN treatment does not affect  bbbbb1 GENEIN eeeee1 -dependent  bbbbb2 CHEMICALIN eeeee2  efflux potential from macrophages but increases circulating GENEIN level, which could provide beneficial vascular effects.
CPR:9	We studied in a clinical trial whether isolated CHEMICALIN treatment in postmenopausal women could affect reverse CHEMICALNOTIN transport as evaluated by  bbbbb1 GENEIN eeeee1 - (GENEIN), dependent  bbbbb2 CHEMICALIN eeeee2  efflux from macrophages
CPR:9	We studied in a clinical trial whether isolated CHEMICALIN treatment in postmenopausal women could affect reverse CHEMICALNOTIN transport as evaluated by GENEIN- ( bbbbb1 GENEIN eeeee1 ), dependent  bbbbb2 CHEMICALIN eeeee2  efflux from macrophages
CPR:9	CHEMICALNOTIN-labeled J774 macrophage cells, with and without GENENOTIN up-regulation, were incubated with the samples, and  bbbbb1 GENEIN eeeee1 -dependent  bbbbb2 CHEMICALIN eeeee2  efflux and serum lipid and GENENOTIN levels were assessed
CPR:9	Thus, CHEMICALIN supplementation did not affect  bbbbb1 GENEIN eeeee1 -dependent  bbbbb2 CHEMICALIN eeeee2  efflux to serum
CPR:9	 bbbbb1 GENEIN eeeee1 -facilitated  bbbbb2 CHEMICALIN eeeee2  efflux and lipid parameters did not differ between CHEMICALNOTIN-producing and non-CHEMICALNOTIN-producing women
CPR:10	The  bbbbb1 CHEMICALIN eeeee1 -resistant  bbbbb2 GENEIN eeeee2 (GENEIN) mutant, associated with systemic mastocytosis, was found to be resistant to CHEMICALIN
CPR:10	The  bbbbb1 CHEMICALIN eeeee1 -resistant GENEIN( bbbbb2 GENEIN eeeee2 ) mutant, associated with systemic mastocytosis, was found to be resistant to CHEMICALIN
CPR:10	The CHEMICALIN-resistant  bbbbb1 GENEIN eeeee1 (GENEIN) mutant, associated with systemic mastocytosis, was found to be resistant to  bbbbb2 CHEMICALIN eeeee2 
CPR:10	The CHEMICALIN-resistant GENEIN( bbbbb1 GENEIN eeeee1 ) mutant, associated with systemic mastocytosis, was found to be resistant to  bbbbb2 CHEMICALIN eeeee2 
CPR:2	The direct effect of  bbbbb1 CHEMICALIN eeeee1  on the activity of these  bbbbb2 GENEIN eeeee2  and their downstream signaling was tested using CHEMICALNOTIN-specific antibodies
CPR:2	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN) is a small molecule GENEIN inhibitor that is used for the treatment of renal cell carcinoma, and has been shown to have activity against  bbbbb2 GENEIN eeeee2  from the GENEIN (GENEIN) and GENEIN (GENEIN) families
CPR:2	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN) is a small molecule GENEIN inhibitor that is used for the treatment of renal cell carcinoma, and has been shown to have activity against GENEIN from the  bbbbb2 GENEIN eeeee2  (GENEIN) and GENEIN (GENEIN) families
CPR:2	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN) is a small molecule GENEIN inhibitor that is used for the treatment of renal cell carcinoma, and has been shown to have activity against GENEIN from the GENEIN ( bbbbb2 GENEIN eeeee2 ) and GENEIN (GENEIN) families
CPR:2	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN) is a small molecule GENEIN inhibitor that is used for the treatment of renal cell carcinoma, and has been shown to have activity against GENEIN from the GENEIN (GENEIN) and  bbbbb2 GENEIN eeeee2  (GENEIN) families
CPR:2	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN) is a small molecule GENEIN inhibitor that is used for the treatment of renal cell carcinoma, and has been shown to have activity against GENEIN from the GENEIN (GENEIN) and GENEIN ( bbbbb2 GENEIN eeeee2 ) families
CPR:2	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN) is a small molecule GENEIN inhibitor that is used for the treatment of renal cell carcinoma, and has been shown to have activity against  bbbbb2 GENEIN eeeee2  from the GENEIN (GENEIN) and GENEIN (GENEIN) families
CPR:2	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN) is a small molecule GENEIN inhibitor that is used for the treatment of renal cell carcinoma, and has been shown to have activity against GENEIN from the  bbbbb2 GENEIN eeeee2  (GENEIN) and GENEIN (GENEIN) families
CPR:2	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN) is a small molecule GENEIN inhibitor that is used for the treatment of renal cell carcinoma, and has been shown to have activity against GENEIN from the GENEIN ( bbbbb2 GENEIN eeeee2 ) and GENEIN (GENEIN) families
CPR:2	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN) is a small molecule GENEIN inhibitor that is used for the treatment of renal cell carcinoma, and has been shown to have activity against GENEIN from the GENEIN (GENEIN) and  bbbbb2 GENEIN eeeee2  (GENEIN) families
CPR:2	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN) is a small molecule GENEIN inhibitor that is used for the treatment of renal cell carcinoma, and has been shown to have activity against GENEIN from the GENEIN (GENEIN) and GENEIN ( bbbbb2 GENEIN eeeee2 ) families
CPR:2	CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ) is a small molecule GENEIN inhibitor that is used for the treatment of renal cell carcinoma, and has been shown to have activity against  bbbbb2 GENEIN eeeee2  from the GENEIN (GENEIN) and GENEIN (GENEIN) families
CPR:2	CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ) is a small molecule GENEIN inhibitor that is used for the treatment of renal cell carcinoma, and has been shown to have activity against GENEIN from the  bbbbb2 GENEIN eeeee2  (GENEIN) and GENEIN (GENEIN) families
CPR:2	CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ) is a small molecule GENEIN inhibitor that is used for the treatment of renal cell carcinoma, and has been shown to have activity against GENEIN from the GENEIN ( bbbbb2 GENEIN eeeee2 ) and GENEIN (GENEIN) families
CPR:2	CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ) is a small molecule GENEIN inhibitor that is used for the treatment of renal cell carcinoma, and has been shown to have activity against GENEIN from the GENEIN (GENEIN) and  bbbbb2 GENEIN eeeee2  (GENEIN) families
CPR:2	CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ) is a small molecule GENEIN inhibitor that is used for the treatment of renal cell carcinoma, and has been shown to have activity against GENEIN from the GENEIN (GENEIN) and GENEIN ( bbbbb2 GENEIN eeeee2 ) families
CPR:4	We investigated the efficacy of  bbbbb1 CHEMICALIN eeeee1  at inhibiting mutants of the  bbbbb2 GENEIN eeeee2  GENEIN, GENEIN, and GENEIN, which are implicated in the pathogenesis of myeloid malignancies
CPR:4	We investigated the efficacy of  bbbbb1 CHEMICALIN eeeee1  at inhibiting mutants of the GENEIN  bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN, which are implicated in the pathogenesis of myeloid malignancies
CPR:4	We investigated the efficacy of  bbbbb1 CHEMICALIN eeeee1  at inhibiting mutants of the GENEIN GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN, which are implicated in the pathogenesis of myeloid malignancies
CPR:4	We investigated the efficacy of  bbbbb1 CHEMICALIN eeeee1  at inhibiting mutants of the GENEIN GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2 , which are implicated in the pathogenesis of myeloid malignancies
CPR:4	The ability of  bbbbb1 CHEMICALIN eeeee1  to inhibit oncogenic  bbbbb2 GENEIN eeeee2  and GENEIN mutants and overcome resistance to other small molecule inhibitors
CPR:4	The ability of  bbbbb1 CHEMICALIN eeeee1  to inhibit oncogenic GENEIN and  bbbbb2 GENEIN eeeee2  mutants and overcome resistance to other small molecule inhibitors
CPR:4	RESULTS: We show that  bbbbb1 CHEMICALIN eeeee1  is a potent inhibitor of  bbbbb2 GENEIN eeeee2 -GENEIN and GENEIN mutants, including some of the mutants that confer resistance to PKC412 and other GENEIN inhibitors
CPR:4	RESULTS: We show that  bbbbb1 CHEMICALIN eeeee1  is a potent inhibitor of GENEIN- bbbbb2 GENEIN eeeee2  and GENEIN mutants, including some of the mutants that confer resistance to PKC412 and other GENEIN inhibitors
CPR:4	RESULTS: We show that  bbbbb1 CHEMICALIN eeeee1  is a potent inhibitor of GENEIN-GENEIN and  bbbbb2 GENEIN eeeee2  mutants, including some of the mutants that confer resistance to PKC412 and other GENEIN inhibitors
CPR:4	RESULTS: We show that  bbbbb1 CHEMICALIN eeeee1  is a potent inhibitor of GENEIN-GENEIN and GENEIN mutants, including some of the mutants that confer resistance to PKC412 and other  bbbbb2 GENEIN eeeee2  inhibitors
CPR:4	 bbbbb1 CHEMICALIN eeeee1  induced a cell cycle block and apoptosis in the acute myeloid leukemia cell lines MV4-11 and MOLM-13, both expressing  bbbbb2 GENEIN eeeee2  with an internal tandem duplication, whereas no effect was observed on four other acute myeloid leukemia cell lines
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN) is a small molecule  bbbbb2 GENEIN eeeee2  inhibitor that is used for the treatment of renal cell carcinoma, and has been shown to have activity against GENEIN from the GENEIN (GENEIN) and GENEIN (GENEIN) families
CPR:4	INTERPRETATION AND CONCLUSIONS: These results warrant further clinical studies of  bbbbb1 CHEMICALIN eeeee1  for the treatment of myeloid malignancies expressing activated forms of  bbbbb2 GENEIN eeeee2  and GENEIN.
CPR:4	INTERPRETATION AND CONCLUSIONS: These results warrant further clinical studies of  bbbbb1 CHEMICALIN eeeee1  for the treatment of myeloid malignancies expressing activated forms of GENEIN and  bbbbb2 GENEIN eeeee2 .
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN) is a small molecule  bbbbb2 GENEIN eeeee2  inhibitor that is used for the treatment of renal cell carcinoma, and has been shown to have activity against GENEIN from the GENEIN (GENEIN) and GENEIN (GENEIN) families
CPR:4	CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ) is a small molecule  bbbbb2 GENEIN eeeee2  inhibitor that is used for the treatment of renal cell carcinoma, and has been shown to have activity against GENEIN from the GENEIN (GENEIN) and GENEIN (GENEIN) families
CPR:2	 bbbbb1 GENEIN eeeee1  expression and activity could account for the low  bbbbb2 CHEMICALIN eeeee2  concentration that is typical of milk.
CPR:2	We conclude that  bbbbb1 CHEMICALIN eeeee1  movement across mammary epithelia is modulated by corticosteroids via a  bbbbb2 GENEIN eeeee2 -mediated mechanism that regulates the expression of the GENENOTIN
CPR:2	 bbbbb1 GENEIN eeeee1  expression and activity could account for the low  bbbbb2 CHEMICALIN eeeee2  concentration that is typical of milk.
CPR:6	Exposure to  bbbbb1 CHEMICALIN eeeee1  (a  bbbbb2 GENEIN eeeee2  antagonist), but not CHEMICALIN (a GENEIN antagonist), precluded both the corticosteroid-induced elevation in CHEMICALNOTIN-sensitive I(sc) and the induced changes in GENENOTIN mRNA
CPR:6	Exposure to CHEMICALIN (a GENEIN antagonist), but not  bbbbb1 CHEMICALIN eeeee1  (a  bbbbb2 GENEIN eeeee2  antagonist), precluded both the corticosteroid-induced elevation in CHEMICALNOTIN-sensitive I(sc) and the induced changes in GENENOTIN mRNA
CPR:4	All three  bbbbb1 CHEMICALIN eeeee1  inhibited the diabetes-induced translocation of  bbbbb2 GENEIN eeeee2  (a subunit of GENEIN) into nuclei of retinal vascular endothelial cells of the isolated retinal vasculature, as well as of GENEIN and GENEIN into nuclei of cells in the ganglion cell layer and inner nuclear layer on whole-retinal sections
CPR:4	All three  bbbbb1 CHEMICALIN eeeee1  inhibited the diabetes-induced translocation of GENEIN (a subunit of GENEIN) into nuclei of retinal vascular endothelial cells of the isolated retinal vasculature, as well as of  bbbbb2 GENEIN eeeee2  and GENEIN into nuclei of cells in the ganglion cell layer and inner nuclear layer on whole-retinal sections
CPR:4	All three  bbbbb1 CHEMICALIN eeeee1  inhibited the diabetes-induced translocation of GENEIN (a subunit of GENEIN) into nuclei of retinal vascular endothelial cells of the isolated retinal vasculature, as well as of GENEIN and  bbbbb2 GENEIN eeeee2  into nuclei of cells in the ganglion cell layer and inner nuclear layer on whole-retinal sections
CPR:4	Oral  bbbbb1 CHEMICALIN eeeee1  (as a representative of the CHEMICALIN family) inhibited diabetes-induced increase in  bbbbb2 GENEIN eeeee2  DNA-binding affinity in electrophoretic mobility shift assay and transcription factor array in nuclear extract isolated from whole retina
CPR:4	Oral CHEMICALIN (as a representative of the  bbbbb1 CHEMICALIN eeeee1  family) inhibited diabetes-induced increase in  bbbbb2 GENEIN eeeee2  DNA-binding affinity in electrophoretic mobility shift assay and transcription factor array in nuclear extract isolated from whole retina
CPR:4	All three  bbbbb1 CHEMICALIN eeeee1  inhibited the diabetes-induced translocation of GENEIN (a subunit of  bbbbb2 GENEIN eeeee2 ) into nuclei of retinal vascular endothelial cells of the isolated retinal vasculature, as well as of GENEIN and GENEIN into nuclei of cells in the ganglion cell layer and inner nuclear layer on whole-retinal sections
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (also as a representative of the CHEMICALIN) inhibited the diabetes-induced upregulation of several inflammatory gene products, which are regulated by  bbbbb2 GENEIN eeeee2 , including vascular cell adhesion molecule, GENEIN, GENEIN, and GENEIN in whole-retinal lysate
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (also as a representative of the CHEMICALIN) inhibited the diabetes-induced upregulation of several inflammatory gene products, which are regulated by GENEIN, including vascular cell adhesion molecule,  bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN in whole-retinal lysate
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (also as a representative of the CHEMICALIN) inhibited the diabetes-induced upregulation of several inflammatory gene products, which are regulated by GENEIN, including vascular cell adhesion molecule, GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN in whole-retinal lysate
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (also as a representative of the CHEMICALIN) inhibited the diabetes-induced upregulation of several inflammatory gene products, which are regulated by GENEIN, including vascular cell adhesion molecule, GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2  in whole-retinal lysate
CPR:4	CHEMICALIN (also as a representative of the  bbbbb1 CHEMICALIN eeeee1 ) inhibited the diabetes-induced upregulation of several inflammatory gene products, which are regulated by  bbbbb2 GENEIN eeeee2 , including vascular cell adhesion molecule, GENEIN, GENEIN, and GENEIN in whole-retinal lysate
CPR:4	 bbbbb1 CHEMICALIN eeeee1 , in doses administrated in our experiments, inhibited  bbbbb2 GENEIN eeeee2 B and perhaps other transcription factors in the retina, were well tolerated, and offered new tools to investigate and inhibit the development of diabetic retinopathy.
CPR:2	We have named this activity GENENOTIN to distinguish it from the  bbbbb1 CHEMICALIN eeeee1 -dependent  bbbbb2 GENEIN eeeee2 
CPR:2	These results demonstrate the presence of a GENENOTIN activity separate from the  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN)-dependent  bbbbb2 GENEIN eeeee2  recently purified and cloned from rat liver
CPR:2	These results demonstrate the presence of a GENENOTIN activity separate from the CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 )-dependent  bbbbb2 GENEIN eeeee2  recently purified and cloned from rat liver
CPR:10	 bbbbb1 CHEMICALIN eeeee1  affected mainly the GENEIN transport rate by reducing the availability of the transporter in the membrane with no significant alteration of either the total  bbbbb2 GENEIN eeeee2  protein content or the GENEIN mRNA level
CPR:10	 bbbbb1 CHEMICALIN eeeee1  affected mainly the GENEIN transport rate by reducing the availability of the transporter in the membrane with no significant alteration of either the total GENEIN protein content or the  bbbbb2 GENEIN eeeee2  mRNA level
CPR:10	These results suggest that the effect of  bbbbb1 CHEMICALIN eeeee1  on the expression of GENEIN is post-translational and has shown itself to be independent of  bbbbb2 GENEIN eeeee2  and GENEIN activity
CPR:10	These results suggest that the effect of  bbbbb1 CHEMICALIN eeeee1  on the expression of GENEIN is post-translational and has shown itself to be independent of GENEIN and  bbbbb2 GENEIN eeeee2  activity
CPR:2	These results suggest that the effect of  bbbbb1 CHEMICALIN eeeee1  on the expression of  bbbbb2 GENEIN eeeee2  is post-translational and has shown itself to be independent of GENEIN and GENEIN activity
CPR:2	 bbbbb1 CHEMICALIN eeeee1  affected mainly the  bbbbb2 GENEIN eeeee2  transport rate by reducing the availability of the transporter in the membrane with no significant alteration of either the total GENEIN protein content or the GENEIN mRNA level
CPR:2	Collectively then, these results indicate that  bbbbb1 GENEIN eeeee1  contributes to the regulation of lymphocytic cholinergic activity via GENEIN-mediated pathways and suggest that  bbbbb2 CHEMICALIN eeeee2  exerts its immunosuppressive effects in part via modification of lymphocytic cholinergic activity.
CPR:2	Collectively then, these results indicate that GENEIN contributes to the regulation of lymphocytic cholinergic activity via  bbbbb1 GENEIN eeeee1 -mediated pathways and suggest that  bbbbb2 CHEMICALIN eeeee2  exerts its immunosuppressive effects in part via modification of lymphocytic cholinergic activity.
CPR:3	In addition, activation of GENENOTIN and increases in intracellular  bbbbb1 CHEMICALIN eeeee1  also enhance cholinergic activity in T cells, and  bbbbb2 GENEIN eeeee2  (GENEIN; GENEIN/GENEIN) is an important mediator of leukocyte migration and T cell activation
CPR:3	In addition, activation of GENENOTIN and increases in intracellular  bbbbb1 CHEMICALIN eeeee1  also enhance cholinergic activity in T cells, and GENEIN ( bbbbb2 GENEIN eeeee2 ; GENEIN/GENEIN) is an important mediator of leukocyte migration and T cell activation
CPR:3	In addition, activation of GENENOTIN and increases in intracellular  bbbbb1 CHEMICALIN eeeee1  also enhance cholinergic activity in T cells, and GENEIN (GENEIN;  bbbbb2 GENEIN eeeee2 /GENEIN) is an important mediator of leukocyte migration and T cell activation
CPR:3	In addition, activation of GENENOTIN and increases in intracellular  bbbbb1 CHEMICALIN eeeee1  also enhance cholinergic activity in T cells, and GENEIN (GENEIN; GENEIN/ bbbbb2 GENEIN eeeee2 ) is an important mediator of leukocyte migration and T cell activation
CPR:4	We found that  bbbbb1 CHEMICALIN eeeee1  abolishes anti- bbbbb2 GENEIN eeeee2  mAb-induced increases in lymphocytic cholinergic activity in a manner independent of its CHEMICALNOTIN-lowering activity
CPR:9	Lymphocytes possess the essential components of a cholinergic system, including CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 );  bbbbb2 GENEIN eeeee2  (GENEIN), its synthesizing enzyme; and both GENENOTIN (GENENOTIN and GENENOTIN, respectively)
CPR:9	Lymphocytes possess the essential components of a cholinergic system, including CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ); GENEIN ( bbbbb2 GENEIN eeeee2 ), its synthesizing enzyme; and both GENENOTIN (GENENOTIN and GENENOTIN, respectively)
CPR:9	Lymphocytes possess the essential components of a cholinergic system, including  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN);  bbbbb2 GENEIN eeeee2  (GENEIN), its synthesizing enzyme; and both GENENOTIN (GENENOTIN and GENENOTIN, respectively)
CPR:9	Lymphocytes possess the essential components of a cholinergic system, including  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN); GENEIN ( bbbbb2 GENEIN eeeee2 ), its synthesizing enzyme; and both GENENOTIN (GENENOTIN and GENENOTIN, respectively)
CPR:2	In addition, BALB/c and C57BL/6 females were treated with  bbbbb1 CHEMICALIN eeeee1  or CHEMICALIN for 1 or 2 months, and mammary glands were excised for histologic studies and for immunohistochemical and Western blot evaluation of  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:2	In addition, BALB/c and C57BL/6 females were treated with  bbbbb1 CHEMICALIN eeeee1  or CHEMICALIN for 1 or 2 months, and mammary glands were excised for histologic studies and for immunohistochemical and Western blot evaluation of GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:2	In addition, BALB/c and C57BL/6 females were treated with CHEMICALIN or  bbbbb1 CHEMICALIN eeeee1  for 1 or 2 months, and mammary glands were excised for histologic studies and for immunohistochemical and Western blot evaluation of  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:2	In addition, BALB/c and C57BL/6 females were treated with CHEMICALIN or  bbbbb1 CHEMICALIN eeeee1  for 1 or 2 months, and mammary glands were excised for histologic studies and for immunohistochemical and Western blot evaluation of GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:2	INTRODUCTION: CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) induces GENEIN (GENEIN)-positive and  bbbbb2 GENEIN eeeee2  (GENEIN)-positive ductal invasive mammary carcinomas in BALB/c mice
CPR:3	 bbbbb1 GENEIN eeeee1  levels were low in virgin control mice and increased after  bbbbb2 CHEMICALIN eeeee2  treatment in both strains
CPR:3	INTRODUCTION: CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) induces GENEIN (GENEIN)-positive and GENEIN ( bbbbb2 GENEIN eeeee2 )-positive ductal invasive mammary carcinomas in BALB/c mice
CPR:3	INTRODUCTION: CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) induces  bbbbb2 GENEIN eeeee2  (GENEIN)-positive and GENEIN (GENEIN)-positive ductal invasive mammary carcinomas in BALB/c mice
CPR:3	INTRODUCTION: CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) induces GENEIN ( bbbbb2 GENEIN eeeee2 )-positive and GENEIN (GENEIN)-positive ductal invasive mammary carcinomas in BALB/c mice
CPR:3	INTRODUCTION:  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) induces GENEIN (GENEIN)-positive and GENEIN ( bbbbb2 GENEIN eeeee2 )-positive ductal invasive mammary carcinomas in BALB/c mice
CPR:3	INTRODUCTION:  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) induces  bbbbb2 GENEIN eeeee2  (GENEIN)-positive and GENEIN (GENEIN)-positive ductal invasive mammary carcinomas in BALB/c mice
CPR:3	INTRODUCTION:  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) induces GENEIN ( bbbbb2 GENEIN eeeee2 )-positive and GENEIN (GENEIN)-positive ductal invasive mammary carcinomas in BALB/c mice
CPR:3	INTRODUCTION:  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) induces GENEIN (GENEIN)-positive and  bbbbb2 GENEIN eeeee2  (GENEIN)-positive ductal invasive mammary carcinomas in BALB/c mice
CPR:4	The expression of  bbbbb1 GENEIN eeeee1  and GENEIN in virgin mice was surprisingly much higher in BALB/c than in C57BL/6 mammary glands, and both receptors were downregulated in  bbbbb2 CHEMICALIN eeeee2 -treated BALB/c mice (P < 0.05)
CPR:4	The expression of GENEIN and  bbbbb1 GENEIN eeeee1  in virgin mice was surprisingly much higher in BALB/c than in C57BL/6 mammary glands, and both receptors were downregulated in  bbbbb2 CHEMICALIN eeeee2 -treated BALB/c mice (P < 0.05)
CPR:2	Several genes involved with  bbbbb1 CHEMICALIN eeeee1  metabolism also showed remarkable expression changes, including increased expression of  bbbbb2 GENEIN eeeee2  (GENEIN; involved in CHEMICALIN production) and decreased expression of GENEIN (involved in CHEMICALIN production)
CPR:2	Several genes involved with  bbbbb1 CHEMICALIN eeeee1  metabolism also showed remarkable expression changes, including increased expression of GENEIN (GENEIN; involved in CHEMICALIN production) and decreased expression of  bbbbb2 GENEIN eeeee2  (involved in CHEMICALIN production)
CPR:3	Various genes controlled by  bbbbb1 CHEMICALIN eeeee1 , including  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN, GENEIN, GENEIN, and GENEIN, were dramatically over-expressed
CPR:3	Various genes controlled by  bbbbb1 CHEMICALIN eeeee1 , including GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN, GENEIN, and GENEIN, were dramatically over-expressed
CPR:3	Various genes controlled by  bbbbb1 CHEMICALIN eeeee1 , including GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN, and GENEIN, were dramatically over-expressed
CPR:3	Various genes controlled by  bbbbb1 CHEMICALIN eeeee1 , including GENEIN, GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN, were dramatically over-expressed
CPR:3	Various genes controlled by  bbbbb1 CHEMICALIN eeeee1 , including GENEIN, GENEIN, GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN, were dramatically over-expressed
CPR:3	Various genes controlled by  bbbbb1 CHEMICALIN eeeee1 , including GENEIN, GENEIN, GENEIN, GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2 , were dramatically over-expressed
CPR:3	 bbbbb1 CHEMICALIN eeeee1 -regulated genes including GENEIN and  bbbbb2 GENEIN eeeee2  were over-expressed, although GENEIN was suppressed
CPR:3	 bbbbb1 CHEMICALIN eeeee1 -regulated genes including  bbbbb2 GENEIN eeeee2  and GENEIN were over-expressed, although GENEIN was suppressed
CPR:4	 bbbbb1 CHEMICALIN eeeee1 -regulated genes including GENEIN and GENEIN were over-expressed, although  bbbbb2 GENEIN eeeee2  was suppressed
CPR:9	Several genes involved with CHEMICALIN metabolism also showed remarkable expression changes, including increased expression of  bbbbb1 GENEIN eeeee1  (GENEIN; involved in  bbbbb2 CHEMICALIN eeeee2  production) and decreased expression of GENEIN (involved in CHEMICALIN production)
CPR:9	Several genes involved with CHEMICALIN metabolism also showed remarkable expression changes, including increased expression of GENEIN ( bbbbb1 GENEIN eeeee1 ; involved in  bbbbb2 CHEMICALIN eeeee2  production) and decreased expression of GENEIN (involved in CHEMICALIN production)
CPR:9	Several genes involved with CHEMICALIN metabolism also showed remarkable expression changes, including increased expression of GENEIN (GENEIN; involved in CHEMICALIN production) and decreased expression of  bbbbb1 GENEIN eeeee1  (involved in  bbbbb2 CHEMICALIN eeeee2  production)
CPR:9	The expression of key genes important in  bbbbb1 CHEMICALIN eeeee1  metabolism, such as  bbbbb2 GENEIN eeeee2 , GENEIN and GENEIN, were suppressed
CPR:9	The expression of key genes important in  bbbbb1 CHEMICALIN eeeee1  metabolism, such as GENEIN,  bbbbb2 GENEIN eeeee2  and GENEIN, were suppressed
CPR:9	The expression of key genes important in  bbbbb1 CHEMICALIN eeeee1  metabolism, such as GENEIN, GENEIN and  bbbbb2 GENEIN eeeee2 , were suppressed
CPR:2	 bbbbb1 CHEMICALIN eeeee1  crystals stimulate monocytes and macrophages to release GENEIN through the  bbbbb2 GENEIN eeeee2  component of the inflammasome
CPR:3	 bbbbb1 CHEMICALIN eeeee1  crystals stimulate monocytes and macrophages to release  bbbbb2 GENEIN eeeee2  through the GENEIN component of the inflammasome
CPR:1	Our structural studies provide a view of a synthetic inhibitory compound in a  bbbbb1 GENEIN eeeee1  active site revealing that CHEMICALIN binds into the  bbbbb2 CHEMICALIN eeeee2 , the product, and the substrate-binding site
CPR:2	We identified  bbbbb1 CHEMICALIN eeeee1  as a compound that binds to  bbbbb2 GENEIN eeeee2  and showed that it inhibits GENEIN activity with an IC(50) value of 22 microM
CPR:2	To provide insights into how sirtuin function is altered by inhibitors, we determined two crystal structures of  bbbbb1 GENEIN eeeee1 , one in complex with  bbbbb2 CHEMICALIN eeeee2 -ribose, the other bound to CHEMICALIN
CPR:2	To provide insights into how sirtuin function is altered by inhibitors, we determined two crystal structures of  bbbbb1 GENEIN eeeee1 , one in complex with CHEMICALIN-ribose, the other bound to  bbbbb2 CHEMICALIN eeeee2 
CPR:2	Our structural studies provide a view of a synthetic inhibitory compound in a  bbbbb1 GENEIN eeeee1  active site revealing that  bbbbb2 CHEMICALIN eeeee2  binds into the CHEMICALIN, the product, and the substrate-binding site
CPR:4	We identified  bbbbb1 CHEMICALIN eeeee1  as a compound that binds to GENEIN and showed that it inhibits  bbbbb2 GENEIN eeeee2  activity with an IC(50) value of 22 microM
CPR:4	Structural basis of inhibition of the  bbbbb1 GENEIN eeeee1  by  bbbbb2 CHEMICALIN eeeee2 
CPR:9	In humans,  bbbbb1 GENEIN eeeee1  deficiency results in the accumulation of  bbbbb2 CHEMICALIN eeeee2  at the expense of CHEMICALNOTIN derivatives required for CHEMICALNOTIN and CHEMICALNOTIN biosynthesis
CPR:3	In summary,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN increase  bbbbb2 GENEIN eeeee2  activity and phosphorylation in the isolated heart
CPR:3	In summary, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  increase  bbbbb2 GENEIN eeeee2  activity and phosphorylation in the isolated heart
CPR:3	Cytosolic [CHEMICALNOTIN] reported metabolically active  bbbbb1 CHEMICALIN eeeee1 , which triggered increased  bbbbb2 GENEIN eeeee2  activity, but measures of total CHEMICALNOTIN did not.
CPR:3	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, which are CHEMICALIN, have been reported to increase  bbbbb2 GENEIN eeeee2  activity without increasing CHEMICALNOTIN/CHEMICALNOTIN
CPR:3	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , which are CHEMICALIN, have been reported to increase  bbbbb2 GENEIN eeeee2  activity without increasing CHEMICALNOTIN/CHEMICALNOTIN
CPR:3	CHEMICALIN and CHEMICALIN, which are  bbbbb1 CHEMICALIN eeeee1 , have been reported to increase  bbbbb2 GENEIN eeeee2  activity without increasing CHEMICALNOTIN/CHEMICALNOTIN
CPR:3	In hearts treated with  bbbbb1 CHEMICALIN eeeee1  for 18 min and then perfused for 20 min with Krebs-Henseleit buffer, [CHEMICALNOTIN] began to increase at 26 min and  bbbbb2 GENEIN eeeee2  activity was elevated at 36 min
CPR:3	In hearts treated with  bbbbb1 CHEMICALIN eeeee1 , [CHEMICALNOTIN] was increased at 50 min and  bbbbb2 GENEIN eeeee2  activity, phosphorylated GENEIN, and GENEIN were elevated at 61 min
CPR:3	In hearts treated with  bbbbb1 CHEMICALIN eeeee1 , [CHEMICALNOTIN] was increased at 50 min and GENEIN activity, phosphorylated  bbbbb2 GENEIN eeeee2 , and GENEIN were elevated at 61 min
CPR:3	In hearts treated with  bbbbb1 CHEMICALIN eeeee1 , [CHEMICALNOTIN] was increased at 50 min and GENEIN activity, phosphorylated GENEIN, and  bbbbb2 GENEIN eeeee2  were elevated at 61 min
CPR:3	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN activate  bbbbb2 GENEIN eeeee2  in the heart by increasing cytosolic CHEMICALNOTIN concentration
CPR:3	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  activate  bbbbb2 GENEIN eeeee2  in the heart by increasing cytosolic CHEMICALNOTIN concentration
CPR:2	Characterization of  bbbbb1 GENEIN eeeee1  receptors in rat spinal cord via  bbbbb2 CHEMICALIN eeeee2  binding and inhibition of CHEMICALNOTIN release
CPR:2	It is currently not known how much this  bbbbb1 GENEIN eeeee1  antagonism of CHEMICALIN contributes to the therapeutic or adverse side effects of  bbbbb2 CHEMICALIN eeeee2 
CPR:2	 bbbbb1 GENEIN eeeee1  involvement in prepulse inhibition and memory function: relevance for the antipsychotic actions of  bbbbb2 CHEMICALIN eeeee2 
CPR:3	In the current project, we found that the selective  bbbbb1 GENEIN eeeee1  antagonist CHEMICALIN also reversed the  bbbbb2 CHEMICALIN eeeee2 -induced impairment in PPI of tactile startle with an auditory prepulse
CPR:4	In summary, the therapeutic effect of  bbbbb1 CHEMICALIN eeeee1  in reversing PPI impairment was mimicked by the  bbbbb2 GENEIN eeeee2  antagonist CHEMICALIN, while CHEMICALIN had a mixed effect on cognition
CPR:4	 bbbbb1 GENEIN eeeee1  blockade is one of the more prominent actions of the multi-receptor acting antipsychotic  bbbbb2 CHEMICALIN eeeee2 
CPR:6	Thus,  bbbbb1 GENEIN eeeee1  antagonism seems to play a role in part of the beneficial actions of antipsychotics, such as  bbbbb2 CHEMICALIN eeeee2 .
CPR:6	It is currently not known how much this  bbbbb1 GENEIN eeeee1  antagonism of  bbbbb2 CHEMICALIN eeeee2  contributes to the therapeutic or adverse side effects of CHEMICALIN
CPR:6	In the current project, we found that the selective  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2  also reversed the CHEMICALIN-induced impairment in PPI of tactile startle with an auditory prepulse
CPR:6	In summary, the therapeutic effect of CHEMICALIN in reversing PPI impairment was mimicked by the  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2 , while CHEMICALIN had a mixed effect on cognition
CPR:6	In summary, the therapeutic effect of CHEMICALIN in reversing PPI impairment was mimicked by the  bbbbb1 GENEIN eeeee1  antagonist CHEMICALIN, while  bbbbb2 CHEMICALIN eeeee2  had a mixed effect on cognition
CPR:10	The mRNA expression of  bbbbb1 GENEIN eeeee1  (GENEIN) and GENEIN (GENEIN) was not reduced by  bbbbb2 CHEMICALIN eeeee2 
CPR:10	The mRNA expression of GENEIN ( bbbbb1 GENEIN eeeee1 ) and GENEIN (GENEIN) was not reduced by  bbbbb2 CHEMICALIN eeeee2 
CPR:10	The mRNA expression of GENEIN (GENEIN) and  bbbbb1 GENEIN eeeee1  (GENEIN) was not reduced by  bbbbb2 CHEMICALIN eeeee2 
CPR:10	The mRNA expression of GENEIN (GENEIN) and GENEIN ( bbbbb1 GENEIN eeeee1 ) was not reduced by  bbbbb2 CHEMICALIN eeeee2 
CPR:10	Similarly, the  bbbbb1 GENEIN eeeee1  enzyme level did not change after  bbbbb2 CHEMICALIN eeeee2  exposure but GENENOTIN could not be probed with the antibody available currently
CPR:9	Furthermore, the enzymatic activity of  bbbbb1 GENEIN eeeee1  (GENEIN), which converts the critical gluconeogenic CHEMICALIN CHEMICALIN into  bbbbb2 CHEMICALIN eeeee2 , is decreased (approximately 50%) in GENENOTIN-/- hepatocytes
CPR:9	Furthermore, the enzymatic activity of GENEIN ( bbbbb1 GENEIN eeeee1 ), which converts the critical gluconeogenic CHEMICALIN CHEMICALIN into  bbbbb2 CHEMICALIN eeeee2 , is decreased (approximately 50%) in GENENOTIN-/- hepatocytes
CPR:9	Furthermore, the enzymatic activity of  bbbbb1 GENEIN eeeee1  (GENEIN), which converts the critical gluconeogenic  bbbbb2 CHEMICALIN eeeee2  CHEMICALIN into CHEMICALIN, is decreased (approximately 50%) in GENENOTIN-/- hepatocytes
CPR:9	Furthermore, the enzymatic activity of GENEIN ( bbbbb1 GENEIN eeeee1 ), which converts the critical gluconeogenic  bbbbb2 CHEMICALIN eeeee2  CHEMICALIN into CHEMICALIN, is decreased (approximately 50%) in GENENOTIN-/- hepatocytes
CPR:9	Furthermore, the enzymatic activity of  bbbbb1 GENEIN eeeee1  (GENEIN), which converts the critical gluconeogenic CHEMICALIN  bbbbb2 CHEMICALIN eeeee2  into CHEMICALIN, is decreased (approximately 50%) in GENENOTIN-/- hepatocytes
CPR:9	Furthermore, the enzymatic activity of GENEIN ( bbbbb1 GENEIN eeeee1 ), which converts the critical gluconeogenic CHEMICALIN  bbbbb2 CHEMICALIN eeeee2  into CHEMICALIN, is decreased (approximately 50%) in GENENOTIN-/- hepatocytes
CPR:10	GENENOTIN and high CHEMICALIN increased GENEIN mRNA expression ( approximately 8-fold) and maximal transport velocity (V(max)),  bbbbb1 CHEMICALIN eeeee1  formation from CHEMICALIN (index of CHEMICALIN synthesis) and GENEIN (GENEIN) protein abundance, but did not alter  bbbbb2 GENEIN eeeee2  phosphorylation
CPR:10	GENENOTIN and high CHEMICALIN increased GENEIN mRNA expression ( approximately 8-fold) and maximal transport velocity (V(max)), CHEMICALIN formation from  bbbbb1 CHEMICALIN eeeee1  (index of CHEMICALIN synthesis) and GENEIN (GENEIN) protein abundance, but did not alter  bbbbb2 GENEIN eeeee2  phosphorylation
CPR:2	 bbbbb1 CHEMICALIN eeeee1  stimulation of CHEMICALNOTIN transport and CHEMICALNOTIN synthesis results from activation of GENENOTIN and GENEIN requiring functional  bbbbb2 GENEIN eeeee2  in human umbilical vein endothelium
CPR:2	High  bbbbb1 CHEMICALIN eeeee1  increases CHEMICALNOTIN transport and GENEIN expression following GENEIN activation by  bbbbb2 GENEIN eeeee2  involving GENENOTIN(GENENOTIN) and GENEIN in HUVEC
CPR:2	We studied whether  bbbbb1 CHEMICALIN eeeee1 -stimulation of CHEMICALNOTIN transport and CHEMICALNOTIN synthesis involves  bbbbb2 GENEIN eeeee2  in primary cultures of HUVEC
CPR:3	GENENOTIN and high  bbbbb1 CHEMICALIN eeeee1  increased GENENOTIN(GENENOTIN) and  bbbbb2 GENEIN eeeee2  phosphorylation, an effect blocked by CHEMICALIN (GENENOTIN inhibitor)
CPR:3	 bbbbb1 CHEMICALIN eeeee1  stimulation of CHEMICALNOTIN transport and CHEMICALNOTIN synthesis results from activation of GENENOTIN and  bbbbb2 GENEIN eeeee2  requiring functional GENEIN in human umbilical vein endothelium
CPR:3	High  bbbbb1 CHEMICALIN eeeee1  increases CHEMICALNOTIN transport and GENEIN expression following  bbbbb2 GENEIN eeeee2  activation by GENEIN involving GENENOTIN(GENENOTIN) and GENEIN in HUVEC
CPR:3	High  bbbbb1 CHEMICALIN eeeee1  increases CHEMICALNOTIN transport and GENEIN expression following GENEIN activation by GENEIN involving GENENOTIN(GENENOTIN) and  bbbbb2 GENEIN eeeee2  in HUVEC
CPR:3	 bbbbb1 GENEIN eeeee1  release was higher ( approximately 1.6-fold) in 25 mM (high) compared with 5 mM (normal)  bbbbb2 CHEMICALIN eeeee2 
CPR:3	GENENOTIN and high  bbbbb1 CHEMICALIN eeeee1  increased  bbbbb2 GENEIN eeeee2  mRNA expression ( approximately 8-fold) and maximal transport velocity (V(max)), CHEMICALIN formation from CHEMICALIN (index of CHEMICALIN synthesis) and GENEIN (GENEIN) protein abundance, but did not alter GENEIN phosphorylation
CPR:3	High  bbbbb1 CHEMICALIN eeeee1  increases CHEMICALNOTIN transport and  bbbbb2 GENEIN eeeee2  expression following GENEIN activation by GENEIN involving GENENOTIN(GENENOTIN) and GENEIN in HUVEC
CPR:3	Elevated extracellular  bbbbb1 CHEMICALIN eeeee1  increases  bbbbb2 GENEIN eeeee2  (GENEIN) release from human umbilical vein endothelium (HUVEC)
CPR:3	Elevated extracellular  bbbbb1 CHEMICALIN eeeee1  increases GENEIN ( bbbbb2 GENEIN eeeee2 ) release from human umbilical vein endothelium (HUVEC)
CPR:4	GENENOTIN and high CHEMICALIN increased GENENOTIN(GENENOTIN) and  bbbbb1 GENEIN eeeee1  phosphorylation, an effect blocked by  bbbbb2 CHEMICALIN eeeee2  (GENENOTIN inhibitor)
CPR:9	GENENOTIN and high CHEMICALIN increased GENEIN mRNA expression ( approximately 8-fold) and maximal transport velocity (V(max)), CHEMICALIN formation from CHEMICALIN (index of  bbbbb1 CHEMICALIN eeeee1  synthesis) and  bbbbb2 GENEIN eeeee2  (GENEIN) protein abundance, but did not alter GENEIN phosphorylation
CPR:9	GENENOTIN and high CHEMICALIN increased GENEIN mRNA expression ( approximately 8-fold) and maximal transport velocity (V(max)), CHEMICALIN formation from CHEMICALIN (index of  bbbbb1 CHEMICALIN eeeee1  synthesis) and GENEIN ( bbbbb2 GENEIN eeeee2 ) protein abundance, but did not alter GENEIN phosphorylation
CPR:2	We demonstrate that only treatment of HaCaT with CHEMICALIN and CHEMICALIN or a  bbbbb1 GENEIN eeeee1  ligand ( bbbbb2 CHEMICALIN eeeee2 ), induced GENEIN expression (protein and mRNA)
CPR:2	The inhibitory effects of  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN (GENEIN antagonists), on  bbbbb2 GENEIN eeeee2  expression and on stimulation of GENEIN activity by CHEMICALIN and CHEMICALIN suggest that GENENOTIN is implicated in GENENOTIN induction
CPR:2	The inhibitory effects of  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN (GENEIN antagonists), on GENEIN expression and on stimulation of  bbbbb2 GENEIN eeeee2  activity by CHEMICALIN and CHEMICALIN suggest that GENENOTIN is implicated in GENENOTIN induction
CPR:2	The inhibitory effects of CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  (GENEIN antagonists), on  bbbbb2 GENEIN eeeee2  expression and on stimulation of GENEIN activity by CHEMICALIN and CHEMICALIN suggest that GENENOTIN is implicated in GENENOTIN induction
CPR:2	The inhibitory effects of CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  (GENEIN antagonists), on GENEIN expression and on stimulation of  bbbbb2 GENEIN eeeee2  activity by CHEMICALIN and CHEMICALIN suggest that GENENOTIN is implicated in GENENOTIN induction
CPR:2	The inhibitory effects of CHEMICALIN and CHEMICALIN (GENEIN antagonists), on GENEIN expression and on stimulation of  bbbbb1 GENEIN eeeee1  activity by  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN suggest that GENENOTIN is implicated in GENENOTIN induction
CPR:2	The inhibitory effects of CHEMICALIN and CHEMICALIN (GENEIN antagonists), on GENEIN expression and on stimulation of  bbbbb1 GENEIN eeeee1  activity by CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  suggest that GENENOTIN is implicated in GENENOTIN induction
CPR:2	Finally, GENEIN inhibitor methyl CHEMICALIN blocked the  bbbbb1 CHEMICALIN eeeee1  effects on  bbbbb2 GENEIN eeeee2  induction, promoter activity and CHEMICALNOTIN mobilization suggesting involvement of CHEMICALIN metabolites in GENEIN activation
CPR:3	Moreover stimulation of  bbbbb1 GENEIN eeeee1  activity was increased by those  bbbbb2 CHEMICALIN eeeee2  or CHEMICALIN
CPR:3	Moreover stimulation of  bbbbb1 GENEIN eeeee1  activity was increased by those CHEMICALIN or  bbbbb2 CHEMICALIN eeeee2 
CPR:3	 bbbbb1 CHEMICALIN eeeee1  induce the expression of GENEIN via  bbbbb2 GENEIN eeeee2  activation in human keratinocyte HaCaT cells
CPR:3	Finally, GENEIN inhibitor methyl CHEMICALIN blocked the CHEMICALIN effects on GENEIN induction, promoter activity and CHEMICALNOTIN mobilization suggesting involvement of  bbbbb1 CHEMICALIN eeeee1  metabolites in  bbbbb2 GENEIN eeeee2  activation
CPR:3	These findings demonstrate that  bbbbb1 CHEMICALIN eeeee1  increased  bbbbb2 GENEIN eeeee2  activity is necessary for the GENEIN induction in HaCaT human keratinocyte cells
CPR:3	These findings demonstrate that  bbbbb1 CHEMICALIN eeeee1  increased GENEIN activity is necessary for the  bbbbb2 GENEIN eeeee2  induction in HaCaT human keratinocyte cells
CPR:3	Given the anti-inflammatory properties of CHEMICALNOTIN, we suggest that induction of  bbbbb1 GENEIN eeeee1  in keratinocytes may be important in the anti-inflammatory and protective mechanism of action of  bbbbb2 CHEMICALIN eeeee2  or n-6.
CPR:3	We demonstrate that only treatment of HaCaT with  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN or a GENEIN ligand (CHEMICALIN), induced  bbbbb2 GENEIN eeeee2  expression (protein and mRNA)
CPR:3	We demonstrate that only treatment of HaCaT with CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  or a GENEIN ligand (CHEMICALIN), induced  bbbbb2 GENEIN eeeee2  expression (protein and mRNA)
CPR:3	We demonstrate that only treatment of HaCaT with CHEMICALIN and CHEMICALIN or a GENEIN ligand ( bbbbb1 CHEMICALIN eeeee1 ), induced  bbbbb2 GENEIN eeeee2  expression (protein and mRNA)
CPR:3	 bbbbb1 CHEMICALIN eeeee1  induce the expression of  bbbbb2 GENEIN eeeee2  via GENEIN activation in human keratinocyte HaCaT cells
CPR:4	Finally,  bbbbb1 GENEIN eeeee1  inhibitor methyl  bbbbb2 CHEMICALIN eeeee2  blocked the CHEMICALIN effects on GENEIN induction, promoter activity and CHEMICALNOTIN mobilization suggesting involvement of CHEMICALIN metabolites in GENEIN activation
CPR:4	Finally, GENEIN inhibitor methyl  bbbbb1 CHEMICALIN eeeee1  blocked the CHEMICALIN effects on  bbbbb2 GENEIN eeeee2  induction, promoter activity and CHEMICALNOTIN mobilization suggesting involvement of CHEMICALIN metabolites in GENEIN activation
CPR:6	The inhibitory effects of  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN ( bbbbb2 GENEIN eeeee2  antagonists), on GENEIN expression and on stimulation of GENEIN activity by CHEMICALIN and CHEMICALIN suggest that GENENOTIN is implicated in GENENOTIN induction
CPR:6	The inhibitory effects of CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  ( bbbbb2 GENEIN eeeee2  antagonists), on GENEIN expression and on stimulation of GENEIN activity by CHEMICALIN and CHEMICALIN suggest that GENENOTIN is implicated in GENENOTIN induction
CPR:2	OBJECTIVE: The aim of this study was to assess the efficacy and tolerability of nebulized CHEMICALIN (a selective, long-acting  bbbbb1 GENEIN eeeee1  agonist that is the CHEMICALIN) and  bbbbb2 CHEMICALIN eeeee2  versus placebo in patients with chronic obstructive pulmonary disease (COPD)
CPR:5	OBJECTIVE: The aim of this study was to assess the efficacy and tolerability of nebulized CHEMICALIN (a selective, long-acting  bbbbb1 GENEIN eeeee1  agonist that is the  bbbbb2 CHEMICALIN eeeee2 ) and CHEMICALIN versus placebo in patients with chronic obstructive pulmonary disease (COPD)
CPR:5	OBJECTIVE: The aim of this study was to assess the efficacy and tolerability of nebulized  bbbbb1 CHEMICALIN eeeee1  (a selective, long-acting  bbbbb2 GENEIN eeeee2  agonist that is the CHEMICALIN) and CHEMICALIN versus placebo in patients with chronic obstructive pulmonary disease (COPD)
CPR:2	The cytosolic  bbbbb1 GENEIN eeeee1  is expressed primarily in liver and adipose tissue, and uses  bbbbb2 CHEMICALIN eeeee2  as a key building block in CHEMICALIN biosynthesis
CPR:9	The cytosolic  bbbbb1 GENEIN eeeee1  is expressed primarily in liver and adipose tissue, and uses CHEMICALIN as a key building block in  bbbbb2 CHEMICALIN eeeee2  biosynthesis
CPR:9	The mitochondrial  bbbbb1 GENEIN eeeee1  is primarily expressed in heart and skeletal muscle, where it is involved in the regulation of  bbbbb2 CHEMICALIN eeeee2  oxidation
CPR:9	 bbbbb1 GENEIN eeeee1  (GENEIN) enzymes exist as two isoforms, GENEIN and GENEIN, which play critical roles in  bbbbb2 CHEMICALIN eeeee2  biosynthesis and oxidation
CPR:9	GENEIN ( bbbbb1 GENEIN eeeee1 ) enzymes exist as two isoforms, GENEIN and GENEIN, which play critical roles in  bbbbb2 CHEMICALIN eeeee2  biosynthesis and oxidation
CPR:9	GENEIN (GENEIN) enzymes exist as two isoforms,  bbbbb1 GENEIN eeeee1  and GENEIN, which play critical roles in  bbbbb2 CHEMICALIN eeeee2  biosynthesis and oxidation
CPR:9	GENEIN (GENEIN) enzymes exist as two isoforms, GENEIN and  bbbbb1 GENEIN eeeee1 , which play critical roles in  bbbbb2 CHEMICALIN eeeee2  biosynthesis and oxidation
CPR:9	In contrast, the  bbbbb1 CHEMICALIN eeeee1  catabolising enzymes  bbbbb2 GENEIN eeeee2  and GENEIN which are known to be CHEMICALNOTIN-responsive were not expressed at all in the developing eye
CPR:9	In contrast, the  bbbbb1 CHEMICALIN eeeee1  catabolising enzymes GENEIN and  bbbbb2 GENEIN eeeee2  which are known to be CHEMICALNOTIN-responsive were not expressed at all in the developing eye
CPR:2	In contrast, GENEIN exerts glucoregulatory actions via slowing of gastric emptying and  bbbbb1 CHEMICALIN eeeee1 -dependent inhibition of  bbbbb2 GENEIN eeeee2  secretion
CPR:2	In contrast,  bbbbb1 GENEIN eeeee1  exerts glucoregulatory actions via slowing of gastric emptying and  bbbbb2 CHEMICALIN eeeee2 -dependent inhibition of GENEIN secretion
CPR:3	GENENOTIN activation leads to  bbbbb1 CHEMICALIN eeeee1 -dependent  bbbbb2 GENEIN eeeee2  secretion, induction of beta-cell proliferation, and enhanced resistance to apoptosis
CPR:10	This report reviews published and unpublished data that suggest that  bbbbb1 CHEMICALIN eeeee1  acts as a selective partial agonist at the GENEIN and does not affect  bbbbb2 GENEIN eeeee2  at therapeutic doses.
CPR:2	It has been claimed that partial agonism of the GENENOTIN and antagonism of the  bbbbb1 GENEIN eeeee1  receptor contribute to the clinical profile of  bbbbb2 CHEMICALIN eeeee2 , a so-called CHEMICALNOTIN- and CHEMICALNOTIN stabiliser
CPR:5	This report reviews published and unpublished data that suggest that  bbbbb1 CHEMICALIN eeeee1  acts as a selective partial agonist at the  bbbbb2 GENEIN eeeee2  and does not affect GENEIN at therapeutic doses.
CPR:4	 bbbbb1 CHEMICALIN eeeee1  blocks  bbbbb2 GENEIN eeeee2  activation without modifying CHEMICALNOTIN synthesis
CPR:2	Autoradiography studies with  bbbbb1 CHEMICALIN eeeee1  show that chronic treatment with CHEMICALIN for 15 days twice daily (1 mg/kg i.p.) significantly increases the density of  bbbbb2 GENEIN eeeee2  in the PVN
CPR:2	Autoradiography studies with CHEMICALIN show that chronic treatment with  bbbbb1 CHEMICALIN eeeee1  for 15 days twice daily (1 mg/kg i.p.) significantly increases the density of  bbbbb2 GENEIN eeeee2  in the PVN
CPR:4	The present findings confirm that PVN GENENOTIN, localized mainly in GABAergic synapses that control in an inhibitory fashion excitatory synapses, exert an inhibitory control on penile erection, demonstrating for the first time that chronic blockade of  bbbbb1 GENEIN eeeee1  by  bbbbb2 CHEMICALIN eeeee2  increases the density of these receptors in the PVN
CPR:6	ENENOTIN in the paraventricular nucleus and central control of penile erection: immunocytochemistry, autoradiography and behavioral studies. [CHEMICALIN] ( bbbbb1 CHEMICALIN eeeee1 ), a selective  bbbbb2 GENEIN eeeee2  antagonist, injected into the paraventricular nucleus of the hypothalamus (PVN) of male rats, induces penile erection
CPR:6	ENENOTIN in the paraventricular nucleus and central control of penile erection: immunocytochemistry, autoradiography and behavioral studies. [ bbbbb1 CHEMICALIN eeeee1 ] (CHEMICALIN), a selective  bbbbb2 GENEIN eeeee2  antagonist, injected into the paraventricular nucleus of the hypothalamus (PVN) of male rats, induces penile erection
CPR:2	 bbbbb1 GENEIN eeeee1  activates platelets through 2 pathways: one is through GENENOTIN, GENENOTIN(GENENOTIN),  bbbbb2 CHEMICALIN eeeee2 -mediated induction of aggregation; the other is through GENENOTIN-mediated aggregation and agglutination
CPR:4	Modulation of the function of GENENOTIN (CD36-/- mice),  bbbbb1 GENEIN eeeee1 (GENEIN) ( bbbbb2 CHEMICALIN eeeee2 ), GENEIN (CHEMICALIN), and GENENOTIN (GENENOTIN, 6D1 antibody) induced approximately 50% inhibition
CPR:4	Modulation of the function of GENENOTIN (CD36-/- mice), GENEIN( bbbbb1 GENEIN eeeee1 ) ( bbbbb2 CHEMICALIN eeeee2 ), GENEIN (CHEMICALIN), and GENENOTIN (GENENOTIN, 6D1 antibody) induced approximately 50% inhibition
CPR:4	Modulation of the function of GENENOTIN (CD36-/- mice), GENEIN(GENEIN) (CHEMICALIN),  bbbbb1 GENEIN eeeee1  ( bbbbb2 CHEMICALIN eeeee2 ), and GENENOTIN (GENENOTIN, 6D1 antibody) induced approximately 50% inhibition
CPR:9	We show that GENENOTIN and GENENOTIN do not reveal activity towards the checked steroids, but that  bbbbb1 GENEIN eeeee1  reduces dihydrotestosterone to  bbbbb2 CHEMICALIN eeeee2 , and is thus also involved in steroid metabolism
CPR:2	The LS/SS genotype of the promoter for  bbbbb1 GENEIN eeeee1  was associated with enhanced weight loss with  bbbbb2 CHEMICALIN eeeee2 
CPR:2	CONCLUSIONS: Weight reduction with  bbbbb1 CHEMICALIN eeeee1  is associated with altered gastric functions and increased GENEIN and is significantly associated with  bbbbb2 GENEIN eeeee2  genotype
CPR:2	The role of genetic variation in  bbbbb1 GENEIN eeeee1  on weight loss in response to  bbbbb2 CHEMICALIN eeeee2  deserves further study.
CPR:3	The  bbbbb1 CHEMICALIN eeeee1  group showed significant retardation in gastric emptying of solids (P = .03), reduced maximum tolerated volume (P = .03), and increased postprandial  bbbbb2 GENEIN eeeee2  compared with the placebo group
CPR:3	CONCLUSIONS: Weight reduction with  bbbbb1 CHEMICALIN eeeee1  is associated with altered gastric functions and increased  bbbbb2 GENEIN eeeee2  and is significantly associated with GENEIN genotype
CPR:1	ultiple  bbbbb1 GENEIN eeeee1  forms are produced by distinct starting points and alternative splicing of the  bbbbb2 CHEMICALIN eeeee2 -terminal exons. 5'-RACE was performed on GENENOTIN mRNA and two new translation initiation ATG's were found
CPR:2	 bbbbb1 CHEMICALIN eeeee1  [(+)-1] is one of the most potent members of a class of chiral drug substances used to regulate the synthesis and release of CHEMICALNOTIN by the  bbbbb2 GENEIN eeeee2 , and as such, is an important biomarker for pharmaceutical companies conducting research in this field
CPR:6	An investigation of the absolute configuration of the potent  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2  using vibrational circular dichroism
CPR:2	In this study the neuromuscular blocking drug CHEMICALIN and the controls CHEMICALIN and CHEMICALIN slowed the rate of  bbbbb1 CHEMICALIN eeeee1  induced CHEMICALIN dissociation from Chinese hamster ovary cells expressing recombinant  bbbbb2 GENEIN eeeee2  K(off) values min(-1); CHEMICALNOTIN (125 nM), CHEMICALNOTIN 0.45+/-0.07+blocker 0.04+/-0.02; CHEMICALNOTIN (21 nM), CHEMICALNOTIN 0.42+/-0.05+blocker 0.15+/-0.04; CHEMICALNOTIN(21 nM), CHEMICALNOTIN 0.36+/-0.03+blocker 0.03+/-0.01)
CPR:2	In this study the neuromuscular blocking drug CHEMICALIN and the controls CHEMICALIN and CHEMICALIN slowed the rate of CHEMICALIN induced  bbbbb1 CHEMICALIN eeeee1  dissociation from Chinese hamster ovary cells expressing recombinant  bbbbb2 GENEIN eeeee2  K(off) values min(-1); CHEMICALNOTIN (125 nM), CHEMICALNOTIN 0.45+/-0.07+blocker 0.04+/-0.02; CHEMICALNOTIN (21 nM), CHEMICALNOTIN 0.42+/-0.05+blocker 0.15+/-0.04; CHEMICALNOTIN(21 nM), CHEMICALNOTIN 0.36+/-0.03+blocker 0.03+/-0.01)
CPR:4	In this study the neuromuscular blocking drug  bbbbb1 CHEMICALIN eeeee1  and the controls CHEMICALIN and CHEMICALIN slowed the rate of CHEMICALIN induced CHEMICALIN dissociation from Chinese hamster ovary cells expressing recombinant  bbbbb2 GENEIN eeeee2  K(off) values min(-1); CHEMICALNOTIN (125 nM), CHEMICALNOTIN 0.45+/-0.07+blocker 0.04+/-0.02; CHEMICALNOTIN (21 nM), CHEMICALNOTIN 0.42+/-0.05+blocker 0.15+/-0.04; CHEMICALNOTIN(21 nM), CHEMICALNOTIN 0.36+/-0.03+blocker 0.03+/-0.01)
CPR:4	In this study the neuromuscular blocking drug CHEMICALIN and the controls  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN slowed the rate of CHEMICALIN induced CHEMICALIN dissociation from Chinese hamster ovary cells expressing recombinant  bbbbb2 GENEIN eeeee2  K(off) values min(-1); CHEMICALNOTIN (125 nM), CHEMICALNOTIN 0.45+/-0.07+blocker 0.04+/-0.02; CHEMICALNOTIN (21 nM), CHEMICALNOTIN 0.42+/-0.05+blocker 0.15+/-0.04; CHEMICALNOTIN(21 nM), CHEMICALNOTIN 0.36+/-0.03+blocker 0.03+/-0.01)
CPR:4	In this study the neuromuscular blocking drug CHEMICALIN and the controls CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  slowed the rate of CHEMICALIN induced CHEMICALIN dissociation from Chinese hamster ovary cells expressing recombinant  bbbbb2 GENEIN eeeee2  K(off) values min(-1); CHEMICALNOTIN (125 nM), CHEMICALNOTIN 0.45+/-0.07+blocker 0.04+/-0.02; CHEMICALNOTIN (21 nM), CHEMICALNOTIN 0.42+/-0.05+blocker 0.15+/-0.04; CHEMICALNOTIN(21 nM), CHEMICALNOTIN 0.36+/-0.03+blocker 0.03+/-0.01)
CPR:7	These data indicate that  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and CHEMICALIN interact with an allosteric site on the  bbbbb2 GENEIN eeeee2  (located on the heart) and this may explain some of their cardiac side effects.
CPR:7	These data indicate that CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN interact with an allosteric site on the  bbbbb2 GENEIN eeeee2  (located on the heart) and this may explain some of their cardiac side effects.
CPR:7	These data indicate that CHEMICALIN, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  interact with an allosteric site on the  bbbbb2 GENEIN eeeee2  (located on the heart) and this may explain some of their cardiac side effects.
CPR:7	Allosteric interaction of the neuromuscular blockers  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN with recombinant  bbbbb2 GENEIN eeeee2 
CPR:7	Allosteric interaction of the neuromuscular blockers CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  with recombinant  bbbbb2 GENEIN eeeee2 
CPR:2	Since 10(-3)M CHEMICALNOTIN oxidises CHEMICALNOTIN and CHEMICALNOTIN residues in proteins, we examined  bbbbb1 CHEMICALIN eeeee1  binding to  bbbbb2 GENEIN eeeee2  in the presence and absence of CHEMICALIN utilising (45)CHEMICALNOTIN
CPR:2	The results showed that all four  bbbbb1 CHEMICALIN eeeee1  atoms exchanged per molecule of  bbbbb2 GENEIN eeeee2 
CPR:2	CHEMICALIN-mediated oxidative stress disrupts  bbbbb1 CHEMICALIN eeeee1  binding on  bbbbb2 GENEIN eeeee2 : more evidence for oxidative stress in vitiligo
CPR:2	Taken together CHEMICALIN-mediated oxidation affects  bbbbb1 CHEMICALIN eeeee1  binding in  bbbbb2 GENEIN eeeee2  leading to perturbed CHEMICALNOTIN homeostasis and perturbed CHEMICALNOTIN-uptake in the epidermis of acute vitiligo.
CPR:2	Since 10(-3)M CHEMICALNOTIN oxidises CHEMICALNOTIN and CHEMICALNOTIN residues in proteins, we examined CHEMICALIN binding to  bbbbb1 GENEIN eeeee1  in the presence and absence of  bbbbb2 CHEMICALIN eeeee2  utilising (45)CHEMICALNOTIN
CPR:2	 bbbbb1 CHEMICALIN eeeee1 -mediated oxidative stress disrupts CHEMICALIN binding on  bbbbb2 GENEIN eeeee2 : more evidence for oxidative stress in vitiligo
CPR:2	Taken together  bbbbb1 CHEMICALIN eeeee1 -mediated oxidation affects CHEMICALIN binding in  bbbbb2 GENEIN eeeee2  leading to perturbed CHEMICALNOTIN homeostasis and perturbed CHEMICALNOTIN-uptake in the epidermis of acute vitiligo.
CPR:9	Patients with acute vitiligo have low epidermal  bbbbb1 GENEIN eeeee1  expression/activities and accumulate 10(-3) M  bbbbb2 CHEMICALIN eeeee2 
CPR:10	Moreover, the  bbbbb1 GENEIN eeeee1  active site is essentially unreactive toward  bbbbb2 CHEMICALIN eeeee2  in the absence of substrate, suggesting an obligate ordered binding of CHEMICALIN prior to CHEMICALIN
CPR:1	The active site coordination of  bbbbb1 GENEIN eeeee1  comprises a mononuclear CHEMICALIN ligated by the Nepsilon atoms of three protein-derived  bbbbb2 CHEMICALIN eeeee2 , thus representing a new variant on the GENENOTIN
CPR:2	The unusual {CHEMICALNOTIN}7 (S = 1/2) electronic configuration adopted by the substrate-bound CHEMICALNOTIN GENENOTIN (termed {ES-CHEMICALNOTIN}7) is a result of the CHEMICALNOTIN coordination of CHEMICALNOTIN in the  bbbbb1 CHEMICALIN eeeee1 -bound  bbbbb2 GENEIN eeeee2  active site
CPR:2	The active site coordination of  bbbbb1 GENEIN eeeee1  comprises a mononuclear  bbbbb2 CHEMICALIN eeeee2  ligated by the Nepsilon atoms of three protein-derived CHEMICALIN, thus representing a new variant on the GENENOTIN
CPR:2	In these experiments,  bbbbb1 GENEIN eeeee1  exhibits an ordered binding of  bbbbb2 CHEMICALIN eeeee2  prior to CHEMICALIN (and presumably CHEMICALIN) similar to that observed for the GENEIN
CPR:2	In these experiments, GENEIN exhibits an ordered binding of  bbbbb1 CHEMICALIN eeeee1  prior to CHEMICALIN (and presumably CHEMICALIN) similar to that observed for the  bbbbb2 GENEIN eeeee2 
CPR:2	In these experiments,  bbbbb1 GENEIN eeeee1  exhibits an ordered binding of CHEMICALIN prior to  bbbbb2 CHEMICALIN eeeee2  (and presumably CHEMICALIN) similar to that observed for the GENEIN
CPR:2	In these experiments, GENEIN exhibits an ordered binding of CHEMICALIN prior to  bbbbb1 CHEMICALIN eeeee1  (and presumably CHEMICALIN) similar to that observed for the  bbbbb2 GENEIN eeeee2 
CPR:2	In these experiments,  bbbbb1 GENEIN eeeee1  exhibits an ordered binding of CHEMICALIN prior to CHEMICALIN (and presumably  bbbbb2 CHEMICALIN eeeee2 ) similar to that observed for the GENEIN
CPR:2	In these experiments, GENEIN exhibits an ordered binding of CHEMICALIN prior to CHEMICALIN (and presumably  bbbbb1 CHEMICALIN eeeee1 ) similar to that observed for the  bbbbb2 GENEIN eeeee2 
CPR:2	Moreover, the  bbbbb1 GENEIN eeeee1  active site is essentially unreactive toward CHEMICALIN in the absence of substrate, suggesting an obligate ordered binding of  bbbbb2 CHEMICALIN eeeee2  prior to CHEMICALIN
CPR:2	Moreover, the  bbbbb1 GENEIN eeeee1  active site is essentially unreactive toward CHEMICALIN in the absence of substrate, suggesting an obligate ordered binding of CHEMICALIN prior to  bbbbb2 CHEMICALIN eeeee2 
CPR:2	Characterization of the  bbbbb1 CHEMICALIN eeeee1  adduct of substrate-bound  bbbbb2 GENEIN eeeee2  by electron paramagnetic resonance: electronic structure of the active site and mechanistic implications
CPR:2	However, upon addition of  bbbbb1 CHEMICALIN eeeee1  to  bbbbb2 GENEIN eeeee2  in the presence of substrate CHEMICALIN, a low-spin {CHEMICALNOTIN}7 (S = 1/2) signal that accounts for approximately 85% of the CHEMICALNOTIN within the enzyme develops
CPR:8	 bbbbb1 GENEIN eeeee1  (GENEIN) is a non-heme  bbbbb2 CHEMICALIN eeeee2  metalloenzyme that catalyzes the first committed step in oxidative CHEMICALIN catabolism
CPR:8	GENEIN ( bbbbb1 GENEIN eeeee1 ) is a non-heme  bbbbb2 CHEMICALIN eeeee2  metalloenzyme that catalyzes the first committed step in oxidative CHEMICALIN catabolism
CPR:9	However, upon addition of CHEMICALIN to  bbbbb1 GENEIN eeeee1  in the presence of substrate  bbbbb2 CHEMICALIN eeeee2 , a low-spin {CHEMICALNOTIN}7 (S = 1/2) signal that accounts for approximately 85% of the CHEMICALNOTIN within the enzyme develops
CPR:9	 bbbbb1 GENEIN eeeee1  (GENEIN) is a non-heme CHEMICALIN metalloenzyme that catalyzes the first committed step in oxidative  bbbbb2 CHEMICALIN eeeee2  catabolism
CPR:9	GENEIN ( bbbbb1 GENEIN eeeee1 ) is a non-heme CHEMICALIN metalloenzyme that catalyzes the first committed step in oxidative  bbbbb2 CHEMICALIN eeeee2  catabolism
CPR:2	The transcriptional activity of torafugu GENEIN was enhanced 4.5- and 11.5-fold by  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN (CHEMICALIN) each at 10 microM, respectively, whereas that of  bbbbb2 GENEIN eeeee2 , 4.5- and 7.3-fold at the same concentration of the respective ligands, respectively
CPR:2	The transcriptional activity of torafugu GENEIN was enhanced 4.5- and 11.5-fold by CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) each at 10 microM, respectively, whereas that of  bbbbb2 GENEIN eeeee2 , 4.5- and 7.3-fold at the same concentration of the respective ligands, respectively
CPR:2	The transcriptional activity of torafugu GENEIN was enhanced 4.5- and 11.5-fold by CHEMICALIN and CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) each at 10 microM, respectively, whereas that of  bbbbb2 GENEIN eeeee2 , 4.5- and 7.3-fold at the same concentration of the respective ligands, respectively
CPR:3	The transcriptional activity of torafugu  bbbbb1 GENEIN eeeee1  was enhanced 4.5- and 11.5-fold by  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN (CHEMICALIN) each at 10 microM, respectively, whereas that of GENEIN, 4.5- and 7.3-fold at the same concentration of the respective ligands, respectively
CPR:3	The transcriptional activity of torafugu GENEIN was enhanced 4.5- and 11.5-fold by  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN (CHEMICALIN) each at 10 microM, respectively, whereas that of  bbbbb2 GENEIN eeeee2 , 4.5- and 7.3-fold at the same concentration of the respective ligands, respectively
CPR:3	The transcriptional activity of torafugu  bbbbb1 GENEIN eeeee1  was enhanced 4.5- and 11.5-fold by CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) each at 10 microM, respectively, whereas that of GENEIN, 4.5- and 7.3-fold at the same concentration of the respective ligands, respectively
CPR:3	The transcriptional activity of torafugu GENEIN was enhanced 4.5- and 11.5-fold by CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) each at 10 microM, respectively, whereas that of  bbbbb2 GENEIN eeeee2 , 4.5- and 7.3-fold at the same concentration of the respective ligands, respectively
CPR:3	The transcriptional activity of torafugu  bbbbb1 GENEIN eeeee1  was enhanced 4.5- and 11.5-fold by CHEMICALIN and CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) each at 10 microM, respectively, whereas that of GENEIN, 4.5- and 7.3-fold at the same concentration of the respective ligands, respectively
CPR:3	The transcriptional activity of torafugu GENEIN was enhanced 4.5- and 11.5-fold by CHEMICALIN and CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) each at 10 microM, respectively, whereas that of  bbbbb2 GENEIN eeeee2 , 4.5- and 7.3-fold at the same concentration of the respective ligands, respectively
CPR:3	Furthermore, the activities of the two  bbbbb1 GENEIN eeeee1  were enhanced 4.3- and 7.6-fold by  bbbbb2 CHEMICALIN eeeee2 , 4.4- and 5.2-fold by CHEMICALIN, and 6.7- and 8.0-fold by CHEMICALIN each at 50 microM, respectively
CPR:3	Furthermore, the activities of the two  bbbbb1 GENEIN eeeee1  were enhanced 4.3- and 7.6-fold by CHEMICALIN, 4.4- and 5.2-fold by  bbbbb2 CHEMICALIN eeeee2 , and 6.7- and 8.0-fold by CHEMICALIN each at 50 microM, respectively
CPR:3	Furthermore, the activities of the two  bbbbb1 GENEIN eeeee1  were enhanced 4.3- and 7.6-fold by CHEMICALIN, 4.4- and 5.2-fold by CHEMICALIN, and 6.7- and 8.0-fold by  bbbbb2 CHEMICALIN eeeee2  each at 50 microM, respectively
CPR:6	Combination chemotherapy with a  bbbbb1 GENEIN eeeee1  antagonist ( bbbbb2 CHEMICALIN eeeee2 ) and CHEMICALIN in a mouse model of human African trypanosomiasis
CPR:6	Combination chemotherapy with a  bbbbb1 GENEIN eeeee1  antagonist (CHEMICALIN) and  bbbbb2 CHEMICALIN eeeee2  in a mouse model of human African trypanosomiasis
CPR:6	In this study we investigated the effects of combination chemotherapy with CHEMICALNOTIN and a  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) in this mouse model
CPR:6	In this study we investigated the effects of combination chemotherapy with CHEMICALNOTIN and a  bbbbb1 GENEIN eeeee1  antagonist CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) in this mouse model
CPR:1	PURPOSE: GENENOTIN (GENENOTIN), transcribed from the GENENOTIN gene, is a  bbbbb1 GENEIN eeeee1  with 316  bbbbb2 CHEMICALIN eeeee2  found in the CHEMICALNOTIN pigment epithelium (RPE) and in CHEMICALNOTIN Muller cells
CPR:9	It is thought to play a critical role in the visual cycle by functioning as an acceptor of  bbbbb1 CHEMICALIN eeeee1  from the  bbbbb2 GENEIN eeeee2  reaction
CPR:10	 bbbbb1 GENEIN eeeee1  or GENEIN isoenzymes were not found to influence  bbbbb2 CHEMICALIN eeeee2  production
CPR:10	GENEIN or  bbbbb1 GENEIN eeeee1  isoenzymes were not found to influence  bbbbb2 CHEMICALIN eeeee2  production
CPR:4	Using this assay, we found that both  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN inhibit renal cortical  bbbbb2 GENEIN eeeee2  activity in vitro.
CPR:4	Using this assay, we found that both CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  inhibit renal cortical  bbbbb2 GENEIN eeeee2  activity in vitro.
CPR:9	Our optimized  bbbbb1 CHEMICALIN eeeee1  production assay to measure  bbbbb2 GENEIN eeeee2  activity correlated closely with the direct measure of the rate of asymmetric CHEMICALIN consumption
CPR:9	 bbbbb1 GENEIN eeeee1  (GENEIN) metabolizes asymmetric CHEMICALIN to generate  bbbbb2 CHEMICALIN eeeee2  and is present in large quantities in the kidney
CPR:9	GENEIN ( bbbbb1 GENEIN eeeee1 ) metabolizes asymmetric CHEMICALIN to generate  bbbbb2 CHEMICALIN eeeee2  and is present in large quantities in the kidney
CPR:9	We present a new study that optimizes the Prescott-Jones colorimetric assay to measure  bbbbb1 GENEIN eeeee1 -dependent  bbbbb2 CHEMICALIN eeeee2  generation in kidney homogenates
CPR:9	Our optimized CHEMICALIN production assay to measure  bbbbb1 GENEIN eeeee1  activity correlated closely with the direct measure of the rate of asymmetric  bbbbb2 CHEMICALIN eeeee2  consumption
CPR:9	We found that the removal of  bbbbb1 CHEMICALIN eeeee1  with  bbbbb2 GENEIN eeeee2  is necessary since CHEMICALNOTIN also produces a positive reaction
CPR:9	 bbbbb1 GENEIN eeeee1  (GENEIN) metabolizes asymmetric  bbbbb2 CHEMICALIN eeeee2  to generate CHEMICALIN and is present in large quantities in the kidney
CPR:9	GENEIN ( bbbbb1 GENEIN eeeee1 ) metabolizes asymmetric  bbbbb2 CHEMICALIN eeeee2  to generate CHEMICALIN and is present in large quantities in the kidney
CPR:2	A humanized antibody to GENENOTIN/GENENOTIN, trastuzumab, is now FDA approved for the treatment of early stage,  bbbbb1 GENEIN eeeee1 /GENEIN overexpressing breast cancer sequenced with chemotherapy including  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, and CHEMICALIN
CPR:2	A humanized antibody to GENENOTIN/GENENOTIN, trastuzumab, is now FDA approved for the treatment of early stage, GENEIN/ bbbbb1 GENEIN eeeee1  overexpressing breast cancer sequenced with chemotherapy including  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, and CHEMICALIN
CPR:2	A humanized antibody to GENENOTIN/GENENOTIN, trastuzumab, is now FDA approved for the treatment of early stage,  bbbbb1 GENEIN eeeee1 /GENEIN overexpressing breast cancer sequenced with chemotherapy including CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , and CHEMICALIN
CPR:2	A humanized antibody to GENENOTIN/GENENOTIN, trastuzumab, is now FDA approved for the treatment of early stage, GENEIN/ bbbbb1 GENEIN eeeee1  overexpressing breast cancer sequenced with chemotherapy including CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , and CHEMICALIN
CPR:2	A humanized antibody to GENENOTIN/GENENOTIN, trastuzumab, is now FDA approved for the treatment of early stage,  bbbbb1 GENEIN eeeee1 /GENEIN overexpressing breast cancer sequenced with chemotherapy including CHEMICALIN, CHEMICALIN, and  bbbbb2 CHEMICALIN eeeee2 
CPR:2	A humanized antibody to GENENOTIN/GENENOTIN, trastuzumab, is now FDA approved for the treatment of early stage, GENEIN/ bbbbb1 GENEIN eeeee1  overexpressing breast cancer sequenced with chemotherapy including CHEMICALIN, CHEMICALIN, and  bbbbb2 CHEMICALIN eeeee2 
CPR:4	The next large phase III adjuvant trial for this subset of breast cancer is an international collaboration designed to evaluate the added or alternative benefit of an oral CHEMICALNOTIN kinase inhibitor targeting  bbbbb1 GENEIN eeeee1 /GENEIN as well as the GENEIN (GENEIN),  bbbbb2 CHEMICALIN eeeee2 
CPR:4	The next large phase III adjuvant trial for this subset of breast cancer is an international collaboration designed to evaluate the added or alternative benefit of an oral CHEMICALNOTIN kinase inhibitor targeting GENEIN/ bbbbb1 GENEIN eeeee1  as well as the GENEIN (GENEIN),  bbbbb2 CHEMICALIN eeeee2 
CPR:4	The next large phase III adjuvant trial for this subset of breast cancer is an international collaboration designed to evaluate the added or alternative benefit of an oral CHEMICALNOTIN kinase inhibitor targeting GENEIN/GENEIN as well as the  bbbbb1 GENEIN eeeee1  (GENEIN),  bbbbb2 CHEMICALIN eeeee2 
CPR:4	The next large phase III adjuvant trial for this subset of breast cancer is an international collaboration designed to evaluate the added or alternative benefit of an oral CHEMICALNOTIN kinase inhibitor targeting GENEIN/GENEIN as well as the GENEIN ( bbbbb1 GENEIN eeeee1 ),  bbbbb2 CHEMICALIN eeeee2 
CPR:2	Exposure of Jurkat cells to either CHEMICALIN [CHEMICALIN] or CHEMICALIN (CHEMICALIN), two selective GENEIN antagonists, limited cell growth by inhibiting cell cycle progression and inducing apoptosis, whereas  bbbbb1 CHEMICALIN eeeee1  (1 microM) and CHEMICALIN (10 microM) significantly increased (137.2+/-22.0%; P<0.01) Jurkat T cell adhesion to  bbbbb2 GENEIN eeeee2 
CPR:2	Exposure of Jurkat cells to either CHEMICALIN [CHEMICALIN] or CHEMICALIN (CHEMICALIN), two selective GENEIN antagonists, limited cell growth by inhibiting cell cycle progression and inducing apoptosis, whereas CHEMICALIN (1 microM) and  bbbbb1 CHEMICALIN eeeee1  (10 microM) significantly increased (137.2+/-22.0%; P<0.01) Jurkat T cell adhesion to  bbbbb2 GENEIN eeeee2 
CPR:6	Exposure of Jurkat cells to either  bbbbb1 CHEMICALIN eeeee1  [CHEMICALIN] or CHEMICALIN (CHEMICALIN), two selective  bbbbb2 GENEIN eeeee2  antagonists, limited cell growth by inhibiting cell cycle progression and inducing apoptosis, whereas CHEMICALIN (1 microM) and CHEMICALIN (10 microM) significantly increased (137.2+/-22.0%; P<0.01) Jurkat T cell adhesion to GENEIN
CPR:6	Exposure of Jurkat cells to either CHEMICALIN [ bbbbb1 CHEMICALIN eeeee1 ] or CHEMICALIN (CHEMICALIN), two selective  bbbbb2 GENEIN eeeee2  antagonists, limited cell growth by inhibiting cell cycle progression and inducing apoptosis, whereas CHEMICALIN (1 microM) and CHEMICALIN (10 microM) significantly increased (137.2+/-22.0%; P<0.01) Jurkat T cell adhesion to GENEIN
CPR:6	Exposure of Jurkat cells to either CHEMICALIN [CHEMICALIN] or  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), two selective  bbbbb2 GENEIN eeeee2  antagonists, limited cell growth by inhibiting cell cycle progression and inducing apoptosis, whereas CHEMICALIN (1 microM) and CHEMICALIN (10 microM) significantly increased (137.2+/-22.0%; P<0.01) Jurkat T cell adhesion to GENEIN
CPR:6	Exposure of Jurkat cells to either CHEMICALIN [CHEMICALIN] or CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), two selective  bbbbb2 GENEIN eeeee2  antagonists, limited cell growth by inhibiting cell cycle progression and inducing apoptosis, whereas CHEMICALIN (1 microM) and CHEMICALIN (10 microM) significantly increased (137.2+/-22.0%; P<0.01) Jurkat T cell adhesion to GENEIN
CPR:10	In an initial search for molecular features that differentially define antagonist binding determinants, we document that Val148 in  bbbbb1 GENEIN eeeee1  selectively disrupts  bbbbb2 CHEMICALIN eeeee2  binding but not that of DVS.
CPR:2	Initial evaluation of the pharmacological properties of CHEMICALNOTIN (J Pharmacol Exp Ther 318:657-665, 2006) revealed significantly reduced potency for the  bbbbb1 GENEIN eeeee1  expressed in membranes compared with whole cells when competing for  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) binding
CPR:2	Initial evaluation of the pharmacological properties of CHEMICALNOTIN (J Pharmacol Exp Ther 318:657-665, 2006) revealed significantly reduced potency for the  bbbbb1 GENEIN eeeee1  expressed in membranes compared with whole cells when competing for CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) binding
CPR:2	Using  bbbbb1 GENEIN eeeee1  in transfected human embryonic kidney-293 cells, this difference in potency for  bbbbb2 CHEMICALIN eeeee2  at sites labeled by CHEMICALIN was found to distinguish CHEMICALIN, the CHEMICALIN analog CHEMICALIN (CHEMICALIN), CHEMICALIN, and the CHEMICALIN analog CHEMICALIN (CHEMICALIN) from other GENEIN antagonists, such as CHEMICALIN, CHEMICALIN, CHEMICALIN antidepressants, and CHEMICALIN
CPR:2	Using  bbbbb1 GENEIN eeeee1  in transfected human embryonic kidney-293 cells, this difference in potency for CHEMICALIN at sites labeled by  bbbbb2 CHEMICALIN eeeee2  was found to distinguish CHEMICALIN, the CHEMICALIN analog CHEMICALIN (CHEMICALIN), CHEMICALIN, and the CHEMICALIN analog CHEMICALIN (CHEMICALIN) from other GENEIN antagonists, such as CHEMICALIN, CHEMICALIN, CHEMICALIN antidepressants, and CHEMICALIN
CPR:6	Using  bbbbb1 GENEIN eeeee1  in transfected human embryonic kidney-293 cells, this difference in potency for CHEMICALIN at sites labeled by CHEMICALIN was found to distinguish CHEMICALIN, the  bbbbb2 CHEMICALIN eeeee2  analog CHEMICALIN (CHEMICALIN), CHEMICALIN, and the CHEMICALIN analog CHEMICALIN (CHEMICALIN) from other GENEIN antagonists, such as CHEMICALIN, CHEMICALIN, CHEMICALIN antidepressants, and CHEMICALIN
CPR:6	Using  bbbbb1 GENEIN eeeee1  in transfected human embryonic kidney-293 cells, this difference in potency for CHEMICALIN at sites labeled by CHEMICALIN was found to distinguish CHEMICALIN, the CHEMICALIN analog  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), CHEMICALIN, and the CHEMICALIN analog CHEMICALIN (CHEMICALIN) from other GENEIN antagonists, such as CHEMICALIN, CHEMICALIN, CHEMICALIN antidepressants, and CHEMICALIN
CPR:6	Using  bbbbb1 GENEIN eeeee1  in transfected human embryonic kidney-293 cells, this difference in potency for CHEMICALIN at sites labeled by CHEMICALIN was found to distinguish CHEMICALIN, the CHEMICALIN analog CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), CHEMICALIN, and the CHEMICALIN analog CHEMICALIN (CHEMICALIN) from other GENEIN antagonists, such as CHEMICALIN, CHEMICALIN, CHEMICALIN antidepressants, and CHEMICALIN
CPR:6	Using  bbbbb1 GENEIN eeeee1  in transfected human embryonic kidney-293 cells, this difference in potency for CHEMICALIN at sites labeled by CHEMICALIN was found to distinguish CHEMICALIN, the CHEMICALIN analog CHEMICALIN (CHEMICALIN),  bbbbb2 CHEMICALIN eeeee2 , and the CHEMICALIN analog CHEMICALIN (CHEMICALIN) from other GENEIN antagonists, such as CHEMICALIN, CHEMICALIN, CHEMICALIN antidepressants, and CHEMICALIN
CPR:6	Using  bbbbb1 GENEIN eeeee1  in transfected human embryonic kidney-293 cells, this difference in potency for CHEMICALIN at sites labeled by CHEMICALIN was found to distinguish CHEMICALIN, the CHEMICALIN analog CHEMICALIN (CHEMICALIN), CHEMICALIN, and the  bbbbb2 CHEMICALIN eeeee2  analog CHEMICALIN (CHEMICALIN) from other GENEIN antagonists, such as CHEMICALIN, CHEMICALIN, CHEMICALIN antidepressants, and CHEMICALIN
CPR:6	Using  bbbbb1 GENEIN eeeee1  in transfected human embryonic kidney-293 cells, this difference in potency for CHEMICALIN at sites labeled by CHEMICALIN was found to distinguish CHEMICALIN, the CHEMICALIN analog CHEMICALIN (CHEMICALIN), CHEMICALIN, and the CHEMICALIN analog  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) from other GENEIN antagonists, such as CHEMICALIN, CHEMICALIN, CHEMICALIN antidepressants, and CHEMICALIN
CPR:6	Using  bbbbb1 GENEIN eeeee1  in transfected human embryonic kidney-293 cells, this difference in potency for CHEMICALIN at sites labeled by CHEMICALIN was found to distinguish CHEMICALIN, the CHEMICALIN analog CHEMICALIN (CHEMICALIN), CHEMICALIN, and the CHEMICALIN analog CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) from other GENEIN antagonists, such as CHEMICALIN, CHEMICALIN, CHEMICALIN antidepressants, and CHEMICALIN
CPR:6	Using GENEIN in transfected human embryonic kidney-293 cells, this difference in potency for CHEMICALIN at sites labeled by CHEMICALIN was found to distinguish CHEMICALIN, the CHEMICALIN analog CHEMICALIN (CHEMICALIN), CHEMICALIN, and the CHEMICALIN analog CHEMICALIN (CHEMICALIN) from other  bbbbb1 GENEIN eeeee1  antagonists, such as  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN antidepressants, and CHEMICALIN
CPR:6	Using GENEIN in transfected human embryonic kidney-293 cells, this difference in potency for CHEMICALIN at sites labeled by CHEMICALIN was found to distinguish CHEMICALIN, the CHEMICALIN analog CHEMICALIN (CHEMICALIN), CHEMICALIN, and the CHEMICALIN analog CHEMICALIN (CHEMICALIN) from other  bbbbb1 GENEIN eeeee1  antagonists, such as CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN antidepressants, and CHEMICALIN
CPR:6	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) is a recently introduced antagonist of the GENENOTIN ( bbbbb2 GENEIN eeeee2  and GENEIN, respectively), currently in clinical development for use in the treatment of major depressive disorder and vasomotor symptoms associated with menopause
CPR:6	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) is a recently introduced antagonist of the GENENOTIN (GENEIN and  bbbbb2 GENEIN eeeee2 , respectively), currently in clinical development for use in the treatment of major depressive disorder and vasomotor symptoms associated with menopause
CPR:6	Using GENEIN in transfected human embryonic kidney-293 cells, this difference in potency for CHEMICALIN at sites labeled by CHEMICALIN was found to distinguish CHEMICALIN, the CHEMICALIN analog CHEMICALIN (CHEMICALIN), CHEMICALIN, and the CHEMICALIN analog CHEMICALIN (CHEMICALIN) from other  bbbbb1 GENEIN eeeee1  antagonists, such as CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2  antidepressants, and CHEMICALIN
CPR:6	Using GENEIN in transfected human embryonic kidney-293 cells, this difference in potency for CHEMICALIN at sites labeled by CHEMICALIN was found to distinguish CHEMICALIN, the CHEMICALIN analog CHEMICALIN (CHEMICALIN), CHEMICALIN, and the CHEMICALIN analog CHEMICALIN (CHEMICALIN) from other  bbbbb1 GENEIN eeeee1  antagonists, such as CHEMICALIN, CHEMICALIN, CHEMICALIN antidepressants, and  bbbbb2 CHEMICALIN eeeee2 
CPR:6	 bbbbb1 CHEMICALIN eeeee1  identifies novel antagonist binding determinants in the  bbbbb2 GENEIN eeeee2 
CPR:6	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) is a recently introduced antagonist of the GENENOTIN ( bbbbb2 GENEIN eeeee2  and GENEIN, respectively), currently in clinical development for use in the treatment of major depressive disorder and vasomotor symptoms associated with menopause
CPR:6	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) is a recently introduced antagonist of the GENENOTIN (GENEIN and  bbbbb2 GENEIN eeeee2 , respectively), currently in clinical development for use in the treatment of major depressive disorder and vasomotor symptoms associated with menopause
CPR:6	Using  bbbbb1 GENEIN eeeee1  in transfected human embryonic kidney-293 cells, this difference in potency for CHEMICALIN at sites labeled by CHEMICALIN was found to distinguish  bbbbb2 CHEMICALIN eeeee2 , the CHEMICALIN analog CHEMICALIN (CHEMICALIN), CHEMICALIN, and the CHEMICALIN analog CHEMICALIN (CHEMICALIN) from other GENEIN antagonists, such as CHEMICALIN, CHEMICALIN, CHEMICALIN antidepressants, and CHEMICALIN
CPR:1	The key difference in structure of  bbbbb1 GENEIN eeeee1  and GENEIN is replacement of  bbbbb2 CHEMICALIN eeeee2  with CHEMICALIN at position 560
CPR:1	The key difference in structure of GENEIN and  bbbbb1 GENEIN eeeee1  is replacement of  bbbbb2 CHEMICALIN eeeee2  with CHEMICALIN at position 560
CPR:1	The key difference in structure of  bbbbb1 GENEIN eeeee1  and GENEIN is replacement of CHEMICALIN with  bbbbb2 CHEMICALIN eeeee2  at position 560
CPR:1	The key difference in structure of GENEIN and  bbbbb1 GENEIN eeeee1  is replacement of CHEMICALIN with  bbbbb2 CHEMICALIN eeeee2  at position 560
CPR:4	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN are synthetic, orally active agents shown to directly inhibit GENENOTIN ( bbbbb2 GENEIN eeeee2 , GENEIN) and GENEIN (GENEIN), while CHEMICALIN is an GENEIN inhibitor
CPR:4	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN are synthetic, orally active agents shown to directly inhibit GENENOTIN (GENEIN,  bbbbb2 GENEIN eeeee2 ) and GENEIN (GENEIN), while CHEMICALIN is an GENEIN inhibitor
CPR:4	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN are synthetic, orally active agents shown to directly inhibit GENENOTIN (GENEIN, GENEIN) and  bbbbb2 GENEIN eeeee2  (GENEIN), while CHEMICALIN is an GENEIN inhibitor
CPR:4	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN are synthetic, orally active agents shown to directly inhibit GENENOTIN (GENEIN, GENEIN) and GENEIN ( bbbbb2 GENEIN eeeee2 ), while CHEMICALIN is an GENEIN inhibitor
CPR:4	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  are synthetic, orally active agents shown to directly inhibit GENENOTIN ( bbbbb2 GENEIN eeeee2 , GENEIN) and GENEIN (GENEIN), while CHEMICALIN is an GENEIN inhibitor
CPR:4	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  are synthetic, orally active agents shown to directly inhibit GENENOTIN (GENEIN,  bbbbb2 GENEIN eeeee2 ) and GENEIN (GENEIN), while CHEMICALIN is an GENEIN inhibitor
CPR:4	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  are synthetic, orally active agents shown to directly inhibit GENENOTIN (GENEIN, GENEIN) and  bbbbb2 GENEIN eeeee2  (GENEIN), while CHEMICALIN is an GENEIN inhibitor
CPR:4	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  are synthetic, orally active agents shown to directly inhibit GENENOTIN (GENEIN, GENEIN) and GENEIN ( bbbbb2 GENEIN eeeee2 ), while CHEMICALIN is an GENEIN inhibitor
CPR:4	CHEMICALIN and CHEMICALIN are synthetic, orally active agents shown to directly inhibit GENENOTIN (GENEIN, GENEIN) and GENEIN (GENEIN), while  bbbbb1 CHEMICALIN eeeee1  is an  bbbbb2 GENEIN eeeee2  inhibitor
CPR:2	One is that the binding of  bbbbb1 CHEMICALIN eeeee1  to nuclear  bbbbb2 GENEIN eeeee2  (GENEIN) does not match their therapeutic efficacy: CHEMICALNOTIN activates the three receptor subtypes, GENENOTIN, without measurable receptor binding, whereas CHEMICALIN preferentially binds to and activates GENENOTIN in preference to GENEIN
CPR:2	One is that the binding of  bbbbb1 CHEMICALIN eeeee1  to nuclear GENEIN ( bbbbb2 GENEIN eeeee2 ) does not match their therapeutic efficacy: CHEMICALNOTIN activates the three receptor subtypes, GENENOTIN, without measurable receptor binding, whereas CHEMICALIN preferentially binds to and activates GENENOTIN in preference to GENEIN
CPR:2	One is that the binding of CHEMICALIN to nuclear GENEIN (GENEIN) does not match their therapeutic efficacy: CHEMICALNOTIN activates the three receptor subtypes, GENENOTIN, without measurable receptor binding, whereas  bbbbb1 CHEMICALIN eeeee1  preferentially binds to and activates GENENOTIN in preference to  bbbbb2 GENEIN eeeee2 
CPR:3	One is that the binding of CHEMICALIN to nuclear GENEIN (GENEIN) does not match their therapeutic efficacy: CHEMICALNOTIN activates the three receptor subtypes, GENENOTIN, without measurable receptor binding, whereas  bbbbb1 CHEMICALIN eeeee1  preferentially binds to and activates GENENOTIN in preference to  bbbbb2 GENEIN eeeee2 
CPR:10	In experimental models,  bbbbb1 CHEMICALIN eeeee1  has been found to have neuroprotective properties that may be independent of  bbbbb2 GENEIN eeeee2  inhibition
CPR:4	CHEMICALIN [ bbbbb1 CHEMICALIN eeeee1 ] is a second-generation CHEMICALIN pharmacophore that selectively and irreversibly inhibits brain  bbbbb2 GENEIN eeeee2  and is specifically designed for the treatment of Parkinson's disease (PD)
CPR:4	CHEMICALIN [CHEMICALIN] is a second-generation  bbbbb1 CHEMICALIN eeeee1  pharmacophore that selectively and irreversibly inhibits brain  bbbbb2 GENEIN eeeee2  and is specifically designed for the treatment of Parkinson's disease (PD)
CPR:4	Comprehensive review of  bbbbb1 CHEMICALIN eeeee1 , a second-generation  bbbbb2 GENEIN eeeee2  inhibitor, for the treatment of Parkinson's disease
CPR:4	Based on the results from those studies, we concluded that  bbbbb1 CHEMICALIN eeeee1  PO QD, at the therapeutic dosage range of 0.5 to 1 rag/d, is effective and well tolerated and completely, selectively, and specifically inhibited  bbbbb2 GENEIN eeeee2 
CPR:4	 bbbbb1 CHEMICALIN eeeee1  [CHEMICALIN] is a second-generation CHEMICALIN pharmacophore that selectively and irreversibly inhibits brain  bbbbb2 GENEIN eeeee2  and is specifically designed for the treatment of Parkinson's disease (PD)
CPR:1	We postulate that this conserved  bbbbb1 CHEMICALIN eeeee1  residue provides a flexible hinge within the  bbbbb2 GENEIN eeeee2  catalytic pocket to facilitate linker dynamics and the structural alterations that accompany drug binding of the covalent enzyme-DNA intermediate.
CPR:1	 bbbbb1 GENEIN eeeee1  clamps around duplex DNA, wherein the core and  bbbbb2 CHEMICALIN eeeee2 -terminal domains are connected by extended GENEIN (GENEIN), which position the active site CHEMICALIN of the CHEMICALIN-terminal domain within the catalytic pocket
CPR:1	GENEIN clamps around duplex DNA, wherein the core and  bbbbb1 CHEMICALIN eeeee1 -terminal domains are connected by extended  bbbbb2 GENEIN eeeee2  (GENEIN), which position the active site CHEMICALIN of the CHEMICALIN-terminal domain within the catalytic pocket
CPR:1	GENEIN clamps around duplex DNA, wherein the core and  bbbbb1 CHEMICALIN eeeee1 -terminal domains are connected by extended GENEIN ( bbbbb2 GENEIN eeeee2 ), which position the active site CHEMICALIN of the CHEMICALIN-terminal domain within the catalytic pocket
CPR:1	We report that mutation of this conserved  bbbbb1 CHEMICALIN eeeee1  in  bbbbb2 GENEIN eeeee2  alters enzyme sensitivity to CHEMICALIN
CPR:1	 bbbbb1 GENEIN eeeee1  clamps around duplex DNA, wherein the core and CHEMICALIN-terminal domains are connected by extended GENEIN (GENEIN), which position the active site  bbbbb2 CHEMICALIN eeeee2  of the CHEMICALIN-terminal domain within the catalytic pocket
CPR:1	GENEIN clamps around duplex DNA, wherein the core and CHEMICALIN-terminal domains are connected by extended  bbbbb1 GENEIN eeeee1  (GENEIN), which position the active site  bbbbb2 CHEMICALIN eeeee2  of the CHEMICALIN-terminal domain within the catalytic pocket
CPR:1	 bbbbb1 GENEIN eeeee1  clamps around duplex DNA, wherein the core and CHEMICALIN-terminal domains are connected by extended GENEIN (GENEIN), which position the active site CHEMICALIN of the  bbbbb2 CHEMICALIN eeeee2 -terminal domain within the catalytic pocket
CPR:1	GENEIN clamps around duplex DNA, wherein the core and CHEMICALIN-terminal domains are connected by extended GENEIN ( bbbbb1 GENEIN eeeee1 ), which position the active site CHEMICALIN of the  bbbbb2 CHEMICALIN eeeee2 -terminal domain within the catalytic pocket
CPR:1	Crystallographic data reveal that a conserved  bbbbb1 CHEMICALIN eeeee1  residue (located at the juncture between the linker and CHEMICALIN-terminal domains) is at one end of a short  bbbbb2 GENEIN eeeee2 , which extends to the active site CHEMICALIN covalently linked to the DNA
CPR:1	Crystallographic data reveal that a conserved CHEMICALIN residue (located at the juncture between the linker and  bbbbb1 CHEMICALIN eeeee1 -terminal domains) is at one end of a short  bbbbb2 GENEIN eeeee2 , which extends to the active site CHEMICALIN covalently linked to the DNA
CPR:1	Crystallographic data reveal that a conserved CHEMICALIN residue (located at the juncture between the linker and CHEMICALIN-terminal domains) is at one end of a short  bbbbb1 GENEIN eeeee1 , which extends to the active site  bbbbb2 CHEMICALIN eeeee2  covalently linked to the DNA
CPR:1	In the presence of drug, the linker is rigid and this  bbbbb1 GENEIN eeeee1  extends to include  bbbbb2 CHEMICALIN eeeee2  and the preceding CHEMICALIN
CPR:1	In the presence of drug, the linker is rigid and this  bbbbb1 GENEIN eeeee1  extends to include CHEMICALIN and the preceding  bbbbb2 CHEMICALIN eeeee2 
CPR:2	 bbbbb1 GENEIN eeeee1  is the cellular target of the anti-cancer drug  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), which reversibly stabilizes a covalent enzyme-DNA intermediate
CPR:2	 bbbbb1 GENEIN eeeee1  is the cellular target of the anti-cancer drug CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), which reversibly stabilizes a covalent enzyme-DNA intermediate
CPR:2	The physical connection of the linker with the  bbbbb1 GENEIN eeeee1  clamp as well as linker flexibility affect enzyme sensitivity to  bbbbb2 CHEMICALIN eeeee2 
CPR:2	Mutation of Gly721 alters  bbbbb1 GENEIN eeeee1  active site architecture and sensitivity to  bbbbb2 CHEMICALIN eeeee2 
CPR:2	We report that mutation of this conserved CHEMICALIN in  bbbbb1 GENEIN eeeee1  alters enzyme sensitivity to  bbbbb2 CHEMICALIN eeeee2 
CPR:1	The binding of CHEMICALIN to the  bbbbb1 GENEIN eeeee1  protein was demonstrated by 1D NMR titration, and the significant perturbation of the chemical shifts of protons at  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, and CHEMICALIN of CHEMICALIN were observed upon CHEMICALIN binding to the engineered GENEIN in a concentration-dependent manner
CPR:1	The binding of CHEMICALIN to the  bbbbb1 GENEIN eeeee1  protein was demonstrated by 1D NMR titration, and the significant perturbation of the chemical shifts of protons at CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , and CHEMICALIN of CHEMICALIN were observed upon CHEMICALIN binding to the engineered GENEIN in a concentration-dependent manner
CPR:1	The binding of CHEMICALIN to the  bbbbb1 GENEIN eeeee1  protein was demonstrated by 1D NMR titration, and the significant perturbation of the chemical shifts of protons at CHEMICALIN, CHEMICALIN, and  bbbbb2 CHEMICALIN eeeee2  of CHEMICALIN were observed upon CHEMICALIN binding to the engineered GENEIN in a concentration-dependent manner
CPR:1	The binding of CHEMICALIN to the  bbbbb1 GENEIN eeeee1  protein was demonstrated by 1D NMR titration, and the significant perturbation of the chemical shifts of protons at CHEMICALIN, CHEMICALIN, and CHEMICALIN of  bbbbb2 CHEMICALIN eeeee2  were observed upon CHEMICALIN binding to the engineered GENEIN in a concentration-dependent manner
CPR:1	The distances between the protons  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, CHEMICALIN and CHEMICALIN, and CHEMICALIN and CHEMICALIN are shorter following their binding to the  bbbbb2 GENEIN eeeee2  in solution-down to within 5 A
CPR:1	The distances between the protons CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and CHEMICALIN, and CHEMICALIN and CHEMICALIN are shorter following their binding to the  bbbbb2 GENEIN eeeee2  in solution-down to within 5 A
CPR:1	The distances between the protons CHEMICALIN and CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, and CHEMICALIN and CHEMICALIN are shorter following their binding to the  bbbbb2 GENEIN eeeee2  in solution-down to within 5 A
CPR:1	The distances between the protons CHEMICALIN and CHEMICALIN, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , and CHEMICALIN and CHEMICALIN are shorter following their binding to the  bbbbb2 GENEIN eeeee2  in solution-down to within 5 A
CPR:1	The distances between the protons CHEMICALIN and CHEMICALIN, CHEMICALIN and CHEMICALIN, and  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN are shorter following their binding to the  bbbbb2 GENEIN eeeee2  in solution-down to within 5 A
CPR:1	The distances between the protons CHEMICALIN and CHEMICALIN, CHEMICALIN and CHEMICALIN, and CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  are shorter following their binding to the  bbbbb2 GENEIN eeeee2  in solution-down to within 5 A
CPR:2	The binding of  bbbbb1 CHEMICALIN eeeee1  to the  bbbbb2 GENEIN eeeee2  protein was demonstrated by 1D NMR titration, and the significant perturbation of the chemical shifts of protons at CHEMICALIN, CHEMICALIN, and CHEMICALIN of CHEMICALIN were observed upon CHEMICALIN binding to the engineered GENEIN in a concentration-dependent manner
CPR:2	The binding of CHEMICALIN to the GENEIN protein was demonstrated by 1D NMR titration, and the significant perturbation of the chemical shifts of protons at CHEMICALIN, CHEMICALIN, and CHEMICALIN of CHEMICALIN were observed upon  bbbbb1 CHEMICALIN eeeee1  binding to the engineered  bbbbb2 GENEIN eeeee2  in a concentration-dependent manner
CPR:2	The detailed conformational change and 3D structure of the  bbbbb1 GENEIN eeeee1 -bound  bbbbb2 CHEMICALIN eeeee2  were further demonstrated by 2D CHEMICALNOTIN NMR experiments using the transferred NOE technique
CPR:2	High-resolution NMR spectroscopy was used to determine the docking of a substrate (CHEMICALIN) mimic ( bbbbb1 CHEMICALIN eeeee1 ) to the engineered  bbbbb2 GENEIN eeeee2  (GENEIN) in solution
CPR:2	High-resolution NMR spectroscopy was used to determine the docking of a substrate (CHEMICALIN) mimic ( bbbbb1 CHEMICALIN eeeee1 ) to the engineered GENEIN ( bbbbb2 GENEIN eeeee2 ) in solution
CPR:2	High-resolution NMR spectroscopy was used to determine the docking of a substrate ( bbbbb1 CHEMICALIN eeeee1 ) mimic (CHEMICALIN) to the engineered  bbbbb2 GENEIN eeeee2  (GENEIN) in solution
CPR:2	High-resolution NMR spectroscopy was used to determine the docking of a substrate ( bbbbb1 CHEMICALIN eeeee1 ) mimic (CHEMICALIN) to the engineered GENEIN ( bbbbb2 GENEIN eeeee2 ) in solution
CPR:2	The bound conformation of  bbbbb1 CHEMICALIN eeeee1  fits the crystal structure of the  bbbbb2 GENEIN eeeee2  substrate binding pocket considerably better than that of the unbound CHEMICALNOTIN
CPR:2	For example, Trp282 could be one of the most important residues and is suspected to play a role in the determination of specific catalytic function, which has been established by the docking studies using the NMR structure of the  bbbbb1 GENEIN eeeee1 -bound form of  bbbbb2 CHEMICALIN eeeee2  and the GENEIN crystal structure
CPR:2	For example, Trp282 could be one of the most important residues and is suspected to play a role in the determination of specific catalytic function, which has been established by the docking studies using the NMR structure of the GENEIN-bound form of  bbbbb1 CHEMICALIN eeeee1  and the  bbbbb2 GENEIN eeeee2  crystal structure
CPR:2	The noted conformational changes where the CHEMICALNOTIN position is closer to the CHEMICALNOTIN position of  bbbbb1 CHEMICALIN eeeee1  provided the first experimental data for understanding the molecular mechanism of the catalytic function of  bbbbb2 GENEIN eeeee2  in the isomerization of CHEMICALNOTIN to CHEMICALNOTIN.
CPR:4	This overview focuses on the indirect antithrombin dependent CHEMICALNOTIN derivatives of CHEMICALNOTIN and on the most advanced oral direct inhibitors to  bbbbb1 GENEIN eeeee1  ( bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN) and IIa (CHEMICALNOTIN)
CPR:4	This overview focuses on the indirect antithrombin dependent CHEMICALNOTIN derivatives of CHEMICALNOTIN and on the most advanced oral direct inhibitors to  bbbbb1 GENEIN eeeee1  (CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 ) and IIa (CHEMICALNOTIN)
CPR:4	INTERVENTIONS: In the 8-week run-in period, all participants received the  bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2  (5 mg), the ARB CHEMICALNOTINn (80 mg), and the diuretic CHEMICALNOTIN (12.5 mg) as double RAAS blockade to achieve the target blood pressure of less than 130/80 mm Hg
CPR:10	Two  bbbbb1 CHEMICALIN eeeee1  molecules, CHEMICALIN and CHEMICALIN, markedly activated both GENEIN and GENEIN whereas only GENEIN, but not  bbbbb2 GENEIN eeeee2 , was activated by the ligands
CPR:10	Two CHEMICALIN molecules,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, markedly activated both GENEIN and GENEIN whereas only GENEIN, but not  bbbbb2 GENEIN eeeee2 , was activated by the ligands
CPR:10	Two CHEMICALIN molecules, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , markedly activated both GENEIN and GENEIN whereas only GENEIN, but not  bbbbb2 GENEIN eeeee2 , was activated by the ligands
CPR:1	Both  bbbbb1 GENEIN eeeee1  and GENEIN proteins were expressed in cell lines and were  bbbbb2 CHEMICALIN eeeee2 -glycosylated
CPR:1	Both GENEIN and  bbbbb1 GENEIN eeeee1  proteins were expressed in cell lines and were  bbbbb2 CHEMICALIN eeeee2 -glycosylated
CPR:2	Two  bbbbb1 CHEMICALIN eeeee1  molecules, CHEMICALIN and CHEMICALIN, markedly activated both  bbbbb2 GENEIN eeeee2  and GENEIN whereas only GENEIN, but not GENEIN, was activated by the ligands
CPR:2	Two  bbbbb1 CHEMICALIN eeeee1  molecules, CHEMICALIN and CHEMICALIN, markedly activated both GENEIN and  bbbbb2 GENEIN eeeee2  whereas only GENEIN, but not GENEIN, was activated by the ligands
CPR:2	Two  bbbbb1 CHEMICALIN eeeee1  molecules, CHEMICALIN and CHEMICALIN, markedly activated both GENEIN and GENEIN whereas only  bbbbb2 GENEIN eeeee2 , but not GENEIN, was activated by the ligands
CPR:2	Two  bbbbb1 CHEMICALIN eeeee1  molecules, CHEMICALIN and CHEMICALIN, markedly activated both GENEIN and GENEIN whereas only GENEIN, but not  bbbbb2 GENEIN eeeee2 , was activated by the ligands
CPR:2	Two CHEMICALIN molecules,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, markedly activated both  bbbbb2 GENEIN eeeee2  and GENEIN whereas only GENEIN, but not GENEIN, was activated by the ligands
CPR:2	Two CHEMICALIN molecules,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, markedly activated both GENEIN and  bbbbb2 GENEIN eeeee2  whereas only GENEIN, but not GENEIN, was activated by the ligands
CPR:2	Two CHEMICALIN molecules,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, markedly activated both GENEIN and GENEIN whereas only  bbbbb2 GENEIN eeeee2 , but not GENEIN, was activated by the ligands
CPR:2	Two CHEMICALIN molecules,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, markedly activated both GENEIN and GENEIN whereas only GENEIN, but not  bbbbb2 GENEIN eeeee2 , was activated by the ligands
CPR:2	Two CHEMICALIN molecules, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , markedly activated both  bbbbb2 GENEIN eeeee2  and GENEIN whereas only GENEIN, but not GENEIN, was activated by the ligands
CPR:2	Two CHEMICALIN molecules, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , markedly activated both GENEIN and  bbbbb2 GENEIN eeeee2  whereas only GENEIN, but not GENEIN, was activated by the ligands
CPR:2	Two CHEMICALIN molecules, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , markedly activated both GENEIN and GENEIN whereas only  bbbbb2 GENEIN eeeee2 , but not GENEIN, was activated by the ligands
CPR:2	Two CHEMICALIN molecules, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , markedly activated both GENEIN and GENEIN whereas only GENEIN, but not  bbbbb2 GENEIN eeeee2 , was activated by the ligands
CPR:2	Porcine GENEIN and GENEIN are both activated by a selective  bbbbb1 GENEIN eeeee1  ligand,  bbbbb2 CHEMICALIN eeeee2 
CPR:3	Two  bbbbb1 CHEMICALIN eeeee1  molecules, CHEMICALIN and CHEMICALIN, markedly activated both  bbbbb2 GENEIN eeeee2  and GENEIN whereas only GENEIN, but not GENEIN, was activated by the ligands
CPR:3	Two  bbbbb1 CHEMICALIN eeeee1  molecules, CHEMICALIN and CHEMICALIN, markedly activated both GENEIN and  bbbbb2 GENEIN eeeee2  whereas only GENEIN, but not GENEIN, was activated by the ligands
CPR:3	Two  bbbbb1 CHEMICALIN eeeee1  molecules, CHEMICALIN and CHEMICALIN, markedly activated both GENEIN and GENEIN whereas only  bbbbb2 GENEIN eeeee2 , but not GENEIN, was activated by the ligands
CPR:3	Two CHEMICALIN molecules,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, markedly activated both  bbbbb2 GENEIN eeeee2  and GENEIN whereas only GENEIN, but not GENEIN, was activated by the ligands
CPR:3	Two CHEMICALIN molecules,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, markedly activated both GENEIN and  bbbbb2 GENEIN eeeee2  whereas only GENEIN, but not GENEIN, was activated by the ligands
CPR:3	Two CHEMICALIN molecules,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, markedly activated both GENEIN and GENEIN whereas only  bbbbb2 GENEIN eeeee2 , but not GENEIN, was activated by the ligands
CPR:3	Two CHEMICALIN molecules, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , markedly activated both  bbbbb2 GENEIN eeeee2  and GENEIN whereas only GENEIN, but not GENEIN, was activated by the ligands
CPR:3	Two CHEMICALIN molecules, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , markedly activated both GENEIN and  bbbbb2 GENEIN eeeee2  whereas only GENEIN, but not GENEIN, was activated by the ligands
CPR:3	Two CHEMICALIN molecules, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , markedly activated both GENEIN and GENEIN whereas only  bbbbb2 GENEIN eeeee2 , but not GENEIN, was activated by the ligands
CPR:3	Porcine GENEIN and  bbbbb1 GENEIN eeeee1  are both activated by a selective GENEIN ligand,  bbbbb2 CHEMICALIN eeeee2 
CPR:3	Porcine  bbbbb1 GENEIN eeeee1  and GENEIN are both activated by a selective GENEIN ligand,  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Moreover, activation of transfected cells and porcine PBMC by  bbbbb1 GENEIN eeeee1  ligands was inhibited by  bbbbb2 CHEMICALIN eeeee2  indicating the requirement of endosomal/lysosomal acidification for activation of the receptors.
CPR:2	Estimated affinities for the fast-inactivated channel state were 81 nM, 312 nM and 227 nM for  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and CHEMICALIN in  bbbbb2 GENEIN eeeee2 , and 450 nM for CHEMICALIN in GENEIN
CPR:2	Estimated affinities for the fast-inactivated channel state were 81 nM, 312 nM and 227 nM for CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN in  bbbbb2 GENEIN eeeee2 , and 450 nM for CHEMICALIN in GENEIN
CPR:2	Estimated affinities for the fast-inactivated channel state were 81 nM, 312 nM and 227 nM for CHEMICALIN, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  in  bbbbb2 GENEIN eeeee2 , and 450 nM for CHEMICALIN in GENEIN
CPR:2	Estimated affinities for the fast-inactivated channel state were 81 nM, 312 nM and 227 nM for CHEMICALIN, CHEMICALIN and CHEMICALIN in GENEIN, and 450 nM for  bbbbb1 CHEMICALIN eeeee1  in  bbbbb2 GENEIN eeeee2 
CPR:2	CONCLUSIONS AND IMPLICATIONS: CHEMICALIN analogues constitute a novel class of  bbbbb1 GENEIN eeeee1 -blocking drugs possessing almost 100-fold higher potency compared with the local anaesthetic and anti-arrhythmic drug  bbbbb2 CHEMICALIN eeeee2 
CPR:4	The IC(50) for block of resting channels at -150 mV was 2.3, 3.9 and 11.3 microM in GENENOTIN, respectively, and 29.2 microM for  bbbbb1 CHEMICALIN eeeee1  in  bbbbb2 GENEIN eeeee2 
CPR:4	Estimated affinities for the fast-inactivated channel state were 81 nM, 312 nM and 227 nM for  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and CHEMICALIN in  bbbbb2 GENEIN eeeee2 , and 450 nM for CHEMICALIN in GENEIN
CPR:4	High-affinity blockade of  bbbbb1 GENEIN eeeee1  by  bbbbb2 CHEMICALIN eeeee2  analogues
CPR:4	Estimated affinities for the fast-inactivated channel state were 81 nM, 312 nM and 227 nM for CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN in  bbbbb2 GENEIN eeeee2 , and 450 nM for CHEMICALIN in GENEIN
CPR:4	Estimated affinities for the fast-inactivated channel state were 81 nM, 312 nM and 227 nM for CHEMICALIN, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  in  bbbbb2 GENEIN eeeee2 , and 450 nM for CHEMICALIN in GENEIN
CPR:4	Estimated affinities for the fast-inactivated channel state were 81 nM, 312 nM and 227 nM for CHEMICALIN, CHEMICALIN and CHEMICALIN in GENEIN, and 450 nM for  bbbbb1 CHEMICALIN eeeee1  in  bbbbb2 GENEIN eeeee2 
CPR:4	CONCLUSIONS AND IMPLICATIONS:  bbbbb1 CHEMICALIN eeeee1  analogues constitute a novel class of  bbbbb2 GENEIN eeeee2 -blocking drugs possessing almost 100-fold higher potency compared with the local anaesthetic and anti-arrhythmic drug CHEMICALIN
CPR:6	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN), an  bbbbb2 GENEIN eeeee2  antagonist, is approved in many countries worldwide for the treatment of hypertension
CPR:6	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN), an  bbbbb2 GENEIN eeeee2  antagonist, is approved in many countries worldwide for the treatment of hypertension
CPR:6	CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN), an  bbbbb2 GENEIN eeeee2  antagonist, is approved in many countries worldwide for the treatment of hypertension
CPR:6	CHEMICALIN (CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN), an  bbbbb2 GENEIN eeeee2  antagonist, is approved in many countries worldwide for the treatment of hypertension
CPR:6	CHEMICALIN (CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ), an  bbbbb2 GENEIN eeeee2  antagonist, is approved in many countries worldwide for the treatment of hypertension
CPR:2	When  bbbbb1 GENEIN eeeee1 , which is a central component of HR, was depleted by siRNA cells were sensitized to  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), which specifically inhibits GENEIN
CPR:2	When  bbbbb1 GENEIN eeeee1 , which is a central component of HR, was depleted by siRNA cells were sensitized to CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), which specifically inhibits GENEIN
CPR:2	 bbbbb1 CHEMICALIN eeeee1  treatment also induced foci of GENEIN, GENEIN, GENEIN, and GENEIN, although the extent of co-localization with  bbbbb2 GENEIN eeeee2  foci varied
CPR:2	Phosphorylation of  bbbbb1 GENEIN eeeee1  (GENEIN subunit) and formation of damage-induced foci were strikingly evident following IC(50) doses of  bbbbb2 CHEMICALIN eeeee2 
CPR:2	Phosphorylation of GENEIN ( bbbbb1 GENEIN eeeee1  subunit) and formation of damage-induced foci were strikingly evident following IC(50) doses of  bbbbb2 CHEMICALIN eeeee2 
CPR:3	 bbbbb1 CHEMICALIN eeeee1  treatment also induced foci of  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN, and GENEIN, although the extent of co-localization with GENEIN foci varied
CPR:3	 bbbbb1 CHEMICALIN eeeee1  treatment also induced foci of GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN, although the extent of co-localization with GENEIN foci varied
CPR:3	 bbbbb1 CHEMICALIN eeeee1  treatment also induced foci of GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN, although the extent of co-localization with GENEIN foci varied
CPR:3	 bbbbb1 CHEMICALIN eeeee1  treatment also induced foci of GENEIN, GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2 , although the extent of co-localization with GENEIN foci varied
CPR:4	When GENEIN, which is a central component of HR, was depleted by siRNA cells were sensitized to CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), which specifically inhibits  bbbbb2 GENEIN eeeee2 
CPR:9	DNA damage is accepted as a consequence of  bbbbb1 CHEMICALIN eeeee1  deprivation induced by chemotherapeutic inhibitors of  bbbbb2 GENEIN eeeee2  (GENEIN), but the types of damage and signaling responses remain incompletely understood
CPR:9	DNA damage is accepted as a consequence of  bbbbb1 CHEMICALIN eeeee1  deprivation induced by chemotherapeutic inhibitors of GENEIN ( bbbbb2 GENEIN eeeee2 ), but the types of damage and signaling responses remain incompletely understood
CPR:2	These data support the concept that adipose tissue  bbbbb1 GENEIN eeeee1  contributes to the increased plasma CHEMICALIN levels in patients treated with  bbbbb2 CHEMICALIN eeeee2 .
CPR:3	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a widely used drug to lower elevated plasma lipid levels, induced  bbbbb2 GENEIN eeeee2  enzyme activity in white adipose tissue of mice
CPR:3	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a widely used drug to lower elevated plasma lipid levels, induced  bbbbb2 GENEIN eeeee2  enzyme activity in white adipose tissue of mice
CPR:4	CHEMICALNOTIN release increased during 3T3-L1 differentiation and was reduced when adipose tissue was treated with the  bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2 
CPR:9	 bbbbb1 GENEIN eeeee1  (GENEIN) catalyses the conversion of CHEMICALIN to  bbbbb2 CHEMICALIN eeeee2  and plays an important role in hepatic detoxification reactions
CPR:9	GENEIN ( bbbbb1 GENEIN eeeee1 ) catalyses the conversion of CHEMICALIN to  bbbbb2 CHEMICALIN eeeee2  and plays an important role in hepatic detoxification reactions
CPR:9	These data support the concept that adipose tissue  bbbbb1 GENEIN eeeee1  contributes to the increased plasma  bbbbb2 CHEMICALIN eeeee2  levels in patients treated with CHEMICALIN.
CPR:9	 bbbbb1 CHEMICALIN eeeee1 , the atherogenic product of the  bbbbb2 GENEIN eeeee2 -catalyzed reaction, was secreted from 3T3-L1 cells or adipose tissue cultures
CPR:9	 bbbbb1 GENEIN eeeee1  (GENEIN) catalyses the conversion of  bbbbb2 CHEMICALIN eeeee2  to CHEMICALIN and plays an important role in hepatic detoxification reactions
CPR:9	GENEIN ( bbbbb1 GENEIN eeeee1 ) catalyses the conversion of  bbbbb2 CHEMICALIN eeeee2  to CHEMICALIN and plays an important role in hepatic detoxification reactions
CPR:2	The GENEIN ( bbbbb1 GENEIN eeeee1 ) isoforms GENEIN and GENEIN display similar CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) binding properties and are both expressed in mammalian brain
CPR:2	The  bbbbb1 GENEIN eeeee1  (GENEIN) isoforms GENEIN and GENEIN display similar CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) binding properties and are both expressed in mammalian brain
CPR:2	The GENEIN (GENEIN) isoforms  bbbbb1 GENEIN eeeee1  and GENEIN display similar CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) binding properties and are both expressed in mammalian brain
CPR:2	The GENEIN (GENEIN) isoforms GENEIN and  bbbbb1 GENEIN eeeee1  display similar CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) binding properties and are both expressed in mammalian brain
CPR:2	Inhibition of  bbbbb1 CHEMICALIN eeeee1  binding to GENENOTINDHP(-/-) (predominantly  bbbbb2 GENEIN eeeee2 ) and wild-type (predominantly GENEIN) brain membranes by unlabeled DHPs revealed a 3- to 4-fold selectivity of CHEMICALIN and CHEMICALIN for the GENEIN binding pocket, a finding further confirmed with heterologously expressed channels
CPR:2	Inhibition of  bbbbb1 CHEMICALIN eeeee1  binding to GENENOTINDHP(-/-) (predominantly GENEIN) and wild-type (predominantly  bbbbb2 GENEIN eeeee2 ) brain membranes by unlabeled DHPs revealed a 3- to 4-fold selectivity of CHEMICALIN and CHEMICALIN for the GENEIN binding pocket, a finding further confirmed with heterologously expressed channels
CPR:2	Inhibition of CHEMICALIN binding to GENENOTINDHP(-/-) (predominantly GENEIN) and wild-type (predominantly GENEIN) brain membranes by unlabeled DHPs revealed a 3- to 4-fold selectivity of  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN for the  bbbbb2 GENEIN eeeee2  binding pocket, a finding further confirmed with heterologously expressed channels
CPR:2	Inhibition of CHEMICALIN binding to GENENOTINDHP(-/-) (predominantly GENEIN) and wild-type (predominantly GENEIN) brain membranes by unlabeled DHPs revealed a 3- to 4-fold selectivity of CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  for the  bbbbb2 GENEIN eeeee2  binding pocket, a finding further confirmed with heterologously expressed channels
CPR:2	 bbbbb1 CHEMICALIN eeeee1  binding to GENENOTINDHP(-/-) and  bbbbb2 GENEIN eeeee2 -DM brains was reduced to 15.1 and 4.4% of wild type, respectively, indicating that GENEIN accounts for 10.7% of brain GENEIN. qPCR revealed that GENENOTIN and GENENOTIN subunits comprised 0.08% of the GENENOTIN transcripts in mouse whole brain, suggesting that they cannot account for the residual binding
CPR:2	 bbbbb1 CHEMICALIN eeeee1  binding to GENENOTINDHP(-/-) and GENEIN-DM brains was reduced to 15.1 and 4.4% of wild type, respectively, indicating that  bbbbb2 GENEIN eeeee2  accounts for 10.7% of brain GENEIN. qPCR revealed that GENENOTIN and GENENOTIN subunits comprised 0.08% of the GENENOTIN transcripts in mouse whole brain, suggesting that they cannot account for the residual binding
CPR:2	 bbbbb1 CHEMICALIN eeeee1  binding to GENENOTINDHP(-/-) and GENEIN-DM brains was reduced to 15.1 and 4.4% of wild type, respectively, indicating that GENEIN accounts for 10.7% of brain  bbbbb2 GENEIN eeeee2 . qPCR revealed that GENENOTIN and GENENOTIN subunits comprised 0.08% of the GENENOTIN transcripts in mouse whole brain, suggesting that they cannot account for the residual binding
CPR:2	The GENEIN ( bbbbb1 GENEIN eeeee1 ) isoforms GENEIN and GENEIN display similar  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) binding properties and are both expressed in mammalian brain
CPR:2	The  bbbbb1 GENEIN eeeee1  (GENEIN) isoforms GENEIN and GENEIN display similar  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) binding properties and are both expressed in mammalian brain
CPR:2	The GENEIN (GENEIN) isoforms  bbbbb1 GENEIN eeeee1  and GENEIN display similar  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) binding properties and are both expressed in mammalian brain
CPR:2	The GENEIN (GENEIN) isoforms GENEIN and  bbbbb1 GENEIN eeeee1  display similar  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) binding properties and are both expressed in mammalian brain
CPR:2	Expression and  bbbbb1 CHEMICALIN eeeee1 -binding properties of brain  bbbbb2 GENEIN eeeee2  isoforms
CPR:10	 bbbbb1 CHEMICALIN eeeee1  did not inhibit  bbbbb2 GENEIN eeeee2  or GENEIN, but prominently targeted the apoptosis-linked GENEIN
CPR:10	 bbbbb1 CHEMICALIN eeeee1  did not inhibit GENEIN or  bbbbb2 GENEIN eeeee2 , but prominently targeted the apoptosis-linked GENEIN
CPR:10	Although in vivo  bbbbb1 CHEMICALIN eeeee1  is inactive against  bbbbb2 GENEIN eeeee2  GENEIN, we found this clinically important mutant to be enzymatically inhibited in the mid-nanomolar range
CPR:10	Although in vivo  bbbbb1 CHEMICALIN eeeee1  is inactive against GENEIN  bbbbb2 GENEIN eeeee2 , we found this clinically important mutant to be enzymatically inhibited in the mid-nanomolar range
CPR:2	 bbbbb1 CHEMICALIN eeeee1  did not inhibit GENEIN or GENEIN, but prominently targeted the apoptosis-linked  bbbbb2 GENEIN eeeee2 
CPR:4	A comparison of CHEMICALIN with  bbbbb1 CHEMICALIN eeeee1  across the whole  bbbbb2 GENEIN eeeee2  panel revealed overlapping, but distinct, inhibition profiles
CPR:4	Global target profile of the  bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2  in primary chronic myeloid leukemia cells
CPR:4	Finally,  bbbbb1 CHEMICALIN eeeee1  is the first  bbbbb2 GENEIN eeeee2  inhibitor shown to target GENEIN, recently implicated in myeloid leukemia cell proliferation.
CPR:4	Finally,  bbbbb1 CHEMICALIN eeeee1  is the first GENEIN inhibitor shown to target  bbbbb2 GENEIN eeeee2 , recently implicated in myeloid leukemia cell proliferation.
CPR:4	Here, we characterized the target profile of the dual  bbbbb1 GENEIN eeeee1 /GENEIN inhibitor  bbbbb2 CHEMICALIN eeeee2  employing a two-tiered approach using chemical proteomics to identify natural binders in whole cell lysates of primary CML and K562 cells in parallel to in vitro GENENOTIN assays against a large recombinant GENENOTIN panel
CPR:4	Here, we characterized the target profile of the dual GENEIN/ bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2  employing a two-tiered approach using chemical proteomics to identify natural binders in whole cell lysates of primary CML and K562 cells in parallel to in vitro GENENOTIN assays against a large recombinant GENENOTIN panel
CPR:4	A comparison of  bbbbb1 CHEMICALIN eeeee1  with CHEMICALIN across the whole  bbbbb2 GENEIN eeeee2  panel revealed overlapping, but distinct, inhibition profiles
CPR:10	A positively charged derivative,  bbbbb1 CHEMICALIN eeeee1 , did not inhibit microtubule assembly or alter the composition of the coassembled  bbbbb2 GENEIN eeeee2 
CPR:10	The uncharged  bbbbb1 CHEMICALIN eeeee1  bound to both GENEIN and GENEIN, but no effects were seen on microtubule assembly, the composition of coassembled  bbbbb2 GENEIN eeeee2  or the microtubule morphology
CPR:1	Both these GENEIN were found to have two to three binding sites for CHEMICALIN which is compatible with the reported number of basic  bbbbb1 CHEMICALIN eeeee1  repeats of these  bbbbb2 GENEIN eeeee2 , considered to be the ultimate GENEIN binding domains
CPR:1	Both these GENEIN were found to have two to three binding sites for CHEMICALIN which is compatible with the reported number of basic  bbbbb1 CHEMICALIN eeeee1  repeats of these GENEIN, considered to be the ultimate  bbbbb2 GENEIN eeeee2  binding domains
CPR:2	Both these  bbbbb1 GENEIN eeeee1  were found to have two to three binding sites for  bbbbb2 CHEMICALIN eeeee2  which is compatible with the reported number of basic CHEMICALIN repeats of these GENEIN, considered to be the ultimate GENEIN binding domains
CPR:2	The Kd for the binding of  bbbbb1 CHEMICALIN eeeee1  to  bbbbb2 GENEIN eeeee2  was estimated to be 20 microM at 4 degrees, and for the binding of tau, 200 microM
CPR:2	The uncharged  bbbbb1 CHEMICALIN eeeee1  bound to both  bbbbb2 GENEIN eeeee2  and GENEIN, but no effects were seen on microtubule assembly, the composition of coassembled GENEIN or the microtubule morphology
CPR:2	The uncharged  bbbbb1 CHEMICALIN eeeee1  bound to both GENEIN and  bbbbb2 GENEIN eeeee2 , but no effects were seen on microtubule assembly, the composition of coassembled GENEIN or the microtubule morphology
CPR:2	Our results suggest that only negatively charged  bbbbb1 CHEMICALIN eeeee1  derivatives have a  bbbbb2 GENEIN eeeee2 -dependent microtubule inhibitory effect
CPR:2	The negatively charged  bbbbb1 CHEMICALIN eeeee1  has been found previously to be a  bbbbb2 GENEIN eeeee2  (GENEIN)-dependent microtubule inhibitor [Wallin M, Deinum J and Friden B, FEBS Lett 179: 289-293, 1985]
CPR:2	The negatively charged  bbbbb1 CHEMICALIN eeeee1  has been found previously to be a GENEIN ( bbbbb2 GENEIN eeeee2 )-dependent microtubule inhibitor [Wallin M, Deinum J and Friden B, FEBS Lett 179: 289-293, 1985]
CPR:2	Two new negatively charged  bbbbb1 CHEMICALIN eeeee1  derivatives, CHEMICALIN and CHEMICALIN, were found to be similar  bbbbb2 GENEIN eeeee2 -dependent microtubule inhibitors
CPR:2	Two new negatively charged CHEMICALIN derivatives,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, were found to be similar  bbbbb2 GENEIN eeeee2 -dependent microtubule inhibitors
CPR:2	Two new negatively charged CHEMICALIN derivatives, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , were found to be similar  bbbbb2 GENEIN eeeee2 -dependent microtubule inhibitors
CPR:10	Unlike bacterial  bbbbb1 GENEIN eeeee1 , the human isomerase reaction is stimulated by  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN, CHEMICALIN)
CPR:10	Unlike bacterial  bbbbb1 GENEIN eeeee1 , the human isomerase reaction is stimulated by CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN)
CPR:10	Unlike bacterial  bbbbb1 GENEIN eeeee1 , the human isomerase reaction is stimulated by CHEMICALIN (CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 )
CPR:10	The  bbbbb1 CHEMICALIN eeeee1  substrate, CHEMICALIN, protects isomerase as well as  bbbbb2 GENEIN eeeee2  from inactivation by CHEMICALIN
CPR:10	The CHEMICALIN substrate,  bbbbb1 CHEMICALIN eeeee1 , protects isomerase as well as  bbbbb2 GENEIN eeeee2  from inactivation by CHEMICALIN
CPR:2	Analysis of coenzyme binding by  bbbbb1 GENEIN eeeee1  and GENEIN using  bbbbb2 CHEMICALIN eeeee2 , an affinity labeling cofactor analog
CPR:2	Analysis of coenzyme binding by GENEIN and  bbbbb1 GENEIN eeeee1  using  bbbbb2 CHEMICALIN eeeee2 , an affinity labeling cofactor analog
CPR:4	The affinity labeling  bbbbb1 CHEMICALIN eeeee1  analog, CHEMICALIN (CHEMICALIN), inactivates the  bbbbb2 GENEIN eeeee2  and isomerase activities at similar rates in an irreversible manner which follows first order kinetics with respect to both time and alkylator concentration (0.2-0.6 mM)
CPR:4	The affinity labeling CHEMICALIN analog,  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), inactivates the  bbbbb2 GENEIN eeeee2  and isomerase activities at similar rates in an irreversible manner which follows first order kinetics with respect to both time and alkylator concentration (0.2-0.6 mM)
CPR:4	The affinity labeling CHEMICALIN analog, CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), inactivates the  bbbbb2 GENEIN eeeee2  and isomerase activities at similar rates in an irreversible manner which follows first order kinetics with respect to both time and alkylator concentration (0.2-0.6 mM)
CPR:4	The CHEMICALIN substrate, CHEMICALIN, protects isomerase as well as  bbbbb1 GENEIN eeeee1  from inactivation by  bbbbb2 CHEMICALIN eeeee2 
CPR:8	Analysis of coenzyme binding by  bbbbb1 GENEIN eeeee1  and GENEIN using  bbbbb2 CHEMICALIN eeeee2 , an affinity labeling cofactor analog
CPR:8	Analysis of coenzyme binding by GENEIN and  bbbbb1 GENEIN eeeee1  using  bbbbb2 CHEMICALIN eeeee2 , an affinity labeling cofactor analog
CPR:8	FSA is a cofactor site-directed reagent that binds with similar affinity as a competitive inhibitor of  bbbbb1 CHEMICALIN eeeee1  reduction by  bbbbb2 GENEIN eeeee2  (Ki = 162 microM) or as a stimulator of isomerase (Km = 153 microM)
CPR:9	Affinity alkylation with 2 CHEMICALNOTIN suggests that the  bbbbb1 GENEIN eeeee1  and isomerase substrate  bbbbb2 CHEMICALIN eeeee2  bind at different sites on the same protein
CPR:4	Others kinase inhibitors used recently in cancer therapy include CHEMICALIN (CHEMICALIN) specific for GENEIN GENEIN, CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN, CHEMICALIN) and CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN) specific for  bbbbb2 GENEIN eeeee2  GENEIN, CHEMICALIN (CHEMICALIN) and CHEMICALIN (CHEMICALIN) specific for GENEIN kinase
CPR:4	Others kinase inhibitors used recently in cancer therapy include CHEMICALIN (CHEMICALIN) specific for GENEIN GENEIN, CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN, CHEMICALIN) and CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN) specific for GENEIN  bbbbb2 GENEIN eeeee2 , CHEMICALIN (CHEMICALIN) and CHEMICALIN (CHEMICALIN) specific for GENEIN kinase
CPR:4	Others kinase inhibitors used recently in cancer therapy include CHEMICALIN (CHEMICALIN) specific for GENEIN GENEIN, CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN, CHEMICALIN) and CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ) specific for  bbbbb2 GENEIN eeeee2  GENEIN, CHEMICALIN (CHEMICALIN) and CHEMICALIN (CHEMICALIN) specific for GENEIN kinase
CPR:4	Others kinase inhibitors used recently in cancer therapy include CHEMICALIN (CHEMICALIN) specific for GENEIN GENEIN, CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN, CHEMICALIN) and CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ) specific for GENEIN  bbbbb2 GENEIN eeeee2 , CHEMICALIN (CHEMICALIN) and CHEMICALIN (CHEMICALIN) specific for GENEIN kinase
CPR:4	Others kinase inhibitors used recently in cancer therapy include CHEMICALIN (CHEMICALIN) specific for GENEIN GENEIN, CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN, CHEMICALIN) and CHEMICALIN (CHEMICALIN, CHEMICALIN) specific for GENEIN GENEIN,  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) and CHEMICALIN (CHEMICALIN) specific for  bbbbb2 GENEIN eeeee2  kinase
CPR:4	Others kinase inhibitors used recently in cancer therapy include CHEMICALIN (CHEMICALIN) specific for GENEIN GENEIN, CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN, CHEMICALIN) and CHEMICALIN (CHEMICALIN, CHEMICALIN) specific for GENEIN GENEIN, CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) and CHEMICALIN (CHEMICALIN) specific for  bbbbb2 GENEIN eeeee2  kinase
CPR:4	Others kinase inhibitors used recently in cancer therapy include CHEMICALIN (CHEMICALIN) specific for GENEIN GENEIN, CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN, CHEMICALIN) and CHEMICALIN (CHEMICALIN, CHEMICALIN) specific for GENEIN GENEIN, CHEMICALIN (CHEMICALIN) and  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) specific for  bbbbb2 GENEIN eeeee2  kinase
CPR:4	Others kinase inhibitors used recently in cancer therapy include CHEMICALIN (CHEMICALIN) specific for GENEIN GENEIN, CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN, CHEMICALIN) and CHEMICALIN (CHEMICALIN, CHEMICALIN) specific for GENEIN GENEIN, CHEMICALIN (CHEMICALIN) and CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) specific for  bbbbb2 GENEIN eeeee2  kinase
CPR:4	The following  bbbbb1 GENEIN eeeee1  blockers for treatment of various human tumors are in clinical development:  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN, CHEMICALIN, CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN/CHEMICALIN), CHEMICALIN (CHEMICALIN, CHEMICALIN), and CHEMICALIN (CHEMICALIN, CHEMICALIN)
CPR:4	The following  bbbbb1 GENEIN eeeee1  blockers for treatment of various human tumors are in clinical development: CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN/CHEMICALIN), CHEMICALIN (CHEMICALIN, CHEMICALIN), and CHEMICALIN (CHEMICALIN, CHEMICALIN)
CPR:4	The following  bbbbb1 GENEIN eeeee1  blockers for treatment of various human tumors are in clinical development: CHEMICALIN (CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN/CHEMICALIN), CHEMICALIN (CHEMICALIN, CHEMICALIN), and CHEMICALIN (CHEMICALIN, CHEMICALIN)
CPR:4	The following  bbbbb1 GENEIN eeeee1  blockers for treatment of various human tumors are in clinical development: CHEMICALIN (CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 ), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN/CHEMICALIN), CHEMICALIN (CHEMICALIN, CHEMICALIN), and CHEMICALIN (CHEMICALIN, CHEMICALIN)
CPR:4	The following  bbbbb1 GENEIN eeeee1  blockers for treatment of various human tumors are in clinical development: CHEMICALIN (CHEMICALIN, CHEMICALIN, CHEMICALIN),  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN/CHEMICALIN), CHEMICALIN (CHEMICALIN, CHEMICALIN), and CHEMICALIN (CHEMICALIN, CHEMICALIN)
CPR:4	The following  bbbbb1 GENEIN eeeee1  blockers for treatment of various human tumors are in clinical development: CHEMICALIN (CHEMICALIN, CHEMICALIN, CHEMICALIN), CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN/CHEMICALIN), CHEMICALIN (CHEMICALIN, CHEMICALIN), and CHEMICALIN (CHEMICALIN, CHEMICALIN)
CPR:4	The following  bbbbb1 GENEIN eeeee1  blockers for treatment of various human tumors are in clinical development: CHEMICALIN (CHEMICALIN, CHEMICALIN, CHEMICALIN), CHEMICALIN (CHEMICALIN),  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), CHEMICALIN (CHEMICALIN/CHEMICALIN), CHEMICALIN (CHEMICALIN, CHEMICALIN), and CHEMICALIN (CHEMICALIN, CHEMICALIN)
CPR:4	The following  bbbbb1 GENEIN eeeee1  blockers for treatment of various human tumors are in clinical development: CHEMICALIN (CHEMICALIN, CHEMICALIN, CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), CHEMICALIN (CHEMICALIN/CHEMICALIN), CHEMICALIN (CHEMICALIN, CHEMICALIN), and CHEMICALIN (CHEMICALIN, CHEMICALIN)
CPR:4	The following  bbbbb1 GENEIN eeeee1  blockers for treatment of various human tumors are in clinical development: CHEMICALIN (CHEMICALIN, CHEMICALIN, CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN),  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN/CHEMICALIN), CHEMICALIN (CHEMICALIN, CHEMICALIN), and CHEMICALIN (CHEMICALIN, CHEMICALIN)
CPR:4	The following  bbbbb1 GENEIN eeeee1  blockers for treatment of various human tumors are in clinical development: CHEMICALIN (CHEMICALIN, CHEMICALIN, CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 /CHEMICALIN), CHEMICALIN (CHEMICALIN, CHEMICALIN), and CHEMICALIN (CHEMICALIN, CHEMICALIN)
CPR:4	The following  bbbbb1 GENEIN eeeee1  blockers for treatment of various human tumors are in clinical development: CHEMICALIN (CHEMICALIN, CHEMICALIN, CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN/ bbbbb2 CHEMICALIN eeeee2 ), CHEMICALIN (CHEMICALIN, CHEMICALIN), and CHEMICALIN (CHEMICALIN, CHEMICALIN)
CPR:4	The following  bbbbb1 GENEIN eeeee1  blockers for treatment of various human tumors are in clinical development: CHEMICALIN (CHEMICALIN, CHEMICALIN, CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN/CHEMICALIN),  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN, CHEMICALIN), and CHEMICALIN (CHEMICALIN, CHEMICALIN)
CPR:4	The following  bbbbb1 GENEIN eeeee1  blockers for treatment of various human tumors are in clinical development: CHEMICALIN (CHEMICALIN, CHEMICALIN, CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN/CHEMICALIN), CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN), and CHEMICALIN (CHEMICALIN, CHEMICALIN)
CPR:4	The following  bbbbb1 GENEIN eeeee1  blockers for treatment of various human tumors are in clinical development: CHEMICALIN (CHEMICALIN, CHEMICALIN, CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN/CHEMICALIN), CHEMICALIN (CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 ), and CHEMICALIN (CHEMICALIN, CHEMICALIN)
CPR:4	Others kinase inhibitors used recently in cancer therapy include  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) specific for  bbbbb2 GENEIN eeeee2  GENEIN, CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN, CHEMICALIN) and CHEMICALIN (CHEMICALIN, CHEMICALIN) specific for GENEIN GENEIN, CHEMICALIN (CHEMICALIN) and CHEMICALIN (CHEMICALIN) specific for GENEIN kinase
CPR:4	Others kinase inhibitors used recently in cancer therapy include  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) specific for GENEIN  bbbbb2 GENEIN eeeee2 , CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN, CHEMICALIN) and CHEMICALIN (CHEMICALIN, CHEMICALIN) specific for GENEIN GENEIN, CHEMICALIN (CHEMICALIN) and CHEMICALIN (CHEMICALIN) specific for GENEIN kinase
CPR:4	The following  bbbbb1 GENEIN eeeee1  blockers for treatment of various human tumors are in clinical development: CHEMICALIN (CHEMICALIN, CHEMICALIN, CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN/CHEMICALIN), CHEMICALIN (CHEMICALIN, CHEMICALIN), and  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN, CHEMICALIN)
CPR:4	The following  bbbbb1 GENEIN eeeee1  blockers for treatment of various human tumors are in clinical development: CHEMICALIN (CHEMICALIN, CHEMICALIN, CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN/CHEMICALIN), CHEMICALIN (CHEMICALIN, CHEMICALIN), and CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN)
CPR:4	The following  bbbbb1 GENEIN eeeee1  blockers for treatment of various human tumors are in clinical development: CHEMICALIN (CHEMICALIN, CHEMICALIN, CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN/CHEMICALIN), CHEMICALIN (CHEMICALIN, CHEMICALIN), and CHEMICALIN (CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 )
CPR:4	The most successful example of  bbbbb1 GENEIN eeeee1  blockers is  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN, CHEMICALIN, CHEMICALIN), the inhibitor of GENEIN/GENEIN oncoprotein, which has become a first-line therapy for chronic myelogenous leukemia
CPR:4	The most successful example of GENEIN blockers is  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN, CHEMICALIN), the inhibitor of  bbbbb2 GENEIN eeeee2 /GENEIN oncoprotein, which has become a first-line therapy for chronic myelogenous leukemia
CPR:4	The most successful example of GENEIN blockers is  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN, CHEMICALIN), the inhibitor of GENEIN/ bbbbb2 GENEIN eeeee2  oncoprotein, which has become a first-line therapy for chronic myelogenous leukemia
CPR:4	The most successful example of  bbbbb1 GENEIN eeeee1  blockers is CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN), the inhibitor of GENEIN/GENEIN oncoprotein, which has become a first-line therapy for chronic myelogenous leukemia
CPR:4	The most successful example of GENEIN blockers is CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN), the inhibitor of  bbbbb2 GENEIN eeeee2 /GENEIN oncoprotein, which has become a first-line therapy for chronic myelogenous leukemia
CPR:4	The most successful example of GENEIN blockers is CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN), the inhibitor of GENEIN/ bbbbb2 GENEIN eeeee2  oncoprotein, which has become a first-line therapy for chronic myelogenous leukemia
CPR:4	The most successful example of  bbbbb1 GENEIN eeeee1  blockers is CHEMICALIN (CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN), the inhibitor of GENEIN/GENEIN oncoprotein, which has become a first-line therapy for chronic myelogenous leukemia
CPR:4	The most successful example of GENEIN blockers is CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN), the inhibitor of  bbbbb2 GENEIN eeeee2 /GENEIN oncoprotein, which has become a first-line therapy for chronic myelogenous leukemia
CPR:4	The most successful example of GENEIN blockers is CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN), the inhibitor of GENEIN/ bbbbb2 GENEIN eeeee2  oncoprotein, which has become a first-line therapy for chronic myelogenous leukemia
CPR:4	The most successful example of  bbbbb1 GENEIN eeeee1  blockers is CHEMICALIN (CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 ), the inhibitor of GENEIN/GENEIN oncoprotein, which has become a first-line therapy for chronic myelogenous leukemia
CPR:4	The most successful example of GENEIN blockers is CHEMICALIN (CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ), the inhibitor of  bbbbb2 GENEIN eeeee2 /GENEIN oncoprotein, which has become a first-line therapy for chronic myelogenous leukemia
CPR:4	The most successful example of GENEIN blockers is CHEMICALIN (CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ), the inhibitor of GENEIN/ bbbbb2 GENEIN eeeee2  oncoprotein, which has become a first-line therapy for chronic myelogenous leukemia
CPR:4	Others kinase inhibitors used recently in cancer therapy include CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) specific for  bbbbb2 GENEIN eeeee2  GENEIN, CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN, CHEMICALIN) and CHEMICALIN (CHEMICALIN, CHEMICALIN) specific for GENEIN GENEIN, CHEMICALIN (CHEMICALIN) and CHEMICALIN (CHEMICALIN) specific for GENEIN kinase
CPR:4	Others kinase inhibitors used recently in cancer therapy include CHEMICALIN (CHEMICALIN) specific for GENEIN GENEIN,  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), CHEMICALIN (CHEMICALIN, CHEMICALIN) and CHEMICALIN (CHEMICALIN, CHEMICALIN) specific for  bbbbb2 GENEIN eeeee2  GENEIN, CHEMICALIN (CHEMICALIN) and CHEMICALIN (CHEMICALIN) specific for GENEIN kinase
CPR:4	Others kinase inhibitors used recently in cancer therapy include CHEMICALIN (CHEMICALIN) specific for GENEIN GENEIN,  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), CHEMICALIN (CHEMICALIN, CHEMICALIN) and CHEMICALIN (CHEMICALIN, CHEMICALIN) specific for GENEIN  bbbbb2 GENEIN eeeee2 , CHEMICALIN (CHEMICALIN) and CHEMICALIN (CHEMICALIN) specific for GENEIN kinase
CPR:4	Others kinase inhibitors used recently in cancer therapy include CHEMICALIN (CHEMICALIN) specific for GENEIN GENEIN, CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), CHEMICALIN (CHEMICALIN, CHEMICALIN) and CHEMICALIN (CHEMICALIN, CHEMICALIN) specific for  bbbbb2 GENEIN eeeee2  GENEIN, CHEMICALIN (CHEMICALIN) and CHEMICALIN (CHEMICALIN) specific for GENEIN kinase
CPR:4	Others kinase inhibitors used recently in cancer therapy include CHEMICALIN (CHEMICALIN) specific for GENEIN GENEIN, CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), CHEMICALIN (CHEMICALIN, CHEMICALIN) and CHEMICALIN (CHEMICALIN, CHEMICALIN) specific for GENEIN  bbbbb2 GENEIN eeeee2 , CHEMICALIN (CHEMICALIN) and CHEMICALIN (CHEMICALIN) specific for GENEIN kinase
CPR:4	Others kinase inhibitors used recently in cancer therapy include CHEMICALIN (CHEMICALIN) specific for GENEIN GENEIN, CHEMICALIN (CHEMICALIN),  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN) and CHEMICALIN (CHEMICALIN, CHEMICALIN) specific for  bbbbb2 GENEIN eeeee2  GENEIN, CHEMICALIN (CHEMICALIN) and CHEMICALIN (CHEMICALIN) specific for GENEIN kinase
CPR:4	Others kinase inhibitors used recently in cancer therapy include CHEMICALIN (CHEMICALIN) specific for GENEIN GENEIN, CHEMICALIN (CHEMICALIN),  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN) and CHEMICALIN (CHEMICALIN, CHEMICALIN) specific for GENEIN  bbbbb2 GENEIN eeeee2 , CHEMICALIN (CHEMICALIN) and CHEMICALIN (CHEMICALIN) specific for GENEIN kinase
CPR:4	Others kinase inhibitors used recently in cancer therapy include CHEMICALIN (CHEMICALIN) specific for GENEIN GENEIN, CHEMICALIN (CHEMICALIN), CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN) and CHEMICALIN (CHEMICALIN, CHEMICALIN) specific for  bbbbb2 GENEIN eeeee2  GENEIN, CHEMICALIN (CHEMICALIN) and CHEMICALIN (CHEMICALIN) specific for GENEIN kinase
CPR:4	Others kinase inhibitors used recently in cancer therapy include CHEMICALIN (CHEMICALIN) specific for GENEIN GENEIN, CHEMICALIN (CHEMICALIN), CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN) and CHEMICALIN (CHEMICALIN, CHEMICALIN) specific for GENEIN  bbbbb2 GENEIN eeeee2 , CHEMICALIN (CHEMICALIN) and CHEMICALIN (CHEMICALIN) specific for GENEIN kinase
CPR:4	Others kinase inhibitors used recently in cancer therapy include CHEMICALIN (CHEMICALIN) specific for GENEIN GENEIN, CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ) and CHEMICALIN (CHEMICALIN, CHEMICALIN) specific for  bbbbb2 GENEIN eeeee2  GENEIN, CHEMICALIN (CHEMICALIN) and CHEMICALIN (CHEMICALIN) specific for GENEIN kinase
CPR:4	Others kinase inhibitors used recently in cancer therapy include CHEMICALIN (CHEMICALIN) specific for GENEIN GENEIN, CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ) and CHEMICALIN (CHEMICALIN, CHEMICALIN) specific for GENEIN  bbbbb2 GENEIN eeeee2 , CHEMICALIN (CHEMICALIN) and CHEMICALIN (CHEMICALIN) specific for GENEIN kinase
CPR:4	Others kinase inhibitors used recently in cancer therapy include CHEMICALIN (CHEMICALIN) specific for GENEIN GENEIN, CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN, CHEMICALIN) and  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN) specific for  bbbbb2 GENEIN eeeee2  GENEIN, CHEMICALIN (CHEMICALIN) and CHEMICALIN (CHEMICALIN) specific for GENEIN kinase
CPR:4	Others kinase inhibitors used recently in cancer therapy include CHEMICALIN (CHEMICALIN) specific for GENEIN GENEIN, CHEMICALIN (CHEMICALIN), CHEMICALIN (CHEMICALIN, CHEMICALIN) and  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN) specific for GENEIN  bbbbb2 GENEIN eeeee2 , CHEMICALIN (CHEMICALIN) and CHEMICALIN (CHEMICALIN) specific for GENEIN kinase
CPR:2	Currently, the use of orally administered  bbbbb1 GENEIN eeeee1  inhibitor antidepressants (eg, CHEMICALIN, CHEMICALIN) is limited by the risk of  bbbbb2 CHEMICALIN eeeee2 -provoked events (eg, acute hypertension and headache, also known as the "cheese reaction") when combined with dietary CHEMICALNOTIN
CPR:4	Currently, the use of orally administered  bbbbb1 GENEIN eeeee1  inhibitor antidepressants (eg,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN) is limited by the risk of CHEMICALIN-provoked events (eg, acute hypertension and headache, also known as the "cheese reaction") when combined with dietary CHEMICALNOTIN
CPR:4	Currently, the use of orally administered  bbbbb1 GENEIN eeeee1  inhibitor antidepressants (eg, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 ) is limited by the risk of CHEMICALIN-provoked events (eg, acute hypertension and headache, also known as the "cheese reaction") when combined with dietary CHEMICALNOTIN
CPR:10	 bbbbb1 CHEMICALIN eeeee1  has a high affinity and selectivity for GENEIN, but little or no affinity for various  bbbbb2 GENEIN eeeee2 
CPR:2	 bbbbb1 CHEMICALIN eeeee1  has a high affinity and selectivity for  bbbbb2 GENEIN eeeee2 , but little or no affinity for various GENEIN
CPR:4	 bbbbb1 GENEIN eeeee1  inhibitors, such as  bbbbb2 CHEMICALIN eeeee2 , are associated with changes in CHEMICALIN pharmacokinetics similar to those observed among poor GENEIN metabolizers
CPR:9	It undergoes extensive biotransformation, which is affected by poor metabolism by  bbbbb1 GENEIN eeeee1  in a small percentage of the population; these patients have greater exposure to and slower elimination of  bbbbb2 CHEMICALIN eeeee2  than extensive metabolizers
CPR:9	GENEIN inhibitors, such as CHEMICALIN, are associated with changes in  bbbbb1 CHEMICALIN eeeee1  pharmacokinetics similar to those observed among poor  bbbbb2 GENEIN eeeee2  metabolizers
CPR:9	 bbbbb1 CHEMICALIN eeeee1  appeared better tolerated among extensive  bbbbb2 GENEIN eeeee2  metabolizers than among poor metabolizers
CPR:2	 bbbbb1 CHEMICALIN eeeee1  forms a ring around the internal cavity in  bbbbb2 GENEIN eeeee2  through aromatic stacking interactions between the drug and GENEIN as well as between the drug molecules themselves
CPR:2	 bbbbb1 CHEMICALIN eeeee1  forms a ring around the internal cavity in GENEIN through aromatic stacking interactions between the drug and  bbbbb2 GENEIN eeeee2  as well as between the drug molecules themselves
CPR:2	 bbbbb1 GENEIN eeeee1  (GENEIN) is a homohexameric enzyme that catalyzes the reversible oxidative deamination of CHEMICALIN to CHEMICALIN using  bbbbb2 CHEMICALIN eeeee2  as coenzyme
CPR:2	GENEIN ( bbbbb1 GENEIN eeeee1 ) is a homohexameric enzyme that catalyzes the reversible oxidative deamination of CHEMICALIN to CHEMICALIN using  bbbbb2 CHEMICALIN eeeee2  as coenzyme
CPR:3	The recently discovered hyperinsulinism/hyperammonemia disorder showed that the loss of allosteric inhibition of GENEIN by  bbbbb1 CHEMICALIN eeeee1  causes excessive secretion of  bbbbb2 GENEIN eeeee2 
CPR:4	Subsequent studies demonstrated that wild-type and hyperinsulinemia/hyperammonemia forms of  bbbbb1 GENEIN eeeee1  are inhibited by the green tea polyphenols,  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:4	Subsequent studies demonstrated that wild-type and hyperinsulinemia/hyperammonemia forms of  bbbbb1 GENEIN eeeee1  are inhibited by the green tea polyphenols, CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:7	The recently discovered hyperinsulinism/hyperammonemia disorder showed that the loss of allosteric inhibition of  bbbbb1 GENEIN eeeee1  by  bbbbb2 CHEMICALIN eeeee2  causes excessive secretion of GENEIN
CPR:9	 bbbbb1 GENEIN eeeee1  (GENEIN) is a homohexameric enzyme that catalyzes the reversible oxidative deamination of CHEMICALIN to  bbbbb2 CHEMICALIN eeeee2  using CHEMICALIN as coenzyme
CPR:9	GENEIN ( bbbbb1 GENEIN eeeee1 ) is a homohexameric enzyme that catalyzes the reversible oxidative deamination of CHEMICALIN to  bbbbb2 CHEMICALIN eeeee2  using CHEMICALIN as coenzyme
CPR:9	 bbbbb1 GENEIN eeeee1  (GENEIN) is a homohexameric enzyme that catalyzes the reversible oxidative deamination of  bbbbb2 CHEMICALIN eeeee2  to CHEMICALIN using CHEMICALIN as coenzyme
CPR:9	GENEIN ( bbbbb1 GENEIN eeeee1 ) is a homohexameric enzyme that catalyzes the reversible oxidative deamination of  bbbbb2 CHEMICALIN eeeee2  to CHEMICALIN using CHEMICALIN as coenzyme
CPR:10	Systemic  bbbbb1 CHEMICALIN eeeee1  did not modify either the hyperalgesia and local inflammation or  bbbbb2 GENEIN eeeee2  expression
CPR:9	BACKGROUND: Peripheral inflammatory pain is associated with an upregulation of spinal cord  bbbbb1 GENEIN eeeee1  (GENEIN), with a subsequent increase in central  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) levels associated with the development of hyperalgesia
CPR:9	BACKGROUND: Peripheral inflammatory pain is associated with an upregulation of spinal cord GENEIN ( bbbbb1 GENEIN eeeee1 ), with a subsequent increase in central  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) levels associated with the development of hyperalgesia
CPR:9	BACKGROUND: Peripheral inflammatory pain is associated with an upregulation of spinal cord  bbbbb1 GENEIN eeeee1  (GENEIN), with a subsequent increase in central CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) levels associated with the development of hyperalgesia
CPR:9	BACKGROUND: Peripheral inflammatory pain is associated with an upregulation of spinal cord GENEIN ( bbbbb1 GENEIN eeeee1 ), with a subsequent increase in central CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) levels associated with the development of hyperalgesia
CPR:2	Computer-assisted analysis of these curvilinear Schild plots in a two-receptor system indicated that  bbbbb1 GENEIN eeeee1  populations responsible for the constrictive response are predominantly (approximately 80-90%) low affinity sites for the two antagonists (pKd approximately 8.1 for CHEMICALIN and pKd approximately 7.1 for CHEMICALIN) and a small population (approximately 10-20%) are high affinity sites (pKd approximately 9.1 for both  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN), which was in good agreement with radioligand binding studies.(ABSTRACT TRUNCATED AT 400 WORDS)
CPR:2	Computer-assisted analysis of these curvilinear Schild plots in a two-receptor system indicated that  bbbbb1 GENEIN eeeee1  populations responsible for the constrictive response are predominantly (approximately 80-90%) low affinity sites for the two antagonists (pKd approximately 8.1 for CHEMICALIN and pKd approximately 7.1 for CHEMICALIN) and a small population (approximately 10-20%) are high affinity sites (pKd approximately 9.1 for both CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 ), which was in good agreement with radioligand binding studies.(ABSTRACT TRUNCATED AT 400 WORDS)
CPR:2	Radioligand binding studies with the nonselective  bbbbb1 GENEIN eeeee1  antagonist radioligand  bbbbb2 CHEMICALIN eeeee2  showed that 73-87% of the binding sites in rabbit aorta are CHEMICALIN sensitive and they are predominantly low affinity sites both for CHEMICALIN (pKd = 8.1) and for CHEMICALIN (pKd = 7.1)
CPR:2	Radioligand binding studies with the nonselective  bbbbb1 GENEIN eeeee1  antagonist radioligand CHEMICALIN showed that 73-87% of the binding sites in rabbit aorta are  bbbbb2 CHEMICALIN eeeee2  sensitive and they are predominantly low affinity sites both for CHEMICALIN (pKd = 8.1) and for CHEMICALIN (pKd = 7.1)
CPR:2	Radioligand binding studies with the nonselective  bbbbb1 GENEIN eeeee1  antagonist radioligand CHEMICALIN showed that 73-87% of the binding sites in rabbit aorta are CHEMICALIN sensitive and they are predominantly low affinity sites both for  bbbbb2 CHEMICALIN eeeee2  (pKd = 8.1) and for CHEMICALIN (pKd = 7.1)
CPR:2	Radioligand binding studies with the nonselective  bbbbb1 GENEIN eeeee1  antagonist radioligand CHEMICALIN showed that 73-87% of the binding sites in rabbit aorta are CHEMICALIN sensitive and they are predominantly low affinity sites both for CHEMICALIN (pKd = 8.1) and for  bbbbb2 CHEMICALIN eeeee2  (pKd = 7.1)
CPR:5	The Schild plots for the competitive antagonists CHEMICALIN and CHEMICALIN against  bbbbb1 GENEIN eeeee1 -selective agonist  bbbbb2 CHEMICALIN eeeee2 -induced contraction were linear and had slopes not significantly different from unity, with a pA2 of 9.07 +/- 0.07 (n = 5) for CHEMICALIN and 9.09 +/- 0.05 (n = 3) for CHEMICALIN
CPR:6	The Schild plots for the competitive antagonists CHEMICALIN and CHEMICALIN against  bbbbb1 GENEIN eeeee1 -selective agonist CHEMICALIN-induced contraction were linear and had slopes not significantly different from unity, with a pA2 of 9.07 +/- 0.07 (n = 5) for  bbbbb2 CHEMICALIN eeeee2  and 9.09 +/- 0.05 (n = 3) for CHEMICALIN
CPR:6	The Schild plots for the competitive antagonists CHEMICALIN and CHEMICALIN against  bbbbb1 GENEIN eeeee1 -selective agonist CHEMICALIN-induced contraction were linear and had slopes not significantly different from unity, with a pA2 of 9.07 +/- 0.07 (n = 5) for CHEMICALIN and 9.09 +/- 0.05 (n = 3) for  bbbbb2 CHEMICALIN eeeee2 
CPR:6	Computer-assisted analysis of these curvilinear Schild plots in a two-receptor system indicated that  bbbbb1 GENEIN eeeee1  populations responsible for the constrictive response are predominantly (approximately 80-90%) low affinity sites for the two antagonists (pKd approximately 8.1 for  bbbbb2 CHEMICALIN eeeee2  and pKd approximately 7.1 for CHEMICALIN) and a small population (approximately 10-20%) are high affinity sites (pKd approximately 9.1 for both CHEMICALIN and CHEMICALIN), which was in good agreement with radioligand binding studies.(ABSTRACT TRUNCATED AT 400 WORDS)
CPR:6	Computer-assisted analysis of these curvilinear Schild plots in a two-receptor system indicated that  bbbbb1 GENEIN eeeee1  populations responsible for the constrictive response are predominantly (approximately 80-90%) low affinity sites for the two antagonists (pKd approximately 8.1 for CHEMICALIN and pKd approximately 7.1 for  bbbbb2 CHEMICALIN eeeee2 ) and a small population (approximately 10-20%) are high affinity sites (pKd approximately 9.1 for both CHEMICALIN and CHEMICALIN), which was in good agreement with radioligand binding studies.(ABSTRACT TRUNCATED AT 400 WORDS)
CPR:6	Using the  bbbbb1 GENEIN eeeee1  subtype-selective antagonists CHEMICALIN (CHEMICALIN), CHEMICALIN, and  bbbbb2 CHEMICALIN eeeee2 , we have examined the possible heterogeneity in the GENENOTIN populations in rabbit aorta
CPR:6	Using the  bbbbb1 GENEIN eeeee1  subtype-selective antagonists  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), CHEMICALIN, and CHEMICALIN, we have examined the possible heterogeneity in the GENENOTIN populations in rabbit aorta
CPR:6	Radioligand binding studies with the nonselective  bbbbb1 GENEIN eeeee1  antagonist radioligand  bbbbb2 CHEMICALIN eeeee2  showed that 73-87% of the binding sites in rabbit aorta are CHEMICALIN sensitive and they are predominantly low affinity sites both for CHEMICALIN (pKd = 8.1) and for CHEMICALIN (pKd = 7.1)
CPR:6	Using the  bbbbb1 GENEIN eeeee1  subtype-selective antagonists CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), CHEMICALIN, and CHEMICALIN, we have examined the possible heterogeneity in the GENENOTIN populations in rabbit aorta
CPR:6	Using the  bbbbb1 GENEIN eeeee1  subtype-selective antagonists CHEMICALIN (CHEMICALIN),  bbbbb2 CHEMICALIN eeeee2 , and CHEMICALIN, we have examined the possible heterogeneity in the GENENOTIN populations in rabbit aorta
CPR:6	The Schild plots for the competitive antagonists  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN against  bbbbb2 GENEIN eeeee2 -selective agonist CHEMICALIN-induced contraction were linear and had slopes not significantly different from unity, with a pA2 of 9.07 +/- 0.07 (n = 5) for CHEMICALIN and 9.09 +/- 0.05 (n = 3) for CHEMICALIN
CPR:6	The Schild plots for the competitive antagonists CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  against  bbbbb2 GENEIN eeeee2 -selective agonist CHEMICALIN-induced contraction were linear and had slopes not significantly different from unity, with a pA2 of 9.07 +/- 0.07 (n = 5) for CHEMICALIN and 9.09 +/- 0.05 (n = 3) for CHEMICALIN
CPR:6	 bbbbb1 CHEMICALIN eeeee1  is an  bbbbb2 GENEIN eeeee2  antagonist (ERA) that was recently approved for treatment of pulmonary arterial hypertension (PAH)
CPR:6	 bbbbb1 CHEMICALIN eeeee1  is the first  bbbbb2 GENEIN eeeee2  selective ERA approved for use in the US
CPR:2	A series of CHEMICALNOTIN analogs were designed and the interaction between  bbbbb1 CHEMICALIN eeeee1  and  bbbbb2 GENEIN eeeee2  studied by the docking method to improve the biological activity and reduce the gastrointestinal side effects of CHEMICALNOTIN
CPR:4	As discussed in this review, various CHEMICALIN including CHEMICALIN and its 20alpha-dihydro-derivative, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and CHEMICALIN can reduce intratissular levels of CHEMICALIN in breast cancer by blocking  bbbbb2 GENEIN eeeee2  and GENEIN activities
CPR:4	As discussed in this review, various CHEMICALIN including CHEMICALIN and its 20alpha-dihydro-derivative, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and CHEMICALIN can reduce intratissular levels of CHEMICALIN in breast cancer by blocking GENEIN and  bbbbb2 GENEIN eeeee2  activities
CPR:4	As discussed in this review, various CHEMICALIN including CHEMICALIN and its 20alpha-dihydro-derivative, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN can reduce intratissular levels of CHEMICALIN in breast cancer by blocking  bbbbb2 GENEIN eeeee2  and GENEIN activities
CPR:4	As discussed in this review, various CHEMICALIN including CHEMICALIN and its 20alpha-dihydro-derivative, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN can reduce intratissular levels of CHEMICALIN in breast cancer by blocking GENEIN and  bbbbb2 GENEIN eeeee2  activities
CPR:4	As discussed in this review, various CHEMICALIN including CHEMICALIN and its 20alpha-dihydro-derivative, CHEMICALIN, CHEMICALIN, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  can reduce intratissular levels of CHEMICALIN in breast cancer by blocking  bbbbb2 GENEIN eeeee2  and GENEIN activities
CPR:4	As discussed in this review, various CHEMICALIN including CHEMICALIN and its 20alpha-dihydro-derivative, CHEMICALIN, CHEMICALIN, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  can reduce intratissular levels of CHEMICALIN in breast cancer by blocking GENEIN and  bbbbb2 GENEIN eeeee2  activities
CPR:4	As discussed in this review, various  bbbbb1 CHEMICALIN eeeee1  including CHEMICALIN and its 20alpha-dihydro-derivative, CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN can reduce intratissular levels of CHEMICALIN in breast cancer by blocking  bbbbb2 GENEIN eeeee2  and GENEIN activities
CPR:4	As discussed in this review, various  bbbbb1 CHEMICALIN eeeee1  including CHEMICALIN and its 20alpha-dihydro-derivative, CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN can reduce intratissular levels of CHEMICALIN in breast cancer by blocking GENEIN and  bbbbb2 GENEIN eeeee2  activities
CPR:4	As discussed in this review, various CHEMICALIN including  bbbbb1 CHEMICALIN eeeee1  and its 20alpha-dihydro-derivative, CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN can reduce intratissular levels of CHEMICALIN in breast cancer by blocking  bbbbb2 GENEIN eeeee2  and GENEIN activities
CPR:4	As discussed in this review, various CHEMICALIN including  bbbbb1 CHEMICALIN eeeee1  and its 20alpha-dihydro-derivative, CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN can reduce intratissular levels of CHEMICALIN in breast cancer by blocking GENEIN and  bbbbb2 GENEIN eeeee2  activities
CPR:4	As discussed in this review, various CHEMICALIN including CHEMICALIN and its 20alpha-dihydro-derivative,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN and CHEMICALIN can reduce intratissular levels of CHEMICALIN in breast cancer by blocking  bbbbb2 GENEIN eeeee2  and GENEIN activities
CPR:4	As discussed in this review, various CHEMICALIN including CHEMICALIN and its 20alpha-dihydro-derivative,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN and CHEMICALIN can reduce intratissular levels of CHEMICALIN in breast cancer by blocking GENEIN and  bbbbb2 GENEIN eeeee2  activities
CPR:9	As discussed in this review, various CHEMICALIN including CHEMICALIN and its 20alpha-dihydro-derivative, CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN can reduce intratissular levels of  bbbbb1 CHEMICALIN eeeee1  in breast cancer by blocking  bbbbb2 GENEIN eeeee2  and GENEIN activities
CPR:9	As discussed in this review, various CHEMICALIN including CHEMICALIN and its 20alpha-dihydro-derivative, CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN can reduce intratissular levels of  bbbbb1 CHEMICALIN eeeee1  in breast cancer by blocking GENEIN and  bbbbb2 GENEIN eeeee2  activities
CPR:2	OBJECTIVE:  bbbbb1 CHEMICALIN eeeee1 , a rapid- and short-acting insulinotropic  bbbbb2 GENEIN eeeee2  ligand, exhibits hypoglycemic action unlike other CHEMICALIN
CPR:2	OBJECTIVE: CHEMICALIN, a rapid- and short-acting insulinotropic  bbbbb1 GENEIN eeeee1  ligand, exhibits hypoglycemic action unlike other  bbbbb2 CHEMICALIN eeeee2 
CPR:4	 bbbbb1 CHEMICALIN eeeee1  reduced fasting plasma CHEMICALNOTIN and  bbbbb2 GENEIN eeeee2  levels after 4 weeks and GENEIN levels after 8 weeks
CPR:4	 bbbbb1 CHEMICALIN eeeee1  reduced fasting plasma CHEMICALNOTIN and GENEIN levels after 4 weeks and  bbbbb2 GENEIN eeeee2  levels after 8 weeks
CPR:1	Cyan fluorescent protein was fused to the  bbbbb1 CHEMICALIN eeeee1  terminus of the  bbbbb2 GENEIN eeeee2 , and a specific binding sequence for the small fluorescent compound CHEMICALIN arsenical hairpin binder, FlAsH, was inserted into the third intracellular loop; the latter site was labeled in intact cells by incubation with FlAsH
CPR:2	Cyan fluorescent protein was fused to the CHEMICALIN terminus of the  bbbbb1 GENEIN eeeee1 , and a specific binding sequence for the small fluorescent compound  bbbbb2 CHEMICALIN eeeee2  arsenical hairpin binder, FlAsH, was inserted into the third intracellular loop; the latter site was labeled in intact cells by incubation with FlAsH
CPR:7	Because these speeds are significantly faster than the responses to antagonists, these data indicate that  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN are allosteric ligands and actively induce a conformation of the  bbbbb2 GENEIN eeeee2  with a reduced affinity for its agonists.
CPR:7	Because these speeds are significantly faster than the responses to antagonists, these data indicate that CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  are allosteric ligands and actively induce a conformation of the  bbbbb2 GENEIN eeeee2  with a reduced affinity for its agonists.
CPR:2	Here, we report that the transcription factor  bbbbb1 GENEIN eeeee1  (GENEIN) is essential for coupling  bbbbb2 CHEMICALIN eeeee2  to GENEIN inhibition and subsequent neurite growth promotion in neurons
CPR:2	Here, we report that the transcription factor GENEIN ( bbbbb1 GENEIN eeeee1 ) is essential for coupling  bbbbb2 CHEMICALIN eeeee2  to GENEIN inhibition and subsequent neurite growth promotion in neurons
CPR:2	Moreover, the effect of  bbbbb1 CHEMICALIN eeeee1  on  bbbbb2 GENEIN eeeee2  activity and neurite growth in neuronal cultures is prevented by selective GENEIN inhibition
CPR:2	Moreover, the effect of  bbbbb1 CHEMICALIN eeeee1  on GENEIN activity and neurite growth in neuronal cultures is prevented by selective  bbbbb2 GENEIN eeeee2  inhibition
CPR:2	These findings support that  bbbbb1 GENEIN eeeee1  plays an essential role in mediating the GENEIN-inhibiting effect of  bbbbb2 CHEMICALIN eeeee2 
CPR:3	 bbbbb1 CHEMICALIN eeeee1  activates  bbbbb2 GENEIN eeeee2  in neuron-like PC12 and B104 cells
CPR:3	In addition, another study suggests that  bbbbb1 CHEMICALIN eeeee1  reduces generation of GENEIN peptide via inactivation of GENEIN signaling, although it may also regulate  bbbbb2 GENEIN eeeee2  formation by direct inhibition of the GENEIN
CPR:4	Recently, we have demonstrated that  bbbbb1 CHEMICALIN eeeee1  inhibits intracellular signaling of  bbbbb2 GENEIN eeeee2  and promotes significant axonal growth and functional recovery following spinal cord lesions in rodents
CPR:4	In addition, another study suggests that  bbbbb1 CHEMICALIN eeeee1  reduces generation of  bbbbb2 GENEIN eeeee2  peptide via inactivation of GENEIN signaling, although it may also regulate GENEIN formation by direct inhibition of the GENEIN
CPR:4	In addition, another study suggests that  bbbbb1 CHEMICALIN eeeee1  reduces generation of GENEIN peptide via inactivation of  bbbbb2 GENEIN eeeee2  signaling, although it may also regulate GENEIN formation by direct inhibition of the GENEIN
CPR:4	The molecular mechanisms by which  bbbbb1 CHEMICALIN eeeee1  inhibits the  bbbbb2 GENEIN eeeee2  signal in neurons, however, remain unclear
CPR:4	Here, we report that the transcription factor GENEIN (GENEIN) is essential for coupling  bbbbb1 CHEMICALIN eeeee1  to  bbbbb2 GENEIN eeeee2  inhibition and subsequent neurite growth promotion in neurons
CPR:4	A molecular mechanism for  bbbbb1 CHEMICALIN eeeee1 -mediated  bbbbb2 GENEIN eeeee2  inhibition in neurons
CPR:4	 bbbbb1 CHEMICALIN eeeee1  is a nonsteroidal anti-inflammatory drug widely used to relieve pain and inflammation in many disorders via inhibition of  bbbbb2 GENEIN eeeee2 
CPR:4	Activation of GENENOTIN with traditional agonists mimics the  bbbbb1 GENEIN eeeee1 -inhibiting properties of  bbbbb2 CHEMICALIN eeeee2  in PC12 cells and, like CHEMICALNOTIN, promotes neurite elongation in primary cultured neurons exposed to axonal growth inhibitors
CPR:4	These findings support that GENEIN plays an essential role in mediating the  bbbbb1 GENEIN eeeee1 -inhibiting effect of  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Elucidation of the novel molecular mechanisms linking  bbbbb1 CHEMICALIN eeeee1  to  bbbbb2 GENEIN eeeee2  inhibition may provide additional therapeutic targets to the disorders characterized by GENENOTIN activation, including spinal cord injuries and Alzheimer's disease.
CPR:4	In addition, another study suggests that  bbbbb1 CHEMICALIN eeeee1  reduces generation of GENEIN peptide via inactivation of GENEIN signaling, although it may also regulate GENEIN formation by direct inhibition of the  bbbbb2 GENEIN eeeee2 
CPR:4	Of these, the  bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2  and GENEIN inhibitor CHEMICALIN have recently been licensed for thromboprophylaxis after orthopaedic surgery mainly in Europe
CPR:4	Of these, the GENEIN inhibitor CHEMICALIN and  bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2  have recently been licensed for thromboprophylaxis after orthopaedic surgery mainly in Europe
CPR:4	In addition, the  bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2  is in late-stage clinical development
CPR:2	We determined whether an GENEIN (GENEIN) inhibitor, CHEMICALIN, inhibits GENENOTIN activity in peritoneal effluents from patients on CAPD, and simulated molecular models of the  bbbbb1 GENEIN eeeee1 - bbbbb2 CHEMICALIN eeeee2  complex
CPR:2	Molecular models of the  bbbbb1 GENEIN eeeee1 - bbbbb2 CHEMICALIN eeeee2  complex were simulated by 1000 iterations of random docking and energy minimization
CPR:2	RESULTS: CHEMICALIN directly inhibited GENEIN activity in peritoneal effluents from patients on CAPD (IC50; 48 micromol/l), and that  bbbbb1 CHEMICALIN eeeee1  binding to the  bbbbb2 GENEIN eeeee2  active site could be formed in each complex model without molecular distortion
CPR:4	We determined whether an  bbbbb1 GENEIN eeeee1  (GENEIN) inhibitor,  bbbbb2 CHEMICALIN eeeee2 , inhibits GENENOTIN activity in peritoneal effluents from patients on CAPD, and simulated molecular models of the GENEIN-CHEMICALIN complex
CPR:4	We determined whether an GENEIN ( bbbbb1 GENEIN eeeee1 ) inhibitor,  bbbbb2 CHEMICALIN eeeee2 , inhibits GENENOTIN activity in peritoneal effluents from patients on CAPD, and simulated molecular models of the GENEIN-CHEMICALIN complex
CPR:4	METHODS: The inhibitory effect of  bbbbb1 CHEMICALIN eeeee1  on  bbbbb2 GENEIN eeeee2  activity was measured in peritoneal effluents from 17 patients on CAPD
CPR:4	RESULTS:  bbbbb1 CHEMICALIN eeeee1  directly inhibited  bbbbb2 GENEIN eeeee2  activity in peritoneal effluents from patients on CAPD (IC50; 48 micromol/l), and that CHEMICALIN binding to the GENEIN active site could be formed in each complex model without molecular distortion
CPR:4	CONCLUSION: GENEIN inhibitors, such as  bbbbb1 CHEMICALIN eeeee1 , may be applied as important compounds for  bbbbb2 GENEIN eeeee2  inhibition in inflammation caused by CAPD.
CPR:4	CONCLUSION:  bbbbb1 GENEIN eeeee1  inhibitors, such as  bbbbb2 CHEMICALIN eeeee2 , may be applied as important compounds for GENEIN inhibition in inflammation caused by CAPD.
CPR:4	 bbbbb1 CHEMICALIN eeeee1  directly inhibits  bbbbb2 GENEIN eeeee2  activity in continuous ambulatory peritoneal dialysis therapy
CPR:10	CHEMICALIN but not  bbbbb1 CHEMICALIN eeeee1  inhibits a number of variants of  bbbbb2 GENEIN eeeee2  including the cloned equivalents of currents present in vascular and non-vascular smooth muscle (GENEIN/GENEIN and GENEIN/GENEIN) and pancreatic beta-cells (GENEIN/GENEIN)
CPR:10	CHEMICALIN but not  bbbbb1 CHEMICALIN eeeee1  inhibits a number of variants of GENEIN including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( bbbbb2 GENEIN eeeee2 /GENEIN and GENEIN/GENEIN) and pancreatic beta-cells (GENEIN/GENEIN)
CPR:10	CHEMICALIN but not  bbbbb1 CHEMICALIN eeeee1  inhibits a number of variants of GENEIN including the cloned equivalents of currents present in vascular and non-vascular smooth muscle (GENEIN/ bbbbb2 GENEIN eeeee2  and GENEIN/GENEIN) and pancreatic beta-cells (GENEIN/GENEIN)
CPR:10	CHEMICALIN but not  bbbbb1 CHEMICALIN eeeee1  inhibits a number of variants of GENEIN including the cloned equivalents of currents present in vascular and non-vascular smooth muscle (GENEIN/GENEIN and  bbbbb2 GENEIN eeeee2 /GENEIN) and pancreatic beta-cells (GENEIN/GENEIN)
CPR:10	CHEMICALIN but not  bbbbb1 CHEMICALIN eeeee1  inhibits a number of variants of GENEIN including the cloned equivalents of currents present in vascular and non-vascular smooth muscle (GENEIN/GENEIN and GENEIN/ bbbbb2 GENEIN eeeee2 ) and pancreatic beta-cells (GENEIN/GENEIN)
CPR:10	CHEMICALIN but not  bbbbb1 CHEMICALIN eeeee1  inhibits a number of variants of GENEIN including the cloned equivalents of currents present in vascular and non-vascular smooth muscle (GENEIN/GENEIN and GENEIN/GENEIN) and pancreatic beta-cells ( bbbbb2 GENEIN eeeee2 /GENEIN)
CPR:10	CHEMICALIN but not  bbbbb1 CHEMICALIN eeeee1  inhibits a number of variants of GENEIN including the cloned equivalents of currents present in vascular and non-vascular smooth muscle (GENEIN/GENEIN and GENEIN/GENEIN) and pancreatic beta-cells (GENEIN/ bbbbb2 GENEIN eeeee2 )
CPR:2	These findings suggest that  bbbbb1 CHEMICALIN eeeee1  interacts directly with the pore-forming  bbbbb2 GENEIN eeeee2  subunit however the GENEIN is able to significantly modulate the affinity
CPR:2	Additionally,  bbbbb1 CHEMICALIN eeeee1  inhibited the current elicited through the GENEIN (functional without  bbbbb2 GENEIN eeeee2 ) channel with an IC50 of 1.78 mM
CPR:2	These findings suggest that  bbbbb1 CHEMICALIN eeeee1  interacts directly with the pore-forming GENEIN subunit however the  bbbbb2 GENEIN eeeee2  is able to significantly modulate the affinity
CPR:4	 bbbbb1 CHEMICALIN eeeee1  reduced the open probability of  bbbbb2 GENEIN eeeee2 /GENEIN channels by approximately 90% in inside-out patches
CPR:4	 bbbbb1 CHEMICALIN eeeee1  reduced the open probability of GENEIN/ bbbbb2 GENEIN eeeee2  channels by approximately 90% in inside-out patches
CPR:4	 bbbbb1 CHEMICALIN eeeee1  but not CHEMICALIN inhibits a number of variants of  bbbbb2 GENEIN eeeee2  including the cloned equivalents of currents present in vascular and non-vascular smooth muscle (GENEIN/GENEIN and GENEIN/GENEIN) and pancreatic beta-cells (GENEIN/GENEIN)
CPR:4	 bbbbb1 CHEMICALIN eeeee1  but not CHEMICALIN inhibits a number of variants of GENEIN including the cloned equivalents of currents present in vascular and non-vascular smooth muscle ( bbbbb2 GENEIN eeeee2 /GENEIN and GENEIN/GENEIN) and pancreatic beta-cells (GENEIN/GENEIN)
CPR:4	 bbbbb1 CHEMICALIN eeeee1  but not CHEMICALIN inhibits a number of variants of GENEIN including the cloned equivalents of currents present in vascular and non-vascular smooth muscle (GENEIN/ bbbbb2 GENEIN eeeee2  and GENEIN/GENEIN) and pancreatic beta-cells (GENEIN/GENEIN)
CPR:4	 bbbbb1 CHEMICALIN eeeee1  but not CHEMICALIN inhibits a number of variants of GENEIN including the cloned equivalents of currents present in vascular and non-vascular smooth muscle (GENEIN/GENEIN and  bbbbb2 GENEIN eeeee2 /GENEIN) and pancreatic beta-cells (GENEIN/GENEIN)
CPR:4	 bbbbb1 CHEMICALIN eeeee1  but not CHEMICALIN inhibits a number of variants of GENEIN including the cloned equivalents of currents present in vascular and non-vascular smooth muscle (GENEIN/GENEIN and GENEIN/ bbbbb2 GENEIN eeeee2 ) and pancreatic beta-cells (GENEIN/GENEIN)
CPR:4	 bbbbb1 CHEMICALIN eeeee1  but not CHEMICALIN inhibits a number of variants of GENEIN including the cloned equivalents of currents present in vascular and non-vascular smooth muscle (GENEIN/GENEIN and GENEIN/GENEIN) and pancreatic beta-cells ( bbbbb2 GENEIN eeeee2 /GENEIN)
CPR:4	 bbbbb1 CHEMICALIN eeeee1  but not CHEMICALIN inhibits a number of variants of GENEIN including the cloned equivalents of currents present in vascular and non-vascular smooth muscle (GENEIN/GENEIN and GENEIN/GENEIN) and pancreatic beta-cells (GENEIN/ bbbbb2 GENEIN eeeee2 )
CPR:4	 bbbbb1 CHEMICALIN eeeee1  has a direct inhibitory effect on the  bbbbb2 GENEIN eeeee2 
CPR:4	The extent and rate of inhibition are similar to that seen with the known  bbbbb1 GENEIN eeeee1  blocker  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Additionally,  bbbbb1 CHEMICALIN eeeee1  inhibited the current elicited through the  bbbbb2 GENEIN eeeee2  (functional without GENEIN) channel with an IC50 of 1.78 mM
CPR:2	In pig parathyroid cells,  bbbbb1 CHEMICALIN eeeee1  and the active form of CHEMICALIN induced  bbbbb2 GENEIN eeeee2  translocation from the cytoplasm into the nucleus, suppressed GENEIN mRNA expression and inhibited cell proliferation in a similar manner, although CHEMICALIN induced the expression of GENEIN mRNA more effectively
CPR:2	In pig parathyroid cells, CHEMICALIN and the active form of  bbbbb1 CHEMICALIN eeeee1  induced  bbbbb2 GENEIN eeeee2  translocation from the cytoplasm into the nucleus, suppressed GENEIN mRNA expression and inhibited cell proliferation in a similar manner, although CHEMICALIN induced the expression of GENEIN mRNA more effectively
CPR:2	Different VDRAs are known to have differential effects on serum CHEMICALNOTIN (CHEMICALNOTIN), which may also affect serum GENENOTIN levels since serum  bbbbb1 CHEMICALIN eeeee1  regulates GENEIN secretion mediated by the  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:2	Different VDRAs are known to have differential effects on serum CHEMICALNOTIN (CHEMICALNOTIN), which may also affect serum GENENOTIN levels since serum  bbbbb1 CHEMICALIN eeeee1  regulates GENEIN secretion mediated by the GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:3	In pig parathyroid cells, CHEMICALIN and the active form of CHEMICALIN induced GENEIN translocation from the cytoplasm into the nucleus, suppressed GENEIN mRNA expression and inhibited cell proliferation in a similar manner, although  bbbbb1 CHEMICALIN eeeee1  induced the expression of  bbbbb2 GENEIN eeeee2  mRNA more effectively
CPR:3	Different VDRAs are known to have differential effects on serum CHEMICALNOTIN (CHEMICALNOTIN), which may also affect serum GENENOTIN levels since serum  bbbbb1 CHEMICALIN eeeee1  regulates  bbbbb2 GENEIN eeeee2  secretion mediated by the GENEIN (GENEIN)
CPR:4	Both drugs at the tested doses (0.042-0.33 mug/kg) suppressed GENEIN mRNA expression and serum  bbbbb1 GENEIN eeeee1  effectively in the 5/6 NX rats, but  bbbbb2 CHEMICALIN eeeee2  was less potent in raising serum CHEMICALNOTIN than CHEMICALIN
CPR:4	Both drugs at the tested doses (0.042-0.33 mug/kg) suppressed GENEIN mRNA expression and serum  bbbbb1 GENEIN eeeee1  effectively in the 5/6 NX rats, but CHEMICALIN was less potent in raising serum CHEMICALNOTIN than  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Both drugs at the tested doses (0.042-0.33 mug/kg) suppressed  bbbbb1 GENEIN eeeee1  mRNA expression and serum GENEIN effectively in the 5/6 NX rats, but  bbbbb2 CHEMICALIN eeeee2  was less potent in raising serum CHEMICALNOTIN than CHEMICALIN
CPR:4	Both drugs at the tested doses (0.042-0.33 mug/kg) suppressed  bbbbb1 GENEIN eeeee1  mRNA expression and serum GENEIN effectively in the 5/6 NX rats, but CHEMICALIN was less potent in raising serum CHEMICALNOTIN than  bbbbb2 CHEMICALIN eeeee2 
CPR:4	In pig parathyroid cells,  bbbbb1 CHEMICALIN eeeee1  and the active form of CHEMICALIN induced GENEIN translocation from the cytoplasm into the nucleus, suppressed  bbbbb2 GENEIN eeeee2  mRNA expression and inhibited cell proliferation in a similar manner, although CHEMICALIN induced the expression of GENEIN mRNA more effectively
CPR:4	In pig parathyroid cells, CHEMICALIN and the active form of  bbbbb1 CHEMICALIN eeeee1  induced GENEIN translocation from the cytoplasm into the nucleus, suppressed  bbbbb2 GENEIN eeeee2  mRNA expression and inhibited cell proliferation in a similar manner, although CHEMICALIN induced the expression of GENEIN mRNA more effectively
CPR:2	 bbbbb1 CHEMICALIN eeeee1  initiates its teratogenic effects by binding to  bbbbb2 GENEIN eeeee2  and inhibiting the associated GENEIN activity
CPR:4	 bbbbb1 CHEMICALIN eeeee1  initiates its teratogenic effects by binding to GENEIN and inhibiting the associated  bbbbb2 GENEIN eeeee2  activity
CPR:4	 bbbbb1 CHEMICALIN eeeee1  is an  bbbbb2 GENEIN eeeee2  blocker (ARB) displaying unique pharmacologic properties, including a longer half life than any other ARB, that result in large and sustained reductions of blood pressure
CPR:2	With the pentapeptide linked through the C7alpha position of  bbbbb1 CHEMICALIN eeeee1 , the resulting PROTAC shows the most effective GENEIN degradation and highest affinity for the  bbbbb2 GENEIN eeeee2 
CPR:2	The  bbbbb1 GENEIN eeeee1 -targeting PROTACs are composed of an  bbbbb2 CHEMICALIN eeeee2  on one end and a GENENOTIN (GENENOTIN)-derived synthetic pentapeptide on the other
CPR:4	With the pentapeptide linked through the C7alpha position of  bbbbb1 CHEMICALIN eeeee1 , the resulting PROTAC shows the most effective  bbbbb2 GENEIN eeeee2  degradation and highest affinity for the GENEIN
CPR:5	Recent studies indicate that  bbbbb1 CHEMICALIN eeeee1  initially acts as an antagonist, but later functions as an  bbbbb2 GENEIN eeeee2  agonist, promoting tumor growth
CPR:6	Recent studies indicate that  bbbbb1 CHEMICALIN eeeee1  initially acts as an antagonist, but later functions as an  bbbbb2 GENEIN eeeee2  agonist, promoting tumor growth
CPR:2	CHEMICALIN for GENEIN; CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  for  bbbbb2 GENEIN eeeee2 ) were found to have subtype-selective intrinsic efficacy
CPR:2	 bbbbb1 CHEMICALIN eeeee1  for  bbbbb2 GENEIN eeeee2 ; CHEMICALIN, CHEMICALIN, CHEMICALIN for GENEIN) were found to have subtype-selective intrinsic efficacy
CPR:2	CHEMICALIN for GENEIN;  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN for  bbbbb2 GENEIN eeeee2 ) were found to have subtype-selective intrinsic efficacy
CPR:2	CHEMICALIN for GENEIN; CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN for  bbbbb2 GENEIN eeeee2 ) were found to have subtype-selective intrinsic efficacy
CPR:5	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, for the  bbbbb2 GENEIN eeeee2  over the GENEIN or GENEIN), while others (e.g
CPR:5	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, for the GENEIN over the  bbbbb2 GENEIN eeeee2  or GENEIN), while others (e.g
CPR:5	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , for the  bbbbb2 GENEIN eeeee2  over the GENEIN or GENEIN), while others (e.g
CPR:5	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , for the GENEIN over the GENEIN or  bbbbb2 GENEIN eeeee2 ), while others (e.g
CPR:3	However, both compounds have similar molecular mechanisms of neuroprotection in neuronal cell cultures and animal neurodegenerative models, indicating that the neuroprotective effect of CHEMICALIN does not depend on inhibition of GENEIN, but rather is associated with the  bbbbb1 CHEMICALIN eeeee1  moiety, which promotes mitochondrial viability and stabilizes permeability transition by regulating  bbbbb2 GENEIN eeeee2  family proteins
CPR:4	 bbbbb1 CHEMICALIN eeeee1 : a novel anti-Parkinsonian  bbbbb2 GENEIN eeeee2  inhibitor with neuroprotective activity
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) is a novel, highly potent irreversible  bbbbb2 GENEIN eeeee2  inhibitor, anti-Parkinsonian drug
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) is a novel, highly potent irreversible  bbbbb2 GENEIN eeeee2  inhibitor, anti-Parkinsonian drug
CPR:4	Its S-isomer,  bbbbb1 CHEMICALIN eeeee1  is thousand times less potent as an  bbbbb2 GENEIN eeeee2  inhibitor
CPR:4	However, both compounds have similar molecular mechanisms of neuroprotection in neuronal cell cultures and animal neurodegenerative models, indicating that the neuroprotective effect of  bbbbb1 CHEMICALIN eeeee1  does not depend on inhibition of  bbbbb2 GENEIN eeeee2 , but rather is associated with the CHEMICALIN moiety, which promotes mitochondrial viability and stabilizes permeability transition by regulating GENEIN family proteins
CPR:10	Supplementation with  bbbbb1 CHEMICALIN eeeee1  at a dose of >350 microg/day did not normalize the serum  bbbbb2 GENEIN eeeee2  level; however, the patient showed normal growth and intelligence at 14 years of age
CPR:2	Consistent with the results of a computer analysis, the binding of  bbbbb1 GENEIN eeeee1  to CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) was significantly decreased to 38% that of the wild type
CPR:2	Consistent with the results of a computer analysis, the binding of  bbbbb1 GENEIN eeeee1  to  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) was significantly decreased to 38% that of the wild type
CPR:2	However, a CHEMICALNOTIN-CHEMICALNOTIN-transferase pull-down assay showed reduced binding of  bbbbb1 GENEIN eeeee1  with GENEIN in the absence of CHEMICALNOTIN and impaired release in the presence of  bbbbb2 CHEMICALIN eeeee2 
CPR:2	However, a CHEMICALNOTIN-CHEMICALNOTIN-transferase pull-down assay showed reduced binding of GENEIN with  bbbbb1 GENEIN eeeee1  in the absence of CHEMICALNOTIN and impaired release in the presence of  bbbbb2 CHEMICALIN eeeee2 
CPR:3	Our findings suggest that GENENOTIN causes reduced association with and impaired release of GENENOTIN, resulting in RTH predominantly at the pituitary level, and that slightly elevated serum  bbbbb1 GENEIN eeeee1  level with high dose of  bbbbb2 CHEMICALIN eeeee2  might be optimum for normal growth.
CPR:4	With exposure to  bbbbb1 CHEMICALIN eeeee1 , a selective  bbbbb2 GENEIN eeeee2  inhibitor, breast cancer risk reduction was appreciable (46%), suggesting a possible role for selective GENEIN inhibitors in breast cancer prophylaxis.
CPR:4	With exposure to  bbbbb1 CHEMICALIN eeeee1 , a selective GENEIN inhibitor, breast cancer risk reduction was appreciable (46%), suggesting a possible role for selective  bbbbb2 GENEIN eeeee2  inhibitors in breast cancer prophylaxis.
CPR:4	METHODS: We conducted a case-control study to measure the association between selective  bbbbb1 GENEIN eeeee1  inhibitors, particularly  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN and non-specific NSAID subgroups, and breast cancer risk
CPR:4	METHODS: We conducted a case-control study to measure the association between selective  bbbbb1 GENEIN eeeee1  inhibitors, particularly CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN and non-specific NSAID subgroups, and breast cancer risk
CPR:4	METHODS: We conducted a case-control study to measure the association between selective  bbbbb1 GENEIN eeeee1  inhibitors, particularly CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2  and non-specific NSAID subgroups, and breast cancer risk
CPR:4	BACKGROUND: Recent epidemiologic and laboratory studies have suggested that non- bbbbb1 CHEMICALIN eeeee1  anti-inflammatory drugs (NSAIDs) may reduce the risk of breast cancer through inhibition of  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:4	BACKGROUND: Recent epidemiologic and laboratory studies have suggested that non- bbbbb1 CHEMICALIN eeeee1  anti-inflammatory drugs (NSAIDs) may reduce the risk of breast cancer through inhibition of GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:10	Pretreatment with  bbbbb1 CHEMICALIN eeeee1  (40 micrograms/100 g b. wt., IP) 3 days or 7 days prior to the injection of CHEMICALNOTIN significantly inhibited the response rate of barrel rotation induced by CHEMICALNOTIN, but not that induced by  bbbbb2 GENEIN eeeee2  (1 microgram/rat, ICV)
CPR:2	These findings suggest that CHEMICALIN specifically suppresses the barrel rotation evoked by  bbbbb1 CHEMICALIN eeeee1  in a long-lasting manner possibly acting through  bbbbb2 GENEIN eeeee2 .
CPR:2	Intracerebroventricular administration of  bbbbb1 CHEMICALIN eeeee1  (5 micrograms/rat), a  bbbbb2 GENEIN eeeee2  analogue, induced barrel rotation in rats
CPR:4	The suppressive effect of  bbbbb1 CHEMICALIN eeeee1  on barrel rotation could be partially countered by CHEMICALIN, a selective peripheral  bbbbb2 GENEIN eeeee2  GENEIN antagonist
CPR:4	The suppressive effect of  bbbbb1 CHEMICALIN eeeee1  on barrel rotation could be partially countered by CHEMICALIN, a selective peripheral GENEIN  bbbbb2 GENEIN eeeee2  antagonist
CPR:4	These findings suggest that  bbbbb1 CHEMICALIN eeeee1  specifically suppresses the barrel rotation evoked by CHEMICALIN in a long-lasting manner possibly acting through  bbbbb2 GENEIN eeeee2 .
CPR:6	The suppressive effect of CHEMICALIN on barrel rotation could be partially countered by  bbbbb1 CHEMICALIN eeeee1 , a selective peripheral  bbbbb2 GENEIN eeeee2  GENEIN antagonist
CPR:6	The suppressive effect of CHEMICALIN on barrel rotation could be partially countered by  bbbbb1 CHEMICALIN eeeee1 , a selective peripheral GENEIN  bbbbb2 GENEIN eeeee2  antagonist
CPR:2	The altered genes associated with  bbbbb1 CHEMICALIN eeeee1 -induced cleft palate included GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN, GENEIN, GENEIN, and GENEIN but the magnitude of the change was relatively small (1.5- to 2-fold)
CPR:2	The altered genes associated with  bbbbb1 CHEMICALIN eeeee1 -induced cleft palate included GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN, GENEIN, and GENEIN but the magnitude of the change was relatively small (1.5- to 2-fold)
CPR:2	The altered genes associated with  bbbbb1 CHEMICALIN eeeee1 -induced cleft palate included GENEIN, GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN, and GENEIN but the magnitude of the change was relatively small (1.5- to 2-fold)
CPR:2	The altered genes associated with  bbbbb1 CHEMICALIN eeeee1 -induced cleft palate included GENEIN, GENEIN, GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN but the magnitude of the change was relatively small (1.5- to 2-fold)
CPR:2	The altered genes associated with  bbbbb1 CHEMICALIN eeeee1 -induced cleft palate included GENEIN, GENEIN, GENEIN, GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN but the magnitude of the change was relatively small (1.5- to 2-fold)
CPR:2	The altered genes associated with  bbbbb1 CHEMICALIN eeeee1 -induced cleft palate included GENEIN, GENEIN, GENEIN, GENEIN, GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2  but the magnitude of the change was relatively small (1.5- to 2-fold)
CPR:2	The altered genes associated with  bbbbb1 CHEMICALIN eeeee1 -induced cleft palate included  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN, GENEIN, GENEIN, GENEIN, and GENEIN but the magnitude of the change was relatively small (1.5- to 2-fold)
CPR:6	BACKGROUND: The effects of  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2  on rat palate development were characterized following in utero exposure
CPR:6	Effects of the  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2  on rat fetal palate development
CPR:1	Using a photo incorporable analogue of the general anesthetic, CHEMICALIN, we identified two transmembrane  bbbbb1 CHEMICALIN eeeee1  that were affinity labelled in purified  bbbbb2 GENEIN eeeee2 
CPR:1	PRINCIPAL FINDINGS: With the knowledge that all general anesthetics positively modulate  bbbbb1 GENEIN eeeee1 -mediated inhibitory transmission, site-directed mutagenesis comparing sequences of GENEIN subunits of varying sensitivity led to identification of  bbbbb2 CHEMICALIN eeeee2  residues in the transmembrane domain that are critical for the drug actions in vitro
CPR:1	PRINCIPAL FINDINGS: With the knowledge that all general anesthetics positively modulate GENEIN-mediated inhibitory transmission, site-directed mutagenesis comparing sequences of  bbbbb1 GENEIN eeeee1  subunits of varying sensitivity led to identification of  bbbbb2 CHEMICALIN eeeee2  residues in the transmembrane domain that are critical for the drug actions in vitro
CPR:2	Using a photo incorporable analogue of the general anesthetic,  bbbbb1 CHEMICALIN eeeee1 , we identified two transmembrane CHEMICALIN that were affinity labelled in purified  bbbbb2 GENEIN eeeee2 
CPR:2	The smooth muscle relaxant, CHEMICALIN, which is believed relatively specific in inhibiting the  bbbbb1 CHEMICALIN eeeee1 - bbbbb2 GENEIN eeeee2  interaction, depressed hyposmolarity-induced GENEIN secretion in a dose-dependent manner (r = -0.991, p less than 0.01)
CPR:2	The smooth muscle relaxant,  bbbbb1 CHEMICALIN eeeee1 , which is believed relatively specific in inhibiting the CHEMICALIN- bbbbb2 GENEIN eeeee2  interaction, depressed hyposmolarity-induced GENEIN secretion in a dose-dependent manner (r = -0.991, p less than 0.01)
CPR:2	Role of extracellular  bbbbb1 CHEMICALIN eeeee1  and GENENOTIN in  bbbbb2 GENEIN eeeee2  secretion induced by hyposmolarity, GENENOTIN, and high CHEMICALNOTIN in GH4C1 cells
CPR:4	The smooth muscle relaxant,  bbbbb1 CHEMICALIN eeeee1 , which is believed relatively specific in inhibiting the CHEMICALIN-GENEIN interaction, depressed hyposmolarity-induced  bbbbb2 GENEIN eeeee2  secretion in a dose-dependent manner (r = -0.991, p less than 0.01)
CPR:4	Removing medium CHEMICALNOTIN, blocking  bbbbb1 GENEIN eeeee1  with 50 mumol/l  bbbbb2 CHEMICALIN eeeee2 , or inhibiting GENEIN activation with 20 mumol/l CHEMICALIN, 10 mumol/l CHEMICALIN or 10 mumol/l CHEMICALIN almost completely blocked hyposmolarity-induced secretion
CPR:4	Removing medium CHEMICALNOTIN, blocking GENEIN with 50 mumol/l CHEMICALIN, or inhibiting  bbbbb1 GENEIN eeeee1  activation with 20 mumol/l  bbbbb2 CHEMICALIN eeeee2 , 10 mumol/l CHEMICALIN or 10 mumol/l CHEMICALIN almost completely blocked hyposmolarity-induced secretion
CPR:4	Removing medium CHEMICALNOTIN, blocking GENEIN with 50 mumol/l CHEMICALIN, or inhibiting  bbbbb1 GENEIN eeeee1  activation with 20 mumol/l CHEMICALIN, 10 mumol/l  bbbbb2 CHEMICALIN eeeee2  or 10 mumol/l CHEMICALIN almost completely blocked hyposmolarity-induced secretion
CPR:4	Removing medium CHEMICALNOTIN, blocking GENEIN with 50 mumol/l CHEMICALIN, or inhibiting  bbbbb1 GENEIN eeeee1  activation with 20 mumol/l CHEMICALIN, 10 mumol/l CHEMICALIN or 10 mumol/l  bbbbb2 CHEMICALIN eeeee2  almost completely blocked hyposmolarity-induced secretion
CPR:9	An essential control in experiments using Gy mice is to demonstrate that the abnormal phenotypes exhibited by these mice are abolished by providing replacement  bbbbb1 CHEMICALIN eeeee1  and this can be accomplished by breeding with CAG- bbbbb2 GENEIN eeeee2  mice that express GENEIN from a ubiquitous promoter
CPR:9	An essential control in experiments using Gy mice is to demonstrate that the abnormal phenotypes exhibited by these mice are abolished by providing replacement  bbbbb1 CHEMICALIN eeeee1  and this can be accomplished by breeding with CAG-GENEIN mice that express  bbbbb2 GENEIN eeeee2  from a ubiquitous promoter
CPR:10	Importantly, treatment with  bbbbb1 CHEMICALIN eeeee1  did not increase lung tumor burden in an experimental model of metastasis, which has been observed with inhibitors of GENEIN signaling that do not target  bbbbb2 GENEIN eeeee2 
CPR:4	Importantly, treatment with  bbbbb1 CHEMICALIN eeeee1  did not increase lung tumor burden in an experimental model of metastasis, which has been observed with inhibitors of  bbbbb2 GENEIN eeeee2  signaling that do not target GENEIN
CPR:4	Collectively, these data suggest that  bbbbb1 CHEMICALIN eeeee1  is a promising agent for inhibiting tumor angiogenesis and metastasis in cancers with dysregulated  bbbbb2 GENEIN eeeee2  and GENEIN signaling.
CPR:4	Collectively, these data suggest that  bbbbb1 CHEMICALIN eeeee1  is a promising agent for inhibiting tumor angiogenesis and metastasis in cancers with dysregulated GENEIN and  bbbbb2 GENEIN eeeee2  signaling.
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) is a small-molecule  bbbbb2 GENEIN eeeee2  inhibitor with potent activity toward GENEIN and GENEIN (GENEIN), as well as a number of other GENEIN that have also been implicated in tumor pathobiology, including GENEIN, GENEIN, GENEIN, and GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) is a small-molecule GENEIN inhibitor with potent activity toward  bbbbb2 GENEIN eeeee2  and GENEIN (GENEIN), as well as a number of other GENEIN that have also been implicated in tumor pathobiology, including GENEIN, GENEIN, GENEIN, and GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) is a small-molecule GENEIN inhibitor with potent activity toward GENEIN and  bbbbb2 GENEIN eeeee2  (GENEIN), as well as a number of other GENEIN that have also been implicated in tumor pathobiology, including GENEIN, GENEIN, GENEIN, and GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) is a small-molecule GENEIN inhibitor with potent activity toward GENEIN and GENEIN ( bbbbb2 GENEIN eeeee2 ), as well as a number of other GENEIN that have also been implicated in tumor pathobiology, including GENEIN, GENEIN, GENEIN, and GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) is a small-molecule GENEIN inhibitor with potent activity toward GENEIN and GENEIN (GENEIN), as well as a number of other  bbbbb2 GENEIN eeeee2  that have also been implicated in tumor pathobiology, including GENEIN, GENEIN, GENEIN, and GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) is a small-molecule GENEIN inhibitor with potent activity toward GENEIN and GENEIN (GENEIN), as well as a number of other GENEIN that have also been implicated in tumor pathobiology, including  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN, and GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) is a small-molecule GENEIN inhibitor with potent activity toward GENEIN and GENEIN (GENEIN), as well as a number of other GENEIN that have also been implicated in tumor pathobiology, including GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) is a small-molecule GENEIN inhibitor with potent activity toward GENEIN and GENEIN (GENEIN), as well as a number of other GENEIN that have also been implicated in tumor pathobiology, including GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) is a small-molecule GENEIN inhibitor with potent activity toward GENEIN and GENEIN (GENEIN), as well as a number of other GENEIN that have also been implicated in tumor pathobiology, including GENEIN, GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2 
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) is a small-molecule  bbbbb2 GENEIN eeeee2  inhibitor with potent activity toward GENEIN and GENEIN (GENEIN), as well as a number of other GENEIN that have also been implicated in tumor pathobiology, including GENEIN, GENEIN, GENEIN, and GENEIN
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) is a small-molecule GENEIN inhibitor with potent activity toward  bbbbb2 GENEIN eeeee2  and GENEIN (GENEIN), as well as a number of other GENEIN that have also been implicated in tumor pathobiology, including GENEIN, GENEIN, GENEIN, and GENEIN
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) is a small-molecule GENEIN inhibitor with potent activity toward GENEIN and  bbbbb2 GENEIN eeeee2  (GENEIN), as well as a number of other GENEIN that have also been implicated in tumor pathobiology, including GENEIN, GENEIN, GENEIN, and GENEIN
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) is a small-molecule GENEIN inhibitor with potent activity toward GENEIN and GENEIN ( bbbbb2 GENEIN eeeee2 ), as well as a number of other GENEIN that have also been implicated in tumor pathobiology, including GENEIN, GENEIN, GENEIN, and GENEIN
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) is a small-molecule GENEIN inhibitor with potent activity toward GENEIN and GENEIN (GENEIN), as well as a number of other  bbbbb2 GENEIN eeeee2  that have also been implicated in tumor pathobiology, including GENEIN, GENEIN, GENEIN, and GENEIN
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) is a small-molecule GENEIN inhibitor with potent activity toward GENEIN and GENEIN (GENEIN), as well as a number of other GENEIN that have also been implicated in tumor pathobiology, including  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN, and GENEIN
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) is a small-molecule GENEIN inhibitor with potent activity toward GENEIN and GENEIN (GENEIN), as well as a number of other GENEIN that have also been implicated in tumor pathobiology, including GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) is a small-molecule GENEIN inhibitor with potent activity toward GENEIN and GENEIN (GENEIN), as well as a number of other GENEIN that have also been implicated in tumor pathobiology, including GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) is a small-molecule GENEIN inhibitor with potent activity toward GENEIN and GENEIN (GENEIN), as well as a number of other GENEIN that have also been implicated in tumor pathobiology, including GENEIN, GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2 
CPR:4	Treatment with  bbbbb1 CHEMICALIN eeeee1  inhibited  bbbbb2 GENEIN eeeee2  and GENEIN phosphorylation in vitro and in tumor models in vivo and led to significant reductions in cell invasion in vitro
CPR:4	Treatment with  bbbbb1 CHEMICALIN eeeee1  inhibited GENEIN and  bbbbb2 GENEIN eeeee2  phosphorylation in vitro and in tumor models in vivo and led to significant reductions in cell invasion in vitro
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a novel  bbbbb2 GENEIN eeeee2  and GENEIN inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a novel GENEIN and  bbbbb2 GENEIN eeeee2  inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a novel  bbbbb2 GENEIN eeeee2  and GENEIN inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a novel GENEIN and  bbbbb2 GENEIN eeeee2  inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth
CPR:2	KEY RESULTS:  bbbbb1 CHEMICALIN eeeee1  suppressed osteoclastogenesis induced by  bbbbb2 GENEIN eeeee2 , and by breast cancer and multiple myeloma cells
CPR:2	 bbbbb1 CHEMICALIN eeeee1  suppresses osteoclastogenesis induced by  bbbbb2 GENEIN eeeee2  and cancer cells through inhibition of inflammatory pathways: a new use for an old drug
CPR:4	Inhibition of the GENENOTIN pathway was responsible for this effect since the  bbbbb1 CHEMICALIN eeeee1  inhibited GENEIN-induced  bbbbb2 GENEIN eeeee2  activation, activation of GENEIN (GENEIN) and suppressed inhibitor of GENEIN (GENEIN) phosphorylation and degradation, an inhibitor of GENEIN
CPR:4	Inhibition of the GENENOTIN pathway was responsible for this effect since the  bbbbb1 CHEMICALIN eeeee1  inhibited GENEIN-induced GENEIN activation, activation of  bbbbb2 GENEIN eeeee2  (GENEIN) and suppressed inhibitor of GENEIN (GENEIN) phosphorylation and degradation, an inhibitor of GENEIN
CPR:4	Inhibition of the GENENOTIN pathway was responsible for this effect since the  bbbbb1 CHEMICALIN eeeee1  inhibited GENEIN-induced GENEIN activation, activation of GENEIN ( bbbbb2 GENEIN eeeee2 ) and suppressed inhibitor of GENEIN (GENEIN) phosphorylation and degradation, an inhibitor of GENEIN
CPR:4	Inhibition of the GENENOTIN pathway was responsible for this effect since the  bbbbb1 CHEMICALIN eeeee1  inhibited GENEIN-induced GENEIN activation, activation of GENEIN (GENEIN) and suppressed inhibitor of  bbbbb2 GENEIN eeeee2  (GENEIN) phosphorylation and degradation, an inhibitor of GENEIN
CPR:4	Inhibition of the GENENOTIN pathway was responsible for this effect since the  bbbbb1 CHEMICALIN eeeee1  inhibited GENEIN-induced GENEIN activation, activation of GENEIN (GENEIN) and suppressed inhibitor of GENEIN ( bbbbb2 GENEIN eeeee2 ) phosphorylation and degradation, an inhibitor of GENEIN
CPR:4	Inhibition of the GENENOTIN pathway was responsible for this effect since the  bbbbb1 CHEMICALIN eeeee1  inhibited GENEIN-induced GENEIN activation, activation of GENEIN (GENEIN) and suppressed inhibitor of GENEIN (GENEIN) phosphorylation and degradation, an inhibitor of  bbbbb2 GENEIN eeeee2 
CPR:4	Inhibition of the GENENOTIN pathway was responsible for this effect since the  bbbbb1 CHEMICALIN eeeee1  inhibited  bbbbb2 GENEIN eeeee2 -induced GENEIN activation, activation of GENEIN (GENEIN) and suppressed inhibitor of GENEIN (GENEIN) phosphorylation and degradation, an inhibitor of GENEIN
CPR:4	CONCLUSIONS AND IMPLICATIONS: Together, these data suggest that  bbbbb1 CHEMICALIN eeeee1  significantly suppressed osteoclastogenesis induced by  bbbbb2 GENEIN eeeee2  and tumour cells via the GENEIN signalling pathway
CPR:4	CONCLUSIONS AND IMPLICATIONS: Together, these data suggest that  bbbbb1 CHEMICALIN eeeee1  significantly suppressed osteoclastogenesis induced by GENEIN and tumour cells via the  bbbbb2 GENEIN eeeee2  signalling pathway
CPR:2	Our findings show evidence that  bbbbb1 GENEIN eeeee1  polymorphisms affect the responses of PED and clinical ED patients to  bbbbb2 CHEMICALIN eeeee2 .
CPR:2	Although genetic polymorphisms in the GENEIN (GENEIN) gene may impair endogenous CHEMICALIN formation, there is little information about how  bbbbb1 GENEIN eeeee1  polymorphisms and haplotypes affect the responses to  bbbbb2 CHEMICALIN eeeee2 
CPR:2	 bbbbb1 GENEIN eeeee1  genotypes and haplotypes modify the responses to  bbbbb2 CHEMICALIN eeeee2  in patients with erectile dysfunction
CPR:9	Although genetic polymorphisms in the GENEIN ( bbbbb1 GENEIN eeeee1 ) gene may impair endogenous  bbbbb2 CHEMICALIN eeeee2  formation, there is little information about how GENEIN polymorphisms and haplotypes affect the responses to CHEMICALIN
CPR:9	Although genetic polymorphisms in the  bbbbb1 GENEIN eeeee1  (GENEIN) gene may impair endogenous  bbbbb2 CHEMICALIN eeeee2  formation, there is little information about how GENEIN polymorphisms and haplotypes affect the responses to CHEMICALIN
CPR:3	Here, we report biochemical evidence that  bbbbb1 CHEMICALIN eeeee1  alone induces  bbbbb2 GENEIN eeeee2  activation, resulting in the induced expression of GENEIN and GENEIN
CPR:3	Here, we report biochemical evidence that  bbbbb1 CHEMICALIN eeeee1  alone induces GENEIN activation, resulting in the induced expression of  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:3	Here, we report biochemical evidence that  bbbbb1 CHEMICALIN eeeee1  alone induces GENEIN activation, resulting in the induced expression of GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:3	 bbbbb1 CHEMICALIN eeeee1  induces the expression of  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:3	 bbbbb1 CHEMICALIN eeeee1  induces the expression of GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:5	Unexpectedly, both the  bbbbb1 GENEIN eeeee1 specific agonist,  bbbbb2 CHEMICALIN eeeee2 , and the GENEIN (GENENOTIN) agonist, CHEMICALIN (LY), induced a CHEMICALNOTIN-insensitive outward current/hyperpolarization
CPR:5	Unexpectedly, both the GENEINspecific agonist, CHEMICALIN, and the  bbbbb1 GENEIN eeeee1  (GENENOTIN) agonist,  bbbbb2 CHEMICALIN eeeee2  (LY), induced a CHEMICALNOTIN-insensitive outward current/hyperpolarization
CPR:6	Both outward currents were significantly reduced by the  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2  and the CHEMICALNOTIN-induced current was blocked by the specific GENEIN antagonist CHEMICALIN
CPR:6	Both outward currents were significantly reduced by the GENEIN antagonist CHEMICALIN and the CHEMICALNOTIN-induced current was blocked by the specific  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2 
CPR:4	We have examined the effectiveness of two novel  bbbbb1 GENEIN eeeee1  selective inhibitors,  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN, in a panel of melanoma cell lines and normal cell types
CPR:4	We have examined the effectiveness of two novel  bbbbb1 GENEIN eeeee1  selective inhibitors, CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 , in a panel of melanoma cell lines and normal cell types
CPR:10	GENEIN was still inhibited by CHEMICALIN in CRC cells after siRNA knockdown of GENENOTIN, indicating GENEIN-dependent and  bbbbb1 GENEIN eeeee1 -independent mechanisms of  bbbbb2 CHEMICALIN eeeee2 -induced inhibition of GENEIN
CPR:2	GENEIN was still inhibited by CHEMICALIN in CRC cells after siRNA knockdown of GENENOTIN, indicating  bbbbb1 GENEIN eeeee1 -dependent and GENEIN-independent mechanisms of  bbbbb2 CHEMICALIN eeeee2 -induced inhibition of GENEIN
CPR:3	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  (an activator of  bbbbb2 GENEIN eeeee2 ) increased inhibition of GENEIN and GENEIN, as well as autophagy in CRC cells
CPR:3	CONCLUSIONS:  bbbbb1 CHEMICALIN eeeee1  is an inhibitor of GENEIN and an activator of  bbbbb2 GENEIN eeeee2 , targeting regulators of intracellular energy homeostasis and metabolism
CPR:3	 bbbbb1 CHEMICALIN eeeee1  inhibits GENEIN signaling, activates  bbbbb2 GENEIN eeeee2 , and induces autophagy in colorectal cancer cells
CPR:3	 bbbbb1 CHEMICALIN eeeee1  changed nucleotide ratios and activated  bbbbb2 GENEIN eeeee2  in CRC cells
CPR:3	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN (an activator of  bbbbb2 GENEIN eeeee2 ) increased inhibition of GENEIN and GENEIN, as well as autophagy in CRC cells
CPR:4	RESULTS:  bbbbb1 CHEMICALIN eeeee1  reduced  bbbbb2 GENEIN eeeee2  signaling in CRC cells by inhibiting the GENEIN effectors GENEIN and GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  inhibits  bbbbb2 GENEIN eeeee2  signaling, activates GENEIN, and induces autophagy in colorectal cancer cells
CPR:4	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  (an activator of GENEIN) increased inhibition of  bbbbb2 GENEIN eeeee2  and GENEIN, as well as autophagy in CRC cells
CPR:4	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  (an activator of GENEIN) increased inhibition of GENEIN and  bbbbb2 GENEIN eeeee2 , as well as autophagy in CRC cells
CPR:4	Rectal mucosal samples from patients given  bbbbb1 CHEMICALIN eeeee1  had reduced phosphorylation of  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:4	Rectal mucosal samples from patients given  bbbbb1 CHEMICALIN eeeee1  had reduced phosphorylation of GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:4	CONCLUSIONS:  bbbbb1 CHEMICALIN eeeee1  is an inhibitor of  bbbbb2 GENEIN eeeee2  and an activator of GENEIN, targeting regulators of intracellular energy homeostasis and metabolism
CPR:4	RESULTS:  bbbbb1 CHEMICALIN eeeee1  reduced GENEIN signaling in CRC cells by inhibiting the  bbbbb2 GENEIN eeeee2  effectors GENEIN and GENEIN
CPR:4	RESULTS:  bbbbb1 CHEMICALIN eeeee1  reduced GENEIN signaling in CRC cells by inhibiting the GENEIN effectors  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:4	RESULTS:  bbbbb1 CHEMICALIN eeeee1  reduced GENEIN signaling in CRC cells by inhibiting the GENEIN effectors GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:4	 bbbbb1 GENEIN eeeee1  was still inhibited by  bbbbb2 CHEMICALIN eeeee2  in CRC cells after siRNA knockdown of GENENOTIN, indicating GENEIN-dependent and GENEIN-independent mechanisms of CHEMICALIN-induced inhibition of GENEIN
CPR:4	GENEIN was still inhibited by CHEMICALIN in CRC cells after siRNA knockdown of GENENOTIN, indicating GENEIN-dependent and GENEIN-independent mechanisms of  bbbbb1 CHEMICALIN eeeee1 -induced inhibition of  bbbbb2 GENEIN eeeee2 
CPR:4	 bbbbb1 CHEMICALIN eeeee1  induced autophagy, a feature of  bbbbb2 GENEIN eeeee2  inhibition
CPR:4	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN (an activator of GENEIN) increased inhibition of  bbbbb2 GENEIN eeeee2  and GENEIN, as well as autophagy in CRC cells
CPR:4	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN (an activator of GENEIN) increased inhibition of GENEIN and  bbbbb2 GENEIN eeeee2 , as well as autophagy in CRC cells
CPR:2	Oncogenic  bbbbb1 GENEIN eeeee1  expression is associated with derangement of the CHEMICALNOTIN/GENEIN pathway and  bbbbb2 CHEMICALIN eeeee2 -reversible alterations of mitochondrial dynamics and respiration
CPR:2	These findings support the notion that  bbbbb1 CHEMICALIN eeeee1  shortage-induced apoptosis, specific of  bbbbb2 GENEIN eeeee2 -transformed cells, is associated to a derangement of GENENOTIN signaling that leads to GENENOTIN decrease, reduction of CHEMICALNOTIN formation, prevalence of mitochondrial fission over fusion, and thereby opening new approaches for development of anticancer drugs.
CPR:2	Exogenous stimulation of GENEIN activity, achieved by  bbbbb1 CHEMICALIN eeeee1  treatment, protected  bbbbb2 GENEIN eeeee2 -transformed cells from apoptosis induced by CHEMICALIN deprivation, enhanced GENEIN activity, intracellular CHEMICALNOTIN (CHEMICALNOTIN) levels, mitochondrial fusion and decreased intracellular reactive CHEMICALNOTIN species (ROS) levels
CPR:2	Oncogenic GENEIN expression is associated with derangement of the CHEMICALNOTIN/ bbbbb1 GENEIN eeeee1  pathway and  bbbbb2 CHEMICALIN eeeee2 -reversible alterations of mitochondrial dynamics and respiration
CPR:3	Exogenous stimulation of  bbbbb1 GENEIN eeeee1  activity, achieved by  bbbbb2 CHEMICALIN eeeee2  treatment, protected GENEIN-transformed cells from apoptosis induced by CHEMICALIN deprivation, enhanced GENEIN activity, intracellular CHEMICALNOTIN (CHEMICALNOTIN) levels, mitochondrial fusion and decreased intracellular reactive CHEMICALNOTIN species (ROS) levels
CPR:3	Exogenous stimulation of GENEIN activity, achieved by  bbbbb1 CHEMICALIN eeeee1  treatment, protected GENEIN-transformed cells from apoptosis induced by CHEMICALIN deprivation, enhanced  bbbbb2 GENEIN eeeee2  activity, intracellular CHEMICALNOTIN (CHEMICALNOTIN) levels, mitochondrial fusion and decreased intracellular reactive CHEMICALNOTIN species (ROS) levels
CPR:4	Exogenous stimulation of GENEIN activity, achieved by CHEMICALIN treatment, protected  bbbbb1 GENEIN eeeee1 -transformed cells from apoptosis induced by  bbbbb2 CHEMICALIN eeeee2  deprivation, enhanced GENEIN activity, intracellular CHEMICALNOTIN (CHEMICALNOTIN) levels, mitochondrial fusion and decreased intracellular reactive CHEMICALNOTIN species (ROS) levels
CPR:2	 bbbbb1 CHEMICALIN eeeee1  exerts suppressive effects on phenotype changes and ECM production in NPDFs via  bbbbb2 GENEIN eeeee2  signaling pathway interference
CPR:2	 bbbbb1 CHEMICALIN eeeee1  inhibits myofibroblast differentiation in nasal polyp-derived fibroblasts via the  bbbbb2 GENEIN eeeee2  pathway
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (a specific inhibitor of GENEIN GENEIN) markedly suppressed the increased expression of  bbbbb2 GENEIN eeeee2  and GENEIN in GENEIN-induced NPDFs
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (a specific inhibitor of GENEIN GENEIN) markedly suppressed the increased expression of GENEIN and  bbbbb2 GENEIN eeeee2  in GENEIN-induced NPDFs
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (a specific inhibitor of GENEIN GENEIN) markedly suppressed the increased expression of GENEIN and GENEIN in  bbbbb2 GENEIN eeeee2 -induced NPDFs
CPR:4	In  bbbbb1 GENEIN eeeee1 -induced NPDFs,  bbbbb2 CHEMICALIN eeeee2  significantly inhibited the expression of GENEIN and GENEIN mRNA and reduced GENEIN and GENEIN protein levels
CPR:4	In GENEIN-induced NPDFs,  bbbbb1 CHEMICALIN eeeee1  significantly inhibited the expression of  bbbbb2 GENEIN eeeee2  and GENEIN mRNA and reduced GENEIN and GENEIN protein levels
CPR:4	In GENEIN-induced NPDFs,  bbbbb1 CHEMICALIN eeeee1  significantly inhibited the expression of GENEIN and  bbbbb2 GENEIN eeeee2  mRNA and reduced GENEIN and GENEIN protein levels
CPR:4	In GENEIN-induced NPDFs,  bbbbb1 CHEMICALIN eeeee1  significantly inhibited the expression of GENEIN and GENEIN mRNA and reduced  bbbbb2 GENEIN eeeee2  and GENEIN protein levels
CPR:4	In GENEIN-induced NPDFs,  bbbbb1 CHEMICALIN eeeee1  significantly inhibited the expression of GENEIN and GENEIN mRNA and reduced GENEIN and  bbbbb2 GENEIN eeeee2  protein levels
CPR:4	 bbbbb1 CHEMICALIN eeeee1  only suppressed the expression of  bbbbb2 GENEIN eeeee2  among the evaluated signaling molecules
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (a specific inhibitor of  bbbbb2 GENEIN eeeee2  GENEIN) markedly suppressed the increased expression of GENEIN and GENEIN in GENEIN-induced NPDFs
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (a specific inhibitor of GENEIN  bbbbb2 GENEIN eeeee2 ) markedly suppressed the increased expression of GENEIN and GENEIN in GENEIN-induced NPDFs
CPR:10	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN inhibited autoubiquitination of GENEIN in HEK293T cells expressing CHEMICALIN-binding competent wild-type GENEIN, but not CHEMICALIN-binding defective  bbbbb2 GENEIN eeeee2 (YW/AA)
CPR:10	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  inhibited autoubiquitination of GENEIN in HEK293T cells expressing CHEMICALIN-binding competent wild-type GENEIN, but not CHEMICALIN-binding defective  bbbbb2 GENEIN eeeee2 (YW/AA)
CPR:2	Our studies demonstrate that CHEMICALIN, CHEMICALIN and another immunomodulatory drug,  bbbbb1 CHEMICALIN eeeee1 , bound endogenous  bbbbb2 GENEIN eeeee2  and recombinant GENEIN-GENEIN (GENEIN) complexes
CPR:2	Our studies demonstrate that CHEMICALIN, CHEMICALIN and another immunomodulatory drug,  bbbbb1 CHEMICALIN eeeee1 , bound endogenous GENEIN and recombinant  bbbbb2 GENEIN eeeee2 -GENEIN (GENEIN) complexes
CPR:2	Our studies demonstrate that CHEMICALIN, CHEMICALIN and another immunomodulatory drug,  bbbbb1 CHEMICALIN eeeee1 , bound endogenous GENEIN and recombinant GENEIN- bbbbb2 GENEIN eeeee2  (GENEIN) complexes
CPR:2	Our studies demonstrate that CHEMICALIN, CHEMICALIN and another immunomodulatory drug,  bbbbb1 CHEMICALIN eeeee1 , bound endogenous GENEIN and recombinant GENEIN-GENEIN ( bbbbb2 GENEIN eeeee2 ) complexes
CPR:2	CHEMICALIN and CHEMICALIN inhibited autoubiquitination of GENEIN in HEK293T cells expressing  bbbbb1 CHEMICALIN eeeee1 -binding competent wild-type  bbbbb2 GENEIN eeeee2 , but not CHEMICALIN-binding defective GENEIN(YW/AA)
CPR:2	CHEMICALIN and CHEMICALIN inhibited autoubiquitination of GENEIN in HEK293T cells expressing CHEMICALIN-binding competent wild-type GENEIN, but not  bbbbb1 CHEMICALIN eeeee1 -binding defective  bbbbb2 GENEIN eeeee2 (YW/AA)
CPR:2	Our studies demonstrate that  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and another immunomodulatory drug, CHEMICALIN, bound endogenous  bbbbb2 GENEIN eeeee2  and recombinant GENEIN-GENEIN (GENEIN) complexes
CPR:2	Our studies demonstrate that  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and another immunomodulatory drug, CHEMICALIN, bound endogenous GENEIN and recombinant  bbbbb2 GENEIN eeeee2 -GENEIN (GENEIN) complexes
CPR:2	Our studies demonstrate that  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and another immunomodulatory drug, CHEMICALIN, bound endogenous GENEIN and recombinant GENEIN- bbbbb2 GENEIN eeeee2  (GENEIN) complexes
CPR:2	Our studies demonstrate that  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and another immunomodulatory drug, CHEMICALIN, bound endogenous GENEIN and recombinant GENEIN-GENEIN ( bbbbb2 GENEIN eeeee2 ) complexes
CPR:2	Our studies demonstrate that CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and another immunomodulatory drug, CHEMICALIN, bound endogenous  bbbbb2 GENEIN eeeee2  and recombinant GENEIN-GENEIN (GENEIN) complexes
CPR:2	Our studies demonstrate that CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and another immunomodulatory drug, CHEMICALIN, bound endogenous GENEIN and recombinant  bbbbb2 GENEIN eeeee2 -GENEIN (GENEIN) complexes
CPR:2	Our studies demonstrate that CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and another immunomodulatory drug, CHEMICALIN, bound endogenous GENEIN and recombinant GENEIN- bbbbb2 GENEIN eeeee2  (GENEIN) complexes
CPR:2	Our studies demonstrate that CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and another immunomodulatory drug, CHEMICALIN, bound endogenous GENEIN and recombinant GENEIN-GENEIN ( bbbbb2 GENEIN eeeee2 ) complexes
CPR:2	 bbbbb1 GENEIN eeeee1  mediated antiproliferative activities of  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN in myeloma cells, as well as CHEMICALIN- and CHEMICALIN-induced GENEIN production in T cells
CPR:2	 bbbbb1 GENEIN eeeee1  mediated antiproliferative activities of CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  in myeloma cells, as well as CHEMICALIN- and CHEMICALIN-induced GENEIN production in T cells
CPR:2	 bbbbb1 GENEIN eeeee1  is a direct protein target for immunomodulatory and antiproliferative activities of CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:2	 bbbbb1 GENEIN eeeee1  is a direct protein target for immunomodulatory and antiproliferative activities of  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:2	Our biophysical, biochemical and gene silencing studies show that  bbbbb1 GENEIN eeeee1  is a proximate, therapeutically important molecular target of  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN.
CPR:2	Our biophysical, biochemical and gene silencing studies show that  bbbbb1 GENEIN eeeee1  is a proximate, therapeutically important molecular target of CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 .
CPR:2	The ubiquitously expressed E3 ligase protein  bbbbb1 GENEIN eeeee1  (GENEIN) has been identified as the primary teratogenic target of  bbbbb2 CHEMICALIN eeeee2 
CPR:2	The ubiquitously expressed E3 ligase protein GENEIN ( bbbbb1 GENEIN eeeee1 ) has been identified as the primary teratogenic target of  bbbbb2 CHEMICALIN eeeee2 
CPR:3	GENEIN mediated antiproliferative activities of CHEMICALIN and CHEMICALIN in myeloma cells, as well as  bbbbb1 CHEMICALIN eeeee1 - and CHEMICALIN-induced  bbbbb2 GENEIN eeeee2  production in T cells
CPR:3	GENEIN mediated antiproliferative activities of CHEMICALIN and CHEMICALIN in myeloma cells, as well as CHEMICALIN- and  bbbbb1 CHEMICALIN eeeee1 -induced  bbbbb2 GENEIN eeeee2  production in T cells
CPR:3	Overexpression of GENENOTIN wild-type protein, but not GENENOTIN(YW/AA) mutant protein, in KMS12 myeloma cells, amplified  bbbbb1 CHEMICALIN eeeee1 -mediated reductions in GENEIN and GENEIN expression and increases in GENEIN( bbbbb2 GENEIN eeeee2 ) expression
CPR:3	Overexpression of GENENOTIN wild-type protein, but not GENENOTIN(YW/AA) mutant protein, in KMS12 myeloma cells, amplified  bbbbb1 CHEMICALIN eeeee1 -mediated reductions in GENEIN and GENEIN expression and increases in  bbbbb2 GENEIN eeeee2 (GENEIN) expression
CPR:4	Overexpression of GENENOTIN wild-type protein, but not GENENOTIN(YW/AA) mutant protein, in KMS12 myeloma cells, amplified  bbbbb1 CHEMICALIN eeeee1 -mediated reductions in  bbbbb2 GENEIN eeeee2  and GENEIN expression and increases in GENEIN(GENEIN) expression
CPR:4	Overexpression of GENENOTIN wild-type protein, but not GENENOTIN(YW/AA) mutant protein, in KMS12 myeloma cells, amplified  bbbbb1 CHEMICALIN eeeee1 -mediated reductions in GENEIN and  bbbbb2 GENEIN eeeee2  expression and increases in GENEIN(GENEIN) expression
CPR:4	Long-term selection for  bbbbb1 CHEMICALIN eeeee1  resistance in H929 myeloma cell lines was accompanied by a reduction in  bbbbb2 GENEIN eeeee2 , while in DF15R myeloma cells resistant to both CHEMICALNOTIN and CHEMICALNOTIN, GENENOTIN protein was undetectable
CPR:4	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN inhibited autoubiquitination of  bbbbb2 GENEIN eeeee2  in HEK293T cells expressing CHEMICALIN-binding competent wild-type GENEIN, but not CHEMICALIN-binding defective GENEIN(YW/AA)
CPR:4	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN inhibited autoubiquitination of GENEIN in HEK293T cells expressing CHEMICALIN-binding competent wild-type  bbbbb2 GENEIN eeeee2 , but not CHEMICALIN-binding defective GENEIN(YW/AA)
CPR:4	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  inhibited autoubiquitination of  bbbbb2 GENEIN eeeee2  in HEK293T cells expressing CHEMICALIN-binding competent wild-type GENEIN, but not CHEMICALIN-binding defective GENEIN(YW/AA)
CPR:4	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  inhibited autoubiquitination of GENEIN in HEK293T cells expressing CHEMICALIN-binding competent wild-type  bbbbb2 GENEIN eeeee2 , but not CHEMICALIN-binding defective GENEIN(YW/AA)
CPR:4	These  bbbbb1 CHEMICALIN eeeee1 , but not GvEx, showed a certain level of inhibition of human-cDNA-expressed  bbbbb2 GENEIN eeeee2 
CPR:2	Emerging data suggest that  bbbbb1 CHEMICALIN eeeee1  may also have activity in other subsets of lung cancer, including tumors demonstrating amplification or mutation of the  bbbbb2 GENEIN eeeee2  oncogene, or translocation of the GENEIN oncogene
CPR:2	Emerging data suggest that  bbbbb1 CHEMICALIN eeeee1  may also have activity in other subsets of lung cancer, including tumors demonstrating amplification or mutation of the GENEIN oncogene, or translocation of the  bbbbb2 GENEIN eeeee2  oncogene
CPR:2	 bbbbb1 CHEMICALIN eeeee1  has demonstrated efficacy against  bbbbb2 GENEIN eeeee2 -rearranged NSCLC, and has potential for broader application in select subsets of lung cancer.
CPR:2	 bbbbb1 CHEMICALIN eeeee1  is an oral GENEIN inhibitor (TKI), which silences the protein product of the GENEIN fusion gene and has recently been approved for the treatment of NSCLC aberrantly expressing  bbbbb2 GENEIN eeeee2 
CPR:4	 bbbbb1 CHEMICALIN eeeee1  is an oral GENEIN inhibitor (TKI), which silences the protein product of the  bbbbb2 GENEIN eeeee2  fusion gene and has recently been approved for the treatment of NSCLC aberrantly expressing GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  is an oral  bbbbb2 GENEIN eeeee2  inhibitor (TKI), which silences the protein product of the GENEIN fusion gene and has recently been approved for the treatment of NSCLC aberrantly expressing GENEIN
CPR:2	There was no escape of i.c.v.-administered CHEMICALNOTIN from brain to the peripheral circulation ruling out a peripheral and supporting a central mechanism of  bbbbb1 CHEMICALIN eeeee1 - bbbbb2 GENEIN eeeee2  interaction.(ABSTRACT TRUNCATED AT 250 WORDS)
CPR:2	To clarify if the behavioral interaction between  bbbbb1 CHEMICALIN eeeee1  and  bbbbb2 GENEIN eeeee2  reported previously occur centrally or due to a peripheral hemodynamic change, the effect of i.c.v
CPR:2	CHEMICALNOTIN agonists and antagonists dose dependently accentuated and attenuated, respectively, CHEMICALNOTIN-induced motor incoordination, thereby suggesting a central mechanism of  bbbbb1 GENEIN eeeee1  modulation of this effect of  bbbbb2 CHEMICALIN eeeee2  and confirmed our previous reports in which CHEMICALNOTIN agonists and antagonists were given i.p. CHEMICALIN, a weak GENEIN antagonist but potent inhibitor of GENEIN, did not alter ethanol's motor incoordination, further supporting involvement of brain GENEIN mechanism(s) in CHEMICALIN-GENEIN interactions
CPR:2	Results from R-PIA and  bbbbb1 CHEMICALIN eeeee1  experiments showed nearly a 40-fold greater potency of R-vs. S-diastereoisomer, suggesting predominance of  bbbbb2 GENEIN eeeee2  subtype
CPR:2	CHEMICALNOTIN agonists and antagonists dose dependently accentuated and attenuated, respectively, CHEMICALNOTIN-induced motor incoordination, thereby suggesting a central mechanism of GENEIN modulation of this effect of CHEMICALIN and confirmed our previous reports in which CHEMICALNOTIN agonists and antagonists were given i.p. CHEMICALIN, a weak GENEIN antagonist but potent inhibitor of GENEIN, did not alter ethanol's motor incoordination, further supporting involvement of brain GENEIN mechanism(s) in  bbbbb1 CHEMICALIN eeeee1 - bbbbb2 GENEIN eeeee2  interactions
CPR:2	CHEMICALNOTIN agonists and antagonists dose dependently accentuated and attenuated, respectively, CHEMICALNOTIN-induced motor incoordination, thereby suggesting a central mechanism of GENEIN modulation of this effect of CHEMICALIN and confirmed our previous reports in which CHEMICALNOTIN agonists and antagonists were given i.p. CHEMICALIN, a weak GENEIN antagonist but potent inhibitor of GENEIN, did not alter ethanol's motor incoordination, further supporting involvement of brain  bbbbb1 GENEIN eeeee1  mechanism(s) in  bbbbb2 CHEMICALIN eeeee2 -GENEIN interactions
CPR:2	However,  bbbbb1 CHEMICALIN eeeee1  data indicate complexity of the mechanism(s) and point toward an additional involvement of a yet unknown subtype of  bbbbb2 GENEIN eeeee2 
CPR:2	No effect of ethanol on blood or brain levels of CHEMICALNOTIN was noted and sufficient amount of the latter entered the brain to suggest  bbbbb1 GENEIN eeeee1  activation adequate to produce behavioral interaction with  bbbbb2 CHEMICALIN eeeee2 
CPR:4	CHEMICALNOTIN agonists and antagonists dose dependently accentuated and attenuated, respectively, CHEMICALNOTIN-induced motor incoordination, thereby suggesting a central mechanism of GENEIN modulation of this effect of CHEMICALIN and confirmed our previous reports in which CHEMICALNOTIN agonists and antagonists were given i.p.  bbbbb1 CHEMICALIN eeeee1 , a weak GENEIN antagonist but potent inhibitor of  bbbbb2 GENEIN eeeee2 , did not alter ethanol's motor incoordination, further supporting involvement of brain GENEIN mechanism(s) in CHEMICALIN-GENEIN interactions
CPR:5	 bbbbb1 GENEIN eeeee1  agonists,  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), CHEMICALIN, CHEMICALIN, antagonists, CHEMICALIN and CHEMICALIN as well as CHEMICALIN on CHEMICALNOTIN-(i.p.)-induced motor incoordination was evaluated by rotorod
CPR:5	 bbbbb1 GENEIN eeeee1  agonists, CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), CHEMICALIN, CHEMICALIN, antagonists, CHEMICALIN and CHEMICALIN as well as CHEMICALIN on CHEMICALNOTIN-(i.p.)-induced motor incoordination was evaluated by rotorod
CPR:5	 bbbbb1 GENEIN eeeee1  agonists, CHEMICALIN (CHEMICALIN),  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, antagonists, CHEMICALIN and CHEMICALIN as well as CHEMICALIN on CHEMICALNOTIN-(i.p.)-induced motor incoordination was evaluated by rotorod
CPR:5	 bbbbb1 GENEIN eeeee1  agonists, CHEMICALIN (CHEMICALIN), CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , antagonists, CHEMICALIN and CHEMICALIN as well as CHEMICALIN on CHEMICALNOTIN-(i.p.)-induced motor incoordination was evaluated by rotorod
CPR:6	 bbbbb1 GENEIN eeeee1  agonists, CHEMICALIN (CHEMICALIN), CHEMICALIN, CHEMICALIN, antagonists,  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN as well as CHEMICALIN on CHEMICALNOTIN-(i.p.)-induced motor incoordination was evaluated by rotorod
CPR:6	 bbbbb1 GENEIN eeeee1  agonists, CHEMICALIN (CHEMICALIN), CHEMICALIN, CHEMICALIN, antagonists, CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  as well as CHEMICALIN on CHEMICALNOTIN-(i.p.)-induced motor incoordination was evaluated by rotorod
CPR:6	 bbbbb1 GENEIN eeeee1  agonists, CHEMICALIN (CHEMICALIN), CHEMICALIN, CHEMICALIN, antagonists, CHEMICALIN and CHEMICALIN as well as  bbbbb2 CHEMICALIN eeeee2  on CHEMICALNOTIN-(i.p.)-induced motor incoordination was evaluated by rotorod
CPR:6	CHEMICALNOTIN agonists and antagonists dose dependently accentuated and attenuated, respectively, CHEMICALNOTIN-induced motor incoordination, thereby suggesting a central mechanism of GENEIN modulation of this effect of CHEMICALIN and confirmed our previous reports in which CHEMICALNOTIN agonists and antagonists were given i.p.  bbbbb1 CHEMICALIN eeeee1 , a weak  bbbbb2 GENEIN eeeee2  antagonist but potent inhibitor of GENEIN, did not alter ethanol's motor incoordination, further supporting involvement of brain GENEIN mechanism(s) in CHEMICALIN-GENEIN interactions
CPR:2	 bbbbb1 CHEMICALIN eeeee1  highlights the therapeutic potential of agents targeting GENEIN as a key node in this pro-oncogenic  bbbbb2 GENEIN eeeee2 -GENEIN signal pathway.
CPR:2	 bbbbb1 CHEMICALIN eeeee1  highlights the therapeutic potential of agents targeting GENEIN as a key node in this pro-oncogenic GENEIN- bbbbb2 GENEIN eeeee2  signal pathway.
CPR:3	 bbbbb1 CHEMICALIN eeeee1  also inhibited cell proliferation, while increasing sub-G0 DNA fragmentation and  bbbbb2 GENEIN eeeee2  markers of apoptosis
CPR:4	 bbbbb1 CHEMICALIN eeeee1 , a GENEIN inhibitor and anti-inflammatory compound used in traditional Chinese medicine, also decreased  bbbbb2 GENEIN eeeee2 -induced phosphorylation of GENEIN and GENEIN, and suppressed basal, GENEIN- and GENEIN (GENENOTIN)-induced GENEIN reporter gene activity
CPR:4	 bbbbb1 CHEMICALIN eeeee1 , a GENEIN inhibitor and anti-inflammatory compound used in traditional Chinese medicine, also decreased GENEIN-induced phosphorylation of GENEIN and GENEIN, and suppressed basal,  bbbbb2 GENEIN eeeee2 - and GENEIN (GENENOTIN)-induced GENEIN reporter gene activity
CPR:4	 bbbbb1 CHEMICALIN eeeee1 , a GENEIN inhibitor and anti-inflammatory compound used in traditional Chinese medicine, also decreased GENEIN-induced phosphorylation of GENEIN and GENEIN, and suppressed basal, GENEIN- and  bbbbb2 GENEIN eeeee2  (GENENOTIN)-induced GENEIN reporter gene activity
CPR:4	 bbbbb1 CHEMICALIN eeeee1 , a  bbbbb2 GENEIN eeeee2  inhibitor and anti-inflammatory compound used in traditional Chinese medicine, also decreased GENEIN-induced phosphorylation of GENEIN and GENEIN, and suppressed basal, GENEIN- and GENEIN (GENENOTIN)-induced GENEIN reporter gene activity
CPR:4	 bbbbb1 CHEMICALIN eeeee1 , a GENEIN inhibitor and anti-inflammatory compound used in traditional Chinese medicine, also decreased GENEIN-induced phosphorylation of  bbbbb2 GENEIN eeeee2  and GENEIN, and suppressed basal, GENEIN- and GENEIN (GENENOTIN)-induced GENEIN reporter gene activity
CPR:4	 bbbbb1 CHEMICALIN eeeee1 , a GENEIN inhibitor and anti-inflammatory compound used in traditional Chinese medicine, also decreased GENEIN-induced phosphorylation of GENEIN and  bbbbb2 GENEIN eeeee2 , and suppressed basal, GENEIN- and GENEIN (GENENOTIN)-induced GENEIN reporter gene activity
CPR:4	 bbbbb1 CHEMICALIN eeeee1 , a GENEIN inhibitor and anti-inflammatory compound used in traditional Chinese medicine, also decreased GENEIN-induced phosphorylation of GENEIN and GENEIN, and suppressed basal, GENEIN- and GENEIN (GENENOTIN)-induced  bbbbb2 GENEIN eeeee2  reporter gene activity
CPR:4	 bbbbb1 CHEMICALIN eeeee1  highlights the therapeutic potential of agents targeting  bbbbb2 GENEIN eeeee2  as a key node in this pro-oncogenic GENEIN-GENEIN signal pathway.
CPR:2	When combined, CHEMICALIN antagonized the effects of the full  bbbbb1 GENEIN eeeee1  agonists in  bbbbb2 CHEMICALIN eeeee2  assays and reduced the stimulation of GENEIN GENEIN and GENENOTIN phosphorylation by CHEMICALIN
CPR:2	In  bbbbb1 CHEMICALIN eeeee1  assays, CHEMICALIN selectively activated  bbbbb2 GENEIN eeeee2 
CPR:2	In rat striatum and nucleus accumbens, CHEMICALIN stimulated  bbbbb1 CHEMICALIN eeeee1  binding in a CHEMICALIN-sensitive manner with maximal effects lower than those of the full  bbbbb2 GENEIN eeeee2  agonists CHEMICALIN and CHEMICALIN
CPR:2	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN increased GENENOTIN phosphorylation in CHO cells expressing  bbbbb2 GENEIN eeeee2  and C6 cells, and these effects were antagonized by CHEMICALIN
CPR:2	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  increased GENENOTIN phosphorylation in CHO cells expressing  bbbbb2 GENEIN eeeee2  and C6 cells, and these effects were antagonized by CHEMICALIN
CPR:2	CHEMICALIN and CHEMICALIN increased GENENOTIN phosphorylation in CHO cells expressing  bbbbb1 GENEIN eeeee1  and C6 cells, and these effects were antagonized by  bbbbb2 CHEMICALIN eeeee2 
CPR:2	In rat striatum and nucleus accumbens,  bbbbb1 CHEMICALIN eeeee1  stimulated CHEMICALIN binding in a CHEMICALIN-sensitive manner with maximal effects lower than those of the full  bbbbb2 GENEIN eeeee2  agonists CHEMICALIN and CHEMICALIN
CPR:2	In rat striatum and nucleus accumbens, CHEMICALIN stimulated CHEMICALIN binding in a  bbbbb1 CHEMICALIN eeeee1 -sensitive manner with maximal effects lower than those of the full  bbbbb2 GENEIN eeeee2  agonists CHEMICALIN and CHEMICALIN
CPR:3	When combined, CHEMICALIN antagonized the effects of the full GENEIN agonists in CHEMICALIN assays and reduced the stimulation of  bbbbb1 GENEIN eeeee1  GENEIN and GENENOTIN phosphorylation by  bbbbb2 CHEMICALIN eeeee2 
CPR:3	When combined, CHEMICALIN antagonized the effects of the full GENEIN agonists in CHEMICALIN assays and reduced the stimulation of GENEIN  bbbbb1 GENEIN eeeee1  and GENENOTIN phosphorylation by  bbbbb2 CHEMICALIN eeeee2 
CPR:3	CONCLUSIONS AND IMPLICATIONS: In different cell systems,  bbbbb1 CHEMICALIN eeeee1  directly activates  bbbbb2 GENEIN eeeee2 , displaying partial agonist activity at brain receptors
CPR:3	In CHEMICALIN assays,  bbbbb1 CHEMICALIN eeeee1  selectively activated  bbbbb2 GENEIN eeeee2 
CPR:4	The agonist activity was antagonized by the selective  bbbbb1 GENEIN eeeee1  blocker  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN)
CPR:4	The agonist activity was antagonized by the selective  bbbbb1 GENEIN eeeee1  blocker CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 )
CPR:4	When combined,  bbbbb1 CHEMICALIN eeeee1  antagonized the effects of the full GENEIN agonists in CHEMICALIN assays and reduced the stimulation of  bbbbb2 GENEIN eeeee2  GENEIN and GENENOTIN phosphorylation by CHEMICALIN
CPR:4	When combined,  bbbbb1 CHEMICALIN eeeee1  antagonized the effects of the full GENEIN agonists in CHEMICALIN assays and reduced the stimulation of GENEIN  bbbbb2 GENEIN eeeee2  and GENENOTIN phosphorylation by CHEMICALIN
CPR:5	We previously reported that  bbbbb1 CHEMICALIN eeeee1  antidepressants act as agonists at distinct  bbbbb2 GENEIN eeeee2 
CPR:5	CONCLUSIONS AND IMPLICATIONS: In different cell systems,  bbbbb1 CHEMICALIN eeeee1  directly activates  bbbbb2 GENEIN eeeee2 , displaying partial agonist activity at brain receptors
CPR:5	The  bbbbb1 CHEMICALIN eeeee1  analogue CHEMICALIN also displayed  bbbbb2 GENEIN eeeee2  agonist activity
CPR:5	The CHEMICALIN analogue  bbbbb1 CHEMICALIN eeeee1  also displayed  bbbbb2 GENEIN eeeee2  agonist activity
CPR:5	The atypical antidepressant  bbbbb1 CHEMICALIN eeeee1  exhibits agonist activity at  bbbbb2 GENEIN eeeee2 
CPR:5	In rat striatum and nucleus accumbens, CHEMICALIN stimulated CHEMICALIN binding in a CHEMICALIN-sensitive manner with maximal effects lower than those of the full  bbbbb1 GENEIN eeeee1  agonists  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:5	In rat striatum and nucleus accumbens, CHEMICALIN stimulated CHEMICALIN binding in a CHEMICALIN-sensitive manner with maximal effects lower than those of the full  bbbbb1 GENEIN eeeee1  agonists CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:6	The agonist activity was antagonized by the selective  bbbbb1 GENEIN eeeee1  blocker  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN)
CPR:6	The agonist activity was antagonized by the selective  bbbbb1 GENEIN eeeee1  blocker CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 )
CPR:6	When combined,  bbbbb1 CHEMICALIN eeeee1  antagonized the effects of the full  bbbbb2 GENEIN eeeee2  agonists in CHEMICALIN assays and reduced the stimulation of GENEIN GENEIN and GENENOTIN phosphorylation by CHEMICALIN
CPR:6	In the present study we tested whether  bbbbb1 CHEMICALIN eeeee1 , a  bbbbb2 GENEIN eeeee2  antagonist commonly used as antihypertensive drug, could ameliorate the cognitive impairments and increases in AD-related markers shown by the senescence-accelerated mouse prone-8 (SAMP8)
CPR:2	Effect of  bbbbb1 CHEMICALIN eeeee1  on lipid peroxidation,  bbbbb2 GENEIN eeeee2 (GENEIN), GENEIN (GENEIN), GENEIN (GENEIN), CHEMICALNOTIN (CHEMICALNOTIN) and expression of cell adhesion molecules (CAM) is summarized stepwise.
CPR:2	Effect of  bbbbb1 CHEMICALIN eeeee1  on lipid peroxidation, GENEIN( bbbbb2 GENEIN eeeee2 ), GENEIN (GENEIN), GENEIN (GENEIN), CHEMICALNOTIN (CHEMICALNOTIN) and expression of cell adhesion molecules (CAM) is summarized stepwise.
CPR:2	Effect of  bbbbb1 CHEMICALIN eeeee1  on lipid peroxidation, GENEIN(GENEIN),  bbbbb2 GENEIN eeeee2  (GENEIN), GENEIN (GENEIN), CHEMICALNOTIN (CHEMICALNOTIN) and expression of cell adhesion molecules (CAM) is summarized stepwise.
CPR:2	Effect of  bbbbb1 CHEMICALIN eeeee1  on lipid peroxidation, GENEIN(GENEIN), GENEIN ( bbbbb2 GENEIN eeeee2 ), GENEIN (GENEIN), CHEMICALNOTIN (CHEMICALNOTIN) and expression of cell adhesion molecules (CAM) is summarized stepwise.
CPR:2	Effect of  bbbbb1 CHEMICALIN eeeee1  on lipid peroxidation, GENEIN(GENEIN), GENEIN (GENEIN),  bbbbb2 GENEIN eeeee2  (GENEIN), CHEMICALNOTIN (CHEMICALNOTIN) and expression of cell adhesion molecules (CAM) is summarized stepwise.
CPR:2	Effect of  bbbbb1 CHEMICALIN eeeee1  on lipid peroxidation, GENEIN(GENEIN), GENEIN (GENEIN), GENEIN ( bbbbb2 GENEIN eeeee2 ), CHEMICALNOTIN (CHEMICALNOTIN) and expression of cell adhesion molecules (CAM) is summarized stepwise.
CPR:2	The purpose of this review is to summarize current knowledge about CHEMICALIN-dependent activation by GENEIN of genes involved in reverse CHEMICALNOTIN transport, and what these defects of cell CHEMICALNOTIN homeostasis can teach us about the critical pathways of  bbbbb1 CHEMICALIN eeeee1  generation for expression of  bbbbb2 GENEIN eeeee2 -dependent genes.
CPR:3	The purpose of this review is to summarize current knowledge about  bbbbb1 CHEMICALIN eeeee1 -dependent activation by  bbbbb2 GENEIN eeeee2  of genes involved in reverse CHEMICALNOTIN transport, and what these defects of cell CHEMICALNOTIN homeostasis can teach us about the critical pathways of CHEMICALIN generation for expression of GENEIN-dependent genes.
CPR:3	 bbbbb1 GENEIN eeeee1  are thought to be activated predominantly by  bbbbb2 CHEMICALIN eeeee2  generated enzymatically from CHEMICALNOTIN in different cell organelles
CPR:9	Defects resulting in slowed release of CHEMICALNOTIN from late endosomes and lysosomes or reduction in  bbbbb1 GENEIN eeeee1  activity lead to specific blocks in  bbbbb2 CHEMICALIN eeeee2  production and impaired GENENOTIN-dependent gene activation
CPR:1	Mass spectral analysis of CHEMICALIN-inhibited  bbbbb1 GENEIN eeeee1  digested with CHEMICALIN-C showed an CHEMICALIN adduct (+106amu) on  bbbbb2 CHEMICALIN eeeee2  499, a residue far from the active site, but not on CHEMICALIN-438
CPR:1	Mass spectral analysis of CHEMICALIN-inhibited  bbbbb1 GENEIN eeeee1  digested with CHEMICALIN-C showed an CHEMICALIN adduct (+106amu) on CHEMICALIN 499, a residue far from the active site, but not on  bbbbb2 CHEMICALIN eeeee2 -438
CPR:1	CHEMICALIN makes multiple adducts on free CHEMICALNOTIN, but does not form an adduct on  bbbbb1 CHEMICALIN eeeee1  438 of  bbbbb2 GENEIN eeeee2 
CPR:1	CHEMICALIN irreversibly inhibits  bbbbb1 GENEIN eeeee1  (GENEIN) in human plasma by forming adducts on the active site  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN-198)
CPR:1	CHEMICALIN irreversibly inhibits GENEIN ( bbbbb1 GENEIN eeeee1 ) in human plasma by forming adducts on the active site  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN-198)
CPR:1	CHEMICALIN irreversibly inhibits  bbbbb1 GENEIN eeeee1  (GENEIN) in human plasma by forming adducts on the active site CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 -198)
CPR:1	CHEMICALIN irreversibly inhibits GENEIN ( bbbbb1 GENEIN eeeee1 ) in human plasma by forming adducts on the active site CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 -198)
CPR:2	Mass spectral analysis of CHEMICALIN-inhibited  bbbbb1 GENEIN eeeee1  digested with CHEMICALIN-C showed an  bbbbb2 CHEMICALIN eeeee2  adduct (+106amu) on CHEMICALIN 499, a residue far from the active site, but not on CHEMICALIN-438
CPR:2	Mass spectral analysis of CHEMICALIN-inhibited  bbbbb1 GENEIN eeeee1  digested with  bbbbb2 CHEMICALIN eeeee2 -C showed an CHEMICALIN adduct (+106amu) on CHEMICALIN 499, a residue far from the active site, but not on CHEMICALIN-438
CPR:2	 bbbbb1 CHEMICALIN eeeee1  makes multiple adducts on free CHEMICALNOTIN, but does not form an adduct on CHEMICALIN 438 of  bbbbb2 GENEIN eeeee2 
CPR:4	Mass spectral analysis of  bbbbb1 CHEMICALIN eeeee1 -inhibited  bbbbb2 GENEIN eeeee2  digested with CHEMICALIN-C showed an CHEMICALIN adduct (+106amu) on CHEMICALIN 499, a residue far from the active site, but not on CHEMICALIN-438
CPR:4	 bbbbb1 CHEMICALIN eeeee1  irreversibly inhibits  bbbbb2 GENEIN eeeee2  (GENEIN) in human plasma by forming adducts on the active site CHEMICALIN (CHEMICALIN-198)
CPR:4	 bbbbb1 CHEMICALIN eeeee1  irreversibly inhibits GENEIN ( bbbbb2 GENEIN eeeee2 ) in human plasma by forming adducts on the active site CHEMICALIN (CHEMICALIN-198)
CPR:3	We previously demonstrated that the somatostatinergic system, implicated in neuronal survival control, can be modulated by  bbbbb1 CHEMICALIN eeeee1  in the rat dentate gyrus, increasing  bbbbb2 GENEIN eeeee2  phosphorylation
CPR:10	After  bbbbb1 CHEMICALIN eeeee1  treatment, cell viability,  bbbbb2 GENEIN eeeee2 , and GENEIN protein levels were not changed
CPR:10	After  bbbbb1 CHEMICALIN eeeee1  treatment, cell viability, GENEIN, and  bbbbb2 GENEIN eeeee2  protein levels were not changed
CPR:2	 bbbbb1 GENEIN eeeee1  sensitizes to  bbbbb2 CHEMICALIN eeeee2  by modulating GENEIN and GENEIN/GENEIN signal pathway in FRO anaplastic thyroid carcinoma cells
CPR:2	GENEIN sensitizes to  bbbbb1 CHEMICALIN eeeee1  by modulating  bbbbb2 GENEIN eeeee2  and GENEIN/GENEIN signal pathway in FRO anaplastic thyroid carcinoma cells
CPR:2	GENEIN sensitizes to  bbbbb1 CHEMICALIN eeeee1  by modulating GENEIN and  bbbbb2 GENEIN eeeee2 /GENEIN signal pathway in FRO anaplastic thyroid carcinoma cells
CPR:2	GENEIN sensitizes to  bbbbb1 CHEMICALIN eeeee1  by modulating GENEIN and GENEIN/ bbbbb2 GENEIN eeeee2  signal pathway in FRO anaplastic thyroid carcinoma cells
CPR:2	In conclusion, these results suggest that GENENOTIN may sensitize FRO ATC cells to  bbbbb1 CHEMICALIN eeeee1  thereby inhibiting cell survival by modulating  bbbbb2 GENEIN eeeee2  and GENEIN/GENEIN signal pathway
CPR:2	In conclusion, these results suggest that GENENOTIN may sensitize FRO ATC cells to  bbbbb1 CHEMICALIN eeeee1  thereby inhibiting cell survival by modulating GENEIN and  bbbbb2 GENEIN eeeee2 /GENEIN signal pathway
CPR:2	In conclusion, these results suggest that GENENOTIN may sensitize FRO ATC cells to  bbbbb1 CHEMICALIN eeeee1  thereby inhibiting cell survival by modulating GENEIN and GENEIN/ bbbbb2 GENEIN eeeee2  signal pathway
CPR:2	Furthermore, these findings imply that  bbbbb1 GENEIN eeeee1  may be a possible candidate as the chemosensitizing factor for induction of cytotoxicity in ATC cells exposed to  bbbbb2 CHEMICALIN eeeee2 .
CPR:2	Moreover, we investigated the roles of  bbbbb1 GENEIN eeeee1  in cell survival under condition of  bbbbb2 CHEMICALIN eeeee2  treatment in FRO ATC cells
CPR:2	 bbbbb1 CHEMICALIN eeeee1  is a reversible, competitive GENEIN (GENEIN) inhibitor and allosteric potentiating ligand of  bbbbb2 GENEIN eeeee2  (GENEIN-APL) that shares many common structural elements with CHEMICALNOTIN-based opioids
CPR:2	 bbbbb1 CHEMICALIN eeeee1  is a reversible, competitive GENEIN (GENEIN) inhibitor and allosteric potentiating ligand of GENEIN ( bbbbb2 GENEIN eeeee2 -APL) that shares many common structural elements with CHEMICALNOTIN-based opioids
CPR:2	The structurally diverse opioids  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, like CHEMICALIN, are also  bbbbb2 GENEIN eeeee2 -APL that have greatly diminished affinity for GENEIN, representing potential lead compounds for selective GENEIN-APL development
CPR:2	The structurally diverse opioids  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, like CHEMICALIN, are also GENEIN-APL that have greatly diminished affinity for  bbbbb2 GENEIN eeeee2 , representing potential lead compounds for selective GENEIN-APL development
CPR:2	The structurally diverse opioids CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , like CHEMICALIN, are also  bbbbb2 GENEIN eeeee2 -APL that have greatly diminished affinity for GENEIN, representing potential lead compounds for selective GENEIN-APL development
CPR:2	The structurally diverse opioids CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , like CHEMICALIN, are also GENEIN-APL that have greatly diminished affinity for  bbbbb2 GENEIN eeeee2 , representing potential lead compounds for selective GENEIN-APL development
CPR:2	The structurally diverse opioids CHEMICALIN and CHEMICALIN, like  bbbbb1 CHEMICALIN eeeee1 , are also  bbbbb2 GENEIN eeeee2 -APL that have greatly diminished affinity for GENEIN, representing potential lead compounds for selective GENEIN-APL development
CPR:2	The structurally diverse opioids CHEMICALIN and CHEMICALIN, like  bbbbb1 CHEMICALIN eeeee1 , are also GENEIN-APL that have greatly diminished affinity for  bbbbb2 GENEIN eeeee2 , representing potential lead compounds for selective GENEIN-APL development
CPR:4	 bbbbb1 CHEMICALIN eeeee1  is a reversible, competitive  bbbbb2 GENEIN eeeee2  (GENEIN) inhibitor and allosteric potentiating ligand of GENEIN (GENEIN-APL) that shares many common structural elements with CHEMICALNOTIN-based opioids
CPR:4	 bbbbb1 CHEMICALIN eeeee1  is a reversible, competitive GENEIN ( bbbbb2 GENEIN eeeee2 ) inhibitor and allosteric potentiating ligand of GENEIN (GENEIN-APL) that shares many common structural elements with CHEMICALNOTIN-based opioids
CPR:7	 bbbbb1 CHEMICALIN eeeee1  is a reversible, competitive GENEIN (GENEIN) inhibitor and allosteric potentiating ligand of  bbbbb2 GENEIN eeeee2  (GENEIN-APL) that shares many common structural elements with CHEMICALNOTIN-based opioids
CPR:7	 bbbbb1 CHEMICALIN eeeee1  is a reversible, competitive GENEIN (GENEIN) inhibitor and allosteric potentiating ligand of GENEIN ( bbbbb2 GENEIN eeeee2 -APL) that shares many common structural elements with CHEMICALNOTIN-based opioids
CPR:7	The structurally diverse opioids  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, like CHEMICALIN, are also  bbbbb2 GENEIN eeeee2 -APL that have greatly diminished affinity for GENEIN, representing potential lead compounds for selective GENEIN-APL development
CPR:7	The structurally diverse opioids  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, like CHEMICALIN, are also GENEIN-APL that have greatly diminished affinity for GENEIN, representing potential lead compounds for selective  bbbbb2 GENEIN eeeee2 -APL development
CPR:7	The structurally diverse opioids CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , like CHEMICALIN, are also  bbbbb2 GENEIN eeeee2 -APL that have greatly diminished affinity for GENEIN, representing potential lead compounds for selective GENEIN-APL development
CPR:7	The structurally diverse opioids CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , like CHEMICALIN, are also GENEIN-APL that have greatly diminished affinity for GENEIN, representing potential lead compounds for selective  bbbbb2 GENEIN eeeee2 -APL development
CPR:7	The structurally diverse opioids CHEMICALIN and CHEMICALIN, like  bbbbb1 CHEMICALIN eeeee1 , are also  bbbbb2 GENEIN eeeee2 -APL that have greatly diminished affinity for GENEIN, representing potential lead compounds for selective GENEIN-APL development
CPR:7	The structurally diverse opioids CHEMICALIN and CHEMICALIN, like  bbbbb1 CHEMICALIN eeeee1 , are also GENEIN-APL that have greatly diminished affinity for GENEIN, representing potential lead compounds for selective  bbbbb2 GENEIN eeeee2 -APL development
CPR:2	Treatment options for DUB are: combined oral contraceptives (COCs), CHEMICALNOTIN, non steroidal anti inflammatory drugs (NSAIDs), CHEMICALNOTIN (anti-fibrinolytic),  bbbbb1 GENEIN eeeee1  analogues,  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN releasing intra uterine system (LNG IUS).
CPR:2	Treatment options for DUB are: combined oral contraceptives (COCs), CHEMICALNOTIN, non steroidal anti inflammatory drugs (NSAIDs), CHEMICALNOTIN (anti-fibrinolytic),  bbbbb1 GENEIN eeeee1  analogues, CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  releasing intra uterine system (LNG IUS).
CPR:2	These results suggest that the regulation of nitrergic system by  bbbbb1 GENEIN eeeee1  may play a role in the control of  bbbbb2 CHEMICALIN eeeee2 -dependent physiological mechanisms regulated by the SON and the PVN.
CPR:5	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of CHEMICALNOTIN, a selective GENEIN agonist-CHEMICALIN [CHEMICALIN], a selective  bbbbb1 GENEIN eeeee1  agonist- bbbbb2 CHEMICALIN eeeee2  [CHEMICALIN], a selective GENEIN antagonist-CHEMICALIN [CHEMICALIN]-CHEMICALIN] or a selective GENEIN antagonist-CHEMICALIN (CHEMICALIN)
CPR:5	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of CHEMICALNOTIN, a selective GENEIN agonist-CHEMICALIN [CHEMICALIN], a selective  bbbbb1 GENEIN eeeee1  agonist-CHEMICALIN [ bbbbb2 CHEMICALIN eeeee2 ], a selective GENEIN antagonist-CHEMICALIN [CHEMICALIN]-CHEMICALIN] or a selective GENEIN antagonist-CHEMICALIN (CHEMICALIN)
CPR:5	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of CHEMICALNOTIN, a selective  bbbbb1 GENEIN eeeee1  agonist- bbbbb2 CHEMICALIN eeeee2  [CHEMICALIN], a selective GENEIN agonist-CHEMICALIN [CHEMICALIN], a selective GENEIN antagonist-CHEMICALIN [CHEMICALIN]-CHEMICALIN] or a selective GENEIN antagonist-CHEMICALIN (CHEMICALIN)
CPR:5	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of CHEMICALNOTIN, a selective  bbbbb1 GENEIN eeeee1  agonist-CHEMICALIN [ bbbbb2 CHEMICALIN eeeee2 ], a selective GENEIN agonist-CHEMICALIN [CHEMICALIN], a selective GENEIN antagonist-CHEMICALIN [CHEMICALIN]-CHEMICALIN] or a selective GENEIN antagonist-CHEMICALIN (CHEMICALIN)
CPR:6	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of CHEMICALNOTIN, a selective GENEIN agonist-CHEMICALIN [CHEMICALIN], a selective GENEIN agonist-CHEMICALIN [CHEMICALIN], a selective  bbbbb1 GENEIN eeeee1  antagonist- bbbbb2 CHEMICALIN eeeee2  [CHEMICALIN]-CHEMICALIN] or a selective GENEIN antagonist-CHEMICALIN (CHEMICALIN)
CPR:6	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of CHEMICALNOTIN, a selective GENEIN agonist-CHEMICALIN [CHEMICALIN], a selective GENEIN agonist-CHEMICALIN [CHEMICALIN], a selective  bbbbb1 GENEIN eeeee1  antagonist-CHEMICALIN [ bbbbb2 CHEMICALIN eeeee2 ]-CHEMICALIN] or a selective GENEIN antagonist-CHEMICALIN (CHEMICALIN)
CPR:6	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of CHEMICALNOTIN, a selective GENEIN agonist-CHEMICALIN [CHEMICALIN], a selective GENEIN agonist-CHEMICALIN [CHEMICALIN], a selective  bbbbb1 GENEIN eeeee1  antagonist-CHEMICALIN [CHEMICALIN]- bbbbb2 CHEMICALIN eeeee2 ] or a selective GENEIN antagonist-CHEMICALIN (CHEMICALIN)
CPR:6	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of CHEMICALNOTIN, a selective GENEIN agonist-CHEMICALIN [CHEMICALIN], a selective GENEIN agonist-CHEMICALIN [CHEMICALIN], a selective GENEIN antagonist-CHEMICALIN [CHEMICALIN]-CHEMICALIN] or a selective  bbbbb1 GENEIN eeeee1  antagonist- bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN)
CPR:6	Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of CHEMICALNOTIN, a selective GENEIN agonist-CHEMICALIN [CHEMICALIN], a selective GENEIN agonist-CHEMICALIN [CHEMICALIN], a selective GENEIN antagonist-CHEMICALIN [CHEMICALIN]-CHEMICALIN] or a selective  bbbbb1 GENEIN eeeee1  antagonist-CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 )
CPR:9	Modulation of the  bbbbb1 CHEMICALIN eeeee1  producing system (demonstrated via the  bbbbb2 GENEIN eeeee2  histochemical reaction) by CHEMICALNOTIN has been established in several structures of the rat brain
CPR:2	The residence time of a stoichiometric bioscavenger, GENEIN ( bbbbb1 GENEIN eeeee1 ), in the plasma more closely matches that of VX than do the residence times of conventional therapy drugs ( bbbbb2 CHEMICALIN eeeee2 , anti-muscarinic, anticonvulsant)
CPR:2	The residence time of a stoichiometric bioscavenger,  bbbbb1 GENEIN eeeee1  (GENEIN), in the plasma more closely matches that of VX than do the residence times of conventional therapy drugs ( bbbbb2 CHEMICALIN eeeee2 , anti-muscarinic, anticonvulsant)
CPR:2	A combination of nerve agent therapy drugs ( bbbbb1 CHEMICALIN eeeee1 , anti-muscarinic, anticonvulsant) with  bbbbb2 GENEIN eeeee2  (i.m.) protected 100% (8/8) of guinea-pigs from a lethal dose of VX (0.74mg/kg) to 48h, even when administered on signs of poisoning
CPR:2	Therefore, we examined whether  bbbbb1 CHEMICALIN eeeee1  (VA) sensitize  bbbbb2 GENEIN eeeee2 -induced apoptosis in cancer cells by induction of ER stress
CPR:2	 bbbbb1 CHEMICALIN eeeee1  sensitizes  bbbbb2 GENEIN eeeee2 -induced apoptosis via the upregulation of GENEIN in an GENEIN/GENEIN-dependent manner
CPR:3	Furthermore,  bbbbb1 CHEMICALIN eeeee1 , a specific  bbbbb2 GENEIN eeeee2  phosphorylation-inducing agent, increased GENEIN and GENEIN expression in the presence of VA
CPR:3	Furthermore,  bbbbb1 CHEMICALIN eeeee1 , a specific GENEIN phosphorylation-inducing agent, increased  bbbbb2 GENEIN eeeee2  and GENEIN expression in the presence of VA
CPR:3	Furthermore,  bbbbb1 CHEMICALIN eeeee1 , a specific GENEIN phosphorylation-inducing agent, increased GENEIN and  bbbbb2 GENEIN eeeee2  expression in the presence of VA
CPR:3	 bbbbb1 CHEMICALIN eeeee1  sensitizes GENEIN-induced apoptosis via the upregulation of  bbbbb2 GENEIN eeeee2  in an GENEIN/GENEIN-dependent manner
CPR:3	 bbbbb1 CHEMICALIN eeeee1  sensitizes GENEIN-induced apoptosis via the upregulation of GENEIN in an  bbbbb2 GENEIN eeeee2 /GENEIN-dependent manner
CPR:3	 bbbbb1 CHEMICALIN eeeee1  sensitizes GENEIN-induced apoptosis via the upregulation of GENEIN in an GENEIN/ bbbbb2 GENEIN eeeee2 -dependent manner
CPR:1	Though microtubule mediated GENENOTIN remodeling through GENENOTIN, reorganization of microtubule depended on  bbbbb1 CHEMICALIN eeeee1  phosphorylation of  bbbbb2 GENEIN eeeee2 , the mechanism is different from GENENOTIN-induced GENENOTIN remodeling, which relied on the activity of GENENOTIN and GENENOTIN
CPR:9	Disruption of microtubule prevented GENENOTIN-induced GENENOTIN remodeling and distal GENENOTIN signal transduction, with reduction in surface  bbbbb1 GENEIN eeeee1  (GENEIN) and  bbbbb2 CHEMICALIN eeeee2  uptake
CPR:9	Disruption of microtubule prevented GENENOTIN-induced GENENOTIN remodeling and distal GENENOTIN signal transduction, with reduction in surface GENEIN ( bbbbb1 GENEIN eeeee1 ) and  bbbbb2 CHEMICALIN eeeee2  uptake
CPR:2	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN showed compound-specific but similar affinities for both  bbbbb2 GENEIN eeeee2 
CPR:2	CHEMICALIN and CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, and CHEMICALIN showed compound-specific but similar affinities for both  bbbbb2 GENEIN eeeee2 
CPR:2	CHEMICALIN and CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, and CHEMICALIN showed compound-specific but similar affinities for both  bbbbb2 GENEIN eeeee2 
CPR:2	CHEMICALIN and CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , and CHEMICALIN showed compound-specific but similar affinities for both  bbbbb2 GENEIN eeeee2 
CPR:2	CHEMICALIN and CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and  bbbbb1 CHEMICALIN eeeee1  showed compound-specific but similar affinities for both  bbbbb2 GENEIN eeeee2 
CPR:2	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN showed compound-specific but similar affinities for both  bbbbb2 GENEIN eeeee2 
CPR:2	Other groups received either an infusion of the selective  bbbbb1 GENEIN eeeee1  antagonist (CHEMICALIN; 10 nmol; intra-mPFC) or vehicle, 10 min prior to  bbbbb2 CHEMICALIN eeeee2  preceding LFS600, or prior to a supra-threshold LTD protocol (900 pulses, 1 Hz; LFS900)
CPR:2	Our data also indicate that  bbbbb1 GENEIN eeeee1  pre-activation is essential to the muscarinic enhancement of mPFC synaptic depression, since CHEMICALIN microinjection into the mPFC blocked the conversion of transient depression into long-lasting LTD produced by  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Our data also indicate that  bbbbb1 GENEIN eeeee1  pre-activation is essential to the muscarinic enhancement of mPFC synaptic depression, since  bbbbb2 CHEMICALIN eeeee2  microinjection into the mPFC blocked the conversion of transient depression into long-lasting LTD produced by CHEMICALIN
CPR:6	Other groups received either an infusion of the selective  bbbbb1 GENEIN eeeee1  antagonist ( bbbbb2 CHEMICALIN eeeee2 ; 10 nmol; intra-mPFC) or vehicle, 10 min prior to CHEMICALIN preceding LFS600, or prior to a supra-threshold LTD protocol (900 pulses, 1 Hz; LFS900)
CPR:9	The acetylation of  bbbbb1 CHEMICALIN eeeee1  is increased in  bbbbb2 GENEIN eeeee2 -overexpressing mice compared with wild-type mice
CPR:9	However, GENENOTIN-deficient mice metabolize  bbbbb1 CHEMICALIN eeeee1  at the same rate as the wild-type mice, indicating the existence of another  bbbbb2 GENEIN eeeee2  respons 2ible for its metabolism in mice
CPR:9	Here, we show that siRNA-mediated knockdown of  bbbbb1 GENEIN eeeee1  in HEPG2 cells and in primary hepatocytes from the GENENOTIN-deficient or wild-type mice reduced the metabolism of  bbbbb2 CHEMICALIN eeeee2  to MAT
CPR:9	By contrast,  bbbbb1 CHEMICALIN eeeee1 (CHEMICALIN), a charge-deficient CHEMICALIN analog, was an extremely poor substrate of GENEIN and was metabolized by  bbbbb2 GENEIN eeeee2  in HEPG2 cells and in wild-type primary hepatocytes
CPR:9	By contrast,  bbbbb1 CHEMICALIN eeeee1 (CHEMICALIN), a charge-deficient CHEMICALIN analog, was an extremely poor substrate of  bbbbb2 GENEIN eeeee2  and was metabolized by GENEIN in HEPG2 cells and in wild-type primary hepatocytes
CPR:9	By contrast, CHEMICALIN( bbbbb1 CHEMICALIN eeeee1 ), a charge-deficient CHEMICALIN analog, was an extremely poor substrate of GENEIN and was metabolized by  bbbbb2 GENEIN eeeee2  in HEPG2 cells and in wild-type primary hepatocytes
CPR:9	By contrast, CHEMICALIN( bbbbb1 CHEMICALIN eeeee1 ), a charge-deficient CHEMICALIN analog, was an extremely poor substrate of  bbbbb2 GENEIN eeeee2  and was metabolized by GENEIN in HEPG2 cells and in wild-type primary hepatocytes
CPR:9	By contrast, CHEMICALIN(CHEMICALIN), a charge-deficient  bbbbb1 CHEMICALIN eeeee1  analog, was an extremely poor substrate of GENEIN and was metabolized by  bbbbb2 GENEIN eeeee2  in HEPG2 cells and in wild-type primary hepatocytes
CPR:9	By contrast, CHEMICALIN(CHEMICALIN), a charge-deficient  bbbbb1 CHEMICALIN eeeee1  analog, was an extremely poor substrate of  bbbbb2 GENEIN eeeee2  and was metabolized by GENEIN in HEPG2 cells and in wild-type primary hepatocytes
CPR:9	Metabolism of  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN by the GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:9	Metabolism of  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN by the  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:9	Metabolism of CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  by the GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:9	Metabolism of CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  by the  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:9	Thus, despite the similar structures of CHEMICALNOTIN and CHEMICALNOTIN,  bbbbb1 GENEIN eeeee1  is the main acetylator of  bbbbb2 CHEMICALIN eeeee2 , whereas CHEMICALIN is primarily acetylated by GENEIN.
CPR:9	Thus, despite the similar structures of CHEMICALNOTIN and CHEMICALNOTIN, GENEIN is the main acetylator of CHEMICALIN, whereas  bbbbb1 CHEMICALIN eeeee1  is primarily acetylated by  bbbbb2 GENEIN eeeee2 .
CPR:9	We recently showed that  bbbbb1 CHEMICALIN eeeee1  is metabolized in vitro by CHEMICALIN catabolic enzyme  bbbbb2 GENEIN eeeee2  (GENEIN) and by GENEIN (GENEIN) to its monoacetylated derivative (MAT)
CPR:9	We recently showed that  bbbbb1 CHEMICALIN eeeee1  is metabolized in vitro by CHEMICALIN catabolic enzyme GENEIN ( bbbbb2 GENEIN eeeee2 ) and by GENEIN (GENEIN) to its monoacetylated derivative (MAT)
CPR:9	We recently showed that  bbbbb1 CHEMICALIN eeeee1  is metabolized in vitro by CHEMICALIN catabolic enzyme GENEIN (GENEIN) and by  bbbbb2 GENEIN eeeee2  (GENEIN) to its monoacetylated derivative (MAT)
CPR:9	We recently showed that  bbbbb1 CHEMICALIN eeeee1  is metabolized in vitro by CHEMICALIN catabolic enzyme GENEIN (GENEIN) and by GENEIN ( bbbbb2 GENEIN eeeee2 ) to its monoacetylated derivative (MAT)
CPR:9	We recently showed that CHEMICALIN is metabolized in vitro by  bbbbb1 CHEMICALIN eeeee1  catabolic enzyme  bbbbb2 GENEIN eeeee2  (GENEIN) and by GENEIN (GENEIN) to its monoacetylated derivative (MAT)
CPR:9	We recently showed that CHEMICALIN is metabolized in vitro by  bbbbb1 CHEMICALIN eeeee1  catabolic enzyme GENEIN ( bbbbb2 GENEIN eeeee2 ) and by GENEIN (GENEIN) to its monoacetylated derivative (MAT)
CPR:2	 bbbbb1 GENEIN eeeee1  has shown to be an essential component in GENEIN catalyzed  bbbbb2 CHEMICALIN eeeee2  formation and provides insights on the disconnect between human liver microsomes data and that of GENENOTIN
CPR:6	In vitro metabolism of the  bbbbb1 GENEIN eeeee1  receptor antagonist  bbbbb2 CHEMICALIN eeeee2 
CPR:9	GENEIN has shown to be an essential component in  bbbbb1 GENEIN eeeee1  catalyzed  bbbbb2 CHEMICALIN eeeee2  formation and provides insights on the disconnect between human liver microsomes data and that of GENENOTIN
CPR:9	The GENENOTIN data was normalized relative to the levels of each GENENOTIN form in native human liver microsomes to better assess the contribution of each  bbbbb1 GENEIN eeeee1  in the metabolism of  bbbbb2 CHEMICALIN eeeee2 
CPR:1	The mutant GENEIN ( bbbbb1 GENEIN eeeee1 ) contained a total of 5  bbbbb2 CHEMICALIN eeeee2  substitutions that conferred an activating to inhibitory ratio of 25 (A/I ratio; GENEIN-R131:GENEIN)
CPR:1	The mutant GENEIN (GENEIN) contained a total of 5  bbbbb1 CHEMICALIN eeeee1  substitutions that conferred an activating to inhibitory ratio of 25 (A/I ratio;  bbbbb2 GENEIN eeeee2 -R131:GENEIN)
CPR:1	The mutant GENEIN (GENEIN) contained a total of 5  bbbbb1 CHEMICALIN eeeee1  substitutions that conferred an activating to inhibitory ratio of 25 (A/I ratio; GENEIN-R131: bbbbb2 GENEIN eeeee2 )
CPR:1	The mutant  bbbbb1 GENEIN eeeee1  (GENEIN) contained a total of 5  bbbbb2 CHEMICALIN eeeee2  substitutions that conferred an activating to inhibitory ratio of 25 (A/I ratio; GENEIN-R131:GENEIN)
CPR:10	In contrast,  bbbbb1 CHEMICALIN eeeee1  had little effect on limb morphology and no significant effect on  bbbbb2 GENEIN eeeee2  activity or the expression of marker genes
CPR:10	Disturbances in these signaling pathways are likely to be a consequence of  bbbbb1 GENEIN eeeee1  inhibition because  bbbbb2 CHEMICALIN eeeee2  did not affect their expressions.
CPR:10	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), the CHEMICALIN derivative of CHEMICALIN, does not inhibit  bbbbb2 GENEIN eeeee2  activity and is a weak teratogen in vivo
CPR:10	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), the CHEMICALIN derivative of CHEMICALIN, does not inhibit  bbbbb2 GENEIN eeeee2  activity and is a weak teratogen in vivo
CPR:10	CHEMICALIN (CHEMICALIN), the  bbbbb1 CHEMICALIN eeeee1  derivative of CHEMICALIN, does not inhibit  bbbbb2 GENEIN eeeee2  activity and is a weak teratogen in vivo
CPR:10	CHEMICALIN (CHEMICALIN), the CHEMICALIN derivative of  bbbbb1 CHEMICALIN eeeee1 , does not inhibit  bbbbb2 GENEIN eeeee2  activity and is a weak teratogen in vivo
CPR:4	The signaling of both  bbbbb1 GENEIN eeeee1  and GENEIN, key regulators of chondrogenesis, was downregulated by  bbbbb2 CHEMICALIN eeeee2 
CPR:4	The signaling of both GENEIN and  bbbbb1 GENEIN eeeee1 , key regulators of chondrogenesis, was downregulated by  bbbbb2 CHEMICALIN eeeee2 
CPR:4	 bbbbb1 CHEMICALIN eeeee1  caused a significant concentration- dependent increase in limb abnormalities, which was correlated with its  bbbbb2 GENEIN eeeee2  inhibitory effect
CPR:4	In utero exposure to  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a  bbbbb2 GENEIN eeeee2  (GENEIN) inhibitor, causes neural tube, heart, and limb defects
CPR:4	In utero exposure to  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a GENEIN ( bbbbb2 GENEIN eeeee2 ) inhibitor, causes neural tube, heart, and limb defects
CPR:4	In utero exposure to CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a  bbbbb2 GENEIN eeeee2  (GENEIN) inhibitor, causes neural tube, heart, and limb defects
CPR:4	In utero exposure to CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a GENEIN ( bbbbb2 GENEIN eeeee2 ) inhibitor, causes neural tube, heart, and limb defects
CPR:3	In summary, activation of  bbbbb1 GENEIN eeeee1  and oxidative stress were observed after  bbbbb2 CHEMICALIN eeeee2 /GENENOTIN cotreatment, and GENENOTIN inhibitors and a lipid-soluble free-radical scavenger attenuated CHEMICALNOTIN/GENENOTIN-induced cytotoxicity.
CPR:4	 bbbbb1 CHEMICALIN eeeee1  plus a  bbbbb2 GENEIN eeeee2  inhibitor completely abolished CHEMICALNOTIN/GENENOTIN-induced cytotoxicity
CPR:1	Studies have indicated that the three-dimensional structure and the domains of  bbbbb1 GENEIN eeeee1  ( bbbbb2 CHEMICALIN eeeee2  pocket, lip of the active center gorge, and the anionic substrate-binding domain) that are critical for the binding of substrate are also essential for the selectivity and binding of inhibitors including OPs
CPR:1	 bbbbb1 CHEMICALIN eeeee1  residues at the N- and C-termini are essential for the folding of active  bbbbb2 GENEIN eeeee2  polypeptide
CPR:9	GENEIN ( bbbbb1 GENEIN eeeee1 ) is currently the most suitable bioscavenger for the prophylaxis of highly toxic  bbbbb2 CHEMICALIN eeeee2  (OP) nerve agents
CPR:9	 bbbbb1 GENEIN eeeee1  (GENEIN) is currently the most suitable bioscavenger for the prophylaxis of highly toxic  bbbbb2 CHEMICALIN eeeee2  (OP) nerve agents
CPR:2	GENEIN and GENEIN regulate sensitivity to  bbbbb1 CHEMICALIN eeeee1  by controlling expression of the GENEIN  bbbbb2 GENEIN eeeee2 
CPR:2	GENEIN and GENEIN regulate sensitivity to  bbbbb1 CHEMICALIN eeeee1  by controlling expression of the  bbbbb2 GENEIN eeeee2  GENEIN
CPR:2	 bbbbb1 GENEIN eeeee1  and GENEIN regulate sensitivity to  bbbbb2 CHEMICALIN eeeee2  by controlling expression of the GENEIN GENEIN
CPR:2	GENEIN and  bbbbb1 GENEIN eeeee1  regulate sensitivity to  bbbbb2 CHEMICALIN eeeee2  by controlling expression of the GENEIN GENEIN
CPR:2	 bbbbb1 CHEMICALIN eeeee1 -dependent  bbbbb2 GENEIN eeeee2  activity was also markedly reduced in both types of GENENOTIN knockdown cells when incubated with the substrate CHEMICALIN
CPR:9	CHEMICALIN-dependent  bbbbb1 GENEIN eeeee1  activity was also markedly reduced in both types of GENENOTIN knockdown cells when incubated with the substrate  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Protein expression of  bbbbb1 GENEIN eeeee1  also decreased and corresponded with reduced in vitro glucuronidation of  bbbbb2 CHEMICALIN eeeee2  in S9 fractions from livers of pregnant mice
CPR:2	However, downregulation of the GENEIN (GENEIN)-driven GENEIN target genes such as  bbbbb1 GENEIN eeeee1 , GENEIN and GENEIN (GENEIN) did not reverse the inhibitory effect of  bbbbb2 CHEMICALIN eeeee2  on GENEIN-induced upregulation of profibrotic genes or extracellular matrix proteins, suggesting an GENEIN-independent anti-fibrotic activity of CHEMICALIN
CPR:2	However, downregulation of the GENEIN (GENEIN)-driven GENEIN target genes such as GENEIN,  bbbbb1 GENEIN eeeee1  and GENEIN (GENEIN) did not reverse the inhibitory effect of  bbbbb2 CHEMICALIN eeeee2  on GENEIN-induced upregulation of profibrotic genes or extracellular matrix proteins, suggesting an GENEIN-independent anti-fibrotic activity of CHEMICALIN
CPR:2	However, downregulation of the GENEIN (GENEIN)-driven GENEIN target genes such as GENEIN, GENEIN and  bbbbb1 GENEIN eeeee1  (GENEIN) did not reverse the inhibitory effect of  bbbbb2 CHEMICALIN eeeee2  on GENEIN-induced upregulation of profibrotic genes or extracellular matrix proteins, suggesting an GENEIN-independent anti-fibrotic activity of CHEMICALIN
CPR:2	However, downregulation of the GENEIN (GENEIN)-driven GENEIN target genes such as GENEIN, GENEIN and GENEIN ( bbbbb1 GENEIN eeeee1 ) did not reverse the inhibitory effect of  bbbbb2 CHEMICALIN eeeee2  on GENEIN-induced upregulation of profibrotic genes or extracellular matrix proteins, suggesting an GENEIN-independent anti-fibrotic activity of CHEMICALIN
CPR:2	However, downregulation of the  bbbbb1 GENEIN eeeee1  (GENEIN)-driven GENEIN target genes such as GENEIN, GENEIN and GENEIN (GENEIN) did not reverse the inhibitory effect of  bbbbb2 CHEMICALIN eeeee2  on GENEIN-induced upregulation of profibrotic genes or extracellular matrix proteins, suggesting an GENEIN-independent anti-fibrotic activity of CHEMICALIN
CPR:2	However, downregulation of the GENEIN ( bbbbb1 GENEIN eeeee1 )-driven GENEIN target genes such as GENEIN, GENEIN and GENEIN (GENEIN) did not reverse the inhibitory effect of  bbbbb2 CHEMICALIN eeeee2  on GENEIN-induced upregulation of profibrotic genes or extracellular matrix proteins, suggesting an GENEIN-independent anti-fibrotic activity of CHEMICALIN
CPR:2	However, downregulation of the GENEIN (GENEIN)-driven  bbbbb1 GENEIN eeeee1  target genes such as GENEIN, GENEIN and GENEIN (GENEIN) did not reverse the inhibitory effect of  bbbbb2 CHEMICALIN eeeee2  on GENEIN-induced upregulation of profibrotic genes or extracellular matrix proteins, suggesting an GENEIN-independent anti-fibrotic activity of CHEMICALIN
CPR:2	However, downregulation of the GENEIN (GENEIN)-driven GENEIN target genes such as GENEIN, GENEIN and GENEIN (GENEIN) did not reverse the inhibitory effect of CHEMICALIN on GENEIN-induced upregulation of profibrotic genes or extracellular matrix proteins, suggesting an  bbbbb1 GENEIN eeeee1 -independent anti-fibrotic activity of  bbbbb2 CHEMICALIN eeeee2 
CPR:2	In summary,  bbbbb1 CHEMICALIN eeeee1  attenuated renal fibrosis via the GENEIN-mediated inhibition of GENEIN/GENEIN signaling in an  bbbbb2 GENEIN eeeee2 -independent manner, suggesting that CHEMICALNOTIN could be used to treat renal fibrosis.
CPR:2	Results showed that CHEMICALIN increased nuclear levels of GENEIN, and both  bbbbb1 CHEMICALIN eeeee1  and adenovirus-mediated overexpression of GENEIN (Ad-GENENOTIN) decreased GENEIN, GENEIN (GENEIN), GENEIN and GENEIN expression in  bbbbb2 GENEIN eeeee2 -treated rat mesangial cells (RMCs) and renal fibroblast cells (NRK-49F)
CPR:2	 bbbbb1 CHEMICALIN eeeee1  attenuates renal fibrosis via  bbbbb2 GENEIN eeeee2 -mediated inhibition of GENEIN/GENEIN signaling
CPR:2	In summary,  bbbbb1 CHEMICALIN eeeee1  attenuated renal fibrosis via the  bbbbb2 GENEIN eeeee2 -mediated inhibition of GENEIN/GENEIN signaling in an GENEIN-independent manner, suggesting that CHEMICALNOTIN could be used to treat renal fibrosis.
CPR:3	Results showed that  bbbbb1 CHEMICALIN eeeee1  increased nuclear levels of  bbbbb2 GENEIN eeeee2 , and both CHEMICALIN and adenovirus-mediated overexpression of GENEIN (Ad-GENENOTIN) decreased GENEIN, GENEIN (GENEIN), GENEIN and GENEIN expression in GENEIN-treated rat mesangial cells (RMCs) and renal fibroblast cells (NRK-49F)
CPR:3	Results showed that CHEMICALIN increased nuclear levels of GENEIN, and both  bbbbb1 CHEMICALIN eeeee1  and adenovirus-mediated overexpression of  bbbbb2 GENEIN eeeee2  (Ad-GENENOTIN) decreased GENEIN, GENEIN (GENEIN), GENEIN and GENEIN expression in GENEIN-treated rat mesangial cells (RMCs) and renal fibroblast cells (NRK-49F)
CPR:3	Finally,  bbbbb1 CHEMICALIN eeeee1  suppressed unilateral ureteral obstruction (UUO)-induced renal fibrosis and GENEIN, GENEIN and GENEIN expression in the obstructed kidneys from UUO mice, along with increased and decreased expression of  bbbbb2 GENEIN eeeee2  and GENEIN, respectively
CPR:4	Additionally,  bbbbb1 CHEMICALIN eeeee1  and Ad-GENENOTIN repressed  bbbbb2 GENEIN eeeee2 -stimulated GENEIN activity by inhibiting GENEIN phosphorylation, which was restored by siRNA-mediated knockdown of GENENOTIN expression
CPR:4	However, downregulation of the GENEIN (GENEIN)-driven GENEIN target genes such as GENEIN, GENEIN and GENEIN (GENEIN) did not reverse the inhibitory effect of  bbbbb1 CHEMICALIN eeeee1  on  bbbbb2 GENEIN eeeee2 -induced upregulation of profibrotic genes or extracellular matrix proteins, suggesting an GENEIN-independent anti-fibrotic activity of CHEMICALIN
CPR:4	Results showed that CHEMICALIN increased nuclear levels of GENEIN, and both  bbbbb1 CHEMICALIN eeeee1  and adenovirus-mediated overexpression of GENEIN (Ad-GENENOTIN) decreased  bbbbb2 GENEIN eeeee2 , GENEIN (GENEIN), GENEIN and GENEIN expression in GENEIN-treated rat mesangial cells (RMCs) and renal fibroblast cells (NRK-49F)
CPR:4	Results showed that CHEMICALIN increased nuclear levels of GENEIN, and both  bbbbb1 CHEMICALIN eeeee1  and adenovirus-mediated overexpression of GENEIN (Ad-GENENOTIN) decreased GENEIN,  bbbbb2 GENEIN eeeee2  (GENEIN), GENEIN and GENEIN expression in GENEIN-treated rat mesangial cells (RMCs) and renal fibroblast cells (NRK-49F)
CPR:4	Results showed that CHEMICALIN increased nuclear levels of GENEIN, and both  bbbbb1 CHEMICALIN eeeee1  and adenovirus-mediated overexpression of GENEIN (Ad-GENENOTIN) decreased GENEIN, GENEIN ( bbbbb2 GENEIN eeeee2 ), GENEIN and GENEIN expression in GENEIN-treated rat mesangial cells (RMCs) and renal fibroblast cells (NRK-49F)
CPR:4	Results showed that CHEMICALIN increased nuclear levels of GENEIN, and both  bbbbb1 CHEMICALIN eeeee1  and adenovirus-mediated overexpression of GENEIN (Ad-GENENOTIN) decreased GENEIN, GENEIN (GENEIN),  bbbbb2 GENEIN eeeee2  and GENEIN expression in GENEIN-treated rat mesangial cells (RMCs) and renal fibroblast cells (NRK-49F)
CPR:4	Results showed that CHEMICALIN increased nuclear levels of GENEIN, and both  bbbbb1 CHEMICALIN eeeee1  and adenovirus-mediated overexpression of GENEIN (Ad-GENENOTIN) decreased GENEIN, GENEIN (GENEIN), GENEIN and  bbbbb2 GENEIN eeeee2  expression in GENEIN-treated rat mesangial cells (RMCs) and renal fibroblast cells (NRK-49F)
CPR:4	 bbbbb1 CHEMICALIN eeeee1  attenuates renal fibrosis via GENEIN-mediated inhibition of GENEIN/ bbbbb2 GENEIN eeeee2  signaling
CPR:4	 bbbbb1 CHEMICALIN eeeee1  attenuates renal fibrosis via GENEIN-mediated inhibition of  bbbbb2 GENEIN eeeee2 /GENEIN signaling
CPR:4	Finally,  bbbbb1 CHEMICALIN eeeee1  suppressed unilateral ureteral obstruction (UUO)-induced renal fibrosis and  bbbbb2 GENEIN eeeee2 , GENEIN and GENEIN expression in the obstructed kidneys from UUO mice, along with increased and decreased expression of GENEIN and GENEIN, respectively
CPR:4	Finally,  bbbbb1 CHEMICALIN eeeee1  suppressed unilateral ureteral obstruction (UUO)-induced renal fibrosis and GENEIN,  bbbbb2 GENEIN eeeee2  and GENEIN expression in the obstructed kidneys from UUO mice, along with increased and decreased expression of GENEIN and GENEIN, respectively
CPR:4	Finally,  bbbbb1 CHEMICALIN eeeee1  suppressed unilateral ureteral obstruction (UUO)-induced renal fibrosis and GENEIN, GENEIN and  bbbbb2 GENEIN eeeee2  expression in the obstructed kidneys from UUO mice, along with increased and decreased expression of GENEIN and GENEIN, respectively
CPR:4	Finally,  bbbbb1 CHEMICALIN eeeee1  suppressed unilateral ureteral obstruction (UUO)-induced renal fibrosis and GENEIN, GENEIN and GENEIN expression in the obstructed kidneys from UUO mice, along with increased and decreased expression of GENEIN and  bbbbb2 GENEIN eeeee2 , respectively
CPR:4	In summary,  bbbbb1 CHEMICALIN eeeee1  attenuated renal fibrosis via the GENEIN-mediated inhibition of  bbbbb2 GENEIN eeeee2 /GENEIN signaling in an GENEIN-independent manner, suggesting that CHEMICALNOTIN could be used to treat renal fibrosis.
CPR:4	In summary,  bbbbb1 CHEMICALIN eeeee1  attenuated renal fibrosis via the GENEIN-mediated inhibition of GENEIN/ bbbbb2 GENEIN eeeee2  signaling in an GENEIN-independent manner, suggesting that CHEMICALNOTIN could be used to treat renal fibrosis.
CPR:4	Additionally,  bbbbb1 CHEMICALIN eeeee1  and Ad-GENENOTIN repressed GENEIN-stimulated  bbbbb2 GENEIN eeeee2  activity by inhibiting GENEIN phosphorylation, which was restored by siRNA-mediated knockdown of GENENOTIN expression
CPR:4	Additionally,  bbbbb1 CHEMICALIN eeeee1  and Ad-GENENOTIN repressed GENEIN-stimulated GENEIN activity by inhibiting  bbbbb2 GENEIN eeeee2  phosphorylation, which was restored by siRNA-mediated knockdown of GENENOTIN expression
CPR:3	The expression of the osteoblast markers GENEIN (GENEIN) and GENEIN was decreased, while  bbbbb1 GENEIN eeeee1  (GENEIN) was augmented in GENENOTIN(-/-) and  bbbbb2 CHEMICALIN eeeee2 -RANTES-treated mice
CPR:3	The expression of the osteoblast markers GENEIN (GENEIN) and GENEIN was decreased, while GENEIN ( bbbbb1 GENEIN eeeee1 ) was augmented in GENENOTIN(-/-) and  bbbbb2 CHEMICALIN eeeee2 -RANTES-treated mice
CPR:4	The expression of the osteoblast markers GENEIN ( bbbbb1 GENEIN eeeee1 ) and GENEIN was decreased, while GENEIN (GENEIN) was augmented in GENENOTIN(-/-) and  bbbbb2 CHEMICALIN eeeee2 -RANTES-treated mice
CPR:4	The expression of the osteoblast markers GENEIN (GENEIN) and  bbbbb1 GENEIN eeeee1  was decreased, while GENEIN (GENEIN) was augmented in GENENOTIN(-/-) and  bbbbb2 CHEMICALIN eeeee2 -RANTES-treated mice
CPR:4	The expression of the osteoblast markers  bbbbb1 GENEIN eeeee1  (GENEIN) and GENEIN was decreased, while GENEIN (GENEIN) was augmented in GENENOTIN(-/-) and  bbbbb2 CHEMICALIN eeeee2 -RANTES-treated mice
CPR:4	Our results showed that bone remodeling was significantly decreased in GENENOTIN(-/-) and GENENOTIN(-/-) mice and in animals treated with CHEMICALIN-RANTES (an antagonist of GENEIN and GENEIN). mRNA levels of  bbbbb1 GENEIN eeeee1  (GENEIN), its ligand GENEIN, GENEIN (GENEIN) and GENEIN/GENEIN (GENEIN) ratio were diminished in the periodontium of GENENOTIN(-/-) mice and in the group treated with  bbbbb2 CHEMICALIN eeeee2 -RANTES
CPR:4	Our results showed that bone remodeling was significantly decreased in GENENOTIN(-/-) and GENENOTIN(-/-) mice and in animals treated with CHEMICALIN-RANTES (an antagonist of GENEIN and GENEIN). mRNA levels of GENEIN ( bbbbb1 GENEIN eeeee1 ), its ligand GENEIN, GENEIN (GENEIN) and GENEIN/GENEIN (GENEIN) ratio were diminished in the periodontium of GENENOTIN(-/-) mice and in the group treated with  bbbbb2 CHEMICALIN eeeee2 -RANTES
CPR:4	Our results showed that bone remodeling was significantly decreased in GENENOTIN(-/-) and GENENOTIN(-/-) mice and in animals treated with CHEMICALIN-RANTES (an antagonist of GENEIN and GENEIN). mRNA levels of GENEIN (GENEIN), its ligand  bbbbb1 GENEIN eeeee1 , GENEIN (GENEIN) and GENEIN/GENEIN (GENEIN) ratio were diminished in the periodontium of GENENOTIN(-/-) mice and in the group treated with  bbbbb2 CHEMICALIN eeeee2 -RANTES
CPR:4	Our results showed that bone remodeling was significantly decreased in GENENOTIN(-/-) and GENENOTIN(-/-) mice and in animals treated with CHEMICALIN-RANTES (an antagonist of GENEIN and GENEIN). mRNA levels of GENEIN (GENEIN), its ligand GENEIN,  bbbbb1 GENEIN eeeee1  (GENEIN) and GENEIN/GENEIN (GENEIN) ratio were diminished in the periodontium of GENENOTIN(-/-) mice and in the group treated with  bbbbb2 CHEMICALIN eeeee2 -RANTES
CPR:4	Our results showed that bone remodeling was significantly decreased in GENENOTIN(-/-) and GENENOTIN(-/-) mice and in animals treated with CHEMICALIN-RANTES (an antagonist of GENEIN and GENEIN). mRNA levels of GENEIN (GENEIN), its ligand GENEIN, GENEIN ( bbbbb1 GENEIN eeeee1 ) and GENEIN/GENEIN (GENEIN) ratio were diminished in the periodontium of GENENOTIN(-/-) mice and in the group treated with  bbbbb2 CHEMICALIN eeeee2 -RANTES
CPR:4	Our results showed that bone remodeling was significantly decreased in GENENOTIN(-/-) and GENENOTIN(-/-) mice and in animals treated with CHEMICALIN-RANTES (an antagonist of GENEIN and GENEIN). mRNA levels of GENEIN (GENEIN), its ligand GENEIN, GENEIN (GENEIN) and  bbbbb1 GENEIN eeeee1 /GENEIN (GENEIN) ratio were diminished in the periodontium of GENENOTIN(-/-) mice and in the group treated with  bbbbb2 CHEMICALIN eeeee2 -RANTES
CPR:4	Our results showed that bone remodeling was significantly decreased in GENENOTIN(-/-) and GENENOTIN(-/-) mice and in animals treated with CHEMICALIN-RANTES (an antagonist of GENEIN and GENEIN). mRNA levels of GENEIN (GENEIN), its ligand GENEIN, GENEIN (GENEIN) and GENEIN/ bbbbb1 GENEIN eeeee1  (GENEIN) ratio were diminished in the periodontium of GENENOTIN(-/-) mice and in the group treated with  bbbbb2 CHEMICALIN eeeee2 -RANTES
CPR:4	Our results showed that bone remodeling was significantly decreased in GENENOTIN(-/-) and GENENOTIN(-/-) mice and in animals treated with CHEMICALIN-RANTES (an antagonist of GENEIN and GENEIN). mRNA levels of GENEIN (GENEIN), its ligand GENEIN, GENEIN (GENEIN) and GENEIN/GENEIN ( bbbbb1 GENEIN eeeee1 ) ratio were diminished in the periodontium of GENENOTIN(-/-) mice and in the group treated with  bbbbb2 CHEMICALIN eeeee2 -RANTES
CPR:4	 bbbbb1 CHEMICALIN eeeee1 -RANTES treatment also reduced the levels of  bbbbb2 GENEIN eeeee2  and GENEIN (GENEIN)
CPR:4	 bbbbb1 CHEMICALIN eeeee1 -RANTES treatment also reduced the levels of GENEIN and  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:4	 bbbbb1 CHEMICALIN eeeee1 -RANTES treatment also reduced the levels of GENEIN and GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:6	Our results showed that bone remodeling was significantly decreased in GENENOTIN(-/-) and GENENOTIN(-/-) mice and in animals treated with  bbbbb1 CHEMICALIN eeeee1 -RANTES (an antagonist of  bbbbb2 GENEIN eeeee2  and GENEIN). mRNA levels of GENEIN (GENEIN), its ligand GENEIN, GENEIN (GENEIN) and GENEIN/GENEIN (GENEIN) ratio were diminished in the periodontium of GENENOTIN(-/-) mice and in the group treated with CHEMICALIN-RANTES
CPR:6	Our results showed that bone remodeling was significantly decreased in GENENOTIN(-/-) and GENENOTIN(-/-) mice and in animals treated with  bbbbb1 CHEMICALIN eeeee1 -RANTES (an antagonist of GENEIN and  bbbbb2 GENEIN eeeee2 ). mRNA levels of GENEIN (GENEIN), its ligand GENEIN, GENEIN (GENEIN) and GENEIN/GENEIN (GENEIN) ratio were diminished in the periodontium of GENENOTIN(-/-) mice and in the group treated with CHEMICALIN-RANTES
CPR:4	The CHEMICALIN (natural products) such as CHEMICALIN, CHEMICALIN, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  carry the common molecular structure of CHEMICALIN that possessed positive ionotropic effect and  bbbbb2 GENEIN eeeee2  blocking activity
CPR:4	The CHEMICALIN (natural products) such as CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN carry the common molecular structure of  bbbbb1 CHEMICALIN eeeee1  that possessed positive ionotropic effect and  bbbbb2 GENEIN eeeee2  blocking activity
CPR:4	The  bbbbb1 CHEMICALIN eeeee1  (natural products) such as CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN carry the common molecular structure of CHEMICALIN that possessed positive ionotropic effect and  bbbbb2 GENEIN eeeee2  blocking activity
CPR:4	The CHEMICALIN (natural products) such as  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN and CHEMICALIN carry the common molecular structure of CHEMICALIN that possessed positive ionotropic effect and  bbbbb2 GENEIN eeeee2  blocking activity
CPR:4	The CHEMICALIN (natural products) such as CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and CHEMICALIN carry the common molecular structure of CHEMICALIN that possessed positive ionotropic effect and  bbbbb2 GENEIN eeeee2  blocking activity
CPR:4	The CHEMICALIN (natural products) such as CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN carry the common molecular structure of CHEMICALIN that possessed positive ionotropic effect and  bbbbb2 GENEIN eeeee2  blocking activity
CPR:2	Multifunctional targets of dietary  bbbbb1 CHEMICALIN eeeee1  in disease: a case for the  bbbbb2 GENEIN eeeee2  network and energy metabolism
CPR:3	Several effects of  bbbbb1 CHEMICALIN eeeee1  are useful in this scenario, including a reduction in the activities of GENEIN and modulation of cellular metabolism through GENEIN inhibitors,  bbbbb2 GENEIN eeeee2  activators, calorie-restriction mimetics or epigenetic regulators
CPR:4	Several effects of  bbbbb1 CHEMICALIN eeeee1  are useful in this scenario, including a reduction in the activities of  bbbbb2 GENEIN eeeee2  and modulation of cellular metabolism through GENEIN inhibitors, GENEIN activators, calorie-restriction mimetics or epigenetic regulators
CPR:4	Several effects of  bbbbb1 CHEMICALIN eeeee1  are useful in this scenario, including a reduction in the activities of GENEIN and modulation of cellular metabolism through  bbbbb2 GENEIN eeeee2  inhibitors, GENEIN activators, calorie-restriction mimetics or epigenetic regulators
CPR:4	 bbbbb1 CHEMICALIN eeeee1  suppressed  bbbbb2 GENEIN eeeee2 -mediated protein levels of GENEIN and GENEIN, and reduced GENEIN expression and activity, concomitantly with a marked inhibition on cell migration and invasion without obvious cellular cytotoxicity
CPR:4	 bbbbb1 CHEMICALIN eeeee1  abrogated  bbbbb2 GENEIN eeeee2 -induced phosphorylation of GENEIN (GENEIN) and GENEIN (GENEIN)/GENEIN
CPR:4	Furthermore, the GENEIN inhibitor  bbbbb1 CHEMICALIN eeeee1  inhibited GENEIN-induced  bbbbb2 GENEIN eeeee2  expression, cell migration and invasion, as well as the activation of GENEIN/GENEIN, suggesting that GENEIN/GENEIN activation occur downstream of GENEIN activation
CPR:4	These findings suggest that  bbbbb1 CHEMICALIN eeeee1  inhibited the GENEIN-induced invasion and migration of MDA-MB-231 cells via GENEIN-dependent  bbbbb2 GENEIN eeeee2 /GENEIN signaling, leading to the down-regulation of GENEIN expression
CPR:4	These findings suggest that  bbbbb1 CHEMICALIN eeeee1  inhibited the GENEIN-induced invasion and migration of MDA-MB-231 cells via GENEIN-dependent GENEIN/ bbbbb2 GENEIN eeeee2  signaling, leading to the down-regulation of GENEIN expression
CPR:4	These findings suggest that  bbbbb1 CHEMICALIN eeeee1  inhibited the GENEIN-induced invasion and migration of MDA-MB-231 cells via GENEIN-dependent GENEIN/GENEIN signaling, leading to the down-regulation of  bbbbb2 GENEIN eeeee2  expression
CPR:4	 bbbbb1 CHEMICALIN eeeee1  suppressed GENEIN-mediated protein levels of  bbbbb2 GENEIN eeeee2  and GENEIN, and reduced GENEIN expression and activity, concomitantly with a marked inhibition on cell migration and invasion without obvious cellular cytotoxicity
CPR:4	 bbbbb1 CHEMICALIN eeeee1  suppressed GENEIN-mediated protein levels of GENEIN and  bbbbb2 GENEIN eeeee2 , and reduced GENEIN expression and activity, concomitantly with a marked inhibition on cell migration and invasion without obvious cellular cytotoxicity
CPR:4	 bbbbb1 CHEMICALIN eeeee1  suppressed GENEIN-mediated protein levels of GENEIN and GENEIN, and reduced  bbbbb2 GENEIN eeeee2  expression and activity, concomitantly with a marked inhibition on cell migration and invasion without obvious cellular cytotoxicity
CPR:4	Furthermore, the GENEIN inhibitor  bbbbb1 CHEMICALIN eeeee1  inhibited GENEIN-induced GENEIN expression, cell migration and invasion, as well as the activation of GENEIN/GENEIN, suggesting that  bbbbb2 GENEIN eeeee2 /GENEIN activation occur downstream of GENEIN activation
CPR:4	Furthermore, the GENEIN inhibitor  bbbbb1 CHEMICALIN eeeee1  inhibited GENEIN-induced GENEIN expression, cell migration and invasion, as well as the activation of GENEIN/GENEIN, suggesting that GENEIN/ bbbbb2 GENEIN eeeee2  activation occur downstream of GENEIN activation
CPR:4	Furthermore, the GENEIN inhibitor  bbbbb1 CHEMICALIN eeeee1  inhibited GENEIN-induced GENEIN expression, cell migration and invasion, as well as the activation of GENEIN/GENEIN, suggesting that GENEIN/GENEIN activation occur downstream of  bbbbb2 GENEIN eeeee2  activation
CPR:4	Furthermore, the  bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2  inhibited GENEIN-induced GENEIN expression, cell migration and invasion, as well as the activation of GENEIN/GENEIN, suggesting that GENEIN/GENEIN activation occur downstream of GENEIN activation
CPR:4	Furthermore, the GENEIN inhibitor  bbbbb1 CHEMICALIN eeeee1  inhibited  bbbbb2 GENEIN eeeee2 -induced GENEIN expression, cell migration and invasion, as well as the activation of GENEIN/GENEIN, suggesting that GENEIN/GENEIN activation occur downstream of GENEIN activation
CPR:4	Furthermore, the GENEIN inhibitor  bbbbb1 CHEMICALIN eeeee1  inhibited GENEIN-induced GENEIN expression, cell migration and invasion, as well as the activation of  bbbbb2 GENEIN eeeee2 /GENEIN, suggesting that GENEIN/GENEIN activation occur downstream of GENEIN activation
CPR:4	Furthermore, the GENEIN inhibitor  bbbbb1 CHEMICALIN eeeee1  inhibited GENEIN-induced GENEIN expression, cell migration and invasion, as well as the activation of GENEIN/ bbbbb2 GENEIN eeeee2 , suggesting that GENEIN/GENEIN activation occur downstream of GENEIN activation
CPR:4	Inhibition of  bbbbb1 GENEIN eeeee1 /GENEIN activation with  bbbbb2 CHEMICALIN eeeee2  blocks migration and invasion of MDA-MB-231 cells
CPR:4	Inhibition of GENEIN/ bbbbb1 GENEIN eeeee1  activation with  bbbbb2 CHEMICALIN eeeee2  blocks migration and invasion of MDA-MB-231 cells
CPR:4	These findings suggest that  bbbbb1 CHEMICALIN eeeee1  inhibited the  bbbbb2 GENEIN eeeee2 -induced invasion and migration of MDA-MB-231 cells via GENEIN-dependent GENEIN/GENEIN signaling, leading to the down-regulation of GENEIN expression
CPR:4	These findings suggest that  bbbbb1 CHEMICALIN eeeee1  inhibited the GENEIN-induced invasion and migration of MDA-MB-231 cells via  bbbbb2 GENEIN eeeee2 -dependent GENEIN/GENEIN signaling, leading to the down-regulation of GENEIN expression
CPR:4	 bbbbb1 CHEMICALIN eeeee1  suppressed GENEIN-mediated protein levels of GENEIN and GENEIN, and reduced  bbbbb2 GENEIN eeeee2  expression and activity, concomitantly with a marked inhibition on cell migration and invasion without obvious cellular cytotoxicity
CPR:4	 bbbbb1 CHEMICALIN eeeee1  abrogated GENEIN-induced phosphorylation of  bbbbb2 GENEIN eeeee2  (GENEIN) and GENEIN (GENEIN)/GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  abrogated GENEIN-induced phosphorylation of GENEIN ( bbbbb2 GENEIN eeeee2 ) and GENEIN (GENEIN)/GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  abrogated GENEIN-induced phosphorylation of GENEIN (GENEIN) and  bbbbb2 GENEIN eeeee2  (GENEIN)/GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  abrogated GENEIN-induced phosphorylation of GENEIN (GENEIN) and GENEIN ( bbbbb2 GENEIN eeeee2 )/GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  abrogated GENEIN-induced phosphorylation of GENEIN (GENEIN) and GENEIN (GENEIN)/ bbbbb2 GENEIN eeeee2 
CPR:4	The specific  bbbbb1 GENEIN eeeee1  inhibitor,  bbbbb2 CHEMICALIN eeeee2 , blocked significantly GENEIN-induced cell migration and invasion
CPR:4	The specific GENEIN inhibitor,  bbbbb1 CHEMICALIN eeeee1 , blocked significantly  bbbbb2 GENEIN eeeee2 -induced cell migration and invasion
CPR:4	Herein, we report the identification and characterization of  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a novel noncyclic CHEMICALIN GENEIN antagonist that is capable of specifically blocking intracellular GENEIN-mediated GENEIN activation and GENEIN phosphorylation, as well as GENEIN-mediated  bbbbb2 GENEIN eeeee2  secretion in pancreatic  cells
CPR:4	Herein, we report the identification and characterization of CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a novel noncyclic CHEMICALIN GENEIN antagonist that is capable of specifically blocking intracellular GENEIN-mediated GENEIN activation and GENEIN phosphorylation, as well as GENEIN-mediated  bbbbb2 GENEIN eeeee2  secretion in pancreatic  cells
CPR:4	Herein, we report the identification and characterization of CHEMICALIN (CHEMICALIN), a novel noncyclic  bbbbb1 CHEMICALIN eeeee1  GENEIN antagonist that is capable of specifically blocking intracellular GENEIN-mediated GENEIN activation and GENEIN phosphorylation, as well as GENEIN-mediated  bbbbb2 GENEIN eeeee2  secretion in pancreatic  cells
CPR:4	Herein, we report the identification and characterization of  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a novel noncyclic CHEMICALIN GENEIN antagonist that is capable of specifically blocking intracellular  bbbbb2 GENEIN eeeee2 -mediated GENEIN activation and GENEIN phosphorylation, as well as GENEIN-mediated GENEIN secretion in pancreatic  cells
CPR:4	Herein, we report the identification and characterization of  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a novel noncyclic CHEMICALIN GENEIN antagonist that is capable of specifically blocking intracellular GENEIN-mediated  bbbbb2 GENEIN eeeee2  activation and GENEIN phosphorylation, as well as GENEIN-mediated GENEIN secretion in pancreatic  cells
CPR:4	Herein, we report the identification and characterization of  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a novel noncyclic CHEMICALIN GENEIN antagonist that is capable of specifically blocking intracellular GENEIN-mediated GENEIN activation and  bbbbb2 GENEIN eeeee2  phosphorylation, as well as GENEIN-mediated GENEIN secretion in pancreatic  cells
CPR:4	Herein, we report the identification and characterization of  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a novel noncyclic CHEMICALIN GENEIN antagonist that is capable of specifically blocking intracellular GENEIN-mediated GENEIN activation and GENEIN phosphorylation, as well as  bbbbb2 GENEIN eeeee2 -mediated GENEIN secretion in pancreatic  cells
CPR:4	Herein, we report the identification and characterization of CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a novel noncyclic CHEMICALIN GENEIN antagonist that is capable of specifically blocking intracellular  bbbbb2 GENEIN eeeee2 -mediated GENEIN activation and GENEIN phosphorylation, as well as GENEIN-mediated GENEIN secretion in pancreatic  cells
CPR:4	Herein, we report the identification and characterization of CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a novel noncyclic CHEMICALIN GENEIN antagonist that is capable of specifically blocking intracellular GENEIN-mediated  bbbbb2 GENEIN eeeee2  activation and GENEIN phosphorylation, as well as GENEIN-mediated GENEIN secretion in pancreatic  cells
CPR:4	Herein, we report the identification and characterization of CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a novel noncyclic CHEMICALIN GENEIN antagonist that is capable of specifically blocking intracellular GENEIN-mediated GENEIN activation and  bbbbb2 GENEIN eeeee2  phosphorylation, as well as GENEIN-mediated GENEIN secretion in pancreatic  cells
CPR:4	Herein, we report the identification and characterization of CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a novel noncyclic CHEMICALIN GENEIN antagonist that is capable of specifically blocking intracellular GENEIN-mediated GENEIN activation and GENEIN phosphorylation, as well as  bbbbb2 GENEIN eeeee2 -mediated GENEIN secretion in pancreatic  cells
CPR:4	Herein, we report the identification and characterization of CHEMICALIN (CHEMICALIN), a novel noncyclic  bbbbb1 CHEMICALIN eeeee1  GENEIN antagonist that is capable of specifically blocking intracellular  bbbbb2 GENEIN eeeee2 -mediated GENEIN activation and GENEIN phosphorylation, as well as GENEIN-mediated GENEIN secretion in pancreatic  cells
CPR:4	Herein, we report the identification and characterization of CHEMICALIN (CHEMICALIN), a novel noncyclic  bbbbb1 CHEMICALIN eeeee1  GENEIN antagonist that is capable of specifically blocking intracellular GENEIN-mediated  bbbbb2 GENEIN eeeee2  activation and GENEIN phosphorylation, as well as GENEIN-mediated GENEIN secretion in pancreatic  cells
CPR:4	Herein, we report the identification and characterization of CHEMICALIN (CHEMICALIN), a novel noncyclic  bbbbb1 CHEMICALIN eeeee1  GENEIN antagonist that is capable of specifically blocking intracellular GENEIN-mediated GENEIN activation and  bbbbb2 GENEIN eeeee2  phosphorylation, as well as GENEIN-mediated GENEIN secretion in pancreatic  cells
CPR:4	Herein, we report the identification and characterization of CHEMICALIN (CHEMICALIN), a novel noncyclic  bbbbb1 CHEMICALIN eeeee1  GENEIN antagonist that is capable of specifically blocking intracellular GENEIN-mediated GENEIN activation and GENEIN phosphorylation, as well as  bbbbb2 GENEIN eeeee2 -mediated GENEIN secretion in pancreatic  cells
CPR:6	Herein, we report the identification and characterization of  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a novel noncyclic CHEMICALIN  bbbbb2 GENEIN eeeee2  antagonist that is capable of specifically blocking intracellular GENEIN-mediated GENEIN activation and GENEIN phosphorylation, as well as GENEIN-mediated GENEIN secretion in pancreatic  cells
CPR:6	Herein, we report the identification and characterization of CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a novel noncyclic CHEMICALIN  bbbbb2 GENEIN eeeee2  antagonist that is capable of specifically blocking intracellular GENEIN-mediated GENEIN activation and GENEIN phosphorylation, as well as GENEIN-mediated GENEIN secretion in pancreatic  cells
CPR:6	Herein, we report the identification and characterization of CHEMICALIN (CHEMICALIN), a novel noncyclic  bbbbb1 CHEMICALIN eeeee1   bbbbb2 GENEIN eeeee2  antagonist that is capable of specifically blocking intracellular GENEIN-mediated GENEIN activation and GENEIN phosphorylation, as well as GENEIN-mediated GENEIN secretion in pancreatic  cells
CPR:2	Our results show that  bbbbb1 CHEMICALIN eeeee1  directly inhibits stomach GENEIN production and secretion through  bbbbb2 GENEIN eeeee2 
CPR:2	 bbbbb1 CHEMICALIN eeeee1  directly inhibits GENEIN secretion through  bbbbb2 GENEIN eeeee2  in rat primary gastric cells
CPR:3	Furthermore, the  bbbbb1 GENEIN eeeee1  activator  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) significantly inhibited GENEIN secretion
CPR:3	Furthermore, the  bbbbb1 GENEIN eeeee1  activator CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) significantly inhibited GENEIN secretion
CPR:3	Finally,  bbbbb1 CHEMICALIN eeeee1  treatment caused a significant increase in the level of  bbbbb2 GENEIN eeeee2 
CPR:3	CHEMICALIN significantly reduced  bbbbb1 GENEIN eeeee1  secretion and GENEIN mRNA production and both these effects were blocked by co-incubation with the GENEIN inhibitor  bbbbb2 CHEMICALIN eeeee2 
CPR:3	CHEMICALIN significantly reduced GENEIN secretion and  bbbbb1 GENEIN eeeee1  mRNA production and both these effects were blocked by co-incubation with the GENEIN inhibitor  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Our results show that  bbbbb1 CHEMICALIN eeeee1  directly inhibits stomach  bbbbb2 GENEIN eeeee2  production and secretion through GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  treatment is also associated with lower circulating levels of the  bbbbb2 GENEIN eeeee2  GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  treatment is also associated with lower circulating levels of the GENEIN  bbbbb2 GENEIN eeeee2 
CPR:4	 bbbbb1 CHEMICALIN eeeee1  directly inhibits  bbbbb2 GENEIN eeeee2  secretion through GENEIN in rat primary gastric cells
CPR:4	 bbbbb1 CHEMICALIN eeeee1  significantly reduced  bbbbb2 GENEIN eeeee2  secretion and GENEIN mRNA production and both these effects were blocked by co-incubation with the GENEIN inhibitor CHEMICALIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  significantly reduced GENEIN secretion and  bbbbb2 GENEIN eeeee2  mRNA production and both these effects were blocked by co-incubation with the GENEIN inhibitor CHEMICALIN
CPR:4	Furthermore, the GENEIN activator CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) significantly inhibited  bbbbb2 GENEIN eeeee2  secretion
CPR:4	CHEMICALIN significantly reduced GENEIN secretion and GENEIN mRNA production and both these effects were blocked by co-incubation with the  bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2 
CPR:2	Through identification of mammary  bbbbb1 GENEIN eeeee1  as a novel target gene of pesticide  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN, our results may therefore help to improve the protection of breast-feeding infants and the consumer of dairy products.
CPR:2	Through identification of mammary  bbbbb1 GENEIN eeeee1  as a novel target gene of pesticide CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 , our results may therefore help to improve the protection of breast-feeding infants and the consumer of dairy products.
CPR:2	 bbbbb1 CHEMICALIN eeeee1  or CHEMICALIN doubled  bbbbb2 GENEIN eeeee2 -mediated CHEMICALIN secretion
CPR:2	CHEMICALIN or  bbbbb1 CHEMICALIN eeeee1  doubled  bbbbb2 GENEIN eeeee2 -mediated CHEMICALIN secretion
CPR:2	Fungicide  bbbbb1 CHEMICALIN eeeee1  and environmental pollutant CHEMICALIN induce the GENEIN transporter in bovine mammary epithelial cells by the  bbbbb2 GENEIN eeeee2  signaling pathway
CPR:2	Fungicide CHEMICALIN and environmental pollutant  bbbbb1 CHEMICALIN eeeee1  induce the GENEIN transporter in bovine mammary epithelial cells by the  bbbbb2 GENEIN eeeee2  signaling pathway
CPR:3	Induction of GENEIN by  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN resulted in a time- and dose-dependent increase of  bbbbb2 GENEIN eeeee2  gene expression and transporter protein levels
CPR:3	Induction of GENEIN by CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  resulted in a time- and dose-dependent increase of  bbbbb2 GENEIN eeeee2  gene expression and transporter protein levels
CPR:3	Fungicide  bbbbb1 CHEMICALIN eeeee1  and environmental pollutant CHEMICALIN induce the  bbbbb2 GENEIN eeeee2  transporter in bovine mammary epithelial cells by the GENEIN signaling pathway
CPR:3	Fungicide CHEMICALIN and environmental pollutant  bbbbb1 CHEMICALIN eeeee1  induce the  bbbbb2 GENEIN eeeee2  transporter in bovine mammary epithelial cells by the GENEIN signaling pathway
CPR:3	Induction of  bbbbb1 GENEIN eeeee1  by  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN resulted in a time- and dose-dependent increase of GENEIN gene expression and transporter protein levels
CPR:3	Induction of  bbbbb1 GENEIN eeeee1  by CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  resulted in a time- and dose-dependent increase of GENEIN gene expression and transporter protein levels
CPR:4	This effect was almost completely reversed by specific  bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2 
CPR:5	As these regulatory motifs mediate regulation of target genes by  bbbbb1 GENEIN eeeee1  agonists including  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN, we have systematically investigated the effect of both contaminants on functional GENENOTIN transport activity in primary bovine mammary epithelial cells
CPR:5	As these regulatory motifs mediate regulation of target genes by  bbbbb1 GENEIN eeeee1  agonists including CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 , we have systematically investigated the effect of both contaminants on functional GENENOTIN transport activity in primary bovine mammary epithelial cells
CPR:6	Receptor binding was significantly reduced by specific  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2 
CPR:9	CHEMICALIN or CHEMICALIN doubled  bbbbb1 GENEIN eeeee1 -mediated  bbbbb2 CHEMICALIN eeeee2  secretion
CPR:2	We found that  bbbbb1 CHEMICALIN eeeee1  NPs were highly cytotoxic to hepatocytes (LC(50)  bbbbb2 GENEIN eeeee2 : 2.5 g/cm(2)) and affected hepatocyte homeostasis by reducing GENEIN release
CPR:3	We observed similar effects of  bbbbb1 CHEMICALIN eeeee1  NPs on inflammatory mediator expression in vitro and in vivo with increase of  bbbbb2 GENEIN eeeee2  (GENEIN)/GENEIN, GENEIN, and GENEIN expression in both models and increased GENEIN protein release in vitro
CPR:3	We observed similar effects of  bbbbb1 CHEMICALIN eeeee1  NPs on inflammatory mediator expression in vitro and in vivo with increase of GENEIN ( bbbbb2 GENEIN eeeee2 )/GENEIN, GENEIN, and GENEIN expression in both models and increased GENEIN protein release in vitro
CPR:3	We observed similar effects of  bbbbb1 CHEMICALIN eeeee1  NPs on inflammatory mediator expression in vitro and in vivo with increase of GENEIN (GENEIN)/ bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN expression in both models and increased GENEIN protein release in vitro
CPR:3	We observed similar effects of  bbbbb1 CHEMICALIN eeeee1  NPs on inflammatory mediator expression in vitro and in vivo with increase of GENEIN (GENEIN)/GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN expression in both models and increased GENEIN protein release in vitro
CPR:3	We observed similar effects of  bbbbb1 CHEMICALIN eeeee1  NPs on inflammatory mediator expression in vitro and in vivo with increase of GENEIN (GENEIN)/GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2  expression in both models and increased GENEIN protein release in vitro
CPR:3	We observed similar effects of  bbbbb1 CHEMICALIN eeeee1  NPs on inflammatory mediator expression in vitro and in vivo with increase of GENEIN (GENEIN)/GENEIN, GENEIN, and GENEIN expression in both models and increased  bbbbb2 GENEIN eeeee2  protein release in vitro
CPR:4	We found that  bbbbb1 CHEMICALIN eeeee1  NPs were highly cytotoxic to hepatocytes (LC(50) GENEIN: 2.5 g/cm(2)) and affected hepatocyte homeostasis by reducing  bbbbb2 GENEIN eeeee2  release
CPR:10	Moreover, mutation of  bbbbb1 GENEIN eeeee1  can alter this coupled equilibrium from  bbbbb2 CHEMICALIN eeeee2 -insensitive agonist binding to more conventional CHEMICALIN-sensitive binding
CPR:10	Moreover, mutation of  bbbbb1 GENEIN eeeee1  can alter this coupled equilibrium from CHEMICALIN-insensitive agonist binding to more conventional  bbbbb2 CHEMICALIN eeeee2 -sensitive binding
CPR:10	Unlike the majority of GENENOTIN, the  bbbbb1 GENEIN eeeee1  binds agonist with high affinity that is insensitive to the presence of  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN)
CPR:10	Unlike the majority of GENENOTIN, the  bbbbb1 GENEIN eeeee1  binds agonist with high affinity that is insensitive to the presence of CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 )
CPR:2	Loss of agonist binding was observed on intact human embryonic kidney 293 cells expressing the  bbbbb1 GENEIN eeeee1  receptor, conditions where high CHEMICALIN levels are present; however, high affinity binding  bbbbb2 CHEMICALIN eeeee2  was observed in broken cell preparations washed free of CHEMICALNOTIN
CPR:2	The  bbbbb1 CHEMICALIN eeeee1  binding of  bbbbb2 GENEIN eeeee2  in broken cell membrane fractions was inhibited by addition of CHEMICALIN (IC(50) 21  1.8 nM)
CPR:2	The CHEMICALIN binding of  bbbbb1 GENEIN eeeee1  in broken cell membrane fractions was inhibited by addition of  bbbbb2 CHEMICALIN eeeee2  (IC(50) 21  1.8 nM)
CPR:2	This suggests that for the mutant receptors, GENENOTIN plays a critical role in linking the agonist bound receptor conformation to the  bbbbb1 GENEIN eeeee1   bbbbb2 CHEMICALIN eeeee2  bound state.
CPR:2	 bbbbb1 GENEIN eeeee1  modulates  bbbbb2 CHEMICALIN eeeee2  sensitivity of the GENEIN
CPR:2	GENEIN modulates  bbbbb1 CHEMICALIN eeeee1  sensitivity of the  bbbbb2 GENEIN eeeee2 
CPR:2	Seven point mutations were introduced into the conserved motif in the  bbbbb1 GENEIN eeeee1  (GENEIN) of GENEIN, resulting in acquisition of  bbbbb2 CHEMICALIN eeeee2 -sensitive agonist binding
CPR:2	Seven point mutations were introduced into the conserved motif in the GENEIN ( bbbbb1 GENEIN eeeee1 ) of GENEIN, resulting in acquisition of  bbbbb2 CHEMICALIN eeeee2 -sensitive agonist binding
CPR:2	Seven point mutations were introduced into the conserved motif in the GENEIN (GENEIN) of  bbbbb1 GENEIN eeeee1 , resulting in acquisition of  bbbbb2 CHEMICALIN eeeee2 -sensitive agonist binding
CPR:2	Loss of agonist binding was observed on intact human embryonic kidney 293 cells expressing the  bbbbb1 GENEIN eeeee1  receptor, conditions where high  bbbbb2 CHEMICALIN eeeee2  levels are present; however, high affinity binding CHEMICALIN was observed in broken cell preparations washed free of CHEMICALNOTIN
CPR:4	Blood pressure was increased in rats exposed to IH, and treatment with the  bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2  [CHEMICALIN] (33 mg/day) lowered blood pressure in IH but not sham group rats
CPR:4	Blood pressure was increased in rats exposed to IH, and treatment with the  bbbbb1 GENEIN eeeee1  inhibitor CHEMICALIN [ bbbbb2 CHEMICALIN eeeee2 ] (33 mg/day) lowered blood pressure in IH but not sham group rats
CPR:2	Interestingly, there was a loss in the binding of  bbbbb1 GENEIN eeeee1  to GENEIN during  bbbbb2 CHEMICALIN eeeee2 -induced germ cell loss, suggesting that a loss of GENENOTIN-GENENOTIN interactions might have facilitated junction restructuring
CPR:3	Following  bbbbb1 CHEMICALIN eeeee1  treatment,  bbbbb2 GENEIN eeeee2  was found to be upregulated during restructuring of the seminiferous epithelium, with round spermatids becoming increasingly immunoreactive for GENENOTIN by 6-16 h
CPR:4	Interestingly, there was a loss in the binding of GENEIN to  bbbbb1 GENEIN eeeee1  during  bbbbb2 CHEMICALIN eeeee2 -induced germ cell loss, suggesting that a loss of GENENOTIN-GENENOTIN interactions might have facilitated junction restructuring
CPR:4	The reaction was inhibited by the specific  bbbbb1 GENEIN eeeee1  inhibitors  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:4	The reaction was inhibited by the specific  bbbbb1 GENEIN eeeee1  inhibitors CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:9	Of the GENENOTIN isoforms studied,  bbbbb1 GENEIN eeeee1  isoforms were the most efficient in catalyzing the CHEMICALIN-demethylation of CHEMICALIN to  bbbbb2 CHEMICALIN eeeee2 , but they were less effective than the GENEIN
CPR:9	Of the GENENOTIN isoforms studied, GENEIN isoforms were the most efficient in catalyzing the CHEMICALIN-demethylation of CHEMICALIN to  bbbbb1 CHEMICALIN eeeee1 , but they were less effective than the  bbbbb2 GENEIN eeeee2 
CPR:9	The catalytic competence of  bbbbb1 GENEIN eeeee1  in the synthesis of  bbbbb2 CHEMICALIN eeeee2  from CHEMICALIN in the brain: an in vitro study
CPR:9	Human liver microsomes of the wild-type  bbbbb1 GENEIN eeeee1  metabolized CHEMICALIN to  bbbbb2 CHEMICALIN eeeee2  more effectively than did the defective GENEIN*4*4 ones
CPR:9	Human liver microsomes of the wild-type GENEIN metabolized CHEMICALIN to  bbbbb1 CHEMICALIN eeeee1  more effectively than did the defective  bbbbb2 GENEIN eeeee2 *4*4 ones
CPR:9	The obtained results indicate that  bbbbb1 GENEIN eeeee1  isoforms catalyze the formation of  bbbbb2 CHEMICALIN eeeee2  from CHEMICALIN, and that the deficit or genetic defect of GENEIN may affect CHEMICALIN metabolism in the brain
CPR:9	The obtained results indicate that GENEIN isoforms catalyze the formation of CHEMICALIN from CHEMICALIN, and that the deficit or genetic defect of  bbbbb1 GENEIN eeeee1  may affect  bbbbb2 CHEMICALIN eeeee2  metabolism in the brain
CPR:9	Of the GENENOTIN isoforms studied,  bbbbb1 GENEIN eeeee1  isoforms were the most efficient in catalyzing the  bbbbb2 CHEMICALIN eeeee2 -demethylation of CHEMICALIN to CHEMICALIN, but they were less effective than the GENEIN
CPR:9	Of the GENENOTIN isoforms studied, GENEIN isoforms were the most efficient in catalyzing the  bbbbb1 CHEMICALIN eeeee1 -demethylation of CHEMICALIN to CHEMICALIN, but they were less effective than the  bbbbb2 GENEIN eeeee2 
CPR:9	Of the GENENOTIN isoforms studied,  bbbbb1 GENEIN eeeee1  isoforms were the most efficient in catalyzing the CHEMICALIN-demethylation of  bbbbb2 CHEMICALIN eeeee2  to CHEMICALIN, but they were less effective than the GENEIN
CPR:9	Of the GENENOTIN isoforms studied, GENEIN isoforms were the most efficient in catalyzing the CHEMICALIN-demethylation of  bbbbb1 CHEMICALIN eeeee1  to CHEMICALIN, but they were less effective than the  bbbbb2 GENEIN eeeee2 
CPR:9	The catalytic competence of  bbbbb1 GENEIN eeeee1  in the synthesis of CHEMICALIN from  bbbbb2 CHEMICALIN eeeee2  in the brain: an in vitro study
CPR:9	Human liver microsomes of the wild-type  bbbbb1 GENEIN eeeee1  metabolized  bbbbb2 CHEMICALIN eeeee2  to CHEMICALIN more effectively than did the defective GENEIN*4*4 ones
CPR:9	Human liver microsomes of the wild-type GENEIN metabolized  bbbbb1 CHEMICALIN eeeee1  to CHEMICALIN more effectively than did the defective  bbbbb2 GENEIN eeeee2 *4*4 ones
CPR:9	The obtained results indicate that  bbbbb1 GENEIN eeeee1  isoforms catalyze the formation of CHEMICALIN from  bbbbb2 CHEMICALIN eeeee2 , and that the deficit or genetic defect of GENEIN may affect CHEMICALIN metabolism in the brain
CPR:2	In breast cancer (BC) epithelial cells, the mitogenic action of  bbbbb1 CHEMICALIN eeeee1  is transduced through binding to two receptors,  bbbbb2 GENEIN eeeee2  and GENEIN, which act as transcription factors
CPR:2	In breast cancer (BC) epithelial cells, the mitogenic action of  bbbbb1 CHEMICALIN eeeee1  is transduced through binding to two receptors, GENEIN and  bbbbb2 GENEIN eeeee2 , which act as transcription factors
CPR:2	 bbbbb1 CHEMICALIN eeeee1  effects are mediated not only through nuclear  bbbbb2 GENEIN eeeee2  but also through cytoplasmic/membrane GENEIN and GENEIN-coupled GENEIN
CPR:2	 bbbbb1 CHEMICALIN eeeee1  effects are mediated not only through nuclear GENEIN but also through cytoplasmic/membrane  bbbbb2 GENEIN eeeee2  and GENEIN-coupled GENEIN
CPR:2	 bbbbb1 CHEMICALIN eeeee1  effects are mediated not only through nuclear GENEIN but also through cytoplasmic/membrane GENEIN and  bbbbb2 GENEIN eeeee2 -coupled GENEIN
CPR:2	 bbbbb1 CHEMICALIN eeeee1  effects are mediated not only through nuclear GENEIN but also through cytoplasmic/membrane GENEIN and GENEIN-coupled  bbbbb2 GENEIN eeeee2 
CPR:2	Taken together, our study suggested, for the first time, that the pro-apoptotic effects of  bbbbb1 CHEMICALIN eeeee1  on HL-60 cells were mediated through  bbbbb2 GENEIN eeeee2  signaling pathway.
CPR:4	 bbbbb1 CHEMICALIN eeeee1  induces apoptosis through suppression of  bbbbb2 GENEIN eeeee2  signaling pathway in HL-60 cells
CPR:4	Western blot analysis indicated that  bbbbb1 CHEMICALIN eeeee1  inhibits the  bbbbb2 GENEIN eeeee2 /GENEIN/GENEIN pathway
CPR:4	Western blot analysis indicated that  bbbbb1 CHEMICALIN eeeee1  inhibits the GENEIN/ bbbbb2 GENEIN eeeee2 /GENEIN pathway
CPR:4	Western blot analysis indicated that  bbbbb1 CHEMICALIN eeeee1  inhibits the GENEIN/GENEIN/ bbbbb2 GENEIN eeeee2  pathway
CPR:3	Administration of low, but not high, doses of oral  bbbbb1 CHEMICALIN eeeee1  in DSS-treated mice resulted in a significant decrease in disease severity, histologic damage scores, as well as colonic level of  bbbbb2 GENEIN eeeee2 
CPR:1	GENENOTIN is expressed in differentiating osteoclast-like cells and the GENENOTIN mutation selectively impairs the GENENOTIN-GENENOTIN interaction in co-immunoprecipitations, which molecular modelling indicates results from effects on critical  bbbbb1 CHEMICALIN eeeee1  bonds required to stabilise the  bbbbb2 GENEIN eeeee2 -GENEIN complex
CPR:1	GENENOTIN is expressed in differentiating osteoclast-like cells and the GENENOTIN mutation selectively impairs the GENENOTIN-GENENOTIN interaction in co-immunoprecipitations, which molecular modelling indicates results from effects on critical  bbbbb1 CHEMICALIN eeeee1  bonds required to stabilise the GENEIN- bbbbb2 GENEIN eeeee2  complex
CPR:2	 bbbbb1 GENEIN eeeee1  (a  bbbbb2 CHEMICALIN eeeee2 -sensing neuropeptide in the hypothalamus) and GENENOTIN (GENENOTIN; a member of the GENENOTIN family) play roles in many physiologic functions, including regulation of CHEMICALNOTIN metabolism
CPR:4	The MCAO-induced decrease in GENEIN levels in the liver and skeletal muscle on day 1 was recovered to control levels by GENENOTIN, and this effect of  bbbbb1 GENEIN eeeee1  was reversed by the administration of  bbbbb2 CHEMICALIN eeeee2  as well as by hypothalamic GENENOTIN knockdown
CPR:4	The MCAO-induced decrease in  bbbbb1 GENEIN eeeee1  levels in the liver and skeletal muscle on day 1 was recovered to control levels by GENENOTIN, and this effect of GENEIN was reversed by the administration of  bbbbb2 CHEMICALIN eeeee2  as well as by hypothalamic GENENOTIN knockdown
CPR:6	Small interfering RNA directed GENENOTIN, GENENOTIN, and  bbbbb1 CHEMICALIN eeeee1  [CHEMICALIN; a specific  bbbbb2 GENEIN eeeee2  antagonist] were administered directly into the hypothalamus
CPR:6	Small interfering RNA directed GENENOTIN, GENENOTIN, and CHEMICALIN [ bbbbb1 CHEMICALIN eeeee1 ; a specific  bbbbb2 GENEIN eeeee2  antagonist] were administered directly into the hypothalamus
CPR:2	Filtering and analysis of data identified three oncogenic pathways interfered by  bbbbb1 CHEMICALIN eeeee1 : GENEIN/GENEIN pathway, cell adhesion and  bbbbb2 GENEIN eeeee2 /GENEIN signaling
CPR:2	Filtering and analysis of data identified three oncogenic pathways interfered by  bbbbb1 CHEMICALIN eeeee1 : GENEIN/GENEIN pathway, cell adhesion and GENEIN/ bbbbb2 GENEIN eeeee2  signaling
CPR:2	Filtering and analysis of data identified three oncogenic pathways interfered by  bbbbb1 CHEMICALIN eeeee1 :  bbbbb2 GENEIN eeeee2 /GENEIN pathway, cell adhesion and GENEIN/GENEIN signaling
CPR:2	Filtering and analysis of data identified three oncogenic pathways interfered by  bbbbb1 CHEMICALIN eeeee1 : GENEIN/ bbbbb2 GENEIN eeeee2  pathway, cell adhesion and GENEIN/GENEIN signaling
CPR:2	 bbbbb1 GENEIN eeeee1  emerged as a consensus target of  bbbbb2 CHEMICALIN eeeee2 , orchestrating these pathways
CPR:2	Our data demonstrates novel pharmacological mechanism of  bbbbb1 CHEMICALIN eeeee1  in modulation of cell adhesion and role of  bbbbb2 GENEIN eeeee2  in APC(min) polyposis
CPR:3	Moreover,  bbbbb1 CHEMICALIN eeeee1  treatment restored membranous expression of adhesion molecules  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:3	Moreover,  bbbbb1 CHEMICALIN eeeee1  treatment restored membranous expression of adhesion molecules GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:4	 bbbbb1 GENEIN eeeee1  expression was elevated in APC(min) polyps and  bbbbb2 CHEMICALIN eeeee2  treatment reduced its expression
CPR:4	We propose that inhibition of  bbbbb1 GENEIN eeeee1  expression by  bbbbb2 CHEMICALIN eeeee2  can impede with neoplastic progression in colorectal carcinogenesis
CPR:4	 bbbbb1 CHEMICALIN eeeee1  modulates intercellular adhesion through inhibition of  bbbbb2 GENEIN eeeee2 
CPR:4	The mechanism of  bbbbb1 GENEIN eeeee1  inhibition and induction of membranous translocation of adhesion proteins by  bbbbb2 CHEMICALIN eeeee2  might be independent of its known anti-inflammatory action.
CPR:3	This study shows ability of  bbbbb1 CHEMICALIN eeeee1  to raise plasma CHEMICALNOTIN concentrations, mainly through  bbbbb2 GENEIN eeeee2  upregulation, and to decrease bile production through reduction in GENENOTIN-mediated CHEMICALNOTIN-independent bile flow
CPR:4	In contrast,  bbbbb1 CHEMICALIN eeeee1  markedly downregulated major  bbbbb2 GENEIN eeeee2  (GENEIN and GENEIN) and regulatory molecules (GENEIN and GENEIN) in the ileum
CPR:4	In contrast,  bbbbb1 CHEMICALIN eeeee1  markedly downregulated major GENEIN ( bbbbb2 GENEIN eeeee2  and GENEIN) and regulatory molecules (GENEIN and GENEIN) in the ileum
CPR:4	In contrast,  bbbbb1 CHEMICALIN eeeee1  markedly downregulated major GENEIN (GENEIN and  bbbbb2 GENEIN eeeee2 ) and regulatory molecules (GENEIN and GENEIN) in the ileum
CPR:4	In contrast,  bbbbb1 CHEMICALIN eeeee1  markedly downregulated major GENEIN (GENEIN and GENEIN) and regulatory molecules ( bbbbb2 GENEIN eeeee2  and GENEIN) in the ileum
CPR:4	In contrast,  bbbbb1 CHEMICALIN eeeee1  markedly downregulated major GENEIN (GENEIN and GENEIN) and regulatory molecules (GENEIN and  bbbbb2 GENEIN eeeee2 ) in the ileum
CPR:1	The GENEIN of type 6 ( bbbbb1 GENEIN eeeee1 ) are quite different from all other GENENOTIN, as they include a short third cytoplasmatic loop and a long  bbbbb2 CHEMICALIN eeeee2 -terminal tail, and one intron located in the middle of the third cytoplasmatic loop
CPR:1	The  bbbbb1 GENEIN eeeee1  of type 6 (GENEIN) are quite different from all other GENENOTIN, as they include a short third cytoplasmatic loop and a long  bbbbb2 CHEMICALIN eeeee2 -terminal tail, and one intron located in the middle of the third cytoplasmatic loop
CPR:2	These results reveal, for the first time, the differential distribution of GENENOTIN in fast- and slow-twitch muscles, which might support the crucial role of  bbbbb1 CHEMICALIN eeeee1 -dependent signaling in controlling the synapse-specific expression of  bbbbb2 GENEIN eeeee2  in fast-twitch muscles.
CPR:2	 bbbbb1 GENEIN eeeee1  is expressed at the neuromuscular junction (NMJ) in fast-twitch muscle, and this expression depends on trophic factors supplied by motor neurons signaling via a  bbbbb2 CHEMICALIN eeeee2 -dependent pathway in muscle
CPR:4	Data at transcriptional level also demonstrated that  bbbbb1 CHEMICALIN eeeee1  potently attenuated gene expressions involved in inflammation, such as  bbbbb2 GENEIN eeeee2 , GENEIN and GENEIN
CPR:4	Data at transcriptional level also demonstrated that  bbbbb1 CHEMICALIN eeeee1  potently attenuated gene expressions involved in inflammation, such as GENEIN,  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:4	Data at transcriptional level also demonstrated that  bbbbb1 CHEMICALIN eeeee1  potently attenuated gene expressions involved in inflammation, such as GENEIN, GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:4	In addition, our exploration further revealed that the suppressive action of  bbbbb1 CHEMICALIN eeeee1  on inflammation was mediated via inhibiting GENEIN ( bbbbb2 GENEIN eeeee2 ) activation
CPR:4	In addition, our exploration further revealed that the suppressive action of  bbbbb1 CHEMICALIN eeeee1  on inflammation was mediated via inhibiting  bbbbb2 GENEIN eeeee2  (GENEIN) activation
CPR:4	 bbbbb1 CHEMICALIN eeeee1  inhibits LPS plus  bbbbb2 GENEIN eeeee2 -induced inflammatory response in astrocytes primary cultures
CPR:4	Collectively, these results suggest that  bbbbb1 CHEMICALIN eeeee1  can exert inhibitory effects on the inflammatory reaction in astrocytes and that inactivation of  bbbbb2 GENEIN eeeee2  could be the major determinant for its anti-inflammatory mechanism
CPR:4	Biochemical analyses showed that CHEMICALNOTIN and ROS production and  bbbbb1 GENEIN eeeee1  activity were significantly reduced by  bbbbb2 CHEMICALIN eeeee2 
CPR:4	 bbbbb1 GENEIN eeeee1  inhibitory effect by CHEMICALIN-type CHEMICALIN from hydrolyzate of total Gynostemma pentaphyllum  bbbbb2 CHEMICALIN eeeee2 
CPR:4	 bbbbb1 GENEIN eeeee1  inhibitory effect by  bbbbb2 CHEMICALIN eeeee2 -type CHEMICALIN from hydrolyzate of total Gynostemma pentaphyllum CHEMICALIN
CPR:4	 bbbbb1 GENEIN eeeee1  inhibitory effect by CHEMICALIN-type  bbbbb2 CHEMICALIN eeeee2  from hydrolyzate of total Gynostemma pentaphyllum CHEMICALIN
CPR:10	Neurodegeneration was related with decreased CHEMICALNOTIN uptake and decreased GENEIN immunoreactivity, however  bbbbb1 GENEIN eeeee1  (CHEMICALIN9) was not altered in  bbbbb2 CHEMICALIN eeeee2  injected rat
CPR:1	Neurodegeneration was related with decreased CHEMICALNOTIN uptake and decreased GENEIN immunoreactivity, however  bbbbb1 GENEIN eeeee1  ( bbbbb2 CHEMICALIN eeeee2 9) was not altered in CHEMICALIN injected rat
CPR:3	Therefore, the present results show that the earlier cerebellar responses to  bbbbb1 CHEMICALIN eeeee1  include disruption of cytoskeletal homeostasis that could be related with  bbbbb2 GENEIN eeeee2  and GENEIN activation and reactive astrogliosis
CPR:3	Therefore, the present results show that the earlier cerebellar responses to  bbbbb1 CHEMICALIN eeeee1  include disruption of cytoskeletal homeostasis that could be related with GENEIN and  bbbbb2 GENEIN eeeee2  activation and reactive astrogliosis
CPR:3	Also, reactive astrogliosis takes part of the early responses to the insult with  bbbbb1 CHEMICALIN eeeee1 , evidenced by upregulated  bbbbb2 GENEIN eeeee2  in Western blot, PCR and immunofluorescence analysis
CPR:4	Six days after CHEMICALNOTIN injection we found persistent astrogliosis, increased CHEMICALNOTIN (PI) positive cells in GENENOTIN positive population evidenced by flow cytometry and reduced immunofluorescence for  bbbbb1 GENEIN eeeee1 , suggesting that the in vivo exposure to  bbbbb2 CHEMICALIN eeeee2  progressed to neuronal death
CPR:4	Neurodegeneration was related with decreased CHEMICALNOTIN uptake and decreased  bbbbb1 GENEIN eeeee1  immunoreactivity, however GENEIN (CHEMICALIN9) was not altered in  bbbbb2 CHEMICALIN eeeee2  injected rat
CPR:9	Fluorescence of the reporter dye is turned on by rapid removal of the CHEMICALNOTIN quencher, an event that immediately occurs only after highly selective, two-electron reduction of the sterically and conformationally restricted  bbbbb1 CHEMICALIN eeeee1  substrate by the cancer-associated  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:9	Fluorescence of the reporter dye is turned on by rapid removal of the CHEMICALNOTIN quencher, an event that immediately occurs only after highly selective, two-electron reduction of the sterically and conformationally restricted  bbbbb1 CHEMICALIN eeeee1  substrate by the cancer-associated GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:4	Synthesis, biological evaluation, and molecular modeling of  bbbbb1 CHEMICALIN eeeee1  derivatives as potent  bbbbb2 GENEIN eeeee2  inhibitors with anti-heart-failure activity in vivo
CPR:6	Within the  bbbbb1 CHEMICALIN eeeee1  scaffold, either electronic or steric perturbations to the central CHEMICALIN ring led to a loss of selective M(1) allosteric agonism and afforded pan- bbbbb2 GENEIN eeeee2  antagonism, which was demonstrated to be mediated via the orthosteric site
CPR:6	Within the CHEMICALIN scaffold, either electronic or steric perturbations to the central  bbbbb1 CHEMICALIN eeeee1  ring led to a loss of selective M(1) allosteric agonism and afforded pan- bbbbb2 GENEIN eeeee2  antagonism, which was demonstrated to be mediated via the orthosteric site
CPR:6	Additional SAR around a related M(1) allosteric agonist family ( bbbbb1 CHEMICALIN eeeee1 ) identified similar, subtle 'molecular switches' that modulated modes of pharmacology from allosteric agonism to pan- bbbbb2 GENEIN eeeee2  orthosteric antagonism
CPR:9	ffects of single or repeated silymarin administration on pharmacokinetics of CHEMICALNOTIN and its major metabolite, CHEMICALNOTIN in rats. 1.The interactions between herbal dietary supplements and therapeutic drugs have emerged as an important issue and GENENOTIN (GENENOTIN) has been reported as one of the significant factors of these interactions. 2.The objective of this article is to examine the effects of single and repeated administrations of silymarin on pharmacokinetics of a  bbbbb1 GENEIN eeeee1  substrate,  bbbbb2 CHEMICALIN eeeee2 , and its major metabolite, CHEMICALIN, in rats. 3.To determine the plasma levels of CHEMICALNOTIN and CHEMICALNOTIN in rats, a HPLC method was developed using a liquid-liquid acid back extraction
CPR:9	ffects of single or repeated silymarin administration on pharmacokinetics of CHEMICALNOTIN and its major metabolite, CHEMICALNOTIN in rats. 1.The interactions between herbal dietary supplements and therapeutic drugs have emerged as an important issue and GENENOTIN (GENENOTIN) has been reported as one of the significant factors of these interactions. 2.The objective of this article is to examine the effects of single and repeated administrations of silymarin on pharmacokinetics of a  bbbbb1 GENEIN eeeee1  substrate, CHEMICALIN, and its major metabolite,  bbbbb2 CHEMICALIN eeeee2 , in rats. 3.To determine the plasma levels of CHEMICALNOTIN and CHEMICALNOTIN in rats, a HPLC method was developed using a liquid-liquid acid back extraction
CPR:1	In this study, we present the synthesis and pharmacological properties of new analogues of  bbbbb1 GENEIN eeeee1  modified in the  bbbbb2 CHEMICALIN eeeee2 -terminal part of the molecule with CHEMICALNOTIN derivatives: CHEMICALNOTIN (CHEMICALNOTIN) and CHEMICALNOTIN
CPR:6	On the other hand, peptides modified with  bbbbb1 CHEMICALIN eeeee1 , apart from their moderate antioxytocic activity, turned out to be weak antagonists of the pressor response to  bbbbb2 GENEIN eeeee2 
CPR:3	 bbbbb1 GENEIN eeeee1  and GENEIN are nuclear receptors activated by  bbbbb2 CHEMICALIN eeeee2 , oxidized derivatives of CHEMICALNOTIN
CPR:3	GENEIN and  bbbbb1 GENEIN eeeee1  are nuclear receptors activated by  bbbbb2 CHEMICALIN eeeee2 , oxidized derivatives of CHEMICALNOTIN
CPR:2	For example, involvement of  bbbbb1 GENEIN eeeee1  in LH induction by  bbbbb2 CHEMICALIN eeeee2  has been discovered
CPR:3	GENENOTIN regulates  bbbbb1 CHEMICALIN eeeee1 -induced  bbbbb2 GENEIN eeeee2  gene expression
CPR:3	Furthermore, knockdown of GENENOTIN significantly attenuated  bbbbb1 CHEMICALIN eeeee1 -induced  bbbbb2 GENEIN eeeee2  expression
CPR:3	Thus, our findings indicate that the expression of GENENOTIN depends on GENENOTIN activity and contributes to  bbbbb1 GENEIN eeeee1  induction by  bbbbb2 CHEMICALIN eeeee2 .
CPR:3	 bbbbb1 CHEMICALIN eeeee1  caused a sustained increase in nuclear  bbbbb2 GENEIN eeeee2  levels, which was significantly reduced by GENENOTIN (GENENOTIN) inhibition
CPR:3	Small interfering RNA-mediated knockdown of GENENOTIN mRNA demonstrated that induction of  bbbbb1 GENEIN eeeee1  mRNA by  bbbbb2 CHEMICALIN eeeee2  depended on GENENOTIN and that regulation of GENENOTIN by GENENOTIN occurred independently of the GENENOTIN-GENENOTIN pathway
CPR:2	In conclusion, in this cellular model,  bbbbb1 CHEMICALIN eeeee1  effectively protects against PQ toxicity by inducing GENEIN and through the interaction with the  bbbbb2 GENEIN eeeee2 , suggesting that compounds presenting this double feature of promoting the efflux and limiting the uptake of PQ could be used as effective antidotes to treat intoxications.
CPR:3	In conclusion, in this cellular model,  bbbbb1 CHEMICALIN eeeee1  effectively protects against PQ toxicity by inducing  bbbbb2 GENEIN eeeee2  and through the interaction with the GENEIN, suggesting that compounds presenting this double feature of promoting the efflux and limiting the uptake of PQ could be used as effective antidotes to treat intoxications.
CPR:3	The aim of the present work was to evaluate the effectiveness of such an antidote by testing whether  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a known  bbbbb2 GENEIN eeeee2  inducer, could efficiently protect Caco-2 cells against PQ cytotoxicity, 6 h after the incubation with the herbicide, reflecting a real-life intoxication scenario
CPR:3	The aim of the present work was to evaluate the effectiveness of such an antidote by testing whether CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a known  bbbbb2 GENEIN eeeee2  inducer, could efficiently protect Caco-2 cells against PQ cytotoxicity, 6 h after the incubation with the herbicide, reflecting a real-life intoxication scenario
CPR:9	The herbicide  bbbbb1 CHEMICALIN eeeee1  (PQ) is a  bbbbb2 GENEIN eeeee2  substrate responsible for thousands of fatal intoxications worldwide that still lacks an effective antidote
CPR:4	 bbbbb1 CHEMICALIN eeeee1  successfully inhibited GENEIN-mediated  bbbbb2 GENEIN eeeee2  signaling and decreased cell viability in NHL and CLL
CPR:4	The selective  bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) inhibits B cell signaling and function in vitro and in vivo and augments the activity of CHEMICALNOTIN in chronic lymphocytic leukemia
CPR:4	The selective  bbbbb1 GENEIN eeeee1  inhibitor CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) inhibits B cell signaling and function in vitro and in vivo and augments the activity of CHEMICALNOTIN in chronic lymphocytic leukemia
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (also known as CHEMICALIN) is a novel, highly selective, and orally bioavailable small molecule  bbbbb2 GENEIN eeeee2  inhibitor (GENEIN IC(50) = 1 nM) with anti-GENEIN activity that is at least 80-fold greater than its affinity for other GENENOTIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (also known as CHEMICALIN) is a novel, highly selective, and orally bioavailable small molecule GENEIN inhibitor ( bbbbb2 GENEIN eeeee2  IC(50) = 1 nM) with anti-GENEIN activity that is at least 80-fold greater than its affinity for other GENENOTIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (also known as CHEMICALIN) is a novel, highly selective, and orally bioavailable small molecule GENEIN inhibitor (GENEIN IC(50) = 1 nM) with anti- bbbbb2 GENEIN eeeee2  activity that is at least 80-fold greater than its affinity for other GENENOTIN
CPR:4	CHEMICALIN (also known as  bbbbb1 CHEMICALIN eeeee1 ) is a novel, highly selective, and orally bioavailable small molecule  bbbbb2 GENEIN eeeee2  inhibitor (GENEIN IC(50) = 1 nM) with anti-GENEIN activity that is at least 80-fold greater than its affinity for other GENENOTIN
CPR:4	CHEMICALIN (also known as  bbbbb1 CHEMICALIN eeeee1 ) is a novel, highly selective, and orally bioavailable small molecule GENEIN inhibitor ( bbbbb2 GENEIN eeeee2  IC(50) = 1 nM) with anti-GENEIN activity that is at least 80-fold greater than its affinity for other GENENOTIN
CPR:4	CHEMICALIN (also known as  bbbbb1 CHEMICALIN eeeee1 ) is a novel, highly selective, and orally bioavailable small molecule GENEIN inhibitor (GENEIN IC(50) = 1 nM) with anti- bbbbb2 GENEIN eeeee2  activity that is at least 80-fold greater than its affinity for other GENENOTIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  successfully inhibited  bbbbb2 GENEIN eeeee2 -mediated GENEIN signaling and decreased cell viability in NHL and CLL
CPR:2	Alleles of  bbbbb1 GENEIN eeeee1  (GENEIN) with elevated slippage rates were identified among  bbbbb2 CHEMICALIN eeeee2 -sensitive mutants and were also isolated using a slippage-dependent reporter gene
CPR:2	Alleles of GENEIN ( bbbbb1 GENEIN eeeee1 ) with elevated slippage rates were identified among  bbbbb2 CHEMICALIN eeeee2 -sensitive mutants and were also isolated using a slippage-dependent reporter gene
CPR:2	We demonstrated that  bbbbb1 GENEIN eeeee1  protein not only functions as a downstream target of  bbbbb2 CHEMICALIN eeeee2 , but also enhances anticancer activity of CHEMICALNOTIN in lung AD cells.
CPR:2	 bbbbb1 GENEIN eeeee1  is a target of  bbbbb2 CHEMICALIN eeeee2  and enhances its anticancer activity in lung adenocarcinoma cells
CPR:4	Although treatment with  bbbbb1 CHEMICALIN eeeee1  reduced  bbbbb2 GENEIN eeeee2  levels and GENEIN-regulated gene expression in lung AD cells, GENENOTIN expression increased anticancer activity of CHEMICALNOTIN
CPR:4	Although treatment with  bbbbb1 CHEMICALIN eeeee1  reduced GENEIN levels and  bbbbb2 GENEIN eeeee2 -regulated gene expression in lung AD cells, GENENOTIN expression increased anticancer activity of CHEMICALNOTIN
CPR:4	In addition,  bbbbb1 CHEMICALIN eeeee1  treatment reduced cell viability,  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN, GENEIN, and GENEIN levels in GENENOTIN-expressing lung AD cells
CPR:4	In addition,  bbbbb1 CHEMICALIN eeeee1  treatment reduced cell viability, GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN, and GENEIN levels in GENENOTIN-expressing lung AD cells
CPR:4	In addition,  bbbbb1 CHEMICALIN eeeee1  treatment reduced cell viability, GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN levels in GENENOTIN-expressing lung AD cells
CPR:4	In addition,  bbbbb1 CHEMICALIN eeeee1  treatment reduced cell viability, GENEIN, GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN levels in GENENOTIN-expressing lung AD cells
CPR:4	In addition,  bbbbb1 CHEMICALIN eeeee1  treatment reduced cell viability, GENEIN, GENEIN, GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2  levels in GENENOTIN-expressing lung AD cells
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), an  bbbbb2 GENEIN eeeee2  inhibitor, is currently under evaluation for its anticancer activity in clinical trials
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), an  bbbbb2 GENEIN eeeee2  inhibitor, is currently under evaluation for its anticancer activity in clinical trials
CPR:10	 bbbbb1 GENEIN eeeee1  did not significantly contribute to  bbbbb2 CHEMICALIN eeeee2  monophosphorylation
CPR:10	In conclusion, the  bbbbb1 GENEIN eeeee1  substitution does not significantly modulate GENEIN activity toward CHEMICALIN, and therefore would not contribute to interindividual variability in response to  bbbbb2 CHEMICALIN eeeee2 
CPR:10	In conclusion, the GENEIN substitution does not significantly modulate  bbbbb1 GENEIN eeeee1  activity toward CHEMICALIN, and therefore would not contribute to interindividual variability in response to  bbbbb2 CHEMICALIN eeeee2 
CPR:9	Wild-type enzymes and variants of  bbbbb1 GENEIN eeeee1  (GENEIN and GENEIN) and GENEIN (GENEIN, GENEIN, and GENEIN) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), CHEMICALIN, and its metabolite CHEMICALIN (CHEMICALIN) as substrates
CPR:9	Wild-type enzymes and variants of GENEIN ( bbbbb1 GENEIN eeeee1  and GENEIN) and GENEIN (GENEIN, GENEIN, and GENEIN) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), CHEMICALIN, and its metabolite CHEMICALIN (CHEMICALIN) as substrates
CPR:9	Wild-type enzymes and variants of GENEIN (GENEIN and  bbbbb1 GENEIN eeeee1 ) and GENEIN (GENEIN, GENEIN, and GENEIN) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), CHEMICALIN, and its metabolite CHEMICALIN (CHEMICALIN) as substrates
CPR:9	Wild-type enzymes and variants of GENEIN (GENEIN and GENEIN) and  bbbbb1 GENEIN eeeee1  (GENEIN, GENEIN, and GENEIN) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), CHEMICALIN, and its metabolite CHEMICALIN (CHEMICALIN) as substrates
CPR:9	Wild-type enzymes and variants of GENEIN (GENEIN and GENEIN) and GENEIN ( bbbbb1 GENEIN eeeee1 , GENEIN, and GENEIN) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), CHEMICALIN, and its metabolite CHEMICALIN (CHEMICALIN) as substrates
CPR:9	Wild-type enzymes and variants of GENEIN (GENEIN and GENEIN) and GENEIN (GENEIN,  bbbbb1 GENEIN eeeee1 , and GENEIN) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), CHEMICALIN, and its metabolite CHEMICALIN (CHEMICALIN) as substrates
CPR:9	Wild-type enzymes and variants of GENEIN (GENEIN and GENEIN) and GENEIN (GENEIN, GENEIN, and  bbbbb1 GENEIN eeeee1 ) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), CHEMICALIN, and its metabolite CHEMICALIN (CHEMICALIN) as substrates
CPR:9	Wild-type enzymes and variants of  bbbbb1 GENEIN eeeee1  (GENEIN and GENEIN) and GENEIN (GENEIN, GENEIN, and GENEIN) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for CHEMICALIN (CHEMICALIN),  bbbbb2 CHEMICALIN eeeee2 , and its metabolite CHEMICALIN (CHEMICALIN) as substrates
CPR:9	Wild-type enzymes and variants of GENEIN ( bbbbb1 GENEIN eeeee1  and GENEIN) and GENEIN (GENEIN, GENEIN, and GENEIN) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for CHEMICALIN (CHEMICALIN),  bbbbb2 CHEMICALIN eeeee2 , and its metabolite CHEMICALIN (CHEMICALIN) as substrates
CPR:9	Wild-type enzymes and variants of GENEIN (GENEIN and  bbbbb1 GENEIN eeeee1 ) and GENEIN (GENEIN, GENEIN, and GENEIN) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for CHEMICALIN (CHEMICALIN),  bbbbb2 CHEMICALIN eeeee2 , and its metabolite CHEMICALIN (CHEMICALIN) as substrates
CPR:9	Wild-type enzymes and variants of GENEIN (GENEIN and GENEIN) and  bbbbb1 GENEIN eeeee1  (GENEIN, GENEIN, and GENEIN) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for CHEMICALIN (CHEMICALIN),  bbbbb2 CHEMICALIN eeeee2 , and its metabolite CHEMICALIN (CHEMICALIN) as substrates
CPR:9	Wild-type enzymes and variants of GENEIN (GENEIN and GENEIN) and GENEIN ( bbbbb1 GENEIN eeeee1 , GENEIN, and GENEIN) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for CHEMICALIN (CHEMICALIN),  bbbbb2 CHEMICALIN eeeee2 , and its metabolite CHEMICALIN (CHEMICALIN) as substrates
CPR:9	Wild-type enzymes and variants of GENEIN (GENEIN and GENEIN) and GENEIN (GENEIN,  bbbbb1 GENEIN eeeee1 , and GENEIN) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for CHEMICALIN (CHEMICALIN),  bbbbb2 CHEMICALIN eeeee2 , and its metabolite CHEMICALIN (CHEMICALIN) as substrates
CPR:9	Wild-type enzymes and variants of GENEIN (GENEIN and GENEIN) and GENEIN (GENEIN, GENEIN, and  bbbbb1 GENEIN eeeee1 ) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for CHEMICALIN (CHEMICALIN),  bbbbb2 CHEMICALIN eeeee2 , and its metabolite CHEMICALIN (CHEMICALIN) as substrates
CPR:9	Wild-type enzymes and variants of  bbbbb1 GENEIN eeeee1  (GENEIN and GENEIN) and GENEIN (GENEIN, GENEIN, and GENEIN) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for CHEMICALIN (CHEMICALIN), CHEMICALIN, and its metabolite  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) as substrates
CPR:9	Wild-type enzymes and variants of GENEIN ( bbbbb1 GENEIN eeeee1  and GENEIN) and GENEIN (GENEIN, GENEIN, and GENEIN) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for CHEMICALIN (CHEMICALIN), CHEMICALIN, and its metabolite  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) as substrates
CPR:9	Wild-type enzymes and variants of GENEIN (GENEIN and  bbbbb1 GENEIN eeeee1 ) and GENEIN (GENEIN, GENEIN, and GENEIN) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for CHEMICALIN (CHEMICALIN), CHEMICALIN, and its metabolite  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) as substrates
CPR:9	Wild-type enzymes and variants of GENEIN (GENEIN and GENEIN) and  bbbbb1 GENEIN eeeee1  (GENEIN, GENEIN, and GENEIN) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for CHEMICALIN (CHEMICALIN), CHEMICALIN, and its metabolite  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) as substrates
CPR:9	Wild-type enzymes and variants of GENEIN (GENEIN and GENEIN) and GENEIN ( bbbbb1 GENEIN eeeee1 , GENEIN, and GENEIN) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for CHEMICALIN (CHEMICALIN), CHEMICALIN, and its metabolite  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) as substrates
CPR:9	Wild-type enzymes and variants of GENEIN (GENEIN and GENEIN) and GENEIN (GENEIN,  bbbbb1 GENEIN eeeee1 , and GENEIN) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for CHEMICALIN (CHEMICALIN), CHEMICALIN, and its metabolite  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) as substrates
CPR:9	Wild-type enzymes and variants of GENEIN (GENEIN and GENEIN) and GENEIN (GENEIN, GENEIN, and  bbbbb1 GENEIN eeeee1 ) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for CHEMICALIN (CHEMICALIN), CHEMICALIN, and its metabolite  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) as substrates
CPR:9	Wild-type enzymes and variants of  bbbbb1 GENEIN eeeee1  (GENEIN and GENEIN) and GENEIN (GENEIN, GENEIN, and GENEIN) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for CHEMICALIN (CHEMICALIN), CHEMICALIN, and its metabolite CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) as substrates
CPR:9	All three  bbbbb1 GENEIN eeeee1  proteins showed similar K(m) and V(max) for  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN deamination, except for GENEIN70Thr, which had a 2.5-fold lower K(m) and 6-fold lower V(max) for CHEMICALIN deamination
CPR:9	All three  bbbbb1 GENEIN eeeee1  proteins showed similar K(m) and V(max) for CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  deamination, except for GENEIN70Thr, which had a 2.5-fold lower K(m) and 6-fold lower V(max) for CHEMICALIN deamination
CPR:9	All three GENEIN proteins showed similar K(m) and V(max) for CHEMICALIN and CHEMICALIN deamination, except for  bbbbb1 GENEIN eeeee1 70Thr, which had a 2.5-fold lower K(m) and 6-fold lower V(max) for  bbbbb2 CHEMICALIN eeeee2  deamination
CPR:9	All four  bbbbb1 GENEIN eeeee1  proteins yielded comparable metabolic activity for  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN monophosphorylation, except for GENEIN24Val, which demonstrated an approximately 2-fold increase (P < 0.05) in the intrinsic clearance of CHEMICALIN monophosphorylation due to a 40% decrease in K(m) (P < 0.05)
CPR:9	All four  bbbbb1 GENEIN eeeee1  proteins yielded comparable metabolic activity for CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  monophosphorylation, except for GENEIN24Val, which demonstrated an approximately 2-fold increase (P < 0.05) in the intrinsic clearance of CHEMICALIN monophosphorylation due to a 40% decrease in K(m) (P < 0.05)
CPR:9	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN) is metabolized by GENEIN (GENEIN) and GENEIN ( bbbbb2 GENEIN eeeee2 ), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear
CPR:9	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN) is metabolized by  bbbbb2 GENEIN eeeee2  (GENEIN) and GENEIN (GENEIN), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear
CPR:9	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN) is metabolized by GENEIN ( bbbbb2 GENEIN eeeee2 ) and GENEIN (GENEIN), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear
CPR:9	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN) is metabolized by GENEIN (GENEIN) and  bbbbb2 GENEIN eeeee2  (GENEIN), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear
CPR:9	All four GENEIN proteins yielded comparable metabolic activity for CHEMICALIN and CHEMICALIN monophosphorylation, except for  bbbbb1 GENEIN eeeee1 24Val, which demonstrated an approximately 2-fold increase (P < 0.05) in the intrinsic clearance of  bbbbb2 CHEMICALIN eeeee2  monophosphorylation due to a 40% decrease in K(m) (P < 0.05)
CPR:9	In conclusion, the  bbbbb1 GENEIN eeeee1  substitution does not significantly modulate GENEIN activity toward  bbbbb2 CHEMICALIN eeeee2 , and therefore would not contribute to interindividual variability in response to CHEMICALIN
CPR:9	In conclusion, the GENEIN substitution does not significantly modulate  bbbbb1 GENEIN eeeee1  activity toward  bbbbb2 CHEMICALIN eeeee2 , and therefore would not contribute to interindividual variability in response to CHEMICALIN
CPR:9	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN) is metabolized by GENEIN (GENEIN) and GENEIN ( bbbbb2 GENEIN eeeee2 ), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear
CPR:9	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN) is metabolized by  bbbbb2 GENEIN eeeee2  (GENEIN) and GENEIN (GENEIN), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear
CPR:9	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN) is metabolized by GENEIN ( bbbbb2 GENEIN eeeee2 ) and GENEIN (GENEIN), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear
CPR:9	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN) is metabolized by GENEIN (GENEIN) and  bbbbb2 GENEIN eeeee2  (GENEIN), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear
CPR:9	The higher in vitro catalytic efficiency of  bbbbb1 GENEIN eeeee1 24Val toward  bbbbb2 CHEMICALIN eeeee2  monophosphorylation may be relevant to CHEMICALIN clinical response
CPR:9	The higher in vitro catalytic efficiency of  bbbbb1 GENEIN eeeee1 24Val toward CHEMICALIN monophosphorylation may be relevant to  bbbbb2 CHEMICALIN eeeee2  clinical response
CPR:9	CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ) is metabolized by GENEIN (GENEIN) and GENEIN ( bbbbb2 GENEIN eeeee2 ), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear
CPR:9	CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ) is metabolized by  bbbbb2 GENEIN eeeee2  (GENEIN) and GENEIN (GENEIN), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear
CPR:9	CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ) is metabolized by GENEIN ( bbbbb2 GENEIN eeeee2 ) and GENEIN (GENEIN), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear
CPR:9	CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ) is metabolized by GENEIN (GENEIN) and  bbbbb2 GENEIN eeeee2  (GENEIN), but the contribution of genetic variation in these enzymes to the variability in systemic exposure and response observed in cancer patients is unclear
CPR:9	Wild-type enzymes and variants of  bbbbb1 GENEIN eeeee1  (GENEIN and GENEIN) and GENEIN (GENEIN, GENEIN, and GENEIN) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), CHEMICALIN, and its metabolite CHEMICALIN (CHEMICALIN) as substrates
CPR:9	Wild-type enzymes and variants of GENEIN ( bbbbb1 GENEIN eeeee1  and GENEIN) and GENEIN (GENEIN, GENEIN, and GENEIN) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), CHEMICALIN, and its metabolite CHEMICALIN (CHEMICALIN) as substrates
CPR:9	Wild-type enzymes and variants of GENEIN (GENEIN and  bbbbb1 GENEIN eeeee1 ) and GENEIN (GENEIN, GENEIN, and GENEIN) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), CHEMICALIN, and its metabolite CHEMICALIN (CHEMICALIN) as substrates
CPR:9	Wild-type enzymes and variants of GENEIN (GENEIN and GENEIN) and  bbbbb1 GENEIN eeeee1  (GENEIN, GENEIN, and GENEIN) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), CHEMICALIN, and its metabolite CHEMICALIN (CHEMICALIN) as substrates
CPR:9	Wild-type enzymes and variants of GENEIN (GENEIN and GENEIN) and GENEIN ( bbbbb1 GENEIN eeeee1 , GENEIN, and GENEIN) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), CHEMICALIN, and its metabolite CHEMICALIN (CHEMICALIN) as substrates
CPR:9	Wild-type enzymes and variants of GENEIN (GENEIN and GENEIN) and GENEIN (GENEIN,  bbbbb1 GENEIN eeeee1 , and GENEIN) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), CHEMICALIN, and its metabolite CHEMICALIN (CHEMICALIN) as substrates
CPR:9	Wild-type enzymes and variants of GENEIN (GENEIN and GENEIN) and GENEIN (GENEIN, GENEIN, and  bbbbb1 GENEIN eeeee1 ) were expressed in and purified from Escherichia coli, and enzyme kinetic parameters were estimated for  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), CHEMICALIN, and its metabolite CHEMICALIN (CHEMICALIN) as substrates
CPR:4	A series of compounds based on a  bbbbb1 CHEMICALIN eeeee1  scaffold that are potent and selective inhibitors of  bbbbb2 GENEIN eeeee2  (GENEIN) activity are described
CPR:4	A series of compounds based on a  bbbbb1 CHEMICALIN eeeee1  scaffold that are potent and selective inhibitors of GENEIN ( bbbbb2 GENEIN eeeee2 ) activity are described
CPR:4	Discovery of  bbbbb1 CHEMICALIN eeeee1  based  bbbbb2 GENEIN eeeee2  inhibitors
CPR:4	Here we present  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN derivatives as a new class of potent and nontoxic  bbbbb2 GENEIN eeeee2  inhibitors
CPR:4	Here we present CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  derivatives as a new class of potent and nontoxic  bbbbb2 GENEIN eeeee2  inhibitors
CPR:4	 bbbbb1 CHEMICALIN eeeee1 -based inhibitors of  bbbbb2 GENEIN eeeee2 
CPR:10	 bbbbb1 CHEMICALIN eeeee1  had no effect on resting intracellular [CHEMICALNOTIN] or  bbbbb2 GENEIN eeeee2 -induced increase in CHEMICALNOTIN mobilization
CPR:1	CHEMICALIN also reduced the formation of stress fibers by GENEIN and suppressed GENEIN-induced phosphorylation of  bbbbb1 GENEIN eeeee1  (GENEIN) on  bbbbb2 CHEMICALIN eeeee2 (19)/CHEMICALIN(18) in endothelial cells (ECs)
CPR:1	CHEMICALIN also reduced the formation of stress fibers by GENEIN and suppressed GENEIN-induced phosphorylation of GENEIN ( bbbbb1 GENEIN eeeee1 ) on  bbbbb2 CHEMICALIN eeeee2 (19)/CHEMICALIN(18) in endothelial cells (ECs)
CPR:1	CHEMICALIN also reduced the formation of stress fibers by GENEIN and suppressed GENEIN-induced phosphorylation of  bbbbb1 GENEIN eeeee1  (GENEIN) on CHEMICALIN(19)/ bbbbb2 CHEMICALIN eeeee2 (18) in endothelial cells (ECs)
CPR:1	CHEMICALIN also reduced the formation of stress fibers by GENEIN and suppressed GENEIN-induced phosphorylation of GENEIN ( bbbbb1 GENEIN eeeee1 ) on CHEMICALIN(19)/ bbbbb2 CHEMICALIN eeeee2 (18) in endothelial cells (ECs)
CPR:2	Phytoestrogen  bbbbb1 CHEMICALIN eeeee1  protects against endothelial barrier dysfunction in vascular endothelial cells through GENEIN-mediated suppression of  bbbbb2 GENEIN eeeee2  signaling
CPR:2	These findings demonstrated that  bbbbb1 CHEMICALIN eeeee1  improves GENEIN-induced endothelial barrier dysfunction in ECs through GENEIN-mediated suppression of  bbbbb2 GENEIN eeeee2  signaling.
CPR:2	Phytoestrogen  bbbbb1 CHEMICALIN eeeee1  protects against endothelial barrier dysfunction in vascular endothelial cells through  bbbbb2 GENEIN eeeee2 -mediated suppression of GENEIN signaling
CPR:2	Inhibition of GENENOTIN significantly attenuated the effect of  bbbbb1 CHEMICALIN eeeee1  on  bbbbb2 GENEIN eeeee2 -induced EC permeability, GENEIN phosphorylation, and GENEIN membrane translocation in ECs
CPR:2	Inhibition of GENENOTIN significantly attenuated the effect of  bbbbb1 CHEMICALIN eeeee1  on GENEIN-induced EC permeability,  bbbbb2 GENEIN eeeee2  phosphorylation, and GENEIN membrane translocation in ECs
CPR:2	Inhibition of GENENOTIN significantly attenuated the effect of  bbbbb1 CHEMICALIN eeeee1  on GENEIN-induced EC permeability, GENEIN phosphorylation, and  bbbbb2 GENEIN eeeee2  membrane translocation in ECs
CPR:2	These findings demonstrated that  bbbbb1 CHEMICALIN eeeee1  improves  bbbbb2 GENEIN eeeee2 -induced endothelial barrier dysfunction in ECs through GENEIN-mediated suppression of GENEIN signaling.
CPR:2	These findings demonstrated that  bbbbb1 CHEMICALIN eeeee1  improves GENEIN-induced endothelial barrier dysfunction in ECs through  bbbbb2 GENEIN eeeee2 -mediated suppression of GENEIN signaling.
CPR:4	Furthermore,  bbbbb1 GENEIN eeeee1  diminished CHEMICALNOTIN production in ECs, which were prevented by treatment with  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Here, we report that  bbbbb1 CHEMICALIN eeeee1  at physiologically relevant concentrations (0.1-10 M) significantly inhibited  bbbbb2 GENEIN eeeee2 -induced increase in endothelial monolayer permeability
CPR:4	 bbbbb1 CHEMICALIN eeeee1  also reduced the formation of stress fibers by  bbbbb2 GENEIN eeeee2  and suppressed GENEIN-induced phosphorylation of GENEIN (GENEIN) on CHEMICALIN(19)/CHEMICALIN(18) in endothelial cells (ECs)
CPR:4	 bbbbb1 CHEMICALIN eeeee1  also reduced the formation of stress fibers by GENEIN and suppressed  bbbbb2 GENEIN eeeee2 -induced phosphorylation of GENEIN (GENEIN) on CHEMICALIN(19)/CHEMICALIN(18) in endothelial cells (ECs)
CPR:4	 bbbbb1 CHEMICALIN eeeee1  also reduced the formation of stress fibers by GENEIN and suppressed GENEIN-induced phosphorylation of  bbbbb2 GENEIN eeeee2  (GENEIN) on CHEMICALIN(19)/CHEMICALIN(18) in endothelial cells (ECs)
CPR:4	 bbbbb1 CHEMICALIN eeeee1  also reduced the formation of stress fibers by GENEIN and suppressed GENEIN-induced phosphorylation of GENEIN ( bbbbb2 GENEIN eeeee2 ) on CHEMICALIN(19)/CHEMICALIN(18) in endothelial cells (ECs)
CPR:10	In contrast,  bbbbb1 CHEMICALIN eeeee1  did not inhibit  bbbbb2 GENEIN eeeee2  based on the lack of changes in CHEMICALNOTIN acid exposure [mean AUC(0-inf) ratio (90% CI) of 1.05 (0.91, 1.21)]. 5.CHEMICALNOTIN has a weak drug interaction with CHEMICALNOTIN and CHEMICALNOTIN
CPR:4	valuation of drug interactions of CHEMICALIN (a GENEIN agonist) with statins: from in vitro data to clinical study design. 1.This work investigated the drug interaction potential of CHEMICALIN, a novel GENEIN agonist, with the GENEIN inhibitors CHEMICALIN and CHEMICALIN. 2.In vitro experiments assessed the inhibition of GENEIN and GENEIN enzymes by CHEMICALIN, and a clinical drug interaction study investigated the effect of CHEMICALNOTIN (300mg BID) on the pharmacokinetic profile of CHEMICALNOTIN (40mg single dose) and CHEMICALNOTIN (10mg single dose). 3.In vitro,  bbbbb1 CHEMICALIN eeeee1  demonstrated little/weak inhibition (IC50 values >30 M) towards  bbbbb2 GENEIN eeeee2  (GENEIN, GENEIN, GENEIN, GENEIN, GENEIN), GENEIN, GENEIN, or GENEIN
CPR:4	valuation of drug interactions of CHEMICALIN (a GENEIN agonist) with statins: from in vitro data to clinical study design. 1.This work investigated the drug interaction potential of CHEMICALIN, a novel GENEIN agonist, with the GENEIN inhibitors CHEMICALIN and CHEMICALIN. 2.In vitro experiments assessed the inhibition of GENEIN and GENEIN enzymes by CHEMICALIN, and a clinical drug interaction study investigated the effect of CHEMICALNOTIN (300mg BID) on the pharmacokinetic profile of CHEMICALNOTIN (40mg single dose) and CHEMICALNOTIN (10mg single dose). 3.In vitro,  bbbbb1 CHEMICALIN eeeee1  demonstrated little/weak inhibition (IC50 values >30 M) towards GENEIN ( bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN, GENEIN, GENEIN), GENEIN, GENEIN, or GENEIN
CPR:4	valuation of drug interactions of CHEMICALIN (a GENEIN agonist) with statins: from in vitro data to clinical study design. 1.This work investigated the drug interaction potential of CHEMICALIN, a novel GENEIN agonist, with the GENEIN inhibitors CHEMICALIN and CHEMICALIN. 2.In vitro experiments assessed the inhibition of GENEIN and GENEIN enzymes by CHEMICALIN, and a clinical drug interaction study investigated the effect of CHEMICALNOTIN (300mg BID) on the pharmacokinetic profile of CHEMICALNOTIN (40mg single dose) and CHEMICALNOTIN (10mg single dose). 3.In vitro,  bbbbb1 CHEMICALIN eeeee1  demonstrated little/weak inhibition (IC50 values >30 M) towards GENEIN (GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN, GENEIN), GENEIN, GENEIN, or GENEIN
CPR:4	valuation of drug interactions of CHEMICALIN (a GENEIN agonist) with statins: from in vitro data to clinical study design. 1.This work investigated the drug interaction potential of CHEMICALIN, a novel GENEIN agonist, with the GENEIN inhibitors CHEMICALIN and CHEMICALIN. 2.In vitro experiments assessed the inhibition of GENEIN and GENEIN enzymes by CHEMICALIN, and a clinical drug interaction study investigated the effect of CHEMICALNOTIN (300mg BID) on the pharmacokinetic profile of CHEMICALNOTIN (40mg single dose) and CHEMICALNOTIN (10mg single dose). 3.In vitro,  bbbbb1 CHEMICALIN eeeee1  demonstrated little/weak inhibition (IC50 values >30 M) towards GENEIN (GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN), GENEIN, GENEIN, or GENEIN
CPR:4	valuation of drug interactions of CHEMICALIN (a GENEIN agonist) with statins: from in vitro data to clinical study design. 1.This work investigated the drug interaction potential of CHEMICALIN, a novel GENEIN agonist, with the GENEIN inhibitors CHEMICALIN and CHEMICALIN. 2.In vitro experiments assessed the inhibition of GENEIN and GENEIN enzymes by CHEMICALIN, and a clinical drug interaction study investigated the effect of CHEMICALNOTIN (300mg BID) on the pharmacokinetic profile of CHEMICALNOTIN (40mg single dose) and CHEMICALNOTIN (10mg single dose). 3.In vitro,  bbbbb1 CHEMICALIN eeeee1  demonstrated little/weak inhibition (IC50 values >30 M) towards GENEIN (GENEIN, GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN), GENEIN, GENEIN, or GENEIN
CPR:4	valuation of drug interactions of CHEMICALIN (a GENEIN agonist) with statins: from in vitro data to clinical study design. 1.This work investigated the drug interaction potential of CHEMICALIN, a novel GENEIN agonist, with the GENEIN inhibitors CHEMICALIN and CHEMICALIN. 2.In vitro experiments assessed the inhibition of GENEIN and GENEIN enzymes by CHEMICALIN, and a clinical drug interaction study investigated the effect of CHEMICALNOTIN (300mg BID) on the pharmacokinetic profile of CHEMICALNOTIN (40mg single dose) and CHEMICALNOTIN (10mg single dose). 3.In vitro,  bbbbb1 CHEMICALIN eeeee1  demonstrated little/weak inhibition (IC50 values >30 M) towards GENEIN (GENEIN, GENEIN, GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 ), GENEIN, GENEIN, or GENEIN
CPR:4	valuation of drug interactions of CHEMICALIN (a GENEIN agonist) with statins: from in vitro data to clinical study design. 1.This work investigated the drug interaction potential of CHEMICALIN, a novel GENEIN agonist, with the GENEIN inhibitors CHEMICALIN and CHEMICALIN. 2.In vitro experiments assessed the inhibition of GENEIN and GENEIN enzymes by CHEMICALIN, and a clinical drug interaction study investigated the effect of CHEMICALNOTIN (300mg BID) on the pharmacokinetic profile of CHEMICALNOTIN (40mg single dose) and CHEMICALNOTIN (10mg single dose). 3.In vitro,  bbbbb1 CHEMICALIN eeeee1  demonstrated little/weak inhibition (IC50 values >30 M) towards GENEIN (GENEIN, GENEIN, GENEIN, GENEIN, GENEIN),  bbbbb2 GENEIN eeeee2 , GENEIN, or GENEIN
CPR:4	valuation of drug interactions of CHEMICALIN (a GENEIN agonist) with statins: from in vitro data to clinical study design. 1.This work investigated the drug interaction potential of CHEMICALIN, a novel GENEIN agonist, with the GENEIN inhibitors CHEMICALIN and CHEMICALIN. 2.In vitro experiments assessed the inhibition of GENEIN and GENEIN enzymes by CHEMICALIN, and a clinical drug interaction study investigated the effect of CHEMICALNOTIN (300mg BID) on the pharmacokinetic profile of CHEMICALNOTIN (40mg single dose) and CHEMICALNOTIN (10mg single dose). 3.In vitro,  bbbbb1 CHEMICALIN eeeee1  demonstrated little/weak inhibition (IC50 values >30 M) towards GENEIN (GENEIN, GENEIN, GENEIN, GENEIN, GENEIN), GENEIN,  bbbbb2 GENEIN eeeee2 , or GENEIN
CPR:4	valuation of drug interactions of CHEMICALIN (a GENEIN agonist) with statins: from in vitro data to clinical study design. 1.This work investigated the drug interaction potential of CHEMICALIN, a novel GENEIN agonist, with the GENEIN inhibitors CHEMICALIN and CHEMICALIN. 2.In vitro experiments assessed the inhibition of GENEIN and GENEIN enzymes by CHEMICALIN, and a clinical drug interaction study investigated the effect of CHEMICALNOTIN (300mg BID) on the pharmacokinetic profile of CHEMICALNOTIN (40mg single dose) and CHEMICALNOTIN (10mg single dose). 3.In vitro,  bbbbb1 CHEMICALIN eeeee1  demonstrated little/weak inhibition (IC50 values >30 M) towards GENEIN (GENEIN, GENEIN, GENEIN, GENEIN, GENEIN), GENEIN, GENEIN, or  bbbbb2 GENEIN eeeee2 
CPR:4	However,  bbbbb1 CHEMICALIN eeeee1  inhibited  bbbbb2 GENEIN eeeee2  and GENEIN, which are transporters involved in statin disposition. 4.In the clinical study, small increases in the AUC(0-inf) of CHEMICALNOTIN [mean ratio (90% CI) of 1.34 (1.22, 1.48)] and CHEMICALNOTIN [mean ratio (90% CI) of 1.39 (1.30, 1.49)] were observed when co-administered with CHEMICALIN, which is consistent with an inhibitory effect on intestinal GENEIN and GENEIN
CPR:4	However,  bbbbb1 CHEMICALIN eeeee1  inhibited GENEIN and  bbbbb2 GENEIN eeeee2 , which are transporters involved in statin disposition. 4.In the clinical study, small increases in the AUC(0-inf) of CHEMICALNOTIN [mean ratio (90% CI) of 1.34 (1.22, 1.48)] and CHEMICALNOTIN [mean ratio (90% CI) of 1.39 (1.30, 1.49)] were observed when co-administered with CHEMICALIN, which is consistent with an inhibitory effect on intestinal GENEIN and GENEIN
CPR:4	However, CHEMICALIN inhibited GENEIN and GENEIN, which are transporters involved in statin disposition. 4.In the clinical study, small increases in the AUC(0-inf) of CHEMICALNOTIN [mean ratio (90% CI) of 1.34 (1.22, 1.48)] and CHEMICALNOTIN [mean ratio (90% CI) of 1.39 (1.30, 1.49)] were observed when co-administered with  bbbbb1 CHEMICALIN eeeee1 , which is consistent with an inhibitory effect on intestinal GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:4	However, CHEMICALIN inhibited GENEIN and GENEIN, which are transporters involved in statin disposition. 4.In the clinical study, small increases in the AUC(0-inf) of CHEMICALNOTIN [mean ratio (90% CI) of 1.34 (1.22, 1.48)] and CHEMICALNOTIN [mean ratio (90% CI) of 1.39 (1.30, 1.49)] were observed when co-administered with  bbbbb1 CHEMICALIN eeeee1 , which is consistent with an inhibitory effect on intestinal  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:4	valuation of drug interactions of CHEMICALIN (a GENEIN agonist) with statins: from in vitro data to clinical study design. 1.This work investigated the drug interaction potential of CHEMICALIN, a novel GENEIN agonist, with the  bbbbb1 GENEIN eeeee1  inhibitors  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN. 2.In vitro experiments assessed the inhibition of GENEIN and GENEIN enzymes by CHEMICALIN, and a clinical drug interaction study investigated the effect of CHEMICALNOTIN (300mg BID) on the pharmacokinetic profile of CHEMICALNOTIN (40mg single dose) and CHEMICALNOTIN (10mg single dose). 3.In vitro, CHEMICALIN demonstrated little/weak inhibition (IC50 values >30 M) towards GENEIN (GENEIN, GENEIN, GENEIN, GENEIN, GENEIN), GENEIN, GENEIN, or GENEIN
CPR:4	This study provides a mechanistic understanding of the in vivo inhibition of  bbbbb1 GENEIN eeeee1  and enzymes by  bbbbb2 CHEMICALIN eeeee2 .
CPR:4	valuation of drug interactions of CHEMICALIN (a GENEIN agonist) with statins: from in vitro data to clinical study design. 1.This work investigated the drug interaction potential of CHEMICALIN, a novel GENEIN agonist, with the  bbbbb1 GENEIN eeeee1  inhibitors CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 . 2.In vitro experiments assessed the inhibition of GENEIN and GENEIN enzymes by CHEMICALIN, and a clinical drug interaction study investigated the effect of CHEMICALNOTIN (300mg BID) on the pharmacokinetic profile of CHEMICALNOTIN (40mg single dose) and CHEMICALNOTIN (10mg single dose). 3.In vitro, CHEMICALIN demonstrated little/weak inhibition (IC50 values >30 M) towards GENEIN (GENEIN, GENEIN, GENEIN, GENEIN, GENEIN), GENEIN, GENEIN, or GENEIN
CPR:4	valuation of drug interactions of CHEMICALIN (a GENEIN agonist) with statins: from in vitro data to clinical study design. 1.This work investigated the drug interaction potential of CHEMICALIN, a novel GENEIN agonist, with the GENEIN inhibitors CHEMICALIN and CHEMICALIN. 2.In vitro experiments assessed the inhibition of  bbbbb1 GENEIN eeeee1  and GENEIN enzymes by  bbbbb2 CHEMICALIN eeeee2 , and a clinical drug interaction study investigated the effect of CHEMICALNOTIN (300mg BID) on the pharmacokinetic profile of CHEMICALNOTIN (40mg single dose) and CHEMICALNOTIN (10mg single dose). 3.In vitro, CHEMICALIN demonstrated little/weak inhibition (IC50 values >30 M) towards GENEIN (GENEIN, GENEIN, GENEIN, GENEIN, GENEIN), GENEIN, GENEIN, or GENEIN
CPR:4	valuation of drug interactions of CHEMICALIN (a GENEIN agonist) with statins: from in vitro data to clinical study design. 1.This work investigated the drug interaction potential of CHEMICALIN, a novel GENEIN agonist, with the GENEIN inhibitors CHEMICALIN and CHEMICALIN. 2.In vitro experiments assessed the inhibition of GENEIN and  bbbbb1 GENEIN eeeee1  enzymes by  bbbbb2 CHEMICALIN eeeee2 , and a clinical drug interaction study investigated the effect of CHEMICALNOTIN (300mg BID) on the pharmacokinetic profile of CHEMICALNOTIN (40mg single dose) and CHEMICALNOTIN (10mg single dose). 3.In vitro, CHEMICALIN demonstrated little/weak inhibition (IC50 values >30 M) towards GENEIN (GENEIN, GENEIN, GENEIN, GENEIN, GENEIN), GENEIN, GENEIN, or GENEIN
CPR:5	valuation of drug interactions of CHEMICALIN (a GENEIN agonist) with statins: from in vitro data to clinical study design. 1.This work investigated the drug interaction potential of  bbbbb1 CHEMICALIN eeeee1 , a novel  bbbbb2 GENEIN eeeee2  agonist, with the GENEIN inhibitors CHEMICALIN and CHEMICALIN. 2.In vitro experiments assessed the inhibition of GENEIN and GENEIN enzymes by CHEMICALIN, and a clinical drug interaction study investigated the effect of CHEMICALNOTIN (300mg BID) on the pharmacokinetic profile of CHEMICALNOTIN (40mg single dose) and CHEMICALNOTIN (10mg single dose). 3.In vitro, CHEMICALIN demonstrated little/weak inhibition (IC50 values >30 M) towards GENEIN (GENEIN, GENEIN, GENEIN, GENEIN, GENEIN), GENEIN, GENEIN, or GENEIN
CPR:5	valuation of drug interactions of  bbbbb1 CHEMICALIN eeeee1  (a  bbbbb2 GENEIN eeeee2  agonist) with statins: from in vitro data to clinical study design. 1.This work investigated the drug interaction potential of CHEMICALIN, a novel GENEIN agonist, with the GENEIN inhibitors CHEMICALIN and CHEMICALIN. 2.In vitro experiments assessed the inhibition of GENEIN and GENEIN enzymes by CHEMICALIN, and a clinical drug interaction study investigated the effect of CHEMICALNOTIN (300mg BID) on the pharmacokinetic profile of CHEMICALNOTIN (40mg single dose) and CHEMICALNOTIN (10mg single dose). 3.In vitro, CHEMICALIN demonstrated little/weak inhibition (IC50 values >30 M) towards GENEIN (GENEIN, GENEIN, GENEIN, GENEIN, GENEIN), GENEIN, GENEIN, or GENEIN
CPR:10	Proteins  bbbbb1 GENEIN eeeee1  and GENEIN were not found to be involved in  bbbbb2 CHEMICALIN eeeee2  import
CPR:10	Proteins GENEIN and  bbbbb1 GENEIN eeeee1  were not found to be involved in  bbbbb2 CHEMICALIN eeeee2  import
CPR:4	The presence of  bbbbb1 CHEMICALIN eeeee1  hormones most probably causes the degradation of the  bbbbb2 GENEIN eeeee2  permease and impairment of CHEMICALNOTIN import.
CPR:2	Promoter replacements conferring constitutive expression of  bbbbb1 GENEIN eeeee1  revealed that the transcriptional induction in response to  bbbbb2 CHEMICALIN eeeee2  is required to maintain induced levels of GENEIN
CPR:2	Promoter replacements conferring constitutive expression of GENEIN revealed that the transcriptional induction in response to  bbbbb1 CHEMICALIN eeeee1  is required to maintain induced levels of  bbbbb2 GENEIN eeeee2 
CPR:4	Further study showed that  bbbbb1 CHEMICALIN eeeee1  dose-dependently inhibited the proliferation and activation of T lymphocytes, and suppressed pro-inflammatory  bbbbb2 GENEIN eeeee2  levels of activated T cells
CPR:4	Inhibition of Th1/Th17 responses via suppression of  bbbbb1 GENEIN eeeee1  and GENEIN activation contributes to the amelioration of murine experimental colitis by a natural CHEMICALIN glucoside  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Inhibition of Th1/Th17 responses via suppression of GENEIN and  bbbbb1 GENEIN eeeee1  activation contributes to the amelioration of murine experimental colitis by a natural CHEMICALIN glucoside  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Moreover,  bbbbb1 CHEMICALIN eeeee1  treatment inhibited the phosphorylations of  bbbbb2 GENEIN eeeee2  and GENEIN in CD4(+) T cells, which were the crucial transcription factors for Th1 and Th17 respectively
CPR:4	Moreover,  bbbbb1 CHEMICALIN eeeee1  treatment inhibited the phosphorylations of GENEIN and  bbbbb2 GENEIN eeeee2  in CD4(+) T cells, which were the crucial transcription factors for Th1 and Th17 respectively
CPR:4	Inhibition of Th1/Th17 responses via suppression of  bbbbb1 GENEIN eeeee1  and GENEIN activation contributes to the amelioration of murine experimental colitis by a natural  bbbbb2 CHEMICALIN eeeee2  glucoside CHEMICALIN
CPR:4	Inhibition of Th1/Th17 responses via suppression of GENEIN and  bbbbb1 GENEIN eeeee1  activation contributes to the amelioration of murine experimental colitis by a natural  bbbbb2 CHEMICALIN eeeee2  glucoside CHEMICALIN
CPR:4	Pharmacological inhibition of GENEIN with  bbbbb1 CHEMICALIN eeeee1  abrogated the  bbbbb2 GENEIN eeeee2 -induced phosphorylation of GENEIN, GENEIN and its downstream effector, GENEIN
CPR:4	Furthermore,  bbbbb1 GENEIN eeeee1 -stimulated T-I cell proliferation and the expression of GENEIN GENEIN, GENEIN and GENEIN were also blocked by  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Furthermore, GENEIN-stimulated T-I cell proliferation and the expression of  bbbbb1 GENEIN eeeee1  GENEIN, GENEIN and GENEIN were also blocked by  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Furthermore, GENEIN-stimulated T-I cell proliferation and the expression of GENEIN  bbbbb1 GENEIN eeeee1 , GENEIN and GENEIN were also blocked by  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Furthermore, GENEIN-stimulated T-I cell proliferation and the expression of GENEIN GENEIN,  bbbbb1 GENEIN eeeee1  and GENEIN were also blocked by  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Furthermore, GENEIN-stimulated T-I cell proliferation and the expression of GENEIN GENEIN, GENEIN and  bbbbb1 GENEIN eeeee1  were also blocked by  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Pharmacological inhibition of  bbbbb1 GENEIN eeeee1  with  bbbbb2 CHEMICALIN eeeee2  abrogated the GENEIN-induced phosphorylation of GENEIN, GENEIN and its downstream effector, GENEIN
CPR:4	Pharmacological inhibition of GENEIN with  bbbbb1 CHEMICALIN eeeee1  abrogated the GENEIN-induced phosphorylation of  bbbbb2 GENEIN eeeee2 , GENEIN and its downstream effector, GENEIN
CPR:4	Pharmacological inhibition of GENEIN with  bbbbb1 CHEMICALIN eeeee1  abrogated the GENEIN-induced phosphorylation of GENEIN,  bbbbb2 GENEIN eeeee2  and its downstream effector, GENEIN
CPR:4	Pharmacological inhibition of GENEIN with  bbbbb1 CHEMICALIN eeeee1  abrogated the GENEIN-induced phosphorylation of GENEIN, GENEIN and its downstream effector,  bbbbb2 GENEIN eeeee2 
CPR:1	GENENOTIN has mostly been studied in the context of the leukemic GENENOTIN-GENENOTIN fusion protein, which lacks the  bbbbb1 CHEMICALIN eeeee1 -terminal PHD fingers of  bbbbb2 GENEIN eeeee2 
CPR:2	We demonstrate that the GENENOTIN region is essential for viability and that the first GENENOTIN contributes to the preferred binding of  bbbbb1 GENEIN eeeee1  to  bbbbb2 CHEMICALIN eeeee2  4-methylated histone H3 tails
CPR:5	We report the discovery of novel series of highly potent  bbbbb1 GENEIN eeeee1  agonists based on CHEMICALIN, 1 and 2 by introducing and optimizing various  bbbbb2 CHEMICALIN eeeee2  onto the CHEMICALIN(9)-position of the CHEMICALIN moiety
CPR:5	We report the discovery of novel series of highly potent  bbbbb1 GENEIN eeeee1  agonists based on CHEMICALIN, 1 and 2 by introducing and optimizing various CHEMICALIN onto the  bbbbb2 CHEMICALIN eeeee2 (9)-position of the CHEMICALIN moiety
CPR:5	We report the discovery of novel series of highly potent  bbbbb1 GENEIN eeeee1  agonists based on CHEMICALIN, 1 and 2 by introducing and optimizing various CHEMICALIN onto the CHEMICALIN(9)-position of the  bbbbb2 CHEMICALIN eeeee2  moiety
CPR:5	The introduction of the  bbbbb1 CHEMICALIN eeeee1  group resulted in not only improved water solubility but also enhanced  bbbbb2 GENEIN eeeee2  agonistic activity
CPR:5	We report the discovery of novel series of highly potent  bbbbb1 GENEIN eeeee1  agonists based on  bbbbb2 CHEMICALIN eeeee2 , 1 and 2 by introducing and optimizing various CHEMICALIN onto the CHEMICALIN(9)-position of the CHEMICALIN moiety
CPR:5	Synthesis and evaluation of  bbbbb1 CHEMICALIN eeeee1  derivatives as potent  bbbbb2 GENEIN eeeee2  agonists with high water solubility
CPR:4	Inhibitors based on a  bbbbb1 CHEMICALIN eeeee1  scaffold were discovered for GENEIN ( bbbbb2 GENEIN eeeee2 ) and subsequently optimized to potent compounds with favorable pharmacokinetic profiles and in vivo efficacy in reducing the desaturation index in a mouse model
CPR:4	Inhibitors based on a  bbbbb1 CHEMICALIN eeeee1  scaffold were discovered for  bbbbb2 GENEIN eeeee2  (GENEIN) and subsequently optimized to potent compounds with favorable pharmacokinetic profiles and in vivo efficacy in reducing the desaturation index in a mouse model
CPR:4	The GENENOTIN (GENENOTIN) refolding assay revealed that compound 1l inhibited  bbbbb1 GENEIN eeeee1  chaperone activity (IC(50): 6.80  0.25 M) and this inhibition activity was higher than that of  bbbbb2 CHEMICALIN eeeee2  (IC(50): 10.9  0.63 M).
CPR:2	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN alleviate intermittent hypoxia induced abnormal  bbbbb2 GENEIN eeeee2  and GENEIN and low CHEMICALNOTIN by suppressing endoplasmic reticulum stress and activated GENEIN in rat testes
CPR:2	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN alleviate intermittent hypoxia induced abnormal GENEIN and  bbbbb2 GENEIN eeeee2  and low CHEMICALNOTIN by suppressing endoplasmic reticulum stress and activated GENEIN in rat testes
CPR:2	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  alleviate intermittent hypoxia induced abnormal  bbbbb2 GENEIN eeeee2  and GENEIN and low CHEMICALNOTIN by suppressing endoplasmic reticulum stress and activated GENEIN in rat testes
CPR:4	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN alleviate intermittent hypoxia induced abnormal GENEIN and GENEIN and low CHEMICALNOTIN by suppressing endoplasmic reticulum stress and activated  bbbbb2 GENEIN eeeee2  in rat testes
CPR:4	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  alleviate intermittent hypoxia induced abnormal GENEIN and GENEIN and low CHEMICALNOTIN by suppressing endoplasmic reticulum stress and activated  bbbbb2 GENEIN eeeee2  in rat testes
CPR:4	We hypothesized that hypoxia induced testicular damage is mediated by an activated GENENOTIN (GENENOTIN), therefore,  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) an inhibitor of  bbbbb2 GENEIN eeeee2  and CHEMICALNOTIN (RS), a CHEMICALNOTIN influx inhibitor were tested if they could attenuate hypoxic toxicity to the testis
CPR:4	We hypothesized that hypoxia induced testicular damage is mediated by an activated GENENOTIN (GENENOTIN), therefore, CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) an inhibitor of  bbbbb2 GENEIN eeeee2  and CHEMICALNOTIN (RS), a CHEMICALNOTIN influx inhibitor were tested if they could attenuate hypoxic toxicity to the testis
CPR:4	 bbbbb1 CHEMICALIN eeeee1  and RS at least partially normalize hypoxia caused male hypogonadism by suppressing ER stress, and  bbbbb2 GENEIN eeeee2  in testes.
CPR:9	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  alleviate intermittent hypoxia induced abnormal GENEIN and  bbbbb2 GENEIN eeeee2  and low CHEMICALNOTIN by suppressing endoplasmic reticulum stress and activated GENEIN in rat testes
CPR:10	Here we found that  bbbbb1 CHEMICALIN eeeee1 , a frontline agent for acute promyelocytic leukemia, inhibits GENEIN but not  bbbbb2 GENEIN eeeee2  expression in time- and dose-dependent manners
CPR:2	In addition, we found that  bbbbb1 CHEMICALIN eeeee1  decreases the stability of GENEIN protein via a GENEIN-dependent pathway but has little effect on the level of  bbbbb2 GENEIN eeeee2  transcript
CPR:2	 bbbbb1 CHEMICALIN eeeee1  suppresses cell survival via GENEIN-mediated proteasomal degradation of  bbbbb2 GENEIN eeeee2  protein
CPR:2	Together, these data suggest that  bbbbb1 CHEMICALIN eeeee1  degrades GENEIN protein at least in part via  bbbbb2 GENEIN eeeee2 -dependent proteolysis and that inhibition of GENEIN expression facilitates tumor cells to CHEMICALNOTIN-induced death.
CPR:2	In addition, we found that  bbbbb1 CHEMICALIN eeeee1  decreases the stability of GENEIN protein via a  bbbbb2 GENEIN eeeee2 -dependent pathway but has little effect on the level of GENEIN transcript
CPR:2	 bbbbb1 CHEMICALIN eeeee1  suppresses cell survival via  bbbbb2 GENEIN eeeee2 -mediated proteasomal degradation of GENEIN protein
CPR:3	Furthermore, we found that  bbbbb1 CHEMICALIN eeeee1  activates the  bbbbb2 GENEIN eeeee2  and consequently induces GENEIN expression
CPR:3	Furthermore, we found that  bbbbb1 CHEMICALIN eeeee1  activates the GENEIN and consequently induces  bbbbb2 GENEIN eeeee2  expression
CPR:4	Consistent with this, we found that knockdown of GENENOTIN inhibits, whereas ectopic expression of GENENOTIN enhances,  bbbbb1 CHEMICALIN eeeee1 -induced degradation of  bbbbb2 GENEIN eeeee2  protein
CPR:4	Together, these data suggest that  bbbbb1 CHEMICALIN eeeee1  degrades  bbbbb2 GENEIN eeeee2  protein at least in part via GENEIN-dependent proteolysis and that inhibition of GENEIN expression facilitates tumor cells to CHEMICALNOTIN-induced death.
CPR:4	Together, these data suggest that  bbbbb1 CHEMICALIN eeeee1  degrades GENEIN protein at least in part via GENEIN-dependent proteolysis and that inhibition of  bbbbb2 GENEIN eeeee2  expression facilitates tumor cells to CHEMICALNOTIN-induced death.
CPR:4	Here we found that  bbbbb1 CHEMICALIN eeeee1 , a frontline agent for acute promyelocytic leukemia, inhibits  bbbbb2 GENEIN eeeee2  but not GENEIN expression in time- and dose-dependent manners
CPR:4	In addition, we found that  bbbbb1 CHEMICALIN eeeee1  decreases the stability of  bbbbb2 GENEIN eeeee2  protein via a GENEIN-dependent pathway but has little effect on the level of GENEIN transcript
CPR:2	 bbbbb1 CHEMICALIN eeeee1  induced G2/M phase cell cycle arrest and modulated the levels of  bbbbb2 GENEIN eeeee2  and GENEIN in Hec1A cells
CPR:2	 bbbbb1 CHEMICALIN eeeee1  induced G2/M phase cell cycle arrest and modulated the levels of GENEIN and  bbbbb2 GENEIN eeeee2  in Hec1A cells
CPR:2	Moreover,  bbbbb1 CHEMICALIN eeeee1  treatment resulted in phosphorylation of  bbbbb2 GENEIN eeeee2 , and pretreatment with the GENEIN inhibitor, CHEMICALIN, attenuated cell growth inhibition by CHEMICALNOTIN
CPR:2	These data suggest that  bbbbb1 CHEMICALIN eeeee1 , isolated from Japanese mugwort, modulates the  bbbbb2 GENEIN eeeee2 /GENEIN/GENENOTIN pathway, leading to inactivation of the GENEIN-GENEIN complex, followed by G2/M cell cycle arrest in endometrial cancer cells.
CPR:2	These data suggest that  bbbbb1 CHEMICALIN eeeee1 , isolated from Japanese mugwort, modulates the GENEIN/ bbbbb2 GENEIN eeeee2 /GENENOTIN pathway, leading to inactivation of the GENEIN-GENEIN complex, followed by G2/M cell cycle arrest in endometrial cancer cells.
CPR:3	Additional mechanistic studies revealed that  bbbbb1 CHEMICALIN eeeee1  treatment resulted in an increase in phosphorylation of  bbbbb2 GENEIN eeeee2  and GENEIN-GENENOTIN
CPR:3	Additional mechanistic studies revealed that  bbbbb1 CHEMICALIN eeeee1  treatment resulted in an increase in phosphorylation of GENEIN and  bbbbb2 GENEIN eeeee2 -GENENOTIN
CPR:3	 bbbbb1 CHEMICALIN eeeee1 , isolated from dietary mugwort (Artemisia princeps), induces G2/M cell cycle arrest by inactivating GENEIN-GENEIN via  bbbbb2 GENEIN eeeee2 -GENENOTIN activation
CPR:4	 bbbbb1 CHEMICALIN eeeee1 , isolated from dietary mugwort (Artemisia princeps), induces G2/M cell cycle arrest by inactivating  bbbbb2 GENEIN eeeee2 -GENEIN via GENEIN-GENENOTIN activation
CPR:4	 bbbbb1 CHEMICALIN eeeee1 , isolated from dietary mugwort (Artemisia princeps), induces G2/M cell cycle arrest by inactivating GENEIN- bbbbb2 GENEIN eeeee2  via GENEIN-GENENOTIN activation
CPR:4	Moreover, CHEMICALIN treatment resulted in phosphorylation of GENEIN, and pretreatment with the  bbbbb1 GENEIN eeeee1  inhibitor,  bbbbb2 CHEMICALIN eeeee2 , attenuated cell growth inhibition by CHEMICALNOTIN
CPR:4	These data suggest that  bbbbb1 CHEMICALIN eeeee1 , isolated from Japanese mugwort, modulates the GENEIN/GENEIN/GENENOTIN pathway, leading to inactivation of the  bbbbb2 GENEIN eeeee2 -GENEIN complex, followed by G2/M cell cycle arrest in endometrial cancer cells.
CPR:4	These data suggest that  bbbbb1 CHEMICALIN eeeee1 , isolated from Japanese mugwort, modulates the GENEIN/GENEIN/GENENOTIN pathway, leading to inactivation of the GENEIN- bbbbb2 GENEIN eeeee2  complex, followed by G2/M cell cycle arrest in endometrial cancer cells.
CPR:2	Electrical Stimuli Release  bbbbb1 CHEMICALIN eeeee1  to Increase  bbbbb2 GENEIN eeeee2  Translocation and CHEMICALIN Uptake via GENEIN-GENEIN-GENEIN in Skeletal Muscle Cells
CPR:2	Electrical Stimuli Release  bbbbb1 CHEMICALIN eeeee1  to Increase GENEIN Translocation and CHEMICALIN Uptake via  bbbbb2 GENEIN eeeee2 -GENEIN-GENEIN in Skeletal Muscle Cells
CPR:2	Electrical Stimuli Release  bbbbb1 CHEMICALIN eeeee1  to Increase GENEIN Translocation and CHEMICALIN Uptake via GENEIN- bbbbb2 GENEIN eeeee2 -GENEIN in Skeletal Muscle Cells
CPR:2	Electrical Stimuli Release  bbbbb1 CHEMICALIN eeeee1  to Increase GENEIN Translocation and CHEMICALIN Uptake via GENEIN-GENEIN- bbbbb2 GENEIN eeeee2  in Skeletal Muscle Cells
CPR:2	 bbbbb1 CHEMICALIN eeeee1  caused translocation of  bbbbb2 GENEIN eeeee2 myc-eGFP to the cell surface, mechanistically mediated by increased exocytosis involving GENENOTIN/GENENOTIN reduced by dominant-negative GENENOTIN or GENENOTIN GENENOTIN-dead mutants, and potentiated by GENENOTIN
CPR:2	 bbbbb1 CHEMICALIN eeeee1  is released from skeletal muscle by contractile activity and can autocrinely signal through  bbbbb2 GENEIN eeeee2 , and we hypothesized it may influence CHEMICALNOTIN uptake
CPR:3	Exogenous  bbbbb1 CHEMICALIN eeeee1  transiently activated  bbbbb2 GENEIN eeeee2  and, inhibiting GENENOTIN (GENENOTIN) or GENENOTIN as well as dominant-negative GENENOTIN mutant, reduced CHEMICALNOTIN-dependent CHEMICALNOTIN uptake and GENENOTIN phosphorylation
CPR:4	Electrical stimulation, CHEMICALNOTIN, and GENENOTIN each increased fluorescent CHEMICALNOTIN (CHEMICALNOTIN) uptake in primary myotubes, but only electrical stimulation and CHEMICALNOTIN-dependent CHEMICALNOTIN uptake were inhibited by  bbbbb1 GENEIN eeeee1  and by GENEIN blockade ( bbbbb2 CHEMICALIN eeeee2 )
CPR:4	Electrical stimulation, CHEMICALNOTIN, and GENENOTIN each increased fluorescent CHEMICALNOTIN (CHEMICALNOTIN) uptake in primary myotubes, but only electrical stimulation and CHEMICALNOTIN-dependent CHEMICALNOTIN uptake were inhibited by GENEIN and by  bbbbb1 GENEIN eeeee1  blockade ( bbbbb2 CHEMICALIN eeeee2 )
CPR:4	Electrical stimulation transiently elevated extracellular CHEMICALNOTIN and caused  bbbbb1 GENEIN eeeee1  phosphorylation that was additive to GENENOTIN and inhibited by  bbbbb2 CHEMICALIN eeeee2 
CPR:4	CHEMICALNOTIN-dependent CHEMICALNOTIN uptake was also inhibited by the GENENOTIN subunit-interacting peptide ark-ct and by the  bbbbb1 GENEIN eeeee1  (GENEIN) inhibitor  bbbbb2 CHEMICALIN eeeee2 
CPR:4	CHEMICALNOTIN-dependent CHEMICALNOTIN uptake was also inhibited by the GENENOTIN subunit-interacting peptide ark-ct and by the GENEIN ( bbbbb1 GENEIN eeeee1 ) inhibitor  bbbbb2 CHEMICALIN eeeee2 
CPR:9	Electrical Stimuli Release CHEMICALIN to Increase  bbbbb1 GENEIN eeeee1  Translocation and  bbbbb2 CHEMICALIN eeeee2  Uptake via GENEIN-GENEIN-GENEIN in Skeletal Muscle Cells
CPR:1	The GENENOTIN/GENENOTIN interaction occurred on the  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN termini of  bbbbb2 GENEIN eeeee2 ; a single internal deletion from CHEMICALIN 455 to 466 (455-466) was found to significantly reduce GENEIN protein stability
CPR:1	The GENENOTIN/GENENOTIN interaction occurred on the CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  termini of  bbbbb2 GENEIN eeeee2 ; a single internal deletion from CHEMICALIN 455 to 466 (455-466) was found to significantly reduce GENEIN protein stability
CPR:1	The GENENOTIN/GENENOTIN interaction occurred on the CHEMICALIN and CHEMICALIN termini of GENEIN; a single internal deletion from  bbbbb1 CHEMICALIN eeeee1  455 to 466 (455-466) was found to significantly reduce  bbbbb2 GENEIN eeeee2  protein stability
CPR:2	A series of  bbbbb1 CHEMICALIN eeeee1  derivatives were synthesized and evaluated for GENEIN inhibition,  bbbbb2 GENEIN eeeee2  expression and suppression of cancer cell growth in vitro
CPR:4	A series of  bbbbb1 CHEMICALIN eeeee1  derivatives were synthesized and evaluated for  bbbbb2 GENEIN eeeee2  inhibition, GENEIN expression and suppression of cancer cell growth in vitro
CPR:4	Structure-based design, synthesis and evaluation of novel  bbbbb1 CHEMICALIN eeeee1  derivatives as  bbbbb2 GENEIN eeeee2  inhibitors and potential for cancer polypharmacology
CPR:2	In addition,  bbbbb1 CHEMICALIN eeeee1  induced  bbbbb2 GENEIN eeeee2  nuclear translocation and up-regulated the expression of GENEIN-GENEIN downstream antioxidant genes, whereas GENENOTIN knockdown by RNA interference blocked the inhibition of CHEMICALNOTIN on myofibroblast differentiation
CPR:2	The present study aimed at investigating the role of reactive CHEMICALNOTIN species (ROS) scavenging by  bbbbb1 CHEMICALIN eeeee1  on  bbbbb2 GENEIN eeeee2  (GENENOTIN-induced myofibroblast differentiation of corneal fibroblasts in vitro
CPR:2	Treatment with CHEMICALIN and the GENENOTIN-GENENOTIN activator resulted in increased inhibition of the  bbbbb1 GENEIN eeeee1 -induced myofibroblast differentiation as compared with treatment with  bbbbb2 CHEMICALIN eeeee2  or CHEMICALIN
CPR:2	Treatment with CHEMICALIN and the GENENOTIN-GENENOTIN activator resulted in increased inhibition of the  bbbbb1 GENEIN eeeee1 -induced myofibroblast differentiation as compared with treatment with CHEMICALIN or  bbbbb2 CHEMICALIN eeeee2 
CPR:3	Human immortalized corneal fibroblasts were treated with GENENOTIN in the presence of CHEMICALNOTIN, the GENEIN inhibitor CHEMICALIN (CHEMICALIN), the antioxidant CHEMICALNOTIN (CHEMICALNOTIN), the  bbbbb1 GENEIN eeeee1 -GENEIN (GENEIN-GENEIN) activator  bbbbb2 CHEMICALIN eeeee2 , or small interfering RNA
CPR:3	Human immortalized corneal fibroblasts were treated with GENENOTIN in the presence of CHEMICALNOTIN, the GENEIN inhibitor CHEMICALIN (CHEMICALIN), the antioxidant CHEMICALNOTIN (CHEMICALNOTIN), the GENEIN- bbbbb1 GENEIN eeeee1  (GENEIN-GENEIN) activator  bbbbb2 CHEMICALIN eeeee2 , or small interfering RNA
CPR:3	Human immortalized corneal fibroblasts were treated with GENENOTIN in the presence of CHEMICALNOTIN, the GENEIN inhibitor CHEMICALIN (CHEMICALIN), the antioxidant CHEMICALNOTIN (CHEMICALNOTIN), the GENEIN-GENEIN ( bbbbb1 GENEIN eeeee1 -GENEIN) activator  bbbbb2 CHEMICALIN eeeee2 , or small interfering RNA
CPR:3	Human immortalized corneal fibroblasts were treated with GENENOTIN in the presence of CHEMICALNOTIN, the GENEIN inhibitor CHEMICALIN (CHEMICALIN), the antioxidant CHEMICALNOTIN (CHEMICALNOTIN), the GENEIN-GENEIN (GENEIN- bbbbb1 GENEIN eeeee1 ) activator  bbbbb2 CHEMICALIN eeeee2 , or small interfering RNA
CPR:3	In conclusion, this study provides the first evidence implicating that  bbbbb1 CHEMICALIN eeeee1  inhibits GENEIN-induced ROS accumulation and myofibroblast differentiation via enhanced  bbbbb2 GENEIN eeeee2 -GENEIN signaling.
CPR:3	In conclusion, this study provides the first evidence implicating that  bbbbb1 CHEMICALIN eeeee1  inhibits GENEIN-induced ROS accumulation and myofibroblast differentiation via enhanced GENEIN- bbbbb2 GENEIN eeeee2  signaling.
CPR:3	 bbbbb1 CHEMICALIN eeeee1  inhibits GENEIN-induced reactive CHEMICALNOTIN species accumulation and myofibroblast differentiation via enhanced  bbbbb2 GENEIN eeeee2 -GENEIN signaling
CPR:3	 bbbbb1 CHEMICALIN eeeee1  inhibits GENEIN-induced reactive CHEMICALNOTIN species accumulation and myofibroblast differentiation via enhanced GENEIN- bbbbb2 GENEIN eeeee2  signaling
CPR:3	In addition,  bbbbb1 CHEMICALIN eeeee1  induced GENEIN nuclear translocation and up-regulated the expression of  bbbbb2 GENEIN eeeee2 -GENEIN downstream antioxidant genes, whereas GENENOTIN knockdown by RNA interference blocked the inhibition of CHEMICALNOTIN on myofibroblast differentiation
CPR:3	In addition,  bbbbb1 CHEMICALIN eeeee1  induced GENEIN nuclear translocation and up-regulated the expression of GENEIN- bbbbb2 GENEIN eeeee2  downstream antioxidant genes, whereas GENENOTIN knockdown by RNA interference blocked the inhibition of CHEMICALNOTIN on myofibroblast differentiation
CPR:4	In conclusion, this study provides the first evidence implicating that  bbbbb1 CHEMICALIN eeeee1  inhibits  bbbbb2 GENEIN eeeee2 -induced ROS accumulation and myofibroblast differentiation via enhanced GENEIN-GENEIN signaling.
CPR:4	Human immortalized corneal fibroblasts were treated with GENENOTIN in the presence of CHEMICALNOTIN, the  bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), the antioxidant CHEMICALNOTIN (CHEMICALNOTIN), the GENEIN-GENEIN (GENEIN-GENEIN) activator CHEMICALIN, or small interfering RNA
CPR:4	Human immortalized corneal fibroblasts were treated with GENENOTIN in the presence of CHEMICALNOTIN, the  bbbbb1 GENEIN eeeee1  inhibitor CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), the antioxidant CHEMICALNOTIN (CHEMICALNOTIN), the GENEIN-GENEIN (GENEIN-GENEIN) activator CHEMICALIN, or small interfering RNA
CPR:4	Treatment with  bbbbb1 CHEMICALIN eeeee1  and the GENENOTIN-GENENOTIN activator resulted in increased inhibition of the  bbbbb2 GENEIN eeeee2 -induced myofibroblast differentiation as compared with treatment with CHEMICALIN or CHEMICALIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  inhibits  bbbbb2 GENEIN eeeee2 -induced reactive CHEMICALNOTIN species accumulation and myofibroblast differentiation via enhanced GENEIN-GENEIN signaling
CPR:4	Furthermore,  bbbbb1 CHEMICALIN eeeee1  also decreased cellular ROS and CHEMICALNOTIN accumulation induced by  bbbbb2 GENEIN eeeee2 , whereas it elevated intracellular CHEMICALNOTIN level and cellular total antioxidant capacity
CPR:2	In the present studies, the GENEIN inverse agonist CHEMICALIN (CHEMICALIN) and the GENEIN neutral antagonist  bbbbb1 CHEMICALIN eeeee1  were compared for their ability to modify  bbbbb2 GENEIN eeeee2 -mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel GENEIN full agonist CHEMICALIN
CPR:2	In the present studies, the GENEIN inverse agonist  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) and the GENEIN neutral antagonist CHEMICALIN were compared for their ability to modify  bbbbb2 GENEIN eeeee2 -mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel GENEIN full agonist CHEMICALIN
CPR:2	In the present studies, the GENEIN inverse agonist CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) and the GENEIN neutral antagonist CHEMICALIN were compared for their ability to modify  bbbbb2 GENEIN eeeee2 -mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel GENEIN full agonist CHEMICALIN
CPR:3	Results indicate that  bbbbb1 CHEMICALIN eeeee1  serves as an effective  bbbbb2 GENEIN eeeee2  discriminative stimulus, with an onset and time course of action comparable with that of the GENEIN agonist CHEMICALIN, and that the inverse agonist CHEMICALIN and the neutral antagonist CHEMICALIN produce dose-related rightward shifts in the CHEMICALIN dose-effect curve, indicating that both drugs surmountably antagonize the discriminative stimulus effects of CHEMICALIN
CPR:5	In the present studies, the GENEIN inverse agonist CHEMICALIN (CHEMICALIN) and the GENEIN neutral antagonist CHEMICALIN were compared for their ability to modify GENEIN-mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel  bbbbb1 GENEIN eeeee1  full agonist  bbbbb2 CHEMICALIN eeeee2 
CPR:5	Results indicate that CHEMICALIN serves as an effective GENEIN discriminative stimulus, with an onset and time course of action comparable with that of the  bbbbb1 GENEIN eeeee1  agonist  bbbbb2 CHEMICALIN eeeee2 , and that the inverse agonist CHEMICALIN and the neutral antagonist CHEMICALIN produce dose-related rightward shifts in the CHEMICALIN dose-effect curve, indicating that both drugs surmountably antagonize the discriminative stimulus effects of CHEMICALIN
CPR:5	Results indicate that CHEMICALIN serves as an effective GENEIN discriminative stimulus, with an onset and time course of action comparable with that of the  bbbbb1 GENEIN eeeee1  agonist CHEMICALIN, and that the inverse agonist CHEMICALIN and the neutral antagonist CHEMICALIN produce dose-related rightward shifts in the  bbbbb2 CHEMICALIN eeeee2  dose-effect curve, indicating that both drugs surmountably antagonize the discriminative stimulus effects of CHEMICALIN
CPR:5	Results indicate that CHEMICALIN serves as an effective GENEIN discriminative stimulus, with an onset and time course of action comparable with that of the  bbbbb1 GENEIN eeeee1  agonist CHEMICALIN, and that the inverse agonist CHEMICALIN and the neutral antagonist CHEMICALIN produce dose-related rightward shifts in the CHEMICALIN dose-effect curve, indicating that both drugs surmountably antagonize the discriminative stimulus effects of  bbbbb2 CHEMICALIN eeeee2 
CPR:5	Results indicate that CHEMICALIN serves as an effective GENEIN discriminative stimulus, with an onset and time course of action comparable with that of the  bbbbb1 GENEIN eeeee1  agonist CHEMICALIN, and that the inverse agonist  bbbbb2 CHEMICALIN eeeee2  and the neutral antagonist CHEMICALIN produce dose-related rightward shifts in the CHEMICALIN dose-effect curve, indicating that both drugs surmountably antagonize the discriminative stimulus effects of CHEMICALIN
CPR:5	In the present studies, the  bbbbb1 GENEIN eeeee1  inverse agonist  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) and the GENEIN neutral antagonist CHEMICALIN were compared for their ability to modify GENEIN-mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel GENEIN full agonist CHEMICALIN
CPR:5	In the present studies, the  bbbbb1 GENEIN eeeee1  inverse agonist CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) and the GENEIN neutral antagonist CHEMICALIN were compared for their ability to modify GENEIN-mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel GENEIN full agonist CHEMICALIN
CPR:5	 bbbbb1 GENEIN eeeee1  (GENEIN) inverse agonists (e.g.,  bbbbb2 CHEMICALIN eeeee2 ) have been reported to produce adverse effects including nausea, emesis, and anhedonia that limit their clinical applications
CPR:5	GENEIN ( bbbbb1 GENEIN eeeee1 ) inverse agonists (e.g.,  bbbbb2 CHEMICALIN eeeee2 ) have been reported to produce adverse effects including nausea, emesis, and anhedonia that limit their clinical applications
CPR:6	In the present studies, the GENEIN inverse agonist CHEMICALIN (CHEMICALIN) and the  bbbbb1 GENEIN eeeee1  neutral antagonist  bbbbb2 CHEMICALIN eeeee2  were compared for their ability to modify GENEIN-mediated discriminative stimulus effects in nonhuman primates trained to discriminate the novel GENEIN full agonist CHEMICALIN
CPR:6	Results indicate that CHEMICALIN serves as an effective GENEIN discriminative stimulus, with an onset and time course of action comparable with that of the  bbbbb1 GENEIN eeeee1  agonist CHEMICALIN, and that the inverse agonist CHEMICALIN and the neutral antagonist  bbbbb2 CHEMICALIN eeeee2  produce dose-related rightward shifts in the CHEMICALIN dose-effect curve, indicating that both drugs surmountably antagonize the discriminative stimulus effects of CHEMICALIN
CPR:2	In early pregnancy, there were no significant differences in  bbbbb1 GENEIN eeeee1  sensitivity (GENENOTIN sensitivity index derived from OGTT [ISOGTT] and homeostasis model assessment for GENENOTIN resistance [HOMA-IR]) and GENENOTIN secretion (a ratio of the total area-under-the-GENENOTIN-curve to the total area-under-the- bbbbb2 CHEMICALIN eeeee2 -curve [AUCins/glu] and insulinogenic index [IGI]) between the NGT and late-onset GDM groups
CPR:4	 bbbbb1 CHEMICALIN eeeee1  has an advantage over the indirect  bbbbb2 GENEIN eeeee2  inhibitors, unfractionated heparin and low-molecular-weight heparin, in that it inhibits free and GENEIN-bound GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  has an advantage over the indirect GENEIN inhibitors, unfractionated heparin and low-molecular-weight heparin, in that it inhibits free and  bbbbb2 GENEIN eeeee2 -bound GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  has an advantage over the indirect GENEIN inhibitors, unfractionated heparin and low-molecular-weight heparin, in that it inhibits free and GENEIN-bound  bbbbb2 GENEIN eeeee2 
CPR:4	The reversible binding of  bbbbb1 CHEMICALIN eeeee1  may provide safer and more predictable anticoagulant treatment than seen with irreversible, non-covalent  bbbbb2 GENEIN eeeee2  inhibitors, e.g. hirudin
CPR:4	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, are potent, oral direct inhibitors of  bbbbb2 GENEIN eeeee2 -bound, clot-associated or free GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, are potent, oral direct inhibitors of GENEIN-bound, clot-associated or free  bbbbb2 GENEIN eeeee2 
CPR:4	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , are potent, oral direct inhibitors of  bbbbb2 GENEIN eeeee2 -bound, clot-associated or free GENEIN
CPR:4	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , are potent, oral direct inhibitors of GENEIN-bound, clot-associated or free  bbbbb2 GENEIN eeeee2 
CPR:4	Although parenteral oral direct  bbbbb1 GENEIN eeeee1  inhibitors (DTIs), such as  bbbbb2 CHEMICALIN eeeee2  and bivalirudin, have been on the market for years, DTIs such as CHEMICALIN are novel synthetic GENEIN antagonists
CPR:6	Although parenteral oral direct GENEIN inhibitors (DTIs), such as CHEMICALIN and bivalirudin, have been on the market for years, DTIs such as  bbbbb1 CHEMICALIN eeeee1  are novel synthetic  bbbbb2 GENEIN eeeee2  antagonists
CPR:2	As the CHEMICALIN ion concentration was increased, there was a consistent decrease of the enzyme catalytic turnover from 0.31 s(-1) (0 M CHEMICALNOTIN) to 0.050 s(-1) (6000 M CHEMICALNOTIN) and a distinct shift in steady-state conformational population from one that favors the  bbbbb1 GENEIN eeeee1 - bbbbb2 CHEMICALIN eeeee2  complex with the shorter fluorescence lifetime (33% excess) in the absence of CHEMICALNOTIN ion to one that favors the GENEIN-CHEMICALIN complex with the longer fluorescence lifetime (13% excess) at 6000 M CHEMICALNOTIN
CPR:2	As the CHEMICALIN ion concentration was increased, there was a consistent decrease of the enzyme catalytic turnover from 0.31 s(-1) (0 M CHEMICALNOTIN) to 0.050 s(-1) (6000 M CHEMICALNOTIN) and a distinct shift in steady-state conformational population from one that favors the GENEIN-CHEMICALIN complex with the shorter fluorescence lifetime (33% excess) in the absence of CHEMICALNOTIN ion to one that favors the  bbbbb1 GENEIN eeeee1 - bbbbb2 CHEMICALIN eeeee2  complex with the longer fluorescence lifetime (13% excess) at 6000 M CHEMICALNOTIN
CPR:2	Physiologic levels of CHEMICALIN ions decrease  bbbbb1 GENEIN eeeee1  activity in part by increasing  bbbbb2 CHEMICALIN eeeee2  binding affinity to the enzyme
CPR:2	This shift in conformational population at higher CHEMICALIN ion concentrations and to lower enzyme activity may be due to longer residence time of the  bbbbb1 CHEMICALIN eeeee1  in the  bbbbb2 GENEIN eeeee2  pocket
CPR:2	The results from monitoring enzyme catalysis in the absence of CHEMICALNOTIN suggests that the  bbbbb1 GENEIN eeeee1 - bbbbb2 CHEMICALIN eeeee2  complex with the shorter fluorescence lifetime is the form initially produced, and the complex with the longer fluorescence lifetime is produced through isomerization.
CPR:2	From the resolved free and bound CHEMICALNOTIN fluorescence signatures, the KD values for both  bbbbb1 CHEMICALIN eeeee1  conformations in  bbbbb2 GENEIN eeeee2  ranged from about 24 M to 1 M for CHEMICALIN ion concentrations of 0-6000 M, respectively
CPR:2	Fluorescence lifetime analysis and effect of CHEMICALNOTIN ions on binding of  bbbbb1 CHEMICALIN eeeee1  to  bbbbb2 GENEIN eeeee2 
CPR:2	From the resolved free and bound CHEMICALNOTIN fluorescence signatures, the KD values for both CHEMICALIN conformations in  bbbbb1 GENEIN eeeee1  ranged from about 24 M to 1 M for  bbbbb2 CHEMICALIN eeeee2  ion concentrations of 0-6000 M, respectively
CPR:4	This shift in conformational population at higher  bbbbb1 CHEMICALIN eeeee1  ion concentrations and to lower enzyme activity may be due to longer residence time of the CHEMICALIN in the  bbbbb2 GENEIN eeeee2  pocket
CPR:4	As the  bbbbb1 CHEMICALIN eeeee1  ion concentration was increased, there was a consistent decrease of the enzyme catalytic turnover from 0.31 s(-1) (0 M CHEMICALNOTIN) to 0.050 s(-1) (6000 M CHEMICALNOTIN) and a distinct shift in steady-state conformational population from one that favors the  bbbbb2 GENEIN eeeee2 -CHEMICALIN complex with the shorter fluorescence lifetime (33% excess) in the absence of CHEMICALNOTIN ion to one that favors the GENEIN-CHEMICALIN complex with the longer fluorescence lifetime (13% excess) at 6000 M CHEMICALNOTIN
CPR:4	Physiologic levels of  bbbbb1 CHEMICALIN eeeee1  ions decrease  bbbbb2 GENEIN eeeee2  activity in part by increasing CHEMICALIN binding affinity to the enzyme
CPR:9	 bbbbb1 GENEIN eeeee1  (GENEIN) catalyzes the oxidation of toxic CHEMICALIN to  bbbbb2 CHEMICALIN eeeee2 
CPR:9	GENEIN ( bbbbb1 GENEIN eeeee1 ) catalyzes the oxidation of toxic CHEMICALIN to  bbbbb2 CHEMICALIN eeeee2 
CPR:9	 bbbbb1 GENEIN eeeee1  (GENEIN) catalyzes the oxidation of toxic  bbbbb2 CHEMICALIN eeeee2  to CHEMICALIN
CPR:9	GENEIN ( bbbbb1 GENEIN eeeee1 ) catalyzes the oxidation of toxic  bbbbb2 CHEMICALIN eeeee2  to CHEMICALIN
CPR:2	Interestingly,  bbbbb1 CHEMICALIN eeeee1  increased proteins' levels of GENEIN ( bbbbb2 GENEIN eeeee2 ), GENEIN (GENEIN) and the GENEIN GENEIN, and decreased GENEIN levels
CPR:3	Moreover,  bbbbb1 CHEMICALIN eeeee1  resulted in activation of astrocytes, up-regulation of  bbbbb2 GENEIN eeeee2  in cortex and down-regulation of GENEIN in hippocampus and cortex
CPR:3	Interestingly,  bbbbb1 CHEMICALIN eeeee1  increased proteins' levels of  bbbbb2 GENEIN eeeee2  (GENEIN), GENEIN (GENEIN) and the GENEIN GENEIN, and decreased GENEIN levels
CPR:3	Interestingly,  bbbbb1 CHEMICALIN eeeee1  increased proteins' levels of GENEIN (GENEIN),  bbbbb2 GENEIN eeeee2  (GENEIN) and the GENEIN GENEIN, and decreased GENEIN levels
CPR:3	Interestingly,  bbbbb1 CHEMICALIN eeeee1  increased proteins' levels of GENEIN (GENEIN), GENEIN ( bbbbb2 GENEIN eeeee2 ) and the GENEIN GENEIN, and decreased GENEIN levels
CPR:3	Interestingly,  bbbbb1 CHEMICALIN eeeee1  increased proteins' levels of GENEIN (GENEIN), GENEIN (GENEIN) and the  bbbbb2 GENEIN eeeee2  GENEIN, and decreased GENEIN levels
CPR:3	Interestingly,  bbbbb1 CHEMICALIN eeeee1  increased proteins' levels of GENEIN (GENEIN), GENEIN (GENEIN) and the GENEIN  bbbbb2 GENEIN eeeee2 , and decreased GENEIN levels
CPR:4	Moreover,  bbbbb1 CHEMICALIN eeeee1  resulted in activation of astrocytes, up-regulation of GENEIN in cortex and down-regulation of  bbbbb2 GENEIN eeeee2  in hippocampus and cortex
CPR:4	Interestingly,  bbbbb1 CHEMICALIN eeeee1  increased proteins' levels of GENEIN (GENEIN), GENEIN (GENEIN) and the GENEIN GENEIN, and decreased  bbbbb2 GENEIN eeeee2  levels
CPR:3	Regulation of sexual reproduction by  bbbbb1 CHEMICALIN eeeee1  involves the activation of  bbbbb2 GENEIN eeeee2  (GENEIN) in the hypothalamus
CPR:3	Regulation of sexual reproduction by  bbbbb1 CHEMICALIN eeeee1  involves the activation of GENEIN ( bbbbb2 GENEIN eeeee2 ) in the hypothalamus
CPR:3	Using surface biotinylation, we observed that treatment of N-38 neurons with CHEMICALIN or with a membrane impermeant  bbbbb1 CHEMICALIN eeeee1  elevated plasma membrane  bbbbb2 GENEIN eeeee2  protein levels, indicating that membrane signaling increased receptor insertion into the cell membrane
CPR:3	These results indicate that membrane  bbbbb1 GENEIN eeeee1  levels in N-38 neurons are dynamically autoregulated by  bbbbb2 CHEMICALIN eeeee2 .
CPR:3	Using surface biotinylation, we observed that treatment of N-38 neurons with  bbbbb1 CHEMICALIN eeeee1  or with a membrane impermeant CHEMICALIN elevated plasma membrane  bbbbb2 GENEIN eeeee2  protein levels, indicating that membrane signaling increased receptor insertion into the cell membrane
CPR:4	Insertion of  bbbbb1 GENEIN eeeee1  was blocked by the GENEIN antagonist  bbbbb2 CHEMICALIN eeeee2  or with the GENEIN (GENEIN) pathway inhibitor CHEMICALIN (CHEMICALIN)
CPR:4	Insertion of  bbbbb1 GENEIN eeeee1  was blocked by the GENEIN antagonist CHEMICALIN or with the GENEIN (GENEIN) pathway inhibitor  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN)
CPR:4	Insertion of GENEIN was blocked by the GENEIN antagonist CHEMICALIN or with the  bbbbb1 GENEIN eeeee1  (GENEIN) pathway inhibitor  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN)
CPR:4	Insertion of GENEIN was blocked by the GENEIN antagonist CHEMICALIN or with the GENEIN ( bbbbb1 GENEIN eeeee1 ) pathway inhibitor  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN)
CPR:4	Insertion of  bbbbb1 GENEIN eeeee1  was blocked by the GENEIN antagonist CHEMICALIN or with the GENEIN (GENEIN) pathway inhibitor CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 )
CPR:4	Insertion of GENEIN was blocked by the GENEIN antagonist CHEMICALIN or with the  bbbbb1 GENEIN eeeee1  (GENEIN) pathway inhibitor CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 )
CPR:4	Insertion of GENEIN was blocked by the GENEIN antagonist CHEMICALIN or with the GENEIN ( bbbbb1 GENEIN eeeee1 ) pathway inhibitor CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 )
CPR:6	Insertion of GENEIN was blocked by the  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2  or with the GENEIN (GENEIN) pathway inhibitor CHEMICALIN (CHEMICALIN)
CPR:2	These findings indicate that the neuroprotective effect of  bbbbb1 CHEMICALIN eeeee1  against CHEMICALIN is through several mechanisms including its anti-inflammatory and antioxidant activities as well as its ability to modulate the methylation and hence activity of  bbbbb2 GENEIN eeeee2 
CPR:2	These findings indicate that the neuroprotective effect of CHEMICALIN against  bbbbb1 CHEMICALIN eeeee1  is through several mechanisms including its anti-inflammatory and antioxidant activities as well as its ability to modulate the methylation and hence activity of  bbbbb2 GENEIN eeeee2 
CPR:2	One of these compounds is  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), which ameliorates the phenotype of  bbbbb2 GENEIN eeeee2  transgenic mice associated with decreased protein aggregation and phosphorylation, improved neuronal integrity and reduced neuroinflammation
CPR:2	One of these compounds is CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), which ameliorates the phenotype of  bbbbb2 GENEIN eeeee2  transgenic mice associated with decreased protein aggregation and phosphorylation, improved neuronal integrity and reduced neuroinflammation
CPR:3	Reductions in striatal CHEMICALNOTIN and  bbbbb1 GENEIN eeeee1  content were also less pronounced with  bbbbb2 CHEMICALIN eeeee2  treatment
CPR:3	Additionally, in SH-SY5Y cells, CHEMICALIN-induced demethylation of  bbbbb1 GENEIN eeeee1  (GENEIN), the master regulator of the cellular phosphoregulatory network, and cytotoxicity were ameliorated by  bbbbb2 CHEMICALIN eeeee2 
CPR:3	Additionally, in SH-SY5Y cells, CHEMICALIN-induced demethylation of GENEIN ( bbbbb1 GENEIN eeeee1 ), the master regulator of the cellular phosphoregulatory network, and cytotoxicity were ameliorated by  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Additionally, in SH-SY5Y cells,  bbbbb1 CHEMICALIN eeeee1 -induced demethylation of  bbbbb2 GENEIN eeeee2  (GENEIN), the master regulator of the cellular phosphoregulatory network, and cytotoxicity were ameliorated by CHEMICALIN
CPR:4	Additionally, in SH-SY5Y cells,  bbbbb1 CHEMICALIN eeeee1 -induced demethylation of GENEIN ( bbbbb2 GENEIN eeeee2 ), the master regulator of the cellular phosphoregulatory network, and cytotoxicity were ameliorated by CHEMICALIN
CPR:4	The neuroinflammatory response to CHEMICALNOTIN was markedly attenuated, and indices of oxidative stress and  bbbbb1 GENEIN eeeee1  activation were significantly prevented with  bbbbb2 CHEMICALIN eeeee2 
CPR:4	In cultured primary microglia and astrocytes,  bbbbb1 CHEMICALIN eeeee1  had a direct anti-inflammatory effect demonstrated by repression of lipopolysaccharide-induced  bbbbb2 GENEIN eeeee2  activation, GENEIN induction, and CHEMICALNOTIN production
CPR:4	In cultured primary microglia and astrocytes,  bbbbb1 CHEMICALIN eeeee1  had a direct anti-inflammatory effect demonstrated by repression of lipopolysaccharide-induced GENEIN activation,  bbbbb2 GENEIN eeeee2  induction, and CHEMICALNOTIN production
CPR:2	Substantial evidence shows that  bbbbb1 CHEMICALIN eeeee1  is involved in aging by inhibiting free-radical reactions, activating GENEIN, and probably interacting with the age-related gene  bbbbb2 GENEIN eeeee2 
CPR:3	Substantial evidence shows that  bbbbb1 CHEMICALIN eeeee1  is involved in aging by inhibiting free-radical reactions, activating  bbbbb2 GENEIN eeeee2 , and probably interacting with the age-related gene GENEIN
CPR:10	The induction of  bbbbb1 GENEIN eeeee1  by EIH was inhibited by CHEMICALIN but not by  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, nor CHEMICALIN
CPR:10	The induction of  bbbbb1 GENEIN eeeee1  by EIH was inhibited by CHEMICALIN but not by CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , nor CHEMICALIN
CPR:10	The induction of  bbbbb1 GENEIN eeeee1  by EIH was inhibited by CHEMICALIN but not by CHEMICALIN, CHEMICALIN, nor  bbbbb2 CHEMICALIN eeeee2 
CPR:3	nduction of  bbbbb1 GENEIN eeeee1  through GENEIN GENEIN/GENENOTIN signaling pathway by  bbbbb2 CHEMICALIN eeeee2  extract of Inula helenium L. reduces inflammation in LPS-activated RAW 264.7 cells and CLP-induced septic mice
CPR:3	nduction of GENEIN through  bbbbb1 GENEIN eeeee1  GENEIN/GENENOTIN signaling pathway by  bbbbb2 CHEMICALIN eeeee2  extract of Inula helenium L. reduces inflammation in LPS-activated RAW 264.7 cells and CLP-induced septic mice
CPR:3	nduction of GENEIN through GENEIN  bbbbb1 GENEIN eeeee1 /GENENOTIN signaling pathway by  bbbbb2 CHEMICALIN eeeee2  extract of Inula helenium L. reduces inflammation in LPS-activated RAW 264.7 cells and CLP-induced septic mice
CPR:4	The induction of  bbbbb1 GENEIN eeeee1  by EIH was inhibited by  bbbbb2 CHEMICALIN eeeee2  but not by CHEMICALIN, CHEMICALIN, nor CHEMICALIN
CPR:2	GENEIN expression is induced by dietary  bbbbb1 CHEMICALIN eeeee1  by a mechanism that involves the  bbbbb2 GENEIN eeeee2  (GENEIN), a CHEMICALIN-activated nuclear receptor
CPR:2	GENEIN expression is induced by dietary  bbbbb1 CHEMICALIN eeeee1  by a mechanism that involves the GENEIN ( bbbbb2 GENEIN eeeee2 ), a CHEMICALIN-activated nuclear receptor
CPR:3	GENEIN expression is induced by dietary CHEMICALIN by a mechanism that involves the  bbbbb1 GENEIN eeeee1  (GENEIN), a  bbbbb2 CHEMICALIN eeeee2 -activated nuclear receptor
CPR:3	GENEIN expression is induced by dietary CHEMICALIN by a mechanism that involves the GENEIN ( bbbbb1 GENEIN eeeee1 ), a  bbbbb2 CHEMICALIN eeeee2 -activated nuclear receptor
CPR:3	 bbbbb1 GENEIN eeeee1  expression is induced by dietary  bbbbb2 CHEMICALIN eeeee2  by a mechanism that involves the GENEIN (GENEIN), a CHEMICALIN-activated nuclear receptor
CPR:4	In mice, this reduction in  bbbbb1 GENEIN eeeee1  expression is due primarily to downregulation by  bbbbb2 CHEMICALIN eeeee2 
CPR:9	Analysis of natural genetic variation among inbred strains of mice indicates that  bbbbb1 GENEIN eeeee1  and  bbbbb2 CHEMICALIN eeeee2  are significantly correlated, and CHEMICALNOTIN levels explain 11% of the variation in atherosclerosis.
CPR:9	We demonstrate that two  bbbbb1 GENEIN eeeee1  family members, GENEIN and GENEIN, oxidize CHEMICALIN (CHEMICALIN), derived from gut flora metabolism of CHEMICALIN, to  bbbbb2 CHEMICALIN eeeee2 
CPR:9	We demonstrate that two GENEIN family members,  bbbbb1 GENEIN eeeee1  and GENEIN, oxidize CHEMICALIN (CHEMICALIN), derived from gut flora metabolism of CHEMICALIN, to  bbbbb2 CHEMICALIN eeeee2 
CPR:9	We demonstrate that two GENEIN family members, GENEIN and  bbbbb1 GENEIN eeeee1 , oxidize CHEMICALIN (CHEMICALIN), derived from gut flora metabolism of CHEMICALIN, to  bbbbb2 CHEMICALIN eeeee2 
CPR:9	GENEIN overexpression in mice significantly increases plasma CHEMICALIN levels while silencing  bbbbb1 GENEIN eeeee1  decreases  bbbbb2 CHEMICALIN eeeee2  levels
CPR:9	We demonstrate that two  bbbbb1 GENEIN eeeee1  family members, GENEIN and GENEIN, oxidize  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), derived from gut flora metabolism of CHEMICALIN, to CHEMICALIN
CPR:9	We demonstrate that two GENEIN family members,  bbbbb1 GENEIN eeeee1  and GENEIN, oxidize  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), derived from gut flora metabolism of CHEMICALIN, to CHEMICALIN
CPR:9	We demonstrate that two GENEIN family members, GENEIN and  bbbbb1 GENEIN eeeee1 , oxidize  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), derived from gut flora metabolism of CHEMICALIN, to CHEMICALIN
CPR:9	We demonstrate that two  bbbbb1 GENEIN eeeee1  family members, GENEIN and GENEIN, oxidize CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), derived from gut flora metabolism of CHEMICALIN, to CHEMICALIN
CPR:9	We demonstrate that two GENEIN family members,  bbbbb1 GENEIN eeeee1  and GENEIN, oxidize CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), derived from gut flora metabolism of CHEMICALIN, to CHEMICALIN
CPR:9	We demonstrate that two GENEIN family members, GENEIN and  bbbbb1 GENEIN eeeee1 , oxidize CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), derived from gut flora metabolism of CHEMICALIN, to CHEMICALIN
CPR:9	We demonstrate that two  bbbbb1 GENEIN eeeee1  family members, GENEIN and GENEIN, oxidize CHEMICALIN (CHEMICALIN), derived from gut flora metabolism of  bbbbb2 CHEMICALIN eeeee2 , to CHEMICALIN
CPR:9	We demonstrate that two GENEIN family members,  bbbbb1 GENEIN eeeee1  and GENEIN, oxidize CHEMICALIN (CHEMICALIN), derived from gut flora metabolism of  bbbbb2 CHEMICALIN eeeee2 , to CHEMICALIN
CPR:9	We demonstrate that two GENEIN family members, GENEIN and  bbbbb1 GENEIN eeeee1 , oxidize CHEMICALIN (CHEMICALIN), derived from gut flora metabolism of  bbbbb2 CHEMICALIN eeeee2 , to CHEMICALIN
CPR:9	 bbbbb1 GENEIN eeeee1  overexpression in mice significantly increases plasma  bbbbb2 CHEMICALIN eeeee2  levels while silencing GENEIN decreases CHEMICALIN levels
CPR:2	However, other  bbbbb1 CHEMICALIN eeeee1 , including CHEMICALIN, CHEMICALIN and CHEMICALIN, which have a saturated A ring containing a CHEMICALIN and a C19 CHEMICALIN group, also mediate physiological responses through binding to  bbbbb2 GENEIN eeeee2  (GENEIN) and GENEIN
CPR:2	However, other  bbbbb1 CHEMICALIN eeeee1 , including CHEMICALIN, CHEMICALIN and CHEMICALIN, which have a saturated A ring containing a CHEMICALIN and a C19 CHEMICALIN group, also mediate physiological responses through binding to GENEIN ( bbbbb2 GENEIN eeeee2 ) and GENEIN
CPR:2	However, other  bbbbb1 CHEMICALIN eeeee1 , including CHEMICALIN, CHEMICALIN and CHEMICALIN, which have a saturated A ring containing a CHEMICALIN and a C19 CHEMICALIN group, also mediate physiological responses through binding to GENEIN (GENEIN) and  bbbbb2 GENEIN eeeee2 
CPR:2	However, other CHEMICALIN, including  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and CHEMICALIN, which have a saturated A ring containing a CHEMICALIN and a C19 CHEMICALIN group, also mediate physiological responses through binding to  bbbbb2 GENEIN eeeee2  (GENEIN) and GENEIN
CPR:2	However, other CHEMICALIN, including  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and CHEMICALIN, which have a saturated A ring containing a CHEMICALIN and a C19 CHEMICALIN group, also mediate physiological responses through binding to GENEIN ( bbbbb2 GENEIN eeeee2 ) and GENEIN
CPR:2	However, other CHEMICALIN, including  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and CHEMICALIN, which have a saturated A ring containing a CHEMICALIN and a C19 CHEMICALIN group, also mediate physiological responses through binding to GENEIN (GENEIN) and  bbbbb2 GENEIN eeeee2 
CPR:2	However, other CHEMICALIN, including CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, which have a saturated A ring containing a CHEMICALIN and a C19 CHEMICALIN group, also mediate physiological responses through binding to  bbbbb2 GENEIN eeeee2  (GENEIN) and GENEIN
CPR:2	However, other CHEMICALIN, including CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, which have a saturated A ring containing a CHEMICALIN and a C19 CHEMICALIN group, also mediate physiological responses through binding to GENEIN ( bbbbb2 GENEIN eeeee2 ) and GENEIN
CPR:2	However, other CHEMICALIN, including CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, which have a saturated A ring containing a CHEMICALIN and a C19 CHEMICALIN group, also mediate physiological responses through binding to GENEIN (GENEIN) and  bbbbb2 GENEIN eeeee2 
CPR:2	However, other CHEMICALIN, including CHEMICALIN, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , which have a saturated A ring containing a CHEMICALIN and a C19 CHEMICALIN group, also mediate physiological responses through binding to  bbbbb2 GENEIN eeeee2  (GENEIN) and GENEIN
CPR:2	However, other CHEMICALIN, including CHEMICALIN, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , which have a saturated A ring containing a CHEMICALIN and a C19 CHEMICALIN group, also mediate physiological responses through binding to GENEIN ( bbbbb2 GENEIN eeeee2 ) and GENEIN
CPR:2	However, other CHEMICALIN, including CHEMICALIN, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , which have a saturated A ring containing a CHEMICALIN and a C19 CHEMICALIN group, also mediate physiological responses through binding to GENEIN (GENEIN) and  bbbbb2 GENEIN eeeee2 
CPR:2	However, other CHEMICALIN, including CHEMICALIN, CHEMICALIN and CHEMICALIN, which have a saturated A ring containing a  bbbbb1 CHEMICALIN eeeee1  and a C19 CHEMICALIN group, also mediate physiological responses through binding to  bbbbb2 GENEIN eeeee2  (GENEIN) and GENEIN
CPR:2	However, other CHEMICALIN, including CHEMICALIN, CHEMICALIN and CHEMICALIN, which have a saturated A ring containing a  bbbbb1 CHEMICALIN eeeee1  and a C19 CHEMICALIN group, also mediate physiological responses through binding to GENEIN ( bbbbb2 GENEIN eeeee2 ) and GENEIN
CPR:2	However, other CHEMICALIN, including CHEMICALIN, CHEMICALIN and CHEMICALIN, which have a saturated A ring containing a  bbbbb1 CHEMICALIN eeeee1  and a C19 CHEMICALIN group, also mediate physiological responses through binding to GENEIN (GENEIN) and  bbbbb2 GENEIN eeeee2 
CPR:2	However, other CHEMICALIN, including CHEMICALIN, CHEMICALIN and CHEMICALIN, which have a saturated A ring containing a CHEMICALIN and a C19  bbbbb1 CHEMICALIN eeeee1  group, also mediate physiological responses through binding to  bbbbb2 GENEIN eeeee2  (GENEIN) and GENEIN
CPR:2	However, other CHEMICALIN, including CHEMICALIN, CHEMICALIN and CHEMICALIN, which have a saturated A ring containing a CHEMICALIN and a C19  bbbbb1 CHEMICALIN eeeee1  group, also mediate physiological responses through binding to GENEIN ( bbbbb2 GENEIN eeeee2 ) and GENEIN
CPR:2	However, other CHEMICALIN, including CHEMICALIN, CHEMICALIN and CHEMICALIN, which have a saturated A ring containing a CHEMICALIN and a C19  bbbbb1 CHEMICALIN eeeee1  group, also mediate physiological responses through binding to GENEIN (GENEIN) and  bbbbb2 GENEIN eeeee2 
CPR:2	Moreover, selective  bbbbb1 CHEMICALIN eeeee1  response modulators (SERMs) with diverse structures also regulate transcription of  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:2	Moreover, selective  bbbbb1 CHEMICALIN eeeee1  response modulators (SERMs) with diverse structures also regulate transcription of GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:2	Further studies of the role of these  bbbbb1 CHEMICALIN eeeee1  and SERMs in regulating responses mediated by  bbbbb2 GENEIN eeeee2  and GENEIN a variety of tissues, during different stages of development, are likely to uncover additional estrogenic activities.
CPR:2	Further studies of the role of these  bbbbb1 CHEMICALIN eeeee1  and SERMs in regulating responses mediated by GENEIN and  bbbbb2 GENEIN eeeee2  a variety of tissues, during different stages of development, are likely to uncover additional estrogenic activities.
CPR:4	Synthesis of  bbbbb1 CHEMICALIN eeeee1  derivatives: discovery of a potent and selective  bbbbb2 GENEIN eeeee2  inhibitor for the treatment of Alzheimer's disease
CPR:9	GENEIN ( bbbbb1 GENEIN eeeee1 ) mediates the degradation of  bbbbb2 CHEMICALIN eeeee2  in a variety of tissues including brain
CPR:9	 bbbbb1 GENEIN eeeee1  (GENEIN) mediates the degradation of  bbbbb2 CHEMICALIN eeeee2  in a variety of tissues including brain
CPR:2	A novel potent compound,  bbbbb1 CHEMICALIN eeeee1  (12c), which binds  bbbbb2 GENEIN eeeee2  with an IC(50) value of 54 nM was obtained
CPR:4	A novel potent compound,  bbbbb1 CHEMICALIN eeeee1  (12c), which binds  bbbbb2 GENEIN eeeee2  with an IC(50) value of 54 nM was obtained
CPR:4	We have previously reported a nanomolar inhibitor of antiapoptotic  bbbbb1 GENEIN eeeee1  protein,  bbbbb2 CHEMICALIN eeeee2  (S1)
CPR:4	Fragment-based design, synthesis, and biological evaluation of  bbbbb1 CHEMICALIN eeeee1  derivatives as novel  bbbbb2 GENEIN eeeee2  inhibitors
CPR:3	 bbbbb1 CHEMICALIN eeeee1 , a CHEMICALIN (CHEMICALIN)ylated peptide-based erythropoiesis-stimulating agent, stimulates the  bbbbb2 GENEIN eeeee2  dimer that governs erythropoiesis
CPR:3	CHEMICALIN, a  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN)ylated peptide-based erythropoiesis-stimulating agent, stimulates the  bbbbb2 GENEIN eeeee2  dimer that governs erythropoiesis
CPR:3	CHEMICALIN, a CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 )ylated peptide-based erythropoiesis-stimulating agent, stimulates the  bbbbb2 GENEIN eeeee2  dimer that governs erythropoiesis
CPR:2	Electron paramagnetic resonance (EPR) studies using  bbbbb1 CHEMICALIN eeeee1  analog spin label probes showed that GENEIN heads are highly ordered in the relaxed fibers and have very low  bbbbb2 GENEIN eeeee2  activity
CPR:2	Electron paramagnetic resonance (EPR) studies using  bbbbb1 CHEMICALIN eeeee1  analog spin label probes showed that  bbbbb2 GENEIN eeeee2  heads are highly ordered in the relaxed fibers and have very low GENEIN activity
CPR:2	GENENOTIN-induced cytoskeleton reorganization therefore makes a previously unrecognized but critically important contribution to the profibrotic activities of  bbbbb1 CHEMICALIN eeeee1  by driving  bbbbb2 GENEIN eeeee2 -dependent GENEIN expression, which, in turn, drives fibroblast proliferation.-Sakai, N., Chun, J., Duffield, J
CPR:2	There has been much recent interest in CHEMICALIN (CHEMICALNOTIN) signaling through one of its receptors, GENEIN, in fibrotic diseases, but the mechanisms by which  bbbbb1 CHEMICALIN eeeee1 - bbbbb2 GENEIN eeeee2  signaling promotes pathological fibrosis remain to be fully elucidated
CPR:2	There has been much recent interest in  bbbbb1 CHEMICALIN eeeee1  (CHEMICALNOTIN) signaling through one of its receptors,  bbbbb2 GENEIN eeeee2 , in fibrotic diseases, but the mechanisms by which CHEMICALIN-GENEIN signaling promotes pathological fibrosis remain to be fully elucidated
CPR:3	GENENOTIN-induced cytoskeleton reorganization therefore makes a previously unrecognized but critically important contribution to the profibrotic activities of  bbbbb1 CHEMICALIN eeeee1  by driving GENEIN-dependent  bbbbb2 GENEIN eeeee2  expression, which, in turn, drives fibroblast proliferation.-Sakai, N., Chun, J., Duffield, J
CPR:2	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  possessed similar affinity for  bbbbb2 GENEIN eeeee2 
CPR:2	We hypothesized that  bbbbb1 CHEMICALIN eeeee1  metabolites have lower affinity than CHEMICALIN toward  bbbbb2 GENEIN eeeee2  and limited ability to induce cooperative effects during metabolism
CPR:2	We hypothesized that CHEMICALIN metabolites have lower affinity than  bbbbb1 CHEMICALIN eeeee1  toward  bbbbb2 GENEIN eeeee2  and limited ability to induce cooperative effects during metabolism
CPR:2	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN possessed similar affinity for  bbbbb2 GENEIN eeeee2 
CPR:2	Cooperative effects for  bbbbb1 GENEIN eeeee1  differ between  bbbbb2 CHEMICALIN eeeee2  and its metabolites
CPR:3	 bbbbb1 CHEMICALIN eeeee1  are signaling molecules that activate GENEIN, such as GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN, and play a critical role in the regulation of lipid, CHEMICALNOTIN, energy, and drug metabolism
CPR:3	 bbbbb1 CHEMICALIN eeeee1  are signaling molecules that activate GENEIN, such as GENEIN, GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2 , and play a critical role in the regulation of lipid, CHEMICALNOTIN, energy, and drug metabolism
CPR:3	 bbbbb1 CHEMICALIN eeeee1  are signaling molecules that activate  bbbbb2 GENEIN eeeee2 , such as GENEIN, GENEIN, GENEIN, and GENEIN, and play a critical role in the regulation of lipid, CHEMICALNOTIN, energy, and drug metabolism
CPR:3	 bbbbb1 CHEMICALIN eeeee1  are signaling molecules that activate GENEIN, such as  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN, and GENEIN, and play a critical role in the regulation of lipid, CHEMICALNOTIN, energy, and drug metabolism
CPR:3	 bbbbb1 CHEMICALIN eeeee1  are signaling molecules that activate GENEIN, such as GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN, and play a critical role in the regulation of lipid, CHEMICALNOTIN, energy, and drug metabolism
CPR:2	The peptide  bbbbb1 CHEMICALIN eeeee1  (YLEIEFSLKHR), obtained by direct substitution of CHEMICALIN with a CHEMICALIN residue in the template sequence, significantly (p<0.05) inhibited  bbbbb2 GENEIN eeeee2 -GENEIN binding, and GENEIN induced GENEIN activity and formation of multinucleated osteoclasts without any cytotoxicity
CPR:2	The peptide  bbbbb1 CHEMICALIN eeeee1  (YLEIEFSLKHR), obtained by direct substitution of CHEMICALIN with a CHEMICALIN residue in the template sequence, significantly (p<0.05) inhibited GENEIN- bbbbb2 GENEIN eeeee2  binding, and GENEIN induced GENEIN activity and formation of multinucleated osteoclasts without any cytotoxicity
CPR:2	The peptide CHEMICALIN (YLEIEFSLKHR), obtained by direct substitution of  bbbbb1 CHEMICALIN eeeee1  with a CHEMICALIN residue in the template sequence, significantly (p<0.05) inhibited  bbbbb2 GENEIN eeeee2 -GENEIN binding, and GENEIN induced GENEIN activity and formation of multinucleated osteoclasts without any cytotoxicity
CPR:2	The peptide CHEMICALIN (YLEIEFSLKHR), obtained by direct substitution of  bbbbb1 CHEMICALIN eeeee1  with a CHEMICALIN residue in the template sequence, significantly (p<0.05) inhibited GENEIN- bbbbb2 GENEIN eeeee2  binding, and GENEIN induced GENEIN activity and formation of multinucleated osteoclasts without any cytotoxicity
CPR:2	The peptide CHEMICALIN (YLEIEFSLKHR), obtained by direct substitution of CHEMICALIN with a  bbbbb1 CHEMICALIN eeeee1  residue in the template sequence, significantly (p<0.05) inhibited  bbbbb2 GENEIN eeeee2 -GENEIN binding, and GENEIN induced GENEIN activity and formation of multinucleated osteoclasts without any cytotoxicity
CPR:2	The peptide CHEMICALIN (YLEIEFSLKHR), obtained by direct substitution of CHEMICALIN with a  bbbbb1 CHEMICALIN eeeee1  residue in the template sequence, significantly (p<0.05) inhibited GENEIN- bbbbb2 GENEIN eeeee2  binding, and GENEIN induced GENEIN activity and formation of multinucleated osteoclasts without any cytotoxicity
CPR:4	Results confirmed that  bbbbb1 CHEMICALIN eeeee1  peptide inhibited pro-inflammatory GENEIN in the sera and hind paw tissues of AIA rats through its suppressive effect on GENEIN induced nuclear translocation of  bbbbb2 GENEIN eeeee2 
CPR:4	The peptide  bbbbb1 CHEMICALIN eeeee1  (YLEIEFSLKHR), obtained by direct substitution of CHEMICALIN with a CHEMICALIN residue in the template sequence, significantly (p<0.05) inhibited GENEIN-GENEIN binding, and  bbbbb2 GENEIN eeeee2  induced GENEIN activity and formation of multinucleated osteoclasts without any cytotoxicity
CPR:4	The peptide  bbbbb1 CHEMICALIN eeeee1  (YLEIEFSLKHR), obtained by direct substitution of CHEMICALIN with a CHEMICALIN residue in the template sequence, significantly (p<0.05) inhibited GENEIN-GENEIN binding, and GENEIN induced  bbbbb2 GENEIN eeeee2  activity and formation of multinucleated osteoclasts without any cytotoxicity
CPR:4	The peptide CHEMICALIN (YLEIEFSLKHR), obtained by direct substitution of  bbbbb1 CHEMICALIN eeeee1  with a CHEMICALIN residue in the template sequence, significantly (p<0.05) inhibited GENEIN-GENEIN binding, and  bbbbb2 GENEIN eeeee2  induced GENEIN activity and formation of multinucleated osteoclasts without any cytotoxicity
CPR:4	The peptide CHEMICALIN (YLEIEFSLKHR), obtained by direct substitution of  bbbbb1 CHEMICALIN eeeee1  with a CHEMICALIN residue in the template sequence, significantly (p<0.05) inhibited GENEIN-GENEIN binding, and GENEIN induced  bbbbb2 GENEIN eeeee2  activity and formation of multinucleated osteoclasts without any cytotoxicity
CPR:4	The peptide CHEMICALIN (YLEIEFSLKHR), obtained by direct substitution of CHEMICALIN with a  bbbbb1 CHEMICALIN eeeee1  residue in the template sequence, significantly (p<0.05) inhibited GENEIN-GENEIN binding, and  bbbbb2 GENEIN eeeee2  induced GENEIN activity and formation of multinucleated osteoclasts without any cytotoxicity
CPR:4	The peptide CHEMICALIN (YLEIEFSLKHR), obtained by direct substitution of CHEMICALIN with a  bbbbb1 CHEMICALIN eeeee1  residue in the template sequence, significantly (p<0.05) inhibited GENEIN-GENEIN binding, and GENEIN induced  bbbbb2 GENEIN eeeee2  activity and formation of multinucleated osteoclasts without any cytotoxicity
CPR:4	Results confirmed that  bbbbb1 CHEMICALIN eeeee1  peptide inhibited pro-inflammatory  bbbbb2 GENEIN eeeee2  in the sera and hind paw tissues of AIA rats through its suppressive effect on GENEIN induced nuclear translocation of GENEIN
CPR:4	Results confirmed that  bbbbb1 CHEMICALIN eeeee1  peptide inhibited pro-inflammatory GENEIN in the sera and hind paw tissues of AIA rats through its suppressive effect on  bbbbb2 GENEIN eeeee2  induced nuclear translocation of GENEIN
CPR:2	RESULTS: In contrast to immune stimulatory sequence ISS 1018, BCG DNA spontaneously formed nanoparticulate structures and induced  bbbbb1 GENEIN eeeee1  polymerization as did synthetic  bbbbb2 CHEMICALIN eeeee2  nanoparticles
CPR:3	The activation of  bbbbb1 GENEIN eeeee1  was induced by  bbbbb2 CHEMICALIN eeeee2  nanoparticles as well as BCG DNA and is suggested as the critical signaling event inducing both cytoskeleton changes as well as inflammatory cell activation
CPR:2	In this small library of novel bioactive macrocyclic  bbbbb1 CHEMICALIN eeeee1  derivatives, designed to evaluate structure-activity relationships essential in overcoming multidrug resistance (MDR), some correlations between MDR reversal and molecular weight, accessible solvent areas, and CHEMICALNOTIN/water partition coefficient were identified that can contribute to the development of new selective  bbbbb2 GENEIN eeeee2  reversal agents.
CPR:3	Additionally, these effects of  bbbbb1 CHEMICALIN eeeee1  on -GENEIN, GENEIN, GENEIN, GENEIN, and GENEIN(GENEIN/GENEIN) were reduced by an  bbbbb2 GENEIN eeeee2  inhibitor
CPR:3	Osteoblasts survive the  bbbbb1 CHEMICALIN eeeee1  treatment by activation of  bbbbb2 GENEIN eeeee2 -mediated pathway
CPR:3	Additionally, these effects of  bbbbb1 CHEMICALIN eeeee1  on -GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN, and GENEIN(GENEIN/GENEIN) were reduced by an GENEIN inhibitor
CPR:3	Additionally, these effects of  bbbbb1 CHEMICALIN eeeee1  on -GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN(GENEIN/GENEIN) were reduced by an GENEIN inhibitor
CPR:3	Additionally, these effects of  bbbbb1 CHEMICALIN eeeee1  on -GENEIN, GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN(GENEIN/GENEIN) were reduced by an GENEIN inhibitor
CPR:3	Additionally, these effects of  bbbbb1 CHEMICALIN eeeee1  on -GENEIN, GENEIN, GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2 (GENEIN/GENEIN) were reduced by an GENEIN inhibitor
CPR:3	Additionally, these effects of  bbbbb1 CHEMICALIN eeeee1  on -GENEIN, GENEIN, GENEIN, GENEIN, and GENEIN( bbbbb2 GENEIN eeeee2 /GENEIN) were reduced by an GENEIN inhibitor
CPR:3	Additionally, these effects of  bbbbb1 CHEMICALIN eeeee1  on -GENEIN, GENEIN, GENEIN, GENEIN, and GENEIN(GENEIN/ bbbbb2 GENEIN eeeee2 ) were reduced by an GENEIN inhibitor
CPR:3	Additionally, these effects of  bbbbb1 CHEMICALIN eeeee1  on - bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN, GENEIN, and GENEIN(GENEIN/GENEIN) were reduced by an GENEIN inhibitor
CPR:3	Furthermore, a mixture of  bbbbb1 CHEMICALIN eeeee1  parent compounds, and a mixture of CHEMICALIN metabolites were found to have  bbbbb2 GENEIN eeeee2  activating abilities
CPR:3	Furthermore, a mixture of CHEMICALIN parent compounds, and a mixture of  bbbbb1 CHEMICALIN eeeee1  metabolites were found to have  bbbbb2 GENEIN eeeee2  activating abilities
CPR:10	Both  bbbbb1 CHEMICALIN eeeee1 , but CHEMICALIN to a lesser extent compared with CHEMICALIN, selectively and dose-dependently reduced the percentage of GENEIN-expressing Th cells in a GENEIN-dependent fashion, whereas the expression of the cell surface marker  bbbbb2 GENEIN eeeee2  was unaltered on activated T cells
CPR:10	Both CHEMICALIN, but  bbbbb1 CHEMICALIN eeeee1  to a lesser extent compared with CHEMICALIN, selectively and dose-dependently reduced the percentage of GENEIN-expressing Th cells in a GENEIN-dependent fashion, whereas the expression of the cell surface marker  bbbbb2 GENEIN eeeee2  was unaltered on activated T cells
CPR:10	Both CHEMICALIN, but CHEMICALIN to a lesser extent compared with  bbbbb1 CHEMICALIN eeeee1 , selectively and dose-dependently reduced the percentage of GENEIN-expressing Th cells in a GENEIN-dependent fashion, whereas the expression of the cell surface marker  bbbbb2 GENEIN eeeee2  was unaltered on activated T cells
CPR:10	In monocytes, both  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN increased GENEIN without affecting  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:10	In monocytes, both  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN increased GENEIN without affecting GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:10	In monocytes, both CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  increased GENEIN without affecting  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:10	In monocytes, both CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  increased GENEIN without affecting GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:2	Both  bbbbb1 CHEMICALIN eeeee1 , but CHEMICALIN to a lesser extent compared with CHEMICALIN, selectively and dose-dependently reduced the percentage of GENEIN-expressing Th cells in a  bbbbb2 GENEIN eeeee2 -dependent fashion, whereas the expression of the cell surface marker GENEIN was unaltered on activated T cells
CPR:2	Both CHEMICALIN, but  bbbbb1 CHEMICALIN eeeee1  to a lesser extent compared with CHEMICALIN, selectively and dose-dependently reduced the percentage of GENEIN-expressing Th cells in a  bbbbb2 GENEIN eeeee2 -dependent fashion, whereas the expression of the cell surface marker GENEIN was unaltered on activated T cells
CPR:2	Both CHEMICALIN, but CHEMICALIN to a lesser extent compared with  bbbbb1 CHEMICALIN eeeee1 , selectively and dose-dependently reduced the percentage of GENEIN-expressing Th cells in a  bbbbb2 GENEIN eeeee2 -dependent fashion, whereas the expression of the cell surface marker GENEIN was unaltered on activated T cells
CPR:3	In monocytes, both  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN increased  bbbbb2 GENEIN eeeee2  without affecting GENEIN and GENEIN
CPR:3	In monocytes, both CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  increased  bbbbb2 GENEIN eeeee2  without affecting GENEIN and GENEIN
CPR:4	Both  bbbbb1 CHEMICALIN eeeee1 , but CHEMICALIN to a lesser extent compared with CHEMICALIN, selectively and dose-dependently reduced the percentage of  bbbbb2 GENEIN eeeee2 -expressing Th cells in a GENEIN-dependent fashion, whereas the expression of the cell surface marker GENEIN was unaltered on activated T cells
CPR:4	Both CHEMICALIN, but  bbbbb1 CHEMICALIN eeeee1  to a lesser extent compared with CHEMICALIN, selectively and dose-dependently reduced the percentage of  bbbbb2 GENEIN eeeee2 -expressing Th cells in a GENEIN-dependent fashion, whereas the expression of the cell surface marker GENEIN was unaltered on activated T cells
CPR:4	Both CHEMICALIN, but CHEMICALIN to a lesser extent compared with  bbbbb1 CHEMICALIN eeeee1 , selectively and dose-dependently reduced the percentage of  bbbbb2 GENEIN eeeee2 -expressing Th cells in a GENEIN-dependent fashion, whereas the expression of the cell surface marker GENEIN was unaltered on activated T cells
CPR:9	In the in vitro model we observed high permeability of  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN with the  bbbbb2 GENEIN eeeee2 -mediated efflux ratios of 0.53 and 0.06, as well as medium permeability of CHEMICALIN with 0.82
CPR:9	In the in vitro model we observed high permeability of CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  with the  bbbbb2 GENEIN eeeee2 -mediated efflux ratios of 0.53 and 0.06, as well as medium permeability of CHEMICALIN with 0.82
CPR:9	In the in vitro model we observed high permeability of CHEMICALIN and CHEMICALIN with the  bbbbb1 GENEIN eeeee1 -mediated efflux ratios of 0.53 and 0.06, as well as medium permeability of  bbbbb2 CHEMICALIN eeeee2  with 0.82
CPR:2	In agreement with these data, the exogenous treatment of  bbbbb1 CHEMICALIN eeeee1  or inhibition of GENEIN by specific siRNA or another type of inhibitor, CHEMICALIN (CHEMICALIN), similarly resulted in antitumorigenic responses, suppressive activity on GENEIN, the alteration of  bbbbb2 GENEIN eeeee2  cytoskeleton, and a change of the colocalization pattern between GENEIN and GENEIN
CPR:2	In agreement with these data, the exogenous treatment of  bbbbb1 CHEMICALIN eeeee1  or inhibition of GENEIN by specific siRNA or another type of inhibitor, CHEMICALIN (CHEMICALIN), similarly resulted in antitumorigenic responses, suppressive activity on GENEIN, the alteration of GENEIN cytoskeleton, and a change of the colocalization pattern between  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:2	In agreement with these data, the exogenous treatment of  bbbbb1 CHEMICALIN eeeee1  or inhibition of GENEIN by specific siRNA or another type of inhibitor, CHEMICALIN (CHEMICALIN), similarly resulted in antitumorigenic responses, suppressive activity on GENEIN, the alteration of GENEIN cytoskeleton, and a change of the colocalization pattern between GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:2	Involvement of  bbbbb1 GENEIN eeeee1  and the GENEIN cytoskeleton in the antitumorigenic action of  bbbbb2 CHEMICALIN eeeee2 
CPR:2	Involvement of GENEIN and the  bbbbb1 GENEIN eeeee1  cytoskeleton in the antitumorigenic action of  bbbbb2 CHEMICALIN eeeee2 
CPR:2	Taken together, these results suggest that  bbbbb1 CHEMICALIN eeeee1 /GENENOTIN-mediated transmethylation could be linked to the tumorigenic processes through cross-regulation between the  bbbbb2 GENEIN eeeee2  cytoskeleton and GENEIN GENEIN activity.
CPR:2	Taken together, these results suggest that  bbbbb1 CHEMICALIN eeeee1 /GENENOTIN-mediated transmethylation could be linked to the tumorigenic processes through cross-regulation between the GENEIN cytoskeleton and  bbbbb2 GENEIN eeeee2  GENEIN activity.
CPR:2	Taken together, these results suggest that  bbbbb1 CHEMICALIN eeeee1 /GENENOTIN-mediated transmethylation could be linked to the tumorigenic processes through cross-regulation between the GENEIN cytoskeleton and GENEIN  bbbbb2 GENEIN eeeee2  activity.
CPR:4	In agreement with these data, the exogenous treatment of  bbbbb1 CHEMICALIN eeeee1  or inhibition of GENEIN by specific siRNA or another type of inhibitor, CHEMICALIN (CHEMICALIN), similarly resulted in antitumorigenic responses, suppressive activity on  bbbbb2 GENEIN eeeee2 , the alteration of GENEIN cytoskeleton, and a change of the colocalization pattern between GENEIN and GENEIN
CPR:4	Through immunoblotting analysis, it was found that  bbbbb1 CHEMICALIN eeeee1  was capable of indirectly diminishing the phosphorylation of oncogenic  bbbbb2 GENEIN eeeee2  and its GENEIN activity
CPR:4	Interestingly,  bbbbb1 CHEMICALIN eeeee1  disrupted GENEIN cytoskeleton structures, leading to morphological changes, and suppressed the formation of a signaling complex composed of  bbbbb2 GENEIN eeeee2  and GENEIN/GENEIN, which is linked to various tumorigenic responses
CPR:4	Interestingly,  bbbbb1 CHEMICALIN eeeee1  disrupted GENEIN cytoskeleton structures, leading to morphological changes, and suppressed the formation of a signaling complex composed of GENEIN and  bbbbb2 GENEIN eeeee2 /GENEIN, which is linked to various tumorigenic responses
CPR:4	Interestingly,  bbbbb1 CHEMICALIN eeeee1  disrupted GENEIN cytoskeleton structures, leading to morphological changes, and suppressed the formation of a signaling complex composed of GENEIN and GENEIN/ bbbbb2 GENEIN eeeee2 , which is linked to various tumorigenic responses
CPR:4	Through immunoblotting analysis, it was found that  bbbbb1 CHEMICALIN eeeee1  was capable of indirectly diminishing the phosphorylation of oncogenic GENEIN and its  bbbbb2 GENEIN eeeee2  activity
CPR:4	Interestingly,  bbbbb1 CHEMICALIN eeeee1  disrupted  bbbbb2 GENEIN eeeee2  cytoskeleton structures, leading to morphological changes, and suppressed the formation of a signaling complex composed of GENEIN and GENEIN/GENEIN, which is linked to various tumorigenic responses
CPR:4	In agreement with these data, the exogenous treatment of CHEMICALIN or inhibition of  bbbbb1 GENEIN eeeee1  by specific siRNA or another type of inhibitor,  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), similarly resulted in antitumorigenic responses, suppressive activity on GENEIN, the alteration of GENEIN cytoskeleton, and a change of the colocalization pattern between GENEIN and GENEIN
CPR:4	In agreement with these data, the exogenous treatment of CHEMICALIN or inhibition of  bbbbb1 GENEIN eeeee1  by specific siRNA or another type of inhibitor, CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), similarly resulted in antitumorigenic responses, suppressive activity on GENEIN, the alteration of GENEIN cytoskeleton, and a change of the colocalization pattern between GENEIN and GENEIN
CPR:4	Treatment with  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), an inhibitor of transmethylation-suppressive  bbbbb2 GENEIN eeeee2  (GENEIN), enhanced the level of CHEMICALIN and effectively blocked the proliferation, migration, and invasion of cancer cells; the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dose-dependent manner
CPR:4	Treatment with  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), an inhibitor of transmethylation-suppressive GENEIN ( bbbbb2 GENEIN eeeee2 ), enhanced the level of CHEMICALIN and effectively blocked the proliferation, migration, and invasion of cancer cells; the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dose-dependent manner
CPR:4	Treatment with CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), an inhibitor of transmethylation-suppressive  bbbbb2 GENEIN eeeee2  (GENEIN), enhanced the level of CHEMICALIN and effectively blocked the proliferation, migration, and invasion of cancer cells; the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dose-dependent manner
CPR:4	Treatment with CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), an inhibitor of transmethylation-suppressive GENEIN ( bbbbb2 GENEIN eeeee2 ), enhanced the level of CHEMICALIN and effectively blocked the proliferation, migration, and invasion of cancer cells; the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dose-dependent manner
CPR:9	Treatment with CHEMICALIN (CHEMICALIN), an inhibitor of transmethylation-suppressive  bbbbb1 GENEIN eeeee1  (GENEIN), enhanced the level of  bbbbb2 CHEMICALIN eeeee2  and effectively blocked the proliferation, migration, and invasion of cancer cells; the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dose-dependent manner
CPR:9	Treatment with CHEMICALIN (CHEMICALIN), an inhibitor of transmethylation-suppressive GENEIN ( bbbbb1 GENEIN eeeee1 ), enhanced the level of  bbbbb2 CHEMICALIN eeeee2  and effectively blocked the proliferation, migration, and invasion of cancer cells; the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dose-dependent manner
CPR:4	A series of  bbbbb1 GENEIN eeeee1  inhibitors have been identified based upon a  bbbbb2 CHEMICALIN eeeee2  scaffold using structure-based drug design methods
CPR:4	Synthesis of derivatives of  bbbbb1 CHEMICALIN eeeee1  and their inhibitory activities against GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:4	Synthesis of derivatives of  bbbbb1 CHEMICALIN eeeee1  and their inhibitory activities against  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:9	All the compounds were evaluated for their anti-tumor activity against MCF-7, A549 and B16-F10 tumor cell lines as well as  bbbbb1 GENEIN eeeee1  (GENEIN)-derived  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) inhibitory activity of murine macrophage RAW 264.7 cell line
CPR:9	All the compounds were evaluated for their anti-tumor activity against MCF-7, A549 and B16-F10 tumor cell lines as well as GENEIN ( bbbbb1 GENEIN eeeee1 )-derived  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) inhibitory activity of murine macrophage RAW 264.7 cell line
CPR:9	All the compounds were evaluated for their anti-tumor activity against MCF-7, A549 and B16-F10 tumor cell lines as well as  bbbbb1 GENEIN eeeee1  (GENEIN)-derived CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) inhibitory activity of murine macrophage RAW 264.7 cell line
CPR:9	All the compounds were evaluated for their anti-tumor activity against MCF-7, A549 and B16-F10 tumor cell lines as well as GENEIN ( bbbbb1 GENEIN eeeee1 )-derived CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) inhibitory activity of murine macrophage RAW 264.7 cell line
CPR:2	It had higher levels of  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a nutraceutical compound exerting actions against  bbbbb2 GENEIN eeeee2  and GENEIN (GENEIN)
CPR:2	It had higher levels of  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a nutraceutical compound exerting actions against GENEIN and  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:2	It had higher levels of  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a nutraceutical compound exerting actions against GENEIN and GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:2	It had higher levels of CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a nutraceutical compound exerting actions against  bbbbb2 GENEIN eeeee2  and GENEIN (GENEIN)
CPR:2	It had higher levels of CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a nutraceutical compound exerting actions against GENEIN and  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:2	It had higher levels of CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a nutraceutical compound exerting actions against GENEIN and GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:9	Its head-space aroma displayed new volatile phytomolecules and also had higher levels of green volatiles from the  bbbbb1 GENEIN eeeee1  (GENEIN)-pathway (one having as precursors the  bbbbb2 CHEMICALIN eeeee2  containing a CHEMICALIN system)
CPR:9	Its head-space aroma displayed new volatile phytomolecules and also had higher levels of green volatiles from the GENEIN ( bbbbb1 GENEIN eeeee1 )-pathway (one having as precursors the  bbbbb2 CHEMICALIN eeeee2  containing a CHEMICALIN system)
CPR:9	Its head-space aroma displayed new volatile phytomolecules and also had higher levels of green volatiles from the  bbbbb1 GENEIN eeeee1  (GENEIN)-pathway (one having as precursors the CHEMICALIN containing a  bbbbb2 CHEMICALIN eeeee2  system)
CPR:9	Its head-space aroma displayed new volatile phytomolecules and also had higher levels of green volatiles from the GENEIN ( bbbbb1 GENEIN eeeee1 )-pathway (one having as precursors the CHEMICALIN containing a  bbbbb2 CHEMICALIN eeeee2  system)
CPR:2	The contrasting activity of  bbbbb1 CHEMICALIN eeeee1  versus CHEMICALIN and CHEMICALIN anticancer complexes: control of cell selectivity, cross-resistance,  bbbbb2 GENEIN eeeee2  dependence, and apoptosis pathway
CPR:2	The contrasting activity of CHEMICALIN versus  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN anticancer complexes: control of cell selectivity, cross-resistance,  bbbbb2 GENEIN eeeee2  dependence, and apoptosis pathway
CPR:2	The contrasting activity of CHEMICALIN versus CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  anticancer complexes: control of cell selectivity, cross-resistance,  bbbbb2 GENEIN eeeee2  dependence, and apoptosis pathway
CPR:2	The  bbbbb1 CHEMICALIN eeeee1  complexes retain potency in  bbbbb2 GENEIN eeeee2  mutant colon cells
CPR:4	In general, antiproliferative activity is greatly enhanced by low levels of the  bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2 
CPR:9	The recent identification of  bbbbb1 CHEMICALIN eeeee1  permeability of the lysosomal GENENOTIN  bbbbb2 GENEIN eeeee2  (GENEIN), and the evidence of abnormal CHEMICALNOTIN levels in cells deficient in GENENOTIN, suggested a role for GENEINin CHEMICALIN transport
CPR:9	The recent identification of  bbbbb1 CHEMICALIN eeeee1  permeability of the lysosomal GENENOTIN GENEIN ( bbbbb2 GENEIN eeeee2 ), and the evidence of abnormal CHEMICALNOTIN levels in cells deficient in GENENOTIN, suggested a role for GENEINin CHEMICALIN transport
CPR:9	The recent identification of CHEMICALIN permeability of the lysosomal GENENOTIN GENEIN (GENEIN), and the evidence of abnormal CHEMICALNOTIN levels in cells deficient in GENENOTIN, suggested a role for  bbbbb1 GENEIN eeeee1 in  bbbbb2 CHEMICALIN eeeee2  transport
CPR:9	Cellular  bbbbb1 CHEMICALIN eeeee1  is controlled by  bbbbb2 GENEIN eeeee2  and by GENEIN
CPR:9	Cellular  bbbbb1 CHEMICALIN eeeee1  is controlled by GENEIN and by  bbbbb2 GENEIN eeeee2 
CPR:9	These results underscore a role for  bbbbb1 GENEIN eeeee1 in  bbbbb2 CHEMICALIN eeeee2  metabolism
CPR:9	Furthermore, they suggest that  bbbbb1 GENEIN eeeee1  works in concert with GENEIN to regulate  bbbbb2 CHEMICALIN eeeee2  translocation between the cytoplasm and lysosomes.
CPR:9	Furthermore, they suggest that GENEIN works in concert with  bbbbb1 GENEIN eeeee1  to regulate  bbbbb2 CHEMICALIN eeeee2  translocation between the cytoplasm and lysosomes.
CPR:2	Similarly, intraperitoneal administration of  bbbbb1 CHEMICALIN eeeee1  (100mg/kg BW) and sandalwood oil (1g/kg BW) for two weeks modulated parameters such as serum GENEIN, GENEIN, CHEMICALNOTIN, GENEIN,  bbbbb2 GENEIN eeeee2 , free CHEMICALNOTIN, protein CHEMICALNOTIN, CHEMICALNOTIN, liver lipid CHEMICALNOTIN contents, and antioxidant capacity in CHEMICALNOTIN mediated oxidative stress induced mice
CPR:2	Similarly, intraperitoneal administration of  bbbbb1 CHEMICALIN eeeee1  (100mg/kg BW) and sandalwood oil (1g/kg BW) for two weeks modulated parameters such as serum  bbbbb2 GENEIN eeeee2 , GENEIN, CHEMICALNOTIN, GENEIN, GENEIN, free CHEMICALNOTIN, protein CHEMICALNOTIN, CHEMICALNOTIN, liver lipid CHEMICALNOTIN contents, and antioxidant capacity in CHEMICALNOTIN mediated oxidative stress induced mice
CPR:2	Similarly, intraperitoneal administration of  bbbbb1 CHEMICALIN eeeee1  (100mg/kg BW) and sandalwood oil (1g/kg BW) for two weeks modulated parameters such as serum GENEIN,  bbbbb2 GENEIN eeeee2 , CHEMICALNOTIN, GENEIN, GENEIN, free CHEMICALNOTIN, protein CHEMICALNOTIN, CHEMICALNOTIN, liver lipid CHEMICALNOTIN contents, and antioxidant capacity in CHEMICALNOTIN mediated oxidative stress induced mice
CPR:2	Similarly, intraperitoneal administration of  bbbbb1 CHEMICALIN eeeee1  (100mg/kg BW) and sandalwood oil (1g/kg BW) for two weeks modulated parameters such as serum GENEIN, GENEIN, CHEMICALNOTIN,  bbbbb2 GENEIN eeeee2 , GENEIN, free CHEMICALNOTIN, protein CHEMICALNOTIN, CHEMICALNOTIN, liver lipid CHEMICALNOTIN contents, and antioxidant capacity in CHEMICALNOTIN mediated oxidative stress induced mice
CPR:10	The increase in GENEIN expression is specific to CHEMICALIN-induced liver damage, because  bbbbb1 GENEIN eeeee1  expression was not induced by other hepatotoxic drugs such as  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, or CHEMICALIN
CPR:10	The increase in GENEIN expression is specific to CHEMICALIN-induced liver damage, because  bbbbb1 GENEIN eeeee1  expression was not induced by other hepatotoxic drugs such as CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , or CHEMICALIN
CPR:10	The increase in GENEIN expression is specific to CHEMICALIN-induced liver damage, because  bbbbb1 GENEIN eeeee1  expression was not induced by other hepatotoxic drugs such as CHEMICALIN, CHEMICALIN, or  bbbbb2 CHEMICALIN eeeee2 
CPR:10	Our in vitro studies showed that  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) accumulation was not a primary cause of the CHEMICALIN-induced  bbbbb2 GENEIN eeeee2  increase
CPR:10	Our in vitro studies showed that CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) accumulation was not a primary cause of the CHEMICALIN-induced  bbbbb2 GENEIN eeeee2  increase
CPR:2	The tocolytic agent  bbbbb1 CHEMICALIN eeeee1  acts on the  bbbbb2 GENEIN eeeee2  and is an effective treatment option for preterm labor
CPR:3	Importantly, expression of the acute-phase reactant  bbbbb1 GENEIN eeeee1  (GENEIN) significantly increased after  bbbbb2 CHEMICALIN eeeee2  injection, with values indicating the largest fold-change
CPR:3	Importantly, expression of the acute-phase reactant GENEIN ( bbbbb1 GENEIN eeeee1 ) significantly increased after  bbbbb2 CHEMICALIN eeeee2  injection, with values indicating the largest fold-change
CPR:3	 bbbbb1 GENEIN eeeee1  upsurge precedes standard biomarkers of hepatotoxicity in  bbbbb2 CHEMICALIN eeeee2 -injected mice
CPR:3	The increase in  bbbbb1 GENEIN eeeee1  expression is specific to  bbbbb2 CHEMICALIN eeeee2 -induced liver damage, because GENEIN expression was not induced by other hepatotoxic drugs such as CHEMICALIN, CHEMICALIN, or CHEMICALIN
CPR:3	Our in vitro studies showed that CHEMICALIN (CHEMICALIN) accumulation was not a primary cause of the  bbbbb1 CHEMICALIN eeeee1 -induced  bbbbb2 GENEIN eeeee2  increase
CPR:10	Pharmacodynamic data suggest that CHEMICALIN-CHEMICALIN is rapidly bactericidal versus  bbbbb1 GENEIN eeeee1 -producing Gram-negative bacilli that are not inhibited by  bbbbb2 CHEMICALIN eeeee2  alone.Clinical trials to date have reported that CHEMICALNOTIN-CHEMICALNOTIN is as effective as standard CHEMICALNOTIN therapy in complicated intra-abdominal infection and complicated urinary tract infection, including infection caused by CHEMICALNOTIN-resistant Gram-negative isolates
CPR:2	Although not a CHEMICALNOTIN, the chemical structure of CHEMICALNOTIN closely resembles portions of the  bbbbb1 CHEMICALIN eeeee1  bicyclic ring system, and CHEMICALIN has been shown to bond covalently to  bbbbb2 GENEIN eeeee2 
CPR:2	Although not a CHEMICALNOTIN, the chemical structure of CHEMICALNOTIN closely resembles portions of the CHEMICALIN bicyclic ring system, and  bbbbb1 CHEMICALIN eeeee1  has been shown to bond covalently to  bbbbb2 GENEIN eeeee2 
CPR:2	Potential future roles for  bbbbb1 CHEMICALIN eeeee1 -CHEMICALIN include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing  bbbbb2 GENEIN eeeee2  (GENEIN), GENEIN (GENEIN) and/or GENEIN
CPR:2	Potential future roles for  bbbbb1 CHEMICALIN eeeee1 -CHEMICALIN include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing GENEIN ( bbbbb2 GENEIN eeeee2 ), GENEIN (GENEIN) and/or GENEIN
CPR:2	Potential future roles for  bbbbb1 CHEMICALIN eeeee1 -CHEMICALIN include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing GENEIN (GENEIN),  bbbbb2 GENEIN eeeee2  (GENEIN) and/or GENEIN
CPR:2	Potential future roles for  bbbbb1 CHEMICALIN eeeee1 -CHEMICALIN include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing GENEIN (GENEIN), GENEIN ( bbbbb2 GENEIN eeeee2 ) and/or GENEIN
CPR:2	Potential future roles for  bbbbb1 CHEMICALIN eeeee1 -CHEMICALIN include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing GENEIN (GENEIN), GENEIN (GENEIN) and/or  bbbbb2 GENEIN eeeee2 
CPR:2	Potential future roles for CHEMICALIN- bbbbb1 CHEMICALIN eeeee1  include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing  bbbbb2 GENEIN eeeee2  (GENEIN), GENEIN (GENEIN) and/or GENEIN
CPR:2	Potential future roles for CHEMICALIN- bbbbb1 CHEMICALIN eeeee1  include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing GENEIN ( bbbbb2 GENEIN eeeee2 ), GENEIN (GENEIN) and/or GENEIN
CPR:2	Potential future roles for CHEMICALIN- bbbbb1 CHEMICALIN eeeee1  include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing GENEIN (GENEIN),  bbbbb2 GENEIN eeeee2  (GENEIN) and/or GENEIN
CPR:2	Potential future roles for CHEMICALIN- bbbbb1 CHEMICALIN eeeee1  include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing GENEIN (GENEIN), GENEIN ( bbbbb2 GENEIN eeeee2 ) and/or GENEIN
CPR:2	Potential future roles for CHEMICALIN- bbbbb1 CHEMICALIN eeeee1  include the treatment of suspected or documented infections caused by resistant Gram-negative-bacilli producing GENEIN (GENEIN), GENEIN (GENEIN) and/or  bbbbb2 GENEIN eeeee2 
CPR:4	Pharmacodynamic data suggest that  bbbbb1 CHEMICALIN eeeee1 -CHEMICALIN is rapidly bactericidal versus  bbbbb2 GENEIN eeeee2 -producing Gram-negative bacilli that are not inhibited by CHEMICALIN alone.Clinical trials to date have reported that CHEMICALNOTIN-CHEMICALNOTIN is as effective as standard CHEMICALNOTIN therapy in complicated intra-abdominal infection and complicated urinary tract infection, including infection caused by CHEMICALNOTIN-resistant Gram-negative isolates
CPR:4	Pharmacodynamic data suggest that CHEMICALIN- bbbbb1 CHEMICALIN eeeee1  is rapidly bactericidal versus  bbbbb2 GENEIN eeeee2 -producing Gram-negative bacilli that are not inhibited by CHEMICALIN alone.Clinical trials to date have reported that CHEMICALNOTIN-CHEMICALNOTIN is as effective as standard CHEMICALNOTIN therapy in complicated intra-abdominal infection and complicated urinary tract infection, including infection caused by CHEMICALNOTIN-resistant Gram-negative isolates
CPR:4	CHEMICALIN (formerly  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN) is a synthetic non-CHEMICALNOTIN, GENEIN inhibitor that inhibits the activities of GENENOTIN and some  bbbbb2 GENEIN eeeee2  enzymes
CPR:4	CHEMICALIN (formerly  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN) is a synthetic non-CHEMICALNOTIN,  bbbbb2 GENEIN eeeee2  inhibitor that inhibits the activities of GENENOTIN and some GENEIN enzymes
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (formerly CHEMICALIN, CHEMICALIN) is a synthetic non-CHEMICALNOTIN, GENEIN inhibitor that inhibits the activities of GENENOTIN and some  bbbbb2 GENEIN eeeee2  enzymes
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (formerly CHEMICALIN, CHEMICALIN) is a synthetic non-CHEMICALNOTIN,  bbbbb2 GENEIN eeeee2  inhibitor that inhibits the activities of GENENOTIN and some GENEIN enzymes
CPR:4	CHEMICALNOTIN-CHEMICALNOTIN appears to be well tolerated in healthy subjects and hospitalized patients, with few serious drug-related treatment-emergent adverse events reported to date.In conclusion,  bbbbb1 CHEMICALIN eeeee1  serves to broaden the spectrum of CHEMICALIN versus  bbbbb2 GENEIN eeeee2 -producing Gram-negative bacilli
CPR:4	CHEMICALNOTIN-CHEMICALNOTIN appears to be well tolerated in healthy subjects and hospitalized patients, with few serious drug-related treatment-emergent adverse events reported to date.In conclusion, CHEMICALIN serves to broaden the spectrum of  bbbbb1 CHEMICALIN eeeee1  versus  bbbbb2 GENEIN eeeee2 -producing Gram-negative bacilli
CPR:4	CHEMICALIN (formerly CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ) is a synthetic non-CHEMICALNOTIN, GENEIN inhibitor that inhibits the activities of GENENOTIN and some  bbbbb2 GENEIN eeeee2  enzymes
CPR:4	CHEMICALIN (formerly CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 ) is a synthetic non-CHEMICALNOTIN,  bbbbb2 GENEIN eeeee2  inhibitor that inhibits the activities of GENENOTIN and some GENEIN enzymes
CPR:4	The addition of  bbbbb1 CHEMICALIN eeeee1  greatly (4-1024-fold minimum inhibitory concentration [MIC] reduction) improves the activity of CHEMICALIN versus most species of Enterobacteriaceae depending on the presence or absence of  bbbbb2 GENEIN eeeee2  enzyme(s)
CPR:4	The addition of CHEMICALIN greatly (4-1024-fold minimum inhibitory concentration [MIC] reduction) improves the activity of  bbbbb1 CHEMICALIN eeeee1  versus most species of Enterobacteriaceae depending on the presence or absence of  bbbbb2 GENEIN eeeee2  enzyme(s)
CPR:4	 bbbbb1 CHEMICALIN eeeee1 -CHEMICALIN: a novel CHEMICALNOTIN/ bbbbb2 GENEIN eeeee2  inhibitor combination
CPR:4	CHEMICALIN- bbbbb1 CHEMICALIN eeeee1 : a novel CHEMICALNOTIN/ bbbbb2 GENEIN eeeee2  inhibitor combination
CPR:4	Moreover, treatment of high-fat-diet-fed GENENOTIN-knockout mice with a selective  bbbbb1 GENEIN eeeee1  inhibitor,  bbbbb2 CHEMICALIN eeeee2 , improved vascular function, and also attenuated obesity
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) is a new small molecule  bbbbb2 GENEIN eeeee2  inhibitor
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) is a new small molecule  bbbbb2 GENEIN eeeee2  inhibitor
CPR:1	Moreover, we show that  bbbbb1 GENEIN eeeee1  is acetylated on multiple  bbbbb2 CHEMICALIN eeeee2  residues and that alteration of a single CHEMICALIN (K129) within the GENEIN is sufficient to alter interaction of the GENENOTIN with the core GENENOTIN complex
CPR:1	Moreover, we show that GENEIN is acetylated on multiple CHEMICALIN residues and that alteration of a single  bbbbb1 CHEMICALIN eeeee1  (K129) within the  bbbbb2 GENEIN eeeee2  is sufficient to alter interaction of the GENENOTIN with the core GENENOTIN complex
CPR:2	Transcripts of GENENOTIN genes were more highly expressed in most tissues examined in vivo (except blood, head kidney and spleen), whereas those of the  bbbbb1 GENEIN eeeee1  genes were more responsive to  bbbbb2 CHEMICALIN eeeee2  exposure in vitro, especially to the organic form
CPR:2	Interestingly,  bbbbb1 GENEIN eeeee1  was the most sensitive to  bbbbb2 CHEMICALIN eeeee2  availability in non stressful conditions, whereas GENEIN and GENEIN were highly induced by exposure to CHEMICALIN levels that had some toxic effects on the cells
CPR:2	Our results lead us to conclude that trout  bbbbb1 GENEIN eeeee1  transcripts expression level may represent a sensitive biomarker for  bbbbb2 CHEMICALIN eeeee2  intake, helping to evaluate if CHEMICALNOTIN concentration and chemical speciation impact on cell homeostasis.
CPR:2	Characterization of  bbbbb1 GENEIN eeeee1  and GENEIN genes in rainbow trout (Oncorhynchus mykiss) and their modulation by in vitro  bbbbb2 CHEMICALIN eeeee2  exposure
CPR:2	Characterization of GENEIN and  bbbbb1 GENEIN eeeee1  genes in rainbow trout (Oncorhynchus mykiss) and their modulation by in vitro  bbbbb2 CHEMICALIN eeeee2  exposure
CPR:3	Interestingly, GENEIN was the most sensitive to CHEMICALIN availability in non stressful conditions, whereas  bbbbb1 GENEIN eeeee1  and GENEIN were highly induced by exposure to  bbbbb2 CHEMICALIN eeeee2  levels that had some toxic effects on the cells
CPR:3	Interestingly, GENEIN was the most sensitive to CHEMICALIN availability in non stressful conditions, whereas GENEIN and  bbbbb1 GENEIN eeeee1  were highly induced by exposure to  bbbbb2 CHEMICALIN eeeee2  levels that had some toxic effects on the cells
CPR:3	These findings are the first to show that long-term exposure to  bbbbb1 CHEMICALIN eeeee1  during a critical period of neurodevelopment causes motor coordination dysfunction with parallel increment in oxidative stress markers,  bbbbb2 GENEIN eeeee2 (GENEIN) phosphorylation and GENEIN activity in the striatum
CPR:3	These findings are the first to show that long-term exposure to  bbbbb1 CHEMICALIN eeeee1  during a critical period of neurodevelopment causes motor coordination dysfunction with parallel increment in oxidative stress markers, GENEIN( bbbbb2 GENEIN eeeee2 ) phosphorylation and GENEIN activity in the striatum
CPR:3	These findings are the first to show that long-term exposure to  bbbbb1 CHEMICALIN eeeee1  during a critical period of neurodevelopment causes motor coordination dysfunction with parallel increment in oxidative stress markers, GENEIN(GENEIN) phosphorylation and  bbbbb2 GENEIN eeeee2  activity in the striatum
CPR:3	 bbbbb1 CHEMICALIN eeeee1  exposure (20mg/kg) increased  bbbbb2 GENEIN eeeee2 (GENEIN) and GENEIN phosphorylation, but decreased GENEIN-Thr-34 phosphorylation
CPR:3	 bbbbb1 CHEMICALIN eeeee1  exposure (20mg/kg) increased GENEIN( bbbbb2 GENEIN eeeee2 ) and GENEIN phosphorylation, but decreased GENEIN-Thr-34 phosphorylation
CPR:3	 bbbbb1 CHEMICALIN eeeee1  exposure (20mg/kg) increased GENEIN(GENEIN) and  bbbbb2 GENEIN eeeee2  phosphorylation, but decreased GENEIN-Thr-34 phosphorylation
CPR:3	 bbbbb1 CHEMICALIN eeeee1  (10 and 20mg/kg) increased  bbbbb2 GENEIN eeeee2  activity and CHEMICALNOTIN production (a biological marker of lipid peroxidation)
CPR:3	Notably, the antioxidant CHEMICALIN reversed the  bbbbb1 CHEMICALIN eeeee1  (20mg/kg)-dependent augmentation in  bbbbb2 GENEIN eeeee2 (GENEIN) phosphorylation and reduced the CHEMICALIN (20mg/kg)-induced GENEIN activity and CHEMICALNOTIN production
CPR:3	Notably, the antioxidant CHEMICALIN reversed the  bbbbb1 CHEMICALIN eeeee1  (20mg/kg)-dependent augmentation in GENEIN( bbbbb2 GENEIN eeeee2 ) phosphorylation and reduced the CHEMICALIN (20mg/kg)-induced GENEIN activity and CHEMICALNOTIN production
CPR:3	Notably, the antioxidant CHEMICALIN reversed the CHEMICALIN (20mg/kg)-dependent augmentation in GENEIN(GENEIN) phosphorylation and reduced the  bbbbb1 CHEMICALIN eeeee1  (20mg/kg)-induced  bbbbb2 GENEIN eeeee2  activity and CHEMICALNOTIN production
CPR:4	 bbbbb1 CHEMICALIN eeeee1  exposure (20mg/kg) increased GENEIN(GENEIN) and GENEIN phosphorylation, but decreased  bbbbb2 GENEIN eeeee2 -Thr-34 phosphorylation
CPR:4	Notably, the antioxidant  bbbbb1 CHEMICALIN eeeee1  reversed the CHEMICALIN (20mg/kg)-dependent augmentation in  bbbbb2 GENEIN eeeee2 (GENEIN) phosphorylation and reduced the CHEMICALIN (20mg/kg)-induced GENEIN activity and CHEMICALNOTIN production
CPR:4	Notably, the antioxidant  bbbbb1 CHEMICALIN eeeee1  reversed the CHEMICALIN (20mg/kg)-dependent augmentation in GENEIN( bbbbb2 GENEIN eeeee2 ) phosphorylation and reduced the CHEMICALIN (20mg/kg)-induced GENEIN activity and CHEMICALNOTIN production
CPR:4	Notably, the antioxidant  bbbbb1 CHEMICALIN eeeee1  reversed the CHEMICALIN (20mg/kg)-dependent augmentation in GENEIN(GENEIN) phosphorylation and reduced the CHEMICALIN (20mg/kg)-induced  bbbbb2 GENEIN eeeee2  activity and CHEMICALNOTIN production
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (1) reduced the pro-inflammatory factor such as CHEMICALNOTIN (CHEMICALNOTIN), CHEMICALNOTIN (CHEMICALNOTIN) and  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (1) reduced the pro-inflammatory factor such as CHEMICALNOTIN (CHEMICALNOTIN), CHEMICALNOTIN (CHEMICALNOTIN) and GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:4	Investigating the enteroenteric recirculation of  bbbbb1 CHEMICALIN eeeee1 , a  bbbbb2 GENEIN eeeee2  inhibitor: administration of activated charcoal to bile duct-cannulated rats and dogs receiving an intravenous dose and use of drug transporter knockout rats
CPR:4	The fecal elimination, IC, and systemic clearance of CHEMICALNOTIN were increased upon AC administration in both BDC rats and dogs and were decreased in BDC rats dosed with  bbbbb1 CHEMICALIN eeeee1 , a dual  bbbbb2 GENEIN eeeee2  and GENEIN inhibitor)
CPR:4	The fecal elimination, IC, and systemic clearance of CHEMICALNOTIN were increased upon AC administration in both BDC rats and dogs and were decreased in BDC rats dosed with  bbbbb1 CHEMICALIN eeeee1 , a dual GENEIN and  bbbbb2 GENEIN eeeee2  inhibitor)
CPR:9	 bbbbb1 GENEIN eeeee1  appeared to play a more important role for absorption and intestinal and renal elimination of  bbbbb2 CHEMICALIN eeeee2  than GENEIN in transporter-KO rats after oral and i.v. dosing, which led to a higher level of active renal excretion in rat than other species
CPR:9	GENEIN appeared to play a more important role for absorption and intestinal and renal elimination of  bbbbb1 CHEMICALIN eeeee1  than  bbbbb2 GENEIN eeeee2  in transporter-KO rats after oral and i.v. dosing, which led to a higher level of active renal excretion in rat than other species
CPR:1	The enzyme (GENEIN) has a very high catalytic activity for the CHEMICALIN hydration reaction, being similar kinetically to the human (h) isoform  bbbbb1 GENEIN eeeee1 , although it is devoid of the  bbbbb2 CHEMICALIN eeeee2 64 proton shuttle
CPR:4	A large number of  bbbbb1 CHEMICALIN eeeee1  and some CHEMICALIN were investigated as  bbbbb2 GENEIN eeeee2  inhibitors
CPR:4	A large number of CHEMICALIN and some  bbbbb1 CHEMICALIN eeeee1  were investigated as  bbbbb2 GENEIN eeeee2  inhibitors
CPR:4	Cloning, Characterization, and  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN Inhibition Studies of an  bbbbb2 GENEIN eeeee2  from Trypanosoma cruzi, the Causative Agent of Chagas Disease
CPR:4	Cloning, Characterization, and CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  Inhibition Studies of an  bbbbb2 GENEIN eeeee2  from Trypanosoma cruzi, the Causative Agent of Chagas Disease
CPR:9	The enzyme (GENEIN) has a very high catalytic activity for the  bbbbb1 CHEMICALIN eeeee1  hydration reaction, being similar kinetically to the human (h) isoform  bbbbb2 GENEIN eeeee2 , although it is devoid of the CHEMICALIN64 proton shuttle
CPR:9	The enzyme ( bbbbb1 GENEIN eeeee1 ) has a very high catalytic activity for the  bbbbb2 CHEMICALIN eeeee2  hydration reaction, being similar kinetically to the human (h) isoform GENEIN, although it is devoid of the CHEMICALIN64 proton shuttle
CPR:10	However, there were detectable concentrations of GENEIN, GENEIN and GENEIN mRNAs but undetectable concentrations of  bbbbb1 GENEIN eeeee1 , GENEIN and GENEIN in the  bbbbb2 CHEMICALIN eeeee2 -treated testes, indicating that these GENENOTIN(pos) cells were newly formed progenitor Leydig cells
CPR:10	However, there were detectable concentrations of GENEIN, GENEIN and GENEIN mRNAs but undetectable concentrations of GENEIN,  bbbbb1 GENEIN eeeee1  and GENEIN in the  bbbbb2 CHEMICALIN eeeee2 -treated testes, indicating that these GENENOTIN(pos) cells were newly formed progenitor Leydig cells
CPR:10	However, there were detectable concentrations of GENEIN, GENEIN and GENEIN mRNAs but undetectable concentrations of GENEIN, GENEIN and  bbbbb1 GENEIN eeeee1  in the  bbbbb2 CHEMICALIN eeeee2 -treated testes, indicating that these GENENOTIN(pos) cells were newly formed progenitor Leydig cells
CPR:10	The mRNA level for  bbbbb1 GENEIN eeeee1  (GENEIN, biomarker for stem Leydig cells) was significantly increased in the control testis on day 4 post-CHEMICALIN, but not in the  bbbbb2 CHEMICALIN eeeee2  treated testes, suggesting that these GENENOTIN positive stem cells were differentiated into progenitor Leydig cells in the CHEMICALNOTIN-treated testes
CPR:10	The mRNA level for GENEIN ( bbbbb1 GENEIN eeeee1 , biomarker for stem Leydig cells) was significantly increased in the control testis on day 4 post-CHEMICALIN, but not in the  bbbbb2 CHEMICALIN eeeee2  treated testes, suggesting that these GENENOTIN positive stem cells were differentiated into progenitor Leydig cells in the CHEMICALNOTIN-treated testes
CPR:2	However, there were detectable concentrations of  bbbbb1 GENEIN eeeee1 , GENEIN and GENEIN mRNAs but undetectable concentrations of GENEIN, GENEIN and GENEIN in the  bbbbb2 CHEMICALIN eeeee2 -treated testes, indicating that these GENENOTIN(pos) cells were newly formed progenitor Leydig cells
CPR:2	However, there were detectable concentrations of GENEIN,  bbbbb1 GENEIN eeeee1  and GENEIN mRNAs but undetectable concentrations of GENEIN, GENEIN and GENEIN in the  bbbbb2 CHEMICALIN eeeee2 -treated testes, indicating that these GENENOTIN(pos) cells were newly formed progenitor Leydig cells
CPR:2	However, there were detectable concentrations of GENEIN, GENEIN and  bbbbb1 GENEIN eeeee1  mRNAs but undetectable concentrations of GENEIN, GENEIN and GENEIN in the  bbbbb2 CHEMICALIN eeeee2 -treated testes, indicating that these GENENOTIN(pos) cells were newly formed progenitor Leydig cells
CPR:3	The mRNA level for  bbbbb1 GENEIN eeeee1  (GENEIN, biomarker for stem Leydig cells) was significantly increased in the control testis on day 4 post- bbbbb2 CHEMICALIN eeeee2 , but not in the CHEMICALIN treated testes, suggesting that these GENENOTIN positive stem cells were differentiated into progenitor Leydig cells in the CHEMICALNOTIN-treated testes
CPR:3	The mRNA level for GENEIN ( bbbbb1 GENEIN eeeee1 , biomarker for stem Leydig cells) was significantly increased in the control testis on day 4 post- bbbbb2 CHEMICALIN eeeee2 , but not in the CHEMICALIN treated testes, suggesting that these GENENOTIN positive stem cells were differentiated into progenitor Leydig cells in the CHEMICALNOTIN-treated testes
CPR:2	Expression of pituitary  bbbbb1 GENEIN eeeee1  and GENEIN, under the control of pulsatile  bbbbb2 CHEMICALIN eeeee2 , is essential for fertility
CPR:2	Expression of pituitary GENEIN and  bbbbb1 GENEIN eeeee1 , under the control of pulsatile  bbbbb2 CHEMICALIN eeeee2 , is essential for fertility
CPR:2	We hypothesized that GENEIN is activated by a distinct signaling pathway in response to pulsatile  bbbbb1 CHEMICALIN eeeee1  in a frequency-dependent manner to dictate the  bbbbb2 GENEIN eeeee2  transcriptional response
CPR:2	A GENENOTIN (GENENOTIN) reduced CHEMICALIN-stimulated GENEIN and markedly decreased  bbbbb1 CHEMICALIN eeeee1  stimulation of GENEIN mRNA and GENEINLUC activity, but had little effect on  bbbbb2 GENEIN eeeee2 LUC activity, indicating relative specificity of this pathway
CPR:3	A GENENOTIN (GENENOTIN) reduced  bbbbb1 CHEMICALIN eeeee1 -stimulated  bbbbb2 GENEIN eeeee2  and markedly decreased CHEMICALIN stimulation of GENEIN mRNA and GENEINLUC activity, but had little effect on GENEINLUC activity, indicating relative specificity of this pathway
CPR:3	A GENENOTIN (GENENOTIN) reduced CHEMICALIN-stimulated GENEIN and markedly decreased  bbbbb1 CHEMICALIN eeeee1  stimulation of GENEIN mRNA and  bbbbb2 GENEIN eeeee2 LUC activity, but had little effect on GENEINLUC activity, indicating relative specificity of this pathway
CPR:3	In perifusion studies, GENEIN mRNA levels and  bbbbb1 GENEIN eeeee1 LUC activities were increased by pulsatile  bbbbb2 CHEMICALIN eeeee2 , with significantly greater increases at low compared with high pulse frequencies
CPR:3	 bbbbb1 CHEMICALIN eeeee1  pulse frequency-dependent stimulation of GENEIN transcription is mediated via activation of GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:3	 bbbbb1 CHEMICALIN eeeee1  pulse frequency-dependent stimulation of GENEIN transcription is mediated via activation of  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:3	Correlating with  bbbbb1 GENEIN eeeee1  activation, both GENEIN activity and levels of GENEIN were increased to a greater extent by low compared with high  bbbbb2 CHEMICALIN eeeee2  pulse frequencies, and the induction of GENEIN was also attenuated by overexpression of GENENOTIN at both low and high pulse frequencies
CPR:3	Correlating with GENEIN activation, both  bbbbb1 GENEIN eeeee1  activity and levels of GENEIN were increased to a greater extent by low compared with high  bbbbb2 CHEMICALIN eeeee2  pulse frequencies, and the induction of GENEIN was also attenuated by overexpression of GENENOTIN at both low and high pulse frequencies
CPR:3	Correlating with GENEIN activation, both GENEIN activity and levels of GENEIN were increased to a greater extent by low compared with high  bbbbb1 CHEMICALIN eeeee1  pulse frequencies, and the induction of  bbbbb2 GENEIN eeeee2  was also attenuated by overexpression of GENENOTIN at both low and high pulse frequencies
CPR:3	Taken together, these data indicate that a GENENOTIN-mediated signaling pathway mediates  bbbbb1 CHEMICALIN eeeee1  activation of  bbbbb2 GENEIN eeeee2  at low-pulse frequencies, playing a significant role in the decoding of the hypothalamic CHEMICALIN signal to result in frequency-dependent GENEIN activation.
CPR:3	Taken together, these data indicate that a GENENOTIN-mediated signaling pathway mediates CHEMICALIN activation of GENEIN at low-pulse frequencies, playing a significant role in the decoding of the hypothalamic  bbbbb1 CHEMICALIN eeeee1  signal to result in frequency-dependent  bbbbb2 GENEIN eeeee2  activation.
CPR:3	GENENOTIN (GENENOTIN) has been implicated in the regulation of GENENOTIN gene expression, but the molecular mechanisms by which pulsatile  bbbbb1 CHEMICALIN eeeee1  regulates  bbbbb2 GENEIN eeeee2  activation remain poorly understood
CPR:3	We hypothesized that  bbbbb1 GENEIN eeeee1  is activated by a distinct signaling pathway in response to pulsatile  bbbbb2 CHEMICALIN eeeee2  in a frequency-dependent manner to dictate the GENEIN transcriptional response
CPR:3	 bbbbb1 CHEMICALIN eeeee1  stimulation of  bbbbb2 GENEIN eeeee2  phosphorylation (GENEIN) in the gonadotrope-derived LT2 cell line was attenuated by a GENEIN (GENEIN) inhibitor, CHEMICALIN
CPR:3	 bbbbb1 CHEMICALIN eeeee1  stimulation of GENEIN phosphorylation ( bbbbb2 GENEIN eeeee2 ) in the gonadotrope-derived LT2 cell line was attenuated by a GENEIN (GENEIN) inhibitor, CHEMICALIN
CPR:3	A GENENOTIN (GENENOTIN) reduced CHEMICALIN-stimulated GENEIN and markedly decreased  bbbbb1 CHEMICALIN eeeee1  stimulation of  bbbbb2 GENEIN eeeee2  mRNA and GENEINLUC activity, but had little effect on GENEINLUC activity, indicating relative specificity of this pathway
CPR:3	In perifusion studies,  bbbbb1 GENEIN eeeee1  mRNA levels and GENEINLUC activities were increased by pulsatile  bbbbb2 CHEMICALIN eeeee2 , with significantly greater increases at low compared with high pulse frequencies
CPR:3	 bbbbb1 CHEMICALIN eeeee1  pulse frequency-dependent stimulation of  bbbbb2 GENEIN eeeee2  transcription is mediated via activation of GENEIN and GENEIN
CPR:3	GENENOTIN markedly reduced these  bbbbb1 CHEMICALIN eeeee1 -stimulated  bbbbb2 GENEIN eeeee2  responses at both low and high pulse frequencies
CPR:3	Correlating with GENEIN activation, both GENEIN activity and levels of  bbbbb1 GENEIN eeeee1  were increased to a greater extent by low compared with high  bbbbb2 CHEMICALIN eeeee2  pulse frequencies, and the induction of GENEIN was also attenuated by overexpression of GENENOTIN at both low and high pulse frequencies
CPR:4	CHEMICALIN stimulation of  bbbbb1 GENEIN eeeee1  phosphorylation (GENEIN) in the gonadotrope-derived LT2 cell line was attenuated by a GENEIN (GENEIN) inhibitor,  bbbbb2 CHEMICALIN eeeee2 
CPR:4	CHEMICALIN stimulation of GENEIN phosphorylation ( bbbbb1 GENEIN eeeee1 ) in the gonadotrope-derived LT2 cell line was attenuated by a GENEIN (GENEIN) inhibitor,  bbbbb2 CHEMICALIN eeeee2 
CPR:4	CHEMICALIN stimulation of GENEIN phosphorylation (GENEIN) in the gonadotrope-derived LT2 cell line was attenuated by a  bbbbb1 GENEIN eeeee1  (GENEIN) inhibitor,  bbbbb2 CHEMICALIN eeeee2 
CPR:4	CHEMICALIN stimulation of GENEIN phosphorylation (GENEIN) in the gonadotrope-derived LT2 cell line was attenuated by a GENEIN ( bbbbb1 GENEIN eeeee1 ) inhibitor,  bbbbb2 CHEMICALIN eeeee2 
CPR:2	 bbbbb1 CHEMICALIN eeeee1 , an effective compound derived from foxtail-like sophora herb and seed, has been reported that it can alleviate non-alcoholic steatohepatitis (NASH) in rats and affect  bbbbb2 GENEIN eeeee2  synthesis
CPR:3	We concluded that  bbbbb1 CHEMICALIN eeeee1  could alleviate hepatocyte steatosis and the potential mechanism might be the activated signaling pathway of  bbbbb2 GENEIN eeeee2 .
CPR:3	 bbbbb1 CHEMICALIN eeeee1  alleviates hepatocyte steatosis through activating  bbbbb2 GENEIN eeeee2  signaling pathway
CPR:3	Moreover, compared with the model group,  bbbbb1 CHEMICALIN eeeee1  could significantly increase GENEIN (>5.82-fold), GENEIN (>1.29-fold) and  bbbbb2 GENEIN eeeee2  (>3.27-fold) protein expressions, and reduce GENEIN (<0.30-fold) and GENEIN (<0.20-fold) protein expression
CPR:3	Moreover, compared with the model group,  bbbbb1 CHEMICALIN eeeee1  could significantly increase  bbbbb2 GENEIN eeeee2  (>5.82-fold), GENEIN (>1.29-fold) and GENEIN (>3.27-fold) protein expressions, and reduce GENEIN (<0.30-fold) and GENEIN (<0.20-fold) protein expression
CPR:3	Moreover, compared with the model group,  bbbbb1 CHEMICALIN eeeee1  could significantly increase GENEIN (>5.82-fold),  bbbbb2 GENEIN eeeee2  (>1.29-fold) and GENEIN (>3.27-fold) protein expressions, and reduce GENEIN (<0.30-fold) and GENEIN (<0.20-fold) protein expression
CPR:3	While  bbbbb1 CHEMICALIN eeeee1  treatment resulted in: significant improvement of steatosis (>50% decrease), decrease of GENEIN expression (<0.57-fold) and increase of  bbbbb2 GENEIN eeeee2  expression (>1.48-fold)
CPR:4	Moreover, compared with the model group,  bbbbb1 CHEMICALIN eeeee1  could significantly increase GENEIN (>5.82-fold), GENEIN (>1.29-fold) and GENEIN (>3.27-fold) protein expressions, and reduce  bbbbb2 GENEIN eeeee2  (<0.30-fold) and GENEIN (<0.20-fold) protein expression
CPR:4	Moreover, compared with the model group,  bbbbb1 CHEMICALIN eeeee1  could significantly increase GENEIN (>5.82-fold), GENEIN (>1.29-fold) and GENEIN (>3.27-fold) protein expressions, and reduce GENEIN (<0.30-fold) and  bbbbb2 GENEIN eeeee2  (<0.20-fold) protein expression
CPR:4	While  bbbbb1 CHEMICALIN eeeee1  treatment resulted in: significant improvement of steatosis (>50% decrease), decrease of  bbbbb2 GENEIN eeeee2  expression (<0.57-fold) and increase of GENEIN expression (>1.48-fold)
CPR:4	The involvement of GENEIN in the absorption of CHEMICALIN was clearly shown by coperfusion of CHEMICALNOTIN with the  bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Upon studying the drug-drug interaction of CHEMICALNOTIN with CHEMICALNOTIN, data were indicative for an inhibitory effect of  bbbbb1 CHEMICALIN eeeee1  on  bbbbb2 GENEIN eeeee2  as the main mechanism for the increased transport of CHEMICALIN across the small intestine.
CPR:9	The involvement of  bbbbb1 GENEIN eeeee1  in the absorption of  bbbbb2 CHEMICALIN eeeee2  was clearly shown by coperfusion of CHEMICALNOTIN with the GENEIN inhibitor CHEMICALIN
CPR:9	Involvement of  bbbbb1 GENEIN eeeee1  mediated metabolism in the absorption of  bbbbb2 CHEMICALIN eeeee2  could not be demonstrated in this rat model
CPR:9	Upon studying the drug-drug interaction of CHEMICALNOTIN with CHEMICALNOTIN, data were indicative for an inhibitory effect of CHEMICALIN on  bbbbb1 GENEIN eeeee1  as the main mechanism for the increased transport of  bbbbb2 CHEMICALIN eeeee2  across the small intestine.
CPR:9	To evaluate to what extent the regional differences in expression of  bbbbb1 GENEIN eeeee1  and GENEIN affect the absorption of a dual substrate, we investigated the transport of  bbbbb2 CHEMICALIN eeeee2  across different small intestinal segments (duodenum, proximal jejunum and ileum)
CPR:9	To evaluate to what extent the regional differences in expression of GENEIN and  bbbbb1 GENEIN eeeee1  affect the absorption of a dual substrate, we investigated the transport of  bbbbb2 CHEMICALIN eeeee2  across different small intestinal segments (duodenum, proximal jejunum and ileum)
CPR:4	In another experiment, topical application of CFB, CFE or  bbbbb1 CHEMICALIN eeeee1  prior to UVB irradiation (200mJ/cm(2)) on BALB/c mice, inhibited the UVB-elevated protein levels of  bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN
CPR:4	In another experiment, topical application of CFB, CFE or  bbbbb1 CHEMICALIN eeeee1  prior to UVB irradiation (200mJ/cm(2)) on BALB/c mice, inhibited the UVB-elevated protein levels of GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN
CPR:4	In another experiment, topical application of CFB, CFE or  bbbbb1 CHEMICALIN eeeee1  prior to UVB irradiation (200mJ/cm(2)) on BALB/c mice, inhibited the UVB-elevated protein levels of GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2 
CPR:4	In HaCaT cells,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN fractions of 80% CHEMICALIN C. fragile extract (CFB or CFE) and a single compound, CHEMICALIN (CHEMICALIN) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including  bbbbb2 GENEIN eeeee2  (GENEIN), GENEIN (GENEIN), and GENEIN (GENEIN)
CPR:4	In HaCaT cells,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN fractions of 80% CHEMICALIN C. fragile extract (CFB or CFE) and a single compound, CHEMICALIN (CHEMICALIN) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including GENEIN ( bbbbb2 GENEIN eeeee2 ), GENEIN (GENEIN), and GENEIN (GENEIN)
CPR:4	In HaCaT cells,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN fractions of 80% CHEMICALIN C. fragile extract (CFB or CFE) and a single compound, CHEMICALIN (CHEMICALIN) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including GENEIN (GENEIN),  bbbbb2 GENEIN eeeee2  (GENEIN), and GENEIN (GENEIN)
CPR:4	In HaCaT cells,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN fractions of 80% CHEMICALIN C. fragile extract (CFB or CFE) and a single compound, CHEMICALIN (CHEMICALIN) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including GENEIN (GENEIN), GENEIN ( bbbbb2 GENEIN eeeee2 ), and GENEIN (GENEIN)
CPR:4	In HaCaT cells,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN fractions of 80% CHEMICALIN C. fragile extract (CFB or CFE) and a single compound, CHEMICALIN (CHEMICALIN) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including GENEIN (GENEIN), GENEIN (GENEIN), and  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:4	In HaCaT cells,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN fractions of 80% CHEMICALIN C. fragile extract (CFB or CFE) and a single compound, CHEMICALIN (CHEMICALIN) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including GENEIN (GENEIN), GENEIN (GENEIN), and GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:4	In HaCaT cells, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  fractions of 80% CHEMICALIN C. fragile extract (CFB or CFE) and a single compound, CHEMICALIN (CHEMICALIN) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including  bbbbb2 GENEIN eeeee2  (GENEIN), GENEIN (GENEIN), and GENEIN (GENEIN)
CPR:4	In HaCaT cells, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  fractions of 80% CHEMICALIN C. fragile extract (CFB or CFE) and a single compound, CHEMICALIN (CHEMICALIN) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including GENEIN ( bbbbb2 GENEIN eeeee2 ), GENEIN (GENEIN), and GENEIN (GENEIN)
CPR:4	In HaCaT cells, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  fractions of 80% CHEMICALIN C. fragile extract (CFB or CFE) and a single compound, CHEMICALIN (CHEMICALIN) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including GENEIN (GENEIN),  bbbbb2 GENEIN eeeee2  (GENEIN), and GENEIN (GENEIN)
CPR:4	In HaCaT cells, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  fractions of 80% CHEMICALIN C. fragile extract (CFB or CFE) and a single compound, CHEMICALIN (CHEMICALIN) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including GENEIN (GENEIN), GENEIN ( bbbbb2 GENEIN eeeee2 ), and GENEIN (GENEIN)
CPR:4	In HaCaT cells, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  fractions of 80% CHEMICALIN C. fragile extract (CFB or CFE) and a single compound, CHEMICALIN (CHEMICALIN) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including GENEIN (GENEIN), GENEIN (GENEIN), and  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:4	In HaCaT cells, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  fractions of 80% CHEMICALIN C. fragile extract (CFB or CFE) and a single compound, CHEMICALIN (CHEMICALIN) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including GENEIN (GENEIN), GENEIN (GENEIN), and GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:4	In HaCaT cells, CHEMICALIN and CHEMICALIN fractions of 80%  bbbbb1 CHEMICALIN eeeee1  C. fragile extract (CFB or CFE) and a single compound, CHEMICALIN (CHEMICALIN) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including  bbbbb2 GENEIN eeeee2  (GENEIN), GENEIN (GENEIN), and GENEIN (GENEIN)
CPR:4	In HaCaT cells, CHEMICALIN and CHEMICALIN fractions of 80%  bbbbb1 CHEMICALIN eeeee1  C. fragile extract (CFB or CFE) and a single compound, CHEMICALIN (CHEMICALIN) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including GENEIN ( bbbbb2 GENEIN eeeee2 ), GENEIN (GENEIN), and GENEIN (GENEIN)
CPR:4	In HaCaT cells, CHEMICALIN and CHEMICALIN fractions of 80%  bbbbb1 CHEMICALIN eeeee1  C. fragile extract (CFB or CFE) and a single compound, CHEMICALIN (CHEMICALIN) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including GENEIN (GENEIN),  bbbbb2 GENEIN eeeee2  (GENEIN), and GENEIN (GENEIN)
CPR:4	In HaCaT cells, CHEMICALIN and CHEMICALIN fractions of 80%  bbbbb1 CHEMICALIN eeeee1  C. fragile extract (CFB or CFE) and a single compound, CHEMICALIN (CHEMICALIN) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including GENEIN (GENEIN), GENEIN ( bbbbb2 GENEIN eeeee2 ), and GENEIN (GENEIN)
CPR:4	In HaCaT cells, CHEMICALIN and CHEMICALIN fractions of 80%  bbbbb1 CHEMICALIN eeeee1  C. fragile extract (CFB or CFE) and a single compound, CHEMICALIN (CHEMICALIN) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including GENEIN (GENEIN), GENEIN (GENEIN), and  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:4	In HaCaT cells, CHEMICALIN and CHEMICALIN fractions of 80%  bbbbb1 CHEMICALIN eeeee1  C. fragile extract (CFB or CFE) and a single compound, CHEMICALIN (CHEMICALIN) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including GENEIN (GENEIN), GENEIN (GENEIN), and GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:4	In HaCaT cells, CHEMICALIN and CHEMICALIN fractions of 80% CHEMICALIN C. fragile extract (CFB or CFE) and a single compound,  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including  bbbbb2 GENEIN eeeee2  (GENEIN), GENEIN (GENEIN), and GENEIN (GENEIN)
CPR:4	In HaCaT cells, CHEMICALIN and CHEMICALIN fractions of 80% CHEMICALIN C. fragile extract (CFB or CFE) and a single compound,  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including GENEIN ( bbbbb2 GENEIN eeeee2 ), GENEIN (GENEIN), and GENEIN (GENEIN)
CPR:4	In HaCaT cells, CHEMICALIN and CHEMICALIN fractions of 80% CHEMICALIN C. fragile extract (CFB or CFE) and a single compound,  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including GENEIN (GENEIN),  bbbbb2 GENEIN eeeee2  (GENEIN), and GENEIN (GENEIN)
CPR:4	In HaCaT cells, CHEMICALIN and CHEMICALIN fractions of 80% CHEMICALIN C. fragile extract (CFB or CFE) and a single compound,  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including GENEIN (GENEIN), GENEIN ( bbbbb2 GENEIN eeeee2 ), and GENEIN (GENEIN)
CPR:4	In HaCaT cells, CHEMICALIN and CHEMICALIN fractions of 80% CHEMICALIN C. fragile extract (CFB or CFE) and a single compound,  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including GENEIN (GENEIN), GENEIN (GENEIN), and  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:4	In HaCaT cells, CHEMICALIN and CHEMICALIN fractions of 80% CHEMICALIN C. fragile extract (CFB or CFE) and a single compound,  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including GENEIN (GENEIN), GENEIN (GENEIN), and GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:4	In HaCaT cells, CHEMICALIN and CHEMICALIN fractions of 80% CHEMICALIN C. fragile extract (CFB or CFE) and a single compound, CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including  bbbbb2 GENEIN eeeee2  (GENEIN), GENEIN (GENEIN), and GENEIN (GENEIN)
CPR:4	In HaCaT cells, CHEMICALIN and CHEMICALIN fractions of 80% CHEMICALIN C. fragile extract (CFB or CFE) and a single compound, CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including GENEIN ( bbbbb2 GENEIN eeeee2 ), GENEIN (GENEIN), and GENEIN (GENEIN)
CPR:4	In HaCaT cells, CHEMICALIN and CHEMICALIN fractions of 80% CHEMICALIN C. fragile extract (CFB or CFE) and a single compound, CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including GENEIN (GENEIN),  bbbbb2 GENEIN eeeee2  (GENEIN), and GENEIN (GENEIN)
CPR:4	In HaCaT cells, CHEMICALIN and CHEMICALIN fractions of 80% CHEMICALIN C. fragile extract (CFB or CFE) and a single compound, CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including GENEIN (GENEIN), GENEIN ( bbbbb2 GENEIN eeeee2 ), and GENEIN (GENEIN)
CPR:4	In HaCaT cells, CHEMICALIN and CHEMICALIN fractions of 80% CHEMICALIN C. fragile extract (CFB or CFE) and a single compound, CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including GENEIN (GENEIN), GENEIN (GENEIN), and  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:4	In HaCaT cells, CHEMICALIN and CHEMICALIN fractions of 80% CHEMICALIN C. fragile extract (CFB or CFE) and a single compound, CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) isolated from CFE attenuated UVB (60mJ/cm(2))-induced cytotoxicity and reduced expression of pro-inflammatory proteins including GENEIN (GENEIN), GENEIN (GENEIN), and GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:2	Interaction of silymarin  bbbbb1 CHEMICALIN eeeee1  with  bbbbb2 GENEIN eeeee2 
CPR:2	The extent of silymarin-drug interactions depends on  bbbbb1 GENEIN eeeee1  isoform specificity and concentrations of  bbbbb2 CHEMICALIN eeeee2  at the site of drug transport
CPR:4	In overexpressing cell lines,  bbbbb1 GENEIN eeeee1 - and GENEIN-mediated CHEMICALIN uptake and GENEIN-mediated CHEMICALIN uptake were inhibited by most of the silymarin  bbbbb2 CHEMICALIN eeeee2  investigated
CPR:4	In overexpressing cell lines, GENEIN- and  bbbbb1 GENEIN eeeee1 -mediated CHEMICALIN uptake and GENEIN-mediated CHEMICALIN uptake were inhibited by most of the silymarin  bbbbb2 CHEMICALIN eeeee2  investigated
CPR:4	In overexpressing cell lines, GENEIN- and GENEIN-mediated CHEMICALIN uptake and  bbbbb1 GENEIN eeeee1 -mediated CHEMICALIN uptake were inhibited by most of the silymarin  bbbbb2 CHEMICALIN eeeee2  investigated
CPR:4	 bbbbb1 GENEIN eeeee1 -, GENEIN-, and GENEIN-mediated substrate transport was inhibited efficiently by silymarin (IC50 values of 1.3, 2.2 and 0.3 M, respectively),  bbbbb2 CHEMICALIN eeeee2  (IC50 values of 9.7, 2.7 and 4.5 M, respectively), CHEMICALIN (IC50 values of 8.5, 5.0 and 0.8 M, respectively), and CHEMICALIN (IC50 values of 9.0, 36.4, and 3.6 M, respectively)
CPR:4	GENEIN-,  bbbbb1 GENEIN eeeee1 -, and GENEIN-mediated substrate transport was inhibited efficiently by silymarin (IC50 values of 1.3, 2.2 and 0.3 M, respectively),  bbbbb2 CHEMICALIN eeeee2  (IC50 values of 9.7, 2.7 and 4.5 M, respectively), CHEMICALIN (IC50 values of 8.5, 5.0 and 0.8 M, respectively), and CHEMICALIN (IC50 values of 9.0, 36.4, and 3.6 M, respectively)
CPR:4	GENEIN-, GENEIN-, and  bbbbb1 GENEIN eeeee1 -mediated substrate transport was inhibited efficiently by silymarin (IC50 values of 1.3, 2.2 and 0.3 M, respectively),  bbbbb2 CHEMICALIN eeeee2  (IC50 values of 9.7, 2.7 and 4.5 M, respectively), CHEMICALIN (IC50 values of 8.5, 5.0 and 0.8 M, respectively), and CHEMICALIN (IC50 values of 9.0, 36.4, and 3.6 M, respectively)
CPR:4	 bbbbb1 GENEIN eeeee1 -, GENEIN-, and GENEIN-mediated substrate transport was inhibited efficiently by silymarin (IC50 values of 1.3, 2.2 and 0.3 M, respectively), CHEMICALIN (IC50 values of 9.7, 2.7 and 4.5 M, respectively),  bbbbb2 CHEMICALIN eeeee2  (IC50 values of 8.5, 5.0 and 0.8 M, respectively), and CHEMICALIN (IC50 values of 9.0, 36.4, and 3.6 M, respectively)
CPR:4	GENEIN-,  bbbbb1 GENEIN eeeee1 -, and GENEIN-mediated substrate transport was inhibited efficiently by silymarin (IC50 values of 1.3, 2.2 and 0.3 M, respectively), CHEMICALIN (IC50 values of 9.7, 2.7 and 4.5 M, respectively),  bbbbb2 CHEMICALIN eeeee2  (IC50 values of 8.5, 5.0 and 0.8 M, respectively), and CHEMICALIN (IC50 values of 9.0, 36.4, and 3.6 M, respectively)
CPR:4	GENEIN-, GENEIN-, and  bbbbb1 GENEIN eeeee1 -mediated substrate transport was inhibited efficiently by silymarin (IC50 values of 1.3, 2.2 and 0.3 M, respectively), CHEMICALIN (IC50 values of 9.7, 2.7 and 4.5 M, respectively),  bbbbb2 CHEMICALIN eeeee2  (IC50 values of 8.5, 5.0 and 0.8 M, respectively), and CHEMICALIN (IC50 values of 9.0, 36.4, and 3.6 M, respectively)
CPR:4	 bbbbb1 GENEIN eeeee1 -, GENEIN-, and GENEIN-mediated substrate transport was inhibited efficiently by silymarin (IC50 values of 1.3, 2.2 and 0.3 M, respectively), CHEMICALIN (IC50 values of 9.7, 2.7 and 4.5 M, respectively), CHEMICALIN (IC50 values of 8.5, 5.0 and 0.8 M, respectively), and  bbbbb2 CHEMICALIN eeeee2  (IC50 values of 9.0, 36.4, and 3.6 M, respectively)
CPR:4	GENEIN-,  bbbbb1 GENEIN eeeee1 -, and GENEIN-mediated substrate transport was inhibited efficiently by silymarin (IC50 values of 1.3, 2.2 and 0.3 M, respectively), CHEMICALIN (IC50 values of 9.7, 2.7 and 4.5 M, respectively), CHEMICALIN (IC50 values of 8.5, 5.0 and 0.8 M, respectively), and  bbbbb2 CHEMICALIN eeeee2  (IC50 values of 9.0, 36.4, and 3.6 M, respectively)
CPR:4	GENEIN-, GENEIN-, and  bbbbb1 GENEIN eeeee1 -mediated substrate transport was inhibited efficiently by silymarin (IC50 values of 1.3, 2.2 and 0.3 M, respectively), CHEMICALIN (IC50 values of 9.7, 2.7 and 4.5 M, respectively), CHEMICALIN (IC50 values of 8.5, 5.0 and 0.8 M, respectively), and  bbbbb2 CHEMICALIN eeeee2  (IC50 values of 9.0, 36.4, and 3.6 M, respectively)
CPR:4	Furthermore, silymarin,  bbbbb1 CHEMICALIN eeeee1 , and CHEMICALIN (100 M) significantly inhibited  bbbbb2 GENEIN eeeee2 -mediated CHEMICALIN and CHEMICALIN uptake into human hepatocytes
CPR:4	Furthermore, silymarin, CHEMICALIN, and  bbbbb1 CHEMICALIN eeeee1  (100 M) significantly inhibited  bbbbb2 GENEIN eeeee2 -mediated CHEMICALIN and CHEMICALIN uptake into human hepatocytes
CPR:9	In overexpressing cell lines,  bbbbb1 GENEIN eeeee1 - and GENEIN-mediated  bbbbb2 CHEMICALIN eeeee2  uptake and GENEIN-mediated CHEMICALIN uptake were inhibited by most of the silymarin CHEMICALIN investigated
CPR:9	In overexpressing cell lines, GENEIN- and  bbbbb1 GENEIN eeeee1 -mediated  bbbbb2 CHEMICALIN eeeee2  uptake and GENEIN-mediated CHEMICALIN uptake were inhibited by most of the silymarin CHEMICALIN investigated
CPR:9	In overexpressing cell lines, GENEIN- and GENEIN-mediated CHEMICALIN uptake and  bbbbb1 GENEIN eeeee1 -mediated  bbbbb2 CHEMICALIN eeeee2  uptake were inhibited by most of the silymarin CHEMICALIN investigated
CPR:9	Furthermore, silymarin, CHEMICALIN, and CHEMICALIN (100 M) significantly inhibited  bbbbb1 GENEIN eeeee1 -mediated  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN uptake into human hepatocytes
CPR:9	Furthermore, silymarin, CHEMICALIN, and CHEMICALIN (100 M) significantly inhibited  bbbbb1 GENEIN eeeee1 -mediated CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  uptake into human hepatocytes
CPR:2	Selective oxidation of CHEMICALIN self-assembled CHEMICALIN monolayers to  bbbbb1 CHEMICALIN eeeee1  is shown to transform the adhesion of model proteins  bbbbb2 GENEIN eeeee2  and GENEIN upon them
CPR:2	Selective oxidation of CHEMICALIN self-assembled CHEMICALIN monolayers to  bbbbb1 CHEMICALIN eeeee1  is shown to transform the adhesion of model proteins GENEIN and  bbbbb2 GENEIN eeeee2  upon them
CPR:2	CHEMICALNOTIN-functionalized sensors adsorbed multilayers of aggregated  bbbbb1 GENEIN eeeee1 , whereas  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN-terminated monolayers are consistent with small protein aggregates
CPR:2	CHEMICALNOTIN-functionalized sensors adsorbed multilayers of aggregated  bbbbb1 GENEIN eeeee1 , whereas CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 -terminated monolayers are consistent with small protein aggregates
CPR:2	Selective oxidation of  bbbbb1 CHEMICALIN eeeee1  self-assembled CHEMICALIN monolayers to CHEMICALIN is shown to transform the adhesion of model proteins  bbbbb2 GENEIN eeeee2  and GENEIN upon them
CPR:2	Selective oxidation of  bbbbb1 CHEMICALIN eeeee1  self-assembled CHEMICALIN monolayers to CHEMICALIN is shown to transform the adhesion of model proteins GENEIN and  bbbbb2 GENEIN eeeee2  upon them
CPR:2	Selective oxidation of CHEMICALIN self-assembled  bbbbb1 CHEMICALIN eeeee1  monolayers to CHEMICALIN is shown to transform the adhesion of model proteins  bbbbb2 GENEIN eeeee2  and GENEIN upon them
CPR:2	Selective oxidation of CHEMICALIN self-assembled  bbbbb1 CHEMICALIN eeeee1  monolayers to CHEMICALIN is shown to transform the adhesion of model proteins GENEIN and  bbbbb2 GENEIN eeeee2  upon them
CPR:2	Oxidation with  bbbbb1 CHEMICALIN eeeee1  was similarly assessed, and adhesion of  bbbbb2 GENEIN eeeee2  and GENEIN from CHEMICALNOTIN buffered saline was then assayed by QCM and imaged by AFM
CPR:2	Oxidation with  bbbbb1 CHEMICALIN eeeee1  was similarly assessed, and adhesion of GENEIN and  bbbbb2 GENEIN eeeee2  from CHEMICALNOTIN buffered saline was then assayed by QCM and imaged by AFM
CPR:3	Further investigation demonstrated that 8k reduced  bbbbb1 CHEMICALIN eeeee1 -induced activation of mitochondrial apoptosis by inhibiting the expression of  bbbbb2 GENEIN eeeee2  and elevating the expression of GENEIN
CPR:4	Further investigation demonstrated that 8k reduced  bbbbb1 CHEMICALIN eeeee1 -induced activation of mitochondrial apoptosis by inhibiting the expression of GENEIN and elevating the expression of  bbbbb2 GENEIN eeeee2 
CPR:2	 bbbbb1 GENEIN eeeee1  levels were negatively correlated with variables of vagal control, reaching significance for rMSSD and log(10)HF, but not for pvRSA, during the last four phases of the hyperglycaemic clamp (hyperglycaemic second phase, GENENOTIN first and second phases, and  bbbbb2 CHEMICALIN eeeee2 )
CPR:3	Three variables of cardiac vagal effects (the root mean square of successive differences [rMSSD] in the interbeat interval of the heart rate [IBI], heart-rate variability [HRV] caused by peak-valley respiratory sinus arrhythmia [pvRSA], and high-frequency power [HF]) and heart rate (HR) were obtained at seven time points during the clamps, characterised by increasing levels of  bbbbb1 GENEIN eeeee1  (achieved by administering GENENOTIN plus  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN only, CHEMICALIN and GENENOTIN, and CHEMICALIN and GENENOTIN combined with CHEMICALIN)
CPR:3	Three variables of cardiac vagal effects (the root mean square of successive differences [rMSSD] in the interbeat interval of the heart rate [IBI], heart-rate variability [HRV] caused by peak-valley respiratory sinus arrhythmia [pvRSA], and high-frequency power [HF]) and heart rate (HR) were obtained at seven time points during the clamps, characterised by increasing levels of  bbbbb1 GENEIN eeeee1  (achieved by administering GENENOTIN plus CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2  only, CHEMICALIN and GENENOTIN, and CHEMICALIN and GENENOTIN combined with CHEMICALIN)
CPR:3	Three variables of cardiac vagal effects (the root mean square of successive differences [rMSSD] in the interbeat interval of the heart rate [IBI], heart-rate variability [HRV] caused by peak-valley respiratory sinus arrhythmia [pvRSA], and high-frequency power [HF]) and heart rate (HR) were obtained at seven time points during the clamps, characterised by increasing levels of  bbbbb1 GENEIN eeeee1  (achieved by administering GENENOTIN plus CHEMICALIN, CHEMICALIN only,  bbbbb2 CHEMICALIN eeeee2  and GENENOTIN, and CHEMICALIN and GENENOTIN combined with CHEMICALIN)
CPR:3	Three variables of cardiac vagal effects (the root mean square of successive differences [rMSSD] in the interbeat interval of the heart rate [IBI], heart-rate variability [HRV] caused by peak-valley respiratory sinus arrhythmia [pvRSA], and high-frequency power [HF]) and heart rate (HR) were obtained at seven time points during the clamps, characterised by increasing levels of  bbbbb1 GENEIN eeeee1  (achieved by administering GENENOTIN plus CHEMICALIN, CHEMICALIN only, CHEMICALIN and GENENOTIN, and  bbbbb2 CHEMICALIN eeeee2  and GENENOTIN combined with CHEMICALIN)
CPR:3	Three variables of cardiac vagal effects (the root mean square of successive differences [rMSSD] in the interbeat interval of the heart rate [IBI], heart-rate variability [HRV] caused by peak-valley respiratory sinus arrhythmia [pvRSA], and high-frequency power [HF]) and heart rate (HR) were obtained at seven time points during the clamps, characterised by increasing levels of  bbbbb1 GENEIN eeeee1  (achieved by administering GENENOTIN plus CHEMICALIN, CHEMICALIN only, CHEMICALIN and GENENOTIN, and CHEMICALIN and GENENOTIN combined with  bbbbb2 CHEMICALIN eeeee2 )
CPR:1	In a mouse tumor model, removal of only the  bbbbb1 CHEMICALIN eeeee1 -terminal propeptide from full-length  bbbbb2 GENEIN eeeee2  was sufficient to enhance angiogenesis and tumor growth
CPR:1	We report for the first time that GENENOTIN binds heparin, and that the  bbbbb1 CHEMICALIN eeeee1 -terminal propeptide significantly enhances this interaction (removal of this propeptide from full-length  bbbbb2 GENEIN eeeee2  completely prevents heparin binding)
CPR:1	We also show that removal of either the  bbbbb1 CHEMICALIN eeeee1 - or CHEMICALIN-terminal propeptide is required for  bbbbb2 GENEIN eeeee2  to drive formation of GENENOTIN/GENENOTIN heterodimers which have recently been shown to positively regulate angiogenic sprouting
CPR:1	We also show that removal of either the CHEMICALIN- or  bbbbb1 CHEMICALIN eeeee1 -terminal propeptide is required for  bbbbb2 GENEIN eeeee2  to drive formation of GENENOTIN/GENENOTIN heterodimers which have recently been shown to positively regulate angiogenic sprouting
CPR:2	The  bbbbb1 GENEIN eeeee1  antagonist CHEMICALIN prevents stress-induced cognitive deficit associated with hippocampal dysfunction: Comparison with  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:2	The  bbbbb1 GENEIN eeeee1  antagonist CHEMICALIN prevents stress-induced cognitive deficit associated with hippocampal dysfunction: Comparison with CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:5	Effects of CHEMICALNOTIN were compared to those of the CHEMICALNOTIN reuptake inhibitor, CHEMICALNOTIN (10mg/kg/day), and the partial  bbbbb1 GENEIN eeeee1  agonist,  bbbbb2 CHEMICALIN eeeee2  (10mg/kg/day), two compounds which have demonstrated clinical efficacy against PTSD
CPR:6	RATIONALE: The selective  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2  has been previously shown to attenuate the long-term cognitive deficit produced by traumatic stress exposure
CPR:6	The  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2  prevents stress-induced cognitive deficit associated with hippocampal dysfunction: Comparison with CHEMICALIN and CHEMICALIN
CPR:6	CONCLUSIONS: These findings confirm that the  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2  is able to attenuate the behavioral effects of traumatic stress exposure and indicate that these effects are associated with a normalization of hippocampal neuronal excitability impaired by stress.
CPR:2	 bbbbb1 CHEMICALIN eeeee1  antagonists bind to  bbbbb2 GENEIN eeeee2  at an intracellular allosteric site denoted site II
CPR:6	A series of  bbbbb1 CHEMICALIN eeeee1  were synthesized and examined as  bbbbb2 GENEIN eeeee2  antagonists
CPR:7	Synthesis and structure-activity relationships of  bbbbb1 CHEMICALIN eeeee1  as allosteric GENEIN ( bbbbb2 GENEIN eeeee2 ) antagonists
CPR:7	Synthesis and structure-activity relationships of  bbbbb1 CHEMICALIN eeeee1  as allosteric  bbbbb2 GENEIN eeeee2  (GENEIN) antagonists
CPR:2	Mice given daily injections of high dose CHEMICALIN (16 mg/kg) for six days displayed decreased  bbbbb1 GENEIN eeeee1  receptor density and function in brain, as assessed in  bbbbb2 CHEMICALIN eeeee2  binding and CHEMICALIN-stimulated [CHEMICALIN]GTPS binding assays, respectively
CPR:2	Mice given daily injections of high dose CHEMICALIN (16 mg/kg) for six days displayed decreased  bbbbb1 GENEIN eeeee1  receptor density and function in brain, as assessed in CHEMICALIN binding and  bbbbb2 CHEMICALIN eeeee2 -stimulated [CHEMICALIN]GTPS binding assays, respectively
CPR:2	Mice given daily injections of high dose CHEMICALIN (16 mg/kg) for six days displayed decreased  bbbbb1 GENEIN eeeee1  receptor density and function in brain, as assessed in CHEMICALIN binding and CHEMICALIN-stimulated [ bbbbb2 CHEMICALIN eeeee2 ]GTPS binding assays, respectively
CPR:2	In contrast, normal  bbbbb1 GENEIN eeeee1  receptor expression and function were maintained following repeated administration of low dose  bbbbb2 CHEMICALIN eeeee2  (8 mg/kg)
CPR:2	Repeated Low Dose Administration of the GENEIN Inhibitor  bbbbb1 CHEMICALIN eeeee1  Retains  bbbbb2 GENEIN eeeee2  Receptor Mediated Antinociceptive and Gastroprotective Effects
CPR:2	In contrast, normal  bbbbb1 GENEIN eeeee1  receptor expression and function were maintained following repeated administration of low dose  bbbbb2 CHEMICALIN eeeee2  (8 mg/kg)
CPR:4	Mice given daily injections of high dose  bbbbb1 CHEMICALIN eeeee1  (16 mg/kg) for six days displayed decreased  bbbbb2 GENEIN eeeee2  receptor density and function in brain, as assessed in CHEMICALIN binding and CHEMICALIN-stimulated [CHEMICALIN]GTPS binding assays, respectively
CPR:4	The GENEIN ( bbbbb1 GENEIN eeeee1 ) inhibitor  bbbbb2 CHEMICALIN eeeee2  produces antinociceptive and anti-inflammatory effects
CPR:4	The  bbbbb1 GENEIN eeeee1  (GENEIN) inhibitor  bbbbb2 CHEMICALIN eeeee2  produces antinociceptive and anti-inflammatory effects
CPR:4	Repeated Low Dose Administration of the  bbbbb1 GENEIN eeeee1  Inhibitor  bbbbb2 CHEMICALIN eeeee2  Retains GENEIN Receptor Mediated Antinociceptive and Gastroprotective Effects
CPR:4	 bbbbb1 CHEMICALIN eeeee1  were designed and synthesized as potent GENEIN- bbbbb2 GENEIN eeeee2  inhibitors
CPR:4	 bbbbb1 CHEMICALIN eeeee1  were designed and synthesized as potent  bbbbb2 GENEIN eeeee2 -GENEIN inhibitors
CPR:4	Design and synthesis of  bbbbb1 CHEMICALIN eeeee1  as potent  bbbbb2 GENEIN eeeee2 -GENEIN inhibitors
CPR:4	Design and synthesis of  bbbbb1 CHEMICALIN eeeee1  as potent GENEIN- bbbbb2 GENEIN eeeee2  inhibitors
CPR:1	While GENENOTIN in hypoxia translocates to the nucleus where it transcribes the target genes including GENENOTIN (GENENOTIN) mRNA,  bbbbb1 GENEIN eeeee1  is degraded under normoxia, which involves its  bbbbb2 CHEMICALIN eeeee2  hydroxylation and subsequent binding to the GENENOTIN-GENENOTIN-GENENOTIN (GENENOTIN) complex
CPR:3	The most potent compound 5 ( bbbbb1 CHEMICALIN eeeee1 ) has demonstrated to inhibit GENEIN activity, downregulate phosphorylation of GENEIN, increase the expression of cleaved  bbbbb2 GENEIN eeeee2 , inhibit cell cycle progression and promote apoptosis in breast and pancreatic cancer cells with low micromolar to nanomolar IC50 values
CPR:4	The most potent compound 5 ( bbbbb1 CHEMICALIN eeeee1 ) has demonstrated to inhibit  bbbbb2 GENEIN eeeee2  activity, downregulate phosphorylation of GENEIN, increase the expression of cleaved GENEIN, inhibit cell cycle progression and promote apoptosis in breast and pancreatic cancer cells with low micromolar to nanomolar IC50 values
CPR:4	The most potent compound 5 ( bbbbb1 CHEMICALIN eeeee1 ) has demonstrated to inhibit GENEIN activity, downregulate phosphorylation of  bbbbb2 GENEIN eeeee2 , increase the expression of cleaved GENEIN, inhibit cell cycle progression and promote apoptosis in breast and pancreatic cancer cells with low micromolar to nanomolar IC50 values
CPR:4	Fragment-based drug design and identification of  bbbbb1 CHEMICALIN eeeee1 , a novel orally bioavailable  bbbbb2 GENEIN eeeee2  inhibitor for cancer therapy
CPR:2	To map supercoiling, we used  bbbbb1 CHEMICALIN eeeee1  as a DNA structure probe to show that the human genome is organized into  bbbbb2 GENEIN eeeee2 
CPR:4	Therefore, we examined whether the  bbbbb1 GENEIN eeeee1 -I  bbbbb2 CHEMICALIN eeeee2  improves memory and executive functioning and affect electroencephalography (EEG) in healthy young adults
CPR:4	The effects of the  bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2  on cognitive performance in healthy adults: a behavioral- electroencephalography study
CPR:10	 bbbbb1 GENEIN eeeee1 , GENEIN and GENEIN activities were not altered by  bbbbb2 CHEMICALIN eeeee2  treatment or withdrawal, as well as protein CHEMICALNOTIN and CHEMICALNOTIN immunoreactivity
CPR:10	GENEIN,  bbbbb1 GENEIN eeeee1  and GENEIN activities were not altered by  bbbbb2 CHEMICALIN eeeee2  treatment or withdrawal, as well as protein CHEMICALNOTIN and CHEMICALNOTIN immunoreactivity
CPR:10	GENEIN, GENEIN and  bbbbb1 GENEIN eeeee1  activities were not altered by  bbbbb2 CHEMICALIN eeeee2  treatment or withdrawal, as well as protein CHEMICALNOTIN and CHEMICALNOTIN immunoreactivity
CPR:3	We found that CHEMICALNOTIN withdrawal decreased levels of CHEMICALNOTIN and GENENOTIN activity, whereas increased  bbbbb1 GENEIN eeeee1  activity and immunoreactivity for the protein nitration marker  bbbbb2 CHEMICALIN eeeee2  in the cerebral cortex
CPR:9	Statins are inhibitors of the enzyme  bbbbb1 GENEIN eeeee1 , the rate-limiting step in  bbbbb2 CHEMICALIN eeeee2  biosynthesis
CPR:2	Hyperthyroidism-induced oxidative stress, reduction in  bbbbb1 GENEIN eeeee1  activity, and myocardial CHEMICALNOTIN concentration were also significantly checked by  bbbbb2 CHEMICALIN eeeee2 
CPR:5	Cardiac hypertrophy, structural remodeling, and expression of the genes associated with CHEMICALNOTIN metabolism were examined in rats treated with CHEMICALNOTIN (T3) alone (8g/100g body weight (BW), i.p.) for 15 days or along with a  bbbbb1 GENEIN eeeee1  agonist  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN; 30g/100g BW, oral) and were found to improve in the CHEMICALNOTIN co-treated condition
CPR:5	Cardiac hypertrophy, structural remodeling, and expression of the genes associated with CHEMICALNOTIN metabolism were examined in rats treated with CHEMICALNOTIN (T3) alone (8g/100g body weight (BW), i.p.) for 15 days or along with a  bbbbb1 GENEIN eeeee1  agonist CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ; 30g/100g BW, oral) and were found to improve in the CHEMICALNOTIN co-treated condition
CPR:2	The serum or  bbbbb1 CHEMICALIN eeeee1 -induced oscillation in the expression of  bbbbb2 GENEIN eeeee2  in cells was abrogated by the downregulation or overexpression of GENEIN, suggesting that GENENOTIN functions as a regulator of GENENOTIN oscillations in the cellular autonomous clock
CPR:2	The serum or  bbbbb1 CHEMICALIN eeeee1 -induced oscillation in the expression of GENEIN in cells was abrogated by the downregulation or overexpression of  bbbbb2 GENEIN eeeee2 , suggesting that GENENOTIN functions as a regulator of GENENOTIN oscillations in the cellular autonomous clock
CPR:5	Moreover, the effects of the  bbbbb1 GENEIN eeeee1  agonist  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN)-induced locomotor hypoactivity were significantly increased when GENEIN proteins were abundant
CPR:5	Moreover, the effects of the GENEIN agonist  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN)-induced locomotor hypoactivity were significantly increased when  bbbbb2 GENEIN eeeee2  proteins were abundant
CPR:5	Moreover, the effects of the  bbbbb1 GENEIN eeeee1  agonist CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 )-induced locomotor hypoactivity were significantly increased when GENEIN proteins were abundant
CPR:5	Moreover, the effects of the GENEIN agonist CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 )-induced locomotor hypoactivity were significantly increased when  bbbbb2 GENEIN eeeee2  proteins were abundant
CPR:2	CHEMICALIN was crystallized with the ligand-binding domain of  bbbbb1 GENEIN eeeee1 , and the structure revealed a complex containing  bbbbb2 CHEMICALIN eeeee2  at the glutamate binding site
CPR:2	 bbbbb1 CHEMICALIN eeeee1  was crystallized with the ligand-binding domain of  bbbbb2 GENEIN eeeee2 , and the structure revealed a complex containing CHEMICALIN at the glutamate binding site
CPR:4	 bbbbb1 CHEMICALIN eeeee1  locks the  bbbbb2 GENEIN eeeee2  in an open form, consistent with a pharmacological action as competitive antagonist of GENEIN.
CPR:6	 bbbbb1 CHEMICALIN eeeee1  locks the GENEIN in an open form, consistent with a pharmacological action as competitive antagonist of  bbbbb2 GENEIN eeeee2 .
CPR:6	Studies on an CHEMICALNOTIN  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2 : asymmetric synthesis, neuroactivity, and structural characterization
CPR:6	 bbbbb1 CHEMICALIN eeeee1  was developed and identified as a member of a new class of heterotricyclic CHEMICALIN analogues that act as  bbbbb2 GENEIN eeeee2 -selective antagonists
CPR:6	CHEMICALIN was developed and identified as a member of a new class of heterotricyclic  bbbbb1 CHEMICALIN eeeee1  analogues that act as  bbbbb2 GENEIN eeeee2 -selective antagonists
CPR:2	In addition, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN were found to induce a Type I spectral change only with  bbbbb2 GENEIN eeeee2 
CPR:2	In addition, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN were found to induce a Type I spectral change only with  bbbbb2 GENEIN eeeee2 
CPR:2	In addition, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN were found to induce a Type I spectral change only with  bbbbb2 GENEIN eeeee2 
CPR:2	In addition, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN were found to induce a Type I spectral change only with  bbbbb2 GENEIN eeeee2 
CPR:2	In addition, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN were found to induce a Type I spectral change only with  bbbbb2 GENEIN eeeee2 
CPR:2	In addition, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN were found to induce a Type I spectral change only with  bbbbb2 GENEIN eeeee2 
CPR:2	In addition, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN were found to induce a Type I spectral change only with  bbbbb2 GENEIN eeeee2 
CPR:2	In addition, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, and CHEMICALIN were found to induce a Type I spectral change only with  bbbbb2 GENEIN eeeee2 
CPR:2	In addition, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, and CHEMICALIN were found to induce a Type I spectral change only with  bbbbb2 GENEIN eeeee2 
CPR:2	In addition, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , and CHEMICALIN were found to induce a Type I spectral change only with  bbbbb2 GENEIN eeeee2 
CPR:2	In addition, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and  bbbbb1 CHEMICALIN eeeee1  were found to induce a Type I spectral change only with  bbbbb2 GENEIN eeeee2 
CPR:2	In addition,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN were found to induce a Type I spectral change only with  bbbbb2 GENEIN eeeee2 
CPR:4	CHEMICALIN 7-hydroxylation, catalyzed by  bbbbb1 GENEIN eeeee1 , was strongly inhibited by CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN; these chemicals induced Type I spectral changes with low Ks values
CPR:4	CHEMICALIN 7-hydroxylation, catalyzed by  bbbbb1 GENEIN eeeee1 , was strongly inhibited by  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN; these chemicals induced Type I spectral changes with low Ks values
CPR:4	CHEMICALIN 7-hydroxylation, catalyzed by  bbbbb1 GENEIN eeeee1 , was strongly inhibited by CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN; these chemicals induced Type I spectral changes with low Ks values
CPR:4	CHEMICALIN 7-hydroxylation, catalyzed by  bbbbb1 GENEIN eeeee1 , was strongly inhibited by CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN; these chemicals induced Type I spectral changes with low Ks values
CPR:4	CHEMICALIN 7-hydroxylation, catalyzed by  bbbbb1 GENEIN eeeee1 , was strongly inhibited by CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN; these chemicals induced Type I spectral changes with low Ks values
CPR:4	CHEMICALIN 7-hydroxylation, catalyzed by  bbbbb1 GENEIN eeeee1 , was strongly inhibited by CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN; these chemicals induced Type I spectral changes with low Ks values
CPR:4	CHEMICALIN 7-hydroxylation, catalyzed by  bbbbb1 GENEIN eeeee1 , was strongly inhibited by CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, and CHEMICALIN; these chemicals induced Type I spectral changes with low Ks values
CPR:4	CHEMICALIN 7-hydroxylation, catalyzed by  bbbbb1 GENEIN eeeee1 , was strongly inhibited by CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN; these chemicals induced Type I spectral changes with low Ks values
CPR:4	CHEMICALIN 7-hydroxylation, catalyzed by  bbbbb1 GENEIN eeeee1 , was strongly inhibited by CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN; these chemicals induced Type I spectral changes with low Ks values
CPR:4	CHEMICALIN 7-hydroxylation, catalyzed by  bbbbb1 GENEIN eeeee1 , was strongly inhibited by CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN; these chemicals induced Type I spectral changes with low Ks values
CPR:4	CHEMICALIN 7-hydroxylation, catalyzed by  bbbbb1 GENEIN eeeee1 , was strongly inhibited by CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, and CHEMICALIN; these chemicals induced Type I spectral changes with low Ks values
CPR:4	CHEMICALIN 7-hydroxylation, catalyzed by  bbbbb1 GENEIN eeeee1 , was strongly inhibited by CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , and CHEMICALIN; these chemicals induced Type I spectral changes with low Ks values
CPR:4	CHEMICALIN 7-hydroxylation, catalyzed by  bbbbb1 GENEIN eeeee1 , was strongly inhibited by CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and  bbbbb2 CHEMICALIN eeeee2 ; these chemicals induced Type I spectral changes with low Ks values
CPR:9	 bbbbb1 CHEMICALIN eeeee1  7-hydroxylation, catalyzed by  bbbbb2 GENEIN eeeee2 , was strongly inhibited by CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN; these chemicals induced Type I spectral changes with low Ks values
CPR:5	Full agonists to the  bbbbb1 GENEIN eeeee1 , such as  bbbbb2 CHEMICALIN eeeee2 , have been associated with a series of undesired side effects, such as weight gain, fluid retention, cardiac hypertrophy, and hepatotoxicity
CPR:1	In contrast, the  bbbbb1 GENEIN eeeee1  sequence showed well-defined structure only near its  bbbbb2 CHEMICALIN eeeee2 -terminal residues
CPR:9	PURPOSE:  bbbbb1 CHEMICALIN eeeee1  has (R)- and (S)-enantiomers, which exhibit different pharmacokinetics (PK) among patients with  bbbbb2 GENEIN eeeee2  genotype groups
CPR:9	The  bbbbb1 CHEMICALIN eeeee1  hydroxylation index reflects  bbbbb2 GENEIN eeeee2  activity in healthy Japanese volunteers
CPR:9	Additionally, there was a significant difference in plasma concentrations of  bbbbb1 CHEMICALIN eeeee1  among  bbbbb2 GENEIN eeeee2  genotype groups, whereas no significant differences were observed in that of CHEMICALIN
CPR:9	Additionally, there was a significant difference in plasma concentrations of CHEMICALIN among  bbbbb1 GENEIN eeeee1  genotype groups, whereas no significant differences were observed in that of  bbbbb2 CHEMICALIN eeeee2 
CPR:9	CONCLUSION: Our findings demonstrate that  bbbbb1 CHEMICALIN eeeee1  HI correlated better with  bbbbb2 GENEIN eeeee2  genotype groups than CHEMICALIN HI, and these results may be useful for classification among patients in GENENOTIN genotype groups prior to omeprazole treatment.
CPR:9	CONCLUSION: Our findings demonstrate that CHEMICALIN HI correlated better with  bbbbb1 GENEIN eeeee1  genotype groups than  bbbbb2 CHEMICALIN eeeee2  HI, and these results may be useful for classification among patients in GENENOTIN genotype groups prior to omeprazole treatment.
CPR:10	Neither  bbbbb1 CHEMICALIN eeeee1  nor its metabolites activated  bbbbb2 GENEIN eeeee2 , GENEIN, or GENEIN
CPR:10	Neither  bbbbb1 CHEMICALIN eeeee1  nor its metabolites activated GENEIN,  bbbbb2 GENEIN eeeee2 , or GENEIN
CPR:10	Neither  bbbbb1 CHEMICALIN eeeee1  nor its metabolites activated GENEIN, GENEIN, or  bbbbb2 GENEIN eeeee2 
CPR:2	Taken together, these findings identify a signature hepatic gene-network associated with repeated CHEMICALNOTIN administration in rats and demonstrate that  bbbbb1 CHEMICALIN eeeee1  alters the expression of many transporters and DMEs (without direct activation of  bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN), which could lead to undesirable DDIs after coadministration of substrates of these transporters/DMEs with CHEMICALNOTIN.
CPR:2	Taken together, these findings identify a signature hepatic gene-network associated with repeated CHEMICALNOTIN administration in rats and demonstrate that  bbbbb1 CHEMICALIN eeeee1  alters the expression of many transporters and DMEs (without direct activation of GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN), which could lead to undesirable DDIs after coadministration of substrates of these transporters/DMEs with CHEMICALNOTIN.
CPR:2	Taken together, these findings identify a signature hepatic gene-network associated with repeated CHEMICALNOTIN administration in rats and demonstrate that  bbbbb1 CHEMICALIN eeeee1  alters the expression of many transporters and DMEs (without direct activation of GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2 ), which could lead to undesirable DDIs after coadministration of substrates of these transporters/DMEs with CHEMICALNOTIN.
CPR:2	Induction of  bbbbb1 GENEIN eeeee1 , transporters, and drug metabolizing enzymes by  bbbbb2 CHEMICALIN eeeee2 
CPR:3	The pleiotropic effects of CHEMICALNOTIN are exerted mainly by one active metabolite,  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), which regulates the expression of a battery of target genes through several families of  bbbbb2 GENEIN eeeee2  (GENEIN, GENEIN and GENENOTIN), GENEIN and multiple coregulators
CPR:3	The pleiotropic effects of CHEMICALNOTIN are exerted mainly by one active metabolite,  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), which regulates the expression of a battery of target genes through several families of GENEIN ( bbbbb2 GENEIN eeeee2 , GENEIN and GENENOTIN), GENEIN and multiple coregulators
CPR:3	The pleiotropic effects of CHEMICALNOTIN are exerted mainly by one active metabolite,  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), which regulates the expression of a battery of target genes through several families of GENEIN (GENEIN,  bbbbb2 GENEIN eeeee2  and GENENOTIN), GENEIN and multiple coregulators
CPR:3	The pleiotropic effects of CHEMICALNOTIN are exerted mainly by one active metabolite,  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), which regulates the expression of a battery of target genes through several families of GENEIN (GENEIN, GENEIN and GENENOTIN),  bbbbb2 GENEIN eeeee2  and multiple coregulators
CPR:3	The pleiotropic effects of CHEMICALNOTIN are exerted mainly by one active metabolite, CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), which regulates the expression of a battery of target genes through several families of  bbbbb2 GENEIN eeeee2  (GENEIN, GENEIN and GENENOTIN), GENEIN and multiple coregulators
CPR:3	The pleiotropic effects of CHEMICALNOTIN are exerted mainly by one active metabolite, CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), which regulates the expression of a battery of target genes through several families of GENEIN ( bbbbb2 GENEIN eeeee2 , GENEIN and GENENOTIN), GENEIN and multiple coregulators
CPR:3	The pleiotropic effects of CHEMICALNOTIN are exerted mainly by one active metabolite, CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), which regulates the expression of a battery of target genes through several families of GENEIN (GENEIN,  bbbbb2 GENEIN eeeee2  and GENENOTIN), GENEIN and multiple coregulators
CPR:3	The pleiotropic effects of CHEMICALNOTIN are exerted mainly by one active metabolite, CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), which regulates the expression of a battery of target genes through several families of GENEIN (GENEIN, GENEIN and GENENOTIN),  bbbbb2 GENEIN eeeee2  and multiple coregulators
CPR:3	Interestingly,  bbbbb1 GENEIN eeeee1  expression positively correlated with urine GENENOTIN  bbbbb2 CHEMICALIN eeeee2  ratio (ACR), GENENOTIN, GENENOTIN (GENENOTIN), and GENENOTIN (GENENOTIN); while negatively correlated with CHEMICALIN clearance ratio (Ccr) and GENENOTIN protein
CPR:4	Interestingly,  bbbbb1 GENEIN eeeee1  expression positively correlated with urine GENENOTIN CHEMICALIN ratio (ACR), GENENOTIN, GENENOTIN (GENENOTIN), and GENENOTIN (GENENOTIN); while negatively correlated with  bbbbb2 CHEMICALIN eeeee2  clearance ratio (Ccr) and GENENOTIN protein
CPR:1	Thus, the formation of  bbbbb1 CHEMICALIN eeeee1  bonds in  bbbbb2 GENEIN eeeee2  is a potentially important reversible mechanism for alterations in the rates of sulfation of both endogenous and xenobiotic substrates.
CPR:1	Modification of the Catalytic Function of  bbbbb1 GENEIN eeeee1  by Formation of  bbbbb2 CHEMICALIN eeeee2  Bonds
CPR:9	Studies on the kinetics of the  bbbbb1 GENEIN eeeee1 -catalyzed sulfation of  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) showed the effects of CHEMICALNOTIN bond formation on the substrate inhibition characteristics of the enzyme
CPR:9	Studies on the kinetics of the  bbbbb1 GENEIN eeeee1 -catalyzed sulfation of CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) showed the effects of CHEMICALNOTIN bond formation on the substrate inhibition characteristics of the enzyme
CPR:9	The  bbbbb1 GENEIN eeeee1  catalyzes the sulfation of a broad range of xenobiotics, as well as endogenous  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:9	The  bbbbb1 GENEIN eeeee1  catalyzes the sulfation of a broad range of xenobiotics, as well as endogenous CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:2	These results provide an example that attachment of a bulky side chain to the C-7 position of E2 can produce GENENOTIN antagonists with  bbbbb1 GENEIN eeeee1  affinity comparable to that of  bbbbb2 CHEMICALIN eeeee2 .
CPR:6	Computational docking analysis was conducted to model the interaction of these antagonists with the GENENOTIN and showed that they could tightly bind to the GENENOTIN in a manner similar to that of  bbbbb1 CHEMICALIN eeeee1 , a pure  bbbbb2 GENEIN eeeee2  antagonist
CPR:6	These results provide an example that attachment of a bulky side chain to the C-7 position of E2 can produce GENENOTIN antagonists with  bbbbb1 GENEIN eeeee1  affinity comparable to that of  bbbbb2 CHEMICALIN eeeee2 .
CPR:4	 bbbbb1 CHEMICALIN eeeee1  11 (CHEMICALIN) was synthesized and evaluated as GENEIN (also known as  bbbbb2 GENEIN eeeee2  or GENEIN) inhibitor
CPR:4	 bbbbb1 CHEMICALIN eeeee1  11 (CHEMICALIN) was synthesized and evaluated as GENEIN (also known as GENEIN or  bbbbb2 GENEIN eeeee2 ) inhibitor
CPR:4	 bbbbb1 CHEMICALIN eeeee1  11 (CHEMICALIN) was synthesized and evaluated as  bbbbb2 GENEIN eeeee2  (also known as GENEIN or GENEIN) inhibitor
CPR:4	CHEMICALIN 11 ( bbbbb1 CHEMICALIN eeeee1 ) was synthesized and evaluated as GENEIN (also known as  bbbbb2 GENEIN eeeee2  or GENEIN) inhibitor
CPR:4	CHEMICALIN 11 ( bbbbb1 CHEMICALIN eeeee1 ) was synthesized and evaluated as GENEIN (also known as GENEIN or  bbbbb2 GENEIN eeeee2 ) inhibitor
CPR:4	CHEMICALIN 11 ( bbbbb1 CHEMICALIN eeeee1 ) was synthesized and evaluated as  bbbbb2 GENEIN eeeee2  (also known as GENEIN or GENEIN) inhibitor
CPR:4	Discovery of  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN): a potent and selective  bbbbb2 GENEIN eeeee2  inhibitor as a topical drug for alopecia
CPR:4	Discovery of CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ): a potent and selective  bbbbb2 GENEIN eeeee2  inhibitor as a topical drug for alopecia
CPR:10	Here, we provide evidence that GENENOTIN physically interacts with GENENOTIN and functions as an  bbbbb1 GENEIN eeeee1  corespressor in both an CHEMICALIN-dependent and  bbbbb2 CHEMICALIN eeeee2 -independent manner
CPR:1	Furthermore, we demonstrated that GENENOTIN binds to both the  bbbbb1 CHEMICALIN eeeee1 -terminal domain and the ligand-binding domain of  bbbbb2 GENEIN eeeee2 , and the GENENOTIN of GENENOTIN is required for the interaction of GENENOTIN and GENENOTIN proteins
CPR:1	GENENOTIN perturbs the CHEMICALIN-induced interaction between the  bbbbb1 CHEMICALIN eeeee1  terminus and CHEMICALIN terminus of  bbbbb2 GENEIN eeeee2 
CPR:1	GENENOTIN perturbs the CHEMICALIN-induced interaction between the CHEMICALIN terminus and  bbbbb1 CHEMICALIN eeeee1  terminus of  bbbbb2 GENEIN eeeee2 
CPR:2	GENENOTIN perturbs the  bbbbb1 CHEMICALIN eeeee1 -induced interaction between the CHEMICALIN terminus and CHEMICALIN terminus of  bbbbb2 GENEIN eeeee2 
CPR:2	Here, we provide evidence that GENENOTIN physically interacts with GENENOTIN and functions as an  bbbbb1 GENEIN eeeee1  corespressor in both an  bbbbb2 CHEMICALIN eeeee2 -dependent and CHEMICALIN-independent manner
CPR:2	This study evaluates the production of inflammatory biomarkers ( bbbbb1 GENEIN eeeee1 , GENEIN, GENEIN, GENEIN) and the influence of gene expression transporters and enzymes related to CHEMICALNOTIN absorption and metabolism (GENEIN, GENEIN, GENEIN, GENEIN) produced by  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN/CHEMICALIN) in Caco-2 cells
CPR:2	This study evaluates the production of inflammatory biomarkers (GENEIN,  bbbbb1 GENEIN eeeee1 , GENEIN, GENEIN) and the influence of gene expression transporters and enzymes related to CHEMICALNOTIN absorption and metabolism (GENEIN, GENEIN, GENEIN, GENEIN) produced by  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN/CHEMICALIN) in Caco-2 cells
CPR:2	This study evaluates the production of inflammatory biomarkers (GENEIN, GENEIN,  bbbbb1 GENEIN eeeee1 , GENEIN) and the influence of gene expression transporters and enzymes related to CHEMICALNOTIN absorption and metabolism (GENEIN, GENEIN, GENEIN, GENEIN) produced by  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN/CHEMICALIN) in Caco-2 cells
CPR:2	This study evaluates the production of inflammatory biomarkers (GENEIN, GENEIN, GENEIN,  bbbbb1 GENEIN eeeee1 ) and the influence of gene expression transporters and enzymes related to CHEMICALNOTIN absorption and metabolism (GENEIN, GENEIN, GENEIN, GENEIN) produced by  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN/CHEMICALIN) in Caco-2 cells
CPR:2	This study evaluates the production of inflammatory biomarkers (GENEIN, GENEIN, GENEIN, GENEIN) and the influence of gene expression transporters and enzymes related to CHEMICALNOTIN absorption and metabolism ( bbbbb1 GENEIN eeeee1 , GENEIN, GENEIN, GENEIN) produced by  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN/CHEMICALIN) in Caco-2 cells
CPR:2	This study evaluates the production of inflammatory biomarkers (GENEIN, GENEIN, GENEIN, GENEIN) and the influence of gene expression transporters and enzymes related to CHEMICALNOTIN absorption and metabolism (GENEIN,  bbbbb1 GENEIN eeeee1 , GENEIN, GENEIN) produced by  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN/CHEMICALIN) in Caco-2 cells
CPR:2	This study evaluates the production of inflammatory biomarkers (GENEIN, GENEIN, GENEIN, GENEIN) and the influence of gene expression transporters and enzymes related to CHEMICALNOTIN absorption and metabolism (GENEIN, GENEIN,  bbbbb1 GENEIN eeeee1 , GENEIN) produced by  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN/CHEMICALIN) in Caco-2 cells
CPR:2	This study evaluates the production of inflammatory biomarkers (GENEIN, GENEIN, GENEIN, GENEIN) and the influence of gene expression transporters and enzymes related to CHEMICALNOTIN absorption and metabolism (GENEIN, GENEIN, GENEIN,  bbbbb1 GENEIN eeeee1 ) produced by  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN/CHEMICALIN) in Caco-2 cells
CPR:2	This study evaluates the production of inflammatory biomarkers ( bbbbb1 GENEIN eeeee1 , GENEIN, GENEIN, GENEIN) and the influence of gene expression transporters and enzymes related to CHEMICALNOTIN absorption and metabolism (GENEIN, GENEIN, GENEIN, GENEIN) produced by CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 /CHEMICALIN) in Caco-2 cells
CPR:2	This study evaluates the production of inflammatory biomarkers (GENEIN,  bbbbb1 GENEIN eeeee1 , GENEIN, GENEIN) and the influence of gene expression transporters and enzymes related to CHEMICALNOTIN absorption and metabolism (GENEIN, GENEIN, GENEIN, GENEIN) produced by CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 /CHEMICALIN) in Caco-2 cells
CPR:2	This study evaluates the production of inflammatory biomarkers (GENEIN, GENEIN,  bbbbb1 GENEIN eeeee1 , GENEIN) and the influence of gene expression transporters and enzymes related to CHEMICALNOTIN absorption and metabolism (GENEIN, GENEIN, GENEIN, GENEIN) produced by CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 /CHEMICALIN) in Caco-2 cells
CPR:2	This study evaluates the production of inflammatory biomarkers (GENEIN, GENEIN, GENEIN,  bbbbb1 GENEIN eeeee1 ) and the influence of gene expression transporters and enzymes related to CHEMICALNOTIN absorption and metabolism (GENEIN, GENEIN, GENEIN, GENEIN) produced by CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 /CHEMICALIN) in Caco-2 cells
CPR:2	This study evaluates the production of inflammatory biomarkers (GENEIN, GENEIN, GENEIN, GENEIN) and the influence of gene expression transporters and enzymes related to CHEMICALNOTIN absorption and metabolism ( bbbbb1 GENEIN eeeee1 , GENEIN, GENEIN, GENEIN) produced by CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 /CHEMICALIN) in Caco-2 cells
CPR:2	This study evaluates the production of inflammatory biomarkers (GENEIN, GENEIN, GENEIN, GENEIN) and the influence of gene expression transporters and enzymes related to CHEMICALNOTIN absorption and metabolism (GENEIN,  bbbbb1 GENEIN eeeee1 , GENEIN, GENEIN) produced by CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 /CHEMICALIN) in Caco-2 cells
CPR:2	This study evaluates the production of inflammatory biomarkers (GENEIN, GENEIN, GENEIN, GENEIN) and the influence of gene expression transporters and enzymes related to CHEMICALNOTIN absorption and metabolism (GENEIN, GENEIN,  bbbbb1 GENEIN eeeee1 , GENEIN) produced by CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 /CHEMICALIN) in Caco-2 cells
CPR:2	This study evaluates the production of inflammatory biomarkers (GENEIN, GENEIN, GENEIN, GENEIN) and the influence of gene expression transporters and enzymes related to CHEMICALNOTIN absorption and metabolism (GENEIN, GENEIN, GENEIN,  bbbbb1 GENEIN eeeee1 ) produced by CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 /CHEMICALIN) in Caco-2 cells
CPR:2	This study evaluates the production of inflammatory biomarkers ( bbbbb1 GENEIN eeeee1 , GENEIN, GENEIN, GENEIN) and the influence of gene expression transporters and enzymes related to CHEMICALNOTIN absorption and metabolism (GENEIN, GENEIN, GENEIN, GENEIN) produced by CHEMICALIN (CHEMICALIN/ bbbbb2 CHEMICALIN eeeee2 ) in Caco-2 cells
CPR:2	This study evaluates the production of inflammatory biomarkers (GENEIN,  bbbbb1 GENEIN eeeee1 , GENEIN, GENEIN) and the influence of gene expression transporters and enzymes related to CHEMICALNOTIN absorption and metabolism (GENEIN, GENEIN, GENEIN, GENEIN) produced by CHEMICALIN (CHEMICALIN/ bbbbb2 CHEMICALIN eeeee2 ) in Caco-2 cells
CPR:2	This study evaluates the production of inflammatory biomarkers (GENEIN, GENEIN,  bbbbb1 GENEIN eeeee1 , GENEIN) and the influence of gene expression transporters and enzymes related to CHEMICALNOTIN absorption and metabolism (GENEIN, GENEIN, GENEIN, GENEIN) produced by CHEMICALIN (CHEMICALIN/ bbbbb2 CHEMICALIN eeeee2 ) in Caco-2 cells
CPR:2	This study evaluates the production of inflammatory biomarkers (GENEIN, GENEIN, GENEIN,  bbbbb1 GENEIN eeeee1 ) and the influence of gene expression transporters and enzymes related to CHEMICALNOTIN absorption and metabolism (GENEIN, GENEIN, GENEIN, GENEIN) produced by CHEMICALIN (CHEMICALIN/ bbbbb2 CHEMICALIN eeeee2 ) in Caco-2 cells
CPR:2	This study evaluates the production of inflammatory biomarkers (GENEIN, GENEIN, GENEIN, GENEIN) and the influence of gene expression transporters and enzymes related to CHEMICALNOTIN absorption and metabolism ( bbbbb1 GENEIN eeeee1 , GENEIN, GENEIN, GENEIN) produced by CHEMICALIN (CHEMICALIN/ bbbbb2 CHEMICALIN eeeee2 ) in Caco-2 cells
CPR:2	This study evaluates the production of inflammatory biomarkers (GENEIN, GENEIN, GENEIN, GENEIN) and the influence of gene expression transporters and enzymes related to CHEMICALNOTIN absorption and metabolism (GENEIN,  bbbbb1 GENEIN eeeee1 , GENEIN, GENEIN) produced by CHEMICALIN (CHEMICALIN/ bbbbb2 CHEMICALIN eeeee2 ) in Caco-2 cells
CPR:2	This study evaluates the production of inflammatory biomarkers (GENEIN, GENEIN, GENEIN, GENEIN) and the influence of gene expression transporters and enzymes related to CHEMICALNOTIN absorption and metabolism (GENEIN, GENEIN,  bbbbb1 GENEIN eeeee1 , GENEIN) produced by CHEMICALIN (CHEMICALIN/ bbbbb2 CHEMICALIN eeeee2 ) in Caco-2 cells
CPR:2	This study evaluates the production of inflammatory biomarkers (GENEIN, GENEIN, GENEIN, GENEIN) and the influence of gene expression transporters and enzymes related to CHEMICALNOTIN absorption and metabolism (GENEIN, GENEIN, GENEIN,  bbbbb1 GENEIN eeeee1 ) produced by CHEMICALIN (CHEMICALIN/ bbbbb2 CHEMICALIN eeeee2 ) in Caco-2 cells
CPR:2	In non-pre-treated cells, only GENEIN were down-regulated by  bbbbb1 CHEMICALIN eeeee1 , showing a greater influence upon  bbbbb2 GENEIN eeeee2  expression
CPR:2	Cell-pre-incubation with  bbbbb1 GENEIN eeeee1  induced changes in GENEIN expression levels after  bbbbb2 CHEMICALIN eeeee2 -incubation; however, the energetic metabolism inhibition reduced GENEIN expression only in CHEMICALIN-incubated cells
CPR:2	Cell-pre-incubation with GENEIN induced changes in  bbbbb1 GENEIN eeeee1  expression levels after  bbbbb2 CHEMICALIN eeeee2 -incubation; however, the energetic metabolism inhibition reduced GENEIN expression only in CHEMICALIN-incubated cells
CPR:2	These results suggest that internalization and excretion of CHEMICALNOTIN is probably influenced by [ bbbbb1 CHEMICALIN eeeee1 ]i, which also could mediate  bbbbb2 GENEIN eeeee2  activity in POPs metabolism
CPR:3	In non-pre-treated cells,  bbbbb1 GENEIN eeeee1  was up-regulated by both  bbbbb2 CHEMICALIN eeeee2 
CPR:4	In non-pre-treated cells, only  bbbbb1 GENEIN eeeee1  were down-regulated by  bbbbb2 CHEMICALIN eeeee2 , showing a greater influence upon GENEIN expression
CPR:4	Cell-pre-incubation with GENEIN induced changes in GENEIN expression levels after CHEMICALIN-incubation; however, the energetic metabolism inhibition reduced  bbbbb1 GENEIN eeeee1  expression only in  bbbbb2 CHEMICALIN eeeee2 -incubated cells
CPR:3	In lymphocytes, the GENEIN and  bbbbb1 GENEIN eeeee1  activities were increased in all groups treated with  bbbbb2 CHEMICALIN eeeee2  when compared to control (P<0.05)
CPR:3	In lymphocytes, the  bbbbb1 GENEIN eeeee1  and GENEIN activities were increased in all groups treated with  bbbbb2 CHEMICALIN eeeee2  when compared to control (P<0.05)
CPR:1	We demonstrate that activation of  bbbbb1 GENEIN eeeee1   bbbbb2 CHEMICALIN eeeee2 -727 and CHEMICALIN-705 phosphorylations is promoted by GENENOTIN(GENENOTIN) activity and that the GENENOTIN is dependent on a GENENOTIN consensus-site for GENENOTIN-mediated activation
CPR:1	We demonstrate that activation of  bbbbb1 GENEIN eeeee1  CHEMICALIN-727 and  bbbbb2 CHEMICALIN eeeee2 -705 phosphorylations is promoted by GENENOTIN(GENENOTIN) activity and that the GENENOTIN is dependent on a GENENOTIN consensus-site for GENENOTIN-mediated activation
CPR:10	When mice were treated ip with the major neonicotinoid  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), metabolism by  bbbbb2 GENEIN eeeee2  oxidation reactions was not appreciably affected, whereas the GENEIN-generated CHEMICALIN metabolite was decreased by 30% with CHEMICALIN and 56% with CHEMICALIN and 86% in the GENENOTIN-deficient mice
CPR:10	When mice were treated ip with the major neonicotinoid CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), metabolism by  bbbbb2 GENEIN eeeee2  oxidation reactions was not appreciably affected, whereas the GENEIN-generated CHEMICALIN metabolite was decreased by 30% with CHEMICALIN and 56% with CHEMICALIN and 86% in the GENENOTIN-deficient mice
CPR:4	The procedure was to reduce liver  bbbbb1 GENEIN eeeee1  activity by providing  bbbbb2 CHEMICALIN eeeee2  or CHEMICALIN in the drinking water or to use the GENENOTIN-deficient DBA/2 mouse strain
CPR:4	The procedure was to reduce liver  bbbbb1 GENEIN eeeee1  activity by providing CHEMICALIN or  bbbbb2 CHEMICALIN eeeee2  in the drinking water or to use the GENENOTIN-deficient DBA/2 mouse strain
CPR:4	Liver  bbbbb1 GENEIN eeeee1  activity was reduced by 45% with  bbbbb2 CHEMICALIN eeeee2  and 61% with CHEMICALIN and 81% in GENENOTIN-deficient mice relative to controls
CPR:4	Liver  bbbbb1 GENEIN eeeee1  activity was reduced by 45% with CHEMICALIN and 61% with  bbbbb2 CHEMICALIN eeeee2  and 81% in GENENOTIN-deficient mice relative to controls
CPR:4	When mice were treated ip with the major neonicotinoid CHEMICALIN (CHEMICALIN), metabolism by GENEIN oxidation reactions was not appreciably affected, whereas the  bbbbb1 GENEIN eeeee1 -generated CHEMICALIN metabolite was decreased by 30% with  bbbbb2 CHEMICALIN eeeee2  and 56% with CHEMICALIN and 86% in the GENENOTIN-deficient mice
CPR:4	When mice were treated ip with the major neonicotinoid CHEMICALIN (CHEMICALIN), metabolism by GENEIN oxidation reactions was not appreciably affected, whereas the  bbbbb1 GENEIN eeeee1 -generated CHEMICALIN metabolite was decreased by 30% with CHEMICALIN and 56% with  bbbbb2 CHEMICALIN eeeee2  and 86% in the GENENOTIN-deficient mice
CPR:9	When mice were treated ip with the major neonicotinoid CHEMICALIN (CHEMICALIN), metabolism by GENEIN oxidation reactions was not appreciably affected, whereas the  bbbbb1 GENEIN eeeee1 -generated  bbbbb2 CHEMICALIN eeeee2  metabolite was decreased by 30% with CHEMICALIN and 56% with CHEMICALIN and 86% in the GENENOTIN-deficient mice
CPR:9	Possible  bbbbb1 GENEIN eeeee1  involvement in  bbbbb2 CHEMICALIN eeeee2  metabolism in insects was evaluated using GENEIN-expressing and GENENOTIN-deficient Drosophila, but no differences were found in CHEMICALNOTIN nitroreduction or sensitivity between the two strains
CPR:9	Possible GENEIN involvement in  bbbbb1 CHEMICALIN eeeee1  metabolism in insects was evaluated using  bbbbb2 GENEIN eeeee2 -expressing and GENENOTIN-deficient Drosophila, but no differences were found in CHEMICALNOTIN nitroreduction or sensitivity between the two strains
CPR:9	This is the first study to establish the in vivo relevance of  bbbbb1 GENEIN eeeee1  in  bbbbb2 CHEMICALIN eeeee2  metabolism in mammals and one of the first for xenobiotics in general.
CPR:9	Currently, the most important insecticides are  bbbbb1 CHEMICALIN eeeee1 , which are metabolized in vitro by  bbbbb2 GENEIN eeeee2  on reduction of the CHEMICALIN group and by GENEIN via oxidation reactions
CPR:9	Currently, the most important insecticides are  bbbbb1 CHEMICALIN eeeee1 , which are metabolized in vitro by GENEIN on reduction of the CHEMICALIN group and by  bbbbb2 GENEIN eeeee2  via oxidation reactions
CPR:9	Currently, the most important insecticides are CHEMICALIN, which are metabolized in vitro by  bbbbb1 GENEIN eeeee1  on reduction of the  bbbbb2 CHEMICALIN eeeee2  group and by GENEIN via oxidation reactions
CPR:9	Thus, decreasing liver  bbbbb1 GENEIN eeeee1  activity by three quite different procedures gave a corresponding decrease for in vivo reductive metabolites in the liver of  bbbbb2 CHEMICALIN eeeee2 -treated mice
CPR:4	Of the compounds active in the present assay system, the most potent compound 7,  bbbbb1 CHEMICALIN eeeee1 , significantly suppressed the induction of GENEIN (GENEIN and  bbbbb2 GENEIN eeeee2  (GENEIN) protein expression, and inhibited adipocyte differentiation induced by CHEMICALIN, a GENEIN agonist
CPR:4	Of the compounds active in the present assay system, the most potent compound 7,  bbbbb1 CHEMICALIN eeeee1 , significantly suppressed the induction of GENEIN (GENEIN and GENEIN ( bbbbb2 GENEIN eeeee2 ) protein expression, and inhibited adipocyte differentiation induced by CHEMICALIN, a GENEIN agonist
CPR:4	Of the compounds active in the present assay system, the most potent compound 7,  bbbbb1 CHEMICALIN eeeee1 , significantly suppressed the induction of  bbbbb2 GENEIN eeeee2  (GENEIN and GENEIN (GENEIN) protein expression, and inhibited adipocyte differentiation induced by CHEMICALIN, a GENEIN agonist
CPR:4	Of the compounds active in the present assay system, the most potent compound 7,  bbbbb1 CHEMICALIN eeeee1 , significantly suppressed the induction of GENEIN ( bbbbb2 GENEIN eeeee2  and GENEIN (GENEIN) protein expression, and inhibited adipocyte differentiation induced by CHEMICALIN, a GENEIN agonist
CPR:5	Of the compounds active in the present assay system, the most potent compound 7, CHEMICALIN, significantly suppressed the induction of GENEIN (GENEIN and GENEIN (GENEIN) protein expression, and inhibited adipocyte differentiation induced by  bbbbb1 CHEMICALIN eeeee1 , a  bbbbb2 GENEIN eeeee2  agonist
CPR:4	Based on our previously published work on GENENOTIN antagonists, we have synthesized a series of  bbbbb1 CHEMICALIN eeeee1  that inhibit the  bbbbb2 GENEIN eeeee2 /GENEIN interaction
CPR:4	Based on our previously published work on GENENOTIN antagonists, we have synthesized a series of  bbbbb1 CHEMICALIN eeeee1  that inhibit the GENEIN/ bbbbb2 GENEIN eeeee2  interaction
CPR:4	These data demonstrate that  bbbbb1 CHEMICALIN eeeee1  are a unique class of  bbbbb2 GENEIN eeeee2  inhibitors with high potency.
CPR:4	 bbbbb1 CHEMICALIN eeeee1 : a unique class of  bbbbb2 GENEIN eeeee2  inhibitors
CPR:9	Measurement of Transport Activities of  bbbbb1 CHEMICALIN eeeee1  in  bbbbb2 GENEIN eeeee2  and GENEIN Using LC-MS/MS
CPR:9	Measurement of Transport Activities of  bbbbb1 CHEMICALIN eeeee1  in GENEIN and  bbbbb2 GENEIN eeeee2  Using LC-MS/MS
CPR:9	The analytical method was applied to measurements of transport activities in membrane vesicles obtained from GENENOTIN-, and  bbbbb1 GENEIN eeeee1 -expressing Sf9 cells for conjugated  bbbbb2 CHEMICALIN eeeee2 
CPR:9	The present study demonstrated that  bbbbb1 GENEIN eeeee1  vesicles accepted conjugated  bbbbb2 CHEMICALIN eeeee2  along with common CHEMICALIN such as CHEMICALIN and CHEMICALIN.
CPR:9	The present study demonstrated that  bbbbb1 GENEIN eeeee1  vesicles accepted conjugated CHEMICALIN along with common  bbbbb2 CHEMICALIN eeeee2  such as CHEMICALIN and CHEMICALIN.
CPR:9	The present study demonstrated that  bbbbb1 GENEIN eeeee1  vesicles accepted conjugated CHEMICALIN along with common CHEMICALIN such as  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN.
CPR:9	The present study demonstrated that  bbbbb1 GENEIN eeeee1  vesicles accepted conjugated CHEMICALIN along with common CHEMICALIN such as CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 .
CPR:1	Here, we report that a specific 29- bbbbb1 CHEMICALIN eeeee1  peptide derived from the intracellular domain fragment of  bbbbb2 GENEIN eeeee2  interacts with and potentiates binding of GENENOTIN to GENENOTIN-expressing cells, leading to increased neurite outgrowth in sympathetic neurons as a result of enhanced GENENOTIN and GENENOTIN signaling
CPR:1	An endogenous intracellular domain fragment of  bbbbb1 GENEIN eeeee1  (GENEIN) containing these 29  bbbbb2 CHEMICALIN eeeee2  is produced by regulated proteolysis of the full-length receptor
CPR:1	An endogenous intracellular domain fragment of GENEIN ( bbbbb1 GENEIN eeeee1 ) containing these 29  bbbbb2 CHEMICALIN eeeee2  is produced by regulated proteolysis of the full-length receptor
CPR:4	A series of substituted  bbbbb1 CHEMICALIN eeeee1  has been synthesised and tested in vitro as potential pro-apoptotic  bbbbb2 GENEIN eeeee2 -inhibitory anticancer agents
CPR:4	Active compounds, such as the  bbbbb1 CHEMICALIN eeeee1  analogue 6c, were found to exhibit sub-micromolar IC50 values in  bbbbb2 GENEIN eeeee2  expressing human cancer cell lines
CPR:4	Synthesis and evaluation of  bbbbb1 CHEMICALIN eeeee1  as  bbbbb2 GENEIN eeeee2  inhibitory anticancer agents
CPR:10	 bbbbb1 GENEIN eeeee1 , a phase II enzyme, was inhibited by both CHEMICALIN and CHEMICALIN but no such inhibition was noted in CHEMICALIN-treated animals pre-exposed to  bbbbb2 CHEMICALIN eeeee2 
CPR:10	 bbbbb1 GENEIN eeeee1 , a phase II enzyme, was inhibited by both CHEMICALIN and CHEMICALIN but no such inhibition was noted in  bbbbb2 CHEMICALIN eeeee2 -treated animals pre-exposed to CHEMICALIN
CPR:3	Upon  bbbbb1 CHEMICALIN eeeee1  pre-exposure, brain  bbbbb2 GENEIN eeeee2  increased, while GENEIN (GENEIN) decreased
CPR:4	Upon  bbbbb1 CHEMICALIN eeeee1  pre-exposure, brain GENEIN increased, while  bbbbb2 GENEIN eeeee2  (GENEIN) decreased
CPR:4	Upon  bbbbb1 CHEMICALIN eeeee1  pre-exposure, brain GENEIN increased, while GENEIN ( bbbbb2 GENEIN eeeee2 ) decreased
CPR:4	The toxic effects of  bbbbb1 GENEIN eeeee1  significantly attenuated with  bbbbb2 CHEMICALIN eeeee2  pre-exposure
CPR:4	 bbbbb1 GENEIN eeeee1 , a phase II enzyme, was inhibited by both  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN but no such inhibition was noted in CHEMICALIN-treated animals pre-exposed to CHEMICALIN
CPR:4	 bbbbb1 GENEIN eeeee1 , a phase II enzyme, was inhibited by both CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  but no such inhibition was noted in CHEMICALIN-treated animals pre-exposed to CHEMICALIN
CPR:2	The model accurately predicted  bbbbb1 GENEIN eeeee1  mRNA fold changes for controls and three  bbbbb2 CHEMICALIN eeeee2  doses (0, 0.5, and 3 g/l) and plasma E2 dose response from the 4-day study
CPR:4	We developed a computational model of the hypothalamic-pituitary-gonadal (HPG) axis in female fathead minnows to predict dose-response and time-course (DRTC) behaviors for endocrine effects of the  bbbbb1 GENEIN eeeee1  inhibitor,  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN)
CPR:4	We developed a computational model of the hypothalamic-pituitary-gonadal (HPG) axis in female fathead minnows to predict dose-response and time-course (DRTC) behaviors for endocrine effects of the  bbbbb1 GENEIN eeeee1  inhibitor, CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 )
CPR:1	Our results suggest that modification of multiple  bbbbb1 CHEMICALIN eeeee1  residues by electrophilic compounds can generate both activation and desensitization of the  bbbbb2 GENEIN eeeee2  channel.
CPR:1	Electrophilic chemicals activate both insect and vertebrate  bbbbb1 GENEIN eeeee1  via covalent modification of  bbbbb2 CHEMICALIN eeeee2  residues in the CHEMICALIN-terminal region
CPR:1	Electrophilic chemicals activate both insect and vertebrate  bbbbb1 GENEIN eeeee1  via covalent modification of CHEMICALIN residues in the  bbbbb2 CHEMICALIN eeeee2 -terminal region
CPR:1	We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type GENENOTIN or  bbbbb1 GENEIN eeeee1  with three  bbbbb2 CHEMICALIN eeeee2 -substituted CHEMICALIN crucial for electrophile activation (GENEIN, GENEIN, GENEIN)
CPR:1	We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type GENENOTIN or GENEIN with three  bbbbb1 CHEMICALIN eeeee1 -substituted CHEMICALIN crucial for electrophile activation ( bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN)
CPR:1	We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type GENENOTIN or GENEIN with three  bbbbb1 CHEMICALIN eeeee1 -substituted CHEMICALIN crucial for electrophile activation (GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN)
CPR:1	We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type GENENOTIN or GENEIN with three  bbbbb1 CHEMICALIN eeeee1 -substituted CHEMICALIN crucial for electrophile activation (GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 )
CPR:1	We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type GENENOTIN or  bbbbb1 GENEIN eeeee1  with three CHEMICALIN-substituted  bbbbb2 CHEMICALIN eeeee2  crucial for electrophile activation (GENEIN, GENEIN, GENEIN)
CPR:1	We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type GENENOTIN or GENEIN with three CHEMICALIN-substituted  bbbbb1 CHEMICALIN eeeee1  crucial for electrophile activation ( bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN)
CPR:1	We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type GENENOTIN or GENEIN with three CHEMICALIN-substituted  bbbbb1 CHEMICALIN eeeee1  crucial for electrophile activation (GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN)
CPR:1	We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type GENENOTIN or GENEIN with three CHEMICALIN-substituted  bbbbb1 CHEMICALIN eeeee1  crucial for electrophile activation (GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 )
CPR:1	CHEMICALIN Reveals a  bbbbb1 CHEMICALIN eeeee1 -Dependent Desensitization Mechanism of  bbbbb2 GENEIN eeeee2 
CPR:1	Interestingly, following CHEMICALIN desensitization, wild-type GENEIN had dramatically reduced response to the nonelectrophile agonist CHEMICALIN, whereas the triple  bbbbb1 CHEMICALIN eeeee1  mutant  bbbbb2 GENEIN eeeee2  retained its full response
CPR:2	 bbbbb1 CHEMICALIN eeeee1  Reveals a CHEMICALIN-Dependent Desensitization Mechanism of  bbbbb2 GENEIN eeeee2 
CPR:2	The current reduction we found at higher  bbbbb1 CHEMICALIN eeeee1  concentrations was a cysteine-dependent desensitization of  bbbbb2 GENEIN eeeee2 , and did not require prior activation
CPR:2	Interestingly, following  bbbbb1 CHEMICALIN eeeee1  desensitization, wild-type  bbbbb2 GENEIN eeeee2  had dramatically reduced response to the nonelectrophile agonist CHEMICALIN, whereas the triple CHEMICALIN mutant GENEIN retained its full response
CPR:3	We found that  bbbbb1 CHEMICALIN eeeee1  activates  bbbbb2 GENEIN eeeee2  starting at 10 nM and peaking at 300 nM; higher concentrations caused rapid activation followed by a fast decline
CPR:5	Interestingly, following CHEMICALIN desensitization, wild-type GENEIN had dramatically reduced response to the nonelectrophile agonist  bbbbb1 CHEMICALIN eeeee1 , whereas the triple CHEMICALIN mutant  bbbbb2 GENEIN eeeee2  retained its full response
CPR:5	Although naturally occurring electrophilic plant compounds, such as mustard oil and  bbbbb1 CHEMICALIN eeeee1 , are  bbbbb2 GENEIN eeeee2  agonists, it is unknown whether arthropod-produced electrophiles activate GENENOTIN
CPR:5	Interestingly, following CHEMICALIN desensitization, wild-type  bbbbb1 GENEIN eeeee1  had dramatically reduced response to the nonelectrophile agonist  bbbbb2 CHEMICALIN eeeee2 , whereas the triple CHEMICALIN mutant GENEIN retained its full response
CPR:4	Synthesis and in-silico studies of some  bbbbb1 CHEMICALIN eeeee1  derivatives as potential  bbbbb2 GENEIN eeeee2  inhibitors
CPR:1	We found that, both in a cell-free system and in cells, CHEMICALIN/CHEMICALIN donors such as CHEMICALIN and CHEMICALIN readily induced the  bbbbb1 CHEMICALIN eeeee1 -nitrosylation of  bbbbb2 GENEIN eeeee2 , causing structural and functional alterations
CPR:1	In particular, nitrosylation promoted CHEMICALNOTIN formation involving the pair of catalytic  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN-52 and CHEMICALIN-173) and disrupted the oligomeric structure of  bbbbb2 GENEIN eeeee2 , leading to loss of GENEIN activity
CPR:1	In particular, nitrosylation promoted CHEMICALNOTIN formation involving the pair of catalytic  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN-52 and CHEMICALIN-173) and disrupted the oligomeric structure of GENEIN, leading to loss of  bbbbb2 GENEIN eeeee2  activity
CPR:1	In particular, nitrosylation promoted CHEMICALNOTIN formation involving the pair of catalytic CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 -52 and CHEMICALIN-173) and disrupted the oligomeric structure of  bbbbb2 GENEIN eeeee2 , leading to loss of GENEIN activity
CPR:1	In particular, nitrosylation promoted CHEMICALNOTIN formation involving the pair of catalytic CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 -52 and CHEMICALIN-173) and disrupted the oligomeric structure of GENEIN, leading to loss of  bbbbb2 GENEIN eeeee2  activity
CPR:1	In particular, nitrosylation promoted CHEMICALNOTIN formation involving the pair of catalytic CHEMICALIN (CHEMICALIN-52 and  bbbbb1 CHEMICALIN eeeee1 -173) and disrupted the oligomeric structure of  bbbbb2 GENEIN eeeee2 , leading to loss of GENEIN activity
CPR:1	In particular, nitrosylation promoted CHEMICALNOTIN formation involving the pair of catalytic CHEMICALIN (CHEMICALIN-52 and  bbbbb1 CHEMICALIN eeeee1 -173) and disrupted the oligomeric structure of GENEIN, leading to loss of  bbbbb2 GENEIN eeeee2  activity
CPR:2	Our findings that CHEMICALIN/ bbbbb1 CHEMICALIN eeeee1  target both  bbbbb2 GENEIN eeeee2  and GENEIN may have implications for understanding the impact of nitrosylation on cellular redox homeostasis.
CPR:2	Our findings that CHEMICALIN/ bbbbb1 CHEMICALIN eeeee1  target both GENEIN and  bbbbb2 GENEIN eeeee2  may have implications for understanding the impact of nitrosylation on cellular redox homeostasis.
CPR:2	We found that, both in a cell-free system and in cells,  bbbbb1 CHEMICALIN eeeee1 /CHEMICALIN donors such as CHEMICALIN and CHEMICALIN readily induced the CHEMICALIN-nitrosylation of  bbbbb2 GENEIN eeeee2 , causing structural and functional alterations
CPR:2	We found that, both in a cell-free system and in cells, CHEMICALIN/ bbbbb1 CHEMICALIN eeeee1  donors such as CHEMICALIN and CHEMICALIN readily induced the CHEMICALIN-nitrosylation of  bbbbb2 GENEIN eeeee2 , causing structural and functional alterations
CPR:2	We found that, both in a cell-free system and in cells, CHEMICALIN/CHEMICALIN donors such as  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN readily induced the CHEMICALIN-nitrosylation of  bbbbb2 GENEIN eeeee2 , causing structural and functional alterations
CPR:2	We found that, both in a cell-free system and in cells, CHEMICALIN/CHEMICALIN donors such as CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  readily induced the CHEMICALIN-nitrosylation of  bbbbb2 GENEIN eeeee2 , causing structural and functional alterations
CPR:2	A highly potent inhibition of the GENEIN catalytic reaction by  bbbbb1 CHEMICALIN eeeee1 /CHEMICALIN was seen in assays employing the coupled  bbbbb2 GENEIN eeeee2 -GENEIN system
CPR:2	A highly potent inhibition of the GENEIN catalytic reaction by  bbbbb1 CHEMICALIN eeeee1 /CHEMICALIN was seen in assays employing the coupled GENEIN- bbbbb2 GENEIN eeeee2  system
CPR:2	A highly potent inhibition of the GENEIN catalytic reaction by CHEMICALIN/ bbbbb1 CHEMICALIN eeeee1  was seen in assays employing the coupled  bbbbb2 GENEIN eeeee2 -GENEIN system
CPR:2	A highly potent inhibition of the GENEIN catalytic reaction by CHEMICALIN/ bbbbb1 CHEMICALIN eeeee1  was seen in assays employing the coupled GENEIN- bbbbb2 GENEIN eeeee2  system
CPR:2	This effect appeared to be due to both competition between  bbbbb1 CHEMICALIN eeeee1  and GENENOTIN for the  bbbbb2 GENEIN eeeee2  system and direct modulation by CHEMICALIN of GENEIN activity
CPR:2	This effect appeared to be due to both competition between CHEMICALIN and GENENOTIN for the GENEIN system and direct modulation by  bbbbb1 CHEMICALIN eeeee1  of  bbbbb2 GENEIN eeeee2  activity
CPR:2	Our findings that  bbbbb1 CHEMICALIN eeeee1 /CHEMICALIN target both  bbbbb2 GENEIN eeeee2  and GENEIN may have implications for understanding the impact of nitrosylation on cellular redox homeostasis.
CPR:2	Our findings that  bbbbb1 CHEMICALIN eeeee1 /CHEMICALIN target both GENEIN and  bbbbb2 GENEIN eeeee2  may have implications for understanding the impact of nitrosylation on cellular redox homeostasis.
CPR:4	A highly potent inhibition of the  bbbbb1 GENEIN eeeee1  catalytic reaction by  bbbbb2 CHEMICALIN eeeee2 /CHEMICALIN was seen in assays employing the coupled GENEIN-GENEIN system
CPR:4	A highly potent inhibition of the  bbbbb1 GENEIN eeeee1  catalytic reaction by CHEMICALIN/ bbbbb2 CHEMICALIN eeeee2  was seen in assays employing the coupled GENEIN-GENEIN system
CPR:4	In this setting,  bbbbb1 CHEMICALIN eeeee1  (10 m) effectively blocked the  bbbbb2 GENEIN eeeee2 -mediated regeneration of GENEIN
CPR:4	In this setting,  bbbbb1 CHEMICALIN eeeee1  (10 m) effectively blocked the GENEIN-mediated regeneration of  bbbbb2 GENEIN eeeee2 
CPR:2	 bbbbb1 CHEMICALIN eeeee1  treatment for 4weeks led to marked liver fibrosis as assessed by serum biochemistry, histopathological examination, and hepatic lipid peroxidation and  bbbbb2 GENEIN eeeee2  content
CPR:3	CK significantly inhibited  bbbbb1 CHEMICALIN eeeee1 -induced increases in serum  bbbbb2 GENEIN eeeee2  (GENEIN) and GENEIN (GENEIN) activities, fibrosis score, and hepatic CHEMICALNOTIN and GENEIN content
CPR:3	CK significantly inhibited  bbbbb1 CHEMICALIN eeeee1 -induced increases in serum GENEIN ( bbbbb2 GENEIN eeeee2 ) and GENEIN (GENEIN) activities, fibrosis score, and hepatic CHEMICALNOTIN and GENEIN content
CPR:3	CK significantly inhibited  bbbbb1 CHEMICALIN eeeee1 -induced increases in serum GENEIN (GENEIN) and  bbbbb2 GENEIN eeeee2  (GENEIN) activities, fibrosis score, and hepatic CHEMICALNOTIN and GENEIN content
CPR:3	CK significantly inhibited  bbbbb1 CHEMICALIN eeeee1 -induced increases in serum GENEIN (GENEIN) and GENEIN ( bbbbb2 GENEIN eeeee2 ) activities, fibrosis score, and hepatic CHEMICALNOTIN and GENEIN content
CPR:3	 bbbbb1 CHEMICALIN eeeee1 -induced GENEIN (GENEIN) expression and  bbbbb2 GENEIN eeeee2  (GENEIN) activation was reduced by CK treatment
CPR:3	 bbbbb1 CHEMICALIN eeeee1 -induced GENEIN (GENEIN) expression and GENEIN ( bbbbb2 GENEIN eeeee2 ) activation was reduced by CK treatment
CPR:3	CK significantly inhibited  bbbbb1 CHEMICALIN eeeee1 -induced increases in serum GENEIN (GENEIN) and GENEIN (GENEIN) activities, fibrosis score, and hepatic CHEMICALNOTIN and  bbbbb2 GENEIN eeeee2  content
CPR:3	Reverse transcription polymerase chain reaction (RT-PCR) and western blot analyses revealed that CK inhibited  bbbbb1 CHEMICALIN eeeee1 -induced increases in  bbbbb2 GENEIN eeeee2  (GENEIN), GENEIN (GENEIN), and GENEIN (GENEIN) mRNA, and GENEIN and GENEIN protein
CPR:3	Reverse transcription polymerase chain reaction (RT-PCR) and western blot analyses revealed that CK inhibited  bbbbb1 CHEMICALIN eeeee1 -induced increases in GENEIN ( bbbbb2 GENEIN eeeee2 ), GENEIN (GENEIN), and GENEIN (GENEIN) mRNA, and GENEIN and GENEIN protein
CPR:3	Reverse transcription polymerase chain reaction (RT-PCR) and western blot analyses revealed that CK inhibited  bbbbb1 CHEMICALIN eeeee1 -induced increases in GENEIN (GENEIN),  bbbbb2 GENEIN eeeee2  (GENEIN), and GENEIN (GENEIN) mRNA, and GENEIN and GENEIN protein
CPR:3	Reverse transcription polymerase chain reaction (RT-PCR) and western blot analyses revealed that CK inhibited  bbbbb1 CHEMICALIN eeeee1 -induced increases in GENEIN (GENEIN), GENEIN ( bbbbb2 GENEIN eeeee2 ), and GENEIN (GENEIN) mRNA, and GENEIN and GENEIN protein
CPR:3	Reverse transcription polymerase chain reaction (RT-PCR) and western blot analyses revealed that CK inhibited  bbbbb1 CHEMICALIN eeeee1 -induced increases in GENEIN (GENEIN), GENEIN (GENEIN), and  bbbbb2 GENEIN eeeee2  (GENEIN) mRNA, and GENEIN and GENEIN protein
CPR:3	Reverse transcription polymerase chain reaction (RT-PCR) and western blot analyses revealed that CK inhibited  bbbbb1 CHEMICALIN eeeee1 -induced increases in GENEIN (GENEIN), GENEIN (GENEIN), and GENEIN ( bbbbb2 GENEIN eeeee2 ) mRNA, and GENEIN and GENEIN protein
CPR:3	Reverse transcription polymerase chain reaction (RT-PCR) and western blot analyses revealed that CK inhibited  bbbbb1 CHEMICALIN eeeee1 -induced increases in GENEIN (GENEIN), GENEIN (GENEIN), and GENEIN (GENEIN) mRNA, and  bbbbb2 GENEIN eeeee2  and GENEIN protein
CPR:3	Reverse transcription polymerase chain reaction (RT-PCR) and western blot analyses revealed that CK inhibited  bbbbb1 CHEMICALIN eeeee1 -induced increases in GENEIN (GENEIN), GENEIN (GENEIN), and GENEIN (GENEIN) mRNA, and GENEIN and  bbbbb2 GENEIN eeeee2  protein
CPR:3	 bbbbb1 CHEMICALIN eeeee1 -induced  bbbbb2 GENEIN eeeee2  (GENEIN) expression and GENEIN (GENEIN) activation was reduced by CK treatment
CPR:3	 bbbbb1 CHEMICALIN eeeee1 -induced GENEIN ( bbbbb2 GENEIN eeeee2 ) expression and GENEIN (GENEIN) activation was reduced by CK treatment
CPR:2	Further analyses revealed that  bbbbb1 CHEMICALIN eeeee1 -QD exposure resulted in apoptosis, indicated by changes in levels of  bbbbb2 GENEIN eeeee2  activity, GENEIN (GENEIN) cleavage and CHEMICALNOTIN externalization
CPR:2	Further analyses revealed that  bbbbb1 CHEMICALIN eeeee1 -QD exposure resulted in apoptosis, indicated by changes in levels of GENEIN activity,  bbbbb2 GENEIN eeeee2  (GENEIN) cleavage and CHEMICALNOTIN externalization
CPR:2	Further analyses revealed that  bbbbb1 CHEMICALIN eeeee1 -QD exposure resulted in apoptosis, indicated by changes in levels of GENEIN activity, GENEIN ( bbbbb2 GENEIN eeeee2 ) cleavage and CHEMICALNOTIN externalization
CPR:3	Extrinsic apoptotic pathway markers such as GENEIN levels and  bbbbb1 GENEIN eeeee1  activity increased as a result of  bbbbb2 CHEMICALIN eeeee2 -QD exposure
CPR:3	Our findings reveal that  bbbbb1 CHEMICALIN eeeee1 -QDs cause oxidative stress, interfere with antioxidant defenses and activate protein  bbbbb2 GENEIN eeeee2 , leading to apoptosis via both extrinsic and intrinsic pathways
CPR:3	Extrinsic apoptotic pathway markers such as  bbbbb1 GENEIN eeeee1  levels and GENEIN activity increased as a result of  bbbbb2 CHEMICALIN eeeee2 -QD exposure
CPR:2	A low molecular weight  bbbbb1 CHEMICALIN eeeee1  modified with CHEMICALIN (PEI1.8-DA)-based delivery strategy was suggested for the cardiac application of  bbbbb2 GENEIN eeeee2  siRNA to overcome the poor gene delivery efficiency to myocardium due to the highly charged structures of the compact cardiac muscles
CPR:2	A low molecular weight CHEMICALIN modified with  bbbbb1 CHEMICALIN eeeee1  (PEI1.8-DA)-based delivery strategy was suggested for the cardiac application of  bbbbb2 GENEIN eeeee2  siRNA to overcome the poor gene delivery efficiency to myocardium due to the highly charged structures of the compact cardiac muscles
CPR:2	Taken together, our data demonstrate that  bbbbb1 CHEMICALIN eeeee1  attenuates CHEMICALIN-induced dopaminergic neuronal degeneration via modulating  bbbbb2 GENEIN eeeee2  expression, GENEIN/GENEIN pathway and CHEMICALNOTIN activation, which subsequently ameliorate CHEMICALIN-induced ROS formation and decrease of GENEIN expression
CPR:2	Taken together, our data demonstrate that CHEMICALIN attenuates  bbbbb1 CHEMICALIN eeeee1 -induced dopaminergic neuronal degeneration via modulating  bbbbb2 GENEIN eeeee2  expression, GENEIN/GENEIN pathway and CHEMICALNOTIN activation, which subsequently ameliorate CHEMICALIN-induced ROS formation and decrease of GENEIN expression
CPR:2	Taken together, our data demonstrate that  bbbbb1 CHEMICALIN eeeee1  attenuates CHEMICALIN-induced dopaminergic neuronal degeneration via modulating GENEIN expression,  bbbbb2 GENEIN eeeee2 /GENEIN pathway and CHEMICALNOTIN activation, which subsequently ameliorate CHEMICALIN-induced ROS formation and decrease of GENEIN expression
CPR:2	Taken together, our data demonstrate that  bbbbb1 CHEMICALIN eeeee1  attenuates CHEMICALIN-induced dopaminergic neuronal degeneration via modulating GENEIN expression, GENEIN/ bbbbb2 GENEIN eeeee2  pathway and CHEMICALNOTIN activation, which subsequently ameliorate CHEMICALIN-induced ROS formation and decrease of GENEIN expression
CPR:2	Taken together, our data demonstrate that CHEMICALIN attenuates  bbbbb1 CHEMICALIN eeeee1 -induced dopaminergic neuronal degeneration via modulating GENEIN expression,  bbbbb2 GENEIN eeeee2 /GENEIN pathway and CHEMICALNOTIN activation, which subsequently ameliorate CHEMICALIN-induced ROS formation and decrease of GENEIN expression
CPR:2	Taken together, our data demonstrate that CHEMICALIN attenuates  bbbbb1 CHEMICALIN eeeee1 -induced dopaminergic neuronal degeneration via modulating GENEIN expression, GENEIN/ bbbbb2 GENEIN eeeee2  pathway and CHEMICALNOTIN activation, which subsequently ameliorate CHEMICALIN-induced ROS formation and decrease of GENEIN expression
CPR:3	 bbbbb1 CHEMICALIN eeeee1  administration enhanced CHEMICALNOTIN (CHEMICALNOTIN) activity, GENEIN (GENEIN) expression and  bbbbb2 GENEIN eeeee2 /GENEIN pathway activation, which might ameliorate CHEMICALNOTIN injection-induced progressive elevation of reactive CHEMICALNOTIN species (ROS) formation in mice
CPR:3	 bbbbb1 CHEMICALIN eeeee1  administration enhanced CHEMICALNOTIN (CHEMICALNOTIN) activity, GENEIN (GENEIN) expression and GENEIN/ bbbbb2 GENEIN eeeee2  pathway activation, which might ameliorate CHEMICALNOTIN injection-induced progressive elevation of reactive CHEMICALNOTIN species (ROS) formation in mice
CPR:3	 bbbbb1 CHEMICALIN eeeee1  administration enhanced CHEMICALNOTIN (CHEMICALNOTIN) activity,  bbbbb2 GENEIN eeeee2  (GENEIN) expression and GENEIN/GENEIN pathway activation, which might ameliorate CHEMICALNOTIN injection-induced progressive elevation of reactive CHEMICALNOTIN species (ROS) formation in mice
CPR:3	 bbbbb1 CHEMICALIN eeeee1  administration enhanced CHEMICALNOTIN (CHEMICALNOTIN) activity, GENEIN ( bbbbb2 GENEIN eeeee2 ) expression and GENEIN/GENEIN pathway activation, which might ameliorate CHEMICALNOTIN injection-induced progressive elevation of reactive CHEMICALNOTIN species (ROS) formation in mice
CPR:4	In addition to the effect on ROS,  bbbbb1 CHEMICALIN eeeee1  ameliorated CHEMICALIN-reduced GENEIN ( bbbbb2 GENEIN eeeee2 ) expression
CPR:4	In addition to the effect on ROS, CHEMICALIN ameliorated  bbbbb1 CHEMICALIN eeeee1 -reduced  bbbbb2 GENEIN eeeee2  (GENEIN) expression
CPR:4	In addition to the effect on ROS, CHEMICALIN ameliorated  bbbbb1 CHEMICALIN eeeee1 -reduced GENEIN ( bbbbb2 GENEIN eeeee2 ) expression
CPR:4	Taken together, our data demonstrate that  bbbbb1 CHEMICALIN eeeee1  attenuates CHEMICALIN-induced dopaminergic neuronal degeneration via modulating GENEIN expression, GENEIN/GENEIN pathway and CHEMICALNOTIN activation, which subsequently ameliorate CHEMICALIN-induced ROS formation and decrease of  bbbbb2 GENEIN eeeee2  expression
CPR:4	Taken together, our data demonstrate that CHEMICALIN attenuates CHEMICALIN-induced dopaminergic neuronal degeneration via modulating GENEIN expression, GENEIN/GENEIN pathway and CHEMICALNOTIN activation, which subsequently ameliorate  bbbbb1 CHEMICALIN eeeee1 -induced ROS formation and decrease of  bbbbb2 GENEIN eeeee2  expression
CPR:2	After 18h incubation with 0.5M  bbbbb1 CHEMICALIN eeeee1  and subsequent red light irradiation (3.6J/cm(2)), a high number of cells die by apoptosis, as evaluated by morphological alterations, immunofluorescent relocalization of  bbbbb2 GENEIN eeeee2  from cytosol to mitochondria, and TUNEL assay
CPR:1	The  bbbbb1 GENEIN eeeee1  subunit contains several functional domains: the  bbbbb2 CHEMICALIN eeeee2 -terminal heptad repeat (NHR) domains fold a triple stranded coiled-coil forming a meta-stable prefusion intermediate
CPR:2	Our results revealed an important role of base excision repair (BER) as the  bbbbb1 GENEIN eeeee1 , GENEIN, GENEIN and GENEIN mutants showed pronounced sensitivity to essential oil and  bbbbb2 CHEMICALIN eeeee2 
CPR:2	Our results revealed an important role of base excision repair (BER) as the GENEIN,  bbbbb1 GENEIN eeeee1 , GENEIN and GENEIN mutants showed pronounced sensitivity to essential oil and  bbbbb2 CHEMICALIN eeeee2 
CPR:2	Our results revealed an important role of base excision repair (BER) as the GENEIN, GENEIN,  bbbbb1 GENEIN eeeee1  and GENEIN mutants showed pronounced sensitivity to essential oil and  bbbbb2 CHEMICALIN eeeee2 
CPR:2	Our results revealed an important role of base excision repair (BER) as the GENEIN, GENEIN, GENEIN and  bbbbb1 GENEIN eeeee1  mutants showed pronounced sensitivity to essential oil and  bbbbb2 CHEMICALIN eeeee2 
CPR:2	The radioactivity was rapidly and widely distributed throughout the body, and remained detectable in all tissues investigated at later time points (24 and 48 hours for [ bbbbb1 CHEMICALIN eeeee1 ]- bbbbb2 GENEIN eeeee2  and [CHEMICALNOTIN]-SSB siRNA, respectively)
CPR:9	Instead, radiolabeled  bbbbb1 CHEMICALIN eeeee1  resulting from  bbbbb2 GENEIN eeeee2  hydrolysis were observed
CPR:10	We also rescued  bbbbb1 CHEMICALIN eeeee1 -resistant clones using exogenous  bbbbb2 GENEIN eeeee2  without inhibitory phosphorylation sites, indicating that the mitotic surge of GENENOTIN activity is dispensable for cell proliferation
CPR:10	We rescued cells lethally depleted of endogenous GENENOTIN with an exogenous  bbbbb1 GENEIN eeeee1  conferring sensitivity to one CHEMICALNOTIN analogue inhibitor (CHEMICALIN) and resistance to another ( bbbbb2 CHEMICALIN eeeee2 )
CPR:2	We rescued cells lethally depleted of endogenous GENENOTIN with an exogenous  bbbbb1 GENEIN eeeee1  conferring sensitivity to one CHEMICALNOTIN analogue inhibitor ( bbbbb2 CHEMICALIN eeeee2 ) and resistance to another (CHEMICALIN)
CPR:2	At no  bbbbb1 CHEMICALIN eeeee1  concentration was mitosis in rescued clones prevented without also inducing endoreduplication, suggesting that these two key roles for  bbbbb2 GENEIN eeeee2  are not simply controlled by different GENENOTIN activity thresholds
CPR:2	A series of  bbbbb1 CHEMICALIN eeeee1 -substituted CHEMICALIN analogues was synthesized and evaluated for their CHEMICALIN binding affinity at the  bbbbb2 GENEIN eeeee2  and for their inhibition of vesicular CHEMICALIN uptake
CPR:2	A series of CHEMICALIN-substituted  bbbbb1 CHEMICALIN eeeee1  analogues was synthesized and evaluated for their CHEMICALIN binding affinity at the  bbbbb2 GENEIN eeeee2  and for their inhibition of vesicular CHEMICALIN uptake
CPR:2	A series of CHEMICALIN-substituted CHEMICALIN analogues was synthesized and evaluated for their  bbbbb1 CHEMICALIN eeeee1  binding affinity at the  bbbbb2 GENEIN eeeee2  and for their inhibition of vesicular CHEMICALIN uptake
CPR:2	Exploring the effect of CHEMICALIN-substitution in  bbbbb1 CHEMICALIN eeeee1  on the interaction with  bbbbb2 GENEIN eeeee2 : discovery of a potential clinical candidate for treatment of CHEMICALNOTIN abuse
CPR:2	Exploring the effect of  bbbbb1 CHEMICALIN eeeee1 -substitution in CHEMICALIN on the interaction with  bbbbb2 GENEIN eeeee2 : discovery of a potential clinical candidate for treatment of CHEMICALNOTIN abuse
CPR:9	A series of CHEMICALIN-substituted CHEMICALIN analogues was synthesized and evaluated for their CHEMICALIN binding affinity at the  bbbbb1 GENEIN eeeee1  and for their inhibition of vesicular  bbbbb2 CHEMICALIN eeeee2  uptake
CPR:2	 bbbbb1 CHEMICALIN eeeee1  is highly bound to plasma proteins and has minimal interaction with  bbbbb2 GENEIN eeeee2 . 4
CPR:4	 bbbbb1 CHEMICALIN eeeee1  is both a substrate and inhibitor (IC50=1.9M) of  bbbbb2 GENEIN eeeee2 . 6
CPR:9	 bbbbb1 CHEMICALIN eeeee1  is both a substrate and inhibitor (IC50=1.9M) of  bbbbb2 GENEIN eeeee2 . 6
CPR:5	Oral  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN()), a selective CHEMICALNOTIN  bbbbb2 GENEIN eeeee2  receptor agonist, is indicated in the US as an adjunct to diet and exercise in the chronic weight management of obese adults, or overweight adults with at least one weight-related comorbidity (e.g. dyslipidaemia, hypertension, type 2 diabetes)
CPR:5	Oral CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ()), a selective CHEMICALNOTIN  bbbbb2 GENEIN eeeee2  receptor agonist, is indicated in the US as an adjunct to diet and exercise in the chronic weight management of obese adults, or overweight adults with at least one weight-related comorbidity (e.g. dyslipidaemia, hypertension, type 2 diabetes)
CPR:4	Biological evaluation revealed that most tested compounds were potent GENENOTIN (GENENOTIN) inhibitors, among them, the  bbbbb1 CHEMICALIN eeeee1  derivative 11h displayed the most potent  bbbbb2 GENEIN eeeee2  inhibitory activity with an IC50 value of 0.247 M
CPR:4	Design, Synthesis, Biological Evaluation, and Docking Studies of CHEMICALIN Derivatives with a  bbbbb1 CHEMICALIN eeeee1  Moiety as Potent  bbbbb2 GENEIN eeeee2  Inhibitors
CPR:4	Design, Synthesis, Biological Evaluation, and Docking Studies of  bbbbb1 CHEMICALIN eeeee1  Derivatives with a CHEMICALIN Moiety as Potent  bbbbb2 GENEIN eeeee2  Inhibitors
CPR:2	 bbbbb1 CHEMICALIN eeeee1 , a  bbbbb2 GENEIN eeeee2  ligand, modestly induced GENEIN.fLUC in GENENOTIN(+/+) and GENENOTIN(-/-) strains, consistent with GENEIN's minor role in GENEIN regulation
CPR:2	In the current study, we crossed GENENOTIN.fLUC mice into the GENENOTIN knockout (GENENOTIN(-/-)) genetic background and injected mice with  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a strong  bbbbb2 GENEIN eeeee2  ligand, and two therapeutically relevant CHEMICALNOTIN, CHEMICALNOTIN and CHEMICALNOTIN
CPR:2	In the current study, we crossed GENENOTIN.fLUC mice into the GENENOTIN knockout (GENENOTIN(-/-)) genetic background and injected mice with CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a strong  bbbbb2 GENEIN eeeee2  ligand, and two therapeutically relevant CHEMICALNOTIN, CHEMICALNOTIN and CHEMICALNOTIN
CPR:2	All three agents induced  bbbbb1 GENEIN eeeee1 .fLUC expression (bioluminescence), but only  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN appeared to act primarily via GENEIN
CPR:2	All three agents induced  bbbbb1 GENEIN eeeee1 .fLUC expression (bioluminescence), but only CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  appeared to act primarily via GENEIN
CPR:2	 bbbbb1 CHEMICALIN eeeee1 , a GENEIN ligand, modestly induced GENEIN.fLUC in GENENOTIN(+/+) and GENENOTIN(-/-) strains, consistent with GENEIN's minor role in  bbbbb2 GENEIN eeeee2  regulation
CPR:2	All three agents induced GENEIN.fLUC expression (bioluminescence), but only  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN appeared to act primarily via  bbbbb2 GENEIN eeeee2 
CPR:2	All three agents induced GENEIN.fLUC expression (bioluminescence), but only CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  appeared to act primarily via  bbbbb2 GENEIN eeeee2 
CPR:2	 bbbbb1 CHEMICALIN eeeee1 , a GENEIN ligand, modestly induced GENEIN.fLUC in GENENOTIN(+/+) and GENENOTIN(-/-) strains, consistent with  bbbbb2 GENEIN eeeee2 's minor role in GENEIN regulation
CPR:3	 bbbbb1 CHEMICALIN eeeee1 , a GENEIN ligand, modestly induced  bbbbb2 GENEIN eeeee2 .fLUC in GENENOTIN(+/+) and GENENOTIN(-/-) strains, consistent with GENEIN's minor role in GENEIN regulation
CPR:2	The inhibitory effect of  bbbbb1 CHEMICALIN eeeee1  on theses pro-inflammatory GENEIN was related with  bbbbb2 GENEIN eeeee2  GENEIN, and GENEIN GENEIN, GENEIN, and GENEIN
CPR:2	The inhibitory effect of  bbbbb1 CHEMICALIN eeeee1  on theses pro-inflammatory GENEIN was related with GENEIN  bbbbb2 GENEIN eeeee2 , and GENEIN GENEIN, GENEIN, and GENEIN
CPR:2	The inhibitory effect of  bbbbb1 CHEMICALIN eeeee1  on theses pro-inflammatory GENEIN was related with GENEIN GENEIN, and  bbbbb2 GENEIN eeeee2  GENEIN, GENEIN, and GENEIN
CPR:2	The inhibitory effect of  bbbbb1 CHEMICALIN eeeee1  on theses pro-inflammatory GENEIN was related with GENEIN GENEIN, and GENEIN  bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN
CPR:2	The inhibitory effect of  bbbbb1 CHEMICALIN eeeee1  on theses pro-inflammatory GENEIN was related with GENEIN GENEIN, and GENEIN GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN
CPR:2	The inhibitory effect of  bbbbb1 CHEMICALIN eeeee1  on theses pro-inflammatory GENEIN was related with GENEIN GENEIN, and GENEIN GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2 
CPR:4	Furthermore,  bbbbb1 CHEMICALIN eeeee1  attenuated  bbbbb2 GENEIN eeeee2 -mediated passive cutaneous anaphylaxis and the expression of GENEIN at the inflamed tissue
CPR:4	 bbbbb1 CHEMICALIN eeeee1  decreased expression of pro-inflammatory  bbbbb2 GENEIN eeeee2 , such as GENEIN, GENEIN GENEIN, GENEIN, and GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  decreased expression of pro-inflammatory GENEIN, such as  bbbbb2 GENEIN eeeee2 , GENEIN GENEIN, GENEIN, and GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  decreased expression of pro-inflammatory GENEIN, such as GENEIN,  bbbbb2 GENEIN eeeee2  GENEIN, GENEIN, and GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  decreased expression of pro-inflammatory GENEIN, such as GENEIN, GENEIN  bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  decreased expression of pro-inflammatory GENEIN, such as GENEIN, GENEIN GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  decreased expression of pro-inflammatory GENEIN, such as GENEIN, GENEIN GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2 
CPR:4	The inhibitory effect of  bbbbb1 CHEMICALIN eeeee1  on theses pro-inflammatory  bbbbb2 GENEIN eeeee2  was related with GENEIN GENEIN, and GENEIN GENEIN, GENEIN, and GENEIN
CPR:4	Furthermore,  bbbbb1 CHEMICALIN eeeee1  attenuated GENEIN-mediated passive cutaneous anaphylaxis and the expression of  bbbbb2 GENEIN eeeee2  at the inflamed tissue
CPR:4	Our results showed that  bbbbb1 CHEMICALIN eeeee1  down-regulates mast cell-derived allergic inflammatory reactions by blocking CHEMICALNOTIN release and expression of pro-inflammatory  bbbbb2 GENEIN eeeee2 
CPR:2	 bbbbb1 GENEIN eeeee1  responded only to  bbbbb2 CHEMICALIN eeeee2 
CPR:10	Furthermore,  bbbbb1 CHEMICALIN eeeee1  could inhibit GENEIN-induced the membrane localization of phosphorylated GENEIN, GENEIN, and GENEIN, but not GENENOTIN and  bbbbb2 GENEIN eeeee2 
CPR:4	Next,  bbbbb1 CHEMICALIN eeeee1  significantly decreased the levels of  bbbbb2 GENEIN eeeee2  and GENEIN in GENEIN or GENEIN siRNA-transfected cells concomitantly with a marked reduction on cell invasion and migration
CPR:4	Next,  bbbbb1 CHEMICALIN eeeee1  significantly decreased the levels of GENEIN and  bbbbb2 GENEIN eeeee2  in GENEIN or GENEIN siRNA-transfected cells concomitantly with a marked reduction on cell invasion and migration
CPR:4	Next,  bbbbb1 CHEMICALIN eeeee1  significantly decreased the levels of GENEIN and GENEIN in  bbbbb2 GENEIN eeeee2  or GENEIN siRNA-transfected cells concomitantly with a marked reduction on cell invasion and migration
CPR:4	Next,  bbbbb1 CHEMICALIN eeeee1  significantly decreased the levels of GENEIN and GENEIN in GENEIN or  bbbbb2 GENEIN eeeee2  siRNA-transfected cells concomitantly with a marked reduction on cell invasion and migration
CPR:4	 bbbbb1 CHEMICALIN eeeee1  attenuates metastasis via both  bbbbb2 GENEIN eeeee2  and GENEIN/GENEIN pathways in GENENOTIN-treated liver cancer HepG2 cells
CPR:4	 bbbbb1 CHEMICALIN eeeee1  attenuates metastasis via both GENEIN and  bbbbb2 GENEIN eeeee2 /GENEIN pathways in GENENOTIN-treated liver cancer HepG2 cells
CPR:4	 bbbbb1 CHEMICALIN eeeee1  attenuates metastasis via both GENEIN and GENEIN/ bbbbb2 GENEIN eeeee2  pathways in GENENOTIN-treated liver cancer HepG2 cells
CPR:4	In conclusion,  bbbbb1 CHEMICALIN eeeee1  attenuates  bbbbb2 GENEIN eeeee2 -induced HepG2 cells metastasis involving both GENEIN and GENEIN/GENEIN pathways and are potentially useful as anti-metastatic agents for the treatment of hepatoma.
CPR:4	In conclusion,  bbbbb1 CHEMICALIN eeeee1  attenuates GENEIN-induced HepG2 cells metastasis involving both  bbbbb2 GENEIN eeeee2  and GENEIN/GENEIN pathways and are potentially useful as anti-metastatic agents for the treatment of hepatoma.
CPR:4	In conclusion,  bbbbb1 CHEMICALIN eeeee1  attenuates GENEIN-induced HepG2 cells metastasis involving both GENEIN and  bbbbb2 GENEIN eeeee2 /GENEIN pathways and are potentially useful as anti-metastatic agents for the treatment of hepatoma.
CPR:4	In conclusion,  bbbbb1 CHEMICALIN eeeee1  attenuates GENEIN-induced HepG2 cells metastasis involving both GENEIN and GENEIN/ bbbbb2 GENEIN eeeee2  pathways and are potentially useful as anti-metastatic agents for the treatment of hepatoma.
CPR:4	Among them,  bbbbb1 CHEMICALIN eeeee1  markedly inhibited  bbbbb2 GENEIN eeeee2 -induced the abilities of the adhesion, invasion, and migration by cell-matrix adhesion assay and transwell-chamber invasion/migration assay under non-cytotoxic concentrations
CPR:4	Data also showed  bbbbb1 CHEMICALIN eeeee1  inhibited  bbbbb2 GENEIN eeeee2 -induced cell scattering and cytoskeleton changed such as filopodia and lamellipodia
CPR:4	Furthermore,  bbbbb1 CHEMICALIN eeeee1  could inhibit  bbbbb2 GENEIN eeeee2 -induced the membrane localization of phosphorylated GENEIN, GENEIN, and GENEIN, but not GENENOTIN and GENEIN
CPR:4	Furthermore,  bbbbb1 CHEMICALIN eeeee1  could inhibit GENEIN-induced the membrane localization of phosphorylated  bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN, but not GENENOTIN and GENEIN
CPR:4	Furthermore,  bbbbb1 CHEMICALIN eeeee1  could inhibit GENEIN-induced the membrane localization of phosphorylated GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN, but not GENENOTIN and GENEIN
CPR:4	Furthermore,  bbbbb1 CHEMICALIN eeeee1  could inhibit GENEIN-induced the membrane localization of phosphorylated GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2 , but not GENENOTIN and GENEIN
CPR:10	In contrast, the latter pathway likely involves  bbbbb1 GENEIN eeeee1  binding peptides displayed as a consequence of CHEMICALIN exposure, but not  bbbbb2 CHEMICALIN eeeee2  itself.
CPR:2	These data suggest that T-cells can be activated by  bbbbb1 CHEMICALIN eeeee1  through a direct interaction with surface and intracellular  bbbbb2 GENEIN eeeee2  (GENEIN) molecules
CPR:2	These data suggest that T-cells can be activated by  bbbbb1 CHEMICALIN eeeee1  through a direct interaction with surface and intracellular GENEIN ( bbbbb2 GENEIN eeeee2 ) molecules
CPR:2	With the former,  bbbbb1 CHEMICALIN eeeee1  seemingly participates in the  bbbbb2 GENEIN eeeee2  GENEIN binding interaction
CPR:2	With the former,  bbbbb1 CHEMICALIN eeeee1  seemingly participates in the GENEIN  bbbbb2 GENEIN eeeee2  binding interaction
CPR:2	In contrast, the latter pathway likely involves  bbbbb1 GENEIN eeeee1  binding peptides displayed as a consequence of  bbbbb2 CHEMICALIN eeeee2  exposure, but not CHEMICALIN itself.
CPR:2	Seventy-four CD8+ clones expressing different  bbbbb1 GENEIN eeeee1  were shown to proliferate and kill target cells via different mechanisms when exposed to  bbbbb2 CHEMICALIN eeeee2 
CPR:2	Excess of  bbbbb1 CHEMICALIN eeeee1  converted into CHEMICALIN may up-regulate GENEIN synthesis which is a scavenger for  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:2	Excess of  bbbbb1 CHEMICALIN eeeee1  converted into CHEMICALIN may up-regulate GENEIN synthesis which is a scavenger for GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:3	Excess of  bbbbb1 CHEMICALIN eeeee1  converted into CHEMICALIN may up-regulate  bbbbb2 GENEIN eeeee2  synthesis which is a scavenger for GENEIN and GENEIN
CPR:3	Excess of CHEMICALIN converted into  bbbbb1 CHEMICALIN eeeee1  may up-regulate  bbbbb2 GENEIN eeeee2  synthesis which is a scavenger for GENEIN and GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  also increases  bbbbb2 GENEIN eeeee2  (GENEIN) deposition and GENEIN pathology
CPR:4	 bbbbb1 CHEMICALIN eeeee1  also increases GENEIN ( bbbbb2 GENEIN eeeee2 ) deposition and GENEIN pathology
CPR:4	 bbbbb1 CHEMICALIN eeeee1  also increases GENEIN (GENEIN) deposition and  bbbbb2 GENEIN eeeee2  pathology
CPR:2	While the function of  bbbbb1 GENEIN eeeee1  within astrocytes is controversial, these GENEIN have been linked to  bbbbb2 CHEMICALIN eeeee2 -dependent vesicular gliotransmitter release
CPR:2	While the function of GENEIN within astrocytes is controversial, these  bbbbb1 GENEIN eeeee1  have been linked to  bbbbb2 CHEMICALIN eeeee2 -dependent vesicular gliotransmitter release
CPR:9	In the current study, we extend these findings to show that the ability of astrocytes to buffer extracellular  bbbbb1 CHEMICALIN eeeee1  is reduced when  bbbbb2 GENEIN eeeee2  is inhibited
CPR:10	Remarkably,  bbbbb1 CHEMICALIN eeeee1  gives no inhibition of  bbbbb2 GENEIN eeeee2 
CPR:4	We have identified  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) as a novel ZBG that is compatible with  bbbbb2 GENEIN eeeee2  inhibition
CPR:4	We have identified CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) as a novel ZBG that is compatible with  bbbbb2 GENEIN eeeee2  inhibition
CPR:4	 bbbbb1 CHEMICALIN eeeee1  inhibits  bbbbb2 GENEIN eeeee2  and GENEIN with an IC50 of 681 and 3675 nM, respectively
CPR:4	 bbbbb1 CHEMICALIN eeeee1  inhibits GENEIN and  bbbbb2 GENEIN eeeee2  with an IC50 of 681 and 3675 nM, respectively
CPR:4	Small molecules bearing hydroxamic acid as the  bbbbb1 CHEMICALIN eeeee1  binding group (ZBG) have been the most effective  bbbbb2 GENEIN eeeee2  inhibitors (GENEINi) to date
CPR:4	Small molecules bearing hydroxamic acid as the  bbbbb1 CHEMICALIN eeeee1  binding group (ZBG) have been the most effective GENEIN inhibitors ( bbbbb2 GENEIN eeeee2 i) to date
CPR:4	Subsequent optimization led to several novel  bbbbb1 CHEMICALIN eeeee1 -based  bbbbb2 GENEIN eeeee2 i that are selective for GENEIN and GENEIN
CPR:4	Subsequent optimization led to several novel  bbbbb1 CHEMICALIN eeeee1 -based GENEINi that are selective for  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:4	Subsequent optimization led to several novel  bbbbb1 CHEMICALIN eeeee1 -based GENEINi that are selective for GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:4	 bbbbb1 CHEMICALIN eeeee1  as Novel CHEMICALIN Binding Group for Selective  bbbbb2 GENEIN eeeee2  Inhibition
CPR:4	CHEMICALIN as Novel  bbbbb1 CHEMICALIN eeeee1  Binding Group for Selective  bbbbb2 GENEIN eeeee2  Inhibition
CPR:2	Native GENENOTIN stimulates  bbbbb1 GENEIN eeeee1  secretion in a  bbbbb2 CHEMICALIN eeeee2 -dependent manner, as well as suppressing GENENOTIN production and slowing gastric emptying
CPR:3	Maqui berry (Aristotelia chilensis) and the constituent  bbbbb1 CHEMICALIN eeeee1  inhibit  bbbbb2 GENEIN eeeee2  cell death induced by visible light
CPR:4	These findings indicate that MBE and its  bbbbb1 CHEMICALIN eeeee1  suppress the light-induced photoreceptor cell death by inhibiting ROS production, suggesting that the inhibition of  bbbbb2 GENEIN eeeee2  may be involved in the underlying mechanism.
CPR:4	Moreover,  bbbbb1 CHEMICALIN eeeee1  could also down-regulate the expression and activity of  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:4	Moreover,  bbbbb1 CHEMICALIN eeeee1  could also down-regulate the expression and activity of GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:4	Moreover,  bbbbb1 CHEMICALIN eeeee1  could also down-regulate the expression and activity of  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:4	Moreover,  bbbbb1 CHEMICALIN eeeee1  could also down-regulate the expression and activity of GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:1	Treatment with CHEMICALIN or CHEMICALIN resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of  bbbbb1 GENEIN eeeee1  at  bbbbb2 CHEMICALIN eeeee2 10, phosphorylation of GENEIN at CHEMICALIN15, expression of GENEIN, and decreased expression of GENEIN
CPR:1	Treatment with CHEMICALIN or CHEMICALIN resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of GENEIN at CHEMICALIN10, phosphorylation of  bbbbb1 GENEIN eeeee1  at  bbbbb2 CHEMICALIN eeeee2 15, expression of GENEIN, and decreased expression of GENEIN
CPR:3	Treatment with  bbbbb1 CHEMICALIN eeeee1  or CHEMICALIN resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of  bbbbb2 GENEIN eeeee2  at CHEMICALIN10, phosphorylation of GENEIN at CHEMICALIN15, expression of GENEIN, and decreased expression of GENEIN
CPR:3	Treatment with  bbbbb1 CHEMICALIN eeeee1  or CHEMICALIN resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of GENEIN at CHEMICALIN10, phosphorylation of  bbbbb2 GENEIN eeeee2  at CHEMICALIN15, expression of GENEIN, and decreased expression of GENEIN
CPR:3	Treatment with CHEMICALIN or  bbbbb1 CHEMICALIN eeeee1  resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of  bbbbb2 GENEIN eeeee2  at CHEMICALIN10, phosphorylation of GENEIN at CHEMICALIN15, expression of GENEIN, and decreased expression of GENEIN
CPR:3	Treatment with CHEMICALIN or  bbbbb1 CHEMICALIN eeeee1  resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of GENEIN at CHEMICALIN10, phosphorylation of  bbbbb2 GENEIN eeeee2  at CHEMICALIN15, expression of GENEIN, and decreased expression of GENEIN
CPR:3	Treatment with  bbbbb1 CHEMICALIN eeeee1  or CHEMICALIN resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of GENEIN at CHEMICALIN10, phosphorylation of GENEIN at CHEMICALIN15, expression of  bbbbb2 GENEIN eeeee2 , and decreased expression of GENEIN
CPR:3	Treatment with CHEMICALIN or  bbbbb1 CHEMICALIN eeeee1  resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of GENEIN at CHEMICALIN10, phosphorylation of GENEIN at CHEMICALIN15, expression of  bbbbb2 GENEIN eeeee2 , and decreased expression of GENEIN
CPR:4	Treatment with  bbbbb1 CHEMICALIN eeeee1  or CHEMICALIN resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of GENEIN at CHEMICALIN10, phosphorylation of GENEIN at CHEMICALIN15, expression of GENEIN, and decreased expression of  bbbbb2 GENEIN eeeee2 
CPR:4	Treatment with CHEMICALIN or  bbbbb1 CHEMICALIN eeeee1  resulted in arresting the MDA-MB-435 and SMMC-7721 cells at G2/M phase, which was further supported by observations of increased phosphorylation of GENEIN at CHEMICALIN10, phosphorylation of GENEIN at CHEMICALIN15, expression of GENEIN, and decreased expression of  bbbbb2 GENEIN eeeee2 
CPR:2	Finally, the involvement of  bbbbb1 GENEIN eeeee1  and GENEIN was also studied, and we showed that both play a role in the antinociceptive mechanism of  bbbbb2 CHEMICALIN eeeee2 
CPR:2	Finally, the involvement of GENEIN and  bbbbb1 GENEIN eeeee1  was also studied, and we showed that both play a role in the antinociceptive mechanism of  bbbbb2 CHEMICALIN eeeee2 
CPR:2	Conclusion The results of this work contribute information regarding the antinociceptive properties of CHEMICALNOTIN on acute pain and show that, at least in part,  bbbbb1 GENEIN eeeee1 , GENEIN, GENEIN, GENEIN, GENEIN and GENEIN participate in  bbbbb2 CHEMICALIN eeeee2 's antinociceptive mechanism.
CPR:2	Conclusion The results of this work contribute information regarding the antinociceptive properties of CHEMICALNOTIN on acute pain and show that, at least in part, GENEIN,  bbbbb1 GENEIN eeeee1 , GENEIN, GENEIN, GENEIN and GENEIN participate in  bbbbb2 CHEMICALIN eeeee2 's antinociceptive mechanism.
CPR:2	Conclusion The results of this work contribute information regarding the antinociceptive properties of CHEMICALNOTIN on acute pain and show that, at least in part, GENEIN, GENEIN,  bbbbb1 GENEIN eeeee1 , GENEIN, GENEIN and GENEIN participate in  bbbbb2 CHEMICALIN eeeee2 's antinociceptive mechanism.
CPR:2	Conclusion The results of this work contribute information regarding the antinociceptive properties of CHEMICALNOTIN on acute pain and show that, at least in part, GENEIN, GENEIN, GENEIN,  bbbbb1 GENEIN eeeee1 , GENEIN and GENEIN participate in  bbbbb2 CHEMICALIN eeeee2 's antinociceptive mechanism.
CPR:2	Conclusion The results of this work contribute information regarding the antinociceptive properties of CHEMICALNOTIN on acute pain and show that, at least in part, GENEIN, GENEIN, GENEIN, GENEIN,  bbbbb1 GENEIN eeeee1  and GENEIN participate in  bbbbb2 CHEMICALIN eeeee2 's antinociceptive mechanism.
CPR:2	Conclusion The results of this work contribute information regarding the antinociceptive properties of CHEMICALNOTIN on acute pain and show that, at least in part, GENEIN, GENEIN, GENEIN, GENEIN, GENEIN and  bbbbb1 GENEIN eeeee1  participate in  bbbbb2 CHEMICALIN eeeee2 's antinociceptive mechanism.
CPR:2	In an investigation into the participation of  bbbbb1 GENEIN eeeee1  and GENEIN in  bbbbb2 CHEMICALIN eeeee2 's antinociceptive mechanism, we used CHEMICALIN (2.2g/paw), CHEMICALIN (10mmol/paw), CHEMICALIN (1.2mmol/paw) and acidified saline (2% CHEMICALIN, pH 1.98)
CPR:2	In an investigation into the participation of GENEIN and  bbbbb1 GENEIN eeeee1  in  bbbbb2 CHEMICALIN eeeee2 's antinociceptive mechanism, we used CHEMICALIN (2.2g/paw), CHEMICALIN (10mmol/paw), CHEMICALIN (1.2mmol/paw) and acidified saline (2% CHEMICALIN, pH 1.98)
CPR:2	In an investigation into the participation of  bbbbb1 GENEIN eeeee1  and GENEIN in CHEMICALIN's antinociceptive mechanism, we used  bbbbb2 CHEMICALIN eeeee2  (2.2g/paw), CHEMICALIN (10mmol/paw), CHEMICALIN (1.2mmol/paw) and acidified saline (2% CHEMICALIN, pH 1.98)
CPR:2	In an investigation into the participation of GENEIN and  bbbbb1 GENEIN eeeee1  in CHEMICALIN's antinociceptive mechanism, we used  bbbbb2 CHEMICALIN eeeee2  (2.2g/paw), CHEMICALIN (10mmol/paw), CHEMICALIN (1.2mmol/paw) and acidified saline (2% CHEMICALIN, pH 1.98)
CPR:2	In an investigation into the participation of  bbbbb1 GENEIN eeeee1  and GENEIN in CHEMICALIN's antinociceptive mechanism, we used CHEMICALIN (2.2g/paw),  bbbbb2 CHEMICALIN eeeee2  (10mmol/paw), CHEMICALIN (1.2mmol/paw) and acidified saline (2% CHEMICALIN, pH 1.98)
CPR:2	In an investigation into the participation of GENEIN and  bbbbb1 GENEIN eeeee1  in CHEMICALIN's antinociceptive mechanism, we used CHEMICALIN (2.2g/paw),  bbbbb2 CHEMICALIN eeeee2  (10mmol/paw), CHEMICALIN (1.2mmol/paw) and acidified saline (2% CHEMICALIN, pH 1.98)
CPR:2	In an investigation into the participation of  bbbbb1 GENEIN eeeee1  and GENEIN in CHEMICALIN's antinociceptive mechanism, we used CHEMICALIN (2.2g/paw), CHEMICALIN (10mmol/paw),  bbbbb2 CHEMICALIN eeeee2  (1.2mmol/paw) and acidified saline (2% CHEMICALIN, pH 1.98)
CPR:2	In an investigation into the participation of GENEIN and  bbbbb1 GENEIN eeeee1  in CHEMICALIN's antinociceptive mechanism, we used CHEMICALIN (2.2g/paw), CHEMICALIN (10mmol/paw),  bbbbb2 CHEMICALIN eeeee2  (1.2mmol/paw) and acidified saline (2% CHEMICALIN, pH 1.98)
CPR:2	In an investigation into the participation of  bbbbb1 GENEIN eeeee1  and GENEIN in CHEMICALIN's antinociceptive mechanism, we used CHEMICALIN (2.2g/paw), CHEMICALIN (10mmol/paw), CHEMICALIN (1.2mmol/paw) and acidified saline (2%  bbbbb2 CHEMICALIN eeeee2 , pH 1.98)
CPR:2	In an investigation into the participation of GENEIN and  bbbbb1 GENEIN eeeee1  in CHEMICALIN's antinociceptive mechanism, we used CHEMICALIN (2.2g/paw), CHEMICALIN (10mmol/paw), CHEMICALIN (1.2mmol/paw) and acidified saline (2%  bbbbb2 CHEMICALIN eeeee2 , pH 1.98)
CPR:2	Importantly, CHEMICALIN and CHEMICALIN exerted more potent inhibitory effects on the proliferation,  bbbbb1 GENEIN eeeee1  expression and invasive phenotype of MDA-MB-231 than  bbbbb2 CHEMICALIN eeeee2 
CPR:4	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN induced apoptosis by  bbbbb2 GENEIN eeeee2  downregulation
CPR:4	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  induced apoptosis by  bbbbb2 GENEIN eeeee2  downregulation
CPR:4	Importantly,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN exerted more potent inhibitory effects on the proliferation,  bbbbb2 GENEIN eeeee2  expression and invasive phenotype of MDA-MB-231 than CHEMICALIN
CPR:4	Importantly, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  exerted more potent inhibitory effects on the proliferation,  bbbbb2 GENEIN eeeee2  expression and invasive phenotype of MDA-MB-231 than CHEMICALIN
CPR:2	 bbbbb1 CHEMICALIN eeeee1  exhibited the predicted binding mode and demonstrated high inhibitory activity for  bbbbb2 GENEIN eeeee2  in enzyme- and cell-based assays
CPR:4	 bbbbb1 CHEMICALIN eeeee1  exhibited the predicted binding mode and demonstrated high inhibitory activity for  bbbbb2 GENEIN eeeee2  in enzyme- and cell-based assays
CPR:4	 bbbbb1 CHEMICALIN eeeee1  Derivatives as Novel  bbbbb2 GENEIN eeeee2  Inhibitors
CPR:4	We identified a series of  bbbbb1 CHEMICALIN eeeee1  derivatives as novel  bbbbb2 GENEIN eeeee2  inhibitors with high potency and substantial cell permeability using fragment-based drug design
CPR:5	GENEIN (GENEIN) catalyzes the oxidation of CHEMICALIN including  bbbbb1 CHEMICALIN eeeee1 , a coagonist of the  bbbbb2 GENEIN eeeee2 
CPR:9	 bbbbb1 GENEIN eeeee1  (GENEIN) catalyzes the oxidation of CHEMICALIN including  bbbbb2 CHEMICALIN eeeee2 , a coagonist of the GENEIN
CPR:9	GENEIN ( bbbbb1 GENEIN eeeee1 ) catalyzes the oxidation of CHEMICALIN including  bbbbb2 CHEMICALIN eeeee2 , a coagonist of the GENEIN
CPR:9	 bbbbb1 GENEIN eeeee1  (GENEIN) catalyzes the oxidation of  bbbbb2 CHEMICALIN eeeee2  including CHEMICALIN, a coagonist of the GENEIN
CPR:9	GENEIN ( bbbbb1 GENEIN eeeee1 ) catalyzes the oxidation of  bbbbb2 CHEMICALIN eeeee2  including CHEMICALIN, a coagonist of the GENEIN
CPR:10	Fourteen of 17 CHEMICALIN exhibited GENEIN and/or GENEIN agonistic activity at concentrations of 110(-5)M, whereas none of the 17  bbbbb1 CHEMICALIN eeeee1  showed  bbbbb2 GENEIN eeeee2  agonistic or antagonistic activity
CPR:2	Comparative study on transcriptional activity of 17  bbbbb1 CHEMICALIN eeeee1  mediated by GENENOTIN and  bbbbb2 GENEIN eeeee2 
CPR:5	Among 12 CHEMICALIN with linear CHEMICALIN chains ranging in length from C1 to C12,  bbbbb1 CHEMICALIN eeeee1  (C7) and CHEMICALIN (C5) showed the most potent  bbbbb2 GENEIN eeeee2  and GENEIN agonistic activity in the order of 10(-7)M and 10(-8)M, respectively, and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12
CPR:5	Among 12 CHEMICALIN with linear CHEMICALIN chains ranging in length from C1 to C12,  bbbbb1 CHEMICALIN eeeee1  (C7) and CHEMICALIN (C5) showed the most potent GENEIN and  bbbbb2 GENEIN eeeee2  agonistic activity in the order of 10(-7)M and 10(-8)M, respectively, and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12
CPR:5	Among 12 CHEMICALIN with linear CHEMICALIN chains ranging in length from C1 to C12, CHEMICALIN (C7) and  bbbbb1 CHEMICALIN eeeee1  (C5) showed the most potent  bbbbb2 GENEIN eeeee2  and GENEIN agonistic activity in the order of 10(-7)M and 10(-8)M, respectively, and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12
CPR:5	Among 12 CHEMICALIN with linear CHEMICALIN chains ranging in length from C1 to C12, CHEMICALIN (C7) and  bbbbb1 CHEMICALIN eeeee1  (C5) showed the most potent GENEIN and  bbbbb2 GENEIN eeeee2  agonistic activity in the order of 10(-7)M and 10(-8)M, respectively, and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12
CPR:5	Most  bbbbb1 CHEMICALIN eeeee1  showing estrogenic activity exhibited  bbbbb2 GENEIN eeeee2 -agonistic activity at lower concentrations than those inducing GENEIN-agonistic activity
CPR:5	Most  bbbbb1 CHEMICALIN eeeee1  showing estrogenic activity exhibited GENEIN-agonistic activity at lower concentrations than those inducing  bbbbb2 GENEIN eeeee2 -agonistic activity
CPR:5	These results indicate that  bbbbb1 CHEMICALIN eeeee1  are selective agonists for  bbbbb2 GENEIN eeeee2  over GENEIN; their interactions with GENENOTIN are dependent on the size and bulkiness of the CHEMICALNOTIN groups; and they are metabolized by GENEIN, leading to attenuation of their estrogenic activity.
CPR:5	These results indicate that  bbbbb1 CHEMICALIN eeeee1  are selective agonists for GENEIN over  bbbbb2 GENEIN eeeee2 ; their interactions with GENENOTIN are dependent on the size and bulkiness of the CHEMICALNOTIN groups; and they are metabolized by GENEIN, leading to attenuation of their estrogenic activity.
CPR:5	Fourteen of 17  bbbbb1 CHEMICALIN eeeee1  exhibited  bbbbb2 GENEIN eeeee2  and/or GENEIN agonistic activity at concentrations of 110(-5)M, whereas none of the 17 CHEMICALIN showed GENEIN agonistic or antagonistic activity
CPR:5	Fourteen of 17  bbbbb1 CHEMICALIN eeeee1  exhibited GENEIN and/or  bbbbb2 GENEIN eeeee2  agonistic activity at concentrations of 110(-5)M, whereas none of the 17 CHEMICALIN showed GENEIN agonistic or antagonistic activity
CPR:5	Among 12  bbbbb1 CHEMICALIN eeeee1  with linear CHEMICALIN chains ranging in length from C1 to C12, CHEMICALIN (C7) and CHEMICALIN (C5) showed the most potent  bbbbb2 GENEIN eeeee2  and GENEIN agonistic activity in the order of 10(-7)M and 10(-8)M, respectively, and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12
CPR:5	Among 12  bbbbb1 CHEMICALIN eeeee1  with linear CHEMICALIN chains ranging in length from C1 to C12, CHEMICALIN (C7) and CHEMICALIN (C5) showed the most potent GENEIN and  bbbbb2 GENEIN eeeee2  agonistic activity in the order of 10(-7)M and 10(-8)M, respectively, and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12
CPR:5	Among 12 CHEMICALIN with linear  bbbbb1 CHEMICALIN eeeee1  chains ranging in length from C1 to C12, CHEMICALIN (C7) and CHEMICALIN (C5) showed the most potent  bbbbb2 GENEIN eeeee2  and GENEIN agonistic activity in the order of 10(-7)M and 10(-8)M, respectively, and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12
CPR:5	Among 12 CHEMICALIN with linear  bbbbb1 CHEMICALIN eeeee1  chains ranging in length from C1 to C12, CHEMICALIN (C7) and CHEMICALIN (C5) showed the most potent GENEIN and  bbbbb2 GENEIN eeeee2  agonistic activity in the order of 10(-7)M and 10(-8)M, respectively, and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12
CPR:9	These results indicate that  bbbbb1 CHEMICALIN eeeee1  are selective agonists for GENEIN over GENEIN; their interactions with GENENOTIN are dependent on the size and bulkiness of the CHEMICALNOTIN groups; and they are metabolized by  bbbbb2 GENEIN eeeee2 , leading to attenuation of their estrogenic activity.
CPR:4	Wattakaka volubilis  bbbbb1 CHEMICALIN eeeee1  mixture (WVSM) and CHEMICALIN (1-50M) significantly inhibited the  bbbbb2 GENEIN eeeee2  and GENEIN enzymes resulting in low levels of PGE2 and NO in LPS-induced RAW 264.7 macrophage cells
CPR:4	Wattakaka volubilis  bbbbb1 CHEMICALIN eeeee1  mixture (WVSM) and CHEMICALIN (1-50M) significantly inhibited the GENEIN and  bbbbb2 GENEIN eeeee2  enzymes resulting in low levels of PGE2 and NO in LPS-induced RAW 264.7 macrophage cells
CPR:4	Wattakaka volubilis CHEMICALIN mixture (WVSM) and  bbbbb1 CHEMICALIN eeeee1  (1-50M) significantly inhibited the  bbbbb2 GENEIN eeeee2  and GENEIN enzymes resulting in low levels of PGE2 and NO in LPS-induced RAW 264.7 macrophage cells
CPR:4	Wattakaka volubilis CHEMICALIN mixture (WVSM) and  bbbbb1 CHEMICALIN eeeee1  (1-50M) significantly inhibited the GENEIN and  bbbbb2 GENEIN eeeee2  enzymes resulting in low levels of PGE2 and NO in LPS-induced RAW 264.7 macrophage cells
CPR:2	 bbbbb1 GENEIN eeeee1  is a transmembrane glycoprotein that mediates  bbbbb2 CHEMICALIN eeeee2 -dependent interactions between adjacent epithelial cells
CPR:2	However, the precise mechanism by which CHEMICALIN counteracts  bbbbb1 GENEIN eeeee1 -mediated  bbbbb2 CHEMICALIN eeeee2  hepatotoxicity through GENEIN system is still remained unclear
CPR:2	CHEMICALIN scavenging blocked the suppression of  bbbbb1 CHEMICALIN eeeee1  only on  bbbbb2 GENEIN eeeee2  activity
CPR:2	CHEMICALIN suppressed  bbbbb1 GENEIN eeeee1 -dependent  bbbbb2 CHEMICALIN eeeee2  hepatotoxicity via depleting heme pool and releasing CHEMICALNOTIN
CPR:2	Thus,  bbbbb1 GENEIN eeeee1 -mediated  bbbbb2 CHEMICALIN eeeee2  hepatotoxicity was alleviated by CHEMICALIN through GENEIN induction
CPR:2	However, the precise mechanism by which  bbbbb1 CHEMICALIN eeeee1  counteracts GENEIN-mediated CHEMICALIN hepatotoxicity through  bbbbb2 GENEIN eeeee2  system is still remained unclear
CPR:3	Our data showed that chronic  bbbbb1 CHEMICALIN eeeee1  over-activated  bbbbb2 GENEIN eeeee2  but suppressed GENEIN with concurrent hepatic oxidative damage, which was partially normalized by CHEMICALNOTIN (100mg/kg.bw.)
CPR:3	 bbbbb1 CHEMICALIN eeeee1  (100M) induced  bbbbb2 GENEIN eeeee2  and depleted heme pool when incubated to human hepatocytes
CPR:3	 bbbbb1 CHEMICALIN eeeee1 -stimulated (100mM)  bbbbb2 GENEIN eeeee2  upregulation was suppressed by CHEMICALIN but further enhanced by GENEIN inhibition with resultant CHEMICALIN accumulation
CPR:3	CHEMICALIN donor dose-dependently inactivated  bbbbb1 GENEIN eeeee1  of  bbbbb2 CHEMICALIN eeeee2 -incubated microsome, which was mimicked by GENENOTIN substrate but abolished by CHEMICALIN scavenger
CPR:3	Thus, GENEIN-mediated CHEMICALIN hepatotoxicity was alleviated by  bbbbb1 CHEMICALIN eeeee1  through  bbbbb2 GENEIN eeeee2  induction
CPR:4	Our data showed that chronic  bbbbb1 CHEMICALIN eeeee1  over-activated GENEIN but suppressed  bbbbb2 GENEIN eeeee2  with concurrent hepatic oxidative damage, which was partially normalized by CHEMICALNOTIN (100mg/kg.bw.)
CPR:4	CHEMICALIN-stimulated (100mM)  bbbbb1 GENEIN eeeee1  upregulation was suppressed by  bbbbb2 CHEMICALIN eeeee2  but further enhanced by GENEIN inhibition with resultant CHEMICALIN accumulation
CPR:4	 bbbbb1 CHEMICALIN eeeee1  scavenging blocked the suppression of CHEMICALIN only on  bbbbb2 GENEIN eeeee2  activity
CPR:4	 bbbbb1 CHEMICALIN eeeee1  donor dose-dependently inactivated  bbbbb2 GENEIN eeeee2  of CHEMICALIN-incubated microsome, which was mimicked by GENENOTIN substrate but abolished by CHEMICALIN scavenger
CPR:4	 bbbbb1 CHEMICALIN eeeee1  suppressed  bbbbb2 GENEIN eeeee2 -dependent CHEMICALIN hepatotoxicity via depleting heme pool and releasing CHEMICALNOTIN
CPR:4	CHEMICALIN donor dose-dependently inactivated  bbbbb1 GENEIN eeeee1  of CHEMICALIN-incubated microsome, which was mimicked by GENENOTIN substrate but abolished by  bbbbb2 CHEMICALIN eeeee2  scavenger
CPR:4	However, the precise mechanism by which  bbbbb1 CHEMICALIN eeeee1  counteracts  bbbbb2 GENEIN eeeee2 -mediated CHEMICALIN hepatotoxicity through GENEIN system is still remained unclear
CPR:4	 bbbbb1 CHEMICALIN eeeee1 -stimulated (100mM) GENEIN upregulation was suppressed by CHEMICALIN but further enhanced by  bbbbb2 GENEIN eeeee2  inhibition with resultant CHEMICALIN accumulation
CPR:4	Depleted heme pool and  bbbbb1 CHEMICALIN eeeee1  releasing limited protein synthesis and inhibited enzymatic activity of  bbbbb2 GENEIN eeeee2 , respectively.
CPR:9	CHEMICALIN-stimulated (100mM) GENEIN upregulation was suppressed by CHEMICALIN but further enhanced by  bbbbb1 GENEIN eeeee1  inhibition with resultant  bbbbb2 CHEMICALIN eeeee2  accumulation
CPR:4	Novel racemic  bbbbb1 CHEMICALIN eeeee1  analogues as potent  bbbbb2 GENEIN eeeee2  inhibitors
CPR:10	Both  bbbbb1 CHEMICALIN eeeee1  treatments, induced a significant decrease (p<0.01) in uterine GENEIN (GENEIN) content, had no effect on uterine  bbbbb2 GENEIN eeeee2  (GENEIN) protein expression and caused marked nuclear localization of GENEIN, in both luminal and glandular uterine epithelium, as compared to vehicle-treated animals
CPR:10	Both  bbbbb1 CHEMICALIN eeeee1  treatments, induced a significant decrease (p<0.01) in uterine GENEIN (GENEIN) content, had no effect on uterine GENEIN ( bbbbb2 GENEIN eeeee2 ) protein expression and caused marked nuclear localization of GENEIN, in both luminal and glandular uterine epithelium, as compared to vehicle-treated animals
CPR:1	We observed that the administration of CHEMICALIN at 08:00h on proestrus day produced a 15% inhibition of luminal epithelial cell proliferation, reduced uterine wet weight by 21% and caused reduction of  bbbbb1 GENEIN eeeee1  phosphorylation at  bbbbb2 CHEMICALIN eeeee2  473 as compared to vehicle-treated animals, whereas CHEMICALNOTIN treatment at 00:00h on estrus day had no effect on these parameters
CPR:2	Both  bbbbb1 CHEMICALIN eeeee1  treatments, induced a significant decrease (p<0.01) in uterine GENEIN (GENEIN) content, had no effect on uterine GENEIN (GENEIN) protein expression and caused marked nuclear localization of  bbbbb2 GENEIN eeeee2 , in both luminal and glandular uterine epithelium, as compared to vehicle-treated animals
CPR:2	Furthermore, we detected that  bbbbb1 CHEMICALIN eeeee1  treatment induced GENEIN (GENEIN) Ser 9 phosphorylation, which correlates with  bbbbb2 GENEIN eeeee2  nuclear localization
CPR:3	Furthermore, we detected that  bbbbb1 CHEMICALIN eeeee1  treatment induced  bbbbb2 GENEIN eeeee2  (GENEIN) Ser 9 phosphorylation, which correlates with GENEIN nuclear localization
CPR:3	Furthermore, we detected that  bbbbb1 CHEMICALIN eeeee1  treatment induced GENEIN ( bbbbb2 GENEIN eeeee2 ) Ser 9 phosphorylation, which correlates with GENEIN nuclear localization
CPR:3	Agonistic activity of  bbbbb1 CHEMICALIN eeeee1  on activation of GENEIN/ bbbbb2 GENEIN eeeee2  pathway in the rat uterus during the estrous cycle
CPR:3	The overall results indicate that  bbbbb1 CHEMICALIN eeeee1  may exert agonistic and antagonistic effects on uterine cell proliferation through differential activation of the  bbbbb2 GENEIN eeeee2  pathway depending on the administration period during the estrous cycle, and indicates that the mechanism of cell proliferation during the physiological conditions of the estrous cycle, is under a different and more complex regulation than in the ovariectomized +E2 animal model.
CPR:4	Both  bbbbb1 CHEMICALIN eeeee1  treatments, induced a significant decrease (p<0.01) in uterine  bbbbb2 GENEIN eeeee2  (GENEIN) content, had no effect on uterine GENEIN (GENEIN) protein expression and caused marked nuclear localization of GENEIN, in both luminal and glandular uterine epithelium, as compared to vehicle-treated animals
CPR:4	Both  bbbbb1 CHEMICALIN eeeee1  treatments, induced a significant decrease (p<0.01) in uterine GENEIN ( bbbbb2 GENEIN eeeee2 ) content, had no effect on uterine GENEIN (GENEIN) protein expression and caused marked nuclear localization of GENEIN, in both luminal and glandular uterine epithelium, as compared to vehicle-treated animals
CPR:4	We observed that the administration of  bbbbb1 CHEMICALIN eeeee1  at 08:00h on proestrus day produced a 15% inhibition of luminal epithelial cell proliferation, reduced uterine wet weight by 21% and caused reduction of  bbbbb2 GENEIN eeeee2  phosphorylation at CHEMICALIN 473 as compared to vehicle-treated animals, whereas CHEMICALNOTIN treatment at 00:00h on estrus day had no effect on these parameters
CPR:5	Agonistic activity of  bbbbb1 CHEMICALIN eeeee1  on activation of  bbbbb2 GENEIN eeeee2 /GENEIN pathway in the rat uterus during the estrous cycle
CPR:2	A series of  bbbbb1 CHEMICALIN eeeee1 , designed as mimics of a cationic high energy intermediate in the GENEIN ( bbbbb2 GENEIN eeeee2 )-mediated cyclization of CHEMICALIN to CHEMICALIN was prepared from CHEMICALNOTIN
CPR:2	A series of  bbbbb1 CHEMICALIN eeeee1 , designed as mimics of a cationic high energy intermediate in the  bbbbb2 GENEIN eeeee2  (GENEIN)-mediated cyclization of CHEMICALIN to CHEMICALIN was prepared from CHEMICALNOTIN
CPR:4	A  bbbbb1 CHEMICALIN eeeee1  derivative showed promising inhibition of  bbbbb2 GENEIN eeeee2  in combination with low cytotoxicity, and showed significant reduction of CHEMICALIN biosynthesis in a human cell line.
CPR:4	 bbbbb1 CHEMICALIN eeeee1  derived from CHEMICALIN as a novel chemotype of  bbbbb2 GENEIN eeeee2  inhibitors
CPR:4	CHEMICALIN derived from  bbbbb1 CHEMICALIN eeeee1  as a novel chemotype of  bbbbb2 GENEIN eeeee2  inhibitors
CPR:9	A series of CHEMICALIN, designed as mimics of a cationic high energy intermediate in the GENEIN ( bbbbb1 GENEIN eeeee1 )-mediated cyclization of CHEMICALIN to  bbbbb2 CHEMICALIN eeeee2  was prepared from CHEMICALNOTIN
CPR:9	A series of CHEMICALIN, designed as mimics of a cationic high energy intermediate in the  bbbbb1 GENEIN eeeee1  (GENEIN)-mediated cyclization of CHEMICALIN to  bbbbb2 CHEMICALIN eeeee2  was prepared from CHEMICALNOTIN
CPR:9	A CHEMICALIN derivative showed promising inhibition of  bbbbb1 GENEIN eeeee1  in combination with low cytotoxicity, and showed significant reduction of  bbbbb2 CHEMICALIN eeeee2  biosynthesis in a human cell line.
CPR:9	A series of CHEMICALIN, designed as mimics of a cationic high energy intermediate in the GENEIN ( bbbbb1 GENEIN eeeee1 )-mediated cyclization of  bbbbb2 CHEMICALIN eeeee2  to CHEMICALIN was prepared from CHEMICALNOTIN
CPR:9	A series of CHEMICALIN, designed as mimics of a cationic high energy intermediate in the  bbbbb1 GENEIN eeeee1  (GENEIN)-mediated cyclization of  bbbbb2 CHEMICALIN eeeee2  to CHEMICALIN was prepared from CHEMICALNOTIN
CPR:10	MRS2179, a GENENOTIN blocker, prevented potentiation in EDL, but not soleus muscles, suggesting that in fast muscles  bbbbb1 CHEMICALIN eeeee1  activates GENEIN but not  bbbbb2 GENEIN eeeee2 
CPR:1	Phosphorylation on  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN residues of  bbbbb2 GENEIN eeeee2  was increased during potentiation, possibly mediating HC opening
CPR:1	Phosphorylation on CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  residues of  bbbbb2 GENEIN eeeee2  was increased during potentiation, possibly mediating HC opening
CPR:2	Immunocytochemical analyses and function were consistent with  bbbbb1 GENEIN eeeee1  localization to T-tubules intercalated with  bbbbb2 CHEMICALIN eeeee2  and GENENOTIN in slow (soleus) and fast (extensor digitorum longus, EDL) muscles
CPR:3	During repetitive stimulation of skeletal muscle, extracellular  bbbbb1 CHEMICALIN eeeee1  levels raise, activating  bbbbb2 GENEIN eeeee2 , increasing CHEMICALNOTIN influx, and enhancing contractile force, a response called potentiation
CPR:3	MRS2179, a GENENOTIN blocker, prevented potentiation in EDL, but not soleus muscles, suggesting that in fast muscles  bbbbb1 CHEMICALIN eeeee1  activates  bbbbb2 GENEIN eeeee2  but not GENEIN
CPR:9	Consistent with two  bbbbb1 CHEMICALIN eeeee1  uptake pathways, induced uptake of CHEMICALIN, a fluorescent CHEMICALNOTIN derivative, was decreased by inhibition of HCs or  bbbbb2 GENEIN eeeee2  (GENEIN), and blocked by dual blockade
CPR:9	Consistent with two  bbbbb1 CHEMICALIN eeeee1  uptake pathways, induced uptake of CHEMICALIN, a fluorescent CHEMICALNOTIN derivative, was decreased by inhibition of HCs or GENEIN ( bbbbb2 GENEIN eeeee2 ), and blocked by dual blockade
CPR:9	Consistent with two CHEMICALIN uptake pathways, induced uptake of  bbbbb1 CHEMICALIN eeeee1 , a fluorescent CHEMICALNOTIN derivative, was decreased by inhibition of HCs or  bbbbb2 GENEIN eeeee2  (GENEIN), and blocked by dual blockade
CPR:9	Consistent with two CHEMICALIN uptake pathways, induced uptake of  bbbbb1 CHEMICALIN eeeee1 , a fluorescent CHEMICALNOTIN derivative, was decreased by inhibition of HCs or GENEIN ( bbbbb2 GENEIN eeeee2 ), and blocked by dual blockade
CPR:9	The  bbbbb1 CHEMICALIN eeeee1  required for potentiation of skeletal muscle contraction is released via  bbbbb2 GENEIN eeeee2  hemichannels
CPR:9	Opening of  bbbbb1 GENEIN eeeee1  HCs during repetitive activation allows efflux of  bbbbb2 CHEMICALIN eeeee2 , influx of CHEMICALIN and possibly CHEMICALIN too, which are required for potentiation of contraction
CPR:9	Opening of  bbbbb1 GENEIN eeeee1  HCs during repetitive activation allows efflux of CHEMICALIN, influx of  bbbbb2 CHEMICALIN eeeee2  and possibly CHEMICALIN too, which are required for potentiation of contraction
CPR:9	Opening of  bbbbb1 GENEIN eeeee1  HCs during repetitive activation allows efflux of CHEMICALIN, influx of CHEMICALIN and possibly  bbbbb2 CHEMICALIN eeeee2  too, which are required for potentiation of contraction
CPR:3	The rate limiting enzyme of beta-oxidation ( bbbbb1 GENEIN eeeee1 ) was significantly over-expressed in the liver with  bbbbb2 CHEMICALIN eeeee2  treatment
CPR:3	These results indicate that  bbbbb1 CHEMICALIN eeeee1  suppresses body weight gain in mice, possibly at least related to the up-regulation of  bbbbb2 GENEIN eeeee2  gene expression.
CPR:3	When dual angiogenic growth factors (GFs), such as GENENOTIN (GENENOTIN) and GENENOTIN (GENENOTIN), are encapsulated separately in the core and shell domains, respectively, the  bbbbb1 GENEIN eeeee1  release rate is much greater than that of GENEIN, and the difference of the cumulative release percentage between the two GFs is about 30% on day 7 with LMW core  bbbbb2 CHEMICALIN eeeee2  and more than 45% with HMW core CHEMICALIN
CPR:3	When dual angiogenic growth factors (GFs), such as GENENOTIN (GENENOTIN) and GENENOTIN (GENENOTIN), are encapsulated separately in the core and shell domains, respectively, the GENEIN release rate is much greater than that of  bbbbb1 GENEIN eeeee1 , and the difference of the cumulative release percentage between the two GFs is about 30% on day 7 with LMW core  bbbbb2 CHEMICALIN eeeee2  and more than 45% with HMW core CHEMICALIN
CPR:3	When dual angiogenic growth factors (GFs), such as GENENOTIN (GENENOTIN) and GENENOTIN (GENENOTIN), are encapsulated separately in the core and shell domains, respectively, the  bbbbb1 GENEIN eeeee1  release rate is much greater than that of GENEIN, and the difference of the cumulative release percentage between the two GFs is about 30% on day 7 with LMW core CHEMICALIN and more than 45% with HMW core  bbbbb2 CHEMICALIN eeeee2 
CPR:3	When dual angiogenic growth factors (GFs), such as GENENOTIN (GENENOTIN) and GENENOTIN (GENENOTIN), are encapsulated separately in the core and shell domains, respectively, the GENEIN release rate is much greater than that of  bbbbb1 GENEIN eeeee1 , and the difference of the cumulative release percentage between the two GFs is about 30% on day 7 with LMW core CHEMICALIN and more than 45% with HMW core  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Potency switch between GENEIN and  bbbbb1 GENEIN eeeee1 : Discovery of  bbbbb2 CHEMICALIN eeeee2 - and CHEMICALIN-based GENEIN inhibitors
CPR:4	Potency switch between GENEIN and GENEIN: Discovery of  bbbbb1 CHEMICALIN eeeee1 - and CHEMICALIN-based  bbbbb2 GENEIN eeeee2  inhibitors
CPR:4	Potency switch between  bbbbb1 GENEIN eeeee1  and GENEIN: Discovery of  bbbbb2 CHEMICALIN eeeee2 - and CHEMICALIN-based GENEIN inhibitors
CPR:4	Potency switch between GENEIN and  bbbbb1 GENEIN eeeee1 : Discovery of CHEMICALIN- and  bbbbb2 CHEMICALIN eeeee2 -based GENEIN inhibitors
CPR:4	Potency switch between GENEIN and GENEIN: Discovery of CHEMICALIN- and  bbbbb1 CHEMICALIN eeeee1 -based  bbbbb2 GENEIN eeeee2  inhibitors
CPR:4	Potency switch between  bbbbb1 GENEIN eeeee1  and GENEIN: Discovery of CHEMICALIN- and  bbbbb2 CHEMICALIN eeeee2 -based GENEIN inhibitors
CPR:1	In the present report, we show that GENENOTIN associates with the activated  bbbbb1 GENEIN eeeee1  (GENEIN) through multiple autophosphorylation sites, i.e.  bbbbb2 CHEMICALIN eeeee2 579, CHEMICALIN581, CHEMICALIN740 and CHEMICALIN1021
CPR:1	In the present report, we show that GENENOTIN associates with the activated GENEIN ( bbbbb1 GENEIN eeeee1 ) through multiple autophosphorylation sites, i.e.  bbbbb2 CHEMICALIN eeeee2 579, CHEMICALIN581, CHEMICALIN740 and CHEMICALIN1021
CPR:1	In the present report, we show that GENENOTIN associates with the activated  bbbbb1 GENEIN eeeee1  (GENEIN) through multiple autophosphorylation sites, i.e. CHEMICALIN579,  bbbbb2 CHEMICALIN eeeee2 581, CHEMICALIN740 and CHEMICALIN1021
CPR:1	In the present report, we show that GENENOTIN associates with the activated GENEIN ( bbbbb1 GENEIN eeeee1 ) through multiple autophosphorylation sites, i.e. CHEMICALIN579,  bbbbb2 CHEMICALIN eeeee2 581, CHEMICALIN740 and CHEMICALIN1021
CPR:1	In the present report, we show that GENENOTIN associates with the activated  bbbbb1 GENEIN eeeee1  (GENEIN) through multiple autophosphorylation sites, i.e. CHEMICALIN579, CHEMICALIN581,  bbbbb2 CHEMICALIN eeeee2 740 and CHEMICALIN1021
CPR:1	In the present report, we show that GENENOTIN associates with the activated GENEIN ( bbbbb1 GENEIN eeeee1 ) through multiple autophosphorylation sites, i.e. CHEMICALIN579, CHEMICALIN581,  bbbbb2 CHEMICALIN eeeee2 740 and CHEMICALIN1021
CPR:1	In the present report, we show that GENENOTIN associates with the activated  bbbbb1 GENEIN eeeee1  (GENEIN) through multiple autophosphorylation sites, i.e. CHEMICALIN579, CHEMICALIN581, CHEMICALIN740 and  bbbbb2 CHEMICALIN eeeee2 1021
CPR:1	In the present report, we show that GENENOTIN associates with the activated GENEIN ( bbbbb1 GENEIN eeeee1 ) through multiple autophosphorylation sites, i.e. CHEMICALIN579, CHEMICALIN581, CHEMICALIN740 and  bbbbb2 CHEMICALIN eeeee2 1021
CPR:6	A series of structurally novel  bbbbb1 CHEMICALIN eeeee1  was derived from optimization of the HTS lead as selective  bbbbb2 GENEIN eeeee2  (GENEIN) antagonists
CPR:6	A series of structurally novel  bbbbb1 CHEMICALIN eeeee1  was derived from optimization of the HTS lead as selective GENEIN ( bbbbb2 GENEIN eeeee2 ) antagonists
CPR:6	Discovery of  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN as potent and selective  bbbbb2 GENEIN eeeee2  antagonists for the treatment of obesity (Part I)
CPR:6	Discovery of CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  as potent and selective  bbbbb2 GENEIN eeeee2  antagonists for the treatment of obesity (Part I)
CPR:2	An increase in the energy required to remove the same anion from the  bbbbb1 GENEIN eeeee1  when compared to the GENENOTIN is explained as being due to the increase in  bbbbb2 CHEMICALIN eeeee2  bonding interactions
CPR:9	In terms of the mechanisms, we found that GENEIN ( bbbbb1 GENEIN eeeee1 ) which degrades  bbbbb2 CHEMICALIN eeeee2 , was upregulated after nerve injury at both ages, so that this upregulation likely did not account for the age-dependent differences
CPR:9	In terms of the mechanisms, we found that  bbbbb1 GENEIN eeeee1  (GENEIN) which degrades  bbbbb2 CHEMICALIN eeeee2 , was upregulated after nerve injury at both ages, so that this upregulation likely did not account for the age-dependent differences
CPR:9	However, enzymes contributing to oxidative metabolism of  bbbbb1 CHEMICALIN eeeee1 , namely  bbbbb2 GENEIN eeeee2  and GENEIN, were increased in the brain of aged mice, possibly enhancing the oxidative breakdown of CHEMICALIN
CPR:9	However, enzymes contributing to oxidative metabolism of  bbbbb1 CHEMICALIN eeeee1 , namely GENEIN and  bbbbb2 GENEIN eeeee2 , were increased in the brain of aged mice, possibly enhancing the oxidative breakdown of CHEMICALIN
CPR:9	However, enzymes contributing to oxidative metabolism of CHEMICALIN, namely  bbbbb1 GENEIN eeeee1  and GENEIN, were increased in the brain of aged mice, possibly enhancing the oxidative breakdown of  bbbbb2 CHEMICALIN eeeee2 
CPR:9	However, enzymes contributing to oxidative metabolism of CHEMICALIN, namely GENEIN and  bbbbb1 GENEIN eeeee1 , were increased in the brain of aged mice, possibly enhancing the oxidative breakdown of  bbbbb2 CHEMICALIN eeeee2 
CPR:10	When the expression of GENENOTIN and GENENOTIN was induced,  bbbbb1 CHEMICALIN eeeee1  efflux was stimulated in the presence of GENEIN (GENEIN), whereas  bbbbb2 GENEIN eeeee2  was not an efficient acceptor
CPR:2	The expression of GENEIN and GENEIN was induced by CHEMICALIN, as well as CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , which are ligands of the  bbbbb2 GENEIN eeeee2  GENEIN/GENEIN
CPR:2	The expression of GENEIN and GENEIN was induced by CHEMICALIN, as well as CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , which are ligands of the GENEIN  bbbbb2 GENEIN eeeee2 /GENEIN
CPR:2	The expression of GENEIN and GENEIN was induced by CHEMICALIN, as well as CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , which are ligands of the GENEIN GENEIN/ bbbbb2 GENEIN eeeee2 
CPR:2	The expression of GENEIN and GENEIN was induced by CHEMICALIN, as well as  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, which are ligands of the  bbbbb2 GENEIN eeeee2  GENEIN/GENEIN
CPR:2	The expression of GENEIN and GENEIN was induced by CHEMICALIN, as well as  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, which are ligands of the GENEIN  bbbbb2 GENEIN eeeee2 /GENEIN
CPR:2	The expression of GENEIN and GENEIN was induced by CHEMICALIN, as well as  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, which are ligands of the GENEIN GENEIN/ bbbbb2 GENEIN eeeee2 
CPR:2	When the expression of GENENOTIN and GENENOTIN was induced,  bbbbb1 CHEMICALIN eeeee1  efflux was stimulated in the presence of  bbbbb2 GENEIN eeeee2  (GENEIN), whereas GENEIN was not an efficient acceptor
CPR:2	When the expression of GENENOTIN and GENENOTIN was induced,  bbbbb1 CHEMICALIN eeeee1  efflux was stimulated in the presence of GENEIN ( bbbbb2 GENEIN eeeee2 ), whereas GENEIN was not an efficient acceptor
CPR:2	To confirm the role of each transporter, we analyzed HEK293 cells stably expressing GENEIN or GENEIN; we clearly observed  bbbbb1 CHEMICALIN eeeee1  efflux in the presence of  bbbbb2 GENEIN eeeee2 , whereas efflux in the presence of GENEIN was marginal
CPR:2	To confirm the role of each transporter, we analyzed HEK293 cells stably expressing GENEIN or GENEIN; we clearly observed  bbbbb1 CHEMICALIN eeeee1  efflux in the presence of GENEIN, whereas efflux in the presence of  bbbbb2 GENEIN eeeee2  was marginal
CPR:2	These results suggest that GENEIN actively eliminates  bbbbb1 CHEMICALIN eeeee1  in the presence of  bbbbb2 GENEIN eeeee2  as a lipid acceptor and protects neuronal cells
CPR:3	The expression of  bbbbb1 GENEIN eeeee1  and GENEIN was induced by CHEMICALIN, as well as CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 , which are ligands of the GENEIN GENEIN/GENEIN
CPR:3	The expression of GENEIN and  bbbbb1 GENEIN eeeee1  was induced by CHEMICALIN, as well as CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 , which are ligands of the GENEIN GENEIN/GENEIN
CPR:3	The expression of  bbbbb1 GENEIN eeeee1  and GENEIN was induced by  bbbbb2 CHEMICALIN eeeee2 , as well as CHEMICALIN and CHEMICALIN, which are ligands of the GENEIN GENEIN/GENEIN
CPR:3	The expression of GENEIN and  bbbbb1 GENEIN eeeee1  was induced by  bbbbb2 CHEMICALIN eeeee2 , as well as CHEMICALIN and CHEMICALIN, which are ligands of the GENEIN GENEIN/GENEIN
CPR:3	The expression of  bbbbb1 GENEIN eeeee1  and GENEIN was induced by CHEMICALIN, as well as  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN, which are ligands of the GENEIN GENEIN/GENEIN
CPR:3	The expression of GENEIN and  bbbbb1 GENEIN eeeee1  was induced by CHEMICALIN, as well as  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN, which are ligands of the GENEIN GENEIN/GENEIN
CPR:9	Because  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), produced by  bbbbb2 GENEIN eeeee2 , induces apoptosis of neuronal cells, it is vital to eliminate it rapidly from cells
CPR:9	Because CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), produced by  bbbbb2 GENEIN eeeee2 , induces apoptosis of neuronal cells, it is vital to eliminate it rapidly from cells
CPR:9	To confirm the role of each transporter, we analyzed HEK293 cells stably expressing  bbbbb1 GENEIN eeeee1  or GENEIN; we clearly observed  bbbbb2 CHEMICALIN eeeee2  efflux in the presence of GENEIN, whereas efflux in the presence of GENEIN was marginal
CPR:9	To confirm the role of each transporter, we analyzed HEK293 cells stably expressing GENEIN or  bbbbb1 GENEIN eeeee1 ; we clearly observed  bbbbb2 CHEMICALIN eeeee2  efflux in the presence of GENEIN, whereas efflux in the presence of GENEIN was marginal
CPR:9	 bbbbb1 CHEMICALIN eeeee1  is actively eliminated from neuronal cells by  bbbbb2 GENEIN eeeee2 
CPR:9	These results suggest that  bbbbb1 GENEIN eeeee1  actively eliminates  bbbbb2 CHEMICALIN eeeee2  in the presence of GENEIN as a lipid acceptor and protects neuronal cells
CPR:9	High  bbbbb1 CHEMICALIN eeeee1  turnover catalyzed by  bbbbb2 GENEIN eeeee2  is essential for neural functions, especially learning
CPR:1	Molecular docking studies were performed with  bbbbb1 GENEIN eeeee1  (GENEIN: PDB 1E78), showing binding pattern with  bbbbb2 CHEMICALIN eeeee2  residues CHEMICALIN218, CHEMICALIN222 and CHEMICALIN444, identifies the ligand-GENENOTIN interaction for the transportation affinity of the ligand at the specific site of the target
CPR:1	Molecular docking studies were performed with GENEIN ( bbbbb1 GENEIN eeeee1 : PDB 1E78), showing binding pattern with  bbbbb2 CHEMICALIN eeeee2  residues CHEMICALIN218, CHEMICALIN222 and CHEMICALIN444, identifies the ligand-GENENOTIN interaction for the transportation affinity of the ligand at the specific site of the target
CPR:1	Molecular docking studies were performed with  bbbbb1 GENEIN eeeee1  (GENEIN: PDB 1E78), showing binding pattern with CHEMICALIN residues  bbbbb2 CHEMICALIN eeeee2 218, CHEMICALIN222 and CHEMICALIN444, identifies the ligand-GENENOTIN interaction for the transportation affinity of the ligand at the specific site of the target
CPR:1	Molecular docking studies were performed with GENEIN ( bbbbb1 GENEIN eeeee1 : PDB 1E78), showing binding pattern with CHEMICALIN residues  bbbbb2 CHEMICALIN eeeee2 218, CHEMICALIN222 and CHEMICALIN444, identifies the ligand-GENENOTIN interaction for the transportation affinity of the ligand at the specific site of the target
CPR:1	Molecular docking studies were performed with  bbbbb1 GENEIN eeeee1  (GENEIN: PDB 1E78), showing binding pattern with CHEMICALIN residues CHEMICALIN218,  bbbbb2 CHEMICALIN eeeee2 222 and CHEMICALIN444, identifies the ligand-GENENOTIN interaction for the transportation affinity of the ligand at the specific site of the target
CPR:1	Molecular docking studies were performed with GENEIN ( bbbbb1 GENEIN eeeee1 : PDB 1E78), showing binding pattern with CHEMICALIN residues CHEMICALIN218,  bbbbb2 CHEMICALIN eeeee2 222 and CHEMICALIN444, identifies the ligand-GENENOTIN interaction for the transportation affinity of the ligand at the specific site of the target
CPR:1	Molecular docking studies were performed with  bbbbb1 GENEIN eeeee1  (GENEIN: PDB 1E78), showing binding pattern with CHEMICALIN residues CHEMICALIN218, CHEMICALIN222 and  bbbbb2 CHEMICALIN eeeee2 444, identifies the ligand-GENENOTIN interaction for the transportation affinity of the ligand at the specific site of the target
CPR:1	Molecular docking studies were performed with GENEIN ( bbbbb1 GENEIN eeeee1 : PDB 1E78), showing binding pattern with CHEMICALIN residues CHEMICALIN218, CHEMICALIN222 and  bbbbb2 CHEMICALIN eeeee2 444, identifies the ligand-GENENOTIN interaction for the transportation affinity of the ligand at the specific site of the target
CPR:2	These experiments show that in striatonigral projections,  bbbbb1 GENEIN eeeee1  inhibits the action of GENEIN in a  bbbbb2 CHEMICALIN eeeee2  dependent manner blocking their modulatory effects on CHEMICALNOTIN release
CPR:2	These experiments show that in striatonigral projections, GENEIN inhibits the action of  bbbbb1 GENEIN eeeee1  in a  bbbbb2 CHEMICALIN eeeee2  dependent manner blocking their modulatory effects on CHEMICALNOTIN release
CPR:2	Immunoblot studies showed that CHEMICALIN-depolarization increased GENEIN phosphorylation in a  bbbbb1 CHEMICALIN eeeee1  sensitive manner and promoted  bbbbb2 GENEIN eeeee2  binding to GENEIN
CPR:2	Immunoblot studies showed that CHEMICALIN-depolarization increased GENEIN phosphorylation in a  bbbbb1 CHEMICALIN eeeee1  sensitive manner and promoted GENEIN binding to  bbbbb2 GENEIN eeeee2 
CPR:2	Immunoblot studies showed that CHEMICALIN-depolarization increased  bbbbb1 GENEIN eeeee1  phosphorylation in a  bbbbb2 CHEMICALIN eeeee2  sensitive manner and promoted GENEIN binding to GENEIN
CPR:2	Immunoblot studies showed that  bbbbb1 CHEMICALIN eeeee1 -depolarization increased  bbbbb2 GENEIN eeeee2  phosphorylation in a CHEMICALIN sensitive manner and promoted GENEIN binding to GENEIN
CPR:2	Presynaptic  bbbbb1 GENEIN eeeee1  modulates GENEIN activation in striatonigral terminals of the rat brain in a  bbbbb2 CHEMICALIN eeeee2  dependent manner
CPR:2	Presynaptic GENEIN modulates  bbbbb1 GENEIN eeeee1  activation in striatonigral terminals of the rat brain in a  bbbbb2 CHEMICALIN eeeee2  dependent manner
CPR:4	The selective  bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2  reversed the blockade produced by CHEMICALIN and CHEMICALNOTIN-depolarization
CPR:4	The selective  bbbbb1 GENEIN eeeee1  inhibitor CHEMICALIN reversed the blockade produced by  bbbbb2 CHEMICALIN eeeee2  and CHEMICALNOTIN-depolarization
CPR:4	In CHEMICALNOTIN-depolarized tissues, GENENOTIN potentiated GENENOTIN-induced stimulation of CHEMICALNOTIN release only when  bbbbb1 GENEIN eeeee1  was blocked with  bbbbb2 CHEMICALIN eeeee2 
CPR:5	In the presence of this inhibitor, the selective  bbbbb1 GENEIN eeeee1  agonist  bbbbb2 CHEMICALIN eeeee2  reduced the ED50 for the GENEIN agonist CHEMICALIN from 56 to 4nM
CPR:5	In the presence of this inhibitor, the selective GENEIN agonist CHEMICALIN reduced the ED50 for the  bbbbb1 GENEIN eeeee1  agonist  bbbbb2 CHEMICALIN eeeee2  from 56 to 4nM
CPR:3	Additionally, treatment with  bbbbb1 CHEMICALIN eeeee1 /CHEMICALIN showed a higher  bbbbb2 GENEIN eeeee2  activity
CPR:3	Additionally, treatment with CHEMICALIN/ bbbbb1 CHEMICALIN eeeee1  showed a higher  bbbbb2 GENEIN eeeee2  activity
CPR:3	The  bbbbb1 GENEIN eeeee1 /GENEIN ratio increased and GENEIN expression decreased in MIN6 cells after  bbbbb2 CHEMICALIN eeeee2  stimulation
CPR:3	The GENEIN/ bbbbb1 GENEIN eeeee1  ratio increased and GENEIN expression decreased in MIN6 cells after  bbbbb2 CHEMICALIN eeeee2  stimulation
CPR:3	Our study revealed that high  bbbbb1 CHEMICALIN eeeee1 /CHEMICALIN concentrations in MIN6 cells induced an increase of the  bbbbb2 GENEIN eeeee2 /GENEIN ratio, an indicator of increased cell apoptosis.
CPR:3	Our study revealed that high  bbbbb1 CHEMICALIN eeeee1 /CHEMICALIN concentrations in MIN6 cells induced an increase of the GENEIN/ bbbbb2 GENEIN eeeee2  ratio, an indicator of increased cell apoptosis.
CPR:3	Our study revealed that high CHEMICALIN/ bbbbb1 CHEMICALIN eeeee1  concentrations in MIN6 cells induced an increase of the  bbbbb2 GENEIN eeeee2 /GENEIN ratio, an indicator of increased cell apoptosis.
CPR:3	Our study revealed that high CHEMICALIN/ bbbbb1 CHEMICALIN eeeee1  concentrations in MIN6 cells induced an increase of the GENEIN/ bbbbb2 GENEIN eeeee2  ratio, an indicator of increased cell apoptosis.
CPR:4	The GENEIN/GENEIN ratio increased and  bbbbb1 GENEIN eeeee1  expression decreased in MIN6 cells after  bbbbb2 CHEMICALIN eeeee2  stimulation
CPR:9	Targeted disruption of the gene encoding the  bbbbb1 GENEIN eeeee1 , GENEIN, abolished  bbbbb2 CHEMICALIN eeeee2  production, and recombinant expression of GENEIN confirms the activity of this enzyme as a GENEIN involved in the formation of the CHEMICALIN-CHEMICALIN moiety.
CPR:9	Targeted disruption of the gene encoding the GENEIN,  bbbbb1 GENEIN eeeee1 , abolished  bbbbb2 CHEMICALIN eeeee2  production, and recombinant expression of GENEIN confirms the activity of this enzyme as a GENEIN involved in the formation of the CHEMICALIN-CHEMICALIN moiety.
CPR:9	Targeted disruption of the gene encoding the GENEIN, GENEIN, abolished CHEMICALIN production, and recombinant expression of  bbbbb1 GENEIN eeeee1  confirms the activity of this enzyme as a GENEIN involved in the formation of the  bbbbb2 CHEMICALIN eeeee2 -CHEMICALIN moiety.
CPR:9	Targeted disruption of the gene encoding the GENEIN, GENEIN, abolished CHEMICALIN production, and recombinant expression of GENEIN confirms the activity of this enzyme as a  bbbbb1 GENEIN eeeee1  involved in the formation of the  bbbbb2 CHEMICALIN eeeee2 -CHEMICALIN moiety.
CPR:9	Targeted disruption of the gene encoding the GENEIN, GENEIN, abolished CHEMICALIN production, and recombinant expression of  bbbbb1 GENEIN eeeee1  confirms the activity of this enzyme as a GENEIN involved in the formation of the CHEMICALIN- bbbbb2 CHEMICALIN eeeee2  moiety.
CPR:9	Targeted disruption of the gene encoding the GENEIN, GENEIN, abolished CHEMICALIN production, and recombinant expression of GENEIN confirms the activity of this enzyme as a  bbbbb1 GENEIN eeeee1  involved in the formation of the CHEMICALIN- bbbbb2 CHEMICALIN eeeee2  moiety.
CPR:9	This includes  bbbbb1 GENEIN eeeee1  (GENEIN) and GENEIN (GENEIN) required for the formation of the  bbbbb2 CHEMICALIN eeeee2  core unit, as well as a suite of tailoring enzymes (e.g., four GENEIN, an GENEIN, and an GENEIN) necessary for further modifications of the core structure
CPR:9	This includes GENEIN ( bbbbb1 GENEIN eeeee1 ) and GENEIN (GENEIN) required for the formation of the  bbbbb2 CHEMICALIN eeeee2  core unit, as well as a suite of tailoring enzymes (e.g., four GENEIN, an GENEIN, and an GENEIN) necessary for further modifications of the core structure
CPR:9	This includes GENEIN (GENEIN) and  bbbbb1 GENEIN eeeee1  (GENEIN) required for the formation of the  bbbbb2 CHEMICALIN eeeee2  core unit, as well as a suite of tailoring enzymes (e.g., four GENEIN, an GENEIN, and an GENEIN) necessary for further modifications of the core structure
CPR:9	This includes GENEIN (GENEIN) and GENEIN ( bbbbb1 GENEIN eeeee1 ) required for the formation of the  bbbbb2 CHEMICALIN eeeee2  core unit, as well as a suite of tailoring enzymes (e.g., four GENEIN, an GENEIN, and an GENEIN) necessary for further modifications of the core structure
CPR:9	This includes GENEIN (GENEIN) and GENEIN (GENEIN) required for the formation of the  bbbbb1 CHEMICALIN eeeee1  core unit, as well as a suite of tailoring enzymes (e.g., four  bbbbb2 GENEIN eeeee2 , an GENEIN, and an GENEIN) necessary for further modifications of the core structure
CPR:9	This includes GENEIN (GENEIN) and GENEIN (GENEIN) required for the formation of the  bbbbb1 CHEMICALIN eeeee1  core unit, as well as a suite of tailoring enzymes (e.g., four GENEIN, an  bbbbb2 GENEIN eeeee2 , and an GENEIN) necessary for further modifications of the core structure
CPR:9	This includes GENEIN (GENEIN) and GENEIN (GENEIN) required for the formation of the  bbbbb1 CHEMICALIN eeeee1  core unit, as well as a suite of tailoring enzymes (e.g., four GENEIN, an GENEIN, and an  bbbbb2 GENEIN eeeee2 ) necessary for further modifications of the core structure
CPR:2	Here, we report that  bbbbb1 GENEIN eeeee1  is necessary for expression of the vesicular  bbbbb2 CHEMICALIN eeeee2  /CHEMICALIN -antiport
CPR:2	Here, we report that  bbbbb1 GENEIN eeeee1  is necessary for expression of the vesicular CHEMICALIN / bbbbb2 CHEMICALIN eeeee2  -antiport
CPR:2	The results were congruent and highly significant:  bbbbb1 CHEMICALIN eeeee1  /CHEMICALIN -antiport activity is detectable only in acidic organelles expressing functional  bbbbb2 GENEIN eeeee2 
CPR:2	The results were congruent and highly significant: CHEMICALIN / bbbbb1 CHEMICALIN eeeee1  -antiport activity is detectable only in acidic organelles expressing functional  bbbbb2 GENEIN eeeee2 
CPR:2	 bbbbb1 GENEIN eeeee1  is required for vesicular  bbbbb2 CHEMICALIN eeeee2  /CHEMICALIN -antiport activity
CPR:2	 bbbbb1 GENEIN eeeee1  is required for vesicular CHEMICALIN / bbbbb2 CHEMICALIN eeeee2  -antiport activity
CPR:2	Therefore, in addition to its previously described functions,  bbbbb1 GENEIN eeeee1  is involved in a rapid vesicular  bbbbb2 CHEMICALIN eeeee2  sequestration through a CHEMICALIN /CHEMICALIN antiport
CPR:2	Therefore, in addition to its previously described functions,  bbbbb1 GENEIN eeeee1  is involved in a rapid vesicular CHEMICALIN sequestration through a  bbbbb2 CHEMICALIN eeeee2  /CHEMICALIN antiport
CPR:2	Therefore, in addition to its previously described functions,  bbbbb1 GENEIN eeeee1  is involved in a rapid vesicular CHEMICALIN sequestration through a CHEMICALIN / bbbbb2 CHEMICALIN eeeee2  antiport
CPR:2	 bbbbb1 GENEIN eeeee1 , a vesicular protein interacting with membranes upon low-affinity  bbbbb2 CHEMICALIN eeeee2  -binding, plays a major role in excitation-release coupling, by synchronizing CHEMICALIN entry with fast neurotransmitter release
CPR:2	 bbbbb1 GENEIN eeeee1 , a vesicular protein interacting with membranes upon low-affinity CHEMICALIN -binding, plays a major role in excitation-release coupling, by synchronizing  bbbbb2 CHEMICALIN eeeee2  entry with fast neurotransmitter release
CPR:2	CHEMICALNOTIN replacement enhances  bbbbb1 CHEMICALIN eeeee1 -stimulated locomotion in female C57BL/6 mice through  bbbbb2 GENEIN eeeee2 
CPR:2	These results suggest that E2 enhances  bbbbb1 CHEMICALIN eeeee1 -stimulated locomotion in mice predominantly through  bbbbb2 GENEIN eeeee2 .
CPR:5	To examine receptor mediation of CHEMICALNOTIN effects, Ovx mice replaced for 2 days with either the  bbbbb1 GENEIN eeeee1 -selective agonist  bbbbb2 CHEMICALIN eeeee2  or the GENEIN-selective agonist CHEMICALIN were compared to Sham mice, and mice lacking either GENENOTIN (GENENOTINKO) or GENENOTIN (GENENOTINKO) were compared to WT littermates
CPR:5	To examine receptor mediation of CHEMICALNOTIN effects, Ovx mice replaced for 2 days with either the GENEIN-selective agonist CHEMICALIN or the  bbbbb1 GENEIN eeeee1 -selective agonist  bbbbb2 CHEMICALIN eeeee2  were compared to Sham mice, and mice lacking either GENENOTIN (GENENOTINKO) or GENENOTIN (GENENOTINKO) were compared to WT littermates
CPR:9	The  bbbbb1 GENEIN eeeee1  Regulates Vascular Smooth Muscle Cell Proliferation via Controlling  bbbbb2 CHEMICALIN eeeee2 -dependent Signaling
CPR:5	The current study examined the bioactivation potential of  bbbbb1 GENEIN eeeee1  inverse agonists, CHEMICALIN (1) and  bbbbb2 CHEMICALIN eeeee2  (2), containing a fused CHEMICALIN motif in the core structure
CPR:5	The current study examined the bioactivation potential of  bbbbb1 GENEIN eeeee1  inverse agonists, CHEMICALIN (1) and CHEMICALIN (2), containing a fused  bbbbb2 CHEMICALIN eeeee2  motif in the core structure
CPR:5	The current study examined the bioactivation potential of  bbbbb1 GENEIN eeeee1  inverse agonists,  bbbbb2 CHEMICALIN eeeee2  (1) and CHEMICALIN (2), containing a fused CHEMICALIN motif in the core structure
CPR:5	Reactive Metabolite Trapping Studies on  bbbbb1 CHEMICALIN eeeee1 -based Inverse Agonists of the  bbbbb2 GENEIN eeeee2 
CPR:2	Moreover, the active permethylated  bbbbb1 CHEMICALIN eeeee1  aglycon derivatives examined exhibit  bbbbb2 GENEIN eeeee2  VRE antimicrobial activity at levels that approach (typically within 2-fold) their activity against sensitive bacteria
CPR:2	 bbbbb1 CHEMICALIN eeeee1  exposure significantly decreased the levels of these four FAs only in pregnant  bbbbb2 GENEIN eeeee2  mice
CPR:2	Taken together, the levels of plasma four FAs with shorter CHEMICALNOTIN chains were higher in pregnant GENENOTIN mice than in other genotypes, and  bbbbb1 CHEMICALIN eeeee1  exposure decreased these specific FA concentrations only in  bbbbb2 GENEIN eeeee2  mice, similarly to CHEMICALNOTIN levels.
CPR:2	Interestingly,  bbbbb1 CHEMICALIN eeeee1  chains of secreted  bbbbb2 GENEIN eeeee2  neutralized the cytotoxic activity of extracellular GENEIN as well as DNA/GENEIN-network-containing "neutrophil extracellular traps", which are formed during invasion of microorganisms
CPR:2	In mature lung tissue of healthy donors,  bbbbb1 CHEMICALIN eeeee1  was exclusively attached to the transmembrane isoform  bbbbb2 GENEIN eeeee2  and located to intracellular compartments of epithelial cells
CPR:2	As shown in a cell culture model,  bbbbb1 CHEMICALIN eeeee1 - bbbbb2 GENEIN eeeee2  was kept in the late trans-Golgi apparatus of lung epithelial cells and stimulation by GENENOTIN or lipopolysaccharide induced GENENOTIN-mediated GENENOTIN shedding, resulting in the secretion of soluble GENENOTIN
CPR:2	Interestingly,  bbbbb1 CHEMICALIN eeeee1  chains of secreted GENEIN neutralized the cytotoxic activity of extracellular  bbbbb2 GENEIN eeeee2  as well as DNA/GENEIN-network-containing "neutrophil extracellular traps", which are formed during invasion of microorganisms
CPR:2	Interestingly,  bbbbb1 CHEMICALIN eeeee1  chains of secreted GENEIN neutralized the cytotoxic activity of extracellular GENEIN as well as DNA/ bbbbb2 GENEIN eeeee2 -network-containing "neutrophil extracellular traps", which are formed during invasion of microorganisms
CPR:2	Processing of  bbbbb1 GENEIN eeeee1  was reproduced in a mouse model by  bbbbb2 CHEMICALIN eeeee2  administration leading to an activation of the inflammasome and secretion of GENEIN
CPR:2	Posttranslational modification of the  bbbbb1 GENEIN eeeee1  (GENEIN) by CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) is well studied in the nervous system and described as a dynamic modulator of plastic processes like precursor cell migration, axon fasciculation, and synaptic plasticity
CPR:2	Posttranslational modification of the GENEIN ( bbbbb1 GENEIN eeeee1 ) by CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) is well studied in the nervous system and described as a dynamic modulator of plastic processes like precursor cell migration, axon fasciculation, and synaptic plasticity
CPR:2	Posttranslational modification of the  bbbbb1 GENEIN eeeee1  (GENEIN) by  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) is well studied in the nervous system and described as a dynamic modulator of plastic processes like precursor cell migration, axon fasciculation, and synaptic plasticity
CPR:2	Posttranslational modification of the GENEIN ( bbbbb1 GENEIN eeeee1 ) by  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) is well studied in the nervous system and described as a dynamic modulator of plastic processes like precursor cell migration, axon fasciculation, and synaptic plasticity
CPR:3	Processing of GENEIN was reproduced in a mouse model by  bbbbb1 CHEMICALIN eeeee1  administration leading to an activation of the inflammasome and secretion of  bbbbb2 GENEIN eeeee2 
CPR:2	 bbbbb1 CHEMICALIN eeeee1 +CHEMICALIN were more effective than placebo+CHEMICALIN in reducing body weight and BMI, glycemic control, HOMA-IR,  bbbbb2 GENEIN eeeee2  and GENEIN resistance measurements
CPR:2	 bbbbb1 CHEMICALIN eeeee1 +CHEMICALIN were more effective than placebo+CHEMICALIN in reducing body weight and BMI, glycemic control, HOMA-IR, GENEIN and  bbbbb2 GENEIN eeeee2  resistance measurements
CPR:2	CHEMICALIN+ bbbbb1 CHEMICALIN eeeee1  were more effective than placebo+CHEMICALIN in reducing body weight and BMI, glycemic control, HOMA-IR,  bbbbb2 GENEIN eeeee2  and GENEIN resistance measurements
CPR:2	CHEMICALIN+ bbbbb1 CHEMICALIN eeeee1  were more effective than placebo+CHEMICALIN in reducing body weight and BMI, glycemic control, HOMA-IR, GENEIN and  bbbbb2 GENEIN eeeee2  resistance measurements
CPR:2	CHEMICALIN+CHEMICALIN were more effective than placebo+ bbbbb1 CHEMICALIN eeeee1  in reducing body weight and BMI, glycemic control, HOMA-IR,  bbbbb2 GENEIN eeeee2  and GENEIN resistance measurements
CPR:2	CHEMICALIN+CHEMICALIN were more effective than placebo+ bbbbb1 CHEMICALIN eeeee1  in reducing body weight and BMI, glycemic control, HOMA-IR, GENEIN and  bbbbb2 GENEIN eeeee2  resistance measurements
CPR:2	We also recorded a significant correlation between M value increase and the decrease of  bbbbb1 GENEIN eeeee1 , GENEIN, and GENEIN obtained with  bbbbb2 CHEMICALIN eeeee2 +CHEMICALIN
CPR:2	We also recorded a significant correlation between M value increase and the decrease of GENEIN,  bbbbb1 GENEIN eeeee1 , and GENEIN obtained with  bbbbb2 CHEMICALIN eeeee2 +CHEMICALIN
CPR:2	We also recorded a significant correlation between M value increase and the decrease of GENEIN, GENEIN, and  bbbbb1 GENEIN eeeee1  obtained with  bbbbb2 CHEMICALIN eeeee2 +CHEMICALIN
CPR:2	We also recorded a significant correlation between M value increase and the decrease of  bbbbb1 GENEIN eeeee1 , GENEIN, and GENEIN obtained with CHEMICALIN+ bbbbb2 CHEMICALIN eeeee2 
CPR:2	We also recorded a significant correlation between M value increase and the decrease of GENEIN,  bbbbb1 GENEIN eeeee1 , and GENEIN obtained with CHEMICALIN+ bbbbb2 CHEMICALIN eeeee2 
CPR:2	We also recorded a significant correlation between M value increase and the decrease of GENEIN, GENEIN, and  bbbbb1 GENEIN eeeee1  obtained with CHEMICALIN+ bbbbb2 CHEMICALIN eeeee2 
CPR:2	 bbbbb1 CHEMICALIN eeeee1 , in addition to CHEMICALIN, proved to be effective in improving -cell function and in reducing  bbbbb2 GENEIN eeeee2  resistance measurements.
CPR:2	CHEMICALIN, in addition to  bbbbb1 CHEMICALIN eeeee1 , proved to be effective in improving -cell function and in reducing  bbbbb2 GENEIN eeeee2  resistance measurements.
CPR:10	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN's active form) failed to prevent E2-induced proteolysis of  bbbbb2 GENEIN eeeee2  and migration, but rather triggered GENEIN cleavage coincident with augmented migration
CPR:10	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN's active form) failed to prevent E2-induced proteolysis of  bbbbb2 GENEIN eeeee2  and migration, but rather triggered GENEIN cleavage coincident with augmented migration
CPR:10	CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 's active form) failed to prevent E2-induced proteolysis of  bbbbb2 GENEIN eeeee2  and migration, but rather triggered GENEIN cleavage coincident with augmented migration
CPR:2	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN, CHEMICALIN's active form) failed to prevent E2-induced proteolysis of GENEIN and migration, but rather triggered  bbbbb2 GENEIN eeeee2  cleavage coincident with augmented migration
CPR:2	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN's active form) failed to prevent E2-induced proteolysis of GENEIN and migration, but rather triggered  bbbbb2 GENEIN eeeee2  cleavage coincident with augmented migration
CPR:2	CHEMICALIN (CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 's active form) failed to prevent E2-induced proteolysis of GENEIN and migration, but rather triggered  bbbbb2 GENEIN eeeee2  cleavage coincident with augmented migration
CPR:2	 bbbbb1 CHEMICALIN eeeee1 -induced  bbbbb2 GENEIN eeeee2  truncation also occurred in SK-BR-3 cells that express GENEIN and lack GENENOTIN, but not in MDA-MB-231 cells that express neither GENENOTIN nor GENENOTIN
CPR:2	Furthermore,  bbbbb1 CHEMICALIN eeeee1 -stimulated cleavage of  bbbbb2 GENEIN eeeee2  and migration were tremendously attenuated by G15, a GENENOTIN antagonist, or siRNA against GENENOTIN
CPR:2	In addition, inhibitors for GENENOTIN or GENENOTIN remarkably suppressed  bbbbb1 CHEMICALIN eeeee1 -induced truncation of  bbbbb2 GENEIN eeeee2 , suggesting involvement of GENEIN signaling
CPR:2	In addition, inhibitors for GENENOTIN or GENENOTIN remarkably suppressed  bbbbb1 CHEMICALIN eeeee1 -induced truncation of GENEIN, suggesting involvement of  bbbbb2 GENEIN eeeee2  signaling
CPR:2	 bbbbb1 CHEMICALIN eeeee1 -induced GENEIN truncation also occurred in SK-BR-3 cells that express  bbbbb2 GENEIN eeeee2  and lack GENENOTIN, but not in MDA-MB-231 cells that express neither GENENOTIN nor GENENOTIN
CPR:2	 bbbbb1 CHEMICALIN eeeee1 -stimulated processing of GENEIN is mediated via GENEIN ( bbbbb2 GENEIN eeeee2  and accompanied by enhanced migration in MCF-7 breast cancer cells
CPR:2	 bbbbb1 CHEMICALIN eeeee1 -stimulated processing of GENEIN is mediated via  bbbbb2 GENEIN eeeee2  (GENEIN and accompanied by enhanced migration in MCF-7 breast cancer cells
CPR:2	Collectively, our data indicate that  bbbbb1 CHEMICALIN eeeee1  contributes to the production of proteolyzed GENEIN via  bbbbb2 GENEIN eeeee2  with augmented migration in MCF-7 cells.
CPR:3	 bbbbb1 CHEMICALIN eeeee1 -stimulated processing of  bbbbb2 GENEIN eeeee2  is mediated via GENEIN (GENEIN and accompanied by enhanced migration in MCF-7 breast cancer cells
CPR:3	 bbbbb1 CHEMICALIN eeeee1  (E2) has been recently shown to induce  bbbbb2 GENEIN eeeee2  processing in breast cancer cells
CPR:3	Collectively, our data indicate that  bbbbb1 CHEMICALIN eeeee1  contributes to the production of proteolyzed  bbbbb2 GENEIN eeeee2  via GENEIN with augmented migration in MCF-7 cells.
CPR:1	NMR spectroscopy was also used to examine the GENENOTIN mutants GENENOTIN, GENENOTIN, and GENENOTIN/GENENOTIN, which are unable to form the structurally conserved CHEMICALNOTIN bond in GENENOTIN, in order to investigate the role of these  bbbbb1 CHEMICALIN eeeee1  during  bbbbb2 GENEIN eeeee2  copper acquisition
CPR:2	We recently showed that the first domain of  bbbbb1 GENEIN eeeee1  (GENEIN) is responsible for  bbbbb2 CHEMICALIN eeeee2  transfer to its protein partner, GENEIN (GENEIN)
CPR:2	We recently showed that the first domain of GENEIN ( bbbbb1 GENEIN eeeee1 ) is responsible for  bbbbb2 CHEMICALIN eeeee2  transfer to its protein partner, GENEIN (GENEIN)
CPR:2	We recently showed that the first domain of GENEIN (GENEIN) is responsible for  bbbbb1 CHEMICALIN eeeee1  transfer to its protein partner,  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:2	We recently showed that the first domain of GENEIN (GENEIN) is responsible for  bbbbb1 CHEMICALIN eeeee1  transfer to its protein partner, GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:2	The NMR solution structure of the  bbbbb1 CHEMICALIN eeeee1 -loaded form of  bbbbb2 GENEIN eeeee2  reported here contributes further to characterization of the copper-transfer mechanism to GENENOTIN
CPR:2	Together, the information on both GENENOTIN and GENENOTIN, along with a sequence analysis of eukaryotic GENENOTIN, allows us to propose important mechanistic aspects regarding the  bbbbb1 CHEMICALIN eeeee1 -transfer process from  bbbbb2 GENEIN eeeee2  to GENEIN.
CPR:2	Together, the information on both GENENOTIN and GENENOTIN, along with a sequence analysis of eukaryotic GENENOTIN, allows us to propose important mechanistic aspects regarding the  bbbbb1 CHEMICALIN eeeee1 -transfer process from GENEIN to  bbbbb2 GENEIN eeeee2 .
CPR:2	Mechanistic Aspects of  bbbbb1 GENEIN eeeee1  Maturation from the Solution Structure of  bbbbb2 CHEMICALIN eeeee2  -Loaded GENEIN and Analysis of CHEMICALNOTIN-Free GENENOTIN Mutants
CPR:2	Mechanistic Aspects of GENEIN Maturation from the Solution Structure of  bbbbb1 CHEMICALIN eeeee1  -Loaded  bbbbb2 GENEIN eeeee2  and Analysis of CHEMICALNOTIN-Free GENENOTIN Mutants
CPR:2	Design, Synthesis and Biological Evaluation of  bbbbb1 CHEMICALIN eeeee1  Derivatives as  bbbbb2 GENEIN eeeee2  Ligands with Potential for Treatment of CHEMICALNOTIN Abuse
CPR:5	In the current study, we show that systematic modification of an  bbbbb1 CHEMICALIN eeeee1  scaffold identifies two new compounds with dual GENEIN antagonist/ bbbbb2 GENEIN eeeee2  agonist activity
CPR:5	Collectively, these initial findings suggest that design and systematic modification of  bbbbb1 CHEMICALIN eeeee1  such as 3 may lead to development of novel cannabinoid ligands with dual GENEIN antagonist/ bbbbb2 GENEIN eeeee2  agonist activity with potential for use as treatments of CHEMICALNOTIN abuse.
CPR:6	We have recently reported that a mono-hydroxylated metabolite of the synthetic  bbbbb1 CHEMICALIN eeeee1  cannabinoid CHEMICALIN (3) exhibits neutral antagonist activity at  bbbbb2 GENEIN eeeee2  and thus may serve as a promising lead for the development of novel CHEMICALNOTIN abuse therapies
CPR:6	We have recently reported that a mono-hydroxylated metabolite of the synthetic CHEMICALIN cannabinoid  bbbbb1 CHEMICALIN eeeee1  (3) exhibits neutral antagonist activity at  bbbbb2 GENEIN eeeee2  and thus may serve as a promising lead for the development of novel CHEMICALNOTIN abuse therapies
CPR:6	In the current study, we show that systematic modification of an  bbbbb1 CHEMICALIN eeeee1  scaffold identifies two new compounds with dual  bbbbb2 GENEIN eeeee2  antagonist/GENEIN agonist activity
CPR:6	Collectively, these initial findings suggest that design and systematic modification of  bbbbb1 CHEMICALIN eeeee1  such as 3 may lead to development of novel cannabinoid ligands with dual  bbbbb2 GENEIN eeeee2  antagonist/GENEIN agonist activity with potential for use as treatments of CHEMICALNOTIN abuse.
CPR:2	Immunoregulatory effects of  bbbbb1 CHEMICALIN eeeee1  exerts anti-asthmatic effects via modulation of Th1/Th2 GENEIN and enhancement of CD4(+)CD25(+)Foxp3(+) regulatory T cells in  bbbbb2 GENEIN eeeee2 -sensitized mice
CPR:2	Immunoregulatory effects of  bbbbb1 CHEMICALIN eeeee1  exerts anti-asthmatic effects via modulation of Th1/Th2  bbbbb2 GENEIN eeeee2  and enhancement of CD4(+)CD25(+)Foxp3(+) regulatory T cells in GENEIN-sensitized mice
CPR:4	The improved survival rates for obese mice chronically treated with  bbbbb1 CHEMICALIN eeeee1  suggest that chronic  bbbbb2 GENEIN eeeee2  inhibition potentially results in additional quality-adjusted life-years for individuals with type 2 diabetes, which is the primary goal of any diabetes therapy.
CPR:4	METHODS: After 1month of HFD alone, the mice were given the  bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2  for a further 11months
CPR:4	Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the  bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2  in an advanced-aged diet-induced obesity mouse model
CPR:9	Protein levels of the  bbbbb1 GENEIN eeeee1  (GENEIN) involved in  bbbbb2 CHEMICALIN eeeee2  transport via these two pathways were also increased
CPR:9	Protein levels of the GENEIN ( bbbbb1 GENEIN eeeee1 ) involved in  bbbbb2 CHEMICALIN eeeee2  transport via these two pathways were also increased
CPR:2	Using small interfering double-stranded RNA technology, we further demonstrate that the effects of  bbbbb1 CHEMICALIN eeeee1  on proliferation, differentiation and survival are mediated by both  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:2	Using small interfering double-stranded RNA technology, we further demonstrate that the effects of  bbbbb1 CHEMICALIN eeeee1  on proliferation, differentiation and survival are mediated by both GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:2	Here we show that CHEMICALIN increases proliferation and differentiation and opposes  bbbbb1 CHEMICALIN eeeee1 -induced apoptosis in human osteoblastic MG-63 cells containing two  bbbbb2 GENEIN eeeee2  (GENEIN) isoforms
CPR:2	Here we show that CHEMICALIN increases proliferation and differentiation and opposes  bbbbb1 CHEMICALIN eeeee1 -induced apoptosis in human osteoblastic MG-63 cells containing two GENEIN ( bbbbb2 GENEIN eeeee2 ) isoforms
CPR:2	Treatment with the  bbbbb1 GENEIN eeeee1  antagonist CHEMICALIN abolishes the above actions of  bbbbb2 CHEMICALIN eeeee2  on osteoblast-derived cells
CPR:2	 bbbbb1 CHEMICALIN eeeee1  stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via  bbbbb2 GENEIN eeeee2 -dependent GENEIN/GENEIN and GENEIN/GENEIN activation
CPR:2	Here we show that  bbbbb1 CHEMICALIN eeeee1  increases proliferation and differentiation and opposes CHEMICALIN-induced apoptosis in human osteoblastic MG-63 cells containing two  bbbbb2 GENEIN eeeee2  (GENEIN) isoforms
CPR:2	Here we show that  bbbbb1 CHEMICALIN eeeee1  increases proliferation and differentiation and opposes CHEMICALIN-induced apoptosis in human osteoblastic MG-63 cells containing two GENEIN ( bbbbb2 GENEIN eeeee2 ) isoforms
CPR:3	 bbbbb1 CHEMICALIN eeeee1  stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via GENEIN-dependent  bbbbb2 GENEIN eeeee2 /GENEIN and GENEIN/GENEIN activation
CPR:3	 bbbbb1 CHEMICALIN eeeee1  stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via GENEIN-dependent GENEIN/ bbbbb2 GENEIN eeeee2  and GENEIN/GENEIN activation
CPR:3	 bbbbb1 CHEMICALIN eeeee1  stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via GENEIN-dependent GENEIN/GENEIN and  bbbbb2 GENEIN eeeee2 /GENEIN activation
CPR:3	 bbbbb1 CHEMICALIN eeeee1  stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via GENEIN-dependent GENEIN/GENEIN and GENEIN/ bbbbb2 GENEIN eeeee2  activation
CPR:3	Moreover, we also demonstrate that  bbbbb1 CHEMICALIN eeeee1  functions at least partially through activation of  bbbbb2 GENEIN eeeee2 /GENEIN and GENEIN/GENEIN signaling
CPR:3	Moreover, we also demonstrate that  bbbbb1 CHEMICALIN eeeee1  functions at least partially through activation of GENEIN/ bbbbb2 GENEIN eeeee2  and GENEIN/GENEIN signaling
CPR:3	CHEMICALNOTIN promotes proliferation by altering cell cycle distribution whereas  bbbbb1 CHEMICALIN eeeee1 -mediated survival may be associated with up-regulation of  bbbbb2 GENEIN eeeee2  expression
CPR:3	Moreover, we also demonstrate that  bbbbb1 CHEMICALIN eeeee1  functions at least partially through activation of GENEIN/GENEIN and  bbbbb2 GENEIN eeeee2 /GENEIN signaling
CPR:3	Moreover, we also demonstrate that  bbbbb1 CHEMICALIN eeeee1  functions at least partially through activation of GENEIN/GENEIN and GENEIN/ bbbbb2 GENEIN eeeee2  signaling
CPR:6	Treatment with the  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2  abolishes the above actions of CHEMICALIN on osteoblast-derived cells
CPR:2	The preventive effect of uncarboxylated GENENOTIN against  bbbbb1 CHEMICALIN eeeee1 -induced endothelial apoptosis through the activation of  bbbbb2 GENEIN eeeee2 /GENEIN signaling pathway: GENENOTIN and endothelial apoptosis
CPR:2	The preventive effect of uncarboxylated GENENOTIN against  bbbbb1 CHEMICALIN eeeee1 -induced endothelial apoptosis through the activation of GENEIN/ bbbbb2 GENEIN eeeee2  signaling pathway: GENENOTIN and endothelial apoptosis
CPR:4	RESULTS: Pretreatment of GENENOTIN (30ng/ml) prevented LA-induced apoptosis in GENENOTIN-stimulated endothelial cells; effects were abolished by pretreatment with the  bbbbb1 GENEIN eeeee1  (GENEIN) inhibitor,  bbbbb2 CHEMICALIN eeeee2 
CPR:4	RESULTS: Pretreatment of GENENOTIN (30ng/ml) prevented LA-induced apoptosis in GENENOTIN-stimulated endothelial cells; effects were abolished by pretreatment with the GENEIN ( bbbbb1 GENEIN eeeee1 ) inhibitor,  bbbbb2 CHEMICALIN eeeee2 
CPR:2	Chronic exposure to  bbbbb1 CHEMICALIN eeeee1  provoked then structural changes but also functional changes in the capacity of biofilm  bbbbb2 GENEIN eeeee2  activity to respond to a sudden increase in concentration, suggesting a selection of species with higher antioxidant capacity
CPR:3	In addition, during acute exposure tests performed at the end of the chronic exposure, biofilms chronically exposed to 75 and 150gL(-1)  bbbbb1 CHEMICALIN eeeee1  showed a higher  bbbbb2 GENEIN eeeee2  activity than controls
CPR:6	The involvement of the various GENENOTIN subtypes in the motor effects of GENENOTIN and GENENOTIN antagonists was evaluated pharmacologically, using  bbbbb1 GENEIN eeeee1 /GENEIN ( bbbbb2 CHEMICALIN eeeee2 ), GENEIN/GENEIN (CHEMICALIN, CHEMICALIN) and GENEIN (CHEMICALIN) receptor antagonists, and by using GENENOTIN knockout mice
CPR:6	The involvement of the various GENENOTIN subtypes in the motor effects of GENENOTIN and GENENOTIN antagonists was evaluated pharmacologically, using GENEIN/ bbbbb1 GENEIN eeeee1  ( bbbbb2 CHEMICALIN eeeee2 ), GENEIN/GENEIN (CHEMICALIN, CHEMICALIN) and GENEIN (CHEMICALIN) receptor antagonists, and by using GENENOTIN knockout mice
CPR:6	The involvement of the various GENENOTIN subtypes in the motor effects of GENENOTIN and GENENOTIN antagonists was evaluated pharmacologically, using GENEIN/GENEIN (CHEMICALIN),  bbbbb1 GENEIN eeeee1 /GENEIN ( bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN) and GENEIN (CHEMICALIN) receptor antagonists, and by using GENENOTIN knockout mice
CPR:6	The involvement of the various GENENOTIN subtypes in the motor effects of GENENOTIN and GENENOTIN antagonists was evaluated pharmacologically, using GENEIN/GENEIN (CHEMICALIN), GENEIN/ bbbbb1 GENEIN eeeee1  ( bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN) and GENEIN (CHEMICALIN) receptor antagonists, and by using GENENOTIN knockout mice
CPR:6	The involvement of the various GENENOTIN subtypes in the motor effects of GENENOTIN and GENENOTIN antagonists was evaluated pharmacologically, using GENEIN/GENEIN (CHEMICALIN),  bbbbb1 GENEIN eeeee1 /GENEIN (CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 ) and GENEIN (CHEMICALIN) receptor antagonists, and by using GENENOTIN knockout mice
CPR:6	The involvement of the various GENENOTIN subtypes in the motor effects of GENENOTIN and GENENOTIN antagonists was evaluated pharmacologically, using GENEIN/GENEIN (CHEMICALIN), GENEIN/ bbbbb1 GENEIN eeeee1  (CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 ) and GENEIN (CHEMICALIN) receptor antagonists, and by using GENENOTIN knockout mice
CPR:6	The involvement of the various GENENOTIN subtypes in the motor effects of GENENOTIN and GENENOTIN antagonists was evaluated pharmacologically, using GENEIN/GENEIN (CHEMICALIN), GENEIN/GENEIN (CHEMICALIN, CHEMICALIN) and  bbbbb1 GENEIN eeeee1  ( bbbbb2 CHEMICALIN eeeee2 ) receptor antagonists, and by using GENENOTIN knockout mice
CPR:1	These results show that CHEMICALIN promotes GENEIN- and GENEIN-dependent phosphorylation of  bbbbb1 GENEIN eeeee1  at  bbbbb2 CHEMICALIN eeeee2 240/244, in a subpopulation of striatal MSNs expressing GENEIN
CPR:2	 bbbbb1 CHEMICALIN eeeee1  promotes  bbbbb2 GENEIN eeeee2 -dependent phosphorylation of GENEIN via GENEIN and inhibition of GENEIN
CPR:2	 bbbbb1 CHEMICALIN eeeee1  promotes GENEIN-dependent phosphorylation of GENEIN via  bbbbb2 GENEIN eeeee2  and inhibition of GENEIN
CPR:2	These results show that  bbbbb1 CHEMICALIN eeeee1  promotes  bbbbb2 GENEIN eeeee2 - and GENEIN-dependent phosphorylation of GENEIN at CHEMICALIN240/244, in a subpopulation of striatal MSNs expressing GENEIN
CPR:2	These results show that  bbbbb1 CHEMICALIN eeeee1  promotes GENEIN- and  bbbbb2 GENEIN eeeee2 -dependent phosphorylation of GENEIN at CHEMICALIN240/244, in a subpopulation of striatal MSNs expressing GENEIN
CPR:2	These results show that  bbbbb1 CHEMICALIN eeeee1  promotes GENEIN- and GENEIN-dependent phosphorylation of GENEIN at CHEMICALIN240/244, in a subpopulation of striatal MSNs expressing  bbbbb2 GENEIN eeeee2 
CPR:2	Administration of  bbbbb1 CHEMICALIN eeeee1  increased CHEMICALNOTIN240/244 phosphorylation in a subpopulation of CHEMICALNOTIN-ergic medium spiny neurons (MSNs), which express  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:2	Administration of  bbbbb1 CHEMICALIN eeeee1  increased CHEMICALNOTIN240/244 phosphorylation in a subpopulation of CHEMICALNOTIN-ergic medium spiny neurons (MSNs), which express GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:3	 bbbbb1 CHEMICALIN eeeee1  promotes GENEIN-dependent phosphorylation of  bbbbb2 GENEIN eeeee2  via GENEIN and inhibition of GENEIN
CPR:3	These results show that  bbbbb1 CHEMICALIN eeeee1  promotes GENEIN- and GENEIN-dependent phosphorylation of  bbbbb2 GENEIN eeeee2  at CHEMICALIN240/244, in a subpopulation of striatal MSNs expressing GENEIN
CPR:4	This effect was prevented by  bbbbb1 CHEMICALIN eeeee1 , an inhibitor of the  bbbbb2 GENEIN eeeee2  (GENEIN), or by CHEMICALIN, a selective inhibitor of the GENEIN (GENEIN)
CPR:4	This effect was prevented by  bbbbb1 CHEMICALIN eeeee1 , an inhibitor of the GENEIN ( bbbbb2 GENEIN eeeee2 ), or by CHEMICALIN, a selective inhibitor of the GENEIN (GENEIN)
CPR:4	This effect was prevented by CHEMICALIN, an inhibitor of the GENEIN (GENEIN), or by  bbbbb1 CHEMICALIN eeeee1 , a selective inhibitor of the  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:4	This effect was prevented by CHEMICALIN, an inhibitor of the GENEIN (GENEIN), or by  bbbbb1 CHEMICALIN eeeee1 , a selective inhibitor of the GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:4	In line with this observation, incubation of striatal slices with  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, two inhibitors of  bbbbb2 GENEIN eeeee2 , increased CHEMICALNOTIN240/244 phosphorylation
CPR:4	 bbbbb1 CHEMICALIN eeeee1  promotes GENEIN-dependent phosphorylation of GENEIN via GENEIN and inhibition of  bbbbb2 GENEIN eeeee2 
CPR:4	In line with this observation, incubation of striatal slices with CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , two inhibitors of  bbbbb2 GENEIN eeeee2 , increased CHEMICALNOTIN240/244 phosphorylation
CPR:1	These compounds resulted from our efforts to merge the pharmacophores of selective GENEIN inhibitor CHEMICALIN with a mimic of the  bbbbb1 CHEMICALIN eeeee1  (GENENOTIN) sequence of  bbbbb2 GENEIN eeeee2  to obtain designed multiple ligands with potential antithrombotic activity
CPR:4	These compounds resulted from our efforts to merge the pharmacophores of selective  bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2  with a mimic of the CHEMICALIN (GENENOTIN) sequence of GENEIN to obtain designed multiple ligands with potential antithrombotic activity
CPR:4	Resulting from this study, a structurally novel class of submicromolar fibrinogen  bbbbb1 GENEIN eeeee1  binding inhibitor bearing  bbbbb2 CHEMICALIN eeeee2  moiety is also described.
CPR:3	The  bbbbb1 GENEIN eeeee1  immunopositivity was increased in degenerating neurons of the  bbbbb2 CHEMICALIN eeeee2  group
CPR:4	Rats intoxicated with  bbbbb1 CHEMICALIN eeeee1  for 30 days, significantly increased tissue CHEMICALNOTIN (CHEMICALNOTIN) levels and significantly decreased enzymatic antioxidants  bbbbb2 GENEIN eeeee2 , GENEIN and GENEIN in the frontal cortex tissue
CPR:4	Rats intoxicated with  bbbbb1 CHEMICALIN eeeee1  for 30 days, significantly increased tissue CHEMICALNOTIN (CHEMICALNOTIN) levels and significantly decreased enzymatic antioxidants GENEIN,  bbbbb2 GENEIN eeeee2  and GENEIN in the frontal cortex tissue
CPR:4	Rats intoxicated with  bbbbb1 CHEMICALIN eeeee1  for 30 days, significantly increased tissue CHEMICALNOTIN (CHEMICALNOTIN) levels and significantly decreased enzymatic antioxidants GENEIN, GENEIN and  bbbbb2 GENEIN eeeee2  in the frontal cortex tissue
CPR:4	In contrast, TSH-induced differentiation of progenitor cells, in particular the expression of the  bbbbb1 GENEIN eeeee1 , was significantly inhibited by  bbbbb2 CHEMICALIN eeeee2 .In conclusion, CHEMICALNOTIN stimulated growth and simultaneously inhibited differentiation of thyroid nodules derived stem/progenitor cells
CPR:2	The editing of  bbbbb1 GENEIN eeeee1  is also completely lost in albino mutants and  bbbbb2 CHEMICALIN eeeee2 -treated seedlings
CPR:2	In addition, the expression of nucleus-encoded  bbbbb1 GENEIN eeeee1  dependent transcripts is specifically induced by  bbbbb2 CHEMICALIN eeeee2 , and the splicing of GENEIN transcripts is significantly reduced in the albino mutants and inhibitor-treated seedlings
CPR:2	In addition, the expression of nucleus-encoded GENEIN dependent transcripts is specifically induced by  bbbbb1 CHEMICALIN eeeee1 , and the splicing of  bbbbb2 GENEIN eeeee2  transcripts is significantly reduced in the albino mutants and inhibitor-treated seedlings
CPR:2	By contrast, the editing of some sites is completely lost or significantly reduced in other non-green tissues; for instance, the editing of  bbbbb1 GENEIN eeeee1 , GENEIN, and GENEIN is completely lost in roots and in  bbbbb2 CHEMICALIN eeeee2 -treated seedlings
CPR:2	By contrast, the editing of some sites is completely lost or significantly reduced in other non-green tissues; for instance, the editing of GENEIN,  bbbbb1 GENEIN eeeee1 , and GENEIN is completely lost in roots and in  bbbbb2 CHEMICALIN eeeee2 -treated seedlings
CPR:2	By contrast, the editing of some sites is completely lost or significantly reduced in other non-green tissues; for instance, the editing of GENEIN, GENEIN, and  bbbbb1 GENEIN eeeee1  is completely lost in roots and in  bbbbb2 CHEMICALIN eeeee2 -treated seedlings
CPR:4	CHEMICALIN and CHEMICALIN metabolized through GENEIN have the highest potency for drug-drug interaction with potent  bbbbb1 GENEIN eeeee1  inhibitors such as CHEMICALIN- or CHEMICALIN-boosted HIV-PI or the hepatitis C virus (HCV) PI, CHEMICALIN or  bbbbb2 CHEMICALIN eeeee2 , and therefore their coadministration is contraindicated
CPR:4	All HIV PIs except CHEMICALNOTIN are coadministered with a low dose of  bbbbb1 CHEMICALIN eeeee1 , a potent  bbbbb2 GENEIN eeeee2  inhibitor to improve their pharmacokinetic properties
CPR:4	The HCV-PIs  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN are both, to different extents, inhibitors of  bbbbb2 GENEIN eeeee2 
CPR:4	The HCV-PIs CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  are both, to different extents, inhibitors of  bbbbb2 GENEIN eeeee2 
CPR:4	CHEMICALIN and CHEMICALIN metabolized through GENEIN have the highest potency for drug-drug interaction with potent  bbbbb1 GENEIN eeeee1  inhibitors such as  bbbbb2 CHEMICALIN eeeee2 - or CHEMICALIN-boosted HIV-PI or the hepatitis C virus (HCV) PI, CHEMICALIN or CHEMICALIN, and therefore their coadministration is contraindicated
CPR:4	CHEMICALIN and CHEMICALIN metabolized through GENEIN have the highest potency for drug-drug interaction with potent  bbbbb1 GENEIN eeeee1  inhibitors such as CHEMICALIN- or  bbbbb2 CHEMICALIN eeeee2 -boosted HIV-PI or the hepatitis C virus (HCV) PI, CHEMICALIN or CHEMICALIN, and therefore their coadministration is contraindicated
CPR:4	CHEMICALIN and CHEMICALIN metabolized through GENEIN have the highest potency for drug-drug interaction with potent  bbbbb1 GENEIN eeeee1  inhibitors such as CHEMICALIN- or CHEMICALIN-boosted HIV-PI or the hepatitis C virus (HCV) PI,  bbbbb2 CHEMICALIN eeeee2  or CHEMICALIN, and therefore their coadministration is contraindicated
CPR:9	 bbbbb1 CHEMICALIN eeeee1  is also a  bbbbb2 GENEIN eeeee2  substrate, but less potent drug-drug interactions have been reported with GENENOTIN inhibitors
CPR:9	Drug-drug interactions are dependent on statins' pharmacokinetic profile:  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and CHEMICALIN are metabolized through  bbbbb2 GENEIN eeeee2 , while the metabolism of the other statins is independent of this GENENOTIN
CPR:9	Drug-drug interactions are dependent on statins' pharmacokinetic profile: CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN are metabolized through  bbbbb2 GENEIN eeeee2 , while the metabolism of the other statins is independent of this GENENOTIN
CPR:9	Drug-drug interactions are dependent on statins' pharmacokinetic profile: CHEMICALIN, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  are metabolized through  bbbbb2 GENEIN eeeee2 , while the metabolism of the other statins is independent of this GENENOTIN
CPR:9	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN metabolized through  bbbbb2 GENEIN eeeee2  have the highest potency for drug-drug interaction with potent GENEIN inhibitors such as CHEMICALIN- or CHEMICALIN-boosted HIV-PI or the hepatitis C virus (HCV) PI, CHEMICALIN or CHEMICALIN, and therefore their coadministration is contraindicated
CPR:9	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  metabolized through  bbbbb2 GENEIN eeeee2  have the highest potency for drug-drug interaction with potent GENEIN inhibitors such as CHEMICALIN- or CHEMICALIN-boosted HIV-PI or the hepatitis C virus (HCV) PI, CHEMICALIN or CHEMICALIN, and therefore their coadministration is contraindicated
CPR:4	The synthesis, preclinical profile, and in vivo efficacy in rat xenograft models of the novel and selective  bbbbb1 GENEIN eeeee1  inhibitor 15b ( bbbbb2 CHEMICALIN eeeee2 ) are described
CPR:4	In this initial report, preliminary structure-activity relationships (SARs) are described as well as the rational design strategy employed to overcome the development deficiencies of the first generation  bbbbb1 GENEIN eeeee1  inhibitor 4 ( bbbbb2 CHEMICALIN eeeee2 )
CPR:10	Limitation of SRF was produced by the anticonvulsant CHEMICALNOTIN (CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN and CHEMICALNOTIN) at low to mid nanomolar concentrations, by a convulsant  bbbbb1 CHEMICALIN eeeee1  which does not bind to high affinity  bbbbb2 GENEIN eeeee2  (CHEMICALIN) at high nanomolar concentrations and by a GENEIN weak partial agonist (CHEMICALIN) at micromolar concentrations
CPR:10	Limitation of SRF was produced by the anticonvulsant CHEMICALNOTIN (CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN and CHEMICALNOTIN) at low to mid nanomolar concentrations, by a convulsant CHEMICALIN which does not bind to high affinity  bbbbb1 GENEIN eeeee1  ( bbbbb2 CHEMICALIN eeeee2 ) at high nanomolar concentrations and by a GENEIN weak partial agonist (CHEMICALIN) at micromolar concentrations
CPR:10	These findings suggest that limitation of SRF was produced by binding of CHEMICALIN, but not  bbbbb1 CHEMICALIN eeeee1 , to  bbbbb2 GENEIN eeeee2  and not to high affinity central GENEIN, and that CHEMICALIN limit SRF by slowing recovery of GENEIN from inactivation
CPR:10	These findings suggest that limitation of SRF was produced by binding of CHEMICALIN, but not  bbbbb1 CHEMICALIN eeeee1 , to GENEIN and not to high affinity central  bbbbb2 GENEIN eeeee2 , and that CHEMICALIN limit SRF by slowing recovery of GENEIN from inactivation
CPR:2	These findings suggest that limitation of SRF was produced by binding of  bbbbb1 CHEMICALIN eeeee1 , but not CHEMICALIN, to  bbbbb2 GENEIN eeeee2  and not to high affinity central GENEIN, and that CHEMICALIN limit SRF by slowing recovery of GENEIN from inactivation
CPR:2	These findings suggest that limitation of SRF was produced by binding of  bbbbb1 CHEMICALIN eeeee1 , but not CHEMICALIN, to GENEIN and not to high affinity central  bbbbb2 GENEIN eeeee2 , and that CHEMICALIN limit SRF by slowing recovery of GENEIN from inactivation
CPR:2	The limitation of SRF by  bbbbb1 CHEMICALIN eeeee1  was not prevented by inverse or partial agonists at the  bbbbb2 GENEIN eeeee2 , including CHEMICALIN and the CHEMICALIN
CPR:3	These findings suggest that limitation of SRF was produced by binding of CHEMICALIN, but not CHEMICALIN, to GENEIN and not to high affinity central GENEIN, and that  bbbbb1 CHEMICALIN eeeee1  limit SRF by slowing recovery of  bbbbb2 GENEIN eeeee2  from inactivation
CPR:5	Limitation of SRF was produced by the anticonvulsant CHEMICALNOTIN (CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN and CHEMICALNOTIN) at low to mid nanomolar concentrations, by a convulsant CHEMICALIN which does not bind to high affinity GENEIN (CHEMICALIN) at high nanomolar concentrations and by a  bbbbb1 GENEIN eeeee1  weak partial agonist ( bbbbb2 CHEMICALIN eeeee2 ) at micromolar concentrations
CPR:5	The limitation of SRF by CHEMICALIN was not prevented by inverse or partial agonists at the  bbbbb1 GENEIN eeeee1 , including  bbbbb2 CHEMICALIN eeeee2  and the CHEMICALIN
CPR:5	The limitation of SRF by CHEMICALIN was not prevented by inverse or partial agonists at the  bbbbb1 GENEIN eeeee1 , including CHEMICALIN and the  bbbbb2 CHEMICALIN eeeee2 
CPR:5	The limitation of SRF by CHEMICALIN was not prevented by inverse or partial agonists at the  bbbbb1 GENEIN eeeee1 , including  bbbbb2 CHEMICALIN eeeee2  and the CHEMICALIN
CPR:5	The limitation of SRF by CHEMICALIN was not prevented by inverse or partial agonists at the  bbbbb1 GENEIN eeeee1 , including CHEMICALIN and the  bbbbb2 CHEMICALIN eeeee2 
CPR:2	The mitogenic effect of  bbbbb1 CHEMICALIN eeeee1  on bone cells was inhibited by antiandrogens (CHEMICALIN and CHEMICALIN) which compete for binding to the  bbbbb2 GENEIN eeeee2 
CPR:2	The mitogenic effect of CHEMICALIN on bone cells was inhibited by antiandrogens ( bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN) which compete for binding to the  bbbbb2 GENEIN eeeee2 
CPR:2	The mitogenic effect of CHEMICALIN on bone cells was inhibited by antiandrogens (CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 ) which compete for binding to the  bbbbb2 GENEIN eeeee2 
CPR:2	We conclude that  bbbbb1 CHEMICALIN eeeee1  can stimulate human and murine osteoblastic cell proliferation in vitro, and induce expression of the GENEIN GENEIN, presumably by an  bbbbb2 GENEIN eeeee2  mediated mechanism.
CPR:3	In addition to effects on cell proliferation,  bbbbb1 CHEMICALIN eeeee1  increased the percentage of  bbbbb2 GENEIN eeeee2  (GENEIN) positive cells in all three bone cell systems tested, and this effect was inhibited by antiandrogens
CPR:3	In addition to effects on cell proliferation,  bbbbb1 CHEMICALIN eeeee1  increased the percentage of GENEIN ( bbbbb2 GENEIN eeeee2 ) positive cells in all three bone cell systems tested, and this effect was inhibited by antiandrogens
CPR:3	We conclude that  bbbbb1 CHEMICALIN eeeee1  can stimulate human and murine osteoblastic cell proliferation in vitro, and induce expression of the  bbbbb2 GENEIN eeeee2  GENEIN, presumably by an GENEIN mediated mechanism.
CPR:3	We conclude that  bbbbb1 CHEMICALIN eeeee1  can stimulate human and murine osteoblastic cell proliferation in vitro, and induce expression of the GENEIN  bbbbb2 GENEIN eeeee2 , presumably by an GENEIN mediated mechanism.
CPR:6	The effect of  bbbbb1 GENEIN eeeee1  antagonism with  bbbbb2 CHEMICALIN eeeee2  on concentration-related CHEMICALNOTIN-induced bronchoconstriction in asthma
CPR:2	Given its efficacy and tolerability, once-daily, oral  bbbbb1 CHEMICALIN eeeee1  is an emerging treatment option for patients with relapsed/refractory MCL or CLL and CLL patients with del 17p or  bbbbb2 GENEIN eeeee2  mutation.
CPR:2	Oral  bbbbb1 CHEMICALIN eeeee1  is indicated for the treatment of patients with relapsed/refractory mantle cell lymphoma (MCL) or chronic lymphocytic leukaemia (CLL) and for the treatment of patients with CLL and a chromosome 17 deletion (del 17p) or  bbbbb2 GENEIN eeeee2  mutation
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) is a first-in-class, potent, orally administered, covalent inhibitor of GENEIN (GENEIN) that inhibits  bbbbb2 GENEIN eeeee2  signalling downstream of GENEIN
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) is a first-in-class, potent, orally administered, covalent inhibitor of GENEIN (GENEIN) that inhibits  bbbbb2 GENEIN eeeee2  signalling downstream of GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) is a first-in-class, potent, orally administered, covalent inhibitor of GENEIN ( bbbbb2 GENEIN eeeee2 ) that inhibits GENEIN signalling downstream of GENEIN
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) is a first-in-class, potent, orally administered, covalent inhibitor of GENEIN (GENEIN) that inhibits GENEIN signalling downstream of  bbbbb2 GENEIN eeeee2 
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) is a first-in-class, potent, orally administered, covalent inhibitor of  bbbbb2 GENEIN eeeee2  (GENEIN) that inhibits GENEIN signalling downstream of GENEIN
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) is a first-in-class, potent, orally administered, covalent inhibitor of GENEIN ( bbbbb2 GENEIN eeeee2 ) that inhibits GENEIN signalling downstream of GENEIN
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) is a first-in-class, potent, orally administered, covalent inhibitor of  bbbbb2 GENEIN eeeee2  (GENEIN) that inhibits GENEIN signalling downstream of GENEIN
CPR:10	 bbbbb1 CHEMICALIN eeeee1  treatment (4 X 100 mg/day) led to a rapid fall in PRA, but did not significantly affect  bbbbb2 GENEIN eeeee2  density
CPR:2	The affinity of  bbbbb1 CHEMICALIN eeeee1  to  bbbbb2 GENEIN eeeee2  was not changed during or after treatment
CPR:3	 bbbbb1 CHEMICALIN eeeee1  treatment (4 X 40 mg/day) increased the density of  bbbbb2 GENEIN eeeee2  by 25% after 2 days; concomitantly PRA and heart rate were reduced
CPR:4	 bbbbb1 CHEMICALIN eeeee1  treatment (2 X 5 mg/day) caused a 30% decrease of  bbbbb2 GENEIN eeeee2  density and PRA after 2 days; both parameters remained reduced during treatment
CPR:6	To study the mechanism underlying this phenomenon, the effects of the nonselective  bbbbb1 GENEIN eeeee1  antagonists  bbbbb2 CHEMICALIN eeeee2  [no intrinsic sympathomimetic activity (ISA)], CHEMICALIN (weak ISA) and CHEMICALIN (strong ISA) on lymphocyte GENENOTIN density--assessed by CHEMICALNOTIN (CHEMICALNOTIN) binding--and plasma GENENOTIN activity (PRA) were investigated in male healthy volunteers aged 23-35 years
CPR:6	To study the mechanism underlying this phenomenon, the effects of the nonselective  bbbbb1 GENEIN eeeee1  antagonists CHEMICALIN [no intrinsic sympathomimetic activity (ISA)],  bbbbb2 CHEMICALIN eeeee2  (weak ISA) and CHEMICALIN (strong ISA) on lymphocyte GENENOTIN density--assessed by CHEMICALNOTIN (CHEMICALNOTIN) binding--and plasma GENENOTIN activity (PRA) were investigated in male healthy volunteers aged 23-35 years
CPR:6	To study the mechanism underlying this phenomenon, the effects of the nonselective  bbbbb1 GENEIN eeeee1  antagonists CHEMICALIN [no intrinsic sympathomimetic activity (ISA)], CHEMICALIN (weak ISA) and  bbbbb2 CHEMICALIN eeeee2  (strong ISA) on lymphocyte GENENOTIN density--assessed by CHEMICALNOTIN (CHEMICALNOTIN) binding--and plasma GENENOTIN activity (PRA) were investigated in male healthy volunteers aged 23-35 years
CPR:4	Inhibition of  bbbbb1 GENEIN eeeee1  pathway of CHEMICALIN metabolism in human neutrophils by CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Inhibition of  bbbbb1 GENEIN eeeee1  pathway of CHEMICALIN metabolism in human neutrophils by  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:4	Interference with  bbbbb1 GENEIN eeeee1  enzymes, rather than a  bbbbb2 CHEMICALIN eeeee2 -like inhibition of CHEMICALIN release from intracellular phospholipids, seems to be the mode of action.
CPR:9	Inhibition of  bbbbb1 GENEIN eeeee1  pathway of  bbbbb2 CHEMICALIN eeeee2  metabolism in human neutrophils by CHEMICALIN and CHEMICALIN
CPR:9	Interference with  bbbbb1 GENEIN eeeee1  enzymes, rather than a CHEMICALIN-like inhibition of  bbbbb2 CHEMICALIN eeeee2  release from intracellular phospholipids, seems to be the mode of action.
CPR:2	Evidence has been obtained in man for interaction with  bbbbb1 GENEIN eeeee1  in the brain; and in the peripheral circulation  bbbbb2 CHEMICALIN eeeee2  does not, as do other beta blockers, increase peripheral vascular resistance, but reduces it
CPR:5	It is suggested that all the additional actions of  bbbbb1 CHEMICALIN eeeee1  can be attributed to a partial agonist action on  bbbbb2 GENEIN eeeee2 .
CPR:6	UNLABELLED:  bbbbb1 CHEMICALIN eeeee1  is a  bbbbb2 GENEIN eeeee2  antagonist that has been shown to be as effective as other beta blockers for the treatment of angina pectoris and hypertension
CPR:6	 bbbbb1 CHEMICALIN eeeee1 : a  bbbbb2 GENEIN eeeee2  antagonist with unique additional actions
CPR:2	 bbbbb1 GENEIN eeeee1  binding of  bbbbb2 CHEMICALIN eeeee2  in vivo: increased receptor number with low-dose CHEMICALIN
CPR:2	The apparent affinity of  bbbbb1 GENEIN eeeee1  for  bbbbb2 CHEMICALIN eeeee2  in mice receiving CHEMICALIN (0.05 mg/kg) was unchanged from that in untreated control mice, an observation suggesting that low doses of CHEMICALIN increased receptor number.(ABSTRACT TRUNCATED AT 250 WORDS)
CPR:2	 bbbbb1 GENEIN eeeee1  binding of CHEMICALIN in vivo: increased receptor number with low-dose  bbbbb2 CHEMICALIN eeeee2 
CPR:2	The apparent affinity of  bbbbb1 GENEIN eeeee1  for CHEMICALIN in mice receiving  bbbbb2 CHEMICALIN eeeee2  (0.05 mg/kg) was unchanged from that in untreated control mice, an observation suggesting that low doses of CHEMICALIN increased receptor number.(ABSTRACT TRUNCATED AT 250 WORDS)
CPR:3	The apparent affinity of  bbbbb1 GENEIN eeeee1  for CHEMICALIN in mice receiving CHEMICALIN (0.05 mg/kg) was unchanged from that in untreated control mice, an observation suggesting that low doses of  bbbbb2 CHEMICALIN eeeee2  increased receptor number.(ABSTRACT TRUNCATED AT 250 WORDS)
CPR:2	In vitro binding affinities of CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN and some of their metabolites for  bbbbb2 GENEIN eeeee2 , GENENOTIN in rat brain were previously reported from our laboratories
CPR:2	CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , and their metabolites had 5-30 times higher binding affinities for  bbbbb2 GENEIN eeeee2  than CHEMICALIN, CHEMICALIN and their metabolites
CPR:2	CHEMICALIN, CHEMICALIN, and their metabolites had 5-30 times higher binding affinities for  bbbbb1 GENEIN eeeee1  than  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN and their metabolites
CPR:2	In vitro binding affinities of CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and some of their metabolites for  bbbbb2 GENEIN eeeee2 , GENENOTIN in rat brain were previously reported from our laboratories
CPR:2	CHEMICALIN, CHEMICALIN, and their metabolites had 5-30 times higher binding affinities for  bbbbb1 GENEIN eeeee1  than CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2  and their metabolites
CPR:2	 bbbbb1 CHEMICALIN eeeee1  was the most potent and CHEMICALIN the least potent of the four drugs in  bbbbb2 GENEIN eeeee2  binding
CPR:2	CHEMICALIN was the most potent and  bbbbb1 CHEMICALIN eeeee1  the least potent of the four drugs in  bbbbb2 GENEIN eeeee2  binding
CPR:2	 bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and CHEMICALIN had only 10% of the potency of the parent drug in  bbbbb2 GENEIN eeeee2  binding, while the CHEMICALIN-metabolites of CHEMICALIN and CHEMICALIN had about 75% of the potency of the parent drug in this binding system
CPR:2	In vitro binding affinities of CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and some of their metabolites for  bbbbb2 GENEIN eeeee2 , GENENOTIN in rat brain were previously reported from our laboratories
CPR:2	CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN had only 10% of the potency of the parent drug in  bbbbb2 GENEIN eeeee2  binding, while the CHEMICALIN-metabolites of CHEMICALIN and CHEMICALIN had about 75% of the potency of the parent drug in this binding system
CPR:2	CHEMICALIN, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  had only 10% of the potency of the parent drug in  bbbbb2 GENEIN eeeee2  binding, while the CHEMICALIN-metabolites of CHEMICALIN and CHEMICALIN had about 75% of the potency of the parent drug in this binding system
CPR:2	CHEMICALIN, CHEMICALIN and CHEMICALIN had only 10% of the potency of the parent drug in  bbbbb1 GENEIN eeeee1  binding, while the  bbbbb2 CHEMICALIN eeeee2 -metabolites of CHEMICALIN and CHEMICALIN had about 75% of the potency of the parent drug in this binding system
CPR:2	CHEMICALIN, CHEMICALIN and CHEMICALIN had only 10% of the potency of the parent drug in  bbbbb1 GENEIN eeeee1  binding, while the CHEMICALIN-metabolites of  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN had about 75% of the potency of the parent drug in this binding system
CPR:2	CHEMICALIN, CHEMICALIN and CHEMICALIN had only 10% of the potency of the parent drug in  bbbbb1 GENEIN eeeee1  binding, while the CHEMICALIN-metabolites of CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  had about 75% of the potency of the parent drug in this binding system
CPR:2	Muscarinic cholinergic and  bbbbb1 GENEIN eeeee1  binding of  bbbbb2 CHEMICALIN eeeee2  drug metabolites
CPR:2	Their  bbbbb1 GENEIN eeeee1  binding affinities indicate that metabolites may contribute to the sedative effects of  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN.
CPR:2	Their  bbbbb1 GENEIN eeeee1  binding affinities indicate that metabolites may contribute to the sedative effects of CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 .
CPR:2	In vitro binding affinities of  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN and some of their metabolites for  bbbbb2 GENEIN eeeee2 , GENENOTIN in rat brain were previously reported from our laboratories
CPR:2	The present study reports the in vitro binding affinities of the same compounds for  bbbbb1 GENEIN eeeee1  and for GENEIN in rat brain, using  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN as radioligands
CPR:2	The present study reports the in vitro binding affinities of the same compounds for GENEIN and for  bbbbb1 GENEIN eeeee1  in rat brain, using  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN as radioligands
CPR:2	The present study reports the in vitro binding affinities of the same compounds for  bbbbb1 GENEIN eeeee1  and for GENEIN in rat brain, using CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  as radioligands
CPR:2	The present study reports the in vitro binding affinities of the same compounds for GENEIN and for  bbbbb1 GENEIN eeeee1  in rat brain, using CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  as radioligands
CPR:2	 bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, and their metabolites had 5-30 times higher binding affinities for  bbbbb2 GENEIN eeeee2  than CHEMICALIN, CHEMICALIN and their metabolites
CPR:10	In contrast, serum  bbbbb1 GENEIN eeeee1  was elevated in animals dosed with CHEMICALIN or CHEMICALIN but not in those dose with  bbbbb2 CHEMICALIN eeeee2 
CPR:10	The  bbbbb1 CHEMICALIN eeeee1  had no effect on  bbbbb2 GENEIN eeeee2  times of animals fed the supplemented diet
CPR:10	 bbbbb1 CHEMICALIN eeeee1 -dosed animals showed no change in  bbbbb2 GENEIN eeeee2  times
CPR:2	CHEMICALIN and CHEMICALIN, but not CHEMICALIN, caused a dose-dependent reduction in plasma  bbbbb1 GENEIN eeeee1 , an effect that correlated with  bbbbb2 CHEMICALIN eeeee2 -induced bone effects
CPR:2	Hence, plasma  bbbbb1 GENEIN eeeee1  is a better predictor of  bbbbb2 CHEMICALIN eeeee2 -induced bone effects than serum GENEIN.
CPR:2	Hence, plasma GENEIN is a better predictor of  bbbbb1 CHEMICALIN eeeee1 -induced bone effects than serum  bbbbb2 GENEIN eeeee2 .
CPR:2	For all  bbbbb1 CHEMICALIN eeeee1 -dosed groups maintained on the purified diet, changes in  bbbbb2 GENEIN eeeee2  times occured as early as 1 week
CPR:3	In contrast, serum  bbbbb1 GENEIN eeeee1  was elevated in animals dosed with  bbbbb2 CHEMICALIN eeeee2  or CHEMICALIN but not in those dose with CHEMICALIN
CPR:3	In contrast, serum  bbbbb1 GENEIN eeeee1  was elevated in animals dosed with CHEMICALIN or  bbbbb2 CHEMICALIN eeeee2  but not in those dose with CHEMICALIN
CPR:3	When CHEMICALNOTIN was omitted from the diet, however,  bbbbb1 CHEMICALIN eeeee1 -dosed animals had elevated  bbbbb2 GENEIN eeeee2  times
CPR:3	In the high-dose  bbbbb1 CHEMICALIN eeeee1  group, there was a twofold increase in  bbbbb2 GENEIN eeeee2  times but only after prolonged dosing
CPR:3	The order of effect was  bbbbb1 CHEMICALIN eeeee1  greater than CHEMICALIN greater than CHEMICALIN, with increases in  bbbbb2 GENEIN eeeee2  times correlating with increases in hemorrhagic deaths
CPR:3	The order of effect was CHEMICALIN greater than  bbbbb1 CHEMICALIN eeeee1  greater than CHEMICALIN, with increases in  bbbbb2 GENEIN eeeee2  times correlating with increases in hemorrhagic deaths
CPR:3	The order of effect was CHEMICALIN greater than CHEMICALIN greater than  bbbbb1 CHEMICALIN eeeee1 , with increases in  bbbbb2 GENEIN eeeee2  times correlating with increases in hemorrhagic deaths
CPR:4	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, but not CHEMICALIN, caused a dose-dependent reduction in plasma  bbbbb2 GENEIN eeeee2 , an effect that correlated with CHEMICALIN-induced bone effects
CPR:4	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , but not CHEMICALIN, caused a dose-dependent reduction in plasma  bbbbb2 GENEIN eeeee2 , an effect that correlated with CHEMICALIN-induced bone effects
CPR:4	CHEMICALIN and CHEMICALIN, but not  bbbbb1 CHEMICALIN eeeee1 , caused a dose-dependent reduction in plasma  bbbbb2 GENEIN eeeee2 , an effect that correlated with CHEMICALIN-induced bone effects
CPR:2	Multiple affinity states of  bbbbb1 GENEIN eeeee1  can be demonstrated further by Scatchard analysis of saturation binding studies with  bbbbb2 CHEMICALIN eeeee2 
CPR:2	These multiple affinity states of receptor in the hybrid cells are agonist-specific, and the percentage of total  bbbbb1 GENEIN eeeee1  in high affinity state is relatively constant in various concentrations of  bbbbb2 CHEMICALIN eeeee2 
CPR:4	However, in the presence of 100 mM  bbbbb1 CHEMICALIN eeeee1 , which is required for opiate inhibition of  bbbbb2 GENEIN eeeee2  activity, analysis of competition binding data revealed three sites: the first, consisting of 17.5% of total receptor population has a Kd = 0.38 +/- 0.18 nM; the second, 50.6% of the population, has a Kd = 6.8 +/- 2.2 nM; and the third, 31.9% of the population, has a Kd of 410 +/- 110 nM
CPR:10	In contrast to CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN; CHEMICALIN), which inhibits the formation of CHEMICALIN in RBL cells at the GENEIN step (EC50 5 microM), did not inhibit the  bbbbb2 GENEIN eeeee2  of these cells
CPR:10	In contrast to CHEMICALIN, CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ; CHEMICALIN), which inhibits the formation of CHEMICALIN in RBL cells at the GENEIN step (EC50 5 microM), did not inhibit the  bbbbb2 GENEIN eeeee2  of these cells
CPR:10	In contrast to CHEMICALIN, CHEMICALIN (CHEMICALIN;  bbbbb1 CHEMICALIN eeeee1 ), which inhibits the formation of CHEMICALIN in RBL cells at the GENEIN step (EC50 5 microM), did not inhibit the  bbbbb2 GENEIN eeeee2  of these cells
CPR:2	Kinetic analysis revealed that the inhibition of the  bbbbb1 GENEIN eeeee1  reaction by CHEMICALIN was competitive with respect to  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Kinetic analysis revealed that the inhibition of the  bbbbb1 GENEIN eeeee1  reaction by  bbbbb2 CHEMICALIN eeeee2  was competitive with respect to CHEMICALIN
CPR:4	In contrast to  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN (CHEMICALIN; CHEMICALIN), which inhibits the formation of CHEMICALIN in RBL cells at the  bbbbb2 GENEIN eeeee2  step (EC50 5 microM), did not inhibit the GENEIN of these cells
CPR:4	In contrast to  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN (CHEMICALIN; CHEMICALIN), which inhibits the formation of CHEMICALIN in RBL cells at the GENEIN step (EC50 5 microM), did not inhibit the  bbbbb2 GENEIN eeeee2  of these cells
CPR:4	In contrast to CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN; CHEMICALIN), which inhibits the formation of CHEMICALIN in RBL cells at the  bbbbb2 GENEIN eeeee2  step (EC50 5 microM), did not inhibit the GENEIN of these cells
CPR:4	In contrast to CHEMICALIN, CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ; CHEMICALIN), which inhibits the formation of CHEMICALIN in RBL cells at the  bbbbb2 GENEIN eeeee2  step (EC50 5 microM), did not inhibit the GENEIN of these cells
CPR:4	In contrast to CHEMICALIN, CHEMICALIN (CHEMICALIN;  bbbbb1 CHEMICALIN eeeee1 ), which inhibits the formation of CHEMICALIN in RBL cells at the  bbbbb2 GENEIN eeeee2  step (EC50 5 microM), did not inhibit the GENEIN of these cells
CPR:4	Inhibition of the GENEIN of rat basophil leukemia cells by CHEMICALIN, and synergism between  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, a  bbbbb2 GENEIN eeeee2  inhibitor
CPR:4	Inhibition of the GENEIN of rat basophil leukemia cells by CHEMICALIN, and synergism between CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , a  bbbbb2 GENEIN eeeee2  inhibitor
CPR:4	Inhibition of the  bbbbb1 GENEIN eeeee1  of rat basophil leukemia cells by  bbbbb2 CHEMICALIN eeeee2 , and synergism between CHEMICALIN and CHEMICALIN, a GENEIN inhibitor
CPR:9	Similar concentrations also inhibited the formation of  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) by  bbbbb2 GENEIN eeeee2 , a detergent-solubilized cell free particulate enzyme from RBL cells which is capable of coupling CHEMICALIN to CHEMICALNOTIN
CPR:9	Similar concentrations also inhibited the formation of CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) by  bbbbb2 GENEIN eeeee2 , a detergent-solubilized cell free particulate enzyme from RBL cells which is capable of coupling CHEMICALIN to CHEMICALNOTIN
CPR:9	In contrast to CHEMICALIN, CHEMICALIN (CHEMICALIN; CHEMICALIN), which inhibits the formation of  bbbbb1 CHEMICALIN eeeee1  in RBL cells at the  bbbbb2 GENEIN eeeee2  step (EC50 5 microM), did not inhibit the GENEIN of these cells
CPR:9	These results are consistent with the interpretation that both CHEMICALNOTIN and CHEMICALNOTIN inhibit CHEMICALNOTIN formation but that they act on sequential steps in the biosynthetic pathway in such a manner as to synergistically interfere with the availability or utilization of  bbbbb1 CHEMICALIN eeeee1  in the  bbbbb2 GENEIN eeeee2  reaction.
CPR:9	Similar concentrations also inhibited the formation of CHEMICALIN (CHEMICALIN) by  bbbbb1 GENEIN eeeee1 , a detergent-solubilized cell free particulate enzyme from RBL cells which is capable of coupling  bbbbb2 CHEMICALIN eeeee2  to CHEMICALNOTIN
CPR:9	The EC50 for inhibition of the  bbbbb1 GENEIN eeeee1  of RBL cells was directly proportional to the  bbbbb2 CHEMICALIN eeeee2  concentration in the incubations, ranging from 1.5 mM at 10 microM CHEMICALNOTIN to over 40 mM at 500 microM CHEMICALNOTIN
CPR:9	The test procedure was verified with respect to intestinal  bbbbb1 CHEMICALIN eeeee1  hydrolysis by demonstrating a linear relationship between CHEMICALIN/CHEMICALIN excretion and log jejunal mucosal  bbbbb2 GENEIN eeeee2  activity by in vitro assay (R2 = 0.95) in a further group of subjects
CPR:9	The test procedure was verified with respect to intestinal CHEMICALIN hydrolysis by demonstrating a linear relationship between  bbbbb1 CHEMICALIN eeeee1 /CHEMICALIN excretion and log jejunal mucosal  bbbbb2 GENEIN eeeee2  activity by in vitro assay (R2 = 0.95) in a further group of subjects
CPR:9	The test procedure was verified with respect to intestinal CHEMICALIN hydrolysis by demonstrating a linear relationship between CHEMICALIN/ bbbbb1 CHEMICALIN eeeee1  excretion and log jejunal mucosal  bbbbb2 GENEIN eeeee2  activity by in vitro assay (R2 = 0.95) in a further group of subjects
CPR:9	Differential  bbbbb1 CHEMICALIN eeeee1 /CHEMICALIN/CHEMICALIN absorption provides a non-invasive and sensitive index of small intestinal integrity of value for the interpretation of prolonged or otherwise complicated enteritis and the distinction of primary secondary intestinal  bbbbb2 GENEIN eeeee2  deficiency.
CPR:9	Differential CHEMICALIN/ bbbbb1 CHEMICALIN eeeee1 /CHEMICALIN absorption provides a non-invasive and sensitive index of small intestinal integrity of value for the interpretation of prolonged or otherwise complicated enteritis and the distinction of primary secondary intestinal  bbbbb2 GENEIN eeeee2  deficiency.
CPR:9	Differential CHEMICALIN/CHEMICALIN/ bbbbb1 CHEMICALIN eeeee1  absorption provides a non-invasive and sensitive index of small intestinal integrity of value for the interpretation of prolonged or otherwise complicated enteritis and the distinction of primary secondary intestinal  bbbbb2 GENEIN eeeee2  deficiency.
CPR:10	The binding of CHEMICALIN to GENEIN was fairly selective in that other GENEIN agents such as  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and CHEMICALIN failed to bind to  bbbbb2 GENEIN eeeee2  when examined under the same experimental conditions
CPR:10	The binding of CHEMICALIN to GENEIN was fairly selective in that other GENEIN agents such as CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN failed to bind to  bbbbb2 GENEIN eeeee2  when examined under the same experimental conditions
CPR:10	The binding of CHEMICALIN to GENEIN was fairly selective in that other GENEIN agents such as CHEMICALIN, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  failed to bind to  bbbbb2 GENEIN eeeee2  when examined under the same experimental conditions
CPR:10	In addition,  bbbbb1 CHEMICALIN eeeee1  showed little or no CHEMICALIN-dependent binding to the  bbbbb2 GENEIN eeeee2 , GENEIN or GENEIN
CPR:10	In addition,  bbbbb1 CHEMICALIN eeeee1  showed little or no CHEMICALIN-dependent binding to the GENEIN,  bbbbb2 GENEIN eeeee2  or GENEIN
CPR:10	In addition,  bbbbb1 CHEMICALIN eeeee1  showed little or no CHEMICALIN-dependent binding to the GENEIN, GENEIN or  bbbbb2 GENEIN eeeee2 
CPR:2	The site at which  bbbbb1 CHEMICALIN eeeee1  bound to  bbbbb2 GENEIN eeeee2  appears to be similar to that at which certain antipsychotic agents bind, since several of them, including CHEMICALIN, CHEMICALIN and CHEMICALIN, prevented the binding of CHEMICALIN to GENEIN
CPR:2	To determine the factors that influence the interaction between  bbbbb1 CHEMICALIN eeeee1  and  bbbbb2 GENEIN eeeee2 , the binding of CHEMICALIN to GENEIN was determined by equilibrium dialysis under a variety of experimental conditions
CPR:2	The site at which CHEMICALIN bound to GENEIN appears to be similar to that at which certain antipsychotic agents bind, since several of them, including  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and CHEMICALIN, prevented the binding of CHEMICALIN to  bbbbb2 GENEIN eeeee2 
CPR:2	The site at which CHEMICALIN bound to GENEIN appears to be similar to that at which certain antipsychotic agents bind, since several of them, including CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, prevented the binding of CHEMICALIN to  bbbbb2 GENEIN eeeee2 
CPR:2	The site at which CHEMICALIN bound to GENEIN appears to be similar to that at which certain antipsychotic agents bind, since several of them, including CHEMICALIN, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , prevented the binding of CHEMICALIN to  bbbbb2 GENEIN eeeee2 
CPR:2	The site at which CHEMICALIN bound to GENEIN appears to be similar to that at which certain antipsychotic agents bind, since several of them, including CHEMICALIN, CHEMICALIN and CHEMICALIN, prevented the binding of  bbbbb1 CHEMICALIN eeeee1  to  bbbbb2 GENEIN eeeee2 
CPR:2	However, in contrast to the reversible binding of most  bbbbb1 CHEMICALIN eeeee1  to  bbbbb2 GENEIN eeeee2 , CHEMICALIN bound to GENEIN irreversibly
CPR:2	However, in contrast to the reversible binding of most CHEMICALIN to GENEIN,  bbbbb1 CHEMICALIN eeeee1  bound to  bbbbb2 GENEIN eeeee2  irreversibly
CPR:2	The binding of  bbbbb1 CHEMICALIN eeeee1  to  bbbbb2 GENEIN eeeee2  was fairly selective in that other GENEIN agents such as CHEMICALIN, CHEMICALIN and CHEMICALIN failed to bind to GENEIN when examined under the same experimental conditions
CPR:2	Characteristics of the binding of  bbbbb1 CHEMICALIN eeeee1  to  bbbbb2 GENEIN eeeee2 
CPR:2	To determine the factors that influence the interaction between CHEMICALIN and GENEIN, the binding of  bbbbb1 CHEMICALIN eeeee1  to  bbbbb2 GENEIN eeeee2  was determined by equilibrium dialysis under a variety of experimental conditions
CPR:2	In addition, CHEMICALIN showed little or no  bbbbb1 CHEMICALIN eeeee1 -dependent binding to the GENEIN, GENEIN or  bbbbb2 GENEIN eeeee2 
CPR:2	The irreversible complex between  bbbbb1 CHEMICALIN eeeee1  and  bbbbb2 GENEIN eeeee2  may be useful for inhibiting certain GENEIN-dependent reactions and for studying the various biological functions of GENENOTIN.
CPR:2	This interaction was found to be similar in some respects to the interaction between  bbbbb1 CHEMICALIN eeeee1  and  bbbbb2 GENEIN eeeee2 
CPR:2	The binding of CHEMICALIN to GENEIN was fairly selective in that other  bbbbb1 GENEIN eeeee1  agents such as  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN and CHEMICALIN failed to bind to GENEIN when examined under the same experimental conditions
CPR:2	The binding of CHEMICALIN to GENEIN was fairly selective in that other  bbbbb1 GENEIN eeeee1  agents such as CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN failed to bind to GENEIN when examined under the same experimental conditions
CPR:2	The binding of CHEMICALIN to GENEIN was fairly selective in that other  bbbbb1 GENEIN eeeee1  agents such as CHEMICALIN, CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  failed to bind to GENEIN when examined under the same experimental conditions
CPR:2	In addition, CHEMICALIN showed little or no  bbbbb1 CHEMICALIN eeeee1 -dependent binding to the  bbbbb2 GENEIN eeeee2 , GENEIN or GENEIN
CPR:2	In addition, CHEMICALIN showed little or no  bbbbb1 CHEMICALIN eeeee1 -dependent binding to the GENEIN,  bbbbb2 GENEIN eeeee2  or GENEIN
CPR:4	The irreversible complex between  bbbbb1 CHEMICALIN eeeee1  and GENEIN may be useful for inhibiting certain  bbbbb2 GENEIN eeeee2 -dependent reactions and for studying the various biological functions of GENENOTIN.
CPR:2	The following was demonstrated in the rat and confirmed in man: interaction of  bbbbb1 CHEMICALIN eeeee1  with the  bbbbb2 GENEIN eeeee2 , antiandrogen activity against CHEMICALNOTIN (in particular against the early transient rise induced by GENENOTIN analogs) and adrenal CHEMICALNOTIN
CPR:2	Replacement of the CHEMICALIN groups of CHEMICALIN with  bbbbb1 CHEMICALIN eeeee1  or larger CHEMICALIN groups yields CHEMICALIN with selectivity for  bbbbb2 GENEIN eeeee2 , particularly when combined with an CHEMICALIN moiety
CPR:2	Replacement of the CHEMICALIN groups of CHEMICALIN with CHEMICALIN or larger  bbbbb1 CHEMICALIN eeeee1  groups yields CHEMICALIN with selectivity for  bbbbb2 GENEIN eeeee2 , particularly when combined with an CHEMICALIN moiety
CPR:2	Replacement of the CHEMICALIN groups of CHEMICALIN with CHEMICALIN or larger CHEMICALIN groups yields  bbbbb1 CHEMICALIN eeeee1  with selectivity for  bbbbb2 GENEIN eeeee2 , particularly when combined with an CHEMICALIN moiety
CPR:2	Replacement of the CHEMICALIN groups of CHEMICALIN with CHEMICALIN or larger CHEMICALIN groups yields CHEMICALIN with selectivity for  bbbbb1 GENEIN eeeee1 , particularly when combined with an  bbbbb2 CHEMICALIN eeeee2  moiety
CPR:2	Certain analogs of  bbbbb1 CHEMICALIN eeeee1  in which the CHEMICALIN group at the 1- or 7-position is replaced with a propargyl or CHEMICALIN group display selectivity for  bbbbb2 GENEIN eeeee2 
CPR:2	Certain analogs of CHEMICALIN in which the  bbbbb1 CHEMICALIN eeeee1  group at the 1- or 7-position is replaced with a propargyl or CHEMICALIN group display selectivity for  bbbbb2 GENEIN eeeee2 
CPR:2	Certain analogs of CHEMICALIN in which the CHEMICALIN group at the 1- or 7-position is replaced with a propargyl or  bbbbb1 CHEMICALIN eeeee1  group display selectivity for  bbbbb2 GENEIN eeeee2 
CPR:2	The profile of a series of  bbbbb1 CHEMICALIN eeeee1  analogs or of CHEMICALIN antagonists can be used to define the nature of  bbbbb2 GENEIN eeeee2 .
CPR:2	The profile of a series of CHEMICALIN analogs or of  bbbbb1 CHEMICALIN eeeee1  antagonists can be used to define the nature of  bbbbb2 GENEIN eeeee2 .
CPR:2	 bbbbb1 CHEMICALIN eeeee1  analogs in particular the CHEMICALIN-substituted compounds are more potent at  bbbbb2 GENEIN eeeee2  than at GENEIN
CPR:2	 bbbbb1 CHEMICALIN eeeee1  analogs in particular the CHEMICALIN-substituted compounds are more potent at GENEIN than at  bbbbb2 GENEIN eeeee2 
CPR:2	CHEMICALIN analogs in particular the  bbbbb1 CHEMICALIN eeeee1 -substituted compounds are more potent at  bbbbb2 GENEIN eeeee2  than at GENEIN
CPR:2	CHEMICALIN analogs in particular the  bbbbb1 CHEMICALIN eeeee1 -substituted compounds are more potent at GENEIN than at  bbbbb2 GENEIN eeeee2 
CPR:2	Certain of the  bbbbb1 CHEMICALIN eeeee1  conjugates are highly selective for  bbbbb2 GENEIN eeeee2 
CPR:2	The subregion of the  bbbbb1 GENEIN eeeee1  that interacts with the  bbbbb2 CHEMICALIN eeeee2 -substituent is different for GENENOTIN, particularly with respect to CHEMICALIN interactions, bulk tolerance and stereoselectivity
CPR:2	The subregion of the  bbbbb1 GENEIN eeeee1  that interacts with the CHEMICALIN-substituent is different for GENENOTIN, particularly with respect to  bbbbb2 CHEMICALIN eeeee2  interactions, bulk tolerance and stereoselectivity
CPR:2	Replacement of the  bbbbb1 CHEMICALIN eeeee1  groups of CHEMICALIN with CHEMICALIN or larger CHEMICALIN groups yields CHEMICALIN with selectivity for  bbbbb2 GENEIN eeeee2 , particularly when combined with an CHEMICALIN moiety
CPR:2	Replacement of the CHEMICALIN groups of  bbbbb1 CHEMICALIN eeeee1  with CHEMICALIN or larger CHEMICALIN groups yields CHEMICALIN with selectivity for  bbbbb2 GENEIN eeeee2 , particularly when combined with an CHEMICALIN moiety
CPR:4	 bbbbb1 CHEMICALIN eeeee1  are classical antagonists for GENEIN for many of their pharmacological actions may be due to blockade of  bbbbb2 GENEIN eeeee2 
CPR:6	 bbbbb1 CHEMICALIN eeeee1  are classical antagonists for  bbbbb2 GENEIN eeeee2  for many of their pharmacological actions may be due to blockade of GENEIN
CPR:10	Co-incubation with GENENOTIN or CHEMICALIN but not CHEMICALIN protected  bbbbb1 GENEIN eeeee1  from  bbbbb2 CHEMICALIN eeeee2 .
CPR:10	Co-incubation with GENENOTIN or CHEMICALIN but not  bbbbb1 CHEMICALIN eeeee1  protected  bbbbb2 GENEIN eeeee2  from CHEMICALIN.
CPR:2	Co-incubation with GENENOTIN or  bbbbb1 CHEMICALIN eeeee1  but not CHEMICALIN protected  bbbbb2 GENEIN eeeee2  from CHEMICALIN.
CPR:4	Inhibition of testicular  bbbbb1 GENEIN eeeee1  from laboratory animals and man by  bbbbb2 CHEMICALIN eeeee2  and its isomers
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (0-100 mumol/l) inhibited  bbbbb2 GENEIN eeeee2  prepared from the testes of the mouse greater than rabbit greater than human greater than rat greater than hamster
CPR:4	The inhibitory effect of  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN upon testicular cytosolic  bbbbb2 GENEIN eeeee2  was measured in vitro
CPR:4	 bbbbb1 CHEMICALIN eeeee1  and its isomers were non-competitive inhibitors of  bbbbb2 GENEIN eeeee2  with respect to the coenzyme CHEMICALIN, competitive inhibitors of GENEIN and noncompetitive-competitive inhibitors of GENEIN with respect to the substrate CHEMICALIN
CPR:4	The inhibitory effect of CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  upon testicular cytosolic  bbbbb2 GENEIN eeeee2  was measured in vitro
CPR:4	CHEMICALIN and its isomers were non-competitive inhibitors of GENEIN with respect to the coenzyme  bbbbb1 CHEMICALIN eeeee1 , competitive inhibitors of  bbbbb2 GENEIN eeeee2  and noncompetitive-competitive inhibitors of GENEIN with respect to the substrate CHEMICALIN
CPR:9	CHEMICALIN and its isomers were non-competitive inhibitors of GENEIN with respect to the coenzyme CHEMICALIN, competitive inhibitors of GENEIN and noncompetitive-competitive inhibitors of  bbbbb1 GENEIN eeeee1  with respect to the substrate  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Most reducing cofactors for the peroxidase protect  bbbbb1 GENEIN eeeee1  and GENEIN from inactivation by  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Most reducing cofactors for the peroxidase protect GENEIN and  bbbbb1 GENEIN eeeee1  from inactivation by  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Chromatographic analysis of the metabolism of CHEMICALIN in this system revealed that CHEMICALIN-dependent inactivation of  bbbbb1 GENEIN eeeee1  is markedly increased in the presence of 100 microM  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Inactivation of  bbbbb1 GENEIN eeeee1  and GENEIN by  bbbbb2 CHEMICALIN eeeee2 
CPR:4	Inactivation of GENEIN and  bbbbb1 GENEIN eeeee1  by  bbbbb2 CHEMICALIN eeeee2 
CPR:8	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a nonsteroidal anti-inflammatory drug, is an efficient reducing cofactor for the peroxidase activity of  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:8	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a nonsteroidal anti-inflammatory drug, is an efficient reducing cofactor for the peroxidase activity of GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:8	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a nonsteroidal anti-inflammatory drug, is an efficient reducing cofactor for the peroxidase activity of  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:8	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a nonsteroidal anti-inflammatory drug, is an efficient reducing cofactor for the peroxidase activity of GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:8	Chromatographic analysis of the metabolism of CHEMICALIN in this system revealed that  bbbbb1 CHEMICALIN eeeee1 -dependent inactivation of  bbbbb2 GENEIN eeeee2  is markedly increased in the presence of 100 microM CHEMICALIN
CPR:9	Chromatographic analysis of the metabolism of  bbbbb1 CHEMICALIN eeeee1  in this system revealed that CHEMICALIN-dependent inactivation of  bbbbb2 GENEIN eeeee2  is markedly increased in the presence of 100 microM CHEMICALIN
CPR:2	Isolation and characterization of labeled peptides from  bbbbb1 CHEMICALIN eeeee1 -modified  bbbbb2 GENEIN eeeee2  indicated that peptides encompassing residues 38-75, 107-126, and 127-148 contained CHEMICALIN label
CPR:2	Isolation and characterization of labeled peptides from CHEMICALIN-modified  bbbbb1 GENEIN eeeee1  indicated that peptides encompassing residues 38-75, 107-126, and 127-148 contained  bbbbb2 CHEMICALIN eeeee2  label
CPR:2	Drug-protein interactions: isolation and characterization of covalent adducts of  bbbbb1 CHEMICALIN eeeee1  and  bbbbb2 GENEIN eeeee2 
CPR:2	 bbbbb1 CHEMICALIN eeeee1 , an alpha-adrenergic antagonist containing a CHEMICALIN group, labels  bbbbb2 GENEIN eeeee2  in the presence of CHEMICALNOTIN
CPR:2	Adducts of  bbbbb1 GENEIN eeeee1  and  bbbbb2 CHEMICALIN eeeee2  were separated by high-performance liquid chromatography into four major fractions: two containing 0.6 and 1.2 mol of drug per mol of protein and two different fractions each containing 2.0 mol/mol
CPR:2	Each adduct had a reduced ability to activate GENENOTIN and GENENOTIN, and the  bbbbb1 CHEMICALIN eeeee1  binding capacities of the CHEMICALIN- bbbbb2 GENEIN eeeee2  adducts were diminished to the extent of CHEMICALNOTIN incorporation into each adduct
CPR:2	CHEMICALIN, an alpha-adrenergic antagonist containing a  bbbbb1 CHEMICALIN eeeee1  group, labels  bbbbb2 GENEIN eeeee2  in the presence of CHEMICALNOTIN
CPR:2	Each adduct had a reduced ability to activate GENENOTIN and GENENOTIN, and the CHEMICALIN binding capacities of the  bbbbb1 CHEMICALIN eeeee1 - bbbbb2 GENEIN eeeee2  adducts were diminished to the extent of CHEMICALNOTIN incorporation into each adduct
CPR:2	In plasma membranes prepared from these isolated brown fat cells by  bbbbb1 CHEMICALIN eeeee1  extraction there was a similar enrichment of activity of GENEIN and of the plasma membrane marker enzyme,  bbbbb2 GENEIN eeeee2 
CPR:2	 bbbbb1 GENEIN eeeee1  activities in brown adipose tissue of the rat: identification of CHEMICALIN-sensitive ( bbbbb2 CHEMICALIN eeeee2 -resistant) activity at the fat cell membrane
CPR:2	 bbbbb1 GENEIN eeeee1  activities in brown adipose tissue of the rat: identification of  bbbbb2 CHEMICALIN eeeee2 -sensitive (CHEMICALIN-resistant) activity at the fat cell membrane
CPR:3	In plasma membranes prepared from these isolated brown fat cells by  bbbbb1 CHEMICALIN eeeee1  extraction there was a similar enrichment of activity of  bbbbb2 GENEIN eeeee2  and of the plasma membrane marker enzyme, GENEIN
CPR:4	Staining was largely absent when substrate was omitted or after pretreatment with the irreversible  bbbbb1 GENEIN eeeee1  inhibitor,  bbbbb2 CHEMICALIN eeeee2  and the slowly reversible inhibitor, CHEMICALIN
CPR:4	Staining was largely absent when substrate was omitted or after pretreatment with the irreversible  bbbbb1 GENEIN eeeee1  inhibitor, CHEMICALIN and the slowly reversible inhibitor,  bbbbb2 CHEMICALIN eeeee2 
CPR:9	Positive staining of mitochondria was achieved in the presence of the  bbbbb1 GENEIN eeeee1  substrate,  bbbbb2 CHEMICALIN eeeee2 
CPR:9	Staining around the edges of the brown fat cells was observed with the  bbbbb1 GENEIN eeeee1  substrates,  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:9	Staining around the edges of the brown fat cells was observed with the  bbbbb1 GENEIN eeeee1  substrates, CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:2	Binding of  bbbbb1 CHEMICALIN eeeee1  to GENEIN produces lysis, binding to  bbbbb2 GENEIN eeeee2  produces round cells, and binding to GENEIN produces long filaments
CPR:2	Binding of  bbbbb1 CHEMICALIN eeeee1  to GENEIN produces lysis, binding to GENEIN produces round cells, and binding to  bbbbb2 GENEIN eeeee2  produces long filaments
CPR:2	Binding of  bbbbb1 CHEMICALIN eeeee1  to  bbbbb2 GENEIN eeeee2  produces lysis, binding to GENEIN produces round cells, and binding to GENEIN produces long filaments
CPR:2	 bbbbb1 CHEMICALIN eeeee1  is a CHEMICALIN derivative that binds specifically to  bbbbb2 GENEIN eeeee2 
CPR:2	CHEMICALIN is a  bbbbb1 CHEMICALIN eeeee1  derivative that binds specifically to  bbbbb2 GENEIN eeeee2 
CPR:2	 bbbbb1 GENEIN eeeee1  and role of  bbbbb2 CHEMICALIN eeeee2  in causing bacterial cell death
CPR:2	The compound is more  bbbbb1 GENEIN eeeee1  stable than  bbbbb2 CHEMICALIN eeeee2  and has no major delay in entry into the periplasmic space as do some CHEMICALNOTIN
CPR:3	This agent acts synergistically with many  bbbbb1 CHEMICALIN eeeee1 , such as CHEMICALIN, CHEMICALIN, and the like, and with CHEMICALIN, CHEMICALIN, CHEMICALIN, or CHEMICALIN to inhibit gram-negative bacilli, probably on the basis of binding to different proteins needed for the production of the  bbbbb2 GENEIN eeeee2  of the bacterial cell wall
CPR:3	This agent acts synergistically with many CHEMICALIN, such as  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, and the like, and with CHEMICALIN, CHEMICALIN, CHEMICALIN, or CHEMICALIN to inhibit gram-negative bacilli, probably on the basis of binding to different proteins needed for the production of the  bbbbb2 GENEIN eeeee2  of the bacterial cell wall
CPR:3	This agent acts synergistically with many CHEMICALIN, such as CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , and the like, and with CHEMICALIN, CHEMICALIN, CHEMICALIN, or CHEMICALIN to inhibit gram-negative bacilli, probably on the basis of binding to different proteins needed for the production of the  bbbbb2 GENEIN eeeee2  of the bacterial cell wall
CPR:3	This agent acts synergistically with many CHEMICALIN, such as CHEMICALIN, CHEMICALIN, and the like, and with  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, or CHEMICALIN to inhibit gram-negative bacilli, probably on the basis of binding to different proteins needed for the production of the  bbbbb2 GENEIN eeeee2  of the bacterial cell wall
CPR:3	This agent acts synergistically with many CHEMICALIN, such as CHEMICALIN, CHEMICALIN, and the like, and with CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, or CHEMICALIN to inhibit gram-negative bacilli, probably on the basis of binding to different proteins needed for the production of the  bbbbb2 GENEIN eeeee2  of the bacterial cell wall
CPR:3	This agent acts synergistically with many CHEMICALIN, such as CHEMICALIN, CHEMICALIN, and the like, and with CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , or CHEMICALIN to inhibit gram-negative bacilli, probably on the basis of binding to different proteins needed for the production of the  bbbbb2 GENEIN eeeee2  of the bacterial cell wall
CPR:3	This agent acts synergistically with many CHEMICALIN, such as CHEMICALIN, CHEMICALIN, and the like, and with CHEMICALIN, CHEMICALIN, CHEMICALIN, or  bbbbb1 CHEMICALIN eeeee1  to inhibit gram-negative bacilli, probably on the basis of binding to different proteins needed for the production of the  bbbbb2 GENEIN eeeee2  of the bacterial cell wall
CPR:10	 bbbbb1 CHEMICALIN eeeee1  did not induce a loss of cell surface  bbbbb2 GENEIN eeeee2 , a membrane protein which is excluded from coated pits and which is not internalized, indicating that the effect of CHEMICALNOTIN was specific for membrane receptors and not a result of bulk depletion of plasma membrane
CPR:2	We have found that certain  bbbbb1 CHEMICALIN eeeee1  [e.g., CHEMICALIN (CHEMICALIN)] and CHEMICALIN [e.g., CHEMICALIN (CHEMICALIN)] induce a loss of cell-surface receptors for  bbbbb2 GENEIN eeeee2 , and GENEIN (GENEIN) in fibroblasts
CPR:2	We have found that certain  bbbbb1 CHEMICALIN eeeee1  [e.g., CHEMICALIN (CHEMICALIN)] and CHEMICALIN [e.g., CHEMICALIN (CHEMICALIN)] induce a loss of cell-surface receptors for GENEIN, and  bbbbb2 GENEIN eeeee2  (GENEIN) in fibroblasts
CPR:2	We have found that certain  bbbbb1 CHEMICALIN eeeee1  [e.g., CHEMICALIN (CHEMICALIN)] and CHEMICALIN [e.g., CHEMICALIN (CHEMICALIN)] induce a loss of cell-surface receptors for GENEIN, and GENEIN ( bbbbb2 GENEIN eeeee2 ) in fibroblasts
CPR:2	The extent of  bbbbb1 GENEIN eeeee1  loss is less than for GENENOTIN, and the GENENOTIN do not reappear at the surface when  bbbbb2 CHEMICALIN eeeee2  is removed
CPR:2	We have found that certain CHEMICALIN [e.g.,  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN)] and CHEMICALIN [e.g., CHEMICALIN (CHEMICALIN)] induce a loss of cell-surface receptors for  bbbbb2 GENEIN eeeee2 , and GENEIN (GENEIN) in fibroblasts
CPR:2	We have found that certain CHEMICALIN [e.g.,  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN)] and CHEMICALIN [e.g., CHEMICALIN (CHEMICALIN)] induce a loss of cell-surface receptors for GENEIN, and  bbbbb2 GENEIN eeeee2  (GENEIN) in fibroblasts
CPR:2	We have found that certain CHEMICALIN [e.g.,  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN)] and CHEMICALIN [e.g., CHEMICALIN (CHEMICALIN)] induce a loss of cell-surface receptors for GENEIN, and GENEIN ( bbbbb2 GENEIN eeeee2 ) in fibroblasts
CPR:2	Loss of GENEIN and  bbbbb1 GENEIN eeeee1  surface binding induced by CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:2	Loss of  bbbbb1 GENEIN eeeee1  and GENEIN surface binding induced by CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:2	We have found that certain CHEMICALIN [e.g., CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 )] and CHEMICALIN [e.g., CHEMICALIN (CHEMICALIN)] induce a loss of cell-surface receptors for  bbbbb2 GENEIN eeeee2 , and GENEIN (GENEIN) in fibroblasts
CPR:2	We have found that certain CHEMICALIN [e.g., CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 )] and CHEMICALIN [e.g., CHEMICALIN (CHEMICALIN)] induce a loss of cell-surface receptors for GENEIN, and  bbbbb2 GENEIN eeeee2  (GENEIN) in fibroblasts
CPR:2	We have found that certain CHEMICALIN [e.g., CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 )] and CHEMICALIN [e.g., CHEMICALIN (CHEMICALIN)] induce a loss of cell-surface receptors for GENEIN, and GENEIN ( bbbbb2 GENEIN eeeee2 ) in fibroblasts
CPR:2	Loss of GENEIN and  bbbbb1 GENEIN eeeee1  surface binding induced by  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:2	Loss of  bbbbb1 GENEIN eeeee1  and GENEIN surface binding induced by  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:2	We have found that certain CHEMICALIN [e.g., CHEMICALIN (CHEMICALIN)] and  bbbbb1 CHEMICALIN eeeee1  [e.g., CHEMICALIN (CHEMICALIN)] induce a loss of cell-surface receptors for  bbbbb2 GENEIN eeeee2 , and GENEIN (GENEIN) in fibroblasts
CPR:2	We have found that certain CHEMICALIN [e.g., CHEMICALIN (CHEMICALIN)] and  bbbbb1 CHEMICALIN eeeee1  [e.g., CHEMICALIN (CHEMICALIN)] induce a loss of cell-surface receptors for GENEIN, and  bbbbb2 GENEIN eeeee2  (GENEIN) in fibroblasts
CPR:2	We have found that certain CHEMICALIN [e.g., CHEMICALIN (CHEMICALIN)] and  bbbbb1 CHEMICALIN eeeee1  [e.g., CHEMICALIN (CHEMICALIN)] induce a loss of cell-surface receptors for GENEIN, and GENEIN ( bbbbb2 GENEIN eeeee2 ) in fibroblasts
CPR:2	We have found that certain CHEMICALIN [e.g., CHEMICALIN (CHEMICALIN)] and CHEMICALIN [e.g.,  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN)] induce a loss of cell-surface receptors for  bbbbb2 GENEIN eeeee2 , and GENEIN (GENEIN) in fibroblasts
CPR:2	We have found that certain CHEMICALIN [e.g., CHEMICALIN (CHEMICALIN)] and CHEMICALIN [e.g.,  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN)] induce a loss of cell-surface receptors for GENEIN, and  bbbbb2 GENEIN eeeee2  (GENEIN) in fibroblasts
CPR:2	We have found that certain CHEMICALIN [e.g., CHEMICALIN (CHEMICALIN)] and CHEMICALIN [e.g.,  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN)] induce a loss of cell-surface receptors for GENEIN, and GENEIN ( bbbbb2 GENEIN eeeee2 ) in fibroblasts
CPR:2	We have found that certain CHEMICALIN [e.g., CHEMICALIN (CHEMICALIN)] and CHEMICALIN [e.g., CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 )] induce a loss of cell-surface receptors for  bbbbb2 GENEIN eeeee2 , and GENEIN (GENEIN) in fibroblasts
CPR:2	We have found that certain CHEMICALIN [e.g., CHEMICALIN (CHEMICALIN)] and CHEMICALIN [e.g., CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 )] induce a loss of cell-surface receptors for GENEIN, and  bbbbb2 GENEIN eeeee2  (GENEIN) in fibroblasts
CPR:2	We have found that certain CHEMICALIN [e.g., CHEMICALIN (CHEMICALIN)] and CHEMICALIN [e.g., CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 )] induce a loss of cell-surface receptors for GENEIN, and GENEIN ( bbbbb2 GENEIN eeeee2 ) in fibroblasts
CPR:2	Three lines of evidence suggest that GENENOTIN inhibition is not responsible for the inhibition of binding and endocytosis: 1) CHEMICALIN, a CHEMICALIN that is a poor inhibitor of calmodulin, is nearly as effective as CHEMICALIN at inhibiting endocytosis; calmidazolium, a potent inhibitor of several GENEIN functions, did not cause a loss of binding; 2) the microinjection of GENENOTIN into cells did not reverse the effects of CHEMICALNOTIN; using pressure microinjection, we introduced up to a 100-fold excess of GENENOTIN over native levels into individual gerbil fibroma cells; using  bbbbb1 CHEMICALIN eeeee1 -labeled  bbbbb2 GENEIN eeeee2 , we saw that the CHEMICALNOTIN induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells; 3) we injected GENENOTIN, a GENENOTIN, into cells (1-3 pg/cell) and observed no effect on the receptor-mediated endocytosis of CHEMICALIN-labeled GENEIN
CPR:2	Three lines of evidence suggest that GENENOTIN inhibition is not responsible for the inhibition of binding and endocytosis: 1) CHEMICALIN, a CHEMICALIN that is a poor inhibitor of calmodulin, is nearly as effective as CHEMICALIN at inhibiting endocytosis; calmidazolium, a potent inhibitor of several GENEIN functions, did not cause a loss of binding; 2) the microinjection of GENENOTIN into cells did not reverse the effects of CHEMICALNOTIN; using pressure microinjection, we introduced up to a 100-fold excess of GENENOTIN over native levels into individual gerbil fibroma cells; using CHEMICALIN-labeled GENEIN, we saw that the CHEMICALNOTIN induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells; 3) we injected GENENOTIN, a GENENOTIN, into cells (1-3 pg/cell) and observed no effect on the receptor-mediated endocytosis of  bbbbb1 CHEMICALIN eeeee1 -labeled  bbbbb2 GENEIN eeeee2 
CPR:4	Since both  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN are potent inhibitors of  bbbbb2 GENEIN eeeee2 , we investigated the possibility that inhibition of GENENOTIN was responsible for the loss of receptors
CPR:4	Since both CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  are potent inhibitors of  bbbbb2 GENEIN eeeee2 , we investigated the possibility that inhibition of GENENOTIN was responsible for the loss of receptors
CPR:4	Three lines of evidence suggest that GENENOTIN inhibition is not responsible for the inhibition of binding and endocytosis: 1)  bbbbb1 CHEMICALIN eeeee1 , a CHEMICALIN that is a poor inhibitor of calmodulin, is nearly as effective as CHEMICALIN at inhibiting endocytosis; calmidazolium, a potent inhibitor of several  bbbbb2 GENEIN eeeee2  functions, did not cause a loss of binding; 2) the microinjection of GENENOTIN into cells did not reverse the effects of CHEMICALNOTIN; using pressure microinjection, we introduced up to a 100-fold excess of GENENOTIN over native levels into individual gerbil fibroma cells; using CHEMICALIN-labeled GENEIN, we saw that the CHEMICALNOTIN induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells; 3) we injected GENENOTIN, a GENENOTIN, into cells (1-3 pg/cell) and observed no effect on the receptor-mediated endocytosis of CHEMICALIN-labeled GENEIN
CPR:4	Three lines of evidence suggest that GENENOTIN inhibition is not responsible for the inhibition of binding and endocytosis: 1) CHEMICALIN, a  bbbbb1 CHEMICALIN eeeee1  that is a poor inhibitor of calmodulin, is nearly as effective as CHEMICALIN at inhibiting endocytosis; calmidazolium, a potent inhibitor of several  bbbbb2 GENEIN eeeee2  functions, did not cause a loss of binding; 2) the microinjection of GENENOTIN into cells did not reverse the effects of CHEMICALNOTIN; using pressure microinjection, we introduced up to a 100-fold excess of GENENOTIN over native levels into individual gerbil fibroma cells; using CHEMICALIN-labeled GENEIN, we saw that the CHEMICALNOTIN induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells; 3) we injected GENENOTIN, a GENENOTIN, into cells (1-3 pg/cell) and observed no effect on the receptor-mediated endocytosis of CHEMICALIN-labeled GENEIN
CPR:4	Three lines of evidence suggest that GENENOTIN inhibition is not responsible for the inhibition of binding and endocytosis: 1) CHEMICALIN, a CHEMICALIN that is a poor inhibitor of calmodulin, is nearly as effective as  bbbbb1 CHEMICALIN eeeee1  at inhibiting endocytosis; calmidazolium, a potent inhibitor of several  bbbbb2 GENEIN eeeee2  functions, did not cause a loss of binding; 2) the microinjection of GENENOTIN into cells did not reverse the effects of CHEMICALNOTIN; using pressure microinjection, we introduced up to a 100-fold excess of GENENOTIN over native levels into individual gerbil fibroma cells; using CHEMICALIN-labeled GENEIN, we saw that the CHEMICALNOTIN induced inhibition of receptor-mediated endocytosis was the same in injected and uninjected cells; 3) we injected GENENOTIN, a GENENOTIN, into cells (1-3 pg/cell) and observed no effect on the receptor-mediated endocytosis of CHEMICALIN-labeled GENEIN
CPR:2	From these results, it is proposed that  bbbbb1 GENEIN eeeee1  activity determines  bbbbb2 CHEMICALIN eeeee2  concentrations by regulating CHEMICALIN availability
CPR:9	From these results, it is proposed that  bbbbb1 GENEIN eeeee1  activity determines CHEMICALIN concentrations by regulating  bbbbb2 CHEMICALIN eeeee2  availability
CPR:4	The binding of  bbbbb1 GENEIN eeeee1 -HIS was inhibited on 35-79% of the platelets by the GENEIN antagonists  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:4	The binding of  bbbbb1 GENEIN eeeee1 -HIS was inhibited on 35-79% of the platelets by the GENEIN antagonists CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:4	The GENEIN antagonist  bbbbb1 CHEMICALIN eeeee1  blocked the  bbbbb2 GENEIN eeeee2 -HIS binding on 14-37% of the platelets
CPR:6	The binding of GENEIN-HIS was inhibited on 35-79% of the platelets by the  bbbbb1 GENEIN eeeee1  antagonists  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN
CPR:6	The binding of GENEIN-HIS was inhibited on 35-79% of the platelets by the  bbbbb1 GENEIN eeeee1  antagonists CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 
CPR:6	The  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2  blocked the GENEIN-HIS binding on 14-37% of the platelets
CPR:9	 bbbbb1 GENEIN eeeee1  (GENEIN) in the liver catalyzes most of the  bbbbb2 CHEMICALIN eeeee2  transamination in mammalian tissues (E
CPR:9	GENEIN ( bbbbb1 GENEIN eeeee1 ) in the liver catalyzes most of the  bbbbb2 CHEMICALIN eeeee2  transamination in mammalian tissues (E
CPR:9	The holo activity of combined peroxisomal and mitochondrial  bbbbb1 GENEIN eeeee1  with a low Km for  bbbbb2 CHEMICALIN eeeee2  rapidly decreased after a lag time of about 2 days during feeding of the CHEMICALNOTIN-deficient diet (by 50% in 5 days, by 86% in 14 days)
CPR:9	The holo activity of GENEIN with a high Km for  bbbbb1 CHEMICALIN eeeee1  decreased more slowly than  bbbbb2 GENEIN eeeee2  (by 33% in 14 days, by 60% in 28 days)
CPR:9	The holo activity of  bbbbb1 GENEIN eeeee1  with a high Km for  bbbbb2 CHEMICALIN eeeee2  decreased more slowly than GENEIN (by 33% in 14 days, by 60% in 28 days)
CPR:4	 bbbbb1 CHEMICALIN eeeee1  inhibited both  bbbbb2 GENEIN eeeee2  and GENEIN with IC-50 values of 43 microM and 227 microM, respectively
CPR:4	 bbbbb1 CHEMICALIN eeeee1  inhibited both GENEIN and  bbbbb2 GENEIN eeeee2  with IC-50 values of 43 microM and 227 microM, respectively
CPR:4	 bbbbb1 CHEMICALIN eeeee1  also inhibited  bbbbb2 GENEIN eeeee2  with an IC-50 of 43 microM
CPR:4	The  bbbbb1 GENEIN eeeee1  was similarly inhibited by  bbbbb2 CHEMICALIN eeeee2  with an IC-50 of 61 microM
CPR:4	Hence,  bbbbb1 CHEMICALIN eeeee1  has the ability to inhibit both the  bbbbb2 GENEIN eeeee2  and GENEIN pathways of CHEMICALIN metabolism with similar efficacy
CPR:4	Hence,  bbbbb1 CHEMICALIN eeeee1  has the ability to inhibit both the GENEIN and  bbbbb2 GENEIN eeeee2  pathways of CHEMICALIN metabolism with similar efficacy
CPR:4	In cell culture experiments, it was found that  bbbbb1 CHEMICALIN eeeee1  inhibited  bbbbb2 GENEIN eeeee2  induced CHEMICALIN production by human gingival fibroblasts in a concentration dependent manner, and at relatively low concentrations
CPR:9	In cell culture experiments, it was found that CHEMICALIN inhibited  bbbbb1 GENEIN eeeee1  induced  bbbbb2 CHEMICALIN eeeee2  production by human gingival fibroblasts in a concentration dependent manner, and at relatively low concentrations
CPR:9	Hence, CHEMICALIN has the ability to inhibit both the  bbbbb1 GENEIN eeeee1  and GENEIN pathways of  bbbbb2 CHEMICALIN eeeee2  metabolism with similar efficacy
CPR:9	Hence, CHEMICALIN has the ability to inhibit both the GENEIN and  bbbbb1 GENEIN eeeee1  pathways of  bbbbb2 CHEMICALIN eeeee2  metabolism with similar efficacy
CPR:2	Extracellular CHEMICALNOTIN (protein bound and free) and intracellular CHEMICALNOTIN (protein bound and free) were determined after culturing L-1210 cells in the presence of CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) bound to  bbbbb2 GENEIN eeeee2  (GENEIN, GENEIN)
CPR:2	Extracellular CHEMICALNOTIN (protein bound and free) and intracellular CHEMICALNOTIN (protein bound and free) were determined after culturing L-1210 cells in the presence of CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) bound to GENEIN ( bbbbb2 GENEIN eeeee2 , GENEIN)
CPR:2	Extracellular CHEMICALNOTIN (protein bound and free) and intracellular CHEMICALNOTIN (protein bound and free) were determined after culturing L-1210 cells in the presence of CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) bound to GENEIN (GENEIN,  bbbbb2 GENEIN eeeee2 )
CPR:2	Intracellular protein-bound  bbbbb1 CHEMICALIN eeeee1  fractionated with  bbbbb2 GENEIN eeeee2  (GENEIN) and GENEIN (GENEIN) activity
CPR:2	Intracellular protein-bound  bbbbb1 CHEMICALIN eeeee1  fractionated with GENEIN ( bbbbb2 GENEIN eeeee2 ) and GENEIN (GENEIN) activity
CPR:2	Intracellular protein-bound  bbbbb1 CHEMICALIN eeeee1  fractionated with GENEIN (GENEIN) and  bbbbb2 GENEIN eeeee2  (GENEIN) activity
CPR:2	Intracellular protein-bound  bbbbb1 CHEMICALIN eeeee1  fractionated with GENEIN (GENEIN) and GENEIN ( bbbbb2 GENEIN eeeee2 ) activity
CPR:2	Extracellular CHEMICALNOTIN (protein bound and free) and intracellular CHEMICALNOTIN (protein bound and free) were determined after culturing L-1210 cells in the presence of  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) bound to  bbbbb2 GENEIN eeeee2  (GENEIN, GENEIN)
CPR:2	Extracellular CHEMICALNOTIN (protein bound and free) and intracellular CHEMICALNOTIN (protein bound and free) were determined after culturing L-1210 cells in the presence of  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) bound to GENEIN ( bbbbb2 GENEIN eeeee2 , GENEIN)
CPR:2	Extracellular CHEMICALNOTIN (protein bound and free) and intracellular CHEMICALNOTIN (protein bound and free) were determined after culturing L-1210 cells in the presence of  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) bound to GENEIN (GENEIN,  bbbbb2 GENEIN eeeee2 )
CPR:3	Cells propagated in medium containing  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN showed a substantial increase in  bbbbb2 GENEIN eeeee2  activity which paralleled the increase in the intracellular concentration of CHEMICALNOTIN and the CHEMICALNOTIN bound to the enzyme.
CPR:3	Cells propagated in medium containing CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  showed a substantial increase in  bbbbb2 GENEIN eeeee2  activity which paralleled the increase in the intracellular concentration of CHEMICALNOTIN and the CHEMICALNOTIN bound to the enzyme.
CPR:2	 bbbbb1 CHEMICALIN eeeee1  inhibition of radioligand binding to the  bbbbb2 GENEIN eeeee2  and CHEMICALIN inhibition of GENEIN (GENEIN)-stimulated CHEMICALIN production in GH4ZR7 cells, stably transfected with a GENENOTIN, were evaluated
CPR:2	Our results indicate that ergot compounds, especially  bbbbb1 CHEMICALIN eeeee1 , bind to  bbbbb2 GENEIN eeeee2  and elicit second messenger responses similar to that of CHEMICALIN
CPR:2	Our results indicate that ergot compounds, especially CHEMICALIN, bind to  bbbbb1 GENEIN eeeee1  and elicit second messenger responses similar to that of  bbbbb2 CHEMICALIN eeeee2 
CPR:2	 bbbbb1 CHEMICALIN eeeee1  binding and activation of  bbbbb2 GENEIN eeeee2  in GH4ZR7 cells
CPR:2	 bbbbb1 CHEMICALIN eeeee1  inhibition of the binding of the  bbbbb2 GENEIN eeeee2 -specific radioligand, CHEMICALIN, exhibited a KI (inhibition constant) of 6.9 +/- 2.6 nM, whereas CHEMICALIN was much less potent (370 +/- 160 nM)
CPR:2	CHEMICALIN inhibition of the binding of the  bbbbb1 GENEIN eeeee1 -specific radioligand,  bbbbb2 CHEMICALIN eeeee2 , exhibited a KI (inhibition constant) of 6.9 +/- 2.6 nM, whereas CHEMICALIN was much less potent (370 +/- 160 nM)
CPR:2	CHEMICALIN inhibition of the binding of the  bbbbb1 GENEIN eeeee1 -specific radioligand, CHEMICALIN, exhibited a KI (inhibition constant) of 6.9 +/- 2.6 nM, whereas  bbbbb2 CHEMICALIN eeeee2  was much less potent (370 +/- 160 nM)
CPR:3	 bbbbb1 CHEMICALIN eeeee1  binding and activation of  bbbbb2 GENEIN eeeee2  in GH4ZR7 cells
CPR:3	These findings suggest that some of the deleterious effects of consumption of endophyte-infected tall fescue, which contains several  bbbbb1 CHEMICALIN eeeee1  including CHEMICALIN, may be due to  bbbbb2 GENEIN eeeee2  activation.
CPR:3	These findings suggest that some of the deleterious effects of consumption of endophyte-infected tall fescue, which contains several CHEMICALIN including  bbbbb1 CHEMICALIN eeeee1 , may be due to  bbbbb2 GENEIN eeeee2  activation.
CPR:4	 bbbbb1 CHEMICALIN eeeee1  were also effective in inhibiting  bbbbb2 GENEIN eeeee2 -stimulated CHEMICALIN production, with EC50 values for CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN of 8 +/- 2, 47 +/- 2, 28 +/- 2, 2 +/- 1, and 8 +/- 1 nM, respectively
CPR:4	CHEMICALIN were also effective in inhibiting  bbbbb1 GENEIN eeeee1 -stimulated CHEMICALIN production, with EC50 values for  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN of 8 +/- 2, 47 +/- 2, 28 +/- 2, 2 +/- 1, and 8 +/- 1 nM, respectively
CPR:4	CHEMICALIN were also effective in inhibiting  bbbbb1 GENEIN eeeee1 -stimulated CHEMICALIN production, with EC50 values for CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, and CHEMICALIN of 8 +/- 2, 47 +/- 2, 28 +/- 2, 2 +/- 1, and 8 +/- 1 nM, respectively
CPR:4	CHEMICALIN were also effective in inhibiting  bbbbb1 GENEIN eeeee1 -stimulated CHEMICALIN production, with EC50 values for CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, and CHEMICALIN of 8 +/- 2, 47 +/- 2, 28 +/- 2, 2 +/- 1, and 8 +/- 1 nM, respectively
CPR:4	CHEMICALIN were also effective in inhibiting  bbbbb1 GENEIN eeeee1 -stimulated CHEMICALIN production, with EC50 values for CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , and CHEMICALIN of 8 +/- 2, 47 +/- 2, 28 +/- 2, 2 +/- 1, and 8 +/- 1 nM, respectively
CPR:4	CHEMICALIN were also effective in inhibiting  bbbbb1 GENEIN eeeee1 -stimulated CHEMICALIN production, with EC50 values for CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and  bbbbb2 CHEMICALIN eeeee2  of 8 +/- 2, 47 +/- 2, 28 +/- 2, 2 +/- 1, and 8 +/- 1 nM, respectively
CPR:4	CHEMICALIN inhibition of radioligand binding to the GENEIN and  bbbbb1 CHEMICALIN eeeee1  inhibition of  bbbbb2 GENEIN eeeee2  (GENEIN)-stimulated CHEMICALIN production in GH4ZR7 cells, stably transfected with a GENENOTIN, were evaluated
CPR:4	CHEMICALIN inhibition of radioligand binding to the GENEIN and  bbbbb1 CHEMICALIN eeeee1  inhibition of GENEIN ( bbbbb2 GENEIN eeeee2 )-stimulated CHEMICALIN production in GH4ZR7 cells, stably transfected with a GENENOTIN, were evaluated
CPR:6	Inhibition of CHEMICALNOTIN production by CHEMICALNOTIN was blocked by the  bbbbb1 GENEIN eeeee1  antagonist,  bbbbb2 CHEMICALIN eeeee2  (IC50, 300 +/- 150 nM)
CPR:9	CHEMICALIN were also effective in inhibiting  bbbbb1 GENEIN eeeee1 -stimulated  bbbbb2 CHEMICALIN eeeee2  production, with EC50 values for CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN of 8 +/- 2, 47 +/- 2, 28 +/- 2, 2 +/- 1, and 8 +/- 1 nM, respectively
CPR:9	CHEMICALIN inhibition of radioligand binding to the GENEIN and CHEMICALIN inhibition of  bbbbb1 GENEIN eeeee1  (GENEIN)-stimulated  bbbbb2 CHEMICALIN eeeee2  production in GH4ZR7 cells, stably transfected with a GENENOTIN, were evaluated
CPR:9	CHEMICALIN inhibition of radioligand binding to the GENEIN and CHEMICALIN inhibition of GENEIN ( bbbbb1 GENEIN eeeee1 )-stimulated  bbbbb2 CHEMICALIN eeeee2  production in GH4ZR7 cells, stably transfected with a GENENOTIN, were evaluated
CPR:2	Saturation experiments showed that  bbbbb1 CHEMICALIN eeeee1  labelled a single population of binding sites in the spleen ( bbbbb2 GENEIN eeeee2 ) and hippocampus (GENEIN and GENEIN) (dissociation constants (KD): 0.26 nM and 0.14 nM respectively)
CPR:2	Saturation experiments showed that  bbbbb1 CHEMICALIN eeeee1  labelled a single population of binding sites in the spleen (GENEIN) and hippocampus ( bbbbb2 GENEIN eeeee2  and GENEIN) (dissociation constants (KD): 0.26 nM and 0.14 nM respectively)
CPR:2	Saturation experiments showed that  bbbbb1 CHEMICALIN eeeee1  labelled a single population of binding sites in the spleen (GENEIN) and hippocampus (GENEIN and  bbbbb2 GENEIN eeeee2 ) (dissociation constants (KD): 0.26 nM and 0.14 nM respectively)
CPR:2	The binding of the antipsychotic drugs CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN was studied at the subtypes of the  bbbbb2 GENEIN eeeee2 
CPR:2	The binding of the antipsychotic drugs CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN and CHEMICALIN was studied at the subtypes of the  bbbbb2 GENEIN eeeee2 
CPR:2	The binding of the antipsychotic drugs CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and CHEMICALIN was studied at the subtypes of the  bbbbb2 GENEIN eeeee2 
CPR:2	Binding of antipsychotic drugs at GENENOTIN:  bbbbb1 CHEMICALIN eeeee1  is selective for the  bbbbb2 GENEIN eeeee2 
CPR:2	With the exception of  bbbbb1 CHEMICALIN eeeee1 , all the antipsychotic drugs tested failed to show selectivity for either of the  bbbbb2 GENEIN eeeee2  subtypes
CPR:2	The binding of the antipsychotic drugs CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN was studied at the subtypes of the  bbbbb2 GENEIN eeeee2 
CPR:2	 bbbbb1 CHEMICALIN eeeee1  was 120-fold more selective for the  bbbbb2 GENEIN eeeee2  with respect to the GENEIN (Ki values: 2.3 +/- 1.2 nM and 283.6 +/- 174.1 nM respectively).
CPR:2	 bbbbb1 CHEMICALIN eeeee1  was 120-fold more selective for the GENEIN with respect to the  bbbbb2 GENEIN eeeee2  (Ki values: 2.3 +/- 1.2 nM and 283.6 +/- 174.1 nM respectively).
CPR:2	The binding of the antipsychotic drugs CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  was studied at the subtypes of the  bbbbb2 GENEIN eeeee2 
CPR:2	The binding of the antipsychotic drugs  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN was studied at the subtypes of the  bbbbb2 GENEIN eeeee2 
CPR:2	The binding of the antipsychotic drugs CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN was studied at the subtypes of the  bbbbb2 GENEIN eeeee2 
CPR:2	Incubation of rat aortic membranes with the irreversible  bbbbb1 GENEIN eeeee1  antagonist, CHEMICALIN (CHEMICALIN: 10 microM) did not change the KD of  bbbbb2 CHEMICALIN eeeee2  binding in comparison to untreated membranes, but reduced by 88% the total number of binding sites (Bmax). 3
CPR:2	The subtypes of  bbbbb1 GENEIN eeeee1  mediating contractions to exogenous  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) in rat aorta have been examined in both biochemical and functional studies. 2
CPR:2	The subtypes of  bbbbb1 GENEIN eeeee1  mediating contractions to exogenous CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) in rat aorta have been examined in both biochemical and functional studies. 2
CPR:2	ediation of  bbbbb1 CHEMICALIN eeeee1 -induced contractions of rat aorta by the  bbbbb2 GENEIN eeeee2  subtype. 1
CPR:2	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN were confirmed as selective for the  bbbbb2 GENEIN eeeee2 , whereas CHEMICALNOTIN was alpha 1B-selective. 6
CPR:2	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  were confirmed as selective for the  bbbbb2 GENEIN eeeee2 , whereas CHEMICALNOTIN was alpha 1B-selective. 6
CPR:6	Incubation of rat aortic membranes with the irreversible  bbbbb1 GENEIN eeeee1  antagonist,  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN: 10 microM) did not change the KD of CHEMICALIN binding in comparison to untreated membranes, but reduced by 88% the total number of binding sites (Bmax). 3
CPR:6	Incubation of rat aortic membranes with the irreversible  bbbbb1 GENEIN eeeee1  antagonist, CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 : 10 microM) did not change the KD of CHEMICALIN binding in comparison to untreated membranes, but reduced by 88% the total number of binding sites (Bmax). 3
CPR:10	Beta 2- but not  bbbbb1 GENEIN eeeee1  are involved in  bbbbb2 CHEMICALIN eeeee2  enhancement of aggressive behavior in long-term isolated mice
CPR:2	Taken together with our previous finding that the  bbbbb1 CHEMICALIN eeeee1 -induced enhancement of aggressive behavior can be blocked by CHEMICALIN, an GENEIN antagonist, the present results indicate that not only alpha 2- but also  bbbbb2 GENEIN eeeee2  stimulation plays important roles in modulation of aggressive behavior in long-term isolated mice.
CPR:5	Moreover,  bbbbb1 CHEMICALIN eeeee1  (0.1-0.5 mg/kg, IP), a lipophilic  bbbbb2 GENEIN eeeee2  agonist, significantly increased the duration of basal aggressive behavior
CPR:6	Taken together with our previous finding that the CHEMICALIN-induced enhancement of aggressive behavior can be blocked by  bbbbb1 CHEMICALIN eeeee1 , an  bbbbb2 GENEIN eeeee2  antagonist, the present results indicate that not only alpha 2- but also GENEIN stimulation plays important roles in modulation of aggressive behavior in long-term isolated mice.
CPR:6	Intraperitoneal administration of  bbbbb1 CHEMICALIN eeeee1  (2.5-10 mg/kg), a nonselective  bbbbb2 GENEIN eeeee2  antagonist, dose dependently attenuated the CHEMICALNOTIN-induced enhancement of aggressive behavior without significantly affecting the basal aggressive responses
CPR:6	 bbbbb1 CHEMICALIN eeeee1  (1.25-5 mg/kg, IP), a selective  bbbbb2 GENEIN eeeee2  antagonist, also blocked the desipramine-induced enhancement of aggressive behavior in a dose-dependent manner, whereas CHEMICALIN (5-20 mg/kg, IP), a selective GENEIN antagonist, did not affect it
CPR:6	CHEMICALIN (1.25-5 mg/kg, IP), a selective GENEIN antagonist, also blocked the desipramine-induced enhancement of aggressive behavior in a dose-dependent manner, whereas  bbbbb1 CHEMICALIN eeeee1  (5-20 mg/kg, IP), a selective  bbbbb2 GENEIN eeeee2  antagonist, did not affect it
CPR:3	Furthermore, the phosphorylation of  bbbbb1 GENEIN eeeee1  produced by  bbbbb2 CHEMICALIN eeeee2  was greater than that produced by CHEMICALIN
CPR:3	Furthermore, the phosphorylation of  bbbbb1 GENEIN eeeee1  produced by CHEMICALIN was greater than that produced by  bbbbb2 CHEMICALIN eeeee2 
CPR:6	In beta-escin-skinned strips of CHEMICALNOTIN-pretreated smooth muscle, the enhancement of CHEMICALNOTIN contraction produced by CHEMICALNOTIN was significantly decreased, whereas the amplitude was the same as that produced by CHEMICALNOTIN or CHEMICALNOTIN; this enhancement was inhibited by the selective  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2  (100 nM)
CPR:10	We conclude that expression of GENEIN is required for efficient killing of neuroendocrine cells by  bbbbb1 CHEMICALIN eeeee1 , and this effect is related to specific recognition of the drug as a transported substrate by GENEIN but not  bbbbb2 GENEIN eeeee2 .
CPR:9	The drug had a potent cytotoxic effect on RIN cells expressing  bbbbb1 GENEIN eeeee1 , but had no effect on cells lacking GENENOTIN expression, as indicated by histological analysis and measurement of the blood  bbbbb2 CHEMICALIN eeeee2  levels of treated animals
CPR:9	Consistent with these data, only  bbbbb1 GENEIN eeeee1 -expressing RIN or AtT-20ins cells transported  bbbbb2 CHEMICALIN eeeee2  efficiently
CPR:9	We conclude that expression of  bbbbb1 GENEIN eeeee1  is required for efficient killing of neuroendocrine cells by  bbbbb2 CHEMICALIN eeeee2 , and this effect is related to specific recognition of the drug as a transported substrate by GENEIN but not GENEIN.
CPR:9	We conclude that expression of GENEIN is required for efficient killing of neuroendocrine cells by  bbbbb1 CHEMICALIN eeeee1 , and this effect is related to specific recognition of the drug as a transported substrate by  bbbbb2 GENEIN eeeee2  but not GENEIN.
CPR:2	The present study utilized blood from normal volunteers and  bbbbb1 CHEMICALIN eeeee1 - bbbbb2 GENEIN eeeee2  in a dilute whole blood clot assay to determine the relative concentrations of CHEMICALIN analogues required for inhibition of clot lysis induced by exogenous GENEIN
CPR:4	The data suggest that  bbbbb1 CHEMICALIN eeeee1  analogues, even at low concentrations, reduce the rate of  bbbbb2 GENEIN eeeee2  induced whole blood clot lysis by several mechanisms.
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (0.06 mM) and CHEMICALIN (0.6 mM) were effective in prolonging clot lysis if (1) whole blood clots were formed and then exposed to a CHEMICALNOTIN analogue and exogenous  bbbbb2 GENEIN eeeee2  or if (2) whole blood clots were formed in the presence of exogenous GENEIN and a CHEMICALNOTIN analogue
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (0.06 mM) and CHEMICALIN (0.6 mM) were effective in prolonging clot lysis if (1) whole blood clots were formed and then exposed to a CHEMICALNOTIN analogue and exogenous GENEIN or if (2) whole blood clots were formed in the presence of exogenous  bbbbb2 GENEIN eeeee2  and a CHEMICALNOTIN analogue
CPR:4	CHEMICALIN (0.06 mM) and  bbbbb1 CHEMICALIN eeeee1  (0.6 mM) were effective in prolonging clot lysis if (1) whole blood clots were formed and then exposed to a CHEMICALNOTIN analogue and exogenous  bbbbb2 GENEIN eeeee2  or if (2) whole blood clots were formed in the presence of exogenous GENEIN and a CHEMICALNOTIN analogue
CPR:4	CHEMICALIN (0.06 mM) and  bbbbb1 CHEMICALIN eeeee1  (0.6 mM) were effective in prolonging clot lysis if (1) whole blood clots were formed and then exposed to a CHEMICALNOTIN analogue and exogenous GENEIN or if (2) whole blood clots were formed in the presence of exogenous  bbbbb2 GENEIN eeeee2  and a CHEMICALNOTIN analogue
CPR:4	Inhibitory effects of  bbbbb1 CHEMICALIN eeeee1  analogues on  bbbbb2 GENEIN eeeee2  induced whole blood clot lysis
CPR:4	However, their inhibitory effect was markedly reduced if clots were formed in the presence of  bbbbb1 GENEIN eeeee1  and then exposed to either of the  bbbbb2 CHEMICALIN eeeee2  analogues
CPR:4	The present study utilized blood from normal volunteers and CHEMICALIN-GENEIN in a dilute whole blood clot assay to determine the relative concentrations of  bbbbb1 CHEMICALIN eeeee1  analogues required for inhibition of clot lysis induced by exogenous  bbbbb2 GENEIN eeeee2 
CPR:3	 bbbbb1 CHEMICALIN eeeee1  enhances the depolarizing afterpotential of immunohistochemically identified CHEMICALNOTIN neurons in the rat supraoptic nucleus via  bbbbb2 GENEIN eeeee2  activation
CPR:3	In summary, these results show that the excitatory effect of  bbbbb1 CHEMICALIN eeeee1  on immunohistochemically identified CHEMICALNOTIN neurons in the supraoptic nucleus is due in part to the  bbbbb2 GENEIN eeeee2 -mediated enhancement of the depolarizing afterpotential independent of any change in the afterhyperpolarizing potential or membrane potential.
CPR:5	The enhancement of the depolarizing afterpotential by CHEMICALNOTIN was mimicked by the  bbbbb1 GENEIN eeeee1  agonist  bbbbb2 CHEMICALIN eeeee2  and was reduced or blocked by the GENEIN antagonist CHEMICALIN, but was not blocked or reduced in the presence of the GENEIN antagonist, CHEMICALIN
CPR:6	The enhancement of the depolarizing afterpotential by CHEMICALNOTIN was mimicked by the GENEIN agonist CHEMICALIN and was reduced or blocked by the  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2 , but was not blocked or reduced in the presence of the GENEIN antagonist, CHEMICALIN
CPR:6	The enhancement of the depolarizing afterpotential by CHEMICALNOTIN was mimicked by the GENEIN agonist CHEMICALIN and was reduced or blocked by the GENEIN antagonist CHEMICALIN, but was not blocked or reduced in the presence of the  bbbbb1 GENEIN eeeee1  antagonist,  bbbbb2 CHEMICALIN eeeee2 
CPR:10	Furthermore,  bbbbb1 CHEMICALIN eeeee1  does not bind to members of the cellular  bbbbb2 GENEIN eeeee2  family
CPR:4	Finally, the three drugs were compared with the  bbbbb1 GENEIN eeeee1  inhibitor  bbbbb2 CHEMICALIN eeeee2 
CPR:4	The goal of the present study was to compare the effects of three potent reference  bbbbb1 GENEIN eeeee1  inhibitors ( bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, and CHEMICALIN) in CHEMICALNOTIN-depleted normotensive squirrel monkeys
CPR:4	The goal of the present study was to compare the effects of three potent reference  bbbbb1 GENEIN eeeee1  inhibitors (CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , and CHEMICALIN) in CHEMICALNOTIN-depleted normotensive squirrel monkeys
CPR:4	The goal of the present study was to compare the effects of three potent reference  bbbbb1 GENEIN eeeee1  inhibitors (CHEMICALIN, CHEMICALIN, and  bbbbb2 CHEMICALIN eeeee2 ) in CHEMICALNOTIN-depleted normotensive squirrel monkeys
CPR:4	One possible explanation is that, in our model,  bbbbb1 CHEMICALIN eeeee1  in contrast to CHEMICALIN and CHEMICALIN is able to inhibit  bbbbb2 GENEIN eeeee2  in a functionally important extraplasmatic compartment.
CPR:4	One possible explanation is that, in our model, CHEMICALIN in contrast to  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN is able to inhibit  bbbbb2 GENEIN eeeee2  in a functionally important extraplasmatic compartment.
CPR:4	One possible explanation is that, in our model, CHEMICALIN in contrast to CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  is able to inhibit  bbbbb2 GENEIN eeeee2  in a functionally important extraplasmatic compartment.
CPR:4	RESULTS:  bbbbb1 CHEMICALIN eeeee1  inhibited the chemotactic response toward CHEMICALNOTIN and GENEIN/GENEIN of  bbbbb2 GENEIN eeeee2  primed eosinophils approximately 60% (inhibitory concentration of 50% [IC50] approximately 1 to 10 nmol/L), whereas these responses of GENEIN primed eosinophils was completely inhibited (IC50 approximately 1 nmol/L)
CPR:4	Inhibition of  bbbbb1 GENEIN eeeee1 -primed eosinophil chemotaxis by  bbbbb2 CHEMICALIN eeeee2 
CPR:4	CONCLUSIONS: The chemotactic responses toward  bbbbb1 GENEIN eeeee1  were inhibited by  bbbbb2 CHEMICALIN eeeee2  at higher concentrations than were required in the priming studies (IC50 approximately 10 to 100 nmol/L)
CPR:4	RESULTS:  bbbbb1 CHEMICALIN eeeee1  inhibited the chemotactic response toward CHEMICALNOTIN and GENEIN/GENEIN of GENEIN primed eosinophils approximately 60% (inhibitory concentration of 50% [IC50] approximately 1 to 10 nmol/L), whereas these responses of  bbbbb2 GENEIN eeeee2  primed eosinophils was completely inhibited (IC50 approximately 1 nmol/L)
CPR:4	RESULTS:  bbbbb1 CHEMICALIN eeeee1  inhibited the chemotactic response toward CHEMICALNOTIN and  bbbbb2 GENEIN eeeee2 /GENEIN of GENEIN primed eosinophils approximately 60% (inhibitory concentration of 50% [IC50] approximately 1 to 10 nmol/L), whereas these responses of GENEIN primed eosinophils was completely inhibited (IC50 approximately 1 nmol/L)
CPR:4	RESULTS:  bbbbb1 CHEMICALIN eeeee1  inhibited the chemotactic response toward CHEMICALNOTIN and GENEIN/ bbbbb2 GENEIN eeeee2  of GENEIN primed eosinophils approximately 60% (inhibitory concentration of 50% [IC50] approximately 1 to 10 nmol/L), whereas these responses of GENEIN primed eosinophils was completely inhibited (IC50 approximately 1 nmol/L)
CPR:10	 bbbbb1 CHEMICALIN eeeee1 -independent GENEIN [ bbbbb2 GENEIN eeeee2 ; GENEIN, GENEIN] is an enzyme responsible for biosynthesis of CHEMICALIN in the central nervous system
CPR:10	 bbbbb1 CHEMICALIN eeeee1 -independent GENEIN [GENEIN;  bbbbb2 GENEIN eeeee2 , GENEIN] is an enzyme responsible for biosynthesis of CHEMICALIN in the central nervous system
CPR:10	 bbbbb1 CHEMICALIN eeeee1 -independent GENEIN [GENEIN; GENEIN,  bbbbb2 GENEIN eeeee2 ] is an enzyme responsible for biosynthesis of CHEMICALIN in the central nervous system
CPR:10	 bbbbb1 CHEMICALIN eeeee1 -independent  bbbbb2 GENEIN eeeee2  [GENEIN; GENEIN, GENEIN] is an enzyme responsible for biosynthesis of CHEMICALIN in the central nervous system
CPR:9	CHEMICALIN-independent GENEIN [ bbbbb1 GENEIN eeeee1 ; GENEIN, GENEIN] is an enzyme responsible for biosynthesis of  bbbbb2 CHEMICALIN eeeee2  in the central nervous system
CPR:9	CHEMICALIN-independent GENEIN [GENEIN;  bbbbb1 GENEIN eeeee1 , GENEIN] is an enzyme responsible for biosynthesis of  bbbbb2 CHEMICALIN eeeee2  in the central nervous system
CPR:9	CHEMICALIN-independent GENEIN [GENEIN; GENEIN,  bbbbb1 GENEIN eeeee1 ] is an enzyme responsible for biosynthesis of  bbbbb2 CHEMICALIN eeeee2  in the central nervous system
CPR:9	CHEMICALIN-independent  bbbbb1 GENEIN eeeee1  [GENEIN; GENEIN, GENEIN] is an enzyme responsible for biosynthesis of  bbbbb2 CHEMICALIN eeeee2  in the central nervous system
CPR:1	This cDNA clone, designated  bbbbb1 GENEIN eeeee1 , shares a 90%  bbbbb2 CHEMICALIN eeeee2  identity with the previously reported GENEIN cDNA splice variant and differed from GENEIN in the CHEMICALIN and CHEMICALIN terminal regions
CPR:1	This cDNA clone, designated GENEIN, shares a 90%  bbbbb1 CHEMICALIN eeeee1  identity with the previously reported  bbbbb2 GENEIN eeeee2  cDNA splice variant and differed from GENEIN in the CHEMICALIN and CHEMICALIN terminal regions
CPR:1	This cDNA clone, designated GENEIN, shares a 90% CHEMICALIN identity with the previously reported GENEIN cDNA splice variant and differed from  bbbbb1 GENEIN eeeee1  in the  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN terminal regions
CPR:1	This cDNA clone, designated GENEIN, shares a 90% CHEMICALIN identity with the previously reported GENEIN cDNA splice variant and differed from  bbbbb1 GENEIN eeeee1  in the CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  terminal regions
CPR:2	The relative potency of compounds in displacing CHEMICALIN binding to  bbbbb1 GENEIN eeeee1  receptor was: domoate > CHEMICALIN > CHEMICALIN = CHEMICALIN > CHEMICALIN (CHEMICALIN) = CHEMICALIN > CHEMICALIN >  bbbbb2 CHEMICALIN eeeee2  > CHEMICALIN.
CPR:2	The relative potency of compounds in displacing CHEMICALIN binding to  bbbbb1 GENEIN eeeee1  receptor was: domoate > CHEMICALIN > CHEMICALIN = CHEMICALIN > CHEMICALIN (CHEMICALIN) = CHEMICALIN > CHEMICALIN > CHEMICALIN >  bbbbb2 CHEMICALIN eeeee2 .
CPR:2	Cell lines stably expressing  bbbbb1 GENEIN eeeee1  protein formed homomeric GENENOTIN responsive, in order of decreasing affinity to domoate,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN and CHEMICALIN (CHEMICALIN)
CPR:2	Cell lines stably expressing  bbbbb1 GENEIN eeeee1  protein formed homomeric GENENOTIN responsive, in order of decreasing affinity to domoate, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN (CHEMICALIN)
CPR:2	Cell lines stably expressing  bbbbb1 GENEIN eeeee1  protein formed homomeric GENENOTIN responsive, in order of decreasing affinity to domoate, CHEMICALIN, CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN)
CPR:2	Cell lines stably expressing  bbbbb1 GENEIN eeeee1  protein formed homomeric GENENOTIN responsive, in order of decreasing affinity to domoate, CHEMICALIN, CHEMICALIN and CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 )
CPR:2	Ligand binding studies with the recombinant  bbbbb1 GENEIN eeeee1  receptor expressed in mammalian cells indicated a high affinity  bbbbb2 CHEMICALIN eeeee2  binding site (Kd = 120 +/- 15.0 nM)
CPR:2	 bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN activated the heteromeric channel with significantly higher affinities than observed for  bbbbb2 GENEIN eeeee2  alone
CPR:2	CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  activated the heteromeric channel with significantly higher affinities than observed for  bbbbb2 GENEIN eeeee2  alone
CPR:2	The relative potency of compounds in displacing  bbbbb1 CHEMICALIN eeeee1  binding to  bbbbb2 GENEIN eeeee2  receptor was: domoate > CHEMICALIN > CHEMICALIN = CHEMICALIN > CHEMICALIN (CHEMICALIN) = CHEMICALIN > CHEMICALIN > CHEMICALIN > CHEMICALIN.
CPR:2	The relative potency of compounds in displacing CHEMICALIN binding to  bbbbb1 GENEIN eeeee1  receptor was: domoate >  bbbbb2 CHEMICALIN eeeee2  > CHEMICALIN = CHEMICALIN > CHEMICALIN (CHEMICALIN) = CHEMICALIN > CHEMICALIN > CHEMICALIN > CHEMICALIN.
CPR:2	The relative potency of compounds in displacing CHEMICALIN binding to  bbbbb1 GENEIN eeeee1  receptor was: domoate > CHEMICALIN >  bbbbb2 CHEMICALIN eeeee2  = CHEMICALIN > CHEMICALIN (CHEMICALIN) = CHEMICALIN > CHEMICALIN > CHEMICALIN > CHEMICALIN.
CPR:2	The relative potency of compounds in displacing CHEMICALIN binding to  bbbbb1 GENEIN eeeee1  receptor was: domoate > CHEMICALIN > CHEMICALIN =  bbbbb2 CHEMICALIN eeeee2  > CHEMICALIN (CHEMICALIN) = CHEMICALIN > CHEMICALIN > CHEMICALIN > CHEMICALIN.
CPR:2	The relative potency of compounds in displacing CHEMICALIN binding to  bbbbb1 GENEIN eeeee1  receptor was: domoate > CHEMICALIN > CHEMICALIN = CHEMICALIN >  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) = CHEMICALIN > CHEMICALIN > CHEMICALIN > CHEMICALIN.
CPR:2	The relative potency of compounds in displacing CHEMICALIN binding to  bbbbb1 GENEIN eeeee1  receptor was: domoate > CHEMICALIN > CHEMICALIN = CHEMICALIN > CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) = CHEMICALIN > CHEMICALIN > CHEMICALIN > CHEMICALIN.
CPR:2	The relative potency of compounds in displacing CHEMICALIN binding to  bbbbb1 GENEIN eeeee1  receptor was: domoate > CHEMICALIN > CHEMICALIN = CHEMICALIN > CHEMICALIN (CHEMICALIN) =  bbbbb2 CHEMICALIN eeeee2  > CHEMICALIN > CHEMICALIN > CHEMICALIN.
CPR:2	The relative potency of compounds in displacing CHEMICALIN binding to  bbbbb1 GENEIN eeeee1  receptor was: domoate > CHEMICALIN > CHEMICALIN = CHEMICALIN > CHEMICALIN (CHEMICALIN) = CHEMICALIN >  bbbbb2 CHEMICALIN eeeee2  > CHEMICALIN > CHEMICALIN.
CPR:4	Although  bbbbb1 CHEMICALIN eeeee1  exerts local antioxidant activity with beneficial effects on lung tissue, this  bbbbb2 GENEIN eeeee2  inhibitor intensifies the blast overpressure caused hemodynamic insufficiency.
CPR:4	One group of experimental animals was treated with  bbbbb1 GENEIN eeeee1  (GENEIN) inhibitor,  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN, Sigma, St
CPR:4	One group of experimental animals was treated with GENEIN ( bbbbb1 GENEIN eeeee1 ) inhibitor,  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN, Sigma, St
CPR:4	One group of experimental animals was treated with  bbbbb1 GENEIN eeeee1  (GENEIN) inhibitor, CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 , Sigma, St
CPR:4	One group of experimental animals was treated with GENEIN ( bbbbb1 GENEIN eeeee1 ) inhibitor, CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 , Sigma, St
CPR:6	 bbbbb1 CHEMICALIN eeeee1 , the first prostate-selective  bbbbb2 GENEIN eeeee2  antagonist
CPR:10	Expressions of GENEIN and GENEIN, but not  bbbbb1 GENEIN eeeee1 , are coordinately regulated by  bbbbb2 CHEMICALIN eeeee2 , consistent with the important role of GENENOTIN in regulating GENENOTIN processing
CPR:1	Single-strand conformational analysis and  bbbbb1 CHEMICALIN eeeee1  sequencing of the entire coding region of the  bbbbb2 GENEIN eeeee2  gene in 102 Japanese subjects with NIDDM revealed missense mutations in exons 2 (GENEIN) and 14 (GENEIN), neither of which was associated with NIDDM in this population
CPR:1	Single-strand conformational analysis and  bbbbb1 CHEMICALIN eeeee1  sequencing of the entire coding region of the GENEIN gene in 102 Japanese subjects with NIDDM revealed missense mutations in exons 2 ( bbbbb2 GENEIN eeeee2 ) and 14 (GENEIN), neither of which was associated with NIDDM in this population
CPR:1	Single-strand conformational analysis and  bbbbb1 CHEMICALIN eeeee1  sequencing of the entire coding region of the GENEIN gene in 102 Japanese subjects with NIDDM revealed missense mutations in exons 2 (GENEIN) and 14 ( bbbbb2 GENEIN eeeee2 ), neither of which was associated with NIDDM in this population
CPR:1	GENENOTIN is a GENENOTIN that initiates the sequential processing of  bbbbb1 GENEIN eeeee1  to GENENOTIN by cleaving the GENEIN molecule on the  bbbbb2 CHEMICALIN eeeee2 -terminal side of the dibasic peptide, Arg31-Arg32, joining the B-chain and CHEMICALIN-peptide
CPR:1	GENENOTIN is a GENENOTIN that initiates the sequential processing of GENEIN to GENENOTIN by cleaving the  bbbbb1 GENEIN eeeee1  molecule on the  bbbbb2 CHEMICALIN eeeee2 -terminal side of the dibasic peptide, Arg31-Arg32, joining the B-chain and CHEMICALIN-peptide
CPR:1	GENENOTIN is a GENENOTIN that initiates the sequential processing of  bbbbb1 GENEIN eeeee1  to GENENOTIN by cleaving the GENEIN molecule on the CHEMICALIN-terminal side of the dibasic peptide, Arg31-Arg32, joining the B-chain and  bbbbb2 CHEMICALIN eeeee2 -peptide
CPR:1	GENENOTIN is a GENENOTIN that initiates the sequential processing of GENEIN to GENENOTIN by cleaving the  bbbbb1 GENEIN eeeee1  molecule on the CHEMICALIN-terminal side of the dibasic peptide, Arg31-Arg32, joining the B-chain and  bbbbb2 CHEMICALIN eeeee2 -peptide
CPR:3	Expressions of  bbbbb1 GENEIN eeeee1  and GENEIN, but not GENEIN, are coordinately regulated by  bbbbb2 CHEMICALIN eeeee2 , consistent with the important role of GENENOTIN in regulating GENENOTIN processing
CPR:3	Expressions of GENEIN and  bbbbb1 GENEIN eeeee1 , but not GENEIN, are coordinately regulated by  bbbbb2 CHEMICALIN eeeee2 , consistent with the important role of GENENOTIN in regulating GENENOTIN processing
CPR:10	Administration of  bbbbb1 CHEMICALIN eeeee1  for 14 or 21 days did not further reduce the number of  bbbbb2 GENEIN eeeee2 
CPR:4	The present results suggest that the action of  bbbbb1 CHEMICALIN eeeee1  in this animal model is unlikely to be directly related to a reduction in  bbbbb2 GENEIN eeeee2  but may be related to a reduction in frontal cortical GENEIN receptors.
CPR:4	After 7 days of  bbbbb1 CHEMICALIN eeeee1  administration the number of  bbbbb2 GENEIN eeeee2  was lower in frontal and occipital cortex and hippocampus
CPR:4	The  bbbbb1 CHEMICALIN eeeee1  induced reduction in  bbbbb2 GENEIN eeeee2  did not differ in OB and sham-operated control rats. 5
CPR:4	 bbbbb1 CHEMICALIN eeeee1  administration for up to 21 days produced a progressive reduction in the number of  bbbbb2 GENEIN eeeee2  receptors in frontal cortex, without significant alterations in occipital cortex. 6
CPR:4	The time course of the reduction in the number of  bbbbb1 GENEIN eeeee1  receptors was similar to that of the  bbbbb2 CHEMICALIN eeeee2 -induced behavioural changes whereas that for the reduction in GENEIN was clearly different. 7
CPR:4	The time course of the reduction in the number of GENEIN receptors was similar to that of the  bbbbb1 CHEMICALIN eeeee1 -induced behavioural changes whereas that for the reduction in  bbbbb2 GENEIN eeeee2  was clearly different. 7
CPR:4	The present results suggest that the action of  bbbbb1 CHEMICALIN eeeee1  in this animal model is unlikely to be directly related to a reduction in GENEIN but may be related to a reduction in frontal cortical  bbbbb2 GENEIN eeeee2  receptors.
CPR:2	We show that the binding of  bbbbb1 CHEMICALIN eeeee1  photoaffinity label to authentic  bbbbb2 GENEIN eeeee2  is competed with both CHEMICALIN and the nonradioactive photoaffinity label at concentrations comparable to those required for inhibition of production of GENEIN from human monocytes, suggesting that GENEIN may be involved in the immunomodulatory activity of CHEMICALIN.
CPR:2	Binding of  bbbbb1 CHEMICALIN eeeee1  to  bbbbb2 GENEIN eeeee2  may be involved in its inhibition of GENEIN production
CPR:2	We show that the binding of CHEMICALIN photoaffinity label to authentic GENEIN is competed with both CHEMICALIN and the nonradioactive photoaffinity label at concentrations comparable to those required for inhibition of production of GENEIN from human monocytes, suggesting that  bbbbb1 GENEIN eeeee1  may be involved in the immunomodulatory activity of  bbbbb2 CHEMICALIN eeeee2 .
CPR:4	We show that the binding of CHEMICALIN photoaffinity label to authentic GENEIN is competed with both  bbbbb1 CHEMICALIN eeeee1  and the nonradioactive photoaffinity label at concentrations comparable to those required for inhibition of production of  bbbbb2 GENEIN eeeee2  from human monocytes, suggesting that GENEIN may be involved in the immunomodulatory activity of CHEMICALIN.
CPR:4	Binding of  bbbbb1 CHEMICALIN eeeee1  to GENEIN may be involved in its inhibition of  bbbbb2 GENEIN eeeee2  production
CPR:4	The immunomodulatory activity of  bbbbb1 CHEMICALIN eeeee1  has been ascribed to the selective inhibition of  bbbbb2 GENEIN eeeee2  from monocytes
CPR:2	Coexpression of the flip and flop splice variants of  bbbbb1 GENEIN eeeee1 , in the absence of GENENOTIN, revealed that heteromeric GENEIN with intermediate sensitivity to  bbbbb2 CHEMICALIN eeeee2 , similar to responses observed for the combinations GENEIN or GENEIN, could be generated independently of the presence of the GENEIN subunit
CPR:2	Coexpression of the flip and flop splice variants of GENEIN, in the absence of GENENOTIN, revealed that heteromeric GENEIN with intermediate sensitivity to  bbbbb1 CHEMICALIN eeeee1 , similar to responses observed for the combinations  bbbbb2 GENEIN eeeee2  or GENEIN, could be generated independently of the presence of the GENEIN subunit
CPR:2	Coexpression of the flip and flop splice variants of GENEIN, in the absence of GENENOTIN, revealed that heteromeric GENEIN with intermediate sensitivity to  bbbbb1 CHEMICALIN eeeee1 , similar to responses observed for the combinations GENEIN or  bbbbb2 GENEIN eeeee2 , could be generated independently of the presence of the GENEIN subunit
CPR:2	Coexpression of the flip and flop splice variants of GENEIN, in the absence of GENENOTIN, revealed that heteromeric GENEIN with intermediate sensitivity to  bbbbb1 CHEMICALIN eeeee1 , similar to responses observed for the combinations GENEIN or GENEIN, could be generated independently of the presence of the  bbbbb2 GENEIN eeeee2  subunit
CPR:2	However, recovery from modulation by  bbbbb1 CHEMICALIN eeeee1  was twofold slower for  bbbbb2 GENEIN eeeee2  than for homomeric GENEIN, indicating that the GENEIN and GENEIN subunits are not functionally equivalent in controlling sensitivity to CHEMICALIN. 5
CPR:2	However, recovery from modulation by  bbbbb1 CHEMICALIN eeeee1  was twofold slower for GENEIN than for homomeric  bbbbb2 GENEIN eeeee2 , indicating that the GENEIN and GENEIN subunits are not functionally equivalent in controlling sensitivity to CHEMICALIN. 5
CPR:2	The kinetics of onset of CHEMICALNOTIN GENEIN desensitization by CHEMICALIN, and the extent of attenuation of  bbbbb1 GENEIN eeeee1  desensitization by  bbbbb2 CHEMICALIN eeeee2 , showed pronounced cell-to-cell variation in cultures of rat hippocampal neurons
CPR:2	The complex patterns of sensitivity to  bbbbb1 CHEMICALIN eeeee1  seen in hippocampal neurons could be reconstituted by assembly of recombinant  bbbbb2 GENEIN eeeee2  subunits generated from cDNAs encoding the flip (i) and flop (o) splice variants of the GENEIN and GENEIN subunits
CPR:2	The complex patterns of sensitivity to  bbbbb1 CHEMICALIN eeeee1  seen in hippocampal neurons could be reconstituted by assembly of recombinant GENEIN subunits generated from cDNAs encoding the flip (i) and flop (o) splice variants of the  bbbbb2 GENEIN eeeee2  and GENEIN subunits
CPR:2	The complex patterns of sensitivity to  bbbbb1 CHEMICALIN eeeee1  seen in hippocampal neurons could be reconstituted by assembly of recombinant GENEIN subunits generated from cDNAs encoding the flip (i) and flop (o) splice variants of the GENEIN and  bbbbb2 GENEIN eeeee2  subunits
CPR:2	Recovery from modulation by  bbbbb1 CHEMICALIN eeeee1  was slower for  bbbbb2 GENEIN eeeee2  and GENEIN than for GENEIN and GENEIN. 4
CPR:2	Recovery from modulation by  bbbbb1 CHEMICALIN eeeee1  was slower for GENEIN and  bbbbb2 GENEIN eeeee2  than for GENEIN and GENEIN. 4
CPR:2	Recovery from modulation by  bbbbb1 CHEMICALIN eeeee1  was slower for GENEIN and GENEIN than for  bbbbb2 GENEIN eeeee2  and GENEIN. 4
CPR:2	Recovery from modulation by  bbbbb1 CHEMICALIN eeeee1  was slower for GENEIN and GENEIN than for GENEIN and  bbbbb2 GENEIN eeeee2 . 4
CPR:2	The kinetics of onset of CHEMICALNOTIN  bbbbb1 GENEIN eeeee1  desensitization by  bbbbb2 CHEMICALIN eeeee2 , and the extent of attenuation of GENEIN desensitization by CHEMICALIN, showed pronounced cell-to-cell variation in cultures of rat hippocampal neurons
CPR:2	Coexpression of the flip and flop splice variants of GENEIN, in the absence of GENENOTIN, revealed that heteromeric  bbbbb1 GENEIN eeeee1  with intermediate sensitivity to  bbbbb2 CHEMICALIN eeeee2 , similar to responses observed for the combinations GENEIN or GENEIN, could be generated independently of the presence of the GENEIN subunit
CPR:2	However, recovery from modulation by CHEMICALIN was twofold slower for GENEIN than for homomeric GENEIN, indicating that the  bbbbb1 GENEIN eeeee1  and GENEIN subunits are not functionally equivalent in controlling sensitivity to  bbbbb2 CHEMICALIN eeeee2 . 5
CPR:2	However, recovery from modulation by CHEMICALIN was twofold slower for GENEIN than for homomeric GENEIN, indicating that the GENEIN and  bbbbb1 GENEIN eeeee1  subunits are not functionally equivalent in controlling sensitivity to  bbbbb2 CHEMICALIN eeeee2 . 5
CPR:2	Striatal GENENOTIN protein (-25 to -46%) and GENENOTIN (-17 to -22%) were reduced, whereas  bbbbb1 GENEIN eeeee1  determined by  bbbbb2 CHEMICALIN eeeee2  binding was normal
CPR:4	In conclusion, our data suggest that chronic  bbbbb1 CHEMICALIN eeeee1  use is associated with modestly reduced levels of striatal CHEMICALNOTIN and the  bbbbb2 GENEIN eeeee2  in some subjects and that these changes might contribute to the neurological and psychiatric effects of the drug.
CPR:1	The predicted structure of  bbbbb1 GENEIN eeeee1  showed three GENEIN, a GENEIN and a GENEIN, from its  bbbbb2 CHEMICALIN eeeee2 -terminus, although GENEIN has a GENEIN, an GENEIN, a GENEIN, an GENEIN, a GENEIN, and a GENEIN, from its CHEMICALIN-terminus.
CPR:1	The predicted structure of GENEIN showed three  bbbbb1 GENEIN eeeee1 , a GENEIN and a GENEIN, from its  bbbbb2 CHEMICALIN eeeee2 -terminus, although GENEIN has a GENEIN, an GENEIN, a GENEIN, an GENEIN, a GENEIN, and a GENEIN, from its CHEMICALIN-terminus.
CPR:1	The predicted structure of GENEIN showed three GENEIN, a  bbbbb1 GENEIN eeeee1  and a GENEIN, from its  bbbbb2 CHEMICALIN eeeee2 -terminus, although GENEIN has a GENEIN, an GENEIN, a GENEIN, an GENEIN, a GENEIN, and a GENEIN, from its CHEMICALIN-terminus.
CPR:1	The predicted structure of GENEIN showed three GENEIN, a GENEIN and a  bbbbb1 GENEIN eeeee1 , from its  bbbbb2 CHEMICALIN eeeee2 -terminus, although GENEIN has a GENEIN, an GENEIN, a GENEIN, an GENEIN, a GENEIN, and a GENEIN, from its CHEMICALIN-terminus.
CPR:1	The predicted structure of GENEIN showed three GENEIN, a GENEIN and a GENEIN, from its CHEMICALIN-terminus, although  bbbbb1 GENEIN eeeee1  has a GENEIN, an GENEIN, a GENEIN, an GENEIN, a GENEIN, and a GENEIN, from its  bbbbb2 CHEMICALIN eeeee2 -terminus.
CPR:1	The predicted structure of GENEIN showed three GENEIN, a GENEIN and a GENEIN, from its CHEMICALIN-terminus, although GENEIN has a  bbbbb1 GENEIN eeeee1 , an GENEIN, a GENEIN, an GENEIN, a GENEIN, and a GENEIN, from its  bbbbb2 CHEMICALIN eeeee2 -terminus.
CPR:1	The predicted structure of GENEIN showed three GENEIN, a GENEIN and a GENEIN, from its CHEMICALIN-terminus, although GENEIN has a GENEIN, an  bbbbb1 GENEIN eeeee1 , a GENEIN, an GENEIN, a GENEIN, and a GENEIN, from its  bbbbb2 CHEMICALIN eeeee2 -terminus.
CPR:1	The predicted structure of GENEIN showed three GENEIN, a GENEIN and a GENEIN, from its CHEMICALIN-terminus, although GENEIN has a GENEIN, an GENEIN, a  bbbbb1 GENEIN eeeee1 , an GENEIN, a GENEIN, and a GENEIN, from its  bbbbb2 CHEMICALIN eeeee2 -terminus.
CPR:1	The predicted structure of GENEIN showed three GENEIN, a GENEIN and a GENEIN, from its CHEMICALIN-terminus, although GENEIN has a GENEIN, an GENEIN, a GENEIN, an  bbbbb1 GENEIN eeeee1 , a GENEIN, and a GENEIN, from its  bbbbb2 CHEMICALIN eeeee2 -terminus.
CPR:1	The predicted structure of GENEIN showed three GENEIN, a GENEIN and a GENEIN, from its CHEMICALIN-terminus, although GENEIN has a GENEIN, an GENEIN, a GENEIN, an GENEIN, a  bbbbb1 GENEIN eeeee1 , and a GENEIN, from its  bbbbb2 CHEMICALIN eeeee2 -terminus.
CPR:1	The predicted structure of GENEIN showed three GENEIN, a GENEIN and a GENEIN, from its CHEMICALIN-terminus, although GENEIN has a GENEIN, an GENEIN, a GENEIN, an GENEIN, a GENEIN, and a  bbbbb1 GENEIN eeeee1 , from its  bbbbb2 CHEMICALIN eeeee2 -terminus.
CPR:1	Thus,  bbbbb1 GENEIN eeeee1  was a heterodimer composed of 50-kDa and 17-kDa subunits, bridged by a  bbbbb2 CHEMICALIN eeeee2  linkage
CPR:1	The  bbbbb1 CHEMICALIN eeeee1  sequence deduced from the CHEMICALIN sequence of the cloned  bbbbb2 GENEIN eeeee2  cDNA exhibited significant homology to that of GENENOTIN (GENENOTIN)
CPR:1	The CHEMICALIN sequence deduced from the  bbbbb1 CHEMICALIN eeeee1  sequence of the cloned  bbbbb2 GENEIN eeeee2  cDNA exhibited significant homology to that of GENENOTIN (GENENOTIN)
CPR:2	It appears likely that the  bbbbb1 GENEIN eeeee1  blocked by CHEMICALIN obviated the pulmonary vasodilator effect of  bbbbb2 CHEMICALIN eeeee2  therapy.
CPR:4	It appears likely that the  bbbbb1 GENEIN eeeee1  blocked by  bbbbb2 CHEMICALIN eeeee2  obviated the pulmonary vasodilator effect of CHEMICALIN therapy.
CPR:2	In conclusion,  bbbbb1 CHEMICALIN eeeee1  and the CHEMICALIN seem to bind to different sites on  bbbbb2 GENEIN eeeee2  but exert strong allosteric interactions with one another and with other domains such as the agonist recognition site
CPR:2	In conclusion, CHEMICALIN and the  bbbbb1 CHEMICALIN eeeee1  seem to bind to different sites on  bbbbb2 GENEIN eeeee2  but exert strong allosteric interactions with one another and with other domains such as the agonist recognition site
CPR:2	The interactions of  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN on  bbbbb2 GENEIN eeeee2 -mediated e.p.s.cs in area CA1 of hippocampal slices provide evidence that the decay time constant of these synaptic events are not governed by desensitization.
CPR:2	The interactions of CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  on  bbbbb2 GENEIN eeeee2 -mediated e.p.s.cs in area CA1 of hippocampal slices provide evidence that the decay time constant of these synaptic events are not governed by desensitization.
CPR:2	 bbbbb1 CHEMICALIN eeeee1  (330 microM) shifted the concentration-response curve for the effects of CHEMICALIN on  bbbbb2 GENEIN eeeee2 -mediated e.p.s.c. peak amplitude to the right (CHEMICALNOTIN IC50 26.9 +/- 9.4 microM)
CPR:2	CHEMICALIN (330 microM) shifted the concentration-response curve for the effects of  bbbbb1 CHEMICALIN eeeee1  on  bbbbb2 GENEIN eeeee2 -mediated e.p.s.c. peak amplitude to the right (CHEMICALNOTIN IC50 26.9 +/- 9.4 microM)
CPR:2	Likewise,  bbbbb1 CHEMICALIN eeeee1  (30-100 microM)) shifted the concentration-response curve for the effects of CHEMICALIN on  bbbbb2 GENEIN eeeee2 -mediated e.p.s.c. decay time constants to the right. 8
CPR:2	Likewise, CHEMICALIN (30-100 microM)) shifted the concentration-response curve for the effects of  bbbbb1 CHEMICALIN eeeee1  on  bbbbb2 GENEIN eeeee2 -mediated e.p.s.c. decay time constants to the right. 8
CPR:2	nteractions of  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN at  bbbbb2 GENEIN eeeee2 : patch clamp recordings in cultured neurones and area CA1 in hippocampal slices. 1
CPR:2	nteractions of CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  at  bbbbb2 GENEIN eeeee2 : patch clamp recordings in cultured neurones and area CA1 in hippocampal slices. 1
CPR:4	 bbbbb1 CHEMICALIN eeeee1  decreased the peak amplitude of hippocampal area CA1  bbbbb2 GENEIN eeeee2 -mediated excitatory postsynaptic currents (e.p.s.cs) (IC50 10.8 +/- 0.8 microM) with no apparent effect on response kinetics
CPR:4	 bbbbb1 CHEMICALIN eeeee1  prolonged the decay time constant of  bbbbb2 GENEIN eeeee2 -mediated e.p.s.cs (EC50 35.7 +/- 6.5 microM) with less pronounced effects in slowing e.p.s.c. onset kinetics and increasing e.p.s.c. amplitude. 7
CPR:2	 bbbbb1 CHEMICALIN eeeee1  was the most selective compound for the high affinity state of the  bbbbb2 GENEIN eeeee2 , displaying 7-, 23- and 9-fold higher affinity than GENENOTIN, GENENOTIN and platelet GENENOTIN, respectively
CPR:2	To identify selective compounds for nonadrenergic GENENOTIN (GENENOTIN), the affinities of 22 ligands for  bbbbb1 CHEMICALIN eeeee1  binding have been compared at  bbbbb2 GENEIN eeeee2  (analyzed under CHEMICALNOTIN mask of GENENOTIN) and at GENENOTIN, GENENOTIN and GENENOTIN stably expressed on transfected Chinese hamster ovary cells
CPR:3	Activation of cytoprotective  bbbbb1 GENEIN eeeee1  by  bbbbb2 CHEMICALIN eeeee2  as a possible explanation for its hair growth-stimulating effect
CPR:3	We thus speculated that activation of  bbbbb1 GENEIN eeeee1  might be a mechanism by which  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) stimulates hair growth in vivo
CPR:3	We thus speculated that activation of  bbbbb1 GENEIN eeeee1  might be a mechanism by which CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) stimulates hair growth in vivo
CPR:3	We demonstrate here that  bbbbb1 CHEMICALIN eeeee1  is a potent activator of purified  bbbbb2 GENEIN eeeee2  (AC50 = 80 microM), as assayed by CHEMICALNOTIN consumption and PGE2 production
CPR:1	In Drosophila,  bbbbb1 GENEIN eeeee1  is a multifunctional synthetase encoded by a unique gene and composed of three domains: the  bbbbb2 CHEMICALIN eeeee2 - and CHEMICALIN-terminal domains catalyze the aminoacylation of CHEMICALIN and proline tRNA species, respectively, and the central domain is made of 75 CHEMICALIN repeated six times amongst which 46 are highly conserved and constitute the repeated motifs [Cerini, C., Kerjan, P., Astier, M., Gratecos, D., Mirande, M. & Semeriva, M. (1991) EMBO J. 10, 4267-4277]
CPR:1	In Drosophila,  bbbbb1 GENEIN eeeee1  is a multifunctional synthetase encoded by a unique gene and composed of three domains: the CHEMICALIN- and  bbbbb2 CHEMICALIN eeeee2 -terminal domains catalyze the aminoacylation of CHEMICALIN and proline tRNA species, respectively, and the central domain is made of 75 CHEMICALIN repeated six times amongst which 46 are highly conserved and constitute the repeated motifs [Cerini, C., Kerjan, P., Astier, M., Gratecos, D., Mirande, M. & Semeriva, M. (1991) EMBO J. 10, 4267-4277]
CPR:1	In Drosophila,  bbbbb1 GENEIN eeeee1  is a multifunctional synthetase encoded by a unique gene and composed of three domains: the CHEMICALIN- and CHEMICALIN-terminal domains catalyze the aminoacylation of  bbbbb2 CHEMICALIN eeeee2  and proline tRNA species, respectively, and the central domain is made of 75 CHEMICALIN repeated six times amongst which 46 are highly conserved and constitute the repeated motifs [Cerini, C., Kerjan, P., Astier, M., Gratecos, D., Mirande, M. & Semeriva, M. (1991) EMBO J. 10, 4267-4277]
CPR:1	In Drosophila,  bbbbb1 GENEIN eeeee1  is a multifunctional synthetase encoded by a unique gene and composed of three domains: the CHEMICALIN- and CHEMICALIN-terminal domains catalyze the aminoacylation of CHEMICALIN and proline tRNA species, respectively, and the central domain is made of 75  bbbbb2 CHEMICALIN eeeee2  repeated six times amongst which 46 are highly conserved and constitute the repeated motifs [Cerini, C., Kerjan, P., Astier, M., Gratecos, D., Mirande, M. & Semeriva, M. (1991) EMBO J. 10, 4267-4277]
CPR:2	Binding and transactivation assays were used to compare affinities and transcriptional activities of CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  for the  bbbbb2 GENEIN eeeee2 , GENEIN (GENEIN)
CPR:2	Binding and transactivation assays were used to compare affinities and transcriptional activities of CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  for the GENEIN,  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:2	Binding and transactivation assays were used to compare affinities and transcriptional activities of CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  for the GENEIN, GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:2	Binding and transactivation assays were used to compare affinities and transcriptional activities of  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN for the  bbbbb2 GENEIN eeeee2 , GENEIN (GENEIN)
CPR:2	Binding and transactivation assays were used to compare affinities and transcriptional activities of  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN for the GENEIN,  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:2	Binding and transactivation assays were used to compare affinities and transcriptional activities of  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN for the GENEIN, GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:2	The  bbbbb1 GENEIN eeeee1  GENEIN and GENEIN mediate the CHEMICALNOTIN activity of  bbbbb2 CHEMICALIN eeeee2 .
CPR:2	The GENEIN  bbbbb1 GENEIN eeeee1  and GENEIN mediate the CHEMICALNOTIN activity of  bbbbb2 CHEMICALIN eeeee2 .
CPR:2	The GENEIN GENEIN and  bbbbb1 GENEIN eeeee1  mediate the CHEMICALNOTIN activity of  bbbbb2 CHEMICALIN eeeee2 .
CPR:10	On the contrary, pretreatment with  bbbbb1 CHEMICALIN eeeee1  worsened CHEMICALIN-induced erosions, however, did not affect gastric mucus secretion,  bbbbb2 GENEIN eeeee2  content or CHEMICALNOTIN levels, although the non-protein CHEMICALNOTIN fraction was significantly decreased
CPR:2	On the contrary, pretreatment with CHEMICALIN worsened  bbbbb1 CHEMICALIN eeeee1 -induced erosions, however, did not affect gastric mucus secretion,  bbbbb2 GENEIN eeeee2  content or CHEMICALNOTIN levels, although the non-protein CHEMICALNOTIN fraction was significantly decreased
CPR:2	We suggest that  bbbbb1 CHEMICALIN eeeee1  dependent mechanisms through  bbbbb2 GENEIN eeeee2  receptor blockade and GENEIN receptor activation could be also involved.
CPR:2	We suggest that  bbbbb1 CHEMICALIN eeeee1  dependent mechanisms through GENEIN receptor blockade and  bbbbb2 GENEIN eeeee2  receptor activation could be also involved.
CPR:5	This study was designed to determine the gastroprotective properties of  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a novel prokinetic CHEMICALIN derivative agonist of  bbbbb2 GENEIN eeeee2  and GENEIN receptors and GENEIN antagonist, on mucosal injury produced by 50% (v/v) CHEMICALNOTIN
CPR:5	This study was designed to determine the gastroprotective properties of  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a novel prokinetic CHEMICALIN derivative agonist of GENEIN and  bbbbb2 GENEIN eeeee2  receptors and GENEIN antagonist, on mucosal injury produced by 50% (v/v) CHEMICALNOTIN
CPR:5	This study was designed to determine the gastroprotective properties of CHEMICALIN (CHEMICALIN), a novel prokinetic  bbbbb1 CHEMICALIN eeeee1  derivative agonist of  bbbbb2 GENEIN eeeee2  and GENEIN receptors and GENEIN antagonist, on mucosal injury produced by 50% (v/v) CHEMICALNOTIN
CPR:5	This study was designed to determine the gastroprotective properties of CHEMICALIN (CHEMICALIN), a novel prokinetic  bbbbb1 CHEMICALIN eeeee1  derivative agonist of GENEIN and  bbbbb2 GENEIN eeeee2  receptors and GENEIN antagonist, on mucosal injury produced by 50% (v/v) CHEMICALNOTIN
CPR:5	This study was designed to determine the gastroprotective properties of CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a novel prokinetic CHEMICALIN derivative agonist of  bbbbb2 GENEIN eeeee2  and GENEIN receptors and GENEIN antagonist, on mucosal injury produced by 50% (v/v) CHEMICALNOTIN
CPR:5	This study was designed to determine the gastroprotective properties of CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a novel prokinetic CHEMICALIN derivative agonist of GENEIN and  bbbbb2 GENEIN eeeee2  receptors and GENEIN antagonist, on mucosal injury produced by 50% (v/v) CHEMICALNOTIN
CPR:6	This study was designed to determine the gastroprotective properties of  bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN), a novel prokinetic CHEMICALIN derivative agonist of GENEIN and GENEIN receptors and  bbbbb2 GENEIN eeeee2  antagonist, on mucosal injury produced by 50% (v/v) CHEMICALNOTIN
CPR:6	This study was designed to determine the gastroprotective properties of CHEMICALIN (CHEMICALIN), a novel prokinetic  bbbbb1 CHEMICALIN eeeee1  derivative agonist of GENEIN and GENEIN receptors and  bbbbb2 GENEIN eeeee2  antagonist, on mucosal injury produced by 50% (v/v) CHEMICALNOTIN
CPR:6	This study was designed to determine the gastroprotective properties of CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ), a novel prokinetic CHEMICALIN derivative agonist of GENEIN and GENEIN receptors and  bbbbb2 GENEIN eeeee2  antagonist, on mucosal injury produced by 50% (v/v) CHEMICALNOTIN
CPR:9	We have identified  bbbbb1 GENEIN eeeee1 , an enzyme involved in  bbbbb2 CHEMICALIN eeeee2  metabolism whose deficiency is associated with severe combined immunodeficiency, as a GENENOTIN binding protein that is not able to bind to GENENOTIN
CPR:10	 bbbbb1 CHEMICALIN eeeee1  inhibited GENEIN with an IC50 value of 23 microM, GENEIN with an IC50 value of 2 microM, and did not inhibit  bbbbb2 GENEIN eeeee2  at concentrations up to 1 mM
CPR:1	 bbbbb1 GENEIN eeeee1  inhibition by CHEMICALIN or CHEMICALIN was diminished by the metal chelating agent CHEMICALIN, or by the reducing agent CHEMICALIN, suggesting that a metal ion and the oxidation of a  bbbbb2 CHEMICALIN eeeee2  residue are required for full inhibition
CPR:2	These observations show substrate- and enzyme-specific GENEIN inhibition by CHEMICALIN and support the possibility that a certain  bbbbb1 GENEIN eeeee1 (s) may be the molecular target for  bbbbb2 CHEMICALIN eeeee2  action.
CPR:2	The hydrolysis of fluorescein CHEMICALIN by  bbbbb1 GENEIN eeeee1  and GENEIN was sensitive to  bbbbb2 CHEMICALIN eeeee2 , with IC50 values of less than 1 microM; GENEIN, however, under the same conditions, was inhibited by only 50% with 141 microM CHEMICALIN
CPR:2	The hydrolysis of fluorescein CHEMICALIN by GENEIN and  bbbbb1 GENEIN eeeee1  was sensitive to  bbbbb2 CHEMICALIN eeeee2 , with IC50 values of less than 1 microM; GENEIN, however, under the same conditions, was inhibited by only 50% with 141 microM CHEMICALIN
CPR:2	Similarly, with the GENENOTIN-pY527 substrate,  bbbbb1 CHEMICALIN eeeee1  inhibition was also  bbbbb2 GENEIN eeeee2  dependent
CPR:2	 bbbbb1 GENEIN eeeee1  inhibition by CHEMICALIN or CHEMICALIN was diminished by the metal chelating agent  bbbbb2 CHEMICALIN eeeee2 , or by the reducing agent CHEMICALIN, suggesting that a metal ion and the oxidation of a CHEMICALIN residue are required for full inhibition
CPR:2	 bbbbb1 GENEIN eeeee1  inhibition by CHEMICALIN or CHEMICALIN was diminished by the metal chelating agent CHEMICALIN, or by the reducing agent  bbbbb2 CHEMICALIN eeeee2 , suggesting that a metal ion and the oxidation of a CHEMICALIN residue are required for full inhibition
CPR:4	Here we report that  bbbbb1 CHEMICALIN eeeee1  is a potent inhibitor of the  bbbbb2 GENEIN eeeee2  (GENEIN)
CPR:4	Here we report that  bbbbb1 CHEMICALIN eeeee1  is a potent inhibitor of the GENEIN ( bbbbb2 GENEIN eeeee2 )
CPR:4	With either substrate,  bbbbb1 CHEMICALIN eeeee1  was a slow binding inhibitor of  bbbbb2 GENEIN eeeee2 
CPR:4	Among the other  bbbbb1 CHEMICALIN eeeee1  studied, CHEMICALIN was more potent and selective for  bbbbb2 GENEIN eeeee2 
CPR:4	Among the other CHEMICALIN studied,  bbbbb1 CHEMICALIN eeeee1  was more potent and selective for  bbbbb2 GENEIN eeeee2 
CPR:4	The hydrolysis of fluorescein CHEMICALIN by GENEIN and GENEIN was sensitive to CHEMICALIN, with IC50 values of less than 1 microM;  bbbbb1 GENEIN eeeee1 , however, under the same conditions, was inhibited by only 50% with 141 microM  bbbbb2 CHEMICALIN eeeee2 
CPR:4	 bbbbb1 CHEMICALIN eeeee1  inhibited  bbbbb2 GENEIN eeeee2  with an IC50 value of 23 microM, GENEIN with an IC50 value of 2 microM, and did not inhibit GENEIN at concentrations up to 1 mM
CPR:4	 bbbbb1 CHEMICALIN eeeee1  inhibited GENEIN with an IC50 value of 23 microM,  bbbbb2 GENEIN eeeee2  with an IC50 value of 2 microM, and did not inhibit GENEIN at concentrations up to 1 mM
CPR:4	 bbbbb1 CHEMICALIN eeeee1  inhibition of  bbbbb2 GENEIN eeeee2 
CPR:4	The  bbbbb1 CHEMICALIN eeeee1  inhibition of these three  bbbbb2 GENEIN eeeee2  and two substrates is consistent with the formation of a ternary complex comprised of enzyme, substrate, and inhibitor
CPR:4	 bbbbb1 GENEIN eeeee1  inhibition by  bbbbb2 CHEMICALIN eeeee2  or CHEMICALIN was diminished by the metal chelating agent CHEMICALIN, or by the reducing agent CHEMICALIN, suggesting that a metal ion and the oxidation of a CHEMICALIN residue are required for full inhibition
CPR:4	 bbbbb1 GENEIN eeeee1  inhibition by CHEMICALIN or  bbbbb2 CHEMICALIN eeeee2  was diminished by the metal chelating agent CHEMICALIN, or by the reducing agent CHEMICALIN, suggesting that a metal ion and the oxidation of a CHEMICALIN residue are required for full inhibition
CPR:4	These observations show substrate- and enzyme-specific  bbbbb1 GENEIN eeeee1  inhibition by  bbbbb2 CHEMICALIN eeeee2  and support the possibility that a certain GENEIN(s) may be the molecular target for CHEMICALIN action.
CPR:9	The hydrolysis of fluorescein  bbbbb1 CHEMICALIN eeeee1  by  bbbbb2 GENEIN eeeee2  and GENEIN was sensitive to CHEMICALIN, with IC50 values of less than 1 microM; GENEIN, however, under the same conditions, was inhibited by only 50% with 141 microM CHEMICALIN
CPR:9	The hydrolysis of fluorescein  bbbbb1 CHEMICALIN eeeee1  by GENEIN and  bbbbb2 GENEIN eeeee2  was sensitive to CHEMICALIN, with IC50 values of less than 1 microM; GENEIN, however, under the same conditions, was inhibited by only 50% with 141 microM CHEMICALIN
CPR:10	The two receptors were discriminated by  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and CHEMICALIN that bound to the GENEIN receptor but not to the  bbbbb2 GENEIN eeeee2  receptor, and by CHEMICALIN that bound to the GENEIN but not to the GENEIN receptor. 6
CPR:10	The two receptors were discriminated by CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN that bound to the GENEIN receptor but not to the  bbbbb2 GENEIN eeeee2  receptor, and by CHEMICALIN that bound to the GENEIN but not to the GENEIN receptor. 6
CPR:10	The two receptors were discriminated by CHEMICALIN, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  that bound to the GENEIN receptor but not to the  bbbbb2 GENEIN eeeee2  receptor, and by CHEMICALIN that bound to the GENEIN but not to the GENEIN receptor. 6
CPR:10	The two receptors were discriminated by CHEMICALIN, CHEMICALIN and CHEMICALIN that bound to the GENEIN receptor but not to the GENEIN receptor, and by  bbbbb1 CHEMICALIN eeeee1  that bound to the GENEIN but not to the  bbbbb2 GENEIN eeeee2  receptor. 6
CPR:10	 bbbbb1 CHEMICALIN eeeee1  and two putative  bbbbb2 GENEIN eeeee2  antagonists, CHEMICALIN and CHEMICALIN, did not show any significant binding to this receptor
CPR:10	CHEMICALIN and two putative  bbbbb1 GENEIN eeeee1  antagonists,  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN, did not show any significant binding to this receptor
CPR:10	CHEMICALIN and two putative  bbbbb1 GENEIN eeeee1  antagonists, CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 , did not show any significant binding to this receptor
CPR:2	The two receptors were discriminated by  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and CHEMICALIN that bound to the  bbbbb2 GENEIN eeeee2  receptor but not to the GENEIN receptor, and by CHEMICALIN that bound to the GENEIN but not to the GENEIN receptor. 6
CPR:2	The two receptors were discriminated by CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN that bound to the  bbbbb2 GENEIN eeeee2  receptor but not to the GENEIN receptor, and by CHEMICALIN that bound to the GENEIN but not to the GENEIN receptor. 6
CPR:2	The two receptors were discriminated by CHEMICALIN, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  that bound to the  bbbbb2 GENEIN eeeee2  receptor but not to the GENEIN receptor, and by CHEMICALIN that bound to the GENEIN but not to the GENEIN receptor. 6
CPR:2	The two receptors were discriminated by CHEMICALIN, CHEMICALIN and CHEMICALIN that bound to the GENEIN receptor but not to the GENEIN receptor, and by  bbbbb1 CHEMICALIN eeeee1  that bound to the  bbbbb2 GENEIN eeeee2  but not to the GENEIN receptor. 6
CPR:2	The  bbbbb1 GENEIN eeeee1  receptor showed the broadest binding profile, and bound  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN, in addition to CHEMICALIN and CHEMICALIN, with Ki values of 0.6-3.7 nM
CPR:2	The  bbbbb1 GENEIN eeeee1  receptor showed the broadest binding profile, and bound CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN, in addition to CHEMICALIN and CHEMICALIN, with Ki values of 0.6-3.7 nM
CPR:2	The  bbbbb1 GENEIN eeeee1  receptor showed the broadest binding profile, and bound CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN and CHEMICALIN, in addition to CHEMICALIN and CHEMICALIN, with Ki values of 0.6-3.7 nM
CPR:2	The  bbbbb1 GENEIN eeeee1  receptor showed the broadest binding profile, and bound CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN and CHEMICALIN, in addition to CHEMICALIN and CHEMICALIN, with Ki values of 0.6-3.7 nM
CPR:2	The  bbbbb1 GENEIN eeeee1  receptor showed the broadest binding profile, and bound CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN, in addition to CHEMICALIN and CHEMICALIN, with Ki values of 0.6-3.7 nM
CPR:2	The  bbbbb1 GENEIN eeeee1  receptor showed the broadest binding profile, and bound CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 , in addition to CHEMICALIN and CHEMICALIN, with Ki values of 0.6-3.7 nM
CPR:2	The  bbbbb1 GENEIN eeeee1  receptor bound  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN and CHEMICALIN in addition to CHEMICALIN and CHEMICALIN, with Ki values of 14-36 nM
CPR:2	The  bbbbb1 GENEIN eeeee1  receptor showed the broadest binding profile, and bound CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN, in addition to  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN, with Ki values of 0.6-3.7 nM
CPR:2	The  bbbbb1 GENEIN eeeee1  receptor showed the broadest binding profile, and bound CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN and CHEMICALIN, in addition to CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 , with Ki values of 0.6-3.7 nM
CPR:2	In addition, three  bbbbb1 GENEIN eeeee1  ligands,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN and CHEMICALIN, and one GENEIN ligand, CHEMICALIN, bound to this receptor with Ki values comparable to the Ki values of these compounds for the CHEMICALNOTIN and GENENOTIN, respectively
CPR:2	In addition, three  bbbbb1 GENEIN eeeee1  ligands, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN, and one GENEIN ligand, CHEMICALIN, bound to this receptor with Ki values comparable to the Ki values of these compounds for the CHEMICALNOTIN and GENENOTIN, respectively
CPR:2	In addition, three  bbbbb1 GENEIN eeeee1  ligands, CHEMICALIN, CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 , and one GENEIN ligand, CHEMICALIN, bound to this receptor with Ki values comparable to the Ki values of these compounds for the CHEMICALNOTIN and GENENOTIN, respectively
CPR:2	In addition, three GENEIN ligands, CHEMICALIN, CHEMICALIN and CHEMICALIN, and one  bbbbb1 GENEIN eeeee1  ligand,  bbbbb2 CHEMICALIN eeeee2 , bound to this receptor with Ki values comparable to the Ki values of these compounds for the CHEMICALNOTIN and GENENOTIN, respectively
CPR:2	The  bbbbb1 GENEIN eeeee1  receptor bound CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN in addition to CHEMICALIN and CHEMICALIN, with Ki values of 14-36 nM
CPR:2	 bbbbb1 CHEMICALIN eeeee1  alpha showed only weak binding to the GENEIN, GENEIN, GENEIN, GENEIN and  bbbbb2 GENEIN eeeee2  receptor at 10 microM concentration.
CPR:2	 bbbbb1 CHEMICALIN eeeee1  alpha showed only weak binding to the  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN, GENEIN and GENEIN receptor at 10 microM concentration.
CPR:2	 bbbbb1 CHEMICALIN eeeee1  alpha showed only weak binding to the GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN, GENEIN and GENEIN receptor at 10 microM concentration.
CPR:2	 bbbbb1 CHEMICALIN eeeee1  alpha showed only weak binding to the GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2 , GENEIN and GENEIN receptor at 10 microM concentration.
CPR:2	 bbbbb1 CHEMICALIN eeeee1  alpha showed only weak binding to the GENEIN, GENEIN, GENEIN,  bbbbb2 GENEIN eeeee2  and GENEIN receptor at 10 microM concentration.
CPR:2	The  bbbbb1 GENEIN eeeee1  receptor bound CHEMICALIN, CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2  in addition to CHEMICALIN and CHEMICALIN, with Ki values of 14-36 nM
CPR:2	The GENENOTIN, GENENOTIN and GENENOTIN showed high ligand binding specificity and only bound their own putative ligands with high affinity such as  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and CHEMICALIN for  bbbbb2 GENEIN eeeee2 , CHEMICALIN, CHEMICALIN and CHEMICALIN for GENEIN, and CHEMICALIN, CHEMICALIN and CHEMICALIN for GENEIN. 3
CPR:2	The GENENOTIN, GENENOTIN and GENENOTIN showed high ligand binding specificity and only bound their own putative ligands with high affinity such as CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN for  bbbbb2 GENEIN eeeee2 , CHEMICALIN, CHEMICALIN and CHEMICALIN for GENEIN, and CHEMICALIN, CHEMICALIN and CHEMICALIN for GENEIN. 3
CPR:2	The GENENOTIN, GENENOTIN and GENENOTIN showed high ligand binding specificity and only bound their own putative ligands with high affinity such as CHEMICALIN, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  for  bbbbb2 GENEIN eeeee2 , CHEMICALIN, CHEMICALIN and CHEMICALIN for GENEIN, and CHEMICALIN, CHEMICALIN and CHEMICALIN for GENEIN. 3
CPR:2	The GENENOTIN, GENENOTIN and GENENOTIN showed high ligand binding specificity and only bound their own putative ligands with high affinity such as CHEMICALIN, CHEMICALIN and CHEMICALIN for GENEIN,  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and CHEMICALIN for  bbbbb2 GENEIN eeeee2 , and CHEMICALIN, CHEMICALIN and CHEMICALIN for GENEIN. 3
CPR:2	The GENENOTIN, GENENOTIN and GENENOTIN showed high ligand binding specificity and only bound their own putative ligands with high affinity such as CHEMICALIN, CHEMICALIN and CHEMICALIN for GENEIN, CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN for  bbbbb2 GENEIN eeeee2 , and CHEMICALIN, CHEMICALIN and CHEMICALIN for GENEIN. 3
CPR:2	The GENENOTIN, GENENOTIN and GENENOTIN showed high ligand binding specificity and only bound their own putative ligands with high affinity such as CHEMICALIN, CHEMICALIN and CHEMICALIN for GENEIN, CHEMICALIN, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  for  bbbbb2 GENEIN eeeee2 , and CHEMICALIN, CHEMICALIN and CHEMICALIN for GENEIN. 3
CPR:2	The  bbbbb1 GENEIN eeeee1  receptor bound CHEMICALIN, CHEMICALIN and CHEMICALIN in addition to  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN, with Ki values of 14-36 nM
CPR:2	The GENENOTIN, GENENOTIN and GENENOTIN showed high ligand binding specificity and only bound their own putative ligands with high affinity such as CHEMICALIN, CHEMICALIN and CHEMICALIN for GENEIN, CHEMICALIN, CHEMICALIN and CHEMICALIN for GENEIN, and  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN and CHEMICALIN for  bbbbb2 GENEIN eeeee2 . 3
CPR:2	The GENENOTIN, GENENOTIN and GENENOTIN showed high ligand binding specificity and only bound their own putative ligands with high affinity such as CHEMICALIN, CHEMICALIN and CHEMICALIN for GENEIN, CHEMICALIN, CHEMICALIN and CHEMICALIN for GENEIN, and CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN for  bbbbb2 GENEIN eeeee2 . 3
CPR:2	The GENENOTIN, GENENOTIN and GENENOTIN showed high ligand binding specificity and only bound their own putative ligands with high affinity such as CHEMICALIN, CHEMICALIN and CHEMICALIN for GENEIN, CHEMICALIN, CHEMICALIN and CHEMICALIN for GENEIN, and CHEMICALIN, CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  for  bbbbb2 GENEIN eeeee2 . 3
CPR:2	The  bbbbb1 GENEIN eeeee1  bound  bbbbb2 CHEMICALIN eeeee2  alpha and CHEMICALIN with Ki values of 3-4 nM
CPR:2	The  bbbbb1 GENEIN eeeee1  bound CHEMICALIN alpha and  bbbbb2 CHEMICALIN eeeee2  with Ki values of 3-4 nM
CPR:2	The  bbbbb1 GENEIN eeeee1  receptor bound CHEMICALIN, CHEMICALIN and CHEMICALIN in addition to CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 , with Ki values of 14-36 nM
CPR:5	 bbbbb1 CHEMICALIN eeeee1 , a putative  bbbbb2 GENEIN eeeee2  agonist, and CHEMICALIN, a putative GENEIN/GENEIN agonist, also bound to this receptor with Ki values of 120 nM. 5
CPR:5	CHEMICALIN, a putative GENEIN agonist, and  bbbbb1 CHEMICALIN eeeee1 , a putative  bbbbb2 GENEIN eeeee2 /GENEIN agonist, also bound to this receptor with Ki values of 120 nM. 5
CPR:5	CHEMICALIN, a putative GENEIN agonist, and  bbbbb1 CHEMICALIN eeeee1 , a putative GENEIN/ bbbbb2 GENEIN eeeee2  agonist, also bound to this receptor with Ki values of 120 nM. 5
CPR:6	CHEMICALIN and two putative  bbbbb1 GENEIN eeeee1  antagonists,  bbbbb2 CHEMICALIN eeeee2  and CHEMICALIN, did not show any significant binding to this receptor
CPR:6	CHEMICALIN and two putative  bbbbb1 GENEIN eeeee1  antagonists, CHEMICALIN and  bbbbb2 CHEMICALIN eeeee2 , did not show any significant binding to this receptor
CPR:1	GENEIN from Herpes simplex virus type 1 ( bbbbb1 GENEIN eeeee1 ) was crystallized in an  bbbbb2 CHEMICALIN eeeee2 -terminally truncated but fully active form
CPR:2	The structures of  bbbbb1 GENEIN eeeee1  complexed with  bbbbb2 CHEMICALIN eeeee2  at the CHEMICALNOTIN-site and CHEMICALNOTIN (CHEMICALNOTIN), CHEMICALNOTIN (CHEMICALNOTIN), or CHEMICALNOTIN (CHEMICALNOTIN) at the substrate-site were refined to 2.75 A, 2.8 A, and 3.0 A resolution, respectively
CPR:2	 bbbbb1 GENEIN eeeee1  from Herpes simplex virus type 1 (GENEIN) was crystallized in an  bbbbb2 CHEMICALIN eeeee2 -terminally truncated but fully active form
CPR:2	The  bbbbb1 GENEIN eeeee1  (GENEIN), which encodes the rapidly activating delayed rectifier CHEMICALNOTIN current and is important in cardiac repolarization, may serve as a target for the action of  bbbbb2 CHEMICALIN eeeee2 
CPR:2	The GENEIN ( bbbbb1 GENEIN eeeee1 ), which encodes the rapidly activating delayed rectifier CHEMICALNOTIN current and is important in cardiac repolarization, may serve as a target for the action of  bbbbb2 CHEMICALIN eeeee2 
CPR:4	At -20 mV, 10 nM  bbbbb1 CHEMICALIN eeeee1  reduced  bbbbb2 GENEIN eeeee2  tail-current amplitude by 5%, whereas, at + 20 mV, the tail-current amplitude was reduced by 45% (n = 4 cells)
CPR:4	Block of  bbbbb1 GENEIN eeeee1  with  bbbbb2 CHEMICALIN eeeee2  after channel activation was voltage dependent
CPR:4	Blockage of the  bbbbb1 GENEIN eeeee1  by the gastrointestinal prokinetic agent  bbbbb2 CHEMICALIN eeeee2 
CPR:4	We conclude that  bbbbb1 CHEMICALIN eeeee1  is a potent blocker of  bbbbb2 GENEIN eeeee2  channels expressed in HEK293 cells
CPR:4	We tested the hypothesis that  bbbbb1 CHEMICALIN eeeee1  blocks  bbbbb2 GENEIN eeeee2 
CPR:4	Under voltage-clamp conditions,  bbbbb1 CHEMICALIN eeeee1  block of  bbbbb2 GENEIN eeeee2  is dose dependent with a half-maximal inhibitory concentration of 6.5 nM at 22 degrees C (n = 25 cells)
CPR:2	 bbbbb1 GENEIN eeeee1  in postmortem human spinal cord were analyzed using  bbbbb2 CHEMICALIN eeeee2  ligand binding and immunoblotting with GENENOTIN subunit-specific antibodies
CPR:2	 bbbbb1 GENEIN eeeee1  and GENEIN mechanisms in the rapid pressor response to  bbbbb2 CHEMICALIN eeeee2 
CPR:2	GENEIN and  bbbbb1 GENEIN eeeee1  mechanisms in the rapid pressor response to  bbbbb2 CHEMICALIN eeeee2 
CPR:4	CHEMICALNOTIN uptake inhibitors structurally analogous to CHEMICALNOTIN (CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN, and CHEMICALNOTIN) also produced this rapid pressor response, whereas structurally unrelated uptake inhibitors with diverse  bbbbb1 GENEIN eeeee1  selectivities ( bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN) either did not produce a rapid pressor response or produced only a small pressor response
CPR:4	CHEMICALNOTIN uptake inhibitors structurally analogous to CHEMICALNOTIN (CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN, and CHEMICALNOTIN) also produced this rapid pressor response, whereas structurally unrelated uptake inhibitors with diverse  bbbbb1 GENEIN eeeee1  selectivities (CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN) either did not produce a rapid pressor response or produced only a small pressor response
CPR:4	CHEMICALNOTIN uptake inhibitors structurally analogous to CHEMICALNOTIN (CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN, and CHEMICALNOTIN) also produced this rapid pressor response, whereas structurally unrelated uptake inhibitors with diverse  bbbbb1 GENEIN eeeee1  selectivities (CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, and CHEMICALIN) either did not produce a rapid pressor response or produced only a small pressor response
CPR:4	CHEMICALNOTIN uptake inhibitors structurally analogous to CHEMICALNOTIN (CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN, and CHEMICALNOTIN) also produced this rapid pressor response, whereas structurally unrelated uptake inhibitors with diverse  bbbbb1 GENEIN eeeee1  selectivities (CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, and CHEMICALIN) either did not produce a rapid pressor response or produced only a small pressor response
CPR:4	CHEMICALNOTIN uptake inhibitors structurally analogous to CHEMICALNOTIN (CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN, and CHEMICALNOTIN) also produced this rapid pressor response, whereas structurally unrelated uptake inhibitors with diverse  bbbbb1 GENEIN eeeee1  selectivities (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , and CHEMICALIN) either did not produce a rapid pressor response or produced only a small pressor response
CPR:4	CHEMICALNOTIN uptake inhibitors structurally analogous to CHEMICALNOTIN (CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN, CHEMICALNOTIN, and CHEMICALNOTIN) also produced this rapid pressor response, whereas structurally unrelated uptake inhibitors with diverse  bbbbb1 GENEIN eeeee1  selectivities (CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and  bbbbb2 CHEMICALIN eeeee2 ) either did not produce a rapid pressor response or produced only a small pressor response
CPR:4	At nonconvulsant doses, the  bbbbb1 GENEIN eeeee1  blockers  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN produced a small pressor response or no increase in BP
CPR:4	At nonconvulsant doses, the  bbbbb1 GENEIN eeeee1  blockers CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN produced a small pressor response or no increase in BP
CPR:4	At nonconvulsant doses, the  bbbbb1 GENEIN eeeee1  blockers CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, CHEMICALIN, and CHEMICALIN produced a small pressor response or no increase in BP
CPR:4	At nonconvulsant doses, the  bbbbb1 GENEIN eeeee1  blockers CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, CHEMICALIN, and CHEMICALIN produced a small pressor response or no increase in BP
CPR:4	At nonconvulsant doses, the  bbbbb1 GENEIN eeeee1  blockers CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, and CHEMICALIN produced a small pressor response or no increase in BP
CPR:4	At nonconvulsant doses, the  bbbbb1 GENEIN eeeee1  blockers CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , and CHEMICALIN produced a small pressor response or no increase in BP
CPR:4	At nonconvulsant doses, the  bbbbb1 GENEIN eeeee1  blockers CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, CHEMICALIN, and  bbbbb2 CHEMICALIN eeeee2  produced a small pressor response or no increase in BP
CPR:4	The  bbbbb1 GENEIN eeeee1 -blocking action of  bbbbb2 CHEMICALIN eeeee2  per se does not appear to be involved in the rapid pressor response to CHEMICALNOTIN
CPR:6	Intravenous (I.V.) CHEMICALNOTIN (0.03-3 mg/kg) produced dose-dependent, rapid, and brief increases in blood pressure (BP) in conscious rats pretreated with the  bbbbb1 GENEIN eeeee1  antagonist,  bbbbb2 CHEMICALIN eeeee2 
CPR:10	Saturation and competition studies in the presence or absence of the GENEIN antagonist, CHEMICALIN, revealed that CHEMICALIN bound with similar affinities to both the  bbbbb1 CHEMICALIN eeeee1 -insensitive  bbbbb2 GENEIN eeeee2  (20% of the total binding population) and the recently cloned CHEMICALIN-sensitive GENEIN (80% of the receptors) (Kd = 6.8 and 4.8 nM, respectively)
CPR:2	In conclusion, these findings indicate that  bbbbb1 CHEMICALIN eeeee1  is a new potent antagonist radioligand which recognizes with high affinity both  bbbbb2 GENEIN eeeee2  and GENEIN and represents thus an excellent tool to study GENEIN in the rat brain.
CPR:2	In conclusion, these findings indicate that  bbbbb1 CHEMICALIN eeeee1  is a new potent antagonist radioligand which recognizes with high affinity both GENEIN and  bbbbb2 GENEIN eeeee2  and represents thus an excellent tool to study GENEIN in the rat brain.
CPR:2	Saturation and competition studies in the presence or absence of the GENEIN antagonist, CHEMICALIN, revealed that  bbbbb1 CHEMICALIN eeeee1  bound with similar affinities to both the CHEMICALIN-insensitive  bbbbb2 GENEIN eeeee2  (20% of the total binding population) and the recently cloned CHEMICALIN-sensitive GENEIN (80% of the receptors) (Kd = 6.8 and 4.8 nM, respectively)
CPR:2	Saturation and competition studies in the presence or absence of the GENEIN antagonist, CHEMICALIN, revealed that  bbbbb1 CHEMICALIN eeeee1  bound with similar affinities to both the CHEMICALIN-insensitive GENEIN (20% of the total binding population) and the recently cloned CHEMICALIN-sensitive  bbbbb2 GENEIN eeeee2  (80% of the receptors) (Kd = 6.8 and 4.8 nM, respectively)
CPR:2	In conclusion, these findings indicate that  bbbbb1 CHEMICALIN eeeee1  is a new potent antagonist radioligand which recognizes with high affinity both GENEIN and GENEIN and represents thus an excellent tool to study  bbbbb2 GENEIN eeeee2  in the rat brain.
CPR:2	Saturation and competition studies in the presence or absence of the GENEIN antagonist, CHEMICALIN, revealed that CHEMICALIN bound with similar affinities to both the CHEMICALIN-insensitive GENEIN (20% of the total binding population) and the recently cloned  bbbbb1 CHEMICALIN eeeee1 -sensitive  bbbbb2 GENEIN eeeee2  (80% of the receptors) (Kd = 6.8 and 4.8 nM, respectively)
CPR:6	In conclusion, these findings indicate that  bbbbb1 CHEMICALIN eeeee1  is a new potent antagonist radioligand which recognizes with high affinity both  bbbbb2 GENEIN eeeee2  and GENEIN and represents thus an excellent tool to study GENEIN in the rat brain.
CPR:6	In conclusion, these findings indicate that  bbbbb1 CHEMICALIN eeeee1  is a new potent antagonist radioligand which recognizes with high affinity both GENEIN and  bbbbb2 GENEIN eeeee2  and represents thus an excellent tool to study GENEIN in the rat brain.
CPR:6	The present study describes the characterization of the binding properties and autoradiographic distribution of a new nonpeptide antagonist of  bbbbb1 GENEIN eeeee1 ,  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN), in the rat brain
CPR:6	The present study describes the characterization of the binding properties and autoradiographic distribution of a new nonpeptide antagonist of  bbbbb1 GENEIN eeeee1 , CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ), in the rat brain
CPR:6	Characterization of binding sites of a new  bbbbb1 GENEIN eeeee1  antagonist,  bbbbb2 CHEMICALIN eeeee2 , in the rat brain
CPR:6	Saturation and competition studies in the presence or absence of the  bbbbb1 GENEIN eeeee1  antagonist,  bbbbb2 CHEMICALIN eeeee2 , revealed that CHEMICALIN bound with similar affinities to both the CHEMICALIN-insensitive GENEIN (20% of the total binding population) and the recently cloned CHEMICALIN-sensitive GENEIN (80% of the receptors) (Kd = 6.8 and 4.8 nM, respectively)
CPR:2	The  bbbbb1 CHEMICALIN eeeee1  action of CHEMICALIN are mediated by the GENEIN GENENOTIN  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:2	The  bbbbb1 CHEMICALIN eeeee1  action of CHEMICALIN are mediated by the GENEIN GENENOTIN GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:2	The  bbbbb1 CHEMICALIN eeeee1  action of CHEMICALIN are mediated by the  bbbbb2 GENEIN eeeee2  GENENOTIN GENEIN and GENEIN
CPR:2	The CHEMICALIN action of  bbbbb1 CHEMICALIN eeeee1  are mediated by the GENEIN GENENOTIN  bbbbb2 GENEIN eeeee2  and GENEIN
CPR:2	The CHEMICALIN action of  bbbbb1 CHEMICALIN eeeee1  are mediated by the GENEIN GENENOTIN GENEIN and  bbbbb2 GENEIN eeeee2 
CPR:2	The CHEMICALIN action of  bbbbb1 CHEMICALIN eeeee1  are mediated by the  bbbbb2 GENEIN eeeee2  GENENOTIN GENEIN and GENEIN
CPR:2	Intrinsic, gating-independent  bbbbb1 GENEIN eeeee1  binding affinity differences must be invoked to explain the isoform-specific sensitivity of the  bbbbb2 CHEMICALIN eeeee2  block.
CPR:2	We expressed cardiac or  bbbbb1 GENEIN eeeee1  subunits in combination with beta2a and alpha2/delta subunits in human embryonic kidney cells, and used 2 mM  bbbbb2 CHEMICALIN eeeee2  as the permeant ion
CPR:4	Isoform-specific inhibition of  bbbbb1 GENEIN eeeee1  by  bbbbb2 CHEMICALIN eeeee2  is independent of isoform-specific gating properties
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (CHEMICALIN) block  bbbbb2 GENEIN eeeee2  more potently at depolarized membrane potentials, consistent with high affinity binding to the inactivated state
CPR:4	We thus conclude that the more potent  bbbbb1 CHEMICALIN eeeee1  inhibition of smooth muscle versus  bbbbb2 GENEIN eeeee2  is not attributable to differences in channel inactivation or activation
CPR:4	 bbbbb1 CHEMICALIN eeeee1  (a CHEMICALIN antagonist) blocks the  bbbbb2 GENEIN eeeee2  more potently than the cardiac one, a phenomenon observed not only in native channels but also in expressed channels
CPR:4	CHEMICALIN (a  bbbbb1 CHEMICALIN eeeee1  antagonist) blocks the  bbbbb2 GENEIN eeeee2  more potently than the cardiac one, a phenomenon observed not only in native channels but also in expressed channels
CPR:4	CHEMICALIN ( bbbbb1 CHEMICALIN eeeee1 ) block  bbbbb2 GENEIN eeeee2  more potently at depolarized membrane potentials, consistent with high affinity binding to the inactivated state
CPR:9	 bbbbb1 GENEIN eeeee1  deficiency impairs  bbbbb2 CHEMICALIN eeeee2  synthesis, defects in cytosolic reduction of CHEMICALNOTIN (CblC/D) impair the synthesis of both CHEMICALNOTIN- and CHEMICALNOTIN and deficiencies of GENEIN (CblE/G) are associated with defective CHEMICALIN synthesis
CPR:9	GENEIN deficiency impairs CHEMICALIN synthesis, defects in cytosolic reduction of CHEMICALNOTIN (CblC/D) impair the synthesis of both CHEMICALNOTIN- and CHEMICALNOTIN and deficiencies of  bbbbb1 GENEIN eeeee1  (CblE/G) are associated with defective  bbbbb2 CHEMICALIN eeeee2  synthesis
CPR:9	These results suggest that  bbbbb1 GENEIN eeeee1  compensates for the loss of functional GENENOTIN in cells derived from GENENOTIN knockout mice and mediates the majority of high affinity  bbbbb2 CHEMICALIN eeeee2  transport.
CPR:9	The majority of  bbbbb1 CHEMICALIN eeeee1  transport is mediated by  bbbbb2 GENEIN eeeee2 , although several other carriers have been kinetically defined
CPR:9	 bbbbb1 GENEIN eeeee1  cationic  bbbbb2 CHEMICALIN eeeee2  transport is mediated by proteins encoded by a family of genes, GENEIN, GENEIN, and GENEIN
CPR:9	GENEIN cationic  bbbbb1 CHEMICALIN eeeee1  transport is mediated by proteins encoded by a family of genes,  bbbbb2 GENEIN eeeee2 , GENEIN, and GENEIN
CPR:9	GENEIN cationic  bbbbb1 CHEMICALIN eeeee1  transport is mediated by proteins encoded by a family of genes, GENEIN,  bbbbb2 GENEIN eeeee2 , and GENEIN
CPR:9	GENEIN cationic  bbbbb1 CHEMICALIN eeeee1  transport is mediated by proteins encoded by a family of genes, GENEIN, GENEIN, and  bbbbb2 GENEIN eeeee2 
CPR:9	However, the apparent affinity for  bbbbb1 CHEMICALIN eeeee1  transport was 2.4 times lower in GENENOTIN(-/-) cells when compared with wild type cells, a property characteristic of  bbbbb2 GENEIN eeeee2 -mediated transport
CPR:9	Increased  bbbbb1 GENEIN eeeee1 -mediated cationic  bbbbb2 CHEMICALIN eeeee2  transport functionally compensates in GENENOTIN knockout cell lines
CPR:3	 bbbbb1 CHEMICALIN eeeee1  markedly increased postprandial plasma  bbbbb2 GENEIN eeeee2  release (P<0.001) while distinctly reducing postprandial GENEIN levels (P<0.01) as compared to placebo
CPR:4	 bbbbb1 CHEMICALIN eeeee1  markedly increased postprandial plasma GENEIN release (P<0.001) while distinctly reducing postprandial  bbbbb2 GENEIN eeeee2  levels (P<0.01) as compared to placebo
CPR:6	The study demonstrates for the first time the marked gastrokinetic properties of the new  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2  in humans.
CPR:6	We studied the role of endogenous GENENOTIN in the emptying of a solid/liquid meal administering the new, highly specific and potent  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2 
CPR:6	Effect of  bbbbb1 CHEMICALIN eeeee1 , a new  bbbbb2 GENEIN eeeee2  antagonist, on gastric emptying of a solid-liquid meal in humans
CPR:2	In addition, the GENEIN-mediated inhibition of  bbbbb1 GENEIN eeeee1 , GENEIN, and GENEIN mRNA accumulation and GENEIN protein secretion were related to the accumulation of intracellular  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) levels
CPR:2	In addition, the GENEIN-mediated inhibition of GENEIN,  bbbbb1 GENEIN eeeee1 , and GENEIN mRNA accumulation and GENEIN protein secretion were related to the accumulation of intracellular  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) levels
CPR:2	In addition, the GENEIN-mediated inhibition of GENEIN, GENEIN, and  bbbbb1 GENEIN eeeee1  mRNA accumulation and GENEIN protein secretion were related to the accumulation of intracellular  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) levels
CPR:2	In addition, the GENEIN-mediated inhibition of GENEIN, GENEIN, and GENEIN mRNA accumulation and  bbbbb1 GENEIN eeeee1  protein secretion were related to the accumulation of intracellular  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) levels
CPR:2	In addition, the GENEIN-mediated inhibition of  bbbbb1 GENEIN eeeee1 , GENEIN, and GENEIN mRNA accumulation and GENEIN protein secretion were related to the accumulation of intracellular CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) levels
CPR:2	In addition, the GENEIN-mediated inhibition of GENEIN,  bbbbb1 GENEIN eeeee1 , and GENEIN mRNA accumulation and GENEIN protein secretion were related to the accumulation of intracellular CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) levels
CPR:2	In addition, the GENEIN-mediated inhibition of GENEIN, GENEIN, and  bbbbb1 GENEIN eeeee1  mRNA accumulation and GENEIN protein secretion were related to the accumulation of intracellular CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) levels
CPR:2	In addition, the GENEIN-mediated inhibition of GENEIN, GENEIN, and GENEIN mRNA accumulation and  bbbbb1 GENEIN eeeee1  protein secretion were related to the accumulation of intracellular CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) levels
CPR:2	In addition, the  bbbbb1 GENEIN eeeee1 -mediated inhibition of GENEIN, GENEIN, and GENEIN mRNA accumulation and GENEIN protein secretion were related to the accumulation of intracellular  bbbbb2 CHEMICALIN eeeee2  (CHEMICALIN) levels
CPR:2	In addition, the  bbbbb1 GENEIN eeeee1 -mediated inhibition of GENEIN, GENEIN, and GENEIN mRNA accumulation and GENEIN protein secretion were related to the accumulation of intracellular CHEMICALIN ( bbbbb2 CHEMICALIN eeeee2 ) levels
CPR:2	 bbbbb1 GENEIN eeeee1  (GENEIN)-induced GENEIN, GENEIN, and GENEIN mRNAs are dose-dependently inhibited by the nonselective GENEIN agonist  bbbbb2 CHEMICALIN eeeee2  and by the selective GENEIN agonist CHEMICALIN
CPR:2	GENEIN ( bbbbb1 GENEIN eeeee1 )-induced GENEIN, GENEIN, and GENEIN mRNAs are dose-dependently inhibited by the nonselective GENEIN agonist  bbbbb2 CHEMICALIN eeeee2  and by the selective GENEIN agonist CHEMICALIN
CPR:2	 bbbbb1 GENEIN eeeee1  (GENEIN)-induced GENEIN, GENEIN, and GENEIN mRNAs are dose-dependently inhibited by the nonselective GENEIN agonist CHEMICALIN and by the selective GENEIN agonist  bbbbb2 CHEMICALIN eeeee2 
CPR:2	GENEIN ( bbbbb1 GENEIN eeeee1 )-induced GENEIN, GENEIN, and GENEIN mRNAs are dose-dependently inhibited by the nonselective GENEIN agonist CHEMICALIN and by the selective GENEIN agonist  bbbbb2 CHEMICALIN eeeee2 
CPR:3	The observed inhibition on  bbbbb1 GENEIN eeeee1 , GENEIN, and GENEIN mRNA was blocked by the selective GENEIN antagonist  bbbbb2 CHEMICALIN eeeee2  (10(-6) M) and by CHEMICALIN (10(-6) M), a nonselective antagonist
CPR:3	The observed inhibition on GENEIN,  bbbbb1 GENEIN eeeee1 , and GENEIN mRNA was blocked by the selective GENEIN antagonist  bbbbb2 CHEMICALIN eeeee2  (10(-6) M) and by CHEMICALIN (10(-6) M), a nonselective antagonist
CPR:3	The observed inhibition on GENEIN, GENEIN, and  bbbbb1 GENEIN eeeee1  mRNA was blocked by the selective GENEIN antagonist  bbbbb2 CHEMICALIN eeeee2  (10(-6) M) and by CHEMICALIN (10(-6) M), a nonselective antagonist
CPR:3	The observed inhibition on  bbbbb1 GENEIN eeeee1 , GENEIN, and GENEIN mRNA was blocked by the selective GENEIN antagonist CHEMICALIN (10(-6) M) and by  bbbbb2 CHEMICALIN eeeee2  (10(-6) M), a nonselective antagonist
CPR:3	The observed inhibition on GENEIN,  bbbbb1 GENEIN eeeee1 , and GENEIN mRNA was blocked by the selective GENEIN antagonist CHEMICALIN (10(-6) M) and by  bbbbb2 CHEMICALIN eeeee2  (10(-6) M), a nonselective antagonist
CPR:3	The observed inhibition on GENEIN, GENEIN, and  bbbbb1 GENEIN eeeee1  mRNA was blocked by the selective GENEIN antagonist CHEMICALIN (10(-6) M) and by  bbbbb2 CHEMICALIN eeeee2  (10(-6) M), a nonselective antagonist
CPR:3	Secretion of  bbbbb1 GENEIN eeeee1  protein in the presence of increasing concentrations of  bbbbb2 CHEMICALIN eeeee2  followed a similar pattern as observed for GENEIN mRNA
CPR:3	Secretion of GENEIN protein in the presence of increasing concentrations of  bbbbb1 CHEMICALIN eeeee1  followed a similar pattern as observed for  bbbbb2 GENEIN eeeee2  mRNA
CPR:4	GENEIN (GENEIN)-induced  bbbbb1 GENEIN eeeee1 , GENEIN, and GENEIN mRNAs are dose-dependently inhibited by the nonselective GENEIN agonist  bbbbb2 CHEMICALIN eeeee2  and by the selective GENEIN agonist CHEMICALIN
CPR:4	GENEIN (GENEIN)-induced GENEIN,  bbbbb1 GENEIN eeeee1 , and GENEIN mRNAs are dose-dependently inhibited by the nonselective GENEIN agonist  bbbbb2 CHEMICALIN eeeee2  and by the selective GENEIN agonist CHEMICALIN
CPR:4	GENEIN (GENEIN)-induced GENEIN, GENEIN, and  bbbbb1 GENEIN eeeee1  mRNAs are dose-dependently inhibited by the nonselective GENEIN agonist  bbbbb2 CHEMICALIN eeeee2  and by the selective GENEIN agonist CHEMICALIN
CPR:4	GENEIN (GENEIN)-induced  bbbbb1 GENEIN eeeee1 , GENEIN, and GENEIN mRNAs are dose-dependently inhibited by the nonselective GENEIN agonist CHEMICALIN and by the selective GENEIN agonist  bbbbb2 CHEMICALIN eeeee2 
CPR:4	GENEIN (GENEIN)-induced GENEIN,  bbbbb1 GENEIN eeeee1 , and GENEIN mRNAs are dose-dependently inhibited by the nonselective GENEIN agonist CHEMICALIN and by the selective GENEIN agonist  bbbbb2 CHEMICALIN eeeee2 
CPR:4	GENEIN (GENEIN)-induced GENEIN, GENEIN, and  bbbbb1 GENEIN eeeee1  mRNAs are dose-dependently inhibited by the nonselective GENEIN agonist CHEMICALIN and by the selective GENEIN agonist  bbbbb2 CHEMICALIN eeeee2 
CPR:5	Although GENENOTIN mRNA was detectable in GENENOTIN-activated T lymphocytes, we could not demonstrate a functional activity in the regulation of GENENOTIN expression: the  bbbbb1 GENEIN eeeee1  agonist  bbbbb2 CHEMICALIN eeeee2  had no effect on the accumulation of the studied GENENOTIN mRNAs, and did not significantly affect cellular CHEMICALNOTIN levels
CPR:5	GENEIN (GENEIN)-induced GENEIN, GENEIN, and GENEIN mRNAs are dose-dependently inhibited by the nonselective  bbbbb1 GENEIN eeeee1  agonist  bbbbb2 CHEMICALIN eeeee2  and by the selective GENEIN agonist CHEMICALIN
CPR:5	GENEIN (GENEIN)-induced GENEIN, GENEIN, and GENEIN mRNAs are dose-dependently inhibited by the nonselective GENEIN agonist CHEMICALIN and by the selective  bbbbb1 GENEIN eeeee1  agonist  bbbbb2 CHEMICALIN eeeee2 
CPR:6	The observed inhibition on GENEIN, GENEIN, and GENEIN mRNA was blocked by the selective  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2  (10(-6) M) and by CHEMICALIN (10(-6) M), a nonselective antagonist
CPR:6	The observed inhibition on GENEIN, GENEIN, and GENEIN mRNA was blocked by the selective  bbbbb1 GENEIN eeeee1  antagonist CHEMICALIN (10(-6) M) and by  bbbbb2 CHEMICALIN eeeee2  (10(-6) M), a nonselective antagonist
CPR:6	The selective  bbbbb1 GENEIN eeeee1  antagonist  bbbbb2 CHEMICALIN eeeee2  (0.3 x 10(-6) M) did not have any effect
CPR:2	Only  bbbbb1 CHEMICALIN eeeee1  bound to the renal  bbbbb2 GENEIN eeeee2  though the binding affinity was very low (61.3 +/- 14.6 nM).
CPR:2	Both  bbbbb1 CHEMICALIN eeeee1 , CHEMICALIN metabolite I and CHEMICALIN metabolite II displayed binding affinities to the myometrial  bbbbb2 GENEIN eeeee2  of a similar magnitude as CHEMICALIN
CPR:2	Both CHEMICALIN,  bbbbb1 CHEMICALIN eeeee1  metabolite I and CHEMICALIN metabolite II displayed binding affinities to the myometrial  bbbbb2 GENEIN eeeee2  of a similar magnitude as CHEMICALIN
CPR:2	Both CHEMICALIN, CHEMICALIN metabolite I and  bbbbb1 CHEMICALIN eeeee1  metabolite II displayed binding affinities to the myometrial  bbbbb2 GENEIN eeeee2  of a similar magnitude as CHEMICALIN
CPR:2	Both CHEMICALIN, CHEMICALIN metabolite I and CHEMICALIN metabolite II displayed binding affinities to the myometrial  bbbbb1 GENEIN eeeee1  of a similar magnitude as  bbbbb2 CHEMICALIN eeeee2 
CPR:2	 bbbbb1 GENEIN eeeee1  binding and uterotonic activity of  bbbbb2 CHEMICALIN eeeee2  and its metabolites following enzymatic degradation
CPR:4	All three compounds displayed antagonistic properties against  bbbbb1 GENEIN eeeee1  in vitro, with  bbbbb2 CHEMICALIN eeeee2  being the strongest inhibitor (pA2 = 8.21) and CHEMICALIN metabolite II (pA2 = 8.01) being stronger than CHEMICALIN metabolite I (pA2 = 7.81)
CPR:4	All three compounds displayed antagonistic properties against  bbbbb1 GENEIN eeeee1  in vitro, with CHEMICALIN being the strongest inhibitor (pA2 = 8.21) and  bbbbb2 CHEMICALIN eeeee2  metabolite II (pA2 = 8.01) being stronger than CHEMICALIN metabolite I (pA2 = 7.81)
CPR:4	All three compounds displayed antagonistic properties against  bbbbb1 GENEIN eeeee1  in vitro, with CHEMICALIN being the strongest inhibitor (pA2 = 8.21) and CHEMICALIN metabolite II (pA2 = 8.01) being stronger than  bbbbb2 CHEMICALIN eeeee2  metabolite I (pA2 = 7.81)
CPR:5	These results indicate that  bbbbb1 CHEMICALIN eeeee1  is a partial agonist/antagonist to the  bbbbb2 GENEIN eeeee2  while the two metabolites CHEMICALIN metabolite I and CHEMICALIN metabolite II are pure antagonists
CPR:6	These results indicate that  bbbbb1 CHEMICALIN eeeee1  is a partial agonist/antagonist to the  bbbbb2 GENEIN eeeee2  while the two metabolites CHEMICALIN metabolite I and CHEMICALIN metabolite II are pure antagonists
CPR:6	These results indicate that CHEMICALIN is a partial agonist/antagonist to the  bbbbb1 GENEIN eeeee1  while the two metabolites  bbbbb2 CHEMICALIN eeeee2  metabolite I and CHEMICALIN metabolite II are pure antagonists
CPR:6	These results indicate that CHEMICALIN is a partial agonist/antagonist to the  bbbbb1 GENEIN eeeee1  while the two metabolites CHEMICALIN metabolite I and  bbbbb2 CHEMICALIN eeeee2  metabolite II are pure antagonists
CPR:2	Crystallographic comparison with the structurally related  bbbbb1 GENEIN eeeee1  binary complex with the oxidized cofactor  bbbbb2 CHEMICALIN eeeee2  revealed overlapping binding sites for the CHEMICALIN and the cofactor, compatible with a competitive type of inhibition of the CHEMICALIN versus BH4
CPR:2	Crystallographic comparison with the structurally related  bbbbb1 GENEIN eeeee1  binary complex with the oxidized cofactor CHEMICALIN revealed overlapping binding sites for the  bbbbb2 CHEMICALIN eeeee2  and the cofactor, compatible with a competitive type of inhibition of the CHEMICALIN versus BH4
CPR:4	Crystallographic analysis of the  bbbbb1 GENEIN eeeee1  with bound  bbbbb2 CHEMICALIN eeeee2  inhibitors at 2.0 A resolution
CPR:4	The  bbbbb1 GENEIN eeeee1  represent a superfamily of structurally and functionally closely related enzymes, one of those functions being reversible inhibition by  bbbbb2 CHEMICALIN eeeee2  derivatives
CPR:4	Crystallographic comparison with the structurally related  bbbbb1 GENEIN eeeee1  binary complex with the oxidized cofactor CHEMICALIN revealed overlapping binding sites for the CHEMICALIN and the cofactor, compatible with a competitive type of inhibition of the  bbbbb2 CHEMICALIN eeeee2  versus BH4
CPR:4	Here we present the crystal structure of the dimeric catalytic domain (residues 117-424) of  bbbbb1 GENEIN eeeee1  (GENEIN), cocrystallized with various potent and well-known  bbbbb2 CHEMICALIN eeeee2  inhibitors and refined at a resolution of 2.0 A
CPR:4	Here we present the crystal structure of the dimeric catalytic domain (residues 117-424) of GENEIN ( bbbbb1 GENEIN eeeee1 ), cocrystallized with various potent and well-known  bbbbb2 CHEMICALIN eeeee2  inhibitors and refined at a resolution of 2.0 A
CPR:8	Crystallographic comparison with the structurally related  bbbbb1 GENEIN eeeee1  binary complex with the oxidized cofactor  bbbbb2 CHEMICALIN eeeee2  revealed overlapping binding sites for the CHEMICALIN and the cofactor, compatible with a competitive type of inhibition of the CHEMICALIN versus BH4
CPR:2	All GCs including the antagonistic compound  bbbbb1 CHEMICALIN eeeee1  efficiently reduced GENEIN-mediated transactivation to comparable extents, suggesting that ligand-induced nuclear localization of the  bbbbb2 GENEIN eeeee2  is sufficient for transrepression
CPR:4	All GCs including the antagonistic compound  bbbbb1 CHEMICALIN eeeee1  efficiently reduced  bbbbb2 GENEIN eeeee2 -mediated transactivation to comparable extents, suggesting that ligand-induced nuclear localization of the GENEIN is sufficient for transrepression
CPR:10	Here, we report that CHEMICALIN and CHEMICALIN, but not the  bbbbb1 CHEMICALIN eeeee1  salt of CHEMICALIN, stabilize the binding of prebound CHEMICALIN to  bbbbb2 GENEIN eeeee2 
CPR:10	Here, we report that CHEMICALIN and CHEMICALIN, but not the CHEMICALIN salt of  bbbbb1 CHEMICALIN eeeee1 , stabilize the binding of prebound CHEMICALIN to  bbbbb2 GENEIN eeeee2 
CPR:10	Mutation in the  bbbbb1 GENEIN eeeee1  of GENEIN of GENEIN abolished this stabilizing effect of  bbbbb2 CHEMICALIN eeeee2 
CPR:10	Mutation in the GENEIN of  bbbbb1 GENEIN eeeee1  of GENEIN abolished this stabilizing effect of  bbbbb2 CHEMICALIN eeeee2 
CPR:10	Mutation in the GENEIN of GENEIN of  bbbbb1 GENEIN eeeee1  abolished this stabilizing effect of  bbbbb2 CHEMICALIN eeeee2 
CPR:2	The GENENOTIN is a heterooligomeric complex of GENENOTIN subunits of the  bbbbb1 CHEMICALIN eeeee1 -binding-cassette superfamily with two  bbbbb2 GENEIN eeeee2  (GENEIN and GENEIN) and the pore-forming GENENOTIN subunits
CPR:2	The GENENOTIN is a heterooligomeric complex of GENENOTIN subunits of the  bbbbb1 CHEMICALIN eeeee1 -binding-cassette superfamily with two GENEIN ( bbbbb2 GENEIN eeeee2  and GENEIN) and the pore-forming GENENOTIN subunits
CPR:2	The GENENOTIN is a heterooligomeric complex of GENENOTIN subunits of the  bbbbb1 CHEMICALIN eeeee1 -binding-cassette superfamily with two GENEIN (GENEIN and  bbbbb2 GENEIN eeeee2 ) and the pore-forming GENENOTIN subunits
CPR:2	Here, we report that CHEMICALIN and CHEMICALIN, but not the CHEMICALIN salt of CHEMICALIN, stabilize the binding of prebound  bbbbb1 CHEMICALIN eeeee1  to  bbbbb2 GENEIN eeeee2 
CPR:2	These results suggest that  bbbbb1 GENEIN eeeee1  binds  bbbbb2 CHEMICALIN eeeee2  strongly at GENEIN and that CHEMICALIN, either by direct binding to GENEIN or by hydrolysis of bound CHEMICALIN at GENEIN, stabilizes prebound CHEMICALIN binding at GENEIN
CPR:2	These results suggest that GENEIN binds  bbbbb1 CHEMICALIN eeeee1  strongly at  bbbbb2 GENEIN eeeee2  and that CHEMICALIN, either by direct binding to GENEIN or by hydrolysis of bound CHEMICALIN at GENEIN, stabilizes prebound CHEMICALIN binding at GENEIN
CPR:2	These results suggest that GENEIN binds CHEMICALIN strongly at GENEIN and that  bbbbb1 CHEMICALIN eeeee1 , either by direct binding to  bbbbb2 GENEIN eeeee2  or by hydrolysis of bound CHEMICALIN at GENEIN, stabilizes prebound CHEMICALIN binding at GENEIN
CPR:2	These results suggest that GENEIN binds CHEMICALIN strongly at GENEIN and that CHEMICALIN, either by direct binding to GENEIN or by hydrolysis of bound CHEMICALIN at GENEIN, stabilizes prebound  bbbbb1 CHEMICALIN eeeee1  binding at  bbbbb2 GENEIN eeeee2 
CPR:2	The  bbbbb1 CHEMICALIN eeeee1  caused release of prebound CHEMICALIN from  bbbbb2 GENEIN eeeee2  in the presence of CHEMICALIN or CHEMICALIN in a concentration-dependent manner
CPR:2	Cooperative binding of  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN in the  bbbbb2 GENEIN eeeee2  is modulated by CHEMICALIN
CPR:2	Cooperative binding of CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  in the  bbbbb2 GENEIN eeeee2  is modulated by CHEMICALIN
CPR:2	The CHEMICALIN caused release of prebound  bbbbb1 CHEMICALIN eeeee1  from  bbbbb2 GENEIN eeeee2  in the presence of CHEMICALIN or CHEMICALIN in a concentration-dependent manner
CPR:2	This direct biochemical evidence of cooperative interaction in  bbbbb1 CHEMICALIN eeeee1  binding of the two  bbbbb2 GENEIN eeeee2  of GENEIN suggests that CHEMICALIN both blocks this cooperative binding of CHEMICALIN and CHEMICALIN and, in cooperation with the CHEMICALIN bound at GENEIN, causes CHEMICALNOTIN to be released from GENEIN.
CPR:2	This direct biochemical evidence of cooperative interaction in  bbbbb1 CHEMICALIN eeeee1  binding of the two GENEIN of  bbbbb2 GENEIN eeeee2  suggests that CHEMICALIN both blocks this cooperative binding of CHEMICALIN and CHEMICALIN and, in cooperation with the CHEMICALIN bound at GENEIN, causes CHEMICALNOTIN to be released from GENEIN.
CPR:2	This direct biochemical evidence of cooperative interaction in CHEMICALIN binding of the two GENEIN of GENEIN suggests that  bbbbb1 CHEMICALIN eeeee1  both blocks this cooperative binding of CHEMICALIN and CHEMICALIN and, in cooperation with the CHEMICALIN bound at  bbbbb2 GENEIN eeeee2 , causes CHEMICALNOTIN to be released from GENEIN.
CPR:2	This direct biochemical evidence of cooperative interaction in CHEMICALIN binding of the two GENEIN of GENEIN suggests that  bbbbb1 CHEMICALIN eeeee1  both blocks this cooperative binding of CHEMICALIN and CHEMICALIN and, in cooperation with the CHEMICALIN bound at GENEIN, causes CHEMICALNOTIN to be released from  bbbbb2 GENEIN eeeee2 .
CPR:2	This direct biochemical evidence of cooperative interaction in CHEMICALIN binding of the two GENEIN of GENEIN suggests that CHEMICALIN both blocks this cooperative binding of  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN and, in cooperation with the CHEMICALIN bound at  bbbbb2 GENEIN eeeee2 , causes CHEMICALNOTIN to be released from GENEIN.
CPR:2	This direct biochemical evidence of cooperative interaction in CHEMICALIN binding of the two GENEIN of GENEIN suggests that CHEMICALIN both blocks this cooperative binding of CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1  and, in cooperation with the CHEMICALIN bound at  bbbbb2 GENEIN eeeee2 , causes CHEMICALNOTIN to be released from GENEIN.
CPR:2	This direct biochemical evidence of cooperative interaction in CHEMICALIN binding of the two GENEIN of GENEIN suggests that CHEMICALIN both blocks this cooperative binding of CHEMICALIN and CHEMICALIN and, in cooperation with the  bbbbb1 CHEMICALIN eeeee1  bound at  bbbbb2 GENEIN eeeee2 , causes CHEMICALNOTIN to be released from GENEIN.
CPR:2	Although electrophysiological studies provide clues to the complex control of  bbbbb1 GENEIN eeeee1  by  bbbbb2 CHEMICALIN eeeee2 , CHEMICALIN, and pharmacological agents, the molecular mechanism of GENENOTIN regulation remains unclear
CPR:2	Although electrophysiological studies provide clues to the complex control of  bbbbb1 GENEIN eeeee1  by CHEMICALIN,  bbbbb2 CHEMICALIN eeeee2 , and pharmacological agents, the molecular mechanism of GENENOTIN regulation remains unclear
CPR:2	Here, we report that  bbbbb1 CHEMICALIN eeeee1  and CHEMICALIN, but not the CHEMICALIN salt of CHEMICALIN, stabilize the binding of prebound CHEMICALIN to  bbbbb2 GENEIN eeeee2 
CPR:2	Here, we report that CHEMICALIN and  bbbbb1 CHEMICALIN eeeee1 , but not the CHEMICALIN salt of CHEMICALIN, stabilize the binding of prebound CHEMICALIN to  bbbbb2 GENEIN eeeee2 
CPR:2	These results suggest that GENEIN binds CHEMICALIN strongly at GENEIN and that CHEMICALIN, either by direct binding to GENEIN or by hydrolysis of bound  bbbbb1 CHEMICALIN eeeee1  at GENEIN, stabilizes prebound CHEMICALIN binding at  bbbbb2 GENEIN eeeee2 
CPR:2	Cooperative binding of CHEMICALIN and CHEMICALIN in the  bbbbb1 GENEIN eeeee1  is modulated by  bbbbb2 CHEMICALIN eeeee2 
CPR:2	The CHEMICALIN caused release of prebound CHEMICALIN from  bbbbb1 GENEIN eeeee1  in the presence of  bbbbb2 CHEMICALIN eeeee2  or CHEMICALIN in a concentration-dependent manner
CPR:2	The CHEMICALIN caused release of prebound CHEMICALIN from  bbbbb1 GENEIN eeeee1  in the presence of CHEMICALIN or  bbbbb2 CHEMICALIN eeeee2  in a concentration-dependent manner
CPR:3	The GENENOTIN in pancreatic beta cells are critical in the regulation of  bbbbb1 CHEMICALIN eeeee1 -induced  bbbbb2 GENEIN eeeee2  secretion
CPR:9	These results suggest that GENEIN binds CHEMICALIN strongly at GENEIN and that CHEMICALIN, either by direct binding to GENEIN or by hydrolysis of bound  bbbbb1 CHEMICALIN eeeee1  at  bbbbb2 GENEIN eeeee2 , stabilizes prebound CHEMICALIN binding at GENEIN